data_2rqv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rqv _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 230' ' ' ASP . 6.0 tp . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 109.301 -0.629 . . . . 74.05 109.301 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.581 ' CD1' ' N ' ' A' ' 159' ' ' TYR . 0.6 OUTLIER -147.8 160.57 42.6 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.521 1.138 . . . . 74.33 111.023 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -132.14 175.59 9.12 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 74.34 109.345 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.496 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -137.41 129.72 42.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.473 1.108 . . . . 62.42 109.334 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.5 ' CG2' ' CD2' ' A' ' 182' ' ' LEU . 4.1 t -80.86 121.07 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.474 1.109 . . . . 72.14 109.329 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.412 HD13 ' CB ' ' A' ' 213' ' ' SER . 0.7 OUTLIER -100.33 -6.36 25.97 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.534 1.146 . . . . 75.51 109.28 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.482 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 88.9 m-85 -148.58 151.65 35.42 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.115 . . . . 73.22 111.033 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -78.84 112.16 15.72 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.533 1.145 . . . . 74.05 109.328 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.556 ' CZ ' ' HD3' ' A' ' 208' ' ' PRO . 11.6 t80 -83.27 152.67 25.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.532 1.145 . . . . 72.45 111.032 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -125.75 116.35 21.48 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.483 1.114 . . . . 75.22 109.292 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.15 121.42 12.47 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.556 1.16 . . . . 73.43 109.256 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 170' ' ' LYS . 9.9 pt-20 -110.63 -46.15 3.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.509 1.131 . . . . 74.13 110.309 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -63.42 179.51 0.44 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.534 1.146 . . . . 74.43 109.31 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.11 -15.18 41.96 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.551 1.157 . . . . 75.24 109.317 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.82 10.19 10.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.471 1.107 . . . . 73.4 109.378 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -77.63 151.34 34.39 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.508 1.13 . . . . 75.22 110.348 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 14.4 mt -120.75 145.74 47.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.449 1.093 . . . . 74.34 109.247 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.2 m -88.03 154.33 20.57 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.47 1.107 . . . . 74.13 110.396 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.428 ' CG2' HG23 ' A' ' 162' ' ' VAL . 5.8 m -135.92 -174.57 3.7 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.555 1.159 . . . . 73.41 110.372 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -134.13 138.43 45.22 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.461 1.101 . . . . 75.21 111.01 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.5 p -55.25 158.32 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.438 1.086 . . . . 74.32 109.228 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 38.94 57.63 1.99 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.508 1.13 . . . . 42.22 111.01 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 15.0 tp10 -121.83 166.34 14.52 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.423 0.719 . . . . 61.55 110.287 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.534 ' N ' HD21 ' A' ' 181' ' ' ASN . 1.5 m-80 -118.58 130.22 55.77 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.438 1.086 . . . . 74.2 109.268 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.5 ' CD2' ' CG2' ' A' ' 162' ' ' VAL . 1.8 pp -157.0 -179.73 8.49 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 75.24 109.297 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -131.45 142.28 49.97 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.428 1.08 . . . . 74.52 111.024 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 23.3 mm -78.53 141.44 15.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.452 1.095 . . . . 75.34 109.337 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 3.4 t -103.49 -24.71 13.42 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.504 1.128 . . . . 64.51 108.294 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.412 ' N ' ' HB ' ' A' ' 194' ' ' ILE . . . -170.11 179.53 3.5 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.505 1.128 . . . . 72.32 109.33 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.567 ' CD2' HG23 ' A' ' 231' ' ' ILE . 7.7 p80 -145.53 142.24 29.01 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 74.42 109.581 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.637 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.6 t-160 -123.72 120.66 33.34 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.475 1.109 . . . . 64.44 109.599 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.453 ' C ' ' N ' ' A' ' 191' ' ' GLU . 14.8 m-20 54.14 30.1 11.55 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.119 . . . . 75.54 109.256 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 11.9 p 43.51 28.29 0.19 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.502 1.126 . . . . 75.3 108.29 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.453 ' N ' ' C ' ' A' ' 189' ' ' ASN . 8.7 pt-20 -123.88 -36.76 2.68 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.491 1.119 . . . . 72.12 110.28 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.492 ' CE3' ' HB3' ' A' ' 206' ' ' LEU . 9.0 m0 -110.55 158.52 18.45 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.443 1.089 . . . . 75.55 108.1 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.501 ' CD2' HG21 ' A' ' 212' ' ' VAL . 8.5 m-85 -131.12 148.49 52.73 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.502 1.126 . . . . 73.52 110.983 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.514 ' CD1' ' CD2' ' A' ' 206' ' ' LEU . 12.7 mm -96.34 88.89 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.495 1.122 . . . . 75.21 109.291 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.458 ' CB ' HG12 ' A' ' 207' ' ' VAL . . . -71.04 164.1 26.23 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.506 1.129 . . . . 71.21 109.315 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.586 1.179 . . . . 75.21 109.311 179.92 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.033 0 N-CA-C 110.949 -0.86 . . . . 74.04 110.949 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -178.65 24.09 Favored 'Cis proline' 0 C--N 1.361 1.201 0 C-N-CA 121.013 -2.495 . . . . 75.53 110.941 0.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -149.13 166.13 29.42 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 124.499 1.124 . . . . 62.34 110.977 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.514 ' CD2' ' CD1' ' A' ' 194' ' ' ILE . 6.6 mt -93.51 134.34 35.89 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.61 0.829 . . . . 75.05 109.253 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.458 HG12 ' CB ' ' A' ' 195' ' ' ALA . 1.8 m -139.1 153.9 71.86 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.537 1.148 . . . . 74.43 109.284 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.556 ' HD3' ' CZ ' ' A' ' 166' ' ' PHE . 18.2 Cg_endo -74.98 155.33 43.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.526 1.803 . . . . 72.1 110.974 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 3.6 p -81.39 -33.66 12.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.409 1.068 . . . . 71.33 109.263 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -64.77 -11.03 48.26 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.5 1.125 . . . . 61.24 110.949 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.471 ' O ' ' CG1' ' A' ' 212' ' ' VAL . 8.2 m-30 -109.89 19.74 18.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.493 0.76 . . . . 75.43 110.974 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.501 HG21 ' CD2' ' A' ' 193' ' ' PHE . 26.9 m -156.16 141.95 10.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.442 1.089 . . . . 73.43 109.275 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' SER . . . . . 0.412 ' CB ' HD13 ' A' ' 163' ' ' LEU . 1.0 OUTLIER -131.06 148.86 52.79 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.475 1.109 . . . . 73.11 110.017 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.461 HG13 ' CG2' ' A' ' 227' ' ' VAL . 12.1 mm -103.95 128.25 57.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.527 1.142 . . . . 75.43 109.346 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.429 ' O ' ' CE2' ' A' ' 159' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.11 . . . . 65.45 109.277 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 17.9 p . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 110.382 -0.229 . . . . 73.24 110.382 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 116.23 4.93 17.69 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 124.481 1.113 . . . . 65.34 110.928 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.639 ' N ' HD21 ' A' ' 225' ' ' ASN . 0.9 OUTLIER -78.19 -176.32 4.56 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.432 0.724 . . . . 72.22 109.292 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.1 169.88 14.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.554 1.159 . . . . 73.11 109.273 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.461 ' CG2' HG13 ' A' ' 214' ' ' ILE . 12.1 p -80.77 -35.28 14.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.474 1.109 . . . . 73.03 109.254 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.4 mp -54.16 -50.37 55.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.517 1.136 . . . . 71.15 109.301 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -59.55 -35.61 74.55 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 74.22 110.295 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.455 ' HB3' ' CD1' ' A' ' 158' ' ' LEU . 5.0 m-20 -78.1 -22.93 48.21 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.468 1.105 . . . . 75.02 109.299 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.567 HG23 ' CD2' ' A' ' 187' ' ' HIS . 35.5 mt -70.61 -36.8 67.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.585 1.178 . . . . 65.33 109.266 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -80.72 -13.98 58.52 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.572 1.17 . . . . 74.25 109.309 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.7 t -81.18 -44.39 17.91 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.526 1.141 . . . . 72.02 109.998 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.435 ' C ' ' N ' ' A' ' 236' ' ' LEU . 7.7 p -99.17 24.25 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.494 1.121 . . . . 70.25 109.343 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 41.36 29.13 0.08 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.534 1.146 . . . . 75.31 109.338 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.435 ' N ' ' C ' ' A' ' 234' ' ' VAL . 1.1 tp -45.21 103.75 0.36 Allowed Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.106 . . . . 73.45 109.286 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 138.19 22.64 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.561 1.822 . . . . 62.25 111.049 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 7.4 p -57.01 148.88 20.27 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 72.41 110.411 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.637 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 3.5 p -53.99 -25.43 12.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.535 1.147 . . . . 75.42 109.323 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.547 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 3.8 mm100 -77.82 -34.36 51.99 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.407 1.067 . . . . 73.04 110.319 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -82.74 -20.87 35.11 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.553 1.158 . . . . 75.34 110.303 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -80.09 -53.25 6.88 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.516 1.135 . . . . 73.44 108.022 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -51.61 -28.17 13.42 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.527 1.142 . . . . 65.34 109.272 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.7 t -73.64 -35.2 65.26 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.451 1.094 . . . . 73.31 109.999 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.497 1.123 . . . . 74.22 109.281 -179.989 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.45 ' CD1' HG13 ' A' ' 234' ' ' VAL . 6.5 mt . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 109.301 -0.629 . . . . 73.12 109.301 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.43 ' CG ' ' C ' ' A' ' 158' ' ' LEU . 35.9 m-85 -154.65 116.73 4.22 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.466 1.104 . . . . 75.04 111.053 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -126.19 168.05 14.59 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.564 1.165 . . . . 75.24 109.382 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.494 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -133.76 130.14 55.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.557 1.16 . . . . 74.01 109.385 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.457 HG23 ' CD1' ' A' ' 182' ' ' LEU . 39.7 t -89.66 111.22 22.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 73.44 109.304 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.406 ' N ' HD21 ' A' ' 163' ' ' LEU . 0.2 OUTLIER -101.97 14.09 32.94 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.551 1.157 . . . . 72.3 109.287 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.569 ' HB3' ' CD2' ' A' ' 211' ' ' PHE . 63.5 m-85 -152.54 137.9 17.57 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.492 1.12 . . . . 73.05 111.031 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.418 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 25.8 t0 -80.16 107.96 13.37 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.482 1.114 . . . . 71.24 109.365 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.598 ' CE2' ' O ' ' A' ' 206' ' ' LEU . 17.1 t80 -80.33 136.58 36.43 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.517 1.136 . . . . 72.54 111.082 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.26 95.31 6.44 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.502 1.126 . . . . 75.05 109.316 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 166' ' ' PHE . . . -57.86 133.4 55.4 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.563 1.164 . . . . 70.13 109.276 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -119.84 -38.63 2.94 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.523 1.139 . . . . 64.02 110.301 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.1 -177.96 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.517 1.135 . . . . 72.41 109.291 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.21 -29.95 22.78 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.459 1.099 . . . . 72.24 109.337 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.73 -11.62 28.76 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.423 1.077 . . . . 72.35 109.25 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.415 ' OE1' ' CZ3' ' A' ' 192' ' ' TRP . 8.6 mt-10 -74.74 134.4 41.88 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 75.33 110.263 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.424 ' N ' ' HB2' ' A' ' 168' ' ' ALA . 5.4 mp -112.67 154.24 26.39 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.544 1.152 . . . . 72.41 109.329 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.9 t -91.65 115.82 28.37 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.503 1.127 . . . . 63.53 110.389 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.0 m -94.0 -173.64 3.18 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.483 1.114 . . . . 71.21 110.384 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -136.35 134.34 37.78 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.487 1.117 . . . . 74.32 110.996 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.418 ' HB ' ' N ' ' A' ' 165' ' ' ASP . 1.8 p -59.59 149.95 6.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.418 1.074 . . . . 74.44 109.286 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 68.22 36.77 85.71 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.505 1.128 . . . . 73.32 111.002 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.494 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 21.7 tp10 -113.42 165.02 12.86 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.527 0.781 . . . . 74.04 110.295 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.411 ' C ' ' CD1' ' A' ' 182' ' ' LEU . 2.7 m-80 -129.24 134.68 48.09 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.414 1.071 . . . . 73.55 109.332 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.457 ' CD1' HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -167.2 164.48 15.57 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.542 1.151 . . . . 74.11 109.363 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.566 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 0.6 OUTLIER -99.69 148.08 24.73 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.592 1.183 . . . . 74.44 110.958 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.462 ' CG2' ' O ' ' A' ' 186' ' ' ALA . 24.2 mm -77.7 112.9 16.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.49 1.119 . . . . 75.53 109.296 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.46 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 0.5 OUTLIER -73.87 -27.56 61.13 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.476 1.11 . . . . 71.42 108.261 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.462 ' O ' ' CG2' ' A' ' 184' ' ' ILE . . . -171.3 179.58 2.93 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.533 1.146 . . . . 73.15 109.289 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.457 ' CE1' HG23 ' A' ' 238' ' ' THR . 9.2 p80 -143.28 143.58 31.77 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.545 1.153 . . . . 75.23 109.594 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.01 121.58 35.64 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.483 1.115 . . . . 74.14 109.628 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.449 ' C ' ' N ' ' A' ' 191' ' ' GLU . 2.5 t-20 53.6 30.59 11.08 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.484 1.115 . . . . 74.42 109.309 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 13.1 p 42.68 29.0 0.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.125 . . . . 73.32 108.269 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.47 ' HG3' ' CD1' ' A' ' 192' ' ' TRP . 13.3 pt-20 -123.38 -37.49 2.67 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 75.02 110.245 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.47 ' CD1' ' HG3' ' A' ' 191' ' ' GLU . 15.8 m0 -112.37 160.48 17.66 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.546 1.154 . . . . 75.41 107.989 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.433 ' CZ ' HG22 ' A' ' 227' ' ' VAL . 21.0 m-85 -136.81 161.16 36.74 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.502 1.126 . . . . 74.22 111.016 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.466 ' CG1' ' HB ' ' A' ' 239' ' ' VAL . 9.5 mm -97.77 108.53 21.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.456 1.098 . . . . 73.01 109.317 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.49 ' CB ' ' CG2' ' A' ' 207' ' ' VAL . . . -99.42 167.98 10.28 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.525 1.14 . . . . 64.03 109.271 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? . . . . . 0 C--N 1.325 -0.468 0 O-C-N 124.429 1.081 . . . . 73.55 109.287 179.961 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.004 0 N-CA-C 111.091 -0.803 . . . . 70.12 111.091 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.472 ' CB ' ' O ' ' A' ' 195' ' ' ALA . 18.4 Cg_endo -75.03 -173.7 12.81 Favored 'Cis proline' 0 C--N 1.36 1.176 0 C-N-CA 121.0 -2.5 . . . . 72.42 111.027 -0.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.13 172.38 20.71 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.503 1.127 . . . . 73.53 110.988 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.598 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 6.5 mt -99.4 134.8 41.75 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.484 0.755 . . . . 74.33 109.316 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.507 HG12 ' CG ' ' A' ' 166' ' ' PHE . 0.7 OUTLIER -134.43 144.27 50.31 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.504 1.128 . . . . 71.1 109.309 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.571 ' HD3' ' CD1' ' A' ' 166' ' ' PHE . 18.2 Cg_endo -74.94 138.84 23.73 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.51 1.795 . . . . 62.22 111.005 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.47 ' HA ' ' CG2' ' A' ' 212' ' ' VAL . 7.5 p -61.13 -34.78 61.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.46 1.1 . . . . 65.15 109.301 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -61.27 -13.01 34.11 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.557 1.16 . . . . 54.53 111.031 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.569 ' CD2' ' HB3' ' A' ' 164' ' ' TYR . 4.4 m-85 -113.51 18.41 17.67 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.546 0.792 . . . . 73.31 111.026 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.47 ' CG2' ' HA ' ' A' ' 209' ' ' VAL . 11.3 m -153.62 153.58 8.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.499 1.124 . . . . 75.52 109.336 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.7 t -139.27 141.55 37.79 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.458 1.098 . . . . 74.24 110.018 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.468 HG13 ' CG2' ' A' ' 227' ' ' VAL . 17.6 mm -82.34 91.71 2.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.535 1.147 . . . . 73.41 109.27 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.417 ' CD1' HG21 ' A' ' 161' ' ' ILE . 1.6 pt . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.125 . . . . 61.35 109.364 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 72.0 p . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 120.562 0.22 . . . . 73.42 110.428 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.08 -1.22 22.7 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.467 1.104 . . . . 70.21 111.01 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -82.25 176.17 9.69 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.475 0.75 . . . . 70.01 109.261 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.44 171.73 9.72 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.458 1.099 . . . . 74.31 109.333 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.468 ' CG2' HG13 ' A' ' 214' ' ' ILE . 12.0 p -80.52 -40.27 19.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.47 1.106 . . . . 70.44 109.239 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.457 HD13 ' CG1' ' A' ' 227' ' ' VAL . 2.4 mp -51.04 -48.51 29.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.156 . . . . 73.43 109.301 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.03 -33.15 74.82 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.491 1.12 . . . . 75.54 110.25 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.89 -14.29 59.9 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.574 1.171 . . . . 71.23 109.292 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.412 HG21 ' NE2' ' A' ' 187' ' ' HIS . 34.6 mt -84.29 -32.4 8.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.483 1.114 . . . . 75.42 109.354 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -84.01 -18.73 36.12 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.421 1.076 . . . . 75.32 109.288 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 6.8 p -68.66 -29.01 67.39 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.527 1.142 . . . . 63.45 109.967 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.45 HG13 ' CD1' ' A' ' 158' ' ' LEU . 6.2 p -126.53 21.34 3.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.506 1.129 . . . . 73.03 109.318 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 40.68 29.74 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.559 1.162 . . . . 73.02 109.334 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.428 ' N ' ' C ' ' A' ' 234' ' ' VAL . 22.9 tp -42.11 113.34 1.2 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.521 1.138 . . . . 72.22 109.325 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 133.72 16.91 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.519 1.799 . . . . 71.24 110.956 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' THR . . . . . 0.457 HG23 ' CE1' ' A' ' 187' ' ' HIS . 9.4 p -57.12 151.56 15.1 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.513 1.133 . . . . 73.23 110.42 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.466 ' HB ' ' CG1' ' A' ' 194' ' ' ILE . 2.7 p -59.72 -24.89 30.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.549 1.156 . . . . 73.41 109.281 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -80.05 -28.59 39.22 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.455 1.097 . . . . 74.22 110.28 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -86.9 -25.06 24.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 74.1 110.233 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -76.75 -52.9 8.73 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.48 1.113 . . . . 63.4 108.001 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 32.5 pttt -48.1 -28.83 3.11 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.504 1.127 . . . . 73.03 109.35 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.6 t -81.32 -44.78 17.15 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.457 1.098 . . . . 70.0 109.98 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . 0.42 ' N ' HD21 ' A' ' 245' ' ' ASN . 1.3 m-80 . . . . . 0 C--N 1.325 -0.458 0 O-C-N 124.543 1.152 . . . . 74.51 109.26 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.54 ' O ' ' CG ' ' A' ' 159' ' ' TYR . 8.2 mt . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 109.3 -0.63 . . . . 62.51 109.3 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.54 ' CG ' ' O ' ' A' ' 158' ' ' LEU . 76.3 m-85 -164.69 141.62 6.2 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.588 1.18 . . . . 74.33 111.064 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.469 ' HB2' ' CD1' ' A' ' 184' ' ' ILE . . . -135.44 130.26 34.5 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.539 1.149 . . . . 52.14 109.297 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.463 ' CG1' ' O ' ' A' ' 180' ' ' GLU . 1.3 tt -100.83 138.85 23.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.519 1.137 . . . . 73.25 109.28 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 179' ' ' GLY . 2.9 t -90.88 114.21 27.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.456 1.097 . . . . 72.42 109.275 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.439 ' O ' ' CD1' ' A' ' 164' ' ' TYR . 0.1 OUTLIER -94.32 12.99 25.02 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.481 1.113 . . . . 72.44 109.296 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.439 ' CD1' ' O ' ' A' ' 163' ' ' LEU . 35.3 m-85 -157.98 131.27 7.61 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.562 1.163 . . . . 75.53 110.969 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -54.06 108.67 0.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 72.52 109.236 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.586 ' CE2' ' O ' ' A' ' 174' ' ' LEU . 5.7 t80 -80.46 136.71 36.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.447 1.092 . . . . 74.35 110.992 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -113.68 111.75 22.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.458 1.099 . . . . 74.44 109.259 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.53 121.65 14.37 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.534 1.146 . . . . 65.32 109.301 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.452 ' CG ' ' N ' ' A' ' 170' ' ' LYS . 14.7 pt-20 -116.62 -44.41 2.85 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.543 1.152 . . . . 73.24 110.256 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.452 ' N ' ' CG ' ' A' ' 169' ' ' GLU . 0.8 OUTLIER -59.78 161.71 6.06 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.537 1.148 . . . . 73.4 109.324 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.76 -19.61 64.33 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.441 1.088 . . . . 73.43 109.262 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -124.44 25.22 7.71 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.415 1.072 . . . . 74.24 109.393 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.426 ' OE2' ' CB ' ' A' ' 170' ' ' LYS . 6.3 tp10 -85.11 157.92 20.55 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 1.118 . . . . 73.52 110.33 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.586 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 0.3 OUTLIER -115.86 149.83 38.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.153 . . . . 75.31 109.335 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 11.6 t -107.72 137.97 44.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.511 1.132 . . . . 74.53 110.402 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.453 HG21 ' CD1' ' A' ' 182' ' ' LEU . 2.5 m -136.54 -164.39 1.56 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.551 1.157 . . . . 65.3 110.463 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -140.62 150.49 43.64 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.433 1.083 . . . . 71.32 111.039 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -45.81 156.47 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.436 1.085 . . . . 74.11 109.313 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 37.51 63.81 0.79 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.518 1.136 . . . . 71.15 111.025 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.463 ' O ' ' CG1' ' A' ' 161' ' ' ILE . 26.5 tp10 -121.85 155.93 34.34 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.541 0.789 . . . . 70.04 110.321 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.457 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.5 OUTLIER -101.5 126.99 48.37 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.534 1.146 . . . . 74.43 109.335 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.453 ' CD1' HG21 ' A' ' 176' ' ' THR . 11.1 mt -146.79 153.21 39.93 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.463 1.102 . . . . 73.55 109.3 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -111.56 131.73 55.04 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.546 1.154 . . . . 74.43 111.016 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 160' ' ' ALA . 31.7 mm -77.71 129.59 37.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 74.53 109.238 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 1.3 t -103.78 -25.45 13.1 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.457 1.098 . . . . 72.12 108.288 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.456 ' HA ' ' CD2' ' A' ' 236' ' ' LEU . . . -164.49 171.95 13.94 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.484 1.115 . . . . 63.13 109.298 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.49 ' CD2' HG23 ' A' ' 231' ' ' ILE . 8.5 p80 -140.23 145.27 37.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.519 1.137 . . . . 74.34 109.616 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.649 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.6 t-160 -122.97 118.28 27.44 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.569 1.168 . . . . 73.43 109.593 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.45 ' C ' ' N ' ' A' ' 191' ' ' GLU . 57.1 m-80 53.82 31.51 13.22 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.549 1.155 . . . . 74.03 109.258 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.411 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 12.7 p 42.96 28.62 0.14 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 72.4 108.244 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.45 ' N ' ' C ' ' A' ' 189' ' ' ASN . 6.1 pt-20 -122.54 -36.05 2.99 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.457 1.098 . . . . 72.55 110.279 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.431 ' CE3' ' HB3' ' A' ' 206' ' ' LEU . 9.1 m0 -114.07 159.91 19.48 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.486 1.116 . . . . 74.33 108.01 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.449 ' CZ ' ' CG2' ' A' ' 227' ' ' VAL . 28.4 m-85 -130.35 157.38 42.73 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.423 1.077 . . . . 74.14 111.02 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.459 ' CG1' ' HB ' ' A' ' 239' ' ' VAL . 22.8 mm -103.44 111.56 33.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.459 1.099 . . . . 74.01 109.228 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -98.08 154.85 17.44 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.589 1.181 . . . . 71.53 109.34 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt . . . . . 0 C--N 1.324 -0.503 0 O-C-N 124.467 1.104 . . . . 71.44 109.318 -179.953 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.962 0 N-CA-C 111.022 -0.831 . . . . 53.55 111.022 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 125.38 11.24 Favored 'Cis proline' 0 C--N 1.362 1.241 0 C-N-CA 120.987 -2.506 . . . . 64.31 110.972 0.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -105.25 172.28 19.47 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.532 1.145 . . . . 62.54 110.972 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.431 ' HB3' ' CE3' ' A' ' 192' ' ' TRP . 3.8 mt -106.07 137.23 44.35 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.507 0.769 . . . . 74.44 109.258 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.467 ' CG2' HG11 ' A' ' 212' ' ' VAL . 0.1 OUTLIER -132.56 138.59 32.42 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.535 1.147 . . . . 73.34 109.327 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.57 ' HD3' ' CZ ' ' A' ' 166' ' ' PHE . 18.2 Cg_endo -75.01 144.58 30.37 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.463 1.77 . . . . 74.11 111.012 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 12.0 p -75.19 -21.84 16.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.545 1.153 . . . . 74.35 109.316 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -75.68 -7.8 83.7 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.488 1.118 . . . . 73.12 111.037 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -113.67 -11.2 12.99 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.447 0.733 . . . . 73.23 111.11 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.467 HG11 ' CG2' ' A' ' 207' ' ' VAL . 15.4 m -128.48 161.55 36.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.527 1.142 . . . . 73.45 109.302 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 6.3 t -149.88 153.17 36.25 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.47 1.106 . . . . 73.34 110.027 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.453 HG13 ' CG2' ' A' ' 227' ' ' VAL . 12.3 mm -96.46 121.42 46.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 124.546 1.154 . . . . 71.32 109.295 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.6 pt . . . . . 0 C--N 1.324 -0.535 0 O-C-N 124.514 1.134 . . . . 73.41 109.335 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' THR . . . . . 0.426 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 58.4 p . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 120.54 0.21 . . . . 74.11 110.447 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 154.08 -22.8 0.68 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.473 1.108 . . . . 71.3 111.033 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.426 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 21.4 m-80 -62.88 -175.95 0.11 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.45 0.735 . . . . 61.02 109.318 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -135.04 176.98 8.17 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.47 1.106 . . . . 70.2 109.254 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.453 ' CG2' HG13 ' A' ' 214' ' ' ILE . 8.3 p -79.6 -32.95 14.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.524 1.14 . . . . 71.52 109.342 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 228' ' ' ILE . 1.5 mp -57.75 -49.23 81.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.43 1.081 . . . . 72.32 109.258 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -59.92 -28.89 67.99 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.447 1.092 . . . . 74.14 110.298 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.75 -31.21 36.02 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.546 1.154 . . . . 72.45 109.277 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.49 HG23 ' CD2' ' A' ' 187' ' ' HIS . 24.3 mt -72.72 -39.03 59.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.459 1.099 . . . . 71.12 109.281 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -76.22 -32.7 59.08 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.536 1.147 . . . . 63.42 109.258 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.4 m -55.65 -39.86 71.45 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 74.13 110.04 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 11.8 p -118.58 13.54 7.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.501 1.126 . . . . 74.05 109.316 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 231' ' ' ILE . 8.5 m120 40.46 43.06 1.44 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.542 1.151 . . . . 73.2 109.321 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.46 HD13 ' CD1' ' A' ' 158' ' ' LEU . 2.1 tt -40.28 140.01 0.99 Allowed Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.525 1.14 . . . . 74.4 109.306 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 139.23 24.02 Favored 'Trans proline' 0 C--N 1.361 1.207 0 O-C-N 124.566 1.824 . . . . 72.43 110.996 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 2.3 p -75.13 152.14 38.52 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.504 1.127 . . . . 73.25 110.41 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.649 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.7 p -53.32 -23.09 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.525 1.14 . . . . 73.41 109.33 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.498 ' O ' ' CB ' ' A' ' 244' ' ' SER . 99.3 mm-40 -86.06 -50.14 7.26 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.46 1.1 . . . . 71.31 110.254 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -59.01 -28.91 66.83 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.536 1.147 . . . . 64.42 110.327 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 22.0 t90 -80.42 -68.0 0.72 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.98 -1.119 . . . . 75.25 107.98 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.8 pttp -50.41 -23.25 2.28 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.516 1.135 . . . . 72.22 109.254 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 240' ' ' GLN . 11.3 t -68.57 -59.67 2.97 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.64 1.213 . . . . 72.42 110.047 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 4.6 m120 . . . . . 0 C--N 1.325 -0.465 0 O-C-N 124.542 1.151 . . . . 71.04 109.381 179.925 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.453 ' C ' ' CD1' ' A' ' 159' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 109.33 -0.619 . . . . 54.21 109.33 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.54 ' CD2' ' HB3' ' A' ' 183' ' ' PHE . 6.0 m-85 -137.41 165.82 25.31 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.493 1.121 . . . . 72.32 110.985 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -125.66 150.7 47.38 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.51 1.131 . . . . 74.11 109.291 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.497 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 1.0 OUTLIER -113.19 122.74 67.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.514 1.134 . . . . 63.52 109.287 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.497 ' CG1' ' O ' ' A' ' 177' ' ' TYR . 19.8 t -76.73 132.31 33.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 72.25 109.293 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.25 -12.38 14.46 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 70.54 109.294 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.423 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 85.1 m-85 -143.06 151.57 40.93 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 72.12 110.939 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.485 ' OD2' ' CE ' ' A' ' 167' ' ' LYS . 0.9 OUTLIER -78.96 104.67 9.75 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.468 1.105 . . . . 64.43 109.273 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.514 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 1.1 t80 -80.87 109.45 15.45 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 1.127 . . . . 75.02 110.992 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.485 ' CE ' ' OD2' ' A' ' 165' ' ' ASP . 13.8 mmtp -81.55 94.41 6.88 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.53 1.143 . . . . 74.02 109.276 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.425 ' HB3' ' N ' ' A' ' 174' ' ' LEU . . . -43.96 124.4 3.79 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.406 1.066 . . . . 74.22 109.244 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -119.72 -38.66 2.95 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.493 1.12 . . . . 71.3 110.269 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 165.01 8.99 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.53 1.144 . . . . 74.25 109.29 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.85 -22.57 62.29 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.509 1.131 . . . . 75.24 109.334 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -117.9 25.25 10.5 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.514 1.134 . . . . 61.14 109.297 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.46 ' CG ' ' CZ ' ' A' ' 166' ' ' PHE . 5.1 tp10 -91.91 147.5 22.92 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.527 1.142 . . . . 74.52 110.373 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.428 ' CG ' ' HA3' ' A' ' 205' ' ' GLY . 0.4 OUTLIER -120.02 143.61 47.98 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.403 1.065 . . . . 75.4 109.287 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.6 t -81.59 143.72 31.77 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.502 1.126 . . . . 63.41 110.414 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.42 HG23 ' CG2' ' A' ' 162' ' ' VAL . 2.6 m -131.37 -176.75 4.13 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.469 1.105 . . . . 73.45 110.399 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.497 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 6.1 m-85 -130.46 155.48 46.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.468 1.105 . . . . 75.21 111.017 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.0 OUTLIER -68.09 156.02 7.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.545 1.153 . . . . 75.43 109.309 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.47 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 37.45 55.1 1.66 Allowed Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.524 1.14 . . . . 54.12 111.011 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.497 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 14.9 tt0 -114.75 165.94 12.28 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.513 0.772 . . . . 63.34 110.307 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.477 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.0 OUTLIER -125.95 121.02 31.91 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.527 1.142 . . . . 74.54 109.269 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.3 pp -140.63 168.27 20.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.462 1.101 . . . . 75.45 109.325 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.54 ' HB3' ' CD2' ' A' ' 159' ' ' TYR . 11.1 p90 -108.41 134.99 50.44 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.529 1.143 . . . . 74.4 110.965 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.456 ' CG2' ' O ' ' A' ' 186' ' ' ALA . 22.9 mm -77.62 124.67 36.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.482 1.114 . . . . 75.45 109.304 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 39.7 m -88.59 -22.58 23.44 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.537 1.148 . . . . 71.43 108.316 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.456 ' O ' ' CG2' ' A' ' 184' ' ' ILE . . . -172.6 179.19 2.5 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.522 1.139 . . . . 75.35 109.275 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.561 ' CD2' HG23 ' A' ' 231' ' ' ILE . 8.8 p80 -144.48 153.75 42.21 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.539 1.15 . . . . 73.32 109.616 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.18 117.11 17.84 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 74.0 109.644 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.78 18.06 5.7 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.462 1.101 . . . . 71.43 109.319 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 4.0 m 57.92 18.62 5.16 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.452 1.095 . . . . 55.34 108.305 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.405 ' O ' ' CG2' ' A' ' 209' ' ' VAL . 11.6 pt-20 -115.97 -33.04 5.21 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.515 1.134 . . . . 72.55 110.284 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 12.9 m0 -112.58 158.47 19.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.568 1.167 . . . . 73.23 108.036 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.65 ' CE2' ' CG2' ' A' ' 209' ' ' VAL . 39.8 m-85 -134.44 163.55 29.43 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.466 1.104 . . . . 73.43 111.027 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.436 ' CG1' ' HB ' ' A' ' 239' ' ' VAL . 33.8 mm -105.97 120.67 57.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.596 1.185 . . . . 75.53 109.262 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -106.0 163.3 12.87 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.491 1.119 . . . . 74.54 109.353 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 74.25 109.295 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.03 0 N-CA-C 110.977 -0.849 . . . . 75.54 110.977 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 160.11 96.98 Favored 'Cis proline' 0 C--N 1.36 1.147 0 C-N-CA 121.006 -2.497 . . . . 73.34 110.926 0.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.428 ' HA3' ' CG ' ' A' ' 174' ' ' LEU . . . -120.13 -172.11 14.76 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.5 1.125 . . . . 71.41 111.006 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.4 mt -108.52 154.98 21.16 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.469 0.746 . . . . 73.31 109.321 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.536 ' CG2' ' CG1' ' A' ' 212' ' ' VAL . 0.2 OUTLIER -153.74 119.04 2.78 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.531 1.144 . . . . 64.02 109.241 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.514 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.5 Cg_endo -74.93 156.68 43.3 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.56 1.821 . . . . 74.11 111.027 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.65 ' CG2' ' CE2' ' A' ' 193' ' ' PHE . 7.1 t -68.68 -15.33 19.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.473 1.108 . . . . 70.22 109.319 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -72.88 -2.5 57.59 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.471 1.107 . . . . 61.24 110.998 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -134.07 11.24 3.91 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.518 0.775 . . . . 73.41 111.024 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.536 ' CG1' ' CG2' ' A' ' 207' ' ' VAL . 14.9 m -148.26 143.99 19.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.508 1.13 . . . . 75.21 109.307 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 9.7 t -128.52 154.61 45.96 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.461 1.101 . . . . 64.34 110.024 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.47 HG13 ' CG2' ' A' ' 227' ' ' VAL . 31.6 mm -107.15 141.73 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.47 1.106 . . . . 74.31 109.279 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.412 HD12 ' N ' ' A' ' 215' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.457 1.098 . . . . 73.34 109.299 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 55.1 p . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.559 0.218 . . . . 75.42 110.427 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.87 -2.54 21.28 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.512 1.133 . . . . 74.1 111.06 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -69.47 171.93 8.01 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.535 0.785 . . . . 72.12 109.285 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.2 168.31 11.0 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.496 1.122 . . . . 71.41 109.281 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.47 ' CG2' HG13 ' A' ' 214' ' ' ILE . 10.4 p -78.47 -34.62 18.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.517 1.135 . . . . 74.11 109.293 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.431 ' CD1' ' N ' ' A' ' 228' ' ' ILE . 1.3 mp -56.54 -50.94 71.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.585 1.178 . . . . 75.02 109.336 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -63.93 -31.95 73.31 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.541 1.151 . . . . 71.33 110.3 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.33 -36.05 74.01 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.508 1.13 . . . . 72.12 109.307 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.561 HG23 ' CD2' ' A' ' 187' ' ' HIS . 23.0 mt -67.76 -43.03 86.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.496 1.123 . . . . 64.43 109.345 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 29.9 mmtt -74.36 -21.21 59.79 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.456 1.097 . . . . 71.11 109.251 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 36.9 m -66.75 -37.44 84.62 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.494 1.121 . . . . 74.1 109.985 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.46 11.67 7.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.527 1.142 . . . . 74.35 109.275 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 57.7 t30 40.48 43.95 1.62 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.549 1.156 . . . . 74.54 109.282 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 237' ' ' PRO . 1.6 tp -52.07 142.87 25.94 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.54 1.15 . . . . 71.22 109.282 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 236' ' ' LEU . 18.3 Cg_endo -74.97 154.1 42.4 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.473 1.775 . . . . 62.22 110.988 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' THR . . . . . 0.422 HG21 ' NE2' ' A' ' 187' ' ' HIS . 3.1 p -94.11 142.06 27.83 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.552 1.158 . . . . 75.33 110.375 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.436 ' HB ' ' CG1' ' A' ' 194' ' ' ILE . 2.7 p -47.04 -25.5 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.445 1.091 . . . . 62.2 109.301 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.411 ' N ' ' C ' ' A' ' 238' ' ' THR . 37.3 mm-40 -80.97 -40.92 23.63 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.524 1.14 . . . . 73.52 110.255 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 238' ' ' THR . 74.9 mt-10 -72.15 -23.44 61.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.526 1.141 . . . . 74.44 110.323 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.434 ' O ' ' N ' ' A' ' 245' ' ' ASN . 3.5 t90 -77.59 -71.59 0.41 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.532 1.145 . . . . 74.23 107.979 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.02 -27.76 0.4 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.561 1.163 . . . . 74.05 109.259 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.42 ' N ' ' C ' ' A' ' 242' ' ' TRP . 3.0 t -73.58 -46.92 44.35 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 63.2 110.025 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 242' ' ' TRP . 16.5 t-20 . . . . . 0 C--N 1.326 -0.428 0 O-C-N 124.547 1.154 . . . . 72.14 109.254 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.451 ' CD2' HG11 ' A' ' 234' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 109.357 -0.609 . . . . 75.03 109.357 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -114.13 135.42 54.05 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.478 1.111 . . . . 72.54 111.011 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -124.31 163.91 20.71 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 71.2 109.291 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.4 ' O ' ' CD2' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -132.69 128.75 57.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.52 1.137 . . . . 73.43 109.359 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.408 ' CG1' ' O ' ' A' ' 164' ' ' TYR . 3.0 t -86.93 109.51 19.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.478 1.111 . . . . 72.25 109.32 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.543 ' O ' ' CG ' ' A' ' 164' ' ' TYR . 0.1 OUTLIER -97.64 17.34 18.06 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.546 1.154 . . . . 72.04 109.308 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.543 ' CG ' ' O ' ' A' ' 163' ' ' LEU . 53.3 m-85 -164.56 147.67 8.93 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.557 1.161 . . . . 64.42 110.984 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.421 ' N ' HG23 ' A' ' 178' ' ' VAL . 0.2 OUTLIER -73.3 158.6 34.81 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.479 1.112 . . . . 74.41 109.304 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.602 ' CD1' ' N ' ' A' ' 167' ' ' LYS . 1.9 t80 -135.55 157.85 45.86 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.575 1.172 . . . . 75.23 111.041 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.602 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 21.5 mmtp -124.76 134.51 52.77 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.483 1.114 . . . . 72.33 109.294 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.43 ' HB3' ' N ' ' A' ' 174' ' ' LEU . . . -99.98 124.07 44.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.487 1.117 . . . . 74.12 109.338 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -117.18 -34.37 4.38 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.496 1.123 . . . . 55.23 110.304 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -68.82 -179.79 1.55 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.447 1.092 . . . . 72.13 109.329 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.51 -29.68 22.54 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.474 1.109 . . . . 72.11 109.294 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.25 21.68 16.13 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.564 1.165 . . . . 71.52 109.278 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -93.44 159.27 15.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.446 1.091 . . . . 72.02 110.295 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.593 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 4.6 mm? -133.0 147.18 52.28 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 74.44 109.289 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 12.2 t -98.21 145.74 26.31 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.484 1.115 . . . . 71.43 110.355 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.7 m -146.52 -178.11 5.99 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.49 1.119 . . . . 73.14 110.44 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -128.97 -179.79 5.31 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.559 1.162 . . . . 74.41 111.038 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 165' ' ' ASP . 28.8 t -74.26 165.01 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.475 1.109 . . . . 74.35 109.316 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 37.57 71.74 0.2 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.507 1.129 . . . . 55.02 111.023 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -121.91 154.2 37.44 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.488 0.758 . . . . 74.01 110.208 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -112.75 119.74 39.09 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.561 1.163 . . . . 75.4 109.327 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.499 ' C ' ' CD1' ' A' ' 182' ' ' LEU . 0.2 OUTLIER -160.64 -175.42 4.97 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.466 1.104 . . . . 74.1 109.343 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.4 ' N ' HD13 ' A' ' 182' ' ' LEU . 25.3 p90 -133.1 147.2 52.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.134 . . . . 74.44 111.004 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 30.6 mm -77.62 128.35 38.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.487 1.117 . . . . 74.35 109.305 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 38.6 m -86.9 -34.38 19.42 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.541 1.151 . . . . 64.21 108.313 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.421 ' N ' ' HB ' ' A' ' 194' ' ' ILE . . . -164.57 179.13 6.85 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.486 1.116 . . . . 73.45 109.239 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.563 ' CD2' HG21 ' A' ' 231' ' ' ILE . 6.1 p80 -139.85 148.69 42.47 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 74.43 109.604 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.645 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.8 t-160 -125.18 115.62 20.72 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.453 1.096 . . . . 74.2 109.569 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.437 ' C ' ' N ' ' A' ' 191' ' ' GLU . 79.6 m-20 53.72 33.1 15.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.438 1.086 . . . . 74.22 109.268 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.413 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 12.6 p 42.95 28.28 0.13 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.55 1.156 . . . . 61.2 108.297 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.437 ' N ' ' C ' ' A' ' 189' ' ' ASN . 4.4 pt-20 -121.81 -35.43 3.2 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.494 1.121 . . . . 74.11 110.324 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.427 ' CD1' ' HG3' ' A' ' 191' ' ' GLU . 10.7 m0 -115.9 165.94 12.53 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.497 1.123 . . . . 75.44 108.029 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.472 ' CD2' HG21 ' A' ' 212' ' ' VAL . 9.9 m-85 -137.75 155.66 48.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.556 1.16 . . . . 63.31 111.003 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.473 ' CG1' ' HB ' ' A' ' 239' ' ' VAL . 20.7 mm -102.14 83.73 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.512 1.132 . . . . 73.53 109.336 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.468 ' O ' ' CA ' ' A' ' 205' ' ' GLY . . . -104.43 179.22 4.33 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.537 1.148 . . . . 73.14 109.317 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.437 ' HB3' ' CA ' ' A' ' 203' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.505 1.128 . . . . 74.13 109.323 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.437 ' CA ' ' HB3' ' A' ' 196' ' ' LYS . . . . . . . . 0 CA--C 1.531 1.035 0 N-CA-C 110.995 -0.842 . . . . 71.11 110.995 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.423 ' CB ' HG21 ' A' ' 194' ' ' ILE . 18.2 Cg_endo -75.01 121.02 7.05 Favored 'Cis proline' 0 C--N 1.36 1.184 0 C-N-CA 121.039 -2.484 . . . . 73.4 110.977 -0.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.468 ' CA ' ' O ' ' A' ' 195' ' ' ALA . . . -96.92 132.37 10.97 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.537 1.148 . . . . 53.25 111.055 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.484 ' O ' ' CZ ' ' A' ' 166' ' ' PHE . 17.9 mt -88.72 125.43 34.85 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.488 0.758 . . . . 74.13 109.275 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.424 ' HA ' ' CE2' ' A' ' 166' ' ' PHE . 1.2 m -141.18 149.44 55.3 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.494 1.121 . . . . 73.22 109.293 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.9 160.28 40.63 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.486 1.782 . . . . 73.34 111.043 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.412 ' HA ' ' CE2' ' A' ' 193' ' ' PHE . 3.3 p -81.9 -25.07 9.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.416 1.072 . . . . 72.04 109.282 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -73.78 -12.04 80.84 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.526 1.141 . . . . 65.21 111.026 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.487 ' O ' ' CG1' ' A' ' 212' ' ' VAL . 8.6 m-30 -109.46 24.96 12.36 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.426 0.721 . . . . 75.43 111.019 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.487 ' CG1' ' O ' ' A' ' 211' ' ' PHE . 32.6 m -157.0 145.06 11.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.488 1.118 . . . . 75.32 109.315 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' SER . . . . . 0.41 ' CB ' HD21 ' A' ' 163' ' ' LEU . 21.6 t -134.19 144.59 48.56 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.548 1.155 . . . . 64.52 109.962 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 16.3 mm -96.73 96.88 5.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.538 1.149 . . . . 75.21 109.266 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 1.8 pt . . . . . 0 C--N 1.325 -0.469 0 O-C-N 124.511 1.132 . . . . 71.31 109.327 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 61.1 p . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 110.395 -0.224 . . . . 74.35 110.395 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 105.32 -18.1 42.54 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.466 1.104 . . . . 72.24 111.003 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -58.15 -175.9 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.397 0.704 . . . . 71.52 109.312 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -123.74 172.68 8.66 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.492 1.12 . . . . 74.41 109.305 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.444 ' CG1' HD12 ' A' ' 228' ' ' ILE . 14.7 p -76.58 -38.61 31.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.468 1.105 . . . . 74.12 109.324 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.444 HD12 ' CG1' ' A' ' 227' ' ' VAL . 1.8 mp -53.59 -52.92 28.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 74.44 109.292 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -56.13 -34.93 66.55 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.476 1.11 . . . . 74.34 110.373 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.49 -26.96 51.75 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.431 1.082 . . . . 74.24 109.24 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.563 HG21 ' CD2' ' A' ' 187' ' ' HIS . 60.7 mt -71.5 -39.51 70.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.51 1.131 . . . . 74.33 109.326 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -29.56 60.21 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.477 1.111 . . . . 74.52 109.286 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 54.8 m -55.57 -44.87 77.28 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.491 1.119 . . . . 61.42 110.043 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.451 HG11 ' CD2' ' A' ' 158' ' ' LEU . 7.7 p -111.15 12.84 8.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.569 1.168 . . . . 74.31 109.309 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 13.7 m120 40.57 38.28 0.58 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.534 1.146 . . . . 71.13 109.313 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.9 tp -40.89 133.51 1.77 Allowed Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.405 1.066 . . . . 74.02 109.284 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.06 131.89 14.74 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.479 1.779 . . . . 71.43 110.955 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' THR . . . . . 0.444 ' C ' ' N ' ' A' ' 240' ' ' GLN . 2.4 p -68.61 150.46 47.96 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.452 1.095 . . . . 71.11 110.348 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.645 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.1 p -40.41 -30.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.467 1.104 . . . . 72.1 109.281 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.444 ' N ' ' C ' ' A' ' 238' ' ' THR . 45.2 mm-40 -81.16 -56.12 4.29 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.474 1.109 . . . . 75.02 110.325 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -53.94 -22.03 9.32 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.531 1.145 . . . . 73.11 110.328 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -86.91 -60.46 1.98 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 72.43 108.046 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -23.48 2.78 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.573 1.171 . . . . 71.3 109.346 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 32.2 t -81.07 -62.25 1.72 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.491 1.119 . . . . 73.23 109.963 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.5 m120 . . . . . 0 C--N 1.325 -0.463 0 O-C-N 124.464 1.103 . . . . 72.32 109.315 179.992 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.49 ' CD2' ' CG1' ' A' ' 234' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.339 -0.615 . . . . 73.52 109.339 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 159' ' ' TYR . 1.3 p90 -136.41 155.14 50.44 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.499 1.124 . . . . 74.34 110.948 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.471 ' HB1' ' CG1' ' A' ' 184' ' ' ILE . . . -121.59 142.16 50.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.468 1.105 . . . . 74.14 109.263 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.515 ' O ' ' CD2' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -110.29 133.72 54.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.557 1.161 . . . . 74.31 109.302 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.0 t -76.27 132.17 33.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.511 1.132 . . . . 75.15 109.31 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.596 ' N ' ' CD2' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -95.54 -31.56 13.26 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.495 1.122 . . . . 72.4 109.287 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -130.19 159.34 37.14 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.54 1.15 . . . . 74.35 110.983 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.64 97.49 5.12 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.531 1.144 . . . . 72.42 109.335 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.564 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 1.7 t80 -82.67 123.91 29.71 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.476 1.11 . . . . 70.34 110.967 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 168' ' ' ALA . 11.4 mmmm -101.93 105.47 16.27 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.493 1.12 . . . . 71.01 109.261 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.418 ' HB2' ' N ' ' A' ' 174' ' ' LEU . . . -40.54 123.8 1.89 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.474 1.109 . . . . 70.41 109.321 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -113.72 -28.94 7.27 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.514 1.134 . . . . 72.11 110.302 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.52 177.79 8.61 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.498 1.124 . . . . 74.21 109.308 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.62 -14.06 43.84 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.582 1.176 . . . . 55.32 109.302 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -124.53 23.43 8.14 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.54 1.15 . . . . 73.22 109.233 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -96.39 163.21 13.16 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 72.14 110.305 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.459 ' CG ' ' HA3' ' A' ' 205' ' ' GLY . 19.5 mt -127.46 153.48 46.25 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.515 1.134 . . . . 75.12 109.27 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.4 t -103.37 147.9 26.54 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.572 1.17 . . . . 74.02 110.448 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.4 m -138.44 -165.86 1.89 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.502 1.126 . . . . 75.23 110.378 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -134.44 134.0 41.11 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.523 1.139 . . . . 71.3 111.001 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.42 HG23 ' N ' ' A' ' 179' ' ' GLY . 0.5 OUTLIER -41.42 143.33 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.487 1.117 . . . . 65.34 109.294 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.42 ' N ' HG23 ' A' ' 178' ' ' VAL . . . 52.03 63.64 4.63 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.583 1.177 . . . . 64.33 111.019 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -122.15 160.93 24.08 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.433 0.725 . . . . 74.21 110.264 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -113.21 119.66 38.52 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.454 1.096 . . . . 62.21 109.345 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.2 mp -136.99 159.88 40.56 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.456 1.098 . . . . 74.13 109.322 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -108.09 128.89 55.08 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.561 1.163 . . . . 75.55 111.01 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.471 ' CG1' ' HB1' ' A' ' 160' ' ' ALA . 30.2 mm -77.62 128.53 38.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.527 1.142 . . . . 74.04 109.293 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 49.7 t -100.55 -23.15 14.76 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.48 1.112 . . . . 70.25 108.261 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -166.62 179.62 5.35 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.494 1.121 . . . . 73.22 109.306 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.551 ' CD2' HG22 ' A' ' 231' ' ' ILE . 8.2 p80 -146.28 157.81 43.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.452 1.095 . . . . 75.01 109.663 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.41 ' O ' ' CD2' ' A' ' 188' ' ' HIS . 0.6 OUTLIER -134.48 115.3 13.8 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.463 1.102 . . . . 71.5 109.596 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 58.74 19.89 7.32 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.59 1.181 . . . . 74.44 109.31 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 23.4 m 57.36 18.78 4.59 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.551 1.157 . . . . 73.14 108.273 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 192' ' ' TRP . 10.1 pt-20 -116.28 -33.0 5.12 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.122 . . . . 73.34 110.277 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.449 ' CE3' ' HB3' ' A' ' 206' ' ' LEU . 9.6 m0 -110.21 155.4 22.04 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 124.5 1.125 . . . . 73.13 108.004 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.566 ' CD2' HG22 ' A' ' 212' ' ' VAL . 24.9 m-85 -133.04 152.22 51.98 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.488 1.117 . . . . 75.33 111.06 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 27.8 mm -99.09 94.28 3.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.533 1.145 . . . . 74.12 109.315 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.488 ' O ' ' CB ' ' A' ' 204' ' ' PRO . . . -75.38 154.73 37.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.436 1.085 . . . . 75.03 109.31 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm . . . . . 0 C--N 1.325 -0.493 0 O-C-N 124.406 1.066 . . . . 75.25 109.275 -179.982 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.986 0 N-CA-C 111.035 -0.826 . . . . 75.01 111.035 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.488 ' CB ' ' O ' ' A' ' 195' ' ' ALA . 18.3 Cg_endo -74.98 178.61 33.89 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 121.036 -2.485 . . . . 62.31 111.071 -0.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.459 ' HA3' ' CG ' ' A' ' 174' ' ' LEU . . . -125.39 168.4 17.51 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.591 1.182 . . . . 71.22 111.016 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.449 ' HB3' ' CE3' ' A' ' 192' ' ' TRP . 2.5 mt -101.16 134.13 44.66 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.451 0.736 . . . . 54.11 109.223 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.546 ' CG2' ' CG1' ' A' ' 212' ' ' VAL . 0.1 OUTLIER -135.14 137.72 27.51 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.586 1.179 . . . . 74.01 109.299 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.564 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.5 Cg_endo -74.92 148.85 36.24 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.542 1.811 . . . . 75.13 111.077 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.44 ' HA ' ' CG2' ' A' ' 212' ' ' VAL . 11.5 p -74.43 -14.06 15.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.504 1.128 . . . . 74.0 109.334 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . 0.52 ' C ' ' CD1' ' A' ' 211' ' ' PHE . . . -84.09 10.47 60.62 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.499 1.124 . . . . 74.12 111.053 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.52 ' CD1' ' C ' ' A' ' 210' ' ' GLY . 17.3 m-85 -143.85 19.06 1.81 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.541 0.789 . . . . 70.31 111.001 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.566 HG22 ' CD2' ' A' ' 193' ' ' PHE . 30.8 m -145.68 147.94 17.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.524 1.14 . . . . 70.13 109.333 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 46.5 t -130.74 152.44 50.09 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.594 1.184 . . . . 63.53 110.001 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.469 HG13 ' CB ' ' A' ' 227' ' ' VAL . 42.3 mm -106.26 161.07 5.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.527 1.142 . . . . 74.45 109.28 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.425 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.438 0 O-C-N 124.483 1.114 . . . . 74.21 109.235 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' THR . . . . . 0.43 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 18.1 p . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 110.399 -0.222 . . . . 72.41 110.399 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.52 10.21 11.85 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.466 1.103 . . . . 74.42 111.008 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.43 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 1.8 m-80 -74.62 -177.02 2.99 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 0.755 . . . . 75.24 109.312 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.41 159.05 35.67 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.592 1.182 . . . . 74.22 109.291 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.469 ' CB ' HG13 ' A' ' 214' ' ' ILE . 12.6 p -78.05 -40.57 26.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 124.45 1.093 . . . . 73.31 109.337 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.1 mp -61.46 -46.39 96.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.496 1.122 . . . . 65.33 109.391 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -64.99 -20.37 66.46 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.587 1.18 . . . . 74.15 110.314 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -89.73 -31.65 17.35 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.125 . . . . 73.24 109.313 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.551 HG22 ' CD2' ' A' ' 187' ' ' HIS . 15.1 mt -66.49 -39.02 82.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.439 1.087 . . . . 75.21 109.261 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -76.33 -31.86 58.37 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.513 1.133 . . . . 75.14 109.283 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 6.6 p -57.0 -44.94 83.25 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.455 1.097 . . . . 72.54 110.032 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.49 ' CG1' ' CD2' ' A' ' 158' ' ' LEU . 3.4 p -106.11 13.13 8.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 124.518 1.136 . . . . 75.42 109.26 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 40.52 32.46 0.14 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.555 1.16 . . . . 73.5 109.247 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.1 tp -40.49 142.65 0.74 Allowed Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.498 1.124 . . . . 74.15 109.229 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 170.74 19.75 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.624 1.855 . . . . 72.12 110.936 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 241' ' ' GLU . 1.4 p -113.21 143.14 44.9 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.461 1.101 . . . . 75.11 110.4 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 p -45.33 -26.36 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.489 1.118 . . . . 74.43 109.266 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.402 ' N ' ' C ' ' A' ' 238' ' ' THR . 86.6 mm-40 -76.23 -43.36 42.48 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.477 1.111 . . . . 62.04 110.26 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 238' ' ' THR . 5.2 mm-40 -74.41 -21.7 59.51 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.528 1.142 . . . . 74.04 110.253 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.444 ' O ' ' N ' ' A' ' 245' ' ' ASN . 9.4 t90 -75.26 -62.36 1.59 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.958 -1.127 . . . . 72.25 107.958 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.7 pttm -50.45 -24.32 3.03 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.465 1.103 . . . . 75.31 109.275 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 2.6 t -88.07 -29.21 20.82 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.494 1.121 . . . . 70.34 110.007 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 242' ' ' TRP . 1.9 t30 . . . . . 0 C--N 1.325 -0.478 0 O-C-N 124.45 1.093 . . . . 75.54 109.246 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.459 ' O ' ' CG ' ' A' ' 159' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 109.295 -0.631 . . . . 73.52 109.295 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.459 ' CG ' ' O ' ' A' ' 158' ' ' LEU . 10.3 m-85 -168.31 107.98 0.52 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.385 1.053 . . . . 73.52 111.041 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -106.58 129.44 54.51 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.518 1.136 . . . . 71.53 109.248 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.2 127.38 51.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.121 . . . . 73.54 109.319 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.594 ' CG2' ' CD2' ' A' ' 182' ' ' LEU . 2.2 t -87.25 119.31 34.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.54 1.15 . . . . 75.14 109.328 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.33 17.67 19.19 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.428 1.08 . . . . 72.21 109.203 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.571 ' HB3' ' CD2' ' A' ' 211' ' ' PHE . 95.6 m-85 -155.89 148.91 24.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.437 1.086 . . . . 75.33 111.041 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.428 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 0.6 OUTLIER -87.47 106.74 18.19 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.475 1.11 . . . . 72.41 109.322 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.563 ' CD1' ' HD3' ' A' ' 208' ' ' PRO . 3.7 t80 -80.41 153.04 28.52 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.578 1.174 . . . . 74.24 110.965 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.531 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.9 mptt -115.51 115.39 26.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 72.05 109.316 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.489 ' CB ' ' OE1' ' A' ' 173' ' ' GLU . . . -56.47 126.59 27.17 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 1.138 . . . . 75.1 109.335 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -130.36 -35.53 1.53 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.481 1.113 . . . . 75.43 110.307 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.468 ' HD3' ' CD1' ' A' ' 206' ' ' LEU . 10.9 tttt -58.37 -163.26 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.448 1.093 . . . . 73.1 109.265 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.78 -50.65 5.93 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.526 1.141 . . . . 71.33 109.345 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.09 28.99 7.12 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.528 1.142 . . . . 73.34 109.324 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.489 ' OE1' ' CB ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -60.27 -176.9 0.05 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.491 1.119 . . . . 74.24 110.325 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.408 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 13.1 mt -151.8 132.54 14.05 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 74.52 109.269 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 15.2 t -78.82 114.1 17.47 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.504 1.128 . . . . 73.13 110.394 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 5.6 m -102.34 -172.14 2.08 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.505 1.128 . . . . 74.04 110.382 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 177' ' ' TYR . 11.1 m-85 -133.3 175.54 9.31 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.429 1.081 . . . . 75.54 110.979 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.428 ' HB ' ' N ' ' A' ' 165' ' ' ASP . 1.3 p -97.47 110.65 25.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 124.474 1.109 . . . . 75.22 109.287 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.46 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 99.23 51.12 1.37 Allowed Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.495 1.122 . . . . 72.34 111.028 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -115.6 169.38 9.23 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.49 0.759 . . . . 74.22 110.313 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.94 128.1 43.06 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 62.43 109.358 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.594 ' CD2' ' CG2' ' A' ' 162' ' ' VAL . 0.6 OUTLIER -167.02 172.7 9.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.454 1.097 . . . . 73.31 109.267 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -112.41 151.15 30.18 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.52 1.138 . . . . 72.13 110.97 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 48.1 mm -79.7 136.79 22.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.468 1.105 . . . . 72.31 109.275 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 9.1 t -101.5 -22.86 14.41 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.499 1.125 . . . . 73.31 108.328 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.46 ' HA ' ' CD2' ' A' ' 236' ' ' LEU . . . -173.7 172.26 3.61 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.497 1.123 . . . . 75.12 109.309 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.566 ' CD2' HG22 ' A' ' 231' ' ' ILE . 6.6 p80 -133.67 145.48 49.97 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.475 1.11 . . . . 74.14 109.588 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.643 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.1 t-160 -123.02 116.33 23.35 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.53 1.144 . . . . 75.32 109.629 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.45 ' C ' ' N ' ' A' ' 191' ' ' GLU . 71.3 m-20 53.79 32.22 14.49 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.465 1.103 . . . . 64.44 109.275 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 12.8 p 42.96 28.41 0.13 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.53 1.143 . . . . 74.54 108.339 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.485 ' O ' ' CG1' ' A' ' 209' ' ' VAL . 5.6 pt-20 -121.99 -35.3 3.19 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.482 1.113 . . . . 72.01 110.294 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -118.1 167.29 11.61 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.922 -1.14 . . . . 74.41 107.922 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.518 ' CZ ' ' CG2' ' A' ' 227' ' ' VAL . 23.7 m-85 -141.78 161.58 37.59 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.492 1.12 . . . . 73.53 111.031 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.467 ' CD1' ' HG ' ' A' ' 206' ' ' LEU . 20.8 mm -99.65 122.9 52.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.51 1.131 . . . . 74.44 109.258 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.428 ' HB2' ' CG2' ' A' ' 207' ' ' VAL . . . -106.24 153.09 22.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.548 1.155 . . . . 61.42 109.281 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.4 tttp . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 72.43 109.255 179.982 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.992 0 N-CA-C 111.028 -0.829 . . . . 64.44 111.028 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 174.41 52.88 Favored 'Cis proline' 0 C--N 1.36 1.134 0 C-N-CA 121.013 -2.495 . . . . 65.1 111.026 0.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -123.13 -173.68 14.11 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.491 1.119 . . . . 62.43 110.985 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.556 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 3.3 mp -115.06 156.08 25.83 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.566 0.803 . . . . 75.54 109.29 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.55 HG13 ' CD2' ' A' ' 166' ' ' PHE . 0.2 OUTLIER -150.99 147.27 20.37 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.455 1.097 . . . . 71.51 109.297 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.563 ' HD3' ' CD1' ' A' ' 166' ' ' PHE . 18.3 Cg_endo -75.02 141.49 26.65 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.551 1.816 . . . . 73.45 110.968 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.485 ' CG1' ' O ' ' A' ' 191' ' ' GLU . 7.2 p -64.48 -37.72 80.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.563 1.164 . . . . 75.53 109.322 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -60.06 -13.93 29.55 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.483 1.114 . . . . 62.12 111.004 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.571 ' CD2' ' HB3' ' A' ' 164' ' ' TYR . 5.9 m-85 -112.19 18.53 18.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.519 0.776 . . . . 73.21 110.94 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.468 ' CG2' ' HA ' ' A' ' 209' ' ' VAL . 10.5 m -153.43 143.63 14.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.52 1.137 . . . . 75.44 109.292 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.5 t -129.5 148.08 51.37 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.476 1.11 . . . . 64.4 110.006 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.469 HG13 ' CG2' ' A' ' 227' ' ' VAL . 25.8 mm -98.87 119.1 46.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.577 1.173 . . . . 71.04 109.327 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 4.0 pt . . . . . 0 C--N 1.325 -0.495 0 O-C-N 124.507 1.129 . . . . 73.44 109.358 179.986 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' THR . . . . . 0.492 ' HG1' ' ND2' ' A' ' 225' ' ' ASN . 60.9 p . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 120.54 0.209 . . . . 74.33 110.467 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 111.53 18.03 8.29 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.479 1.112 . . . . 74.23 110.993 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.556 ' N ' HD21 ' A' ' 225' ' ' ASN . 1.0 OUTLIER -79.93 175.39 10.67 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 0.758 . . . . 73.22 109.322 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -131.1 162.42 29.89 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.408 1.068 . . . . 74.32 109.307 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.518 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 11.4 p -77.92 -45.01 28.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.56 1.162 . . . . 74.41 109.278 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.0 mp -54.09 -44.85 64.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.5 1.125 . . . . 73.33 109.345 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -63.76 -28.78 70.11 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.481 1.113 . . . . 64.4 110.237 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.41 -19.87 35.2 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 74.31 109.328 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.566 HG22 ' CD2' ' A' ' 187' ' ' HIS . 37.8 mt -76.76 -36.53 26.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.511 1.132 . . . . 53.53 109.279 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -83.97 -12.02 55.95 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.107 . . . . 73.41 109.282 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.8 p -78.86 -41.67 29.35 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 71.25 109.961 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.425 ' C ' ' N ' ' A' ' 236' ' ' LEU . 7.7 p -108.72 26.28 2.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.527 1.142 . . . . 73.14 109.266 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 12.6 m120 45.6 26.21 0.31 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.518 1.136 . . . . 74.51 109.331 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.467 ' HB3' ' CG2' ' A' ' 231' ' ' ILE . 0.8 OUTLIER -43.91 103.8 0.34 Allowed Pre-proline 0 C--N 1.326 -0.433 0 O-C-N 124.484 1.115 . . . . 73.2 109.299 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 140.49 25.48 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.507 1.793 . . . . 73.43 111.0 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' THR . . . . . 0.552 HG21 ' CE1' ' A' ' 187' ' ' HIS . 15.7 p -57.66 155.69 9.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.551 1.157 . . . . 72.12 110.326 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.643 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 1.9 p -61.83 -21.04 24.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.458 1.099 . . . . 60.54 109.358 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.469 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 40.2 mm-40 -85.58 -26.23 26.25 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 75.55 110.286 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -84.3 -35.55 23.24 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.513 1.133 . . . . 73.22 110.291 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 245' ' ' ASN . 1.2 t90 -65.49 -52.07 55.42 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.001 -1.111 . . . . 75.13 108.001 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.04 -33.32 11.13 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.435 1.084 . . . . 75.42 109.258 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.4 t -78.88 -30.23 44.88 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.441 1.088 . . . . 72.1 110.03 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 242' ' ' TRP . 5.4 t-20 . . . . . 0 C--N 1.324 -0.503 0 O-C-N 124.46 1.1 . . . . 74.32 109.223 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.46 ' HG ' ' CG1' ' A' ' 234' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 109.266 -0.642 . . . . 70.43 109.266 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 159' ' ' TYR . 1.1 p90 -129.95 116.43 18.6 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.507 1.13 . . . . 75.11 111.003 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.46 ' CB ' HD12 ' A' ' 214' ' ' ILE . . . -95.23 132.37 40.27 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.529 1.143 . . . . 65.02 109.297 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -108.43 130.41 61.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.119 . . . . 73.03 109.322 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.488 ' CG1' ' O ' ' A' ' 211' ' ' PHE . 2.2 t -81.33 122.11 35.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.499 1.124 . . . . 74.15 109.265 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.44 -26.14 19.99 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.485 1.115 . . . . 73.45 109.295 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -130.67 147.83 52.39 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.517 1.136 . . . . 72.43 111.023 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -61.06 108.42 0.88 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 75.54 109.309 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.605 ' CE2' ' O ' ' A' ' 174' ' ' LEU . 1.7 t80 -80.95 132.31 35.39 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.434 1.084 . . . . 74.4 110.983 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.602 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 0.4 OUTLIER -103.66 140.96 36.87 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.433 1.083 . . . . 71.32 109.322 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.5 ' CB ' ' OE1' ' A' ' 173' ' ' GLU . . . -84.34 126.58 33.34 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.514 1.134 . . . . 73.51 109.322 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -127.67 -33.65 2.27 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.506 1.129 . . . . 74.32 110.299 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.425 ' C ' ' HG3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -58.09 -164.43 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.504 1.128 . . . . 70.32 109.283 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.16 -51.56 5.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.469 1.106 . . . . 71.12 109.323 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -107.57 28.64 7.95 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.427 1.08 . . . . 71.33 109.288 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.5 ' OE1' ' CB ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -59.73 177.94 0.19 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.503 1.127 . . . . 74.4 110.313 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.605 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 12.4 mt -145.09 133.2 21.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 1.137 . . . . 71.53 109.277 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.8 t -81.47 154.92 26.08 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 75.1 110.44 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.503 ' C ' ' CD1' ' A' ' 177' ' ' TYR . 2.6 m -142.46 -165.44 2.04 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.529 1.143 . . . . 74.13 110.393 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.503 ' CD1' ' C ' ' A' ' 176' ' ' THR . 20.7 m-85 -143.86 137.92 28.27 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.525 1.141 . . . . 75.31 111.011 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 179' ' ' GLY . 0.7 OUTLIER -44.53 146.52 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.46 1.1 . . . . 75.34 109.315 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.455 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 52.67 60.55 7.77 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.494 1.121 . . . . 73.24 111.04 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -118.51 166.21 12.97 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.518 0.775 . . . . 72.1 110.322 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.09 136.37 52.83 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.483 1.114 . . . . 71.01 109.257 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.487 ' CD2' ' CG2' ' A' ' 162' ' ' VAL . 0.5 OUTLIER -167.19 157.83 11.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.452 1.095 . . . . 64.44 109.329 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.459 ' C ' ' CD1' ' A' ' 183' ' ' PHE . 6.8 p90 -99.54 150.48 22.18 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.447 1.092 . . . . 63.54 111.059 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.502 HD11 ' CG ' ' A' ' 193' ' ' PHE . 19.6 mm -88.93 133.41 31.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 124.489 1.118 . . . . 73.34 109.334 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.464 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 3.6 t -97.56 -27.73 14.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.409 1.068 . . . . 73.1 108.249 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 184' ' ' ILE . . . -160.62 179.44 8.57 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.568 1.168 . . . . 74.0 109.342 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.572 ' CD2' HG22 ' A' ' 231' ' ' ILE . 8.3 p80 -147.05 120.63 9.12 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.475 1.109 . . . . 75.31 109.58 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.563 ' CD2' HG12 ' A' ' 239' ' ' VAL . 0.9 OUTLIER -99.7 114.53 27.7 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.451 1.094 . . . . 64.55 109.619 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.428 ' C ' ' N ' ' A' ' 191' ' ' GLU . 9.6 t30 53.69 34.19 18.33 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.543 1.152 . . . . 75.11 109.356 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 13.4 p 42.53 28.47 0.12 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.482 1.114 . . . . 70.43 108.299 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.428 ' N ' ' C ' ' A' ' 189' ' ' ASN . 3.8 pt-20 -121.64 -33.97 3.5 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.563 1.165 . . . . 72.32 110.297 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 8.2 m0 -117.22 157.48 25.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.518 1.136 . . . . 73.32 108.009 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.52 ' CD2' HG22 ' A' ' 212' ' ' VAL . 36.6 m-85 -130.66 159.14 38.11 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.478 1.111 . . . . 75.44 110.98 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.472 ' CG1' ' HB ' ' A' ' 239' ' ' VAL . 31.0 mm -102.7 96.0 4.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.456 1.098 . . . . 74.43 109.298 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.487 ' CB ' ' CD1' ' A' ' 182' ' ' LEU . . . -79.38 166.09 22.42 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.157 . . . . 74.13 109.233 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.1 tptp . . . . . 0 C--N 1.326 -0.434 0 O-C-N 124.514 1.134 . . . . 75.22 109.275 -179.978 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.053 0 N-CA-C 110.969 -0.852 . . . . 74.33 110.969 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 162.46 92.8 Favored 'Cis proline' 0 C--N 1.359 1.129 0 C-N-CA 120.973 -2.511 . . . . 73.21 110.935 0.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.416 ' HA3' ' CG ' ' A' ' 174' ' ' LEU . . . -133.64 160.28 23.97 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.545 1.153 . . . . 75.33 111.022 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.457 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 3.8 mt -99.61 137.27 38.32 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.531 0.783 . . . . 73.03 109.317 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.472 ' CG2' ' CG1' ' A' ' 212' ' ' VAL . 0.1 OUTLIER -133.94 136.78 27.02 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.583 1.177 . . . . 75.23 109.319 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.56 ' HD3' ' CE1' ' A' ' 166' ' ' PHE . 18.5 Cg_endo -74.93 138.12 22.79 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.491 1.785 . . . . 74.03 111.006 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.2 -15.66 18.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.525 1.14 . . . . 74.23 109.295 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -83.87 10.86 58.98 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.485 1.116 . . . . 73.13 111.052 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.488 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 19.0 m-85 -140.7 15.53 2.33 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.501 0.765 . . . . 64.41 111.009 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.52 HG22 ' CD2' ' A' ' 193' ' ' PHE . 21.9 m -147.53 149.55 15.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.475 1.11 . . . . 74.32 109.283 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.42 152.44 49.82 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.453 1.096 . . . . 71.32 109.952 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.469 HG13 ' CG2' ' A' ' 227' ' ' VAL . 31.0 mm -111.09 95.66 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 72.01 109.349 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 27.8 pt . . . . . 0 C--N 1.324 -0.504 0 O-C-N 124.455 1.097 . . . . 71.12 109.349 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 39.1 p . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 110.405 -0.22 . . . . 51.55 110.405 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 122.09 3.71 9.66 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.558 1.161 . . . . 52.41 111.017 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -83.1 -177.6 6.82 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.433 0.725 . . . . 74.31 109.306 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.23 178.61 6.84 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.564 1.165 . . . . 72.43 109.288 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.474 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 2.5 p -82.99 -34.37 11.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.522 1.139 . . . . 75.23 109.329 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.473 ' CD1' HG12 ' A' ' 227' ' ' VAL . 1.6 mp -59.87 -37.48 72.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.463 1.102 . . . . 74.42 109.241 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -67.15 -42.72 83.9 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.477 1.111 . . . . 74.14 110.266 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.42 -32.99 74.24 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.496 1.123 . . . . 72.12 109.279 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.572 HG22 ' CD2' ' A' ' 187' ' ' HIS . 24.7 mt -63.61 -43.69 98.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.477 1.111 . . . . 75.23 109.311 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -78.46 -11.98 59.98 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 73.12 109.273 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.7 m -76.9 -44.89 30.05 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.526 1.141 . . . . 71.2 110.05 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.46 ' CG1' ' HG ' ' A' ' 158' ' ' LEU . 9.9 p -109.26 30.06 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.488 1.118 . . . . 73.11 109.31 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 42.41 28.46 0.11 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.516 1.135 . . . . 74.55 109.281 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.452 ' HB3' ' CG2' ' A' ' 231' ' ' ILE . 1.6 tm? -42.77 102.38 0.27 Allowed Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.587 1.179 . . . . 52.31 109.288 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.03 152.9 41.17 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.523 1.802 . . . . 74.11 111.02 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 8.8 p -67.17 151.41 47.6 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.549 1.155 . . . . 71.14 110.386 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.563 HG12 ' CD2' ' A' ' 188' ' ' HIS . 1.3 p -50.79 -23.91 2.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.464 1.103 . . . . 72.4 109.318 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -83.82 -46.7 11.9 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.536 1.147 . . . . 72.34 110.342 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -63.25 -23.83 67.6 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.514 1.134 . . . . 74.05 110.343 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -80.14 -65.87 0.95 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.509 1.131 . . . . 75.41 107.98 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.39 -28.74 1.43 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.578 1.174 . . . . 75.14 109.28 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.4 t -71.49 -51.59 22.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.536 1.147 . . . . 72.44 109.973 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.425 1.078 . . . . 63.31 109.346 179.968 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 14.1 tp . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 109.271 -0.64 . . . . 74.33 109.271 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -137.38 115.92 12.02 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.556 1.16 . . . . 74.35 111.012 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -115.51 152.18 33.46 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.521 1.138 . . . . 75.24 109.325 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.53 ' CD1' ' ND2' ' A' ' 181' ' ' ASN . 1.4 tp -120.12 128.88 75.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.487 1.117 . . . . 74.21 109.264 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.439 HG23 ' CD1' ' A' ' 182' ' ' LEU . 18.2 t -92.83 112.17 25.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.529 1.143 . . . . 65.23 109.359 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.599 ' O ' ' CD2' ' A' ' 164' ' ' TYR . 0.1 OUTLIER -101.03 28.95 4.91 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.496 1.123 . . . . 75.31 109.327 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.599 ' CD2' ' O ' ' A' ' 163' ' ' LEU . 78.9 m-85 -164.57 131.07 2.98 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.555 1.159 . . . . 73.54 110.958 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.463 ' CB ' HG21 ' A' ' 178' ' ' VAL . 2.7 t0 -79.59 101.19 8.17 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 75.43 109.329 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.568 ' CD1' ' HD3' ' A' ' 208' ' ' PRO . 60.9 t80 -83.21 152.67 25.11 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 74.05 111.024 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.561 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 6.9 mmmm -110.69 154.82 23.31 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.514 1.134 . . . . 63.05 109.25 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.414 ' HB2' ' N ' ' A' ' 174' ' ' LEU . . . -95.49 125.0 39.8 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.539 1.149 . . . . 73.11 109.287 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -121.68 -40.31 2.56 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.477 1.11 . . . . 73.03 110.365 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -174.56 0.23 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.573 1.171 . . . . 73.03 109.284 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.38 -34.05 20.32 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.546 1.154 . . . . 72.41 109.307 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.5 10.35 33.21 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.626 1.204 . . . . 74.14 109.264 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -75.12 172.87 11.6 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.125 . . . . 70.22 110.296 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.414 ' N ' ' HB2' ' A' ' 168' ' ' ALA . 1.3 tp -155.56 157.68 37.22 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.53 1.144 . . . . 74.22 109.265 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.0 t -102.89 137.08 41.57 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.496 1.122 . . . . 74.41 110.407 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 3.4 m -113.71 -166.01 1.05 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.547 1.154 . . . . 71.14 110.366 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -138.57 150.69 46.58 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.456 1.097 . . . . 74.4 110.965 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.463 HG21 ' CB ' ' A' ' 165' ' ' ASP . 60.8 t -60.84 163.66 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.133 . . . . 75.42 109.301 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 37.74 57.73 1.54 Allowed Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.45 1.094 . . . . 74.53 110.995 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.464 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 12.7 mm-40 -114.19 155.89 25.26 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.485 0.756 . . . . 73.23 110.326 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.53 ' ND2' ' CD1' ' A' ' 161' ' ' ILE . 2.3 m-80 -123.32 125.09 44.38 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.531 1.144 . . . . 53.43 109.349 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.469 ' CD1' ' N ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -162.53 162.65 27.47 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.51 1.131 . . . . 74.53 109.308 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 184' ' ' ILE . 2.7 t80 -98.96 147.93 24.49 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.433 1.083 . . . . 73.4 111.007 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.508 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 8.9 mm -77.67 112.49 15.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.472 1.108 . . . . 71.42 109.325 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.451 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 10.9 t -78.71 -22.73 46.19 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.525 1.141 . . . . 62.35 108.285 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.491 ' O ' ' CG2' ' A' ' 184' ' ' ILE . . . -171.9 179.65 2.67 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.58 1.175 . . . . 74.02 109.308 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.444 ' CE1' HG23 ' A' ' 238' ' ' THR . 8.0 p80 -148.05 151.25 35.37 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.526 1.141 . . . . 61.34 109.522 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.437 ' CE1' HE21 ' A' ' 240' ' ' GLN . 1.8 t-160 -132.48 122.45 24.92 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.493 1.12 . . . . 70.5 109.597 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.444 ' C ' ' N ' ' A' ' 191' ' ' GLU . 3.0 m-20 54.15 30.4 12.08 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.477 1.111 . . . . 74.21 109.281 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 12.7 p 42.95 28.95 0.15 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 72.43 108.299 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.444 ' N ' ' C ' ' A' ' 189' ' ' ASN . 9.8 pt-20 -124.5 -37.18 2.54 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.564 1.165 . . . . 73.25 110.257 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.493 ' CE3' ' HB3' ' A' ' 206' ' ' LEU . 11.2 m0 -109.71 158.2 18.34 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.492 1.12 . . . . 74.04 108.004 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.491 ' CZ ' HG23 ' A' ' 227' ' ' VAL . 44.7 m-85 -137.56 157.16 47.12 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.532 1.145 . . . . 72.32 111.005 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.455 ' CD1' ' HG ' ' A' ' 206' ' ' LEU . 30.8 mm -96.83 98.85 8.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.543 1.152 . . . . 72.31 109.266 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.92 158.02 15.66 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.557 1.161 . . . . 75.02 109.267 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt . . . . . 0 C--N 1.325 -0.47 0 O-C-N 124.527 1.142 . . . . 70.05 109.297 179.924 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.975 0 N-CA-C 111.027 -0.829 . . . . 65.4 111.027 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -170.45 8.28 Favored 'Cis proline' 0 C--N 1.359 1.124 0 C-N-CA 120.953 -2.52 . . . . 65.11 110.951 0.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -150.32 156.17 26.59 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.438 1.086 . . . . 74.41 110.983 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.506 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 1.7 mt -97.26 127.45 43.23 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.543 0.79 . . . . 73.22 109.343 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.458 HG12 ' CG ' ' A' ' 166' ' ' PHE . 0.3 OUTLIER -129.54 145.47 57.07 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.466 1.104 . . . . 73.24 109.35 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.568 ' HD3' ' CD1' ' A' ' 166' ' ' PHE . 18.6 Cg_endo -74.96 148.11 35.04 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.436 1.756 . . . . 75.02 110.994 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.46 ' HA ' ' CG2' ' A' ' 212' ' ' VAL . 8.0 p -66.79 -32.06 56.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.469 1.105 . . . . 75.11 109.297 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . 0.407 ' N ' HG11 ' A' ' 209' ' ' VAL . . . -66.01 -9.1 45.83 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.478 1.111 . . . . 74.44 111.046 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.562 ' HA ' ' CD2' ' A' ' 164' ' ' TYR . 4.6 m-85 -113.84 5.04 16.12 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.471 0.748 . . . . 72.42 110.928 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.46 ' CG2' ' HA ' ' A' ' 209' ' ' VAL . 18.4 m -140.47 162.14 24.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.49 1.119 . . . . 72.23 109.26 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.8 t -144.97 144.18 30.92 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.502 1.126 . . . . 73.34 110.008 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.461 HG13 ' CG2' ' A' ' 227' ' ' VAL . 36.0 mm -96.13 105.95 17.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.478 1.111 . . . . 62.52 109.303 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 1.9 pt . . . . . 0 C--N 1.325 -0.463 0 O-C-N 124.497 1.123 . . . . 74.41 109.256 -179.945 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' THR . . . . . 0.446 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 11.0 p . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 110.411 -0.218 . . . . 75.51 110.411 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 138.99 -13.2 3.35 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.474 1.109 . . . . 63.23 110.979 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.446 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 2.6 p30 -54.4 168.51 0.25 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.505 0.768 . . . . 72.32 109.251 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -114.57 175.24 5.57 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.469 1.105 . . . . 73.32 109.311 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.491 HG23 ' CZ ' ' A' ' 193' ' ' PHE . 11.0 p -80.77 -33.17 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.459 1.099 . . . . 72.4 109.316 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.6 mp -60.58 -51.49 72.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.477 1.111 . . . . 75.12 109.338 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -61.96 -22.66 65.83 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.49 1.118 . . . . 74.53 110.268 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.468 ' O ' ' CG2' ' A' ' 234' ' ' VAL . 2.9 m-20 -83.6 -35.91 24.31 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.454 1.096 . . . . 64.41 109.257 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.501 ' CG2' ' HB3' ' A' ' 236' ' ' LEU . 12.2 mt -59.87 -29.99 44.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 74.31 109.287 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -84.08 -11.52 56.55 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.445 1.09 . . . . 72.34 109.257 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.03 -11.85 29.87 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.478 1.111 . . . . 71.12 109.988 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' A' ' 230' ' ' ASP . 0.0 OUTLIER -132.56 10.69 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.525 1.14 . . . . 65.13 109.295 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 236' ' ' LEU . 74.0 m-20 52.95 20.74 1.76 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 63.32 109.327 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.501 ' HB3' ' CG2' ' A' ' 231' ' ' ILE . 0.0 OUTLIER -39.55 100.51 0.21 Allowed Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.476 1.11 . . . . 74.45 109.311 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.89 142.94 28.83 Favored 'Trans proline' 0 C--N 1.359 1.099 0 O-C-N 124.445 1.76 . . . . 71.21 111.012 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' THR . . . . . 0.444 HG23 ' CE1' ' A' ' 187' ' ' HIS . 7.1 p -60.23 148.08 37.8 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.547 1.154 . . . . 73.53 110.434 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 1.4 p -52.82 -25.8 9.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.497 1.123 . . . . 73.41 109.281 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.437 HE21 ' CE1' ' A' ' 188' ' ' HIS . 98.3 mm-40 -75.5 -39.38 58.59 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.561 1.163 . . . . 74.15 110.37 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -76.99 -23.1 52.28 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.454 1.096 . . . . 74.12 110.326 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -79.93 -61.69 1.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.541 1.151 . . . . 74.22 107.978 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.31 -25.03 5.21 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.49 1.119 . . . . 72.13 109.291 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 29.5 t -72.55 -35.7 68.07 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.128 . . . . 61.4 109.997 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 1.9 t30 . . . . . 0 C--N 1.324 -0.521 0 O-C-N 124.542 1.151 . . . . 70.41 109.306 179.976 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.7 tp . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 109.348 -0.612 . . . . 75.24 109.348 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.53 ' CE2' ' O ' ' A' ' 215' ' ' ILE . 2.4 p90 -152.01 152.26 32.22 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.518 1.136 . . . . 73.34 110.974 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.47 ' HB2' ' CG1' ' A' ' 184' ' ' ILE . . . -122.39 141.27 51.76 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.513 1.133 . . . . 52.41 109.232 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.51 128.38 55.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.472 1.107 . . . . 75.12 109.255 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 179' ' ' GLY . 43.4 t -84.56 92.54 3.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.547 1.155 . . . . 74.45 109.332 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.565 HD13 ' CE2' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -92.51 25.09 3.16 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 72.31 109.321 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.565 ' CE2' HD13 ' A' ' 163' ' ' LEU . 37.3 m-85 -165.18 141.11 5.44 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.481 1.113 . . . . 74.22 111.014 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -67.22 98.66 0.62 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.493 1.121 . . . . 64.15 109.257 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.578 ' CE2' ' O ' ' A' ' 174' ' ' LEU . 0.6 OUTLIER -80.3 123.53 28.05 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.436 1.085 . . . . 75.03 111.017 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.515 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 7.8 mmmm -93.25 138.93 31.16 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.454 1.096 . . . . 73.2 109.341 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.489 ' CB ' ' OE1' ' A' ' 173' ' ' GLU . . . -82.0 122.1 27.37 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.415 1.072 . . . . 75.44 109.275 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -126.97 -34.93 2.31 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.562 1.164 . . . . 73.12 110.27 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 4.8 mttp -58.56 -164.09 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.423 1.077 . . . . 73.5 109.357 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.31 -51.28 5.65 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.578 1.174 . . . . 74.33 109.306 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -105.36 29.48 6.43 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.503 1.127 . . . . 74.11 109.262 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.492 ' O ' ' CD2' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -59.02 172.5 0.56 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.531 1.144 . . . . 70.43 110.325 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.578 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 1.7 mm? -146.95 108.07 4.22 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.417 1.073 . . . . 75.35 109.278 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.09 143.28 54.24 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.461 1.1 . . . . 75.22 110.361 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.8 m -139.9 -169.01 2.63 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.525 1.14 . . . . 70.52 110.378 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -130.94 147.43 52.58 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.448 1.092 . . . . 63.42 111.021 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.9 p -59.15 155.55 2.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.576 1.172 . . . . 71.53 109.285 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 61.51 41.39 99.55 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.444 1.09 . . . . 43.14 110.972 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -121.84 171.33 8.98 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.428 0.723 . . . . 62.23 110.273 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -119.03 131.57 55.99 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.494 1.121 . . . . 75.24 109.318 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 18.2 mt -140.61 124.38 17.16 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.501 1.126 . . . . 73.42 109.332 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -79.25 128.32 33.16 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.471 1.107 . . . . 75.45 111.01 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.47 ' CG1' ' HB2' ' A' ' 160' ' ' ALA . 15.6 mm -77.68 121.29 30.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.453 1.096 . . . . 74.44 109.359 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 62.9 m -95.73 -31.37 13.25 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.494 1.121 . . . . 73.11 108.248 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.462 ' HA ' ' CD2' ' A' ' 236' ' ' LEU . . . -164.03 161.66 22.73 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.498 1.124 . . . . 70.24 109.247 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.569 ' CE1' HG21 ' A' ' 231' ' ' ILE . 9.0 p80 -128.74 147.4 50.77 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.552 1.157 . . . . 74.04 109.577 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.594 ' CD2' ' CG1' ' A' ' 239' ' ' VAL . 1.0 OUTLIER -120.91 119.17 31.85 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.51 1.131 . . . . 74.13 109.542 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.436 ' O ' ' C ' ' A' ' 190' ' ' CYS . 5.5 m-80 48.62 37.92 10.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 73.05 109.302 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.5 p 38.72 38.77 0.29 Allowed 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.501 1.125 . . . . 63.33 108.251 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.491 ' O ' ' CG2' ' A' ' 209' ' ' VAL . 11.6 pt-20 -132.52 -37.52 1.06 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.509 1.131 . . . . 70.12 110.289 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.476 ' N ' ' HG3' ' A' ' 191' ' ' GLU . 20.8 m95 -113.51 163.1 15.35 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.482 1.114 . . . . 75.41 108.088 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.57 ' CE2' HG21 ' A' ' 209' ' ' VAL . 13.7 m-85 -133.59 161.72 33.87 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 74.11 111.002 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.459 ' CG1' ' HB ' ' A' ' 239' ' ' VAL . 20.0 mm -111.92 95.38 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.145 . . . . 70.21 109.248 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.44 ' CB ' HG13 ' A' ' 207' ' ' VAL . . . -86.3 -175.18 5.39 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.532 1.145 . . . . 71.31 109.364 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.4 pttp . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 73.24 109.266 -179.938 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.041 0 N-CA-C 110.926 -0.87 . . . . 62.44 110.926 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.462 ' HG3' ' CH2' ' A' ' 242' ' ' TRP . 18.5 Cg_endo -74.89 144.95 82.57 Favored 'Cis proline' 0 C--N 1.361 1.2 0 C-N-CA 120.967 -2.514 . . . . 72.22 111.095 -0.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.469 ' HA3' ' CD2' ' A' ' 174' ' ' LEU . . . -106.99 160.06 14.38 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.509 1.13 . . . . 72.4 110.981 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.481 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 2.6 mt -103.55 139.63 38.61 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.465 0.744 . . . . 74.01 109.271 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.541 ' CG2' ' CG1' ' A' ' 212' ' ' VAL . 0.2 OUTLIER -143.89 127.52 9.03 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.49 1.119 . . . . 74.11 109.244 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 207' ' ' VAL . 18.4 Cg_endo -74.98 157.72 42.7 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.493 1.786 . . . . 75.53 111.043 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.57 HG21 ' CE2' ' A' ' 193' ' ' PHE . 21.3 t -80.94 3.26 2.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.547 1.154 . . . . 74.14 109.311 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . 0.431 ' O ' ' CD1' ' A' ' 211' ' ' PHE . . . -89.16 -3.01 76.56 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.467 1.105 . . . . 71.35 110.942 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.431 ' CD1' ' O ' ' A' ' 210' ' ' GLY . 21.4 m-85 -136.69 14.59 3.15 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.474 0.749 . . . . 75.32 110.972 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.541 ' CG1' ' CG2' ' A' ' 207' ' ' VAL . 8.7 m -142.4 146.94 21.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.464 1.102 . . . . 72.13 109.324 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' SER . . . . . 0.409 ' CB ' HD23 ' A' ' 163' ' ' LEU . 26.0 t -129.33 160.76 32.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.551 1.157 . . . . 71.52 110.011 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.486 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 16.6 mm -102.65 145.75 11.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 75.22 109.306 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.53 ' O ' ' CE2' ' A' ' 159' ' ' TYR . 44.3 pt . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.571 1.17 . . . . 71.2 109.205 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 110.402 -0.222 . . . . 72.35 110.402 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 106.88 -0.58 36.0 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.51 1.132 . . . . 72.43 111.037 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.419 ' N ' HD21 ' A' ' 225' ' ' ASN . 1.7 m-80 -70.02 -175.92 1.03 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.528 0.781 . . . . 71.33 109.3 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -114.08 173.22 6.55 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.493 1.12 . . . . 74.13 109.352 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.468 ' CG2' HG13 ' A' ' 214' ' ' ILE . 2.8 p -84.16 -33.56 9.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.371 1.044 . . . . 75.05 109.329 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 1.8 mp -61.24 -50.87 78.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.498 1.123 . . . . 74.15 109.363 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -58.28 -31.42 67.45 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 64.01 110.351 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.54 -35.74 52.96 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.497 1.123 . . . . 64.14 109.354 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.569 HG21 ' CE1' ' A' ' 187' ' ' HIS . 29.7 mt -68.34 -38.43 79.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.131 . . . . 74.25 109.29 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.29 -33.85 59.08 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.536 1.147 . . . . 74.54 109.336 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.7 m -58.79 -38.24 78.1 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.561 1.163 . . . . 73.41 109.989 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.0 p -112.6 6.93 8.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.494 1.121 . . . . 74.53 109.325 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 231' ' ' ILE . 9.2 p30 40.46 51.72 2.91 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.471 1.107 . . . . 74.3 109.269 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.462 ' CD2' ' HA ' ' A' ' 186' ' ' ALA . 1.1 tt -50.79 140.72 19.3 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.554 1.159 . . . . 75.34 109.369 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 129.45 12.3 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.55 1.816 . . . . 64.11 111.002 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 3.0 p -67.17 152.39 45.84 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.479 1.112 . . . . 73.42 110.353 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.594 ' CG1' ' CD2' ' A' ' 188' ' ' HIS . 1.7 p -46.99 -25.58 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.544 1.153 . . . . 71.15 109.286 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -86.63 -50.43 6.81 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 74.11 110.337 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -57.1 -25.15 58.3 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.548 1.155 . . . . 74.54 110.249 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.462 ' CH2' ' HG3' ' A' ' 204' ' ' PRO . 26.9 t90 -85.77 -61.85 1.66 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 74.44 108.022 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -50.88 -23.2 2.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.433 1.083 . . . . 74.52 109.284 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.9 t -86.85 -61.81 1.64 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.413 1.071 . . . . 75.21 110.007 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 C--N 1.324 -0.507 0 O-C-N 124.518 1.136 . . . . 73.41 109.289 179.946 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.4 tp . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.3 -0.63 . . . . 74.22 109.3 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.477 ' HB3' ' CE2' ' A' ' 183' ' ' PHE . 33.8 p90 -103.65 144.11 31.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.512 1.132 . . . . 75.22 110.998 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -140.83 141.83 34.67 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.557 1.161 . . . . 74.42 109.315 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.5 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -109.07 133.73 53.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 74.45 109.329 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.4 t -86.05 125.1 40.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.452 1.095 . . . . 73.45 109.378 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.54 ' N ' ' CD2' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -112.88 12.88 19.53 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.538 1.149 . . . . 72.43 109.317 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.408 ' CG ' ' O ' ' A' ' 163' ' ' LEU . 97.4 m-85 -158.24 145.14 17.73 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.467 1.105 . . . . 74.21 111.02 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -79.92 103.01 9.52 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.406 1.066 . . . . 63.35 109.277 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.545 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 7.4 t80 -83.1 137.82 33.94 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 73.14 111.015 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.486 ' HA ' ' CE ' ' A' ' 167' ' ' LYS . 0.5 OUTLIER -105.47 123.54 48.06 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.532 1.145 . . . . 73.12 109.304 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.425 ' CB ' ' OE1' ' A' ' 173' ' ' GLU . . . -71.0 123.26 21.64 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.595 1.185 . . . . 75.14 109.313 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -126.78 -34.16 2.42 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.541 1.151 . . . . 72.41 110.309 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 0.4 OUTLIER -58.62 -164.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 O-C-N 124.435 1.084 . . . . 74.34 109.316 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.34 -51.22 5.67 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.487 1.117 . . . . 73.52 109.266 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.64 29.42 6.96 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.521 1.138 . . . . 74.01 109.287 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.464 ' CD ' ' N ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -58.95 -178.42 0.05 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.561 1.163 . . . . 75.25 110.251 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.525 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -147.54 119.97 8.46 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.544 1.153 . . . . 71.32 109.277 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.53 130.41 35.95 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.555 1.159 . . . . 74.31 110.439 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.7 m -126.91 -176.08 3.6 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.593 1.183 . . . . 75.51 110.435 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 177' ' ' TYR . 23.9 m-85 -136.09 143.35 44.56 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.558 1.161 . . . . 64.44 110.987 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.5 p -56.24 147.28 4.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.469 1.106 . . . . 71.21 109.291 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.81 58.07 13.85 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.495 1.122 . . . . 75.41 111.034 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.5 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 10.9 tp10 -121.83 166.16 14.8 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.547 0.792 . . . . 74.53 110.303 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.415 ' N ' HD21 ' A' ' 181' ' ' ASN . 2.3 m-80 -119.35 133.44 55.72 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.442 1.089 . . . . 71.31 109.292 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.457 ' C ' ' CD1' ' A' ' 182' ' ' LEU . 1.2 pp -166.93 -175.45 3.05 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.546 1.154 . . . . 74.22 109.309 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.477 ' CE2' ' HB3' ' A' ' 159' ' ' TYR . 22.4 m-85 -134.07 139.91 46.29 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.474 1.109 . . . . 72.2 110.998 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.453 ' CD1' ' HB3' ' A' ' 193' ' ' PHE . 27.9 mm -77.7 138.08 21.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.487 1.117 . . . . 75.4 109.337 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.456 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 0.6 OUTLIER -95.1 -28.13 15.24 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.102 . . . . 73.1 108.338 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.403 ' N ' ' HB ' ' A' ' 194' ' ' ILE . . . -172.41 179.56 2.49 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.497 1.123 . . . . 72.42 109.325 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.565 ' CD2' HG23 ' A' ' 231' ' ' ILE . 8.5 p80 -136.56 154.32 50.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.486 1.116 . . . . 75.32 109.607 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.487 ' O ' ' CG ' ' A' ' 191' ' ' GLU . 0.0 OUTLIER -126.97 117.94 23.51 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.469 1.106 . . . . 64.25 109.511 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 2.2 m120 50.85 33.91 9.41 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.479 1.112 . . . . 73.0 109.292 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.464 ' HB3' ' CG1' ' A' ' 228' ' ' ILE . 99.2 m 43.77 38.16 1.93 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.473 1.108 . . . . 62.12 108.286 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 188' ' ' HIS . 8.3 pt-20 -135.26 -40.51 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.562 1.164 . . . . 71.42 110.318 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -107.23 165.78 11.12 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.989 -1.115 . . . . 74.22 107.989 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.562 ' CZ ' HG23 ' A' ' 209' ' ' VAL . 12.4 m-85 -137.79 159.03 43.11 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.499 1.124 . . . . 74.22 110.978 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.456 ' CG2' ' HB3' ' A' ' 185' ' ' CYS . 21.1 mm -100.37 114.43 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.504 1.127 . . . . 74.13 109.288 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.46 ' CB ' HG13 ' A' ' 207' ' ' VAL . . . -92.59 168.07 11.49 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.543 1.152 . . . . 75.23 109.273 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.496 ' CG ' ' O ' ' A' ' 196' ' ' LYS . 1.8 pttt . . . . . 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.128 . . . . 73.25 109.34 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.032 0 N-CA-C 111.014 -0.834 . . . . 62.24 111.014 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 145.22 83.34 Favored 'Cis proline' 0 C--N 1.359 1.118 0 C-N-CA 121.048 -2.48 . . . . 73.12 111.017 0.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.467 ' HA3' ' CD2' ' A' ' 174' ' ' LEU . . . -119.09 -166.01 13.31 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.597 1.186 . . . . 65.51 111.006 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.454 HD23 ' CD1' ' A' ' 194' ' ' ILE . 3.1 mt -119.69 142.74 48.22 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.422 0.719 . . . . 73.2 109.302 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.46 HG13 ' CB ' ' A' ' 195' ' ' ALA . 1.6 m -143.9 155.06 59.32 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.487 1.117 . . . . 75.01 109.323 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.515 ' HD3' ' CE1' ' A' ' 166' ' ' PHE . 18.4 Cg_endo -74.93 160.44 40.35 Favored 'Trans proline' 0 C--N 1.359 1.108 0 O-C-N 124.53 1.805 . . . . 74.33 111.055 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.562 HG23 ' CZ ' ' A' ' 193' ' ' PHE . 10.1 p -84.97 -19.04 8.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 74.05 109.349 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -82.83 9.33 60.05 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.487 1.117 . . . . 70.12 110.994 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.545 ' CE2' ' HA ' ' A' ' 166' ' ' PHE . 11.2 m-85 -128.46 18.67 6.35 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 0.768 . . . . 71.53 111.009 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.514 HG23 ' CD2' ' A' ' 193' ' ' PHE . 31.7 m -156.9 144.5 10.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.496 1.123 . . . . 65.13 109.333 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' SER . . . . . 0.453 ' CB ' HD21 ' A' ' 163' ' ' LEU . 22.3 t -134.73 140.19 45.76 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 72.54 110.03 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.444 ' CG2' ' CG ' ' A' ' 230' ' ' ASP . 11.0 mm -86.82 89.3 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.53 1.144 . . . . 74.13 109.339 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.426 ' CG2' ' C ' ' A' ' 214' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.501 1.125 . . . . 72.43 109.262 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 73.3 p . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 110.453 -0.203 . . . . 71.12 110.453 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 113.21 13.54 10.72 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.531 1.145 . . . . 70.55 111.008 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -88.49 -176.81 5.44 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.5 0.765 . . . . 64.41 109.331 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -130.1 171.28 13.0 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.526 1.141 . . . . 63.4 109.25 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 12.6 p -78.25 -40.88 25.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.478 1.111 . . . . 74.23 109.318 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.464 ' CG1' ' HB3' ' A' ' 190' ' ' CYS . 2.1 mp -50.7 -53.41 13.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.519 1.137 . . . . 72.43 109.386 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -61.82 -33.08 73.49 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.458 1.099 . . . . 74.2 110.286 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.444 ' CG ' ' CG2' ' A' ' 214' ' ' ILE . 1.1 m-20 -70.86 -30.5 66.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.492 1.12 . . . . 71.41 109.294 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.565 HG23 ' CD2' ' A' ' 187' ' ' HIS . 19.2 mt -68.93 -36.25 73.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.529 1.143 . . . . 74.15 109.305 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -74.61 -20.53 59.88 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.53 1.144 . . . . 74.44 109.295 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 6.7 p -68.64 -34.66 76.11 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.44 1.087 . . . . 71.32 110.014 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.419 ' C ' ' N ' ' A' ' 236' ' ' LEU . 6.8 p -114.75 19.0 7.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.549 1.155 . . . . 73.3 109.267 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 43.06 28.17 0.13 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.567 1.167 . . . . 63.35 109.341 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.419 ' N ' ' C ' ' A' ' 234' ' ' VAL . 18.8 tp -51.55 109.95 1.61 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.48 1.112 . . . . 74.34 109.321 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.93 137.21 21.59 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.519 1.799 . . . . 75.25 110.966 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' THR . . . . . 0.529 HG21 ' CE1' ' A' ' 187' ' ' HIS . 10.2 p -57.04 157.97 5.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 71.42 110.37 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.445 ' HB ' ' CG1' ' A' ' 194' ' ' ILE . 1.5 p -54.04 -27.99 16.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.443 1.089 . . . . 74.42 109.261 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -80.03 -30.7 39.54 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.454 1.096 . . . . 74.5 110.327 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -81.78 -24.06 36.22 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.517 1.136 . . . . 71.5 110.282 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.443 ' O ' ' N ' ' A' ' 245' ' ' ASN . 9.5 t90 -83.3 -66.39 0.9 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.12 . . . . 74.33 108.046 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.5 -29.86 0.1 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.514 1.134 . . . . 74.42 109.282 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.433 ' N ' ' C ' ' A' ' 242' ' ' TRP . 47.4 t -64.16 -52.85 57.05 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.439 1.087 . . . . 64.44 110.004 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 242' ' ' TRP . 22.3 m-80 . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.479 1.112 . . . . 74.24 109.355 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.584 ' C ' ' CD1' ' A' ' 159' ' ' TYR . 8.2 mt . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 109.262 -0.644 . . . . 73.05 109.262 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.584 ' CD1' ' C ' ' A' ' 158' ' ' LEU . 36.4 m-85 -157.56 115.06 3.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.493 1.121 . . . . 74.43 111.031 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.506 ' CB ' ' CD1' ' A' ' 214' ' ' ILE . . . -114.79 133.21 56.11 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.471 1.107 . . . . 74.43 109.292 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.448 HG22 ' CD1' ' A' ' 215' ' ' ILE . 0.4 OUTLIER -100.62 130.78 49.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.449 1.093 . . . . 64.14 109.27 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 179' ' ' GLY . 2.0 t -88.84 127.72 41.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.512 1.133 . . . . 74.23 109.365 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -107.39 -5.97 17.41 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.477 1.111 . . . . 71.32 109.379 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -147.05 147.34 30.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 73.22 111.059 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.452 ' N ' HG11 ' A' ' 178' ' ' VAL . 0.2 OUTLIER -79.4 111.71 15.92 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.47 1.106 . . . . 71.42 109.325 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.629 ' CG ' ' CD ' ' A' ' 208' ' ' PRO . 7.9 t80 -80.51 150.17 29.74 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.597 1.185 . . . . 75.11 111.002 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.545 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 0.1 OUTLIER -108.26 132.4 53.71 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.412 1.07 . . . . 73.23 109.272 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.501 ' CB ' ' OE2' ' A' ' 173' ' ' GLU . . . -78.47 127.51 32.28 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.598 1.186 . . . . 73.33 109.282 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -130.35 -33.18 1.71 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.498 1.124 . . . . 75.54 110.263 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -58.04 -166.15 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.567 1.167 . . . . 70.5 109.304 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.96 -45.35 9.26 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.497 1.123 . . . . 64.14 109.333 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -111.23 28.66 8.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 1.117 . . . . 74.2 109.326 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.501 ' OE2' ' CB ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -63.44 -176.76 0.17 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.442 1.089 . . . . 74.34 110.298 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.8 mt -157.25 133.15 9.43 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.509 1.131 . . . . 75.13 109.22 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.72 130.97 35.24 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.498 1.124 . . . . 72.22 110.387 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.6 m -111.11 -176.82 3.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.505 1.128 . . . . 75.05 110.373 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 177' ' ' TYR . 15.5 m-85 -130.12 157.25 42.93 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.517 1.136 . . . . 73.43 110.944 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.452 HG11 ' N ' ' A' ' 165' ' ' ASP . 1.0 OUTLIER -67.33 162.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.405 1.065 . . . . 63.42 109.252 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 37.28 61.34 1.01 Allowed Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.456 1.098 . . . . 72.02 110.997 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -121.2 176.82 5.42 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 0.778 . . . . 64.14 110.298 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -146.71 134.48 21.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.458 1.099 . . . . 75.21 109.28 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.45 ' CD2' ' C ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -166.48 160.32 15.31 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.494 1.121 . . . . 75.14 109.284 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.434 ' CE1' ' O ' ' A' ' 184' ' ' ILE . 5.5 t80 -92.07 137.21 32.55 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.593 1.183 . . . . 75.34 111.04 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.434 ' O ' ' CE1' ' A' ' 183' ' ' PHE . 42.7 mm -77.54 124.78 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.496 1.122 . . . . 74.4 109.291 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.429 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 10.2 t -79.94 -26.24 40.15 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 64.12 108.274 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -176.84 166.95 2.56 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 71.43 109.312 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.564 ' CE1' HG23 ' A' ' 238' ' ' THR . 8.2 p80 -123.42 151.01 43.07 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.497 1.123 . . . . 74.14 109.545 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.593 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 3.8 t-160 -124.76 112.95 17.31 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.498 1.124 . . . . 75.52 109.556 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.401 ' C ' ' N ' ' A' ' 191' ' ' GLU . 8.4 t-20 57.26 23.45 8.78 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.547 1.154 . . . . 64.12 109.32 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 6.8 m 53.08 21.46 2.13 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.484 1.115 . . . . 51.54 108.235 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.401 ' N ' ' C ' ' A' ' 189' ' ' ASN . 5.0 pt-20 -116.95 -31.95 5.24 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.465 1.103 . . . . 75.44 110.27 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -118.92 166.45 12.83 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.923 -1.14 . . . . 74.12 107.923 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.551 ' CZ ' HG23 ' A' ' 227' ' ' VAL . 36.3 m-85 -140.44 162.07 36.2 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.454 1.096 . . . . 73.14 111.021 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.473 ' CD1' ' HG ' ' A' ' 206' ' ' LEU . 34.6 mm -103.16 124.38 57.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.433 1.083 . . . . 72.45 109.343 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -112.56 174.9 5.67 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.493 1.12 . . . . 73.23 109.29 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.1 tptp . . . . . 0 C--N 1.324 -0.517 0 O-C-N 124.573 1.17 . . . . 73.21 109.326 179.96 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.075 0 N-CA-C 110.952 -0.859 . . . . 63.24 110.952 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.1 165.92 84.6 Favored 'Cis proline' 0 C--N 1.36 1.174 0 C-N-CA 121.012 -2.495 . . . . 64.11 110.975 0.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -122.46 179.72 16.11 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.545 1.153 . . . . 64.21 110.993 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.473 ' HG ' ' CD1' ' A' ' 194' ' ' ILE . 3.8 mp -117.59 168.49 10.37 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.439 0.729 . . . . 73.34 109.318 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.526 HG22 ' CD2' ' A' ' 166' ' ' PHE . 6.1 p -159.81 140.18 8.78 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.519 1.137 . . . . 64.31 109.223 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.629 ' CD ' ' CG ' ' A' ' 166' ' ' PHE . 18.1 Cg_endo -75.0 152.2 40.48 Favored 'Trans proline' 0 C--N 1.361 1.21 0 O-C-N 124.505 1.792 . . . . 64.31 110.997 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.459 ' HA ' ' CG2' ' A' ' 212' ' ' VAL . 11.6 p -78.83 -18.94 13.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.539 1.149 . . . . 73.2 109.26 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -73.83 -2.38 61.08 Favored Glycine 0 CA--C 1.531 1.091 0 O-C-N 124.539 1.149 . . . . 61.24 110.947 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -126.52 -0.3 6.87 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.56 0.8 . . . . 73.21 110.976 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.48 HG23 ' CD2' ' A' ' 193' ' ' PHE . 11.8 m -133.5 153.01 36.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 73.13 109.326 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.7 t -143.2 155.91 44.64 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.5 1.125 . . . . 74.5 110.05 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.506 ' CD1' ' CB ' ' A' ' 160' ' ' ALA . 18.9 mm -111.41 154.26 13.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.507 1.129 . . . . 75.33 109.308 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.448 ' CD1' HG22 ' A' ' 161' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 O-C-N 124.513 1.133 . . . . 74.34 109.247 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 16.4 p . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 110.43 -0.211 . . . . 75.43 110.43 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 119.65 8.09 9.29 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.583 1.177 . . . . 75.35 110.982 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.704 ' N ' HD21 ' A' ' 225' ' ' ASN . 0.8 OUTLIER -85.44 -178.56 6.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.576 0.809 . . . . 75.55 109.289 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.2 172.58 10.45 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.5 1.125 . . . . 74.2 109.298 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.551 HG23 ' CZ ' ' A' ' 193' ' ' PHE . 13.2 p -81.1 -37.76 16.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.548 1.155 . . . . 62.41 109.319 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.6 mp -54.69 -53.58 30.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.49 1.119 . . . . 75.43 109.268 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -55.44 -31.01 61.56 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.575 1.172 . . . . 70.54 110.306 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.43 ' CG ' ' CG2' ' A' ' 214' ' ' ILE . 0.5 OUTLIER -77.29 -34.9 55.47 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.509 1.131 . . . . 62.32 109.332 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.559 HG21 ' CD2' ' A' ' 187' ' ' HIS . 21.3 mt -67.6 -35.13 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.486 1.116 . . . . 73.2 109.3 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -82.39 -26.97 32.35 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.511 1.132 . . . . 74.01 109.245 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 46.8 p -60.06 -32.66 71.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.533 1.146 . . . . 74.31 109.991 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.448 ' O ' ' CG2' ' A' ' 234' ' ' VAL . 2.6 p -118.06 10.65 7.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.135 . . . . 75.03 109.327 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 4.4 m120 40.51 35.79 0.32 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.505 1.128 . . . . 65.31 109.272 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.49 144.04 12.84 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.472 1.107 . . . . 73.24 109.314 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.97 151.45 39.66 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.474 1.776 . . . . 75.44 111.02 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' THR . . . . . 0.564 HG23 ' CE1' ' A' ' 187' ' ' HIS . 2.1 p -86.17 141.29 29.46 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.517 1.136 . . . . 74.33 110.386 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.593 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 4.4 p -42.76 -28.31 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.556 1.16 . . . . 75.24 109.323 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.474 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 14.7 mm-40 -78.78 -46.32 19.07 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.522 1.139 . . . . 62.13 110.249 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 238' ' ' THR . 17.3 mt-10 -66.3 -19.79 65.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.448 1.092 . . . . 74.22 110.273 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.423 ' C ' ' N ' ' A' ' 244' ' ' SER . 2.0 t90 -81.37 -70.37 0.54 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 73.43 107.979 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -40.39 -29.93 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.398 1.061 . . . . 72.32 109.301 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.423 ' N ' ' C ' ' A' ' 242' ' ' TRP . 5.2 t -84.32 -59.24 2.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 61.41 110.044 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 . . . . . 0 C--N 1.326 -0.456 0 O-C-N 124.493 1.121 . . . . 75.11 109.254 179.97 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 11.4 tp . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 109.275 -0.639 . . . . 74.21 109.275 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -132.04 130.58 41.53 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.466 1.104 . . . . 75.2 110.97 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.58 151.01 38.42 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.127 . . . . 74.13 109.259 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.63 129.19 74.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.54 1.15 . . . . 74.43 109.322 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.577 ' CG2' ' CD2' ' A' ' 182' ' ' LEU . 1.9 t -76.96 132.64 32.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.557 1.161 . . . . 71.31 109.302 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.461 ' O ' ' CG2' ' A' ' 178' ' ' VAL . 0.2 OUTLIER -111.56 -7.38 14.31 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.572 1.17 . . . . 74.32 109.317 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -142.23 143.56 32.95 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.548 1.155 . . . . 71.14 111.019 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.435 ' O ' ' NZ ' ' A' ' 167' ' ' LYS . 4.6 t0 -73.26 108.17 5.99 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.532 1.145 . . . . 75.02 109.326 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.604 ' CZ ' ' O ' ' A' ' 206' ' ' LEU . 3.8 t80 -80.41 147.31 31.05 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.533 1.146 . . . . 72.1 110.948 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.435 ' NZ ' ' O ' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -107.06 137.9 44.25 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.503 1.127 . . . . 72.33 109.29 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.467 ' CB ' ' OE1' ' A' ' 173' ' ' GLU . . . -89.45 122.74 32.93 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.547 1.154 . . . . 71.24 109.301 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -126.3 -29.42 2.99 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.484 1.115 . . . . 74.1 110.294 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 4.2 tttp -59.09 -173.34 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.463 1.102 . . . . 74.24 109.263 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.82 -29.49 17.54 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.394 1.059 . . . . 73.24 109.267 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.47 28.36 6.65 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.601 1.188 . . . . 74.11 109.323 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.467 ' OE1' ' CB ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -68.49 -176.37 0.77 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.541 1.151 . . . . 74.15 110.319 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.49 110.67 2.51 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.457 1.098 . . . . 72.33 109.329 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.1 t -68.29 136.2 53.1 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.465 1.103 . . . . 71.35 110.379 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 3.2 m -120.38 -164.3 1.08 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.567 1.167 . . . . 70.43 110.437 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.479 ' CB ' ' OE1' ' A' ' 180' ' ' GLU . 31.3 m-85 -128.47 173.61 10.08 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.433 1.083 . . . . 70.0 111.008 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 163' ' ' LEU . 1.4 p -93.67 137.46 22.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.469 1.106 . . . . 64.11 109.349 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 67.16 52.58 31.12 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.451 1.094 . . . . 75.31 110.972 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.479 ' OE1' ' CB ' ' A' ' 177' ' ' TYR . 2.4 mp0 -121.9 165.67 15.58 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.542 0.789 . . . . 73.22 110.293 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.456 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.4 OUTLIER -115.85 126.82 54.46 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.501 1.126 . . . . 74.52 109.369 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.577 ' CD2' ' CG2' ' A' ' 162' ' ' VAL . 0.4 OUTLIER -148.97 177.79 9.26 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.473 1.108 . . . . 63.54 109.327 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -122.85 131.13 53.61 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.532 1.145 . . . . 75.33 111.044 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 38.3 mm -77.52 122.63 32.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.488 1.117 . . . . 74.11 109.344 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 3.6 m -85.42 -28.97 24.75 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.122 . . . . 71.41 108.302 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -167.22 179.58 5.02 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.484 1.115 . . . . 73.24 109.252 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.421 ' NE2' HG21 ' A' ' 231' ' ' ILE . 7.5 p80 -136.26 154.65 50.84 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 75.34 109.605 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.466 ' C ' ' CD2' ' A' ' 188' ' ' HIS . 0.2 OUTLIER -128.98 111.91 13.51 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.536 1.147 . . . . 72.23 109.596 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.65 21.53 8.87 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.544 1.152 . . . . 61.41 109.36 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 69.9 m 56.33 19.2 3.82 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.495 1.122 . . . . 74.24 108.332 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 192' ' ' TRP . 6.7 pt-20 -116.52 -31.74 5.45 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.566 1.166 . . . . 73.52 110.325 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.425 ' N ' ' HG3' ' A' ' 191' ' ' GLU . 16.7 m0 -115.33 165.12 13.31 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.613 1.196 . . . . 64.55 108.012 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.474 ' CE2' ' HB ' ' A' ' 209' ' ' VAL . 9.0 m-85 -143.87 159.16 43.03 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.518 1.136 . . . . 74.43 111.006 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.468 ' CG1' ' HB ' ' A' ' 239' ' ' VAL . 19.9 mm -100.9 121.91 52.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.525 1.141 . . . . 71.41 109.341 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -118.78 170.83 8.66 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.572 1.17 . . . . 71.21 109.336 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.498 1.123 . . . . 73.52 109.271 -179.999 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.971 0 N-CA-C 110.994 -0.842 . . . . 75.45 110.994 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 145.06 82.88 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 120.951 -2.52 . . . . 75.12 111.015 0.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 194' ' ' ILE . . . -90.61 156.73 24.97 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.531 1.145 . . . . 55.42 111.021 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.604 ' O ' ' CZ ' ' A' ' 166' ' ' PHE . 1.5 mt -119.94 135.74 54.79 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 0.763 . . . . 74.35 109.269 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.527 HG12 ' CG ' ' A' ' 166' ' ' PHE . 0.6 OUTLIER -148.17 139.37 13.64 Favored Pre-proline 0 C--N 1.323 -0.547 0 O-C-N 124.519 1.137 . . . . 71.02 109.34 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.43 ' HD3' ' CD1' ' A' ' 166' ' ' PHE . 18.3 Cg_endo -75.03 152.98 41.27 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.51 1.795 . . . . 75.54 110.979 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.474 ' HB ' ' CE2' ' A' ' 193' ' ' PHE . 3.9 p -67.57 -25.16 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.481 1.113 . . . . 75.13 109.314 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -67.51 -8.07 49.8 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.505 1.128 . . . . 52.51 111.016 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.446 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 8.0 m-85 -120.08 15.57 12.4 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.5 0.765 . . . . 75.22 111.008 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.426 ' CG1' ' O ' ' A' ' 211' ' ' PHE . 17.7 m -154.3 144.49 13.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.497 1.123 . . . . 61.0 109.291 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 42.0 t -128.27 147.91 50.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.495 1.122 . . . . 70.11 110.018 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.472 HG13 ' CG2' ' A' ' 227' ' ' VAL . 23.0 mm -91.81 146.54 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.413 1.071 . . . . 63.31 109.258 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.464 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 2.7 pp . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.464 1.102 . . . . 71.15 109.291 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' THR . . . . . 0.445 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 11.5 p . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 110.376 -0.231 . . . . 71.24 110.376 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 137.88 -11.8 3.65 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.5 1.125 . . . . 73.21 111.036 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.445 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 2.6 p30 -51.74 179.86 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.518 0.775 . . . . 74.43 109.353 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -118.74 172.48 7.48 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.484 1.115 . . . . 72.31 109.223 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.472 ' CG2' HG13 ' A' ' 214' ' ' ILE . 11.1 p -83.18 -40.49 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.459 1.099 . . . . 74.41 109.28 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 3.6 mp -55.14 -43.84 72.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.547 1.154 . . . . 72.23 109.28 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -66.04 -35.12 79.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.517 1.135 . . . . 72.32 110.311 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.01 -21.43 46.97 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.515 1.135 . . . . 75.54 109.355 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 227' ' ' VAL . 21.6 mt -69.14 -36.74 74.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.485 1.116 . . . . 71.34 109.33 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -78.03 -28.67 49.08 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.553 1.158 . . . . 72.53 109.314 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.3 m -56.14 -40.14 73.35 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.459 1.1 . . . . 71.03 110.003 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.428 ' C ' ' N ' ' A' ' 236' ' ' LEU . 7.2 p -111.65 21.29 5.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.521 1.138 . . . . 75.42 109.235 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 40.85 29.67 0.08 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.439 1.087 . . . . 75.44 109.251 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.428 ' N ' ' C ' ' A' ' 234' ' ' VAL . 38.7 tp -44.25 110.24 0.97 Allowed Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 73.22 109.3 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.07 140.88 25.79 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.589 1.836 . . . . 70.53 111.011 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 5.8 p -57.52 150.08 19.73 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.503 1.127 . . . . 73.42 110.367 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.468 ' HB ' ' CG1' ' A' ' 194' ' ' ILE . 0.9 OUTLIER -47.26 -25.6 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.474 1.109 . . . . 73.3 109.351 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -83.51 -49.63 9.06 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 72.34 110.319 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -56.94 -28.86 62.6 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.566 1.166 . . . . 74.13 110.361 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -78.13 -70.58 0.48 Allowed 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.478 1.111 . . . . 65.31 108.067 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.1 ptmm? -41.8 -33.75 0.55 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.435 1.084 . . . . 75.12 109.348 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 27.0 t -61.4 -59.0 5.93 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.476 1.11 . . . . 74.3 110.032 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.465 1.103 . . . . 70.23 109.325 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.435 ' C ' ' CD1' ' A' ' 159' ' ' TYR . 33.9 tp . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.283 -0.636 . . . . 74.03 109.283 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.435 ' CD1' ' C ' ' A' ' 158' ' ' LEU . 3.0 m-85 -136.43 136.55 39.62 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.519 1.137 . . . . 74.21 111.004 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -125.92 136.76 53.4 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.419 1.074 . . . . 73.23 109.316 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.409 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.0 OUTLIER -99.09 126.69 52.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.568 1.168 . . . . 72.31 109.303 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.465 HG21 ' CG2' ' A' ' 176' ' ' THR . 2.1 t -81.99 125.89 39.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.472 1.107 . . . . 73.53 109.292 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.426 ' C ' ' CD1' ' A' ' 164' ' ' TYR . 0.5 OUTLIER -93.08 -28.04 16.59 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 70.0 109.316 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.426 ' CD1' ' C ' ' A' ' 163' ' ' LEU . 2.1 m-85 -128.07 -171.93 2.57 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.513 1.133 . . . . 74.5 110.973 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.457 ' N ' HG12 ' A' ' 178' ' ' VAL . 12.3 t0 -111.27 139.56 46.57 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.516 1.135 . . . . 74.24 109.363 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.58 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 4.8 t80 -113.11 132.31 55.48 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 75.14 111.024 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -99.97 101.59 12.73 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.517 1.136 . . . . 71.03 109.312 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.421 ' HB1' ' N ' ' A' ' 175' ' ' THR . . . -55.16 119.21 5.16 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.503 1.127 . . . . 73.54 109.232 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -115.63 -36.84 4.12 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.419 1.074 . . . . 65.2 110.341 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -74.82 152.81 38.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.453 1.096 . . . . 75.41 109.323 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.34 -28.78 67.15 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.523 1.139 . . . . 74.0 109.332 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -109.45 28.35 8.62 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.53 1.144 . . . . 72.11 109.361 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.475 ' HG3' ' CE2' ' A' ' 166' ' ' PHE . 5.6 tp10 -100.61 148.02 25.31 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.463 1.102 . . . . 73.42 110.247 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.7 mt -121.24 141.99 50.35 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 74.51 109.306 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.421 ' N ' ' HB1' ' A' ' 168' ' ' ALA . 3.3 m -84.86 155.01 21.92 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.534 1.146 . . . . 63.23 110.421 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.47 ' C ' ' CD1' ' A' ' 177' ' ' TYR . 2.4 m -142.12 -175.04 4.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.474 1.109 . . . . 74.12 110.415 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.47 ' CD1' ' C ' ' A' ' 176' ' ' THR . 13.0 m-85 -139.87 158.33 44.25 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.534 1.146 . . . . 73.4 111.047 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.0 OUTLIER -67.72 153.64 8.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.49 1.119 . . . . 73.54 109.354 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 37.2 56.71 1.43 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.547 1.155 . . . . 73.14 110.983 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -120.71 172.33 7.95 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.523 0.778 . . . . 75.0 110.261 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -111.28 119.78 40.04 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.473 1.108 . . . . 74.53 109.319 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.7 tp -135.88 159.75 40.7 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.422 1.076 . . . . 74.24 109.283 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 0.4 OUTLIER -122.76 124.78 44.12 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.46 1.1 . . . . 75.35 110.957 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 23.1 mm -77.54 132.8 31.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.557 1.161 . . . . 75.33 109.275 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 33.9 t -99.65 -27.91 13.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.443 1.089 . . . . 74.24 108.313 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.457 ' HA ' ' CD1' ' A' ' 236' ' ' LEU . . . -163.9 177.47 8.54 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.482 1.114 . . . . 45.13 109.268 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -143.54 156.76 44.7 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.431 1.082 . . . . 73.33 109.632 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.602 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 1.7 t-160 -131.92 116.4 17.11 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.567 1.167 . . . . 74.23 109.602 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 58.31 20.7 7.49 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.465 1.103 . . . . 64.41 109.327 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.442 ' HB3' ' CG1' ' A' ' 228' ' ' ILE . 42.5 m 55.79 19.87 3.73 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.438 1.086 . . . . 72.32 108.331 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -117.02 -32.86 4.91 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.48 1.112 . . . . 73.4 110.29 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -112.4 160.26 17.91 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.542 1.151 . . . . 75.41 107.999 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.56 ' CD2' HG22 ' A' ' 212' ' ' VAL . 16.1 m-85 -132.78 161.45 34.05 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.121 . . . . 72.4 110.94 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.458 HD12 ' CG2' ' A' ' 239' ' ' VAL . 35.5 mm -109.46 120.32 60.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.56 1.162 . . . . 73.13 109.37 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -96.93 122.85 40.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.12 . . . . 74.54 109.332 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.513 0 O-C-N 124.536 1.148 . . . . 74.31 109.222 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.979 0 N-CA-C 110.995 -0.842 . . . . 45.42 110.995 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.9 151.97 97.61 Favored 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 120.947 -2.522 . . . . 71.22 111.033 -0.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.93 -164.5 11.08 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.454 1.096 . . . . 71.51 110.995 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.449 HD22 ' CD1' ' A' ' 194' ' ' ILE . 1.3 mt -109.19 164.6 12.31 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.508 0.769 . . . . 73.23 109.318 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -155.24 137.46 9.95 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.428 1.08 . . . . 73.15 109.291 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.58 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.2 Cg_endo -75.03 144.32 30.0 Favored 'Trans proline' 0 C--N 1.362 1.243 0 O-C-N 124.44 1.758 . . . . 75.33 110.991 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.449 HG22 ' CZ ' ' A' ' 193' ' ' PHE . 12.6 p -73.41 -16.91 17.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.505 1.128 . . . . 75.01 109.333 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -77.37 2.35 62.47 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.525 1.141 . . . . 63.02 110.994 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.482 ' O ' ' CG1' ' A' ' 212' ' ' VAL . 20.4 m-85 -133.46 23.85 4.06 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.435 0.726 . . . . 74.24 110.99 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.56 HG22 ' CD2' ' A' ' 193' ' ' PHE . 33.1 m -156.94 148.49 10.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.534 1.146 . . . . 72.14 109.251 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.1 t -133.65 159.29 40.95 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.488 1.117 . . . . 61.4 109.98 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.435 ' CG2' ' CG ' ' A' ' 230' ' ' ASP . 24.2 mm -110.83 102.42 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 73.45 109.276 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.485 ' CD1' ' C ' ' A' ' 215' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.324 -0.521 0 O-C-N 124.539 1.149 . . . . 74.43 109.321 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 77.8 p . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 110.435 -0.209 . . . . 74.21 110.435 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.53 6.06 17.97 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.534 1.146 . . . . 70.35 110.995 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -79.43 -179.2 6.67 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.583 0.814 . . . . 73.43 109.291 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.86 179.98 4.78 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.466 1.104 . . . . 72.12 109.292 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.435 ' CG2' HG13 ' A' ' 214' ' ' ILE . 5.6 p -82.1 -32.42 10.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 74.43 109.296 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.442 ' CG1' ' HB3' ' A' ' 190' ' ' CYS . 3.0 mp -62.02 -51.36 73.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.41 1.068 . . . . 63.2 109.323 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -62.1 -19.06 62.58 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.46 1.1 . . . . 72.14 110.392 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.435 ' CG ' ' CG2' ' A' ' 214' ' ' ILE . 0.8 OUTLIER -88.89 -34.68 16.87 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.49 1.119 . . . . 63.44 109.263 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 19.5 mt -61.35 -26.39 39.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.534 1.146 . . . . 74.32 109.284 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -83.57 -11.49 57.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.448 1.092 . . . . 74.22 109.317 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.7 m -93.21 -5.49 49.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.517 1.136 . . . . 71.31 109.986 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.411 ' C ' ' N ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -130.8 7.54 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.429 1.081 . . . . 74.43 109.317 -179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 4.1 m120 44.44 26.99 0.2 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.463 1.102 . . . . 64.35 109.288 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.457 ' CD1' ' HA ' ' A' ' 186' ' ' ALA . 3.5 tp -55.8 113.53 5.86 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.497 1.123 . . . . 73.12 109.317 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 145.08 31.1 Favored 'Trans proline' 0 C--N 1.361 1.231 0 O-C-N 124.505 1.792 . . . . 72.14 111.034 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 3.9 p -57.42 161.12 3.62 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.434 1.083 . . . . 73.3 110.367 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.602 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.8 p -61.32 -24.37 33.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.459 1.1 . . . . 72.11 109.317 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.513 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 4.4 mm100 -80.85 -36.64 31.19 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.119 . . . . 72.42 110.31 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -75.4 -25.77 57.88 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.498 1.124 . . . . 70.42 110.291 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -82.99 -63.61 1.33 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.003 -1.11 . . . . 71.51 108.003 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -44.04 -30.79 0.78 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.477 1.111 . . . . 72.35 109.315 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 22.7 t -72.99 -48.16 38.89 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.474 1.109 . . . . 62.32 110.01 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.324 -0.532 0 O-C-N 124.508 1.13 . . . . 75.55 109.26 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.468 ' CD2' HG12 ' A' ' 234' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 109.277 -0.638 . . . . 54.42 109.277 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -105.97 126.55 52.32 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.439 1.087 . . . . 75.42 111.06 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -105.66 162.74 13.25 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 62.5 109.273 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.406 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.0 OUTLIER -130.62 127.51 62.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.471 1.107 . . . . 72.54 109.26 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.512 ' CG2' ' CD2' ' A' ' 182' ' ' LEU . 4.9 t -86.14 122.55 38.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.488 1.118 . . . . 64.03 109.318 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.477 ' O ' ' CG2' ' A' ' 178' ' ' VAL . 0.3 OUTLIER -107.07 -9.42 16.19 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.13 . . . . 75.33 109.273 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -135.13 145.1 47.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.542 1.151 . . . . 75.33 110.992 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -82.58 104.59 12.96 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.56 1.162 . . . . 75.32 109.331 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -85.99 122.75 30.48 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.513 1.133 . . . . 74.32 111.007 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.78 99.94 11.3 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.454 1.096 . . . . 75.05 109.287 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.424 ' HB2' ' CA ' ' A' ' 174' ' ' LEU . . . -47.68 125.45 8.56 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.435 1.084 . . . . 74.12 109.324 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -120.38 -40.68 2.66 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.496 1.122 . . . . 64.21 110.289 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.88 170.57 10.88 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.523 1.139 . . . . 73.21 109.275 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.66 -38.09 62.56 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.497 1.123 . . . . 63.41 109.299 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -100.07 27.45 5.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.477 1.111 . . . . 63.45 109.353 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.593 ' OE2' ' CH2' ' A' ' 192' ' ' TRP . 3.5 mm-40 -108.57 153.17 23.76 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 74.41 110.317 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.443 ' CG ' ' HA3' ' A' ' 205' ' ' GLY . 17.3 mt -125.77 159.94 31.07 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.468 1.105 . . . . 73.04 109.313 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 15.1 t -101.55 154.04 19.2 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.538 1.149 . . . . 64.21 110.439 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.3 m -138.25 -168.98 2.48 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.454 1.096 . . . . 74.02 110.366 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -138.82 134.33 33.23 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.522 1.139 . . . . 74.43 111.014 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 163' ' ' LEU . 1.6 p -58.09 146.65 7.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.41 1.069 . . . . 72.1 109.28 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 58.74 47.17 91.72 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.457 1.098 . . . . 62.53 110.971 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -121.9 172.37 8.24 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.488 0.758 . . . . 63.11 110.306 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.414 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.4 OUTLIER -123.25 137.57 54.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.446 1.092 . . . . 72.04 109.374 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.512 ' CD2' ' CG2' ' A' ' 162' ' ' VAL . 3.1 pp -158.74 168.19 27.51 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 71.13 109.25 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.598 ' CE1' ' O ' ' A' ' 184' ' ' ILE . 4.2 t80 -112.13 148.24 34.4 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.487 1.117 . . . . 63.31 110.997 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.598 ' O ' ' CE1' ' A' ' 183' ' ' PHE . 26.4 mm -90.51 134.12 30.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.394 1.059 . . . . 75.44 109.327 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 16.5 t -101.59 -26.02 13.68 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.483 1.114 . . . . 72.31 108.325 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -164.27 179.38 6.87 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.135 . . . . 74.14 109.306 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.674 ' CD2' ' CG2' ' A' ' 231' ' ' ILE . 9.5 p80 -138.3 148.71 44.93 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 75.01 109.566 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.437 ' ND1' ' C ' ' A' ' 188' ' ' HIS . 0.0 OUTLIER -122.17 114.48 20.92 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.507 1.129 . . . . 61.11 109.555 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.45 ' O ' ' SG ' ' A' ' 190' ' ' CYS . 2.4 m-20 55.8 27.42 10.83 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.541 1.151 . . . . 73.01 109.272 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 1.5 p 50.81 20.04 0.71 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.569 1.168 . . . . 72.33 108.303 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.438 ' N ' ' C ' ' A' ' 189' ' ' ASN . 1.3 pt-20 -125.0 -10.45 7.14 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.497 1.123 . . . . 71.21 110.335 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.593 ' CH2' ' OE2' ' A' ' 173' ' ' GLU . 6.8 m95 -130.68 166.58 20.42 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.961 -1.126 . . . . 75.25 107.961 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.563 ' CE2' ' HB ' ' A' ' 209' ' ' VAL . 31.3 m-85 -139.59 163.31 32.89 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.427 1.079 . . . . 73.43 110.994 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.468 ' CG1' ' HB ' ' A' ' 239' ' ' VAL . 30.0 mm -109.35 117.67 55.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.506 1.129 . . . . 74.11 109.283 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.43 145.29 28.42 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 74.11 109.336 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 O-C-N 124.534 1.146 . . . . 75.44 109.228 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.975 0 N-CA-C 111.04 -0.824 . . . . 65.25 111.04 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 170.47 71.76 Favored 'Cis proline' 0 C--N 1.359 1.101 0 C-N-CA 121.008 -2.497 . . . . 71.12 110.986 -0.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.443 ' HA3' ' CG ' ' A' ' 174' ' ' LEU . . . -134.9 167.06 24.17 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.502 1.126 . . . . 52.44 110.976 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.576 ' HB3' ' CE3' ' A' ' 192' ' ' TRP . 3.2 mt -108.68 155.32 20.85 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.483 0.755 . . . . 63.34 109.311 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.471 ' CG2' HG11 ' A' ' 212' ' ' VAL . 0.2 OUTLIER -156.42 118.28 2.21 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.57 1.169 . . . . 74.42 109.294 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.508 ' HD3' ' CZ3' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -75.04 137.94 22.28 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.544 1.813 . . . . 61.12 111.0 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.563 ' HB ' ' CE2' ' A' ' 193' ' ' PHE . 13.3 p -58.26 -17.32 9.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.516 1.135 . . . . 73.23 109.314 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -71.44 -3.87 55.13 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 124.453 1.096 . . . . 72.1 111.047 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -128.73 2.39 5.45 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.405 0.709 . . . . 71.44 111.063 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.471 HG11 ' CG2' ' A' ' 207' ' ' VAL . 14.8 m -143.34 163.88 16.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.439 1.087 . . . . 75.2 109.246 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' SER . . . . . 0.408 ' N ' HD12 ' A' ' 163' ' ' LEU . 1.4 t -144.87 160.61 41.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.133 . . . . 72.31 109.981 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.466 HG13 ' CG2' ' A' ' 227' ' ' VAL . 28.1 mm -109.23 138.24 37.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.464 1.103 . . . . 75.34 109.349 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.514 1.134 . . . . 72.44 109.269 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 69.1 p . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 110.462 -0.199 . . . . 75.44 110.462 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 105.42 0.53 40.53 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.578 1.174 . . . . 72.12 111.014 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.537 ' N ' HD21 ' A' ' 225' ' ' ASN . 1.2 m-80 -74.97 -176.15 2.83 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.541 0.789 . . . . 75.3 109.345 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.22 158.57 38.67 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.493 1.121 . . . . 70.21 109.285 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.472 HG23 ' CZ ' ' A' ' 193' ' ' PHE . 8.6 p -77.46 -34.86 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.504 1.127 . . . . 74.2 109.334 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.44 ' CD1' ' N ' ' A' ' 228' ' ' ILE . 1.1 mp -52.1 -47.6 43.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 124.502 1.126 . . . . 72.14 109.227 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 233' ' ' SER . 7.0 mt-10 -66.75 -35.32 79.83 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.573 1.17 . . . . 73.01 110.268 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.24 -27.8 65.78 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.565 1.166 . . . . 70.24 109.309 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.674 ' CG2' ' CD2' ' A' ' 187' ' ' HIS . 26.8 mt -74.49 -40.96 49.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.387 1.054 . . . . 74.13 109.261 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 26.4 mmtt -83.77 -19.98 34.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.389 1.055 . . . . 71.14 109.296 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 229' ' ' GLU . 8.7 m -60.59 -23.35 64.61 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.489 1.118 . . . . 72.2 110.027 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.468 HG12 ' CD2' ' A' ' 158' ' ' LEU . 6.3 p -126.39 21.81 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.549 1.156 . . . . 70.54 109.29 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 53.0 t30 47.36 28.46 1.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.532 1.145 . . . . 73.3 109.301 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 10.4 tp -58.45 112.15 4.55 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.135 . . . . 74.14 109.307 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 149.34 36.66 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.493 1.786 . . . . 74.03 111.012 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' THR . . . . . 0.465 ' CG2' ' CE1' ' A' ' 187' ' ' HIS . 2.3 p -57.15 149.54 19.37 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.522 1.139 . . . . 75.44 110.342 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.468 ' HB ' ' CG1' ' A' ' 194' ' ' ILE . 0.4 OUTLIER -41.18 -31.02 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.109 . . . . 64.32 109.337 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.444 ' O ' ' CB ' ' A' ' 244' ' ' SER . 58.4 mm-40 -81.37 -49.34 10.79 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.455 1.097 . . . . 73.02 110.296 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -59.09 -21.84 59.84 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.449 1.093 . . . . 74.33 110.287 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.402 ' O ' ' N ' ' A' ' 245' ' ' ASN . 4.2 t90 -83.33 -71.17 0.51 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.507 1.129 . . . . 72.33 108.008 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.9 -24.51 1.5 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.455 1.097 . . . . 74.01 109.246 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 240' ' ' GLN . 43.9 t -77.4 -39.86 45.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.557 1.16 . . . . 70.24 110.004 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 242' ' ' TRP . 4.0 t-20 . . . . . 0 C--N 1.325 -0.485 0 O-C-N 124.46 1.1 . . . . 65.31 109.264 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.427 HD12 ' CG1' ' A' ' 234' ' ' VAL . 9.0 mt . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 109.297 -0.631 . . . . 71.45 109.297 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -160.7 139.78 10.47 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.466 1.104 . . . . 74.2 111.039 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.467 ' HB1' ' CD1' ' A' ' 214' ' ' ILE . . . -132.85 162.28 31.96 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.467 1.105 . . . . 72.13 109.298 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.466 HG21 ' CD1' ' A' ' 215' ' ' ILE . 0.7 OUTLIER -127.95 121.16 55.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.478 1.111 . . . . 74.33 109.271 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.452 HG22 ' CD1' ' A' ' 182' ' ' LEU . 55.9 t -79.11 98.02 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 74.32 109.323 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.525 ' O ' ' CG ' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -92.05 35.08 0.99 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.576 1.172 . . . . 73.13 109.306 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.556 ' HB3' ' CD2' ' A' ' 211' ' ' PHE . 18.2 m-85 -170.98 133.4 0.9 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.469 1.106 . . . . 75.23 111.014 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.13 102.99 3.16 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.524 1.14 . . . . 73.11 109.3 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.6 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 7.3 t80 -80.35 153.04 28.61 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.488 1.118 . . . . 74.4 110.937 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.6 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 11.4 mmmm -112.04 135.21 52.97 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.55 1.156 . . . . 74.25 109.297 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.475 ' CB ' ' OE1' ' A' ' 173' ' ' GLU . . . -84.25 123.81 30.53 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.484 1.115 . . . . 52.05 109.278 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -126.4 -30.62 2.85 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.544 1.153 . . . . 75.32 110.328 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.483 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 3.7 tttt -59.03 -173.72 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.594 1.184 . . . . 71.23 109.293 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.5 -27.82 17.99 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.523 1.139 . . . . 72.13 109.319 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.54 28.75 6.49 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.517 1.135 . . . . 74.33 109.354 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -71.13 -176.4 1.42 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.448 1.092 . . . . 72.12 110.271 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.428 ' CB ' ' HA3' ' A' ' 205' ' ' GLY . 1.6 tp -157.62 113.94 2.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 71.0 109.285 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 2.0 t -68.95 145.29 53.75 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.562 1.164 . . . . 73.04 110.394 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.7 m -129.25 -169.5 2.11 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.103 . . . . 70.32 110.405 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.418 ' O ' ' CG ' ' A' ' 180' ' ' GLU . 29.3 m-85 -138.4 133.73 33.23 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.438 1.087 . . . . 75.45 111.011 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' ' 177' ' ' TYR . 0.2 OUTLIER -39.41 156.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.515 1.134 . . . . 75.45 109.354 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 51.02 48.37 46.12 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.441 1.088 . . . . 64.33 110.991 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.452 ' HB3' ' CD1' ' A' ' 182' ' ' LEU . 7.6 mm-40 -107.36 151.49 25.43 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.53 0.782 . . . . 71.33 110.202 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.486 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.3 OUTLIER -108.27 127.28 53.71 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.56 1.162 . . . . 71.55 109.282 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.452 ' CD1' HG22 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -158.81 168.7 26.12 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.477 1.11 . . . . 64.21 109.311 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 184' ' ' ILE . 2.0 t80 -114.2 144.34 43.35 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.589 1.18 . . . . 75.15 111.002 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.493 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 9.3 mm -77.68 100.74 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.503 1.127 . . . . 70.05 109.308 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.426 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 1.3 t -73.6 -28.9 62.06 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.475 1.11 . . . . 75.25 108.246 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.414 ' HB2' ' N ' ' A' ' 239' ' ' VAL . . . -174.36 170.85 3.53 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.539 1.15 . . . . 65.34 109.352 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.411 ' NE2' HG21 ' A' ' 231' ' ' ILE . 6.4 p80 -129.16 149.51 50.94 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.559 1.162 . . . . 75.24 109.629 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.526 ' CE1' ' CD ' ' A' ' 240' ' ' GLN . 2.3 t-160 -124.54 114.94 20.08 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.441 1.088 . . . . 72.23 109.591 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.451 ' C ' ' N ' ' A' ' 191' ' ' GLU . 2.3 m120 53.85 32.8 15.75 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.491 1.12 . . . . 73.14 109.301 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 12.7 p 42.96 28.23 0.13 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 73.44 108.314 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.451 ' N ' ' C ' ' A' ' 189' ' ' ASN . 5.0 pt-20 -121.57 -34.79 3.36 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.465 1.103 . . . . 74.4 110.331 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.47 ' CE3' ' HB3' ' A' ' 206' ' ' LEU . 7.8 m0 -118.04 165.56 13.59 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.534 1.146 . . . . 75.42 107.945 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.47 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 20.3 m-85 -143.53 157.4 44.46 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 73.23 111.002 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.426 ' CG2' ' HB3' ' A' ' 185' ' ' CYS . 31.3 mm -95.62 101.93 12.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.497 1.123 . . . . 72.25 109.317 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.449 ' HB1' ' CG2' ' A' ' 207' ' ' VAL . . . -84.82 168.4 15.15 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.521 1.138 . . . . 63.03 109.245 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 63.42 109.262 -179.993 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.072 0 N-CA-C 110.958 -0.857 . . . . 74.35 110.958 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.05 -178.72 24.31 Favored 'Cis proline' 0 C--N 1.36 1.153 0 C-N-CA 121.073 -2.47 . . . . 75.33 111.034 0.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 174' ' ' LEU . . . -133.8 172.38 21.67 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 124.475 1.11 . . . . 74.2 111.047 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.6 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 2.7 mt -106.41 129.6 54.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 0.754 . . . . 73.03 109.283 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.527 HG11 ' CG ' ' A' ' 166' ' ' PHE . 0.2 OUTLIER -135.88 145.82 54.36 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.471 1.107 . . . . 75.42 109.308 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.564 ' HD3' ' CD1' ' A' ' 166' ' ' PHE . 18.2 Cg_endo -75.03 157.68 42.49 Favored 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.515 1.797 . . . . 64.34 110.977 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.2 p -76.23 -20.27 15.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 124.416 1.072 . . . . 75.23 109.338 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -84.5 5.99 78.9 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.534 1.146 . . . . 50.01 110.977 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.556 ' CD2' ' HB3' ' A' ' 164' ' ' TYR . 11.5 m-85 -130.17 12.21 5.56 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.507 0.769 . . . . 72.51 111.023 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.4 m -149.4 148.04 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 75.32 109.309 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 10.6 t -126.87 147.43 50.06 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.514 1.134 . . . . 72.42 110.037 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.467 ' CD1' ' HB1' ' A' ' 160' ' ' ALA . 22.2 mm -94.12 133.66 34.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.557 1.161 . . . . 74.05 109.351 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.466 ' CD1' HG21 ' A' ' 161' ' ' ILE . 9.6 pt . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.442 1.089 . . . . 74.55 109.273 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' THR . . . . . 0.441 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 11.5 p . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 110.423 -0.214 . . . . 71.41 110.423 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 145.26 -18.47 1.9 Allowed Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.472 1.107 . . . . 63.4 111.021 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.441 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 2.3 p30 -47.8 172.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.449 0.735 . . . . 74.41 109.324 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.67 165.31 18.13 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.531 1.144 . . . . 72.54 109.269 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.47 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 12.3 p -75.55 -44.94 40.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.466 1.104 . . . . 74.41 109.267 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 1.7 mp -49.42 -54.47 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.42 1.075 . . . . 75.14 109.324 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.11 -28.67 69.26 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.554 1.159 . . . . 72.11 110.293 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.11 -14.96 58.09 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.475 1.109 . . . . 73.24 109.307 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.411 HG21 ' NE2' ' A' ' 187' ' ' HIS . 38.3 mt -83.87 -30.45 7.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.534 1.146 . . . . 72.54 109.267 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -82.97 -20.72 34.64 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.507 1.129 . . . . 74.34 109.332 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 36.8 m -66.41 -39.17 88.83 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.566 1.166 . . . . 72.12 110.004 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.427 ' CG1' HD12 ' A' ' 158' ' ' LEU . 4.2 p -114.82 15.56 8.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.518 1.136 . . . . 72.25 109.326 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 41.41 29.4 0.1 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.496 1.123 . . . . 72.03 109.337 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.423 ' N ' ' C ' ' A' ' 234' ' ' VAL . 6.1 tp -41.37 121.01 2.04 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.524 1.14 . . . . 71.42 109.293 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 135.65 19.28 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.559 1.82 . . . . 73.12 111.002 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 2.3 p -57.97 152.36 16.48 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.508 1.13 . . . . 63.42 110.395 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.414 ' N ' ' HB2' ' A' ' 186' ' ' ALA . 1.3 p -51.2 -22.9 2.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.544 1.153 . . . . 65.03 109.322 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.526 ' CD ' ' CE1' ' A' ' 188' ' ' HIS . 8.8 mm100 -86.63 -45.54 10.92 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.465 1.103 . . . . 74.45 110.366 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -63.86 -25.52 68.2 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.465 1.103 . . . . 74.0 110.29 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -77.43 -65.87 0.9 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.553 1.158 . . . . 74.5 107.968 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -52.08 -25.36 8.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 1.13 . . . . 70.11 109.26 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 43.9 t -76.89 -50.37 13.48 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.552 1.158 . . . . 71.34 110.009 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 . . . . . 0 C--N 1.325 -0.458 0 O-C-N 124.496 1.122 . . . . 73.25 109.331 179.961 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.467 ' CD2' HG13 ' A' ' 234' ' ' VAL . 1.6 mm? . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.274 -0.639 . . . . 72.04 109.274 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -138.52 122.71 18.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.485 1.116 . . . . 74.5 111.02 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -103.87 174.52 5.83 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.495 1.122 . . . . 74.44 109.299 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.462 HG22 ' CD1' ' A' ' 215' ' ' ILE . 0.0 OUTLIER -135.98 128.79 46.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.442 1.089 . . . . 74.12 109.251 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.45 ' CG2' HG22 ' A' ' 176' ' ' THR . 80.9 t -88.95 122.61 40.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.511 1.132 . . . . 74.11 109.252 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.8 2.73 23.79 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.469 1.105 . . . . 73.05 109.278 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -153.96 131.59 11.44 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.446 1.091 . . . . 74.21 110.999 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -63.45 104.82 0.67 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.537 1.148 . . . . 74.34 109.261 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.578 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 7.3 t80 -80.42 139.46 36.48 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.556 1.16 . . . . 74.42 110.963 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.489 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 26.7 mmmt -98.31 141.92 30.6 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.128 . . . . 75.23 109.298 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.492 ' CB ' ' OE1' ' A' ' 173' ' ' GLU . . . -92.02 123.39 35.34 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.422 1.076 . . . . 72.33 109.313 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -125.61 -29.35 3.18 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.527 1.142 . . . . 72.24 110.297 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.443 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 3.9 tttp -59.15 -173.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.566 1.166 . . . . 74.03 109.332 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.19 -31.07 17.2 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.43 1.081 . . . . 72.31 109.332 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.91 27.93 7.04 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.51 1.131 . . . . 73.43 109.312 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.492 ' OE1' ' CB ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -67.97 -176.24 0.66 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.478 1.111 . . . . 61.24 110.302 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.466 ' CG ' ' HA3' ' A' ' 205' ' ' GLY . 12.3 mt -151.85 132.36 13.86 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.467 1.104 . . . . 74.55 109.269 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 12.4 t -78.96 127.88 32.57 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.543 1.152 . . . . 74.02 110.426 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.45 HG22 ' CG2' ' A' ' 162' ' ' VAL . 2.5 m -106.47 -172.67 2.13 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.444 1.09 . . . . 63.02 110.374 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.4 ' O ' ' CB ' ' A' ' 180' ' ' GLU . 52.0 m-85 -143.86 133.56 23.72 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.509 1.131 . . . . 74.35 110.972 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.435 ' CG2' ' N ' ' A' ' 179' ' ' GLY . 1.3 p -51.84 161.37 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.468 1.105 . . . . 75.01 109.249 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 37.56 51.47 1.86 Allowed Glycine 0 CA--C 1.531 1.057 0 O-C-N 124.533 1.146 . . . . 75.14 111.005 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 177' ' ' TYR . 20.3 tt0 -121.85 167.59 12.84 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.555 0.797 . . . . 74.15 110.288 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.444 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.4 OUTLIER -119.58 120.99 38.32 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.508 1.13 . . . . 71.01 109.302 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.02 156.9 47.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.417 1.073 . . . . 45.33 109.319 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -102.77 129.24 49.36 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.474 1.109 . . . . 73.33 111.035 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 25.1 mm -77.65 121.32 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 73.23 109.298 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -88.66 -26.77 21.68 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.557 1.161 . . . . 74.41 108.299 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -171.8 176.94 3.48 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.461 1.101 . . . . 74.45 109.272 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.555 ' CE1' HG23 ' A' ' 231' ' ' ILE . 8.3 p80 -137.27 151.89 49.19 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.495 1.122 . . . . 75.34 109.565 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.638 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.3 t-160 -124.61 114.72 19.74 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.129 . . . . 74.43 109.566 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.449 ' C ' ' N ' ' A' ' 191' ' ' GLU . 2.7 t30 54.18 33.21 17.51 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.484 1.115 . . . . 70.3 109.283 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.417 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 12.8 p 43.06 28.43 0.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.595 1.185 . . . . 75.54 108.237 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.449 ' N ' ' C ' ' A' ' 189' ' ' ASN . 5.3 pt-20 -122.17 -34.88 3.24 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.539 1.149 . . . . 72.31 110.257 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.438 ' CD1' ' HG3' ' A' ' 191' ' ' GLU . 11.9 m0 -116.32 164.73 14.09 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.572 1.17 . . . . 74.34 108.005 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.531 ' CE2' ' HB ' ' A' ' 209' ' ' VAL . 16.6 m-85 -135.5 159.66 40.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.509 1.131 . . . . 72.4 111.002 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.469 ' CD1' HD23 ' A' ' 206' ' ' LEU . 20.2 mm -103.49 119.57 52.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.508 1.13 . . . . 73.11 109.303 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.405 ' CB ' HG11 ' A' ' 207' ' ' VAL . . . -100.77 175.98 5.45 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.489 1.118 . . . . 73.04 109.307 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.524 1.14 . . . . 73.45 109.305 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.948 0 N-CA-C 110.995 -0.842 . . . . 72.21 110.995 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.99 153.3 99.09 Favored 'Cis proline' 0 C--N 1.36 1.174 0 C-N-CA 121.033 -2.486 . . . . 62.12 110.97 0.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.466 ' HA3' ' CG ' ' A' ' 174' ' ' LEU . . . -117.25 178.33 17.03 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.503 1.127 . . . . 72.11 110.963 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.469 HD23 ' CD1' ' A' ' 194' ' ' ILE . 1.3 mt -118.88 165.19 14.36 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.437 0.728 . . . . 73.43 109.334 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.459 ' CG2' HG11 ' A' ' 212' ' ' VAL . 0.2 OUTLIER -162.66 129.96 2.6 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.443 1.089 . . . . 74.33 109.317 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.578 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.4 Cg_endo -74.9 137.58 22.14 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.488 1.783 . . . . 74.02 110.991 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.531 ' HB ' ' CE2' ' A' ' 193' ' ' PHE . 7.3 p -67.14 -27.16 38.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.515 1.134 . . . . 72.55 109.251 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -68.81 -13.36 66.11 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.538 1.149 . . . . 74.52 111.017 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 7.8 m-30 -113.11 3.16 15.96 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.486 0.757 . . . . 71.31 111.007 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.468 ' CG2' ' HA ' ' A' ' 209' ' ' VAL . 15.0 m -140.08 173.78 9.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.541 1.15 . . . . 74.42 109.319 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.9 t -152.09 160.76 43.35 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.519 1.137 . . . . 72.23 109.995 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.466 HG13 ' CG2' ' A' ' 227' ' ' VAL . 19.1 mm -104.05 96.59 4.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.55 1.156 . . . . 63.32 109.314 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.462 ' CD1' HG22 ' A' ' 161' ' ' ILE . 1.2 pt . . . . . 0 C--N 1.324 -0.504 0 O-C-N 124.504 1.128 . . . . 74.34 109.353 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' THR . . . . . 0.425 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 12.6 p . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 110.424 -0.213 . . . . 74.34 110.424 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 139.65 -19.06 2.99 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.54 1.15 . . . . 71.2 111.052 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.425 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 2.2 p30 -50.08 176.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.465 0.744 . . . . 72.34 109.263 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -134.63 157.76 45.79 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.494 1.121 . . . . 65.5 109.312 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.466 ' CG2' HG13 ' A' ' 214' ' ' ILE . 2.5 p -77.67 -34.49 20.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.493 1.121 . . . . 73.25 109.298 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.21 -44.87 92.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 124.531 1.145 . . . . 75.43 109.284 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.95 -45.81 90.69 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.551 1.157 . . . . 75.34 110.291 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -67.97 -26.0 65.72 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.396 1.06 . . . . 72.23 109.33 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.555 HG23 ' CE1' ' A' ' 187' ' ' HIS . 16.8 mt -67.69 -41.56 85.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.507 1.129 . . . . 75.22 109.332 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -83.94 -20.16 33.43 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.558 1.161 . . . . 75.13 109.237 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 41.9 m -61.07 -25.73 67.15 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.49 1.119 . . . . 73.23 110.005 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.467 HG13 ' CD2' ' A' ' 158' ' ' LEU . 7.5 p -126.39 20.73 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.424 1.077 . . . . 72.31 109.351 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 40.55 30.12 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.504 1.128 . . . . 74.23 109.33 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 234' ' ' VAL . 12.7 tp -46.88 120.31 6.25 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.426 1.079 . . . . 75.52 109.277 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.93 131.05 13.92 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.486 1.782 . . . . 72.12 110.99 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 2.7 p -57.04 157.07 6.18 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.107 . . . . 74.35 110.418 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.638 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.1 p -46.29 -27.11 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.477 1.111 . . . . 74.31 109.272 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.402 ' NE2' ' HD3' ' A' ' 243' ' ' LYS . 37.6 mm-40 -86.77 -47.02 9.45 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.514 1.134 . . . . 75.33 110.39 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -61.4 -20.47 63.09 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.409 1.068 . . . . 71.44 110.308 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.442 ' C ' ' N ' ' A' ' 244' ' ' SER . 13.9 t90 -88.12 -65.51 1.01 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.958 -1.127 . . . . 75.44 107.958 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.402 ' HD3' ' NE2' ' A' ' 240' ' ' GLN . 2.9 ptmm? -41.79 -28.87 0.17 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.514 1.134 . . . . 72.53 109.333 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.442 ' N ' ' C ' ' A' ' 242' ' ' TRP . 1.2 t -73.36 -65.83 0.76 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.453 1.096 . . . . 72.34 109.994 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.563 1.165 . . . . 65.22 109.346 179.997 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.584 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 109.236 -0.653 . . . . 73.15 109.236 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.418 ' N ' HD12 ' A' ' 158' ' ' LEU . 26.7 m-85 -120.01 141.87 49.32 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 74.0 110.993 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.401 ' O ' ' O ' ' A' ' 182' ' ' LEU . . . -140.14 143.21 36.06 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.419 1.075 . . . . 75.45 109.393 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.494 ' CG1' ' O ' ' A' ' 180' ' ' GLU . 0.8 OUTLIER -121.65 136.0 59.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.463 1.102 . . . . 75.52 109.313 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.501 ' CG1' ' O ' ' A' ' 211' ' ' PHE . 2.5 t -85.58 127.36 40.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.546 1.154 . . . . 72.11 109.313 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.8 -17.06 20.48 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.563 1.164 . . . . 72.35 109.338 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.422 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 42.9 m-85 -137.94 148.46 45.28 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.502 1.127 . . . . 74.23 111.039 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.02 100.1 0.11 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.54 1.15 . . . . 73.01 109.299 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.559 ' CE2' ' O ' ' A' ' 174' ' ' LEU . 26.5 t80 -81.34 126.1 31.18 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.137 . . . . 75.41 111.009 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.39 129.63 55.53 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.539 1.149 . . . . 73.41 109.273 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.6 122.63 15.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.102 . . . . 64.43 109.332 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.447 ' CG ' ' N ' ' A' ' 170' ' ' LYS . 9.0 pt-20 -107.85 -43.73 4.39 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.543 1.152 . . . . 71.01 110.277 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.447 ' N ' ' CG ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -70.0 -176.07 1.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.137 . . . . 72.32 109.306 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.43 -19.01 30.26 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.515 1.135 . . . . 73.01 109.317 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -123.52 27.82 7.25 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.496 1.123 . . . . 55.23 109.327 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -91.88 155.88 17.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.453 1.096 . . . . 71.14 110.271 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.559 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 0.3 OUTLIER -112.45 159.97 18.23 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.484 1.115 . . . . 70.31 109.316 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 13.1 t -118.58 122.8 43.49 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.495 1.122 . . . . 74.11 110.423 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.428 ' CG2' HG23 ' A' ' 162' ' ' VAL . 2.2 m -114.61 -168.82 1.43 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.521 1.138 . . . . 74.1 110.47 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 177' ' ' TYR . 14.3 m-85 -134.44 143.6 47.65 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.404 1.065 . . . . 74.43 110.97 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 179' ' ' GLY . 0.3 OUTLIER -40.46 152.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.478 1.111 . . . . 72.25 109.321 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 36.93 64.87 0.61 Allowed Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.565 1.165 . . . . 64.34 110.999 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.494 ' O ' ' CG1' ' A' ' 161' ' ' ILE . 18.3 tt0 -121.72 148.58 44.43 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.48 0.753 . . . . 74.1 110.328 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.404 ' ND2' ' N ' ' A' ' 181' ' ' ASN . 0.2 OUTLIER -100.82 139.42 36.53 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.493 1.121 . . . . 71.32 109.301 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.457 HD21 ' CG2' ' A' ' 162' ' ' VAL . 4.5 pp -166.95 163.28 16.05 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.468 1.105 . . . . 65.34 109.272 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.584 ' CD2' ' O ' ' A' ' 158' ' ' LEU . 1.0 OUTLIER -115.29 134.13 55.4 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.479 1.112 . . . . 72.45 110.98 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.498 ' O ' ' CE1' ' A' ' 183' ' ' PHE . 36.9 mm -78.21 134.0 29.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.506 1.128 . . . . 72.41 109.242 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.495 ' O ' ' CD1' ' A' ' 236' ' ' LEU . 3.3 m -96.09 -35.0 11.51 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.517 1.136 . . . . 71.41 108.297 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.432 ' HB2' ' N ' ' A' ' 239' ' ' VAL . . . -154.0 179.79 8.58 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.471 1.107 . . . . 73.12 109.28 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.565 ' CE1' HG22 ' A' ' 231' ' ' ILE . 12.7 p80 -147.38 138.53 23.73 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.464 1.102 . . . . 74.13 109.566 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.552 ' NE2' ' CG ' ' A' ' 240' ' ' GLN . 2.6 t-80 -114.21 116.42 29.02 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.485 1.116 . . . . 74.45 109.572 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.422 ' C ' ' N ' ' A' ' 191' ' ' GLU . 37.7 m-20 55.69 26.69 9.64 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.483 1.114 . . . . 62.12 109.276 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.436 ' HB3' ' CD1' ' A' ' 228' ' ' ILE . 3.6 m 49.83 22.8 0.9 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.51 1.131 . . . . 74.51 108.353 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.508 ' HG3' ' CD1' ' A' ' 192' ' ' TRP . 5.1 pt-20 -116.81 -32.49 5.1 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.375 1.047 . . . . 73.31 110.335 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.508 ' CD1' ' HG3' ' A' ' 191' ' ' GLU . 19.2 m0 -117.08 159.34 22.71 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.468 1.105 . . . . 72.42 108.027 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.66 ' CE2' ' CG2' ' A' ' 209' ' ' VAL . 43.7 m-85 -138.4 156.77 47.28 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 71.13 111.004 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 194' ' ' ILE . 0.5 OUTLIER -102.35 107.18 21.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.461 1.101 . . . . 71.15 109.247 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.43 ' CB ' HG11 ' A' ' 207' ' ' VAL . . . -97.85 151.61 20.04 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.476 1.11 . . . . 74.34 109.298 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.455 ' CD ' ' HB3' ' A' ' 204' ' ' PRO . 8.8 mtpp . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.525 1.14 . . . . 72.04 109.261 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.494 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.531 1.059 0 N-CA-C 111.001 -0.84 . . . . 71.34 111.001 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.494 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.5 Cg_endo -74.99 134.74 37.3 Favored 'Cis proline' 0 C--N 1.359 1.113 0 C-N-CA 121.003 -2.499 . . . . 73.42 111.049 -0.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.422 ' HA3' ' CD2' ' A' ' 174' ' ' LEU . . . -126.86 158.22 20.78 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.431 1.082 . . . . 60.33 111.045 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.474 ' CD2' HD13 ' A' ' 194' ' ' ILE . 4.6 mt -81.07 147.55 30.07 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.546 0.792 . . . . 75.34 109.318 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.442 HG21 ' CG1' ' A' ' 212' ' ' VAL . 0.2 OUTLIER -146.36 125.39 6.53 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.531 1.144 . . . . 72.3 109.286 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.492 ' CD ' ' CE1' ' A' ' 166' ' ' PHE . 18.5 Cg_endo -74.96 147.51 34.22 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.524 1.802 . . . . 74.05 110.997 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.66 ' CG2' ' CE2' ' A' ' 193' ' ' PHE . 3.5 t -63.83 -18.31 22.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.517 1.136 . . . . 73.32 109.265 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -74.07 -1.8 60.58 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.477 1.111 . . . . 70.42 111.08 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.501 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 30.2 m-85 -128.66 2.37 5.5 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.562 0.801 . . . . 70.02 110.961 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.442 ' CG1' HG21 ' A' ' 207' ' ' VAL . 35.4 m -148.95 154.41 9.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.578 1.174 . . . . 74.42 109.251 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 42.3 t -139.63 160.27 40.25 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.491 1.12 . . . . 71.25 110.043 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.484 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 8.4 mm -109.14 164.8 5.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.495 1.122 . . . . 62.25 109.267 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.484 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.421 0 O-C-N 124.488 1.117 . . . . 75.13 109.264 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' THR . . . . . 0.441 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 11.0 p . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 120.559 0.219 . . . . 74.31 110.468 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 141.93 -17.44 2.57 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.5 1.125 . . . . 63.41 111.021 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.441 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 1.5 p30 -51.02 174.23 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 0.746 . . . . 71.11 109.341 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.77 172.96 7.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 71.43 109.296 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.564 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 12.3 p -78.94 -30.9 14.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.133 . . . . 74.51 109.291 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.436 ' CD1' ' HB3' ' A' ' 190' ' ' CYS . 1.4 mp -60.82 -46.49 96.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 64.15 109.339 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.73 -43.02 99.89 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.558 1.162 . . . . 75.11 110.304 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.98 -34.32 77.83 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.554 1.159 . . . . 64.43 109.282 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.565 HG22 ' CE1' ' A' ' 187' ' ' HIS . 38.8 mt -63.25 -46.22 96.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.141 . . . . 74.32 109.309 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -76.56 -15.73 59.78 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.499 1.125 . . . . 75.13 109.315 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.0 p -69.55 -40.03 77.06 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.429 1.081 . . . . 72.31 110.029 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.42 ' CG1' HD21 ' A' ' 158' ' ' LEU . 11.3 p -109.4 14.03 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.511 1.132 . . . . 70.25 109.333 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 234' ' ' VAL . 7.5 t-20 40.35 43.1 1.39 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 71.42 109.287 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.495 ' CD1' ' O ' ' A' ' 185' ' ' CYS . 3.3 tp -66.79 132.2 93.98 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.462 1.101 . . . . 71.01 109.284 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.03 156.43 42.85 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.478 1.778 . . . . 75.21 110.997 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' THR . . . . . 0.401 ' C ' ' N ' ' A' ' 240' ' ' GLN . 4.2 p -77.98 148.41 34.44 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.492 1.12 . . . . 75.42 110.336 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.45 ' CG1' ' CD2' ' A' ' 188' ' ' HIS . 2.5 p -49.68 -23.57 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.45 1.093 . . . . 73.32 109.266 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.552 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 75.6 mm-40 -83.98 -41.71 17.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.476 1.11 . . . . 74.22 110.257 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -70.49 -23.16 62.63 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.432 1.082 . . . . 75.33 110.33 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -78.52 -59.99 2.56 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.501 1.125 . . . . 74.44 108.013 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.0 ptmm? -59.62 -17.44 33.48 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.116 . . . . 64.02 109.27 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.5 t -77.99 -26.51 48.69 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.59 1.181 . . . . 65.12 109.947 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.5 t30 . . . . . 0 C--N 1.325 -0.497 0 O-C-N 124.48 1.113 . . . . 73.31 109.25 -179.995 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.401 ' O ' ' CG ' ' A' ' 159' ' ' TYR . 9.2 mt . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 109.317 -0.623 . . . . 75.22 109.317 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.401 ' CG ' ' O ' ' A' ' 158' ' ' LEU . 25.0 m-85 -163.7 118.4 1.58 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.48 1.113 . . . . 75.34 110.975 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.402 ' O ' ' O ' ' A' ' 182' ' ' LEU . . . -106.25 167.35 9.88 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.505 1.128 . . . . 65.12 109.361 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.49 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -137.48 129.24 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.44 1.087 . . . . 73.11 109.317 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.534 ' CG2' ' CD2' ' A' ' 182' ' ' LEU . 2.7 t -81.72 117.73 28.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.538 1.149 . . . . 75.3 109.273 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.431 HD13 ' CB ' ' A' ' 213' ' ' SER . 0.2 OUTLIER -96.18 -3.86 43.61 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.545 1.153 . . . . 73.53 109.268 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.489 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 53.4 m-85 -153.6 153.88 33.17 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.472 1.108 . . . . 72.44 110.968 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.423 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 11.0 t0 -83.47 103.58 12.94 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.433 1.083 . . . . 74.24 109.287 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.583 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 1.9 t80 -85.25 125.22 32.71 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.119 . . . . 73.11 111.0 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.87 115.79 29.64 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.455 1.097 . . . . 72.42 109.335 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -40.31 140.55 0.61 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.456 1.098 . . . . 64.31 109.342 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.467 ' CG ' ' N ' ' A' ' 170' ' ' LYS . 7.9 pt-20 -136.88 -45.28 0.58 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.427 1.079 . . . . 75.35 110.236 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.467 ' N ' ' CG ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -64.47 -170.7 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.506 1.129 . . . . 73.33 109.307 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.62 -33.25 20.21 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.432 1.083 . . . . 74.45 109.273 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.39 9.3 29.83 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.509 1.13 . . . . 73.5 109.254 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -75.43 159.89 30.86 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.524 1.14 . . . . 75.34 110.249 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.8 tp -138.33 159.6 41.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.457 1.098 . . . . 74.12 109.299 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.2 t -91.64 153.46 19.68 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.496 1.123 . . . . 74.13 110.389 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 3.3 m -139.19 -164.39 1.65 Allowed 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.514 1.134 . . . . 71.2 110.345 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -136.8 138.04 40.42 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.546 1.154 . . . . 75.11 110.972 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.463 ' CG2' ' N ' ' A' ' 179' ' ' GLY . 1.4 p -56.57 163.41 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.452 1.095 . . . . 73.53 109.285 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.463 ' N ' ' CG2' ' A' ' 178' ' ' VAL . . . 37.59 59.47 1.3 Allowed Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.474 1.109 . . . . 64.11 110.961 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.49 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 13.2 tp10 -121.4 166.9 13.43 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.557 0.798 . . . . 74.21 110.338 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -120.51 122.29 40.3 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.455 1.097 . . . . 74.31 109.352 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.534 ' CD2' ' CG2' ' A' ' 162' ' ' VAL . 0.6 OUTLIER -147.0 163.65 35.53 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.103 . . . . 74.54 109.362 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.591 ' CE1' ' O ' ' A' ' 184' ' ' ILE . 2.2 t80 -110.63 139.12 46.19 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.457 1.098 . . . . 75.2 111.023 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.591 ' O ' ' CE1' ' A' ' 183' ' ' PHE . 9.6 mm -77.7 120.92 29.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.471 1.107 . . . . 73.55 109.227 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 5.6 t -91.45 -24.42 19.7 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.432 1.082 . . . . 75.45 108.27 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.443 ' HA ' ' CD2' ' A' ' 236' ' ' LEU . . . -164.8 179.65 6.39 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.501 1.126 . . . . 75.02 109.253 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.568 ' CD2' HG23 ' A' ' 231' ' ' ILE . 9.3 p80 -149.38 129.86 13.91 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.466 1.104 . . . . 74.1 109.571 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.651 ' CD2' ' CB ' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -111.0 119.03 37.69 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.536 1.148 . . . . 72.51 109.633 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.433 ' C ' ' N ' ' A' ' 191' ' ' GLU . 3.5 m120 54.0 32.82 16.21 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.48 1.112 . . . . 71.25 109.325 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.411 ' SG ' ' CE1' ' A' ' 187' ' ' HIS . 49.9 m 42.1 29.04 0.12 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 74.21 108.3 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.575 ' HG3' ' CD1' ' A' ' 192' ' ' TRP . 6.4 pt-20 -120.94 -38.04 2.89 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.509 1.131 . . . . 74.13 110.312 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.651 ' CB ' ' CD2' ' A' ' 188' ' ' HIS . 27.7 m0 -116.87 164.42 14.7 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.126 . . . . 74.25 107.987 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.456 ' N ' ' O ' ' A' ' 207' ' ' VAL . 39.5 m-85 -141.94 168.93 18.58 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.542 1.151 . . . . 75.4 110.995 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.566 ' CD1' ' CD2' ' A' ' 206' ' ' LEU . 47.0 mm -103.55 109.07 25.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.544 1.153 . . . . 71.21 109.324 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.428 ' CB ' HG11 ' A' ' 207' ' ' VAL . . . -116.57 163.78 15.58 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.488 1.117 . . . . 72.13 109.321 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 O-C-N 124.483 1.114 . . . . 75.43 109.267 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.012 0 N-CA-C 110.98 -0.848 . . . . 74.23 110.98 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.95 179.42 30.67 Favored 'Cis proline' 0 C--N 1.36 1.181 0 C-N-CA 121.02 -2.492 . . . . 73.22 110.983 0.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -129.64 161.62 22.85 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.531 1.145 . . . . 54.14 110.967 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.566 ' CD2' ' CD1' ' A' ' 194' ' ' ILE . 9.3 mt -92.91 149.14 21.45 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.514 0.773 . . . . 70.42 109.272 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.533 ' CG2' ' CG1' ' A' ' 212' ' ' VAL . 0.6 OUTLIER -148.5 122.6 4.81 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.123 . . . . 75.54 109.32 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.583 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.6 Cg_endo -74.91 149.87 37.79 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.502 1.791 . . . . 62.44 111.026 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.415 ' HB ' ' CE2' ' A' ' 193' ' ' PHE . 5.0 p -63.71 -20.88 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 73.44 109.293 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -74.57 -0.91 60.01 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.446 1.091 . . . . 75.13 110.956 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -129.8 3.32 4.93 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.491 0.759 . . . . 74.32 111.008 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.533 ' CG1' ' CG2' ' A' ' 207' ' ' VAL . 32.9 m -151.89 149.67 13.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 74.53 109.311 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' SER . . . . . 0.431 ' CB ' HD13 ' A' ' 163' ' ' LEU . 1.6 t -131.54 160.93 33.82 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.513 1.133 . . . . 75.52 109.966 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.468 HG13 ' CG2' ' A' ' 227' ' ' VAL . 32.1 mm -100.53 106.82 19.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.524 1.14 . . . . 75.35 109.295 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.419 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 11.0 pt . . . . . 0 C--N 1.324 -0.515 0 O-C-N 124.53 1.144 . . . . 75.32 109.275 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 69.2 p . . . . . 0 N--CA 1.453 -0.321 0 N-CA-C 110.402 -0.221 . . . . 72.22 110.402 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 123.86 -18.03 7.6 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.64 1.212 . . . . 72.21 110.956 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -75.71 177.08 7.12 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.527 0.781 . . . . 72.32 109.288 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.15 -178.65 3.72 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.524 1.14 . . . . 75.41 109.332 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.468 ' CG2' HG13 ' A' ' 214' ' ' ILE . 3.0 p -79.02 -34.25 16.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.531 1.145 . . . . 71.24 109.336 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.1 mp -65.44 -56.85 13.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.483 1.114 . . . . 74.4 109.334 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -58.29 -21.43 48.89 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.489 1.118 . . . . 71.33 110.283 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -86.8 -34.96 19.38 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.426 1.079 . . . . 72.34 109.29 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.568 HG23 ' CD2' ' A' ' 187' ' ' HIS . 18.8 mt -64.81 -27.42 42.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.576 1.172 . . . . 74.11 109.338 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -83.99 -11.59 56.58 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.46 1.1 . . . . 74.31 109.318 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 68.5 m -95.12 -8.9 35.14 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.464 1.103 . . . . 70.21 110.019 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.13 5.98 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.465 1.103 . . . . 72.21 109.27 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . 0.437 ' N ' ' OD1' ' A' ' 235' ' ' ASN . 0.6 OUTLIER 47.91 30.33 1.94 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.45 1.093 . . . . 72.14 109.275 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.443 ' CD2' ' HA ' ' A' ' 186' ' ' ALA . 0.7 OUTLIER -43.95 118.4 2.96 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.408 1.068 . . . . 71.43 109.261 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 135.57 19.16 Favored 'Trans proline' 0 C--N 1.361 1.211 0 O-C-N 124.453 1.765 . . . . 64.44 110.977 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' THR . . . . . 0.405 ' OG1' ' CG ' ' A' ' 241' ' ' GLU . 2.0 p -69.51 144.07 53.27 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.521 1.138 . . . . 74.43 110.376 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.548 HG13 ' CG ' ' A' ' 188' ' ' HIS . 7.6 p -51.0 -31.23 10.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.556 1.16 . . . . 70.31 109.298 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -76.76 -32.07 57.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.127 . . . . 63.33 110.305 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.405 ' CG ' ' OG1' ' A' ' 238' ' ' THR . 69.0 mt-10 -76.71 -30.01 56.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.517 1.136 . . . . 75.22 110.274 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -72.88 -54.89 7.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.499 1.124 . . . . 74.44 108.046 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.88 -29.02 69.29 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.547 1.154 . . . . 72.5 109.302 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 18.3 t -77.26 -41.25 41.72 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.563 1.164 . . . . 74.44 110.057 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 . . . . . 0 C--N 1.324 -0.5 0 O-C-N 124.529 1.143 . . . . 74.23 109.323 179.932 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 109.332 -0.618 . . . . 74.52 109.332 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.411 ' CD2' ' CE2' ' A' ' 183' ' ' PHE . 1.7 t80 -121.47 122.82 40.59 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.475 1.11 . . . . 72.35 111.021 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -117.82 170.84 8.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.564 1.165 . . . . 73.54 109.318 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.407 ' N ' ' O ' ' A' ' 213' ' ' SER . 0.1 OUTLIER -142.29 126.69 16.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.479 1.112 . . . . 74.34 109.352 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.662 ' CG2' ' CE1' ' A' ' 211' ' ' PHE . 18.1 t -72.04 133.99 30.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.546 1.154 . . . . 74.42 109.28 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.9 0.33 14.39 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.441 1.088 . . . . 74.41 109.287 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.497 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 70.1 m-85 -144.66 147.02 32.57 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.581 1.175 . . . . 74.42 111.023 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -77.58 94.4 4.35 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.477 1.111 . . . . 73.43 109.298 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.502 ' CZ ' ' OE2' ' A' ' 173' ' ' GLU . 3.9 t80 -88.0 137.72 32.08 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.523 1.139 . . . . 74.54 110.97 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -119.85 103.38 9.3 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.469 1.106 . . . . 75.54 109.32 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -40.27 139.65 0.71 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.478 1.111 . . . . 52.23 109.278 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -123.73 -41.43 2.25 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.441 1.088 . . . . 71.4 110.236 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.32 -169.81 1.29 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.509 1.131 . . . . 74.33 109.304 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.29 -45.35 11.34 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.531 1.144 . . . . 65.25 109.279 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -94.43 26.59 3.33 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.455 1.097 . . . . 75.35 109.34 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.502 ' OE2' ' CZ ' ' A' ' 166' ' ' PHE . 2.9 mm-40 -96.82 140.88 30.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.473 1.108 . . . . 64.51 110.303 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.456 ' CD2' ' HA3' ' A' ' 205' ' ' GLY . 0.2 OUTLIER -102.53 160.07 14.88 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.545 1.153 . . . . 72.24 109.297 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.408 ' C ' ' OG1' ' A' ' 176' ' ' THR . 9.9 t -124.16 150.7 44.85 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.541 1.151 . . . . 61.43 110.426 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.408 ' OG1' ' C ' ' A' ' 175' ' ' THR . 11.6 m -157.34 -177.11 6.36 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.516 1.135 . . . . 72.43 110.366 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 177' ' ' TYR . 7.6 m-85 -121.03 156.7 31.62 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.46 1.1 . . . . 72.34 111.057 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.8 p -59.83 131.25 24.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.559 1.162 . . . . 72.52 109.28 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 71.76 59.21 4.89 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.465 1.103 . . . . 54.21 111.032 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 162' ' ' VAL . 5.4 tp10 -122.16 165.76 15.64 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.563 0.802 . . . . 73.54 110.281 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.447 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.7 OUTLIER -115.63 119.53 36.43 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 64.05 109.273 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.424 ' N ' HD13 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -152.35 158.63 42.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.533 1.146 . . . . 73.13 109.318 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.411 ' CE2' ' CD2' ' A' ' 159' ' ' TYR . 4.6 m-85 -107.04 170.64 7.83 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 73.2 110.996 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.451 ' CD1' ' HB3' ' A' ' 193' ' ' PHE . 32.5 mm -107.9 147.31 12.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.534 1.146 . . . . 74.44 109.241 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.404 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 0.1 OUTLIER -106.26 -19.46 13.69 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.535 1.147 . . . . 73.23 108.313 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.451 ' HA ' ' CD1' ' A' ' 236' ' ' LEU . . . 179.64 179.63 0.48 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.554 1.159 . . . . 71.14 109.309 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.561 ' CD2' HG23 ' A' ' 231' ' ' ILE . 6.2 p80 -137.39 152.98 50.23 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.549 1.156 . . . . 75.05 109.583 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.637 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 1.0 OUTLIER -129.45 112.8 14.15 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.463 1.102 . . . . 75.52 109.584 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 3.1 m120 57.97 21.24 7.52 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.436 1.085 . . . . 73.12 109.343 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 87.1 m 55.34 19.74 3.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 1.139 . . . . 71.42 108.336 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -115.94 -30.94 5.91 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.548 1.155 . . . . 62.25 110.299 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -116.25 158.99 22.49 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.959 -1.126 . . . . 74.4 107.959 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 12.8 m-85 -133.92 161.33 35.08 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.534 1.146 . . . . 65.3 110.96 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.421 ' HB ' ' N ' ' A' ' 186' ' ' ALA . 17.7 mm -105.56 85.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.486 1.116 . . . . 74.42 109.323 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.53 ' CB ' ' CG1' ' A' ' 207' ' ' VAL . . . -67.48 160.16 28.12 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.481 1.113 . . . . 72.51 109.345 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.465 0 O-C-N 124.558 1.161 . . . . 72.22 109.306 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.036 0 N-CA-C 111.019 -0.833 . . . . 74.43 111.019 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 172.31 63.61 Favored 'Cis proline' 0 C--N 1.36 1.171 0 C-N-CA 120.95 -2.521 . . . . 73.34 111.011 -0.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -157.59 156.35 27.22 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.471 1.107 . . . . 73.34 110.947 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.1 mt -83.94 134.02 34.68 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.524 0.779 . . . . 73.43 109.262 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.53 ' CG1' ' CB ' ' A' ' 195' ' ' ALA . 2.0 m -143.34 151.92 56.04 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.544 1.153 . . . . 74.23 109.313 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 159.5 41.15 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.488 1.783 . . . . 53.03 111.003 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 3.0 p -84.85 -20.51 8.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.517 1.136 . . . . 70.43 109.22 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -82.47 11.84 49.22 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.5 1.125 . . . . 73.12 110.994 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.684 ' CD2' ' CG1' ' A' ' 212' ' ' VAL . 0.0 OUTLIER -130.33 2.22 4.64 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.434 0.726 . . . . 73.02 110.943 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.684 ' CG1' ' CD2' ' A' ' 211' ' ' PHE . 14.3 m -137.8 145.8 28.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.456 1.098 . . . . 72.02 109.271 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' SER . . . . . 0.407 ' O ' ' N ' ' A' ' 161' ' ' ILE . 12.5 t -132.78 131.75 41.47 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 61.44 110.06 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.46 HG13 ' CG2' ' A' ' 227' ' ' VAL . 15.6 mm -83.77 149.73 4.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.113 . . . . 74.44 109.304 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.9 pt . . . . . 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 74.43 109.302 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 17.6 p . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.549 0.214 . . . . 73.34 110.465 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 114.19 21.24 5.64 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.487 1.117 . . . . 63.21 110.957 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.487 ' N ' ' ND2' ' A' ' 225' ' ' ASN . 0.6 OUTLIER -84.16 171.95 12.36 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.488 0.758 . . . . 73.01 109.32 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.72 166.62 11.19 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.481 1.113 . . . . 75.23 109.335 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.498 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 11.2 p -78.92 -44.36 24.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.454 1.096 . . . . 73.25 109.278 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.3 mp -51.3 -53.25 16.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.607 1.192 . . . . 75.14 109.31 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -62.54 -32.76 73.76 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 64.44 110.275 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -73.91 -25.89 60.23 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.42 1.075 . . . . 71.01 109.255 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.561 HG23 ' CD2' ' A' ' 187' ' ' HIS . 42.0 mt -72.05 -34.79 51.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.519 1.137 . . . . 71.23 109.272 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -78.53 -29.84 46.69 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.466 1.104 . . . . 74.34 109.332 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.8 m -53.92 -40.78 67.0 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.472 1.108 . . . . 74.32 109.999 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.436 ' C ' ' N ' ' A' ' 236' ' ' LEU . 4.0 p -107.63 20.19 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.505 1.128 . . . . 74.43 109.287 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 41.94 28.86 0.1 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.532 1.145 . . . . 72.33 109.329 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.451 ' CD1' ' HA ' ' A' ' 186' ' ' ALA . 12.2 tp -47.16 115.53 3.56 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 75.43 109.281 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.01 147.15 33.51 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.551 1.816 . . . . 72.32 111.036 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 2.7 p -57.09 149.36 19.5 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.526 1.141 . . . . 73.35 110.411 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.637 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.4 p -48.78 -28.58 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.528 1.142 . . . . 75.44 109.291 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.404 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 76.6 mm-40 -80.17 -45.83 17.42 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.489 1.118 . . . . 71.54 110.311 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -58.46 -30.07 66.67 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.451 1.094 . . . . 75.14 110.285 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -76.91 -62.22 1.72 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.511 1.132 . . . . 71.15 108.003 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.38 -25.8 6.72 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 73.41 109.319 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 45.8 t -76.89 -36.47 56.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.444 1.09 . . . . 70.42 110.052 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.469 1.105 . . . . 71.03 109.302 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.987 0 N-CA-C 111.022 -0.831 . . . . 72.1 111.022 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 143.29 28.89 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.554 1.818 . . . . 60.13 111.018 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -126.92 -175.27 3.37 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.524 1.14 . . . . 73.35 109.279 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.43 -10.35 9.24 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.436 1.085 . . . . 62.13 111.018 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.7 p -150.65 114.52 5.01 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.5 0.765 . . . . 61.43 110.005 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 230' ' ' ASP . 6.0 tp -110.96 153.48 25.46 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.445 1.091 . . . . 74.05 109.301 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.581 ' CD1' ' N ' ' A' ' 159' ' ' TYR . 0.6 OUTLIER -147.8 160.57 42.6 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.521 1.138 . . . . 74.33 111.023 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -132.14 175.59 9.12 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 74.34 109.345 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.496 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -137.41 129.72 42.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.473 1.108 . . . . 62.42 109.334 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.5 ' CG2' ' CD2' ' A' ' 182' ' ' LEU . 4.1 t -80.86 121.07 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.474 1.109 . . . . 72.14 109.329 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.412 HD13 ' CB ' ' A' ' 213' ' ' SER . 0.7 OUTLIER -100.33 -6.36 25.97 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.534 1.146 . . . . 75.51 109.28 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.482 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 88.9 m-85 -148.58 151.65 35.42 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.115 . . . . 73.22 111.033 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -78.84 112.16 15.72 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.533 1.145 . . . . 74.05 109.328 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.556 ' CZ ' ' HD3' ' A' ' 208' ' ' PRO . 11.6 t80 -83.27 152.67 25.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.532 1.145 . . . . 72.45 111.032 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -125.75 116.35 21.48 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.483 1.114 . . . . 75.22 109.292 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.15 121.42 12.47 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.556 1.16 . . . . 73.43 109.256 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 170' ' ' LYS . 9.9 pt-20 -110.63 -46.15 3.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.509 1.131 . . . . 74.13 110.309 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -63.42 179.51 0.44 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.534 1.146 . . . . 74.43 109.31 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.11 -15.18 41.96 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.551 1.157 . . . . 75.24 109.317 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.82 10.19 10.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.471 1.107 . . . . 73.4 109.378 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -77.63 151.34 34.39 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.508 1.13 . . . . 75.22 110.348 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 14.4 mt -120.75 145.74 47.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.449 1.093 . . . . 74.34 109.247 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.2 m -88.03 154.33 20.57 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.47 1.107 . . . . 74.13 110.396 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.428 ' CG2' HG23 ' A' ' 162' ' ' VAL . 5.8 m -135.92 -174.57 3.7 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.555 1.159 . . . . 73.41 110.372 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -134.13 138.43 45.22 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.461 1.101 . . . . 75.21 111.01 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.5 p -55.25 158.32 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.438 1.086 . . . . 74.32 109.228 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 38.94 57.63 1.99 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.508 1.13 . . . . 42.22 111.01 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 15.0 tp10 -121.83 166.34 14.52 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.423 0.719 . . . . 61.55 110.287 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.534 ' N ' HD21 ' A' ' 181' ' ' ASN . 1.5 m-80 -118.58 130.22 55.77 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.438 1.086 . . . . 74.2 109.268 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.5 ' CD2' ' CG2' ' A' ' 162' ' ' VAL . 1.8 pp -157.0 -179.73 8.49 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 75.24 109.297 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -131.45 142.28 49.97 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.428 1.08 . . . . 74.52 111.024 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 23.3 mm -78.53 141.44 15.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.452 1.095 . . . . 75.34 109.337 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 3.4 t -103.49 -24.71 13.42 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.504 1.128 . . . . 64.51 108.294 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.412 ' N ' ' HB ' ' A' ' 194' ' ' ILE . . . -170.11 179.53 3.5 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.505 1.128 . . . . 72.32 109.33 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.567 ' CD2' HG23 ' A' ' 231' ' ' ILE . 7.7 p80 -145.53 142.24 29.01 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 74.42 109.581 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.637 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.6 t-160 -123.72 120.66 33.34 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.475 1.109 . . . . 64.44 109.599 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.453 ' C ' ' N ' ' A' ' 191' ' ' GLU . 14.8 m-20 54.14 30.1 11.55 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.119 . . . . 75.54 109.256 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 11.9 p 43.51 28.29 0.19 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.502 1.126 . . . . 75.3 108.29 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.453 ' N ' ' C ' ' A' ' 189' ' ' ASN . 8.7 pt-20 -123.88 -36.76 2.68 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.491 1.119 . . . . 72.12 110.28 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.492 ' CE3' ' HB3' ' A' ' 206' ' ' LEU . 9.0 m0 -110.55 158.52 18.45 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.443 1.089 . . . . 75.55 108.1 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.501 ' CD2' HG21 ' A' ' 212' ' ' VAL . 8.5 m-85 -131.12 148.49 52.73 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.502 1.126 . . . . 73.52 110.983 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.514 ' CD1' ' CD2' ' A' ' 206' ' ' LEU . 12.7 mm -96.34 88.89 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.495 1.122 . . . . 75.21 109.291 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.458 ' CB ' HG12 ' A' ' 207' ' ' VAL . . . -71.04 164.1 26.23 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.506 1.129 . . . . 71.21 109.315 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -164.82 82.75 1.2 Allowed Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.586 1.179 . . . . 75.21 109.311 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 152.99 41.19 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.512 1.796 . . . . 73.52 111.016 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 14.8 pt -103.53 -21.98 5.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.57 1.169 . . . . 73.35 109.294 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -46.93 -29.4 4.44 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.503 1.127 . . . . 55.31 111.038 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -138.94 140.34 38.27 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.483 0.755 . . . . 75.43 110.241 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 49.0 tp -71.04 98.25 1.6 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.569 1.168 . . . . 63.45 109.311 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -172.04 -135.12 1.9 Allowed Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.475 1.11 . . . . 74.1 110.959 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 51.43 178.3 0.04 OUTLIER Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.949 -0.86 . . . . 74.04 110.949 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -178.65 24.09 Favored 'Cis proline' 0 C--N 1.361 1.201 0 C-N-CA 121.013 -2.495 . . . . 75.53 110.941 0.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -149.13 166.13 29.42 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 124.499 1.124 . . . . 62.34 110.977 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.514 ' CD2' ' CD1' ' A' ' 194' ' ' ILE . 6.6 mt -93.51 134.34 35.89 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.61 0.829 . . . . 75.05 109.253 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.458 HG12 ' CB ' ' A' ' 195' ' ' ALA . 1.8 m -139.1 153.9 71.86 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.537 1.148 . . . . 74.43 109.284 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.556 ' HD3' ' CZ ' ' A' ' 166' ' ' PHE . 18.2 Cg_endo -74.98 155.33 43.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.526 1.803 . . . . 72.1 110.974 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 3.6 p -81.39 -33.66 12.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.409 1.068 . . . . 71.33 109.263 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -64.77 -11.03 48.26 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.5 1.125 . . . . 61.24 110.949 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.471 ' O ' ' CG1' ' A' ' 212' ' ' VAL . 8.2 m-30 -109.89 19.74 18.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.493 0.76 . . . . 75.43 110.974 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.501 HG21 ' CD2' ' A' ' 193' ' ' PHE . 26.9 m -156.16 141.95 10.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.442 1.089 . . . . 73.43 109.275 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' SER . . . . . 0.412 ' CB ' HD13 ' A' ' 163' ' ' LEU . 1.0 OUTLIER -131.06 148.86 52.79 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.475 1.109 . . . . 73.11 110.017 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.461 HG13 ' CG2' ' A' ' 227' ' ' VAL . 12.1 mm -103.95 128.25 57.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.527 1.142 . . . . 75.43 109.346 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.429 ' O ' ' CE2' ' A' ' 159' ' ' TYR . 0.2 OUTLIER -151.86 156.85 5.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.11 . . . . 65.45 109.277 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' A' ' 217' ' ' ILE . 12.6 t70 -86.35 167.56 14.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.532 1.145 . . . . 74.43 109.296 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.416 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 9.6 tt -53.11 113.85 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 74.45 109.303 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -172.87 -175.54 1.27 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.558 1.161 . . . . 52.54 109.296 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 220' ' ' GLY . 5.1 t -54.61 -45.27 73.63 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.595 1.184 . . . . 73.34 110.428 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.412 ' N ' HG22 ' A' ' 219' ' ' THR . . . 133.99 79.28 0.13 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.442 1.089 . . . . 74.41 111.069 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -139.76 171.01 14.83 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.522 0.778 . . . . 63.33 110.983 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -107.89 114.18 27.93 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.471 1.107 . . . . 73.32 109.275 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 17.9 p -72.7 -26.25 61.53 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 73.24 110.382 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 116.23 4.93 17.69 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 124.481 1.113 . . . . 65.34 110.928 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.639 ' N ' HD21 ' A' ' 225' ' ' ASN . 0.9 OUTLIER -78.19 -176.32 4.56 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.432 0.724 . . . . 72.22 109.292 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.1 169.88 14.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.554 1.159 . . . . 73.11 109.273 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.461 ' CG2' HG13 ' A' ' 214' ' ' ILE . 12.1 p -80.77 -35.28 14.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.474 1.109 . . . . 73.03 109.254 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.4 mp -54.16 -50.37 55.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.517 1.136 . . . . 71.15 109.301 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -59.55 -35.61 74.55 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 74.22 110.295 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.455 ' HB3' ' CD1' ' A' ' 158' ' ' LEU . 5.0 m-20 -78.1 -22.93 48.21 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.468 1.105 . . . . 75.02 109.299 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.567 HG23 ' CD2' ' A' ' 187' ' ' HIS . 35.5 mt -70.61 -36.8 67.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.585 1.178 . . . . 65.33 109.266 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -80.72 -13.98 58.52 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.572 1.17 . . . . 74.25 109.309 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.457 ' O ' ' CD1' ' A' ' 155' ' ' LEU . 2.7 t -81.18 -44.39 17.91 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.526 1.141 . . . . 72.02 109.998 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.435 ' C ' ' N ' ' A' ' 236' ' ' LEU . 7.7 p -99.17 24.25 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.494 1.121 . . . . 70.25 109.343 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 41.36 29.13 0.08 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.534 1.146 . . . . 75.31 109.338 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.435 ' N ' ' C ' ' A' ' 234' ' ' VAL . 1.1 tp -45.21 103.75 0.36 Allowed Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.106 . . . . 73.45 109.286 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 138.19 22.64 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.561 1.822 . . . . 62.25 111.049 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 7.4 p -57.01 148.88 20.27 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 72.41 110.411 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.637 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 3.5 p -53.99 -25.43 12.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.535 1.147 . . . . 75.42 109.323 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.547 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 3.8 mm100 -77.82 -34.36 51.99 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.407 1.067 . . . . 73.04 110.319 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -82.74 -20.87 35.11 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.553 1.158 . . . . 75.34 110.303 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -80.09 -53.25 6.88 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.516 1.135 . . . . 73.44 108.022 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -51.61 -28.17 13.42 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.527 1.142 . . . . 65.34 109.272 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.7 t -73.64 -35.2 65.26 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.451 1.094 . . . . 73.31 109.999 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -76.11 -24.06 54.95 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.497 1.123 . . . . 74.22 109.281 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 8.3 mm -68.93 129.14 33.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.528 1.142 . . . . 65.55 109.261 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . 74.85 3.89 4.25 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.536 1.148 . . . . 74.24 109.362 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.04 -59.98 1.85 Allowed 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.499 1.124 . . . . 75.23 110.366 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -93.5 177.57 5.98 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.477 1.111 . . . . 75.31 110.955 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -130.87 152.19 50.46 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.445 1.091 . . . . 73.53 109.273 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -44.54 122.34 3.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.472 1.107 . . . . 70.4 109.325 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 87.0 p -139.65 179.32 6.64 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.518 1.136 . . . . 70.1 109.994 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.87 141.49 51.99 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.495 1.122 . . . . 74.14 109.336 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 19.5 tt -127.96 155.86 39.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.526 1.141 . . . . 72.1 109.264 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 13.6 t -57.96 144.19 40.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.544 1.152 . . . . 74.24 110.004 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 34.6 tp -137.58 142.62 41.31 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.513 1.133 . . . . 74.13 109.302 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -80.34 -161.76 25.18 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.537 1.148 . . . . 54.32 111.042 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.4 t -168.14 134.42 1.98 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.507 0.769 . . . . 74.14 109.979 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 13.7 p -171.41 113.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.482 1.114 . . . . 73.33 109.283 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 C--N 1.324 -0.523 0 O-C-N 124.524 1.14 . . . . 75.54 110.258 -179.961 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.058 0 N-CA-C 110.96 -0.856 . . . . 70.24 110.96 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.95 149.48 36.98 Favored 'Trans proline' 0 C--N 1.359 1.113 0 O-C-N 124.489 1.784 . . . . 64.32 111.001 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.4 mp -91.23 -176.4 4.57 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.528 1.143 . . . . 72.25 109.304 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 102.2 6.49 48.14 Favored Glycine 0 CA--C 1.531 1.057 0 O-C-N 124.544 1.153 . . . . 72.3 111.034 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.0 t -159.71 151.0 19.7 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.559 0.799 . . . . 73.24 109.973 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.45 ' CD1' HG13 ' A' ' 234' ' ' VAL . 6.5 mt -114.42 165.95 12.2 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.485 1.116 . . . . 73.12 109.301 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.43 ' CG ' ' C ' ' A' ' 158' ' ' LEU . 35.9 m-85 -154.65 116.73 4.22 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.466 1.104 . . . . 75.04 111.053 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -126.19 168.05 14.59 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.564 1.165 . . . . 75.24 109.382 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.494 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -133.76 130.14 55.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.557 1.16 . . . . 74.01 109.385 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.457 HG23 ' CD1' ' A' ' 182' ' ' LEU . 39.7 t -89.66 111.22 22.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 73.44 109.304 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.406 ' N ' HD21 ' A' ' 163' ' ' LEU . 0.2 OUTLIER -101.97 14.09 32.94 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.551 1.157 . . . . 72.3 109.287 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.569 ' HB3' ' CD2' ' A' ' 211' ' ' PHE . 63.5 m-85 -152.54 137.9 17.57 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.492 1.12 . . . . 73.05 111.031 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.418 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 25.8 t0 -80.16 107.96 13.37 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.482 1.114 . . . . 71.24 109.365 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.598 ' CE2' ' O ' ' A' ' 206' ' ' LEU . 17.1 t80 -80.33 136.58 36.43 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.517 1.136 . . . . 72.54 111.082 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.26 95.31 6.44 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.502 1.126 . . . . 75.05 109.316 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 166' ' ' PHE . . . -57.86 133.4 55.4 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.563 1.164 . . . . 70.13 109.276 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -119.84 -38.63 2.94 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.523 1.139 . . . . 64.02 110.301 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.1 -177.96 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.517 1.135 . . . . 72.41 109.291 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.21 -29.95 22.78 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.459 1.099 . . . . 72.24 109.337 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.73 -11.62 28.76 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.423 1.077 . . . . 72.35 109.25 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.415 ' OE1' ' CZ3' ' A' ' 192' ' ' TRP . 8.6 mt-10 -74.74 134.4 41.88 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 75.33 110.263 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.424 ' N ' ' HB2' ' A' ' 168' ' ' ALA . 5.4 mp -112.67 154.24 26.39 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.544 1.152 . . . . 72.41 109.329 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.9 t -91.65 115.82 28.37 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.503 1.127 . . . . 63.53 110.389 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.0 m -94.0 -173.64 3.18 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.483 1.114 . . . . 71.21 110.384 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -136.35 134.34 37.78 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.487 1.117 . . . . 74.32 110.996 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.418 ' HB ' ' N ' ' A' ' 165' ' ' ASP . 1.8 p -59.59 149.95 6.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.418 1.074 . . . . 74.44 109.286 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 68.22 36.77 85.71 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.505 1.128 . . . . 73.32 111.002 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.494 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 21.7 tp10 -113.42 165.02 12.86 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.527 0.781 . . . . 74.04 110.295 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.411 ' C ' ' CD1' ' A' ' 182' ' ' LEU . 2.7 m-80 -129.24 134.68 48.09 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.414 1.071 . . . . 73.55 109.332 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.457 ' CD1' HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -167.2 164.48 15.57 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.542 1.151 . . . . 74.11 109.363 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.566 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 0.6 OUTLIER -99.69 148.08 24.73 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.592 1.183 . . . . 74.44 110.958 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.462 ' CG2' ' O ' ' A' ' 186' ' ' ALA . 24.2 mm -77.7 112.9 16.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.49 1.119 . . . . 75.53 109.296 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.46 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 0.5 OUTLIER -73.87 -27.56 61.13 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.476 1.11 . . . . 71.42 108.261 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.462 ' O ' ' CG2' ' A' ' 184' ' ' ILE . . . -171.3 179.58 2.93 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.533 1.146 . . . . 73.15 109.289 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.457 ' CE1' HG23 ' A' ' 238' ' ' THR . 9.2 p80 -143.28 143.58 31.77 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.545 1.153 . . . . 75.23 109.594 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.01 121.58 35.64 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.483 1.115 . . . . 74.14 109.628 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.449 ' C ' ' N ' ' A' ' 191' ' ' GLU . 2.5 t-20 53.6 30.59 11.08 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.484 1.115 . . . . 74.42 109.309 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 13.1 p 42.68 29.0 0.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.125 . . . . 73.32 108.269 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.47 ' HG3' ' CD1' ' A' ' 192' ' ' TRP . 13.3 pt-20 -123.38 -37.49 2.67 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 75.02 110.245 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.47 ' CD1' ' HG3' ' A' ' 191' ' ' GLU . 15.8 m0 -112.37 160.48 17.66 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.546 1.154 . . . . 75.41 107.989 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.433 ' CZ ' HG22 ' A' ' 227' ' ' VAL . 21.0 m-85 -136.81 161.16 36.74 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.502 1.126 . . . . 74.22 111.016 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.466 ' CG1' ' HB ' ' A' ' 239' ' ' VAL . 9.5 mm -97.77 108.53 21.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.456 1.098 . . . . 73.01 109.317 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.49 ' CB ' ' CG2' ' A' ' 207' ' ' VAL . . . -99.42 167.98 10.28 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.525 1.14 . . . . 64.03 109.271 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -153.94 91.79 3.15 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.429 1.081 . . . . 73.55 109.287 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -162.47 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.198 0 O-C-N 124.518 1.799 . . . . 61.21 111.004 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.44 ' CD1' ' N ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -40.14 126.51 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 75.45 109.291 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -37.77 115.33 0.35 Allowed Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.546 1.154 . . . . 64.02 110.975 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 202' ' ' GLY . 44.5 ttt180 -151.23 115.99 5.19 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.451 0.736 . . . . 74.15 110.337 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 14.8 mt -49.21 94.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.501 1.126 . . . . 71.32 109.321 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 200' ' ' ARG . . . 165.84 -31.28 0.22 Allowed Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.468 1.105 . . . . 74.13 111.033 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -72.15 176.05 41.45 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.58 0.812 . . . . 70.12 111.091 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.472 ' CB ' ' O ' ' A' ' 195' ' ' ALA . 18.4 Cg_endo -75.03 -173.7 12.81 Favored 'Cis proline' 0 C--N 1.36 1.176 0 C-N-CA 121.0 -2.5 . . . . 72.42 111.027 -0.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.13 172.38 20.71 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.503 1.127 . . . . 73.53 110.988 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.598 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 6.5 mt -99.4 134.8 41.75 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.484 0.755 . . . . 74.33 109.316 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.507 HG12 ' CG ' ' A' ' 166' ' ' PHE . 0.7 OUTLIER -134.43 144.27 50.31 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.504 1.128 . . . . 71.1 109.309 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.571 ' HD3' ' CD1' ' A' ' 166' ' ' PHE . 18.2 Cg_endo -74.94 138.84 23.73 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.51 1.795 . . . . 62.22 111.005 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.47 ' HA ' ' CG2' ' A' ' 212' ' ' VAL . 7.5 p -61.13 -34.78 61.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.46 1.1 . . . . 65.15 109.301 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -61.27 -13.01 34.11 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.557 1.16 . . . . 54.53 111.031 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.569 ' CD2' ' HB3' ' A' ' 164' ' ' TYR . 4.4 m-85 -113.51 18.41 17.67 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.546 0.792 . . . . 73.31 111.026 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.47 ' CG2' ' HA ' ' A' ' 209' ' ' VAL . 11.3 m -153.62 153.58 8.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.499 1.124 . . . . 75.52 109.336 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.7 t -139.27 141.55 37.79 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.458 1.098 . . . . 74.24 110.018 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.468 HG13 ' CG2' ' A' ' 227' ' ' VAL . 17.6 mm -82.34 91.71 2.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.535 1.147 . . . . 73.41 109.27 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.417 ' CD1' HG21 ' A' ' 161' ' ' ILE . 1.6 pt -148.6 131.86 7.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.125 . . . . 61.35 109.364 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -112.12 17.99 19.08 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.507 1.129 . . . . 71.45 109.318 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 61.1 mt -87.9 -35.13 7.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.511 1.132 . . . . 65.24 109.294 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 74.51 49.21 0.11 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.499 1.124 . . . . 74.25 109.292 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.546 ' HB ' ' CE2' ' A' ' 221' ' ' TYR . 10.1 p -133.47 -49.48 0.84 Allowed 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.513 1.133 . . . . 75.53 110.411 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 129.19 -6.61 6.36 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.524 1.14 . . . . 75.55 110.973 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.546 ' CE2' ' HB ' ' A' ' 219' ' ' THR . 4.9 m-85 -85.8 -179.93 6.92 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.48 0.753 . . . . 73.31 111.009 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -139.71 155.73 47.2 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.472 1.108 . . . . 74.33 109.336 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 72.0 p -91.94 -17.85 24.57 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.517 1.135 . . . . 73.42 110.428 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.08 -1.22 22.7 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.467 1.104 . . . . 70.21 111.01 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -82.25 176.17 9.69 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.475 0.75 . . . . 70.01 109.261 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.44 171.73 9.72 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.458 1.099 . . . . 74.31 109.333 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.468 ' CG2' HG13 ' A' ' 214' ' ' ILE . 12.0 p -80.52 -40.27 19.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.47 1.106 . . . . 70.44 109.239 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.457 HD13 ' CG1' ' A' ' 227' ' ' VAL . 2.4 mp -51.04 -48.51 29.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.156 . . . . 73.43 109.301 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.03 -33.15 74.82 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.491 1.12 . . . . 75.54 110.25 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.89 -14.29 59.9 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.574 1.171 . . . . 71.23 109.292 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.412 HG21 ' NE2' ' A' ' 187' ' ' HIS . 34.6 mt -84.29 -32.4 8.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.483 1.114 . . . . 75.42 109.354 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -84.01 -18.73 36.12 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.421 1.076 . . . . 75.32 109.288 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 6.8 p -68.66 -29.01 67.39 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.527 1.142 . . . . 63.45 109.967 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.45 HG13 ' CD1' ' A' ' 158' ' ' LEU . 6.2 p -126.53 21.34 3.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.506 1.129 . . . . 73.03 109.318 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 40.68 29.74 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.559 1.162 . . . . 73.02 109.334 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.428 ' N ' ' C ' ' A' ' 234' ' ' VAL . 22.9 tp -42.11 113.34 1.2 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.521 1.138 . . . . 72.22 109.325 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 133.72 16.91 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.519 1.799 . . . . 71.24 110.956 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' THR . . . . . 0.457 HG23 ' CE1' ' A' ' 187' ' ' HIS . 9.4 p -57.12 151.56 15.1 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.513 1.133 . . . . 73.23 110.42 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.466 ' HB ' ' CG1' ' A' ' 194' ' ' ILE . 2.7 p -59.72 -24.89 30.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.549 1.156 . . . . 73.41 109.281 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -80.05 -28.59 39.22 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.455 1.097 . . . . 74.22 110.28 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -86.9 -25.06 24.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 74.1 110.233 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -76.75 -52.9 8.73 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.48 1.113 . . . . 63.4 108.001 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 32.5 pttt -48.1 -28.83 3.11 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.504 1.127 . . . . 73.03 109.35 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.6 t -81.32 -44.78 17.15 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.457 1.098 . . . . 70.0 109.98 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.42 ' N ' HD21 ' A' ' 245' ' ' ASN . 1.3 m-80 -63.07 -16.39 59.76 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.543 1.152 . . . . 74.51 109.26 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 55.5 mt -69.06 129.53 33.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 O-C-N 124.591 1.182 . . . . 72.21 109.299 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.03 153.71 40.77 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.486 1.116 . . . . 73.33 109.248 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -162.61 175.49 11.35 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.462 1.101 . . . . 75.01 110.304 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' ' 248' ' ' ARG . 25.1 t80 -35.07 112.57 0.16 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.128 . . . . 74.34 110.95 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -115.87 132.72 56.56 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.505 1.128 . . . . 75.14 109.3 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.99 176.77 7.6 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.477 1.111 . . . . 74.55 109.264 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 1.5 t -63.88 133.61 53.63 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.554 1.159 . . . . 73.23 110.07 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -152.82 -177.03 6.01 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.567 1.167 . . . . 74.13 109.28 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 19.6 mm -110.14 164.6 6.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.539 1.149 . . . . 74.01 109.363 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 61.2 p -96.76 -175.88 3.42 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.548 1.155 . . . . 72.44 109.974 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.98 -66.7 0.98 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.528 1.142 . . . . 72.23 109.281 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 165.28 -170.79 40.38 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.573 1.17 . . . . 74.44 110.955 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.3 p -125.03 131.37 53.39 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.442 0.73 . . . . 74.33 109.978 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.8 m -54.55 177.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.547 1.154 . . . . 75.44 109.351 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 . . . . . 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 73.32 110.29 179.972 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.94 0 N-CA-C 111.07 -0.812 . . . . 73.3 111.07 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 107.97 2.61 Favored 'Trans proline' 0 C--N 1.361 1.205 0 O-C-N 124.466 1.772 . . . . 75.43 111.025 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 16.3 mt -87.51 -27.69 22.47 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.545 1.153 . . . . 75.22 109.271 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 52.16 20.22 6.52 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.546 1.154 . . . . 64.32 110.99 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.2 p -166.32 153.49 9.62 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.474 0.75 . . . . 64.44 110.044 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.54 ' O ' ' CG ' ' A' ' 159' ' ' TYR . 8.2 mt -146.64 -178.65 6.28 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.514 1.134 . . . . 62.51 109.3 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.54 ' CG ' ' O ' ' A' ' 158' ' ' LEU . 76.3 m-85 -164.69 141.62 6.2 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.588 1.18 . . . . 74.33 111.064 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.469 ' HB2' ' CD1' ' A' ' 184' ' ' ILE . . . -135.44 130.26 34.5 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.539 1.149 . . . . 52.14 109.297 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.463 ' CG1' ' O ' ' A' ' 180' ' ' GLU . 1.3 tt -100.83 138.85 23.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.519 1.137 . . . . 73.25 109.28 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 179' ' ' GLY . 2.9 t -90.88 114.21 27.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.456 1.097 . . . . 72.42 109.275 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.439 ' O ' ' CD1' ' A' ' 164' ' ' TYR . 0.1 OUTLIER -94.32 12.99 25.02 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.481 1.113 . . . . 72.44 109.296 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.439 ' CD1' ' O ' ' A' ' 163' ' ' LEU . 35.3 m-85 -157.98 131.27 7.61 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.562 1.163 . . . . 75.53 110.969 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -54.06 108.67 0.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 72.52 109.236 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.586 ' CE2' ' O ' ' A' ' 174' ' ' LEU . 5.7 t80 -80.46 136.71 36.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.447 1.092 . . . . 74.35 110.992 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -113.68 111.75 22.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.458 1.099 . . . . 74.44 109.259 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.53 121.65 14.37 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.534 1.146 . . . . 65.32 109.301 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.452 ' CG ' ' N ' ' A' ' 170' ' ' LYS . 14.7 pt-20 -116.62 -44.41 2.85 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.543 1.152 . . . . 73.24 110.256 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.452 ' N ' ' CG ' ' A' ' 169' ' ' GLU . 0.8 OUTLIER -59.78 161.71 6.06 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.537 1.148 . . . . 73.4 109.324 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.76 -19.61 64.33 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.441 1.088 . . . . 73.43 109.262 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -124.44 25.22 7.71 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.415 1.072 . . . . 74.24 109.393 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.426 ' OE2' ' CB ' ' A' ' 170' ' ' LYS . 6.3 tp10 -85.11 157.92 20.55 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 1.118 . . . . 73.52 110.33 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.586 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 0.3 OUTLIER -115.86 149.83 38.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.153 . . . . 75.31 109.335 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 11.6 t -107.72 137.97 44.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.511 1.132 . . . . 74.53 110.402 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.453 HG21 ' CD1' ' A' ' 182' ' ' LEU . 2.5 m -136.54 -164.39 1.56 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.551 1.157 . . . . 65.3 110.463 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -140.62 150.49 43.64 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.433 1.083 . . . . 71.32 111.039 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -45.81 156.47 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.436 1.085 . . . . 74.11 109.313 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 37.51 63.81 0.79 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.518 1.136 . . . . 71.15 111.025 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.463 ' O ' ' CG1' ' A' ' 161' ' ' ILE . 26.5 tp10 -121.85 155.93 34.34 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.541 0.789 . . . . 70.04 110.321 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.457 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.5 OUTLIER -101.5 126.99 48.37 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.534 1.146 . . . . 74.43 109.335 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.453 ' CD1' HG21 ' A' ' 176' ' ' THR . 11.1 mt -146.79 153.21 39.93 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.463 1.102 . . . . 73.55 109.3 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -111.56 131.73 55.04 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.546 1.154 . . . . 74.43 111.016 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 160' ' ' ALA . 31.7 mm -77.71 129.59 37.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 74.53 109.238 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 1.3 t -103.78 -25.45 13.1 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.457 1.098 . . . . 72.12 108.288 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.456 ' HA ' ' CD2' ' A' ' 236' ' ' LEU . . . -164.49 171.95 13.94 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.484 1.115 . . . . 63.13 109.298 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.49 ' CD2' HG23 ' A' ' 231' ' ' ILE . 8.5 p80 -140.23 145.27 37.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.519 1.137 . . . . 74.34 109.616 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.649 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.6 t-160 -122.97 118.28 27.44 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.569 1.168 . . . . 73.43 109.593 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.45 ' C ' ' N ' ' A' ' 191' ' ' GLU . 57.1 m-80 53.82 31.51 13.22 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.549 1.155 . . . . 74.03 109.258 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.411 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 12.7 p 42.96 28.62 0.14 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 72.4 108.244 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.45 ' N ' ' C ' ' A' ' 189' ' ' ASN . 6.1 pt-20 -122.54 -36.05 2.99 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.457 1.098 . . . . 72.55 110.279 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.431 ' CE3' ' HB3' ' A' ' 206' ' ' LEU . 9.1 m0 -114.07 159.91 19.48 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.486 1.116 . . . . 74.33 108.01 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.449 ' CZ ' ' CG2' ' A' ' 227' ' ' VAL . 28.4 m-85 -130.35 157.38 42.73 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.423 1.077 . . . . 74.14 111.02 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.459 ' CG1' ' HB ' ' A' ' 239' ' ' VAL . 22.8 mm -103.44 111.56 33.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.459 1.099 . . . . 74.01 109.228 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -98.08 154.85 17.44 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.589 1.181 . . . . 71.53 109.34 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -142.9 154.64 62.37 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.467 1.104 . . . . 71.44 109.318 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 163.1 36.01 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.435 1.755 . . . . 75.14 111.034 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 18.2 tt -70.78 -21.21 22.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.481 1.113 . . . . 75.24 109.311 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 159.86 53.75 0.01 OUTLIER Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.462 1.101 . . . . 73.21 111.01 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 48.0 mmm-85 -150.01 -175.87 5.22 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.545 0.791 . . . . 75.35 110.279 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.25 123.47 30.17 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.503 1.127 . . . . 73.42 109.279 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 175.57 -96.21 0.1 Allowed Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.475 1.109 . . . . 65.13 111.005 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -50.14 -178.88 0.02 OUTLIER Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.022 -0.831 . . . . 53.55 111.022 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 125.38 11.24 Favored 'Cis proline' 0 C--N 1.362 1.241 0 C-N-CA 120.987 -2.506 . . . . 64.31 110.972 0.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -105.25 172.28 19.47 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.532 1.145 . . . . 62.54 110.972 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.431 ' HB3' ' CE3' ' A' ' 192' ' ' TRP . 3.8 mt -106.07 137.23 44.35 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.507 0.769 . . . . 74.44 109.258 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.467 ' CG2' HG11 ' A' ' 212' ' ' VAL . 0.1 OUTLIER -132.56 138.59 32.42 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.535 1.147 . . . . 73.34 109.327 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.57 ' HD3' ' CZ ' ' A' ' 166' ' ' PHE . 18.2 Cg_endo -75.01 144.58 30.37 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.463 1.77 . . . . 74.11 111.012 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 12.0 p -75.19 -21.84 16.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.545 1.153 . . . . 74.35 109.316 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -75.68 -7.8 83.7 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.488 1.118 . . . . 73.12 111.037 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -113.67 -11.2 12.99 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.447 0.733 . . . . 73.23 111.11 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.467 HG11 ' CG2' ' A' ' 207' ' ' VAL . 15.4 m -128.48 161.55 36.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.527 1.142 . . . . 73.45 109.302 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 6.3 t -149.88 153.17 36.25 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.47 1.106 . . . . 73.34 110.027 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.453 HG13 ' CG2' ' A' ' 227' ' ' VAL . 12.3 mm -96.46 121.42 46.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 124.546 1.154 . . . . 71.32 109.295 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.6 pt -149.89 156.48 7.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.514 1.134 . . . . 73.41 109.335 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -85.94 -58.75 2.52 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.533 1.146 . . . . 62.3 109.311 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.6 mt -152.17 112.64 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.53 1.144 . . . . 75.34 109.295 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -174.33 132.62 0.39 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.43 1.081 . . . . 75.31 109.368 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 9.5 t -58.14 -30.84 66.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.577 1.173 . . . . 73.45 110.409 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 173.53 65.7 0.05 OUTLIER Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.524 1.14 . . . . 74.32 111.038 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -137.11 -175.14 3.94 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 0.783 . . . . 75.31 111.069 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -155.64 109.62 2.83 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.483 1.115 . . . . 75.13 109.354 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.426 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 58.4 p -45.68 -48.33 15.0 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.485 1.115 . . . . 74.11 110.447 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 154.08 -22.8 0.68 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.473 1.108 . . . . 71.3 111.033 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.426 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 21.4 m-80 -62.88 -175.95 0.11 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.45 0.735 . . . . 61.02 109.318 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -135.04 176.98 8.17 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.47 1.106 . . . . 70.2 109.254 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.453 ' CG2' HG13 ' A' ' 214' ' ' ILE . 8.3 p -79.6 -32.95 14.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.524 1.14 . . . . 71.52 109.342 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 228' ' ' ILE . 1.5 mp -57.75 -49.23 81.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.43 1.081 . . . . 72.32 109.258 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -59.92 -28.89 67.99 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.447 1.092 . . . . 74.14 110.298 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.75 -31.21 36.02 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.546 1.154 . . . . 72.45 109.277 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.49 HG23 ' CD2' ' A' ' 187' ' ' HIS . 24.3 mt -72.72 -39.03 59.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.459 1.099 . . . . 71.12 109.281 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -76.22 -32.7 59.08 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.536 1.147 . . . . 63.42 109.258 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.4 m -55.65 -39.86 71.45 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 74.13 110.04 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 11.8 p -118.58 13.54 7.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.501 1.126 . . . . 74.05 109.316 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 231' ' ' ILE . 8.5 m120 40.46 43.06 1.44 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.542 1.151 . . . . 73.2 109.321 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.46 HD13 ' CD1' ' A' ' 158' ' ' LEU . 2.1 tt -40.28 140.01 0.99 Allowed Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.525 1.14 . . . . 74.4 109.306 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 139.23 24.02 Favored 'Trans proline' 0 C--N 1.361 1.207 0 O-C-N 124.566 1.824 . . . . 72.43 110.996 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 2.3 p -75.13 152.14 38.52 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.504 1.127 . . . . 73.25 110.41 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.649 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.7 p -53.32 -23.09 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.525 1.14 . . . . 73.41 109.33 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.498 ' O ' ' CB ' ' A' ' 244' ' ' SER . 99.3 mm-40 -86.06 -50.14 7.26 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.46 1.1 . . . . 71.31 110.254 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -59.01 -28.91 66.83 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.536 1.147 . . . . 64.42 110.327 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 22.0 t90 -80.42 -68.0 0.72 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.98 -1.119 . . . . 75.25 107.98 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.8 pttp -50.41 -23.25 2.28 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.516 1.135 . . . . 72.22 109.254 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 240' ' ' GLN . 11.3 t -68.57 -59.67 2.97 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.64 1.213 . . . . 72.42 110.047 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -59.27 -24.33 63.14 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.542 1.151 . . . . 71.04 109.381 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 3.3 mm -78.47 155.06 5.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 74.04 109.216 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -43.75 155.91 0.07 Allowed 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.462 1.101 . . . . 72.21 109.32 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . 0.431 ' C ' ' CD ' ' A' ' 248' ' ' ARG . 0.0 OUTLIER 175.06 -174.4 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.441 1.088 . . . . 75.11 110.322 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -125.89 172.26 10.04 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.456 1.097 . . . . 75.53 110.969 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -92.7 -40.66 10.59 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.558 1.161 . . . . 63.25 109.314 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -144.72 145.08 31.53 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.505 1.128 . . . . 72.41 109.35 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 55.0 m -116.7 163.13 16.59 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.477 1.111 . . . . 65.12 110.015 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -100.12 18.83 17.62 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.467 1.104 . . . . 74.02 109.246 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 3.8 pt -93.83 17.8 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.485 1.116 . . . . 73.53 109.288 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.7 t -97.43 138.32 35.06 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.484 1.115 . . . . 71.22 109.949 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 13.8 mt -123.53 150.44 43.99 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.525 1.14 . . . . 73.25 109.318 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.94 71.79 2.35 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.503 1.127 . . . . 73.2 110.977 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.5 t -82.72 135.93 34.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.49 0.759 . . . . 64.34 109.997 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.65 130.25 16.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.433 1.083 . . . . 75.43 109.326 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.506 0 O-C-N 124.468 1.105 . . . . 72.31 110.277 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.047 0 N-CA-C 111.016 -0.834 . . . . 73.21 111.016 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 177.79 8.12 Favored 'Trans proline' 0 C--N 1.361 1.208 0 O-C-N 124.487 1.783 . . . . 73.33 110.984 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 7.0 mt -126.15 138.15 53.64 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.582 1.176 . . . . 73.32 109.368 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 169.03 58.21 0.03 OUTLIER Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.551 1.157 . . . . 54.2 111.009 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.8 m -166.13 121.36 1.22 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 0.769 . . . . 65.15 109.997 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.453 ' C ' ' CD1' ' A' ' 159' ' ' TYR . 0.5 OUTLIER -164.32 122.68 1.81 Allowed 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.502 1.126 . . . . 54.21 109.33 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.54 ' CD2' ' HB3' ' A' ' 183' ' ' PHE . 6.0 m-85 -137.41 165.82 25.31 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.493 1.121 . . . . 72.32 110.985 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -125.66 150.7 47.38 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.51 1.131 . . . . 74.11 109.291 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.497 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 1.0 OUTLIER -113.19 122.74 67.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.514 1.134 . . . . 63.52 109.287 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.497 ' CG1' ' O ' ' A' ' 177' ' ' TYR . 19.8 t -76.73 132.31 33.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 72.25 109.293 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.25 -12.38 14.46 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 70.54 109.294 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.423 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 85.1 m-85 -143.06 151.57 40.93 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 72.12 110.939 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.485 ' OD2' ' CE ' ' A' ' 167' ' ' LYS . 0.9 OUTLIER -78.96 104.67 9.75 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.468 1.105 . . . . 64.43 109.273 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.514 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 1.1 t80 -80.87 109.45 15.45 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 1.127 . . . . 75.02 110.992 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.485 ' CE ' ' OD2' ' A' ' 165' ' ' ASP . 13.8 mmtp -81.55 94.41 6.88 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.53 1.143 . . . . 74.02 109.276 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.425 ' HB3' ' N ' ' A' ' 174' ' ' LEU . . . -43.96 124.4 3.79 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.406 1.066 . . . . 74.22 109.244 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -119.72 -38.66 2.95 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.493 1.12 . . . . 71.3 110.269 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 165.01 8.99 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.53 1.144 . . . . 74.25 109.29 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.85 -22.57 62.29 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.509 1.131 . . . . 75.24 109.334 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -117.9 25.25 10.5 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.514 1.134 . . . . 61.14 109.297 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.46 ' CG ' ' CZ ' ' A' ' 166' ' ' PHE . 5.1 tp10 -91.91 147.5 22.92 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.527 1.142 . . . . 74.52 110.373 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.428 ' CG ' ' HA3' ' A' ' 205' ' ' GLY . 0.4 OUTLIER -120.02 143.61 47.98 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.403 1.065 . . . . 75.4 109.287 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.6 t -81.59 143.72 31.77 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.502 1.126 . . . . 63.41 110.414 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.42 HG23 ' CG2' ' A' ' 162' ' ' VAL . 2.6 m -131.37 -176.75 4.13 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.469 1.105 . . . . 73.45 110.399 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.497 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 6.1 m-85 -130.46 155.48 46.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.468 1.105 . . . . 75.21 111.017 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.0 OUTLIER -68.09 156.02 7.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.545 1.153 . . . . 75.43 109.309 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.47 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 37.45 55.1 1.66 Allowed Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.524 1.14 . . . . 54.12 111.011 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.497 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 14.9 tt0 -114.75 165.94 12.28 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.513 0.772 . . . . 63.34 110.307 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.477 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.0 OUTLIER -125.95 121.02 31.91 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.527 1.142 . . . . 74.54 109.269 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.3 pp -140.63 168.27 20.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.462 1.101 . . . . 75.45 109.325 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.54 ' HB3' ' CD2' ' A' ' 159' ' ' TYR . 11.1 p90 -108.41 134.99 50.44 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.529 1.143 . . . . 74.4 110.965 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.456 ' CG2' ' O ' ' A' ' 186' ' ' ALA . 22.9 mm -77.62 124.67 36.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.482 1.114 . . . . 75.45 109.304 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 39.7 m -88.59 -22.58 23.44 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.537 1.148 . . . . 71.43 108.316 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.456 ' O ' ' CG2' ' A' ' 184' ' ' ILE . . . -172.6 179.19 2.5 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.522 1.139 . . . . 75.35 109.275 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.561 ' CD2' HG23 ' A' ' 231' ' ' ILE . 8.8 p80 -144.48 153.75 42.21 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.539 1.15 . . . . 73.32 109.616 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.18 117.11 17.84 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 74.0 109.644 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.78 18.06 5.7 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.462 1.101 . . . . 71.43 109.319 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 4.0 m 57.92 18.62 5.16 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.452 1.095 . . . . 55.34 108.305 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.405 ' O ' ' CG2' ' A' ' 209' ' ' VAL . 11.6 pt-20 -115.97 -33.04 5.21 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.515 1.134 . . . . 72.55 110.284 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 12.9 m0 -112.58 158.47 19.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.568 1.167 . . . . 73.23 108.036 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.65 ' CE2' ' CG2' ' A' ' 209' ' ' VAL . 39.8 m-85 -134.44 163.55 29.43 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.466 1.104 . . . . 73.43 111.027 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.436 ' CG1' ' HB ' ' A' ' 239' ' ' VAL . 33.8 mm -105.97 120.67 57.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.596 1.185 . . . . 75.53 109.262 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -106.0 163.3 12.87 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.491 1.119 . . . . 74.54 109.353 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.94 87.7 3.3 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 74.25 109.295 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.06 95.03 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.488 1.783 . . . . 72.34 110.967 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 7.8 tp -65.4 163.5 2.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.449 1.093 . . . . 65.14 109.317 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 113.11 -41.09 2.31 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.506 1.129 . . . . 74.43 111.015 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 60.3 mmt-85 -125.29 179.86 4.9 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.482 0.754 . . . . 73.0 110.32 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 11.7 mt -96.68 74.57 2.74 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.481 1.113 . . . . 74.04 109.32 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -156.01 113.8 0.58 Allowed Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.557 1.161 . . . . 62.33 110.995 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 133.67 177.4 14.91 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.977 -0.849 . . . . 75.54 110.977 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 160.11 96.98 Favored 'Cis proline' 0 C--N 1.36 1.147 0 C-N-CA 121.006 -2.497 . . . . 73.34 110.926 0.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.428 ' HA3' ' CG ' ' A' ' 174' ' ' LEU . . . -120.13 -172.11 14.76 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.5 1.125 . . . . 71.41 111.006 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.4 mt -108.52 154.98 21.16 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.469 0.746 . . . . 73.31 109.321 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.536 ' CG2' ' CG1' ' A' ' 212' ' ' VAL . 0.2 OUTLIER -153.74 119.04 2.78 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.531 1.144 . . . . 64.02 109.241 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.514 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.5 Cg_endo -74.93 156.68 43.3 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.56 1.821 . . . . 74.11 111.027 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.65 ' CG2' ' CE2' ' A' ' 193' ' ' PHE . 7.1 t -68.68 -15.33 19.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.473 1.108 . . . . 70.22 109.319 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -72.88 -2.5 57.59 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.471 1.107 . . . . 61.24 110.998 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -134.07 11.24 3.91 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.518 0.775 . . . . 73.41 111.024 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.536 ' CG1' ' CG2' ' A' ' 207' ' ' VAL . 14.9 m -148.26 143.99 19.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.508 1.13 . . . . 75.21 109.307 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 9.7 t -128.52 154.61 45.96 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.461 1.101 . . . . 64.34 110.024 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.47 HG13 ' CG2' ' A' ' 227' ' ' VAL . 31.6 mm -107.15 141.73 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.47 1.106 . . . . 74.31 109.279 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.412 HD12 ' N ' ' A' ' 215' ' ' ILE . 0.2 OUTLIER -142.66 157.63 18.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.457 1.098 . . . . 73.34 109.299 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -136.23 127.47 28.18 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.481 1.113 . . . . 64.43 109.345 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 21.2 tt 42.15 44.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.477 1.111 . . . . 73.43 109.345 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -134.78 136.37 42.54 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.524 1.14 . . . . 62.44 109.282 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 219' ' ' THR . 8.8 t -89.09 76.13 7.81 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.486 1.116 . . . . 75.25 110.394 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.71 -28.51 8.38 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 124.511 1.132 . . . . 61.15 111.043 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -80.05 -176.41 5.51 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.505 0.768 . . . . 75.54 111.011 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -131.86 148.93 52.58 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.491 1.12 . . . . 75.11 109.289 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 55.1 p -92.11 -17.51 24.86 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.43 1.081 . . . . 75.42 110.427 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.87 -2.54 21.28 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.512 1.133 . . . . 74.1 111.06 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -69.47 171.93 8.01 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.535 0.785 . . . . 72.12 109.285 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.2 168.31 11.0 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.496 1.122 . . . . 71.41 109.281 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.47 ' CG2' HG13 ' A' ' 214' ' ' ILE . 10.4 p -78.47 -34.62 18.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.517 1.135 . . . . 74.11 109.293 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.431 ' CD1' ' N ' ' A' ' 228' ' ' ILE . 1.3 mp -56.54 -50.94 71.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.585 1.178 . . . . 75.02 109.336 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -63.93 -31.95 73.31 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.541 1.151 . . . . 71.33 110.3 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.33 -36.05 74.01 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.508 1.13 . . . . 72.12 109.307 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.561 HG23 ' CD2' ' A' ' 187' ' ' HIS . 23.0 mt -67.76 -43.03 86.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.496 1.123 . . . . 64.43 109.345 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 29.9 mmtt -74.36 -21.21 59.79 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.456 1.097 . . . . 71.11 109.251 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 36.9 m -66.75 -37.44 84.62 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.494 1.121 . . . . 74.1 109.985 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.46 11.67 7.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.527 1.142 . . . . 74.35 109.275 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 57.7 t30 40.48 43.95 1.62 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.549 1.156 . . . . 74.54 109.282 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 237' ' ' PRO . 1.6 tp -52.07 142.87 25.94 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.54 1.15 . . . . 71.22 109.282 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 236' ' ' LEU . 18.3 Cg_endo -74.97 154.1 42.4 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.473 1.775 . . . . 62.22 110.988 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' THR . . . . . 0.422 HG21 ' NE2' ' A' ' 187' ' ' HIS . 3.1 p -94.11 142.06 27.83 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.552 1.158 . . . . 75.33 110.375 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.436 ' HB ' ' CG1' ' A' ' 194' ' ' ILE . 2.7 p -47.04 -25.5 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.445 1.091 . . . . 62.2 109.301 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.411 ' N ' ' C ' ' A' ' 238' ' ' THR . 37.3 mm-40 -80.97 -40.92 23.63 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.524 1.14 . . . . 73.52 110.255 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 238' ' ' THR . 74.9 mt-10 -72.15 -23.44 61.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.526 1.141 . . . . 74.44 110.323 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.434 ' O ' ' N ' ' A' ' 245' ' ' ASN . 3.5 t90 -77.59 -71.59 0.41 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.532 1.145 . . . . 74.23 107.979 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.02 -27.76 0.4 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.561 1.163 . . . . 74.05 109.259 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.42 ' N ' ' C ' ' A' ' 242' ' ' TRP . 3.0 t -73.58 -46.92 44.35 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 63.2 110.025 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 242' ' ' TRP . 16.5 t-20 -56.25 -26.32 51.09 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.547 1.154 . . . . 72.14 109.254 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 16.4 mm -79.26 92.79 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.527 1.142 . . . . 70.11 109.269 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -174.48 116.06 0.19 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.529 1.143 . . . . 74.14 109.232 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 13.2 mmm-85 -84.5 174.41 10.06 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.52 1.138 . . . . 75.03 110.311 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 42.49 42.37 2.7 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.446 1.091 . . . . 73.32 110.975 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -112.75 -70.0 0.83 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.138 . . . . 74.01 109.252 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -158.6 145.46 17.45 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.496 1.122 . . . . 74.01 109.34 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 2.2 p -58.13 149.04 24.72 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.514 1.134 . . . . 71.02 110.007 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -134.5 109.39 8.68 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 74.45 109.251 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 29.6 mt -134.22 123.85 44.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.468 1.105 . . . . 75.15 109.278 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 5.4 t -55.16 159.19 2.63 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.465 1.103 . . . . 73.13 110.012 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 4.7 tp -127.58 94.7 4.03 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.548 1.155 . . . . 73.02 109.294 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -81.38 158.44 39.73 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.521 1.138 . . . . 70.42 110.998 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.2 m -116.03 -9.98 11.64 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.548 0.793 . . . . 63.44 110.017 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.42 142.37 16.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.502 1.126 . . . . 71.22 109.325 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.125 . . . . 72.51 110.302 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.996 0 N-CA-C 110.994 -0.842 . . . . 75.51 110.994 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 148.32 35.32 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.498 1.788 . . . . 73.4 110.991 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.4 mt -110.99 162.96 14.32 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.523 1.14 . . . . 72.12 109.322 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.81 -16.74 6.89 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.519 1.137 . . . . 72.32 111.001 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.0 p -173.55 153.42 2.31 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.478 0.752 . . . . 72.22 110.02 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.451 ' CD2' HG11 ' A' ' 234' ' ' VAL . 0.0 OUTLIER -126.62 158.94 34.99 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.482 1.114 . . . . 75.03 109.357 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -114.13 135.42 54.05 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.478 1.111 . . . . 72.54 111.011 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -124.31 163.91 20.71 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 71.2 109.291 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.4 ' O ' ' CD2' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -132.69 128.75 57.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.52 1.137 . . . . 73.43 109.359 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.408 ' CG1' ' O ' ' A' ' 164' ' ' TYR . 3.0 t -86.93 109.51 19.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.478 1.111 . . . . 72.25 109.32 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.543 ' O ' ' CG ' ' A' ' 164' ' ' TYR . 0.1 OUTLIER -97.64 17.34 18.06 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.546 1.154 . . . . 72.04 109.308 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.543 ' CG ' ' O ' ' A' ' 163' ' ' LEU . 53.3 m-85 -164.56 147.67 8.93 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.557 1.161 . . . . 64.42 110.984 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.421 ' N ' HG23 ' A' ' 178' ' ' VAL . 0.2 OUTLIER -73.3 158.6 34.81 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.479 1.112 . . . . 74.41 109.304 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.602 ' CD1' ' N ' ' A' ' 167' ' ' LYS . 1.9 t80 -135.55 157.85 45.86 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.575 1.172 . . . . 75.23 111.041 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.602 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 21.5 mmtp -124.76 134.51 52.77 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.483 1.114 . . . . 72.33 109.294 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.43 ' HB3' ' N ' ' A' ' 174' ' ' LEU . . . -99.98 124.07 44.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.487 1.117 . . . . 74.12 109.338 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -117.18 -34.37 4.38 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.496 1.123 . . . . 55.23 110.304 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -68.82 -179.79 1.55 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.447 1.092 . . . . 72.13 109.329 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.51 -29.68 22.54 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.474 1.109 . . . . 72.11 109.294 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.25 21.68 16.13 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.564 1.165 . . . . 71.52 109.278 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -93.44 159.27 15.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.446 1.091 . . . . 72.02 110.295 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.593 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 4.6 mm? -133.0 147.18 52.28 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 74.44 109.289 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 12.2 t -98.21 145.74 26.31 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.484 1.115 . . . . 71.43 110.355 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.7 m -146.52 -178.11 5.99 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.49 1.119 . . . . 73.14 110.44 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -128.97 -179.79 5.31 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.559 1.162 . . . . 74.41 111.038 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 165' ' ' ASP . 28.8 t -74.26 165.01 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.475 1.109 . . . . 74.35 109.316 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 37.57 71.74 0.2 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.507 1.129 . . . . 55.02 111.023 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -121.91 154.2 37.44 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.488 0.758 . . . . 74.01 110.208 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -112.75 119.74 39.09 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.561 1.163 . . . . 75.4 109.327 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.499 ' C ' ' CD1' ' A' ' 182' ' ' LEU . 0.2 OUTLIER -160.64 -175.42 4.97 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.466 1.104 . . . . 74.1 109.343 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.4 ' N ' HD13 ' A' ' 182' ' ' LEU . 25.3 p90 -133.1 147.2 52.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.134 . . . . 74.44 111.004 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 30.6 mm -77.62 128.35 38.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.487 1.117 . . . . 74.35 109.305 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 38.6 m -86.9 -34.38 19.42 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.541 1.151 . . . . 64.21 108.313 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.421 ' N ' ' HB ' ' A' ' 194' ' ' ILE . . . -164.57 179.13 6.85 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.486 1.116 . . . . 73.45 109.239 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.563 ' CD2' HG21 ' A' ' 231' ' ' ILE . 6.1 p80 -139.85 148.69 42.47 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 74.43 109.604 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.645 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.8 t-160 -125.18 115.62 20.72 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.453 1.096 . . . . 74.2 109.569 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.437 ' C ' ' N ' ' A' ' 191' ' ' GLU . 79.6 m-20 53.72 33.1 15.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.438 1.086 . . . . 74.22 109.268 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.413 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 12.6 p 42.95 28.28 0.13 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.55 1.156 . . . . 61.2 108.297 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.437 ' N ' ' C ' ' A' ' 189' ' ' ASN . 4.4 pt-20 -121.81 -35.43 3.2 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.494 1.121 . . . . 74.11 110.324 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.427 ' CD1' ' HG3' ' A' ' 191' ' ' GLU . 10.7 m0 -115.9 165.94 12.53 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.497 1.123 . . . . 75.44 108.029 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.472 ' CD2' HG21 ' A' ' 212' ' ' VAL . 9.9 m-85 -137.75 155.66 48.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.556 1.16 . . . . 63.31 111.003 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.473 ' CG1' ' HB ' ' A' ' 239' ' ' VAL . 20.7 mm -102.14 83.73 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.512 1.132 . . . . 73.53 109.336 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.468 ' O ' ' CA ' ' A' ' 205' ' ' GLY . . . -104.43 179.22 4.33 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.537 1.148 . . . . 73.14 109.317 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.437 ' HB3' ' CA ' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -177.94 155.72 1.05 Allowed Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.505 1.128 . . . . 74.13 109.323 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 147.78 34.26 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.592 1.838 . . . . 72.24 110.996 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 8.7 pt -81.8 173.14 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.539 1.15 . . . . 75.51 109.326 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 104.41 -56.64 0.55 Allowed Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.476 1.11 . . . . 65.42 111.038 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 -147.0 145.56 29.77 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.569 0.805 . . . . 75.23 110.3 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 7.9 tt -43.16 112.09 0.33 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.514 1.134 . . . . 71.14 109.332 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -118.01 -44.48 0.53 Allowed Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.428 1.08 . . . . 63.23 110.965 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.437 ' CA ' ' HB3' ' A' ' 196' ' ' LYS . . . -56.51 -178.46 0.41 Allowed Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.995 -0.842 . . . . 71.11 110.995 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.423 ' CB ' HG21 ' A' ' 194' ' ' ILE . 18.2 Cg_endo -75.01 121.02 7.05 Favored 'Cis proline' 0 C--N 1.36 1.184 0 C-N-CA 121.039 -2.484 . . . . 73.4 110.977 -0.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.468 ' CA ' ' O ' ' A' ' 195' ' ' ALA . . . -96.92 132.37 10.97 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.537 1.148 . . . . 53.25 111.055 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.484 ' O ' ' CZ ' ' A' ' 166' ' ' PHE . 17.9 mt -88.72 125.43 34.85 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.488 0.758 . . . . 74.13 109.275 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.424 ' HA ' ' CE2' ' A' ' 166' ' ' PHE . 1.2 m -141.18 149.44 55.3 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.494 1.121 . . . . 73.22 109.293 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.9 160.28 40.63 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.486 1.782 . . . . 73.34 111.043 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.412 ' HA ' ' CE2' ' A' ' 193' ' ' PHE . 3.3 p -81.9 -25.07 9.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.416 1.072 . . . . 72.04 109.282 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -73.78 -12.04 80.84 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.526 1.141 . . . . 65.21 111.026 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.487 ' O ' ' CG1' ' A' ' 212' ' ' VAL . 8.6 m-30 -109.46 24.96 12.36 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.426 0.721 . . . . 75.43 111.019 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.487 ' CG1' ' O ' ' A' ' 211' ' ' PHE . 32.6 m -157.0 145.06 11.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.488 1.118 . . . . 75.32 109.315 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' SER . . . . . 0.41 ' CB ' HD21 ' A' ' 163' ' ' LEU . 21.6 t -134.19 144.59 48.56 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.548 1.155 . . . . 64.52 109.962 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 16.3 mm -96.73 96.88 5.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.538 1.149 . . . . 75.21 109.266 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 1.8 pt -141.16 150.39 20.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.511 1.132 . . . . 71.31 109.327 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -58.22 -178.73 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.496 1.122 . . . . 73.02 109.268 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.46 67.39 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.492 1.12 . . . . 74.41 109.268 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -120.0 -179.34 3.89 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.437 1.086 . . . . 53.35 109.339 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 6.2 t -42.37 -40.32 2.47 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.539 1.149 . . . . 54.35 110.381 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 152.07 87.64 0.06 OUTLIER Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.568 1.168 . . . . 61.23 110.997 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -131.65 178.71 6.54 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.463 0.743 . . . . 74.31 111.022 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -159.22 110.13 2.03 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.462 1.101 . . . . 74.23 109.3 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 61.1 p -52.04 -25.27 8.18 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.434 1.084 . . . . 74.35 110.395 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 105.32 -18.1 42.54 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.466 1.104 . . . . 72.24 111.003 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -58.15 -175.9 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.397 0.704 . . . . 71.52 109.312 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -123.74 172.68 8.66 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.492 1.12 . . . . 74.41 109.305 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.444 ' CG1' HD12 ' A' ' 228' ' ' ILE . 14.7 p -76.58 -38.61 31.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.468 1.105 . . . . 74.12 109.324 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.444 HD12 ' CG1' ' A' ' 227' ' ' VAL . 1.8 mp -53.59 -52.92 28.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 74.44 109.292 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -56.13 -34.93 66.55 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.476 1.11 . . . . 74.34 110.373 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.49 -26.96 51.75 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.431 1.082 . . . . 74.24 109.24 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.563 HG21 ' CD2' ' A' ' 187' ' ' HIS . 60.7 mt -71.5 -39.51 70.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.51 1.131 . . . . 74.33 109.326 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -29.56 60.21 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.477 1.111 . . . . 74.52 109.286 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 54.8 m -55.57 -44.87 77.28 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.491 1.119 . . . . 61.42 110.043 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.451 HG11 ' CD2' ' A' ' 158' ' ' LEU . 7.7 p -111.15 12.84 8.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.569 1.168 . . . . 74.31 109.309 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 13.7 m120 40.57 38.28 0.58 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.534 1.146 . . . . 71.13 109.313 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.9 tp -40.89 133.51 1.77 Allowed Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.405 1.066 . . . . 74.02 109.284 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.06 131.89 14.74 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.479 1.779 . . . . 71.43 110.955 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' THR . . . . . 0.444 ' C ' ' N ' ' A' ' 240' ' ' GLN . 2.4 p -68.61 150.46 47.96 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.452 1.095 . . . . 71.11 110.348 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.645 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.1 p -40.41 -30.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.467 1.104 . . . . 72.1 109.281 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.444 ' N ' ' C ' ' A' ' 238' ' ' THR . 45.2 mm-40 -81.16 -56.12 4.29 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.474 1.109 . . . . 75.02 110.325 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -53.94 -22.03 9.32 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.531 1.145 . . . . 73.11 110.328 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.448 ' CD2' HD13 ' A' ' 246' ' ' ILE . 26.9 t90 -86.91 -60.46 1.98 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 72.43 108.046 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -23.48 2.78 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.573 1.171 . . . . 71.3 109.346 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 32.2 t -81.07 -62.25 1.72 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.491 1.119 . . . . 73.23 109.963 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -46.15 -48.05 17.43 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.464 1.103 . . . . 72.32 109.315 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.448 HD13 ' CD2' ' A' ' 242' ' ' TRP . 62.4 mt -42.27 120.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.548 1.155 . . . . 75.25 109.348 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -86.3 -39.15 16.79 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.529 1.143 . . . . 71.24 109.269 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.93 159.83 31.92 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.487 1.117 . . . . 73.43 110.319 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 50.57 54.31 11.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 75.14 110.958 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -96.82 -32.31 12.17 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.458 1.099 . . . . 73.4 109.3 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -100.99 145.48 28.63 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.527 1.142 . . . . 75.4 109.242 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 48.5 t -97.86 57.25 1.3 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.525 1.141 . . . . 63.24 109.905 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -147.96 113.58 5.68 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.494 1.121 . . . . 74.22 109.262 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 14.6 tt -127.39 21.41 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.453 1.096 . . . . 73.43 109.237 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 47.8 t -171.51 128.19 0.66 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.462 1.101 . . . . 75.45 110.016 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 17.5 tp -98.33 -21.94 16.37 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.566 1.167 . . . . 72.13 109.294 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 126.48 -91.34 0.38 Allowed Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.487 1.117 . . . . 34.34 111.011 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 88.7 p 43.22 48.03 5.56 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.472 0.748 . . . . 61.54 109.998 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 49.4 t -92.83 140.97 15.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.462 1.101 . . . . 71.41 109.286 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 . . . . . 0 C--N 1.324 -0.526 0 O-C-N 124.494 1.122 . . . . 75.55 110.326 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.989 0 N-CA-C 111.073 -0.811 . . . . 64.42 111.073 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 119.21 5.56 Favored 'Trans proline' 0 C--N 1.359 1.095 0 O-C-N 124.491 1.785 . . . . 75.21 111.028 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.466 ' O ' ' CD1' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -42.82 134.82 3.17 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.454 1.096 . . . . 75.52 109.304 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.449 ' HA2' ' CG2' ' A' ' 234' ' ' VAL . . . -169.44 35.19 0.18 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.447 1.092 . . . . 75.32 110.947 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -177.94 149.7 0.59 Allowed 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.478 0.752 . . . . 75.52 109.966 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.49 ' CD2' ' CG1' ' A' ' 234' ' ' VAL . 0.4 OUTLIER -150.39 154.0 36.99 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.518 1.136 . . . . 73.52 109.339 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 159' ' ' TYR . 1.3 p90 -136.41 155.14 50.44 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.499 1.124 . . . . 74.34 110.948 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.471 ' HB1' ' CG1' ' A' ' 184' ' ' ILE . . . -121.59 142.16 50.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.468 1.105 . . . . 74.14 109.263 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.515 ' O ' ' CD2' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -110.29 133.72 54.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.557 1.161 . . . . 74.31 109.302 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.0 t -76.27 132.17 33.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.511 1.132 . . . . 75.15 109.31 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.596 ' N ' ' CD2' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -95.54 -31.56 13.26 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.495 1.122 . . . . 72.4 109.287 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -130.19 159.34 37.14 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.54 1.15 . . . . 74.35 110.983 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.64 97.49 5.12 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.531 1.144 . . . . 72.42 109.335 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.564 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 1.7 t80 -82.67 123.91 29.71 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.476 1.11 . . . . 70.34 110.967 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 168' ' ' ALA . 11.4 mmmm -101.93 105.47 16.27 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.493 1.12 . . . . 71.01 109.261 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.418 ' HB2' ' N ' ' A' ' 174' ' ' LEU . . . -40.54 123.8 1.89 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.474 1.109 . . . . 70.41 109.321 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -113.72 -28.94 7.27 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.514 1.134 . . . . 72.11 110.302 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.52 177.79 8.61 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.498 1.124 . . . . 74.21 109.308 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.62 -14.06 43.84 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.582 1.176 . . . . 55.32 109.302 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -124.53 23.43 8.14 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.54 1.15 . . . . 73.22 109.233 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -96.39 163.21 13.16 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 72.14 110.305 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.459 ' CG ' ' HA3' ' A' ' 205' ' ' GLY . 19.5 mt -127.46 153.48 46.25 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.515 1.134 . . . . 75.12 109.27 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.4 t -103.37 147.9 26.54 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.572 1.17 . . . . 74.02 110.448 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.4 m -138.44 -165.86 1.89 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.502 1.126 . . . . 75.23 110.378 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -134.44 134.0 41.11 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.523 1.139 . . . . 71.3 111.001 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.42 HG23 ' N ' ' A' ' 179' ' ' GLY . 0.5 OUTLIER -41.42 143.33 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.487 1.117 . . . . 65.34 109.294 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.42 ' N ' HG23 ' A' ' 178' ' ' VAL . . . 52.03 63.64 4.63 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.583 1.177 . . . . 64.33 111.019 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -122.15 160.93 24.08 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.433 0.725 . . . . 74.21 110.264 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -113.21 119.66 38.52 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.454 1.096 . . . . 62.21 109.345 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.2 mp -136.99 159.88 40.56 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.456 1.098 . . . . 74.13 109.322 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -108.09 128.89 55.08 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.561 1.163 . . . . 75.55 111.01 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.471 ' CG1' ' HB1' ' A' ' 160' ' ' ALA . 30.2 mm -77.62 128.53 38.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.527 1.142 . . . . 74.04 109.293 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 49.7 t -100.55 -23.15 14.76 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.48 1.112 . . . . 70.25 108.261 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -166.62 179.62 5.35 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.494 1.121 . . . . 73.22 109.306 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.551 ' CD2' HG22 ' A' ' 231' ' ' ILE . 8.2 p80 -146.28 157.81 43.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.452 1.095 . . . . 75.01 109.663 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.41 ' O ' ' CD2' ' A' ' 188' ' ' HIS . 0.6 OUTLIER -134.48 115.3 13.8 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.463 1.102 . . . . 71.5 109.596 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 58.74 19.89 7.32 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.59 1.181 . . . . 74.44 109.31 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 23.4 m 57.36 18.78 4.59 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.551 1.157 . . . . 73.14 108.273 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 192' ' ' TRP . 10.1 pt-20 -116.28 -33.0 5.12 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.122 . . . . 73.34 110.277 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.449 ' CE3' ' HB3' ' A' ' 206' ' ' LEU . 9.6 m0 -110.21 155.4 22.04 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 124.5 1.125 . . . . 73.13 108.004 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.566 ' CD2' HG22 ' A' ' 212' ' ' VAL . 24.9 m-85 -133.04 152.22 51.98 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.488 1.117 . . . . 75.33 111.06 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 27.8 mm -99.09 94.28 3.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.533 1.145 . . . . 74.12 109.315 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.488 ' O ' ' CB ' ' A' ' 204' ' ' PRO . . . -75.38 154.73 37.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.436 1.085 . . . . 75.03 109.31 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -148.54 78.89 9.03 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.406 1.066 . . . . 75.25 109.275 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 152.87 41.23 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.578 1.831 . . . . 74.13 110.972 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 5.2 mp -112.8 143.31 22.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.385 1.053 . . . . 75.35 109.312 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 128.52 -26.52 4.6 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.49 1.119 . . . . 51.34 110.965 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -130.8 118.84 21.4 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.489 0.758 . . . . 74.21 110.295 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 8.8 mp -55.83 99.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.528 1.143 . . . . 74.53 109.279 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 172.49 -177.45 45.08 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.473 1.108 . . . . 75.13 111.015 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 92.46 -178.89 40.14 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.035 -0.826 . . . . 75.01 111.035 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.488 ' CB ' ' O ' ' A' ' 195' ' ' ALA . 18.3 Cg_endo -74.98 178.61 33.89 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 121.036 -2.485 . . . . 62.31 111.071 -0.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.459 ' HA3' ' CG ' ' A' ' 174' ' ' LEU . . . -125.39 168.4 17.51 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.591 1.182 . . . . 71.22 111.016 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.449 ' HB3' ' CE3' ' A' ' 192' ' ' TRP . 2.5 mt -101.16 134.13 44.66 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.451 0.736 . . . . 54.11 109.223 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.546 ' CG2' ' CG1' ' A' ' 212' ' ' VAL . 0.1 OUTLIER -135.14 137.72 27.51 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.586 1.179 . . . . 74.01 109.299 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.564 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.5 Cg_endo -74.92 148.85 36.24 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.542 1.811 . . . . 75.13 111.077 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.44 ' HA ' ' CG2' ' A' ' 212' ' ' VAL . 11.5 p -74.43 -14.06 15.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.504 1.128 . . . . 74.0 109.334 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . 0.52 ' C ' ' CD1' ' A' ' 211' ' ' PHE . . . -84.09 10.47 60.62 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.499 1.124 . . . . 74.12 111.053 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.52 ' CD1' ' C ' ' A' ' 210' ' ' GLY . 17.3 m-85 -143.85 19.06 1.81 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.541 0.789 . . . . 70.31 111.001 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.566 HG22 ' CD2' ' A' ' 193' ' ' PHE . 30.8 m -145.68 147.94 17.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.524 1.14 . . . . 70.13 109.333 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 46.5 t -130.74 152.44 50.09 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.594 1.184 . . . . 63.53 110.001 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.469 HG13 ' CB ' ' A' ' 227' ' ' VAL . 42.3 mm -106.26 161.07 5.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.527 1.142 . . . . 74.45 109.28 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.425 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 0.2 OUTLIER -153.8 170.11 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.483 1.114 . . . . 74.21 109.235 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -129.27 -59.3 1.1 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.419 1.075 . . . . 73.4 109.323 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 2.8 mp -132.5 89.5 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.531 1.144 . . . . 73.32 109.334 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -172.45 155.47 3.45 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.425 1.078 . . . . 72.01 109.35 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 13.1 t -102.42 34.78 2.64 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.563 1.164 . . . . 74.13 110.417 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 139.0 -17.15 3.21 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.49 1.119 . . . . 71.2 111.04 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -84.54 178.35 7.74 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.523 0.778 . . . . 70.14 110.982 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -129.37 131.4 46.85 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.487 1.117 . . . . 75.14 109.288 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.43 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 18.1 p -73.57 -25.26 60.29 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.494 1.121 . . . . 72.41 110.399 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.52 10.21 11.85 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.466 1.103 . . . . 74.42 111.008 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.43 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 1.8 m-80 -74.62 -177.02 2.99 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 0.755 . . . . 75.24 109.312 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.41 159.05 35.67 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.592 1.182 . . . . 74.22 109.291 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.469 ' CB ' HG13 ' A' ' 214' ' ' ILE . 12.6 p -78.05 -40.57 26.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 124.45 1.093 . . . . 73.31 109.337 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.1 mp -61.46 -46.39 96.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.496 1.122 . . . . 65.33 109.391 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -64.99 -20.37 66.46 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.587 1.18 . . . . 74.15 110.314 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -89.73 -31.65 17.35 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.125 . . . . 73.24 109.313 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.551 HG22 ' CD2' ' A' ' 187' ' ' HIS . 15.1 mt -66.49 -39.02 82.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.439 1.087 . . . . 75.21 109.261 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -76.33 -31.86 58.37 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.513 1.133 . . . . 75.14 109.283 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 6.6 p -57.0 -44.94 83.25 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.455 1.097 . . . . 72.54 110.032 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.49 ' CG1' ' CD2' ' A' ' 158' ' ' LEU . 3.4 p -106.11 13.13 8.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 124.518 1.136 . . . . 75.42 109.26 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 40.52 32.46 0.14 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.555 1.16 . . . . 73.5 109.247 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.1 tp -40.49 142.65 0.74 Allowed Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.498 1.124 . . . . 74.15 109.229 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 170.74 19.75 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.624 1.855 . . . . 72.12 110.936 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 241' ' ' GLU . 1.4 p -113.21 143.14 44.9 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.461 1.101 . . . . 75.11 110.4 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 p -45.33 -26.36 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.489 1.118 . . . . 74.43 109.266 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.402 ' N ' ' C ' ' A' ' 238' ' ' THR . 86.6 mm-40 -76.23 -43.36 42.48 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.477 1.111 . . . . 62.04 110.26 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 238' ' ' THR . 5.2 mm-40 -74.41 -21.7 59.51 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.528 1.142 . . . . 74.04 110.253 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.444 ' O ' ' N ' ' A' ' 245' ' ' ASN . 9.4 t90 -75.26 -62.36 1.59 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.958 -1.127 . . . . 72.25 107.958 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.7 pttm -50.45 -24.32 3.03 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.465 1.103 . . . . 75.31 109.275 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 2.6 t -88.07 -29.21 20.82 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.494 1.121 . . . . 70.34 110.007 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 242' ' ' TRP . 1.9 t30 -72.08 -39.79 68.72 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.45 1.093 . . . . 75.54 109.246 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 5.6 mt -40.28 152.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.524 1.14 . . . . 74.34 109.321 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.585 ' O ' ' CE2' ' A' ' 249' ' ' TYR . . . -41.03 -78.69 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.52 1.137 . . . . 72.42 109.296 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . 0.482 ' CB ' ' O ' ' A' ' 247' ' ' ALA . 1.8 tmm_? 83.79 22.01 0.15 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.464 1.103 . . . . 73.04 110.305 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.585 ' CE2' ' O ' ' A' ' 247' ' ' ALA . 5.2 p90 179.74 179.18 0.52 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.518 1.136 . . . . 70.04 110.996 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? 61.98 37.89 14.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.547 1.154 . . . . 74.13 109.253 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -119.99 170.13 9.55 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.492 1.12 . . . . 74.11 109.3 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 1.4 m -44.19 154.8 0.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.464 1.102 . . . . 74.42 110.007 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -75.63 96.71 3.62 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.41 1.069 . . . . 75.22 109.285 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.56 136.14 57.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.487 1.117 . . . . 74.32 109.295 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 36.2 t 45.43 40.27 5.38 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.441 1.088 . . . . 53.32 110.055 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -46.85 -48.9 20.87 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.53 1.144 . . . . 73.23 109.329 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -52.16 98.67 0.03 OUTLIER Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.485 1.116 . . . . 72.11 111.02 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 10.4 m -161.67 165.62 27.93 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.547 0.792 . . . . 74.41 109.981 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 28.9 m -133.98 57.96 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.471 1.107 . . . . 75.43 109.263 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 . . . . . 0 C--N 1.324 -0.521 0 O-C-N 124.591 1.182 . . . . 71.22 110.248 179.942 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.025 0 N-CA-C 110.953 -0.859 . . . . 63.04 110.953 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 129.69 12.52 Favored 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.43 1.752 . . . . 74.4 111.046 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.8 mt -78.45 158.36 28.69 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.522 1.139 . . . . 74.21 109.285 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 116.3 34.91 1.26 Allowed Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.469 1.106 . . . . 64.15 110.974 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 76.5 p -135.5 76.3 1.61 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.495 0.762 . . . . 74.33 109.976 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.459 ' O ' ' CG ' ' A' ' 159' ' ' TYR . 0.5 OUTLIER -98.56 156.55 16.74 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.58 1.175 . . . . 73.52 109.295 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.459 ' CG ' ' O ' ' A' ' 158' ' ' LEU . 10.3 m-85 -168.31 107.98 0.52 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.385 1.053 . . . . 73.52 111.041 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -106.58 129.44 54.51 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.518 1.136 . . . . 71.53 109.248 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.2 127.38 51.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.121 . . . . 73.54 109.319 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.594 ' CG2' ' CD2' ' A' ' 182' ' ' LEU . 2.2 t -87.25 119.31 34.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.54 1.15 . . . . 75.14 109.328 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.33 17.67 19.19 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.428 1.08 . . . . 72.21 109.203 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.571 ' HB3' ' CD2' ' A' ' 211' ' ' PHE . 95.6 m-85 -155.89 148.91 24.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.437 1.086 . . . . 75.33 111.041 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.428 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 0.6 OUTLIER -87.47 106.74 18.19 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.475 1.11 . . . . 72.41 109.322 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.563 ' CD1' ' HD3' ' A' ' 208' ' ' PRO . 3.7 t80 -80.41 153.04 28.52 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.578 1.174 . . . . 74.24 110.965 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.531 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.9 mptt -115.51 115.39 26.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 72.05 109.316 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.489 ' CB ' ' OE1' ' A' ' 173' ' ' GLU . . . -56.47 126.59 27.17 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 1.138 . . . . 75.1 109.335 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -130.36 -35.53 1.53 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.481 1.113 . . . . 75.43 110.307 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.468 ' HD3' ' CD1' ' A' ' 206' ' ' LEU . 10.9 tttt -58.37 -163.26 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.448 1.093 . . . . 73.1 109.265 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.78 -50.65 5.93 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.526 1.141 . . . . 71.33 109.345 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.09 28.99 7.12 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.528 1.142 . . . . 73.34 109.324 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.489 ' OE1' ' CB ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -60.27 -176.9 0.05 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.491 1.119 . . . . 74.24 110.325 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.408 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 13.1 mt -151.8 132.54 14.05 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 74.52 109.269 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 15.2 t -78.82 114.1 17.47 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.504 1.128 . . . . 73.13 110.394 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 5.6 m -102.34 -172.14 2.08 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.505 1.128 . . . . 74.04 110.382 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 177' ' ' TYR . 11.1 m-85 -133.3 175.54 9.31 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.429 1.081 . . . . 75.54 110.979 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.428 ' HB ' ' N ' ' A' ' 165' ' ' ASP . 1.3 p -97.47 110.65 25.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 124.474 1.109 . . . . 75.22 109.287 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.46 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 99.23 51.12 1.37 Allowed Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.495 1.122 . . . . 72.34 111.028 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -115.6 169.38 9.23 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.49 0.759 . . . . 74.22 110.313 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.94 128.1 43.06 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 62.43 109.358 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.594 ' CD2' ' CG2' ' A' ' 162' ' ' VAL . 0.6 OUTLIER -167.02 172.7 9.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.454 1.097 . . . . 73.31 109.267 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -112.41 151.15 30.18 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.52 1.138 . . . . 72.13 110.97 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 48.1 mm -79.7 136.79 22.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.468 1.105 . . . . 72.31 109.275 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 9.1 t -101.5 -22.86 14.41 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.499 1.125 . . . . 73.31 108.328 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.46 ' HA ' ' CD2' ' A' ' 236' ' ' LEU . . . -173.7 172.26 3.61 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.497 1.123 . . . . 75.12 109.309 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.566 ' CD2' HG22 ' A' ' 231' ' ' ILE . 6.6 p80 -133.67 145.48 49.97 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.475 1.11 . . . . 74.14 109.588 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.643 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.1 t-160 -123.02 116.33 23.35 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.53 1.144 . . . . 75.32 109.629 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.45 ' C ' ' N ' ' A' ' 191' ' ' GLU . 71.3 m-20 53.79 32.22 14.49 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.465 1.103 . . . . 64.44 109.275 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 12.8 p 42.96 28.41 0.13 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.53 1.143 . . . . 74.54 108.339 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.485 ' O ' ' CG1' ' A' ' 209' ' ' VAL . 5.6 pt-20 -121.99 -35.3 3.19 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.482 1.113 . . . . 72.01 110.294 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -118.1 167.29 11.61 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.922 -1.14 . . . . 74.41 107.922 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.518 ' CZ ' ' CG2' ' A' ' 227' ' ' VAL . 23.7 m-85 -141.78 161.58 37.59 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.492 1.12 . . . . 73.53 111.031 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.467 ' CD1' ' HG ' ' A' ' 206' ' ' LEU . 20.8 mm -99.65 122.9 52.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.51 1.131 . . . . 74.44 109.258 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.428 ' HB2' ' CG2' ' A' ' 207' ' ' VAL . . . -106.24 153.09 22.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.548 1.155 . . . . 61.42 109.281 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -137.49 143.74 42.26 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 72.43 109.255 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.464 ' CB ' HD11 ' A' ' 201' ' ' LEU . 18.2 Cg_endo -74.98 -174.52 1.96 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 O-C-N 124.444 1.76 . . . . 70.24 111.024 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 10.6 mm -91.18 -69.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.136 . . . . 74.53 109.309 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -60.82 -120.24 0.01 OUTLIER Glycine 0 CA--C 1.529 0.947 0 O-C-N 124.476 1.11 . . . . 72.05 111.059 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -151.34 115.72 5.08 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.479 0.752 . . . . 73.34 110.318 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.543 ' CD1' ' N ' ' A' ' 201' ' ' LEU . 0.0 OUTLIER -170.8 111.46 0.37 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.456 1.098 . . . . 74.41 109.296 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 44.38 -127.87 6.85 Favored Glycine 0 CA--C 1.531 1.059 0 O-C-N 124.553 1.158 . . . . 72.12 110.956 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 50.33 177.59 0.02 OUTLIER Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.028 -0.829 . . . . 64.44 111.028 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 174.41 52.88 Favored 'Cis proline' 0 C--N 1.36 1.134 0 C-N-CA 121.013 -2.495 . . . . 65.1 111.026 0.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -123.13 -173.68 14.11 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.491 1.119 . . . . 62.43 110.985 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.556 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 3.3 mp -115.06 156.08 25.83 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.566 0.803 . . . . 75.54 109.29 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.55 HG13 ' CD2' ' A' ' 166' ' ' PHE . 0.2 OUTLIER -150.99 147.27 20.37 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.455 1.097 . . . . 71.51 109.297 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.563 ' HD3' ' CD1' ' A' ' 166' ' ' PHE . 18.3 Cg_endo -75.02 141.49 26.65 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.551 1.816 . . . . 73.45 110.968 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.485 ' CG1' ' O ' ' A' ' 191' ' ' GLU . 7.2 p -64.48 -37.72 80.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.563 1.164 . . . . 75.53 109.322 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -60.06 -13.93 29.55 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.483 1.114 . . . . 62.12 111.004 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.571 ' CD2' ' HB3' ' A' ' 164' ' ' TYR . 5.9 m-85 -112.19 18.53 18.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.519 0.776 . . . . 73.21 110.94 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.468 ' CG2' ' HA ' ' A' ' 209' ' ' VAL . 10.5 m -153.43 143.63 14.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.52 1.137 . . . . 75.44 109.292 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.5 t -129.5 148.08 51.37 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.476 1.11 . . . . 64.4 110.006 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.469 HG13 ' CG2' ' A' ' 227' ' ' VAL . 25.8 mm -98.87 119.1 46.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.577 1.173 . . . . 71.04 109.327 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 4.0 pt -145.89 116.96 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.507 1.129 . . . . 73.44 109.358 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -57.89 142.22 46.79 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.516 1.135 . . . . 72.03 109.335 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 14.0 tt -60.19 -27.52 39.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.43 1.081 . . . . 75.11 109.29 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.88 -62.41 1.58 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 62.42 109.253 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.691 ' CG2' ' CE2' ' A' ' 221' ' ' TYR . 4.2 m -88.12 165.72 14.92 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 72.2 110.435 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -114.43 7.51 22.66 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.414 1.072 . . . . 70.33 110.948 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.691 ' CE2' ' CG2' ' A' ' 219' ' ' THR . 25.5 p90 -138.03 -177.26 4.75 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.569 0.805 . . . . 74.03 111.002 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -85.4 114.28 22.34 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.5 1.125 . . . . 71.23 109.336 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.492 ' HG1' ' ND2' ' A' ' 225' ' ' ASN . 60.9 p -81.48 -19.82 41.52 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.503 1.127 . . . . 74.33 110.467 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 111.53 18.03 8.29 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.479 1.112 . . . . 74.23 110.993 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.556 ' N ' HD21 ' A' ' 225' ' ' ASN . 1.0 OUTLIER -79.93 175.39 10.67 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 0.758 . . . . 73.22 109.322 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -131.1 162.42 29.89 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.408 1.068 . . . . 74.32 109.307 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.518 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 11.4 p -77.92 -45.01 28.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.56 1.162 . . . . 74.41 109.278 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.0 mp -54.09 -44.85 64.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.5 1.125 . . . . 73.33 109.345 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -63.76 -28.78 70.11 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.481 1.113 . . . . 64.4 110.237 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.41 -19.87 35.2 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 74.31 109.328 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.566 HG22 ' CD2' ' A' ' 187' ' ' HIS . 37.8 mt -76.76 -36.53 26.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.511 1.132 . . . . 53.53 109.279 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -83.97 -12.02 55.95 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.107 . . . . 73.41 109.282 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.8 p -78.86 -41.67 29.35 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 71.25 109.961 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.425 ' C ' ' N ' ' A' ' 236' ' ' LEU . 7.7 p -108.72 26.28 2.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.527 1.142 . . . . 73.14 109.266 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 12.6 m120 45.6 26.21 0.31 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.518 1.136 . . . . 74.51 109.331 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.467 ' HB3' ' CG2' ' A' ' 231' ' ' ILE . 0.8 OUTLIER -43.91 103.8 0.34 Allowed Pre-proline 0 C--N 1.326 -0.433 0 O-C-N 124.484 1.115 . . . . 73.2 109.299 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 140.49 25.48 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.507 1.793 . . . . 73.43 111.0 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' THR . . . . . 0.552 HG21 ' CE1' ' A' ' 187' ' ' HIS . 15.7 p -57.66 155.69 9.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.551 1.157 . . . . 72.12 110.326 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.643 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 1.9 p -61.83 -21.04 24.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.458 1.099 . . . . 60.54 109.358 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.469 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 40.2 mm-40 -85.58 -26.23 26.25 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 75.55 110.286 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -84.3 -35.55 23.24 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.513 1.133 . . . . 73.22 110.291 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 245' ' ' ASN . 1.2 t90 -65.49 -52.07 55.42 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.001 -1.111 . . . . 75.13 108.001 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.04 -33.32 11.13 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.435 1.084 . . . . 75.42 109.258 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.4 t -78.88 -30.23 44.88 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.441 1.088 . . . . 72.1 110.03 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 242' ' ' TRP . 5.4 t-20 -68.99 -36.7 78.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.46 1.1 . . . . 74.32 109.223 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 96.6 mt -42.4 150.67 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.556 1.16 . . . . 71.12 109.278 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . 75.74 4.45 3.91 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.45 1.094 . . . . 73.3 109.321 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . 0.537 ' CD ' ' CD2' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -46.55 141.18 3.86 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 74.34 110.376 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.537 ' CD2' ' CD ' ' A' ' 248' ' ' ARG . 8.6 m-85 44.77 46.01 8.51 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 72.44 110.935 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.91 151.54 50.08 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.532 1.145 . . . . 74.14 109.312 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -42.4 106.96 0.07 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.562 1.164 . . . . 74.24 109.331 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -175.32 157.28 2.16 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.526 1.141 . . . . 72.52 110.06 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -79.32 103.34 9.18 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.465 1.103 . . . . 75.03 109.29 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.545 ' CD1' ' N ' ' A' ' 255' ' ' SER . 1.0 OUTLIER -106.33 177.98 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.531 1.144 . . . . 72.22 109.244 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.545 ' N ' ' CD1' ' A' ' 254' ' ' ILE . 33.2 t -151.87 175.12 12.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.536 1.147 . . . . 71.33 110.033 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 3.5 tt -112.53 139.5 48.06 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.494 1.122 . . . . 74.11 109.312 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -73.81 -150.72 1.8 Allowed Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.472 1.108 . . . . 72.24 110.986 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 85.5 p -119.33 173.38 6.99 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.519 0.776 . . . . 75.31 109.958 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 13.6 m -123.86 -178.87 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.503 1.127 . . . . 65.41 109.316 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.472 1.108 . . . . 72.3 110.288 -179.99 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.963 0 N-CA-C 111.046 -0.822 . . . . 75.21 111.046 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 165.93 30.26 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.469 1.773 . . . . 73.11 110.965 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.1 mp -92.45 179.37 5.55 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.499 1.124 . . . . 74.42 109.336 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -119.49 0.91 14.12 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.523 1.14 . . . . 71.33 111.006 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.4 p -169.74 160.62 8.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.496 0.762 . . . . 72.43 110.003 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.46 ' HG ' ' CG1' ' A' ' 234' ' ' VAL . 0.2 OUTLIER -136.4 149.07 48.13 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.557 1.161 . . . . 70.43 109.266 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 159' ' ' TYR . 1.1 p90 -129.95 116.43 18.6 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.507 1.13 . . . . 75.11 111.003 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.46 ' CB ' HD12 ' A' ' 214' ' ' ILE . . . -95.23 132.37 40.27 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.529 1.143 . . . . 65.02 109.297 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -108.43 130.41 61.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.119 . . . . 73.03 109.322 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.488 ' CG1' ' O ' ' A' ' 211' ' ' PHE . 2.2 t -81.33 122.11 35.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.499 1.124 . . . . 74.15 109.265 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.44 -26.14 19.99 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.485 1.115 . . . . 73.45 109.295 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -130.67 147.83 52.39 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.517 1.136 . . . . 72.43 111.023 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -61.06 108.42 0.88 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 75.54 109.309 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.605 ' CE2' ' O ' ' A' ' 174' ' ' LEU . 1.7 t80 -80.95 132.31 35.39 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.434 1.084 . . . . 74.4 110.983 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.602 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 0.4 OUTLIER -103.66 140.96 36.87 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.433 1.083 . . . . 71.32 109.322 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.5 ' CB ' ' OE1' ' A' ' 173' ' ' GLU . . . -84.34 126.58 33.34 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.514 1.134 . . . . 73.51 109.322 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -127.67 -33.65 2.27 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.506 1.129 . . . . 74.32 110.299 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.425 ' C ' ' HG3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -58.09 -164.43 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.504 1.128 . . . . 70.32 109.283 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.16 -51.56 5.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.469 1.106 . . . . 71.12 109.323 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -107.57 28.64 7.95 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.427 1.08 . . . . 71.33 109.288 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.5 ' OE1' ' CB ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -59.73 177.94 0.19 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.503 1.127 . . . . 74.4 110.313 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.605 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 12.4 mt -145.09 133.2 21.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 1.137 . . . . 71.53 109.277 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.8 t -81.47 154.92 26.08 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 75.1 110.44 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.503 ' C ' ' CD1' ' A' ' 177' ' ' TYR . 2.6 m -142.46 -165.44 2.04 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.529 1.143 . . . . 74.13 110.393 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.503 ' CD1' ' C ' ' A' ' 176' ' ' THR . 20.7 m-85 -143.86 137.92 28.27 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.525 1.141 . . . . 75.31 111.011 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 179' ' ' GLY . 0.7 OUTLIER -44.53 146.52 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.46 1.1 . . . . 75.34 109.315 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.455 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 52.67 60.55 7.77 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.494 1.121 . . . . 73.24 111.04 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -118.51 166.21 12.97 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.518 0.775 . . . . 72.1 110.322 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.09 136.37 52.83 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.483 1.114 . . . . 71.01 109.257 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.487 ' CD2' ' CG2' ' A' ' 162' ' ' VAL . 0.5 OUTLIER -167.19 157.83 11.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.452 1.095 . . . . 64.44 109.329 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.459 ' C ' ' CD1' ' A' ' 183' ' ' PHE . 6.8 p90 -99.54 150.48 22.18 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.447 1.092 . . . . 63.54 111.059 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.502 HD11 ' CG ' ' A' ' 193' ' ' PHE . 19.6 mm -88.93 133.41 31.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 124.489 1.118 . . . . 73.34 109.334 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.464 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 3.6 t -97.56 -27.73 14.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.409 1.068 . . . . 73.1 108.249 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 184' ' ' ILE . . . -160.62 179.44 8.57 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.568 1.168 . . . . 74.0 109.342 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.572 ' CD2' HG22 ' A' ' 231' ' ' ILE . 8.3 p80 -147.05 120.63 9.12 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.475 1.109 . . . . 75.31 109.58 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.563 ' CD2' HG12 ' A' ' 239' ' ' VAL . 0.9 OUTLIER -99.7 114.53 27.7 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.451 1.094 . . . . 64.55 109.619 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.428 ' C ' ' N ' ' A' ' 191' ' ' GLU . 9.6 t30 53.69 34.19 18.33 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.543 1.152 . . . . 75.11 109.356 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 13.4 p 42.53 28.47 0.12 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.482 1.114 . . . . 70.43 108.299 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.428 ' N ' ' C ' ' A' ' 189' ' ' ASN . 3.8 pt-20 -121.64 -33.97 3.5 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.563 1.165 . . . . 72.32 110.297 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 8.2 m0 -117.22 157.48 25.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.518 1.136 . . . . 73.32 108.009 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.52 ' CD2' HG22 ' A' ' 212' ' ' VAL . 36.6 m-85 -130.66 159.14 38.11 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.478 1.111 . . . . 75.44 110.98 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.472 ' CG1' ' HB ' ' A' ' 239' ' ' VAL . 31.0 mm -102.7 96.0 4.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.456 1.098 . . . . 74.43 109.298 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.487 ' CB ' ' CD1' ' A' ' 182' ' ' LEU . . . -79.38 166.09 22.42 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.157 . . . . 74.13 109.233 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -166.36 90.48 0.82 Allowed Pre-proline 0 C--N 1.326 -0.434 0 O-C-N 124.514 1.134 . . . . 75.22 109.275 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.09 155.54 42.53 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.467 1.772 . . . . 62.21 110.968 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 27.1 mt -108.16 149.84 11.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.51 1.131 . . . . 74.14 109.321 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 125.23 -33.68 3.59 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.498 1.124 . . . . 62.42 111.034 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -151.22 117.82 5.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.52 0.776 . . . . 73.23 110.238 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 10.8 tp -54.18 101.06 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.541 1.151 . . . . 72.4 109.274 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -135.55 -52.25 0.07 OUTLIER Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.481 1.113 . . . . 65.43 110.991 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -49.17 179.55 0.01 OUTLIER Glycine 0 CA--C 1.531 1.053 0 N-CA-C 110.969 -0.852 . . . . 74.33 110.969 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 162.46 92.8 Favored 'Cis proline' 0 C--N 1.359 1.129 0 C-N-CA 120.973 -2.511 . . . . 73.21 110.935 0.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.416 ' HA3' ' CG ' ' A' ' 174' ' ' LEU . . . -133.64 160.28 23.97 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.545 1.153 . . . . 75.33 111.022 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.457 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 3.8 mt -99.61 137.27 38.32 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.531 0.783 . . . . 73.03 109.317 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.472 ' CG2' ' CG1' ' A' ' 212' ' ' VAL . 0.1 OUTLIER -133.94 136.78 27.02 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.583 1.177 . . . . 75.23 109.319 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.56 ' HD3' ' CE1' ' A' ' 166' ' ' PHE . 18.5 Cg_endo -74.93 138.12 22.79 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.491 1.785 . . . . 74.03 111.006 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.2 -15.66 18.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.525 1.14 . . . . 74.23 109.295 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -83.87 10.86 58.98 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.485 1.116 . . . . 73.13 111.052 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.488 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 19.0 m-85 -140.7 15.53 2.33 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.501 0.765 . . . . 64.41 111.009 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.52 HG22 ' CD2' ' A' ' 193' ' ' PHE . 21.9 m -147.53 149.55 15.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.475 1.11 . . . . 74.32 109.283 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.42 152.44 49.82 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.453 1.096 . . . . 71.32 109.952 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.469 HG13 ' CG2' ' A' ' 227' ' ' VAL . 31.0 mm -111.09 95.66 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 72.01 109.349 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 27.8 pt -99.81 171.33 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.455 1.097 . . . . 71.12 109.349 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -109.37 170.01 8.33 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.513 1.133 . . . . 74.12 109.285 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.486 ' CG2' ' OH ' ' A' ' 159' ' ' TYR . 2.0 pp -89.19 -44.72 15.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.555 1.159 . . . . 75.34 109.378 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.423 ' N ' ' CD1' ' A' ' 217' ' ' ILE . . . -41.08 -29.54 0.12 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.54 1.15 . . . . 70.22 109.28 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.644 ' CG2' ' CZ ' ' A' ' 221' ' ' TYR . 4.3 m -126.87 173.5 9.54 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.487 1.117 . . . . 74.25 110.369 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -112.32 3.62 26.66 Favored Glycine 0 CA--C 1.529 0.939 0 O-C-N 124.516 1.135 . . . . 74.45 111.032 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.644 ' CZ ' ' CG2' ' A' ' 219' ' ' THR . 3.0 p90 -140.73 -175.89 4.46 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.464 0.744 . . . . 73.13 111.053 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.25 117.03 6.6 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.478 1.111 . . . . 75.31 109.326 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 39.1 p -83.49 -24.04 31.9 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.449 1.093 . . . . 51.55 110.405 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 122.09 3.71 9.66 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.558 1.161 . . . . 52.41 111.017 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -83.1 -177.6 6.82 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.433 0.725 . . . . 74.31 109.306 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.23 178.61 6.84 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.564 1.165 . . . . 72.43 109.288 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.474 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 2.5 p -82.99 -34.37 11.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.522 1.139 . . . . 75.23 109.329 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.473 ' CD1' HG12 ' A' ' 227' ' ' VAL . 1.6 mp -59.87 -37.48 72.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.463 1.102 . . . . 74.42 109.241 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -67.15 -42.72 83.9 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.477 1.111 . . . . 74.14 110.266 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.42 -32.99 74.24 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.496 1.123 . . . . 72.12 109.279 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.572 HG22 ' CD2' ' A' ' 187' ' ' HIS . 24.7 mt -63.61 -43.69 98.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.477 1.111 . . . . 75.23 109.311 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -78.46 -11.98 59.98 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 73.12 109.273 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.7 m -76.9 -44.89 30.05 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.526 1.141 . . . . 71.2 110.05 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.46 ' CG1' ' HG ' ' A' ' 158' ' ' LEU . 9.9 p -109.26 30.06 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.488 1.118 . . . . 73.11 109.31 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 42.41 28.46 0.11 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.516 1.135 . . . . 74.55 109.281 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.452 ' HB3' ' CG2' ' A' ' 231' ' ' ILE . 1.6 tm? -42.77 102.38 0.27 Allowed Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.587 1.179 . . . . 52.31 109.288 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.03 152.9 41.17 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.523 1.802 . . . . 74.11 111.02 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 8.8 p -67.17 151.41 47.6 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.549 1.155 . . . . 71.14 110.386 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.563 HG12 ' CD2' ' A' ' 188' ' ' HIS . 1.3 p -50.79 -23.91 2.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.464 1.103 . . . . 72.4 109.318 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -83.82 -46.7 11.9 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.536 1.147 . . . . 72.34 110.342 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -63.25 -23.83 67.6 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.514 1.134 . . . . 74.05 110.343 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -80.14 -65.87 0.95 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.509 1.131 . . . . 75.41 107.98 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.39 -28.74 1.43 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.578 1.174 . . . . 75.14 109.28 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.4 t -71.49 -51.59 22.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.536 1.147 . . . . 72.44 109.973 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -61.95 -24.0 66.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.425 1.078 . . . . 63.31 109.346 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 3.4 mm -74.15 93.61 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.512 1.132 . . . . 74.23 109.349 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -154.64 163.82 39.66 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.549 1.155 . . . . 63.54 109.299 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -76.17 160.74 29.43 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.474 1.109 . . . . 74.13 110.252 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 52.45 42.8 31.35 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.552 1.157 . . . . 72.33 110.935 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.52 104.1 14.49 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.485 1.116 . . . . 70.31 109.289 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -115.28 16.68 16.81 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.493 1.121 . . . . 65.52 109.257 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 2.1 p -60.2 106.29 0.5 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.436 1.085 . . . . 74.44 109.972 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.412 ' C ' ' CD1' ' A' ' 254' ' ' ILE . 14.9 t-20 -89.86 -21.86 22.34 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.474 1.109 . . . . 73.03 109.349 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.412 ' CD1' ' C ' ' A' ' 253' ' ' ASN . 0.2 OUTLIER 40.51 34.94 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 124.469 1.105 . . . . 73.44 109.374 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.5 p -51.48 104.21 0.08 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.465 1.103 . . . . 72.12 109.931 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 2.8 pp -147.87 137.11 22.26 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 74.42 109.282 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 164.26 148.25 5.37 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.505 1.128 . . . . 74.25 110.971 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 15.1 p -172.12 148.3 2.18 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.474 0.75 . . . . 71.44 110.082 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 14.7 p -161.88 167.04 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.467 1.104 . . . . 71.24 109.305 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.441 1.088 . . . . 72.12 110.314 -179.991 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.976 0 N-CA-C 110.981 -0.847 . . . . 63.0 110.981 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 136.74 20.73 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.455 1.766 . . . . 53.44 110.951 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 8.5 mt 40.15 47.17 2.01 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.529 1.143 . . . . 74.54 109.282 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -147.28 17.9 1.52 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.468 1.105 . . . . 74.13 110.999 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 68.2 p -135.42 115.08 12.78 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.536 0.786 . . . . 74.22 109.98 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 14.1 tp -132.31 160.34 36.53 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.445 1.091 . . . . 74.33 109.271 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -137.38 115.92 12.02 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.556 1.16 . . . . 74.35 111.012 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -115.51 152.18 33.46 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.521 1.138 . . . . 75.24 109.325 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.53 ' CD1' ' ND2' ' A' ' 181' ' ' ASN . 1.4 tp -120.12 128.88 75.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.487 1.117 . . . . 74.21 109.264 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.439 HG23 ' CD1' ' A' ' 182' ' ' LEU . 18.2 t -92.83 112.17 25.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.529 1.143 . . . . 65.23 109.359 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.599 ' O ' ' CD2' ' A' ' 164' ' ' TYR . 0.1 OUTLIER -101.03 28.95 4.91 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.496 1.123 . . . . 75.31 109.327 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.599 ' CD2' ' O ' ' A' ' 163' ' ' LEU . 78.9 m-85 -164.57 131.07 2.98 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.555 1.159 . . . . 73.54 110.958 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.463 ' CB ' HG21 ' A' ' 178' ' ' VAL . 2.7 t0 -79.59 101.19 8.17 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 75.43 109.329 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.568 ' CD1' ' HD3' ' A' ' 208' ' ' PRO . 60.9 t80 -83.21 152.67 25.11 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 74.05 111.024 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.561 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 6.9 mmmm -110.69 154.82 23.31 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.514 1.134 . . . . 63.05 109.25 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.414 ' HB2' ' N ' ' A' ' 174' ' ' LEU . . . -95.49 125.0 39.8 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.539 1.149 . . . . 73.11 109.287 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -121.68 -40.31 2.56 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.477 1.11 . . . . 73.03 110.365 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -174.56 0.23 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.573 1.171 . . . . 73.03 109.284 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.38 -34.05 20.32 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.546 1.154 . . . . 72.41 109.307 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.5 10.35 33.21 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.626 1.204 . . . . 74.14 109.264 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -75.12 172.87 11.6 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.125 . . . . 70.22 110.296 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.414 ' N ' ' HB2' ' A' ' 168' ' ' ALA . 1.3 tp -155.56 157.68 37.22 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.53 1.144 . . . . 74.22 109.265 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.0 t -102.89 137.08 41.57 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.496 1.122 . . . . 74.41 110.407 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 3.4 m -113.71 -166.01 1.05 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.547 1.154 . . . . 71.14 110.366 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -138.57 150.69 46.58 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.456 1.097 . . . . 74.4 110.965 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.463 HG21 ' CB ' ' A' ' 165' ' ' ASP . 60.8 t -60.84 163.66 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.133 . . . . 75.42 109.301 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 37.74 57.73 1.54 Allowed Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.45 1.094 . . . . 74.53 110.995 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.464 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 12.7 mm-40 -114.19 155.89 25.26 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.485 0.756 . . . . 73.23 110.326 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.53 ' ND2' ' CD1' ' A' ' 161' ' ' ILE . 2.3 m-80 -123.32 125.09 44.38 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.531 1.144 . . . . 53.43 109.349 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.469 ' CD1' ' N ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -162.53 162.65 27.47 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.51 1.131 . . . . 74.53 109.308 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 184' ' ' ILE . 2.7 t80 -98.96 147.93 24.49 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.433 1.083 . . . . 73.4 111.007 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.508 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 8.9 mm -77.67 112.49 15.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.472 1.108 . . . . 71.42 109.325 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.451 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 10.9 t -78.71 -22.73 46.19 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.525 1.141 . . . . 62.35 108.285 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.491 ' O ' ' CG2' ' A' ' 184' ' ' ILE . . . -171.9 179.65 2.67 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.58 1.175 . . . . 74.02 109.308 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.444 ' CE1' HG23 ' A' ' 238' ' ' THR . 8.0 p80 -148.05 151.25 35.37 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.526 1.141 . . . . 61.34 109.522 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.437 ' CE1' HE21 ' A' ' 240' ' ' GLN . 1.8 t-160 -132.48 122.45 24.92 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.493 1.12 . . . . 70.5 109.597 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.444 ' C ' ' N ' ' A' ' 191' ' ' GLU . 3.0 m-20 54.15 30.4 12.08 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.477 1.111 . . . . 74.21 109.281 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 12.7 p 42.95 28.95 0.15 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 72.43 108.299 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.444 ' N ' ' C ' ' A' ' 189' ' ' ASN . 9.8 pt-20 -124.5 -37.18 2.54 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.564 1.165 . . . . 73.25 110.257 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.493 ' CE3' ' HB3' ' A' ' 206' ' ' LEU . 11.2 m0 -109.71 158.2 18.34 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.492 1.12 . . . . 74.04 108.004 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.491 ' CZ ' HG23 ' A' ' 227' ' ' VAL . 44.7 m-85 -137.56 157.16 47.12 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.532 1.145 . . . . 72.32 111.005 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.455 ' CD1' ' HG ' ' A' ' 206' ' ' LEU . 30.8 mm -96.83 98.85 8.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.543 1.152 . . . . 72.31 109.266 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.92 158.02 15.66 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.557 1.161 . . . . 75.02 109.267 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -152.42 157.61 33.66 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.527 1.142 . . . . 70.05 109.297 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.94 -167.33 0.41 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.564 1.823 . . . . 64.33 111.038 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 5.1 tp -85.6 -21.62 7.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.474 1.109 . . . . 72.21 109.368 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 166.03 85.28 0.06 OUTLIER Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.563 1.164 . . . . 75.5 110.967 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -150.94 131.47 13.85 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.492 0.76 . . . . 74.32 110.31 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.87 72.72 0.25 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.477 1.11 . . . . 73.31 109.28 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -149.03 -59.19 0.01 OUTLIER Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.462 1.101 . . . . 74.35 110.92 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -55.67 -178.54 0.29 Allowed Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.027 -0.829 . . . . 65.4 111.027 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -170.45 8.28 Favored 'Cis proline' 0 C--N 1.359 1.124 0 C-N-CA 120.953 -2.52 . . . . 65.11 110.951 0.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -150.32 156.17 26.59 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.438 1.086 . . . . 74.41 110.983 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.506 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 1.7 mt -97.26 127.45 43.23 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.543 0.79 . . . . 73.22 109.343 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.458 HG12 ' CG ' ' A' ' 166' ' ' PHE . 0.3 OUTLIER -129.54 145.47 57.07 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.466 1.104 . . . . 73.24 109.35 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.568 ' HD3' ' CD1' ' A' ' 166' ' ' PHE . 18.6 Cg_endo -74.96 148.11 35.04 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.436 1.756 . . . . 75.02 110.994 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.46 ' HA ' ' CG2' ' A' ' 212' ' ' VAL . 8.0 p -66.79 -32.06 56.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.469 1.105 . . . . 75.11 109.297 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . 0.407 ' N ' HG11 ' A' ' 209' ' ' VAL . . . -66.01 -9.1 45.83 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.478 1.111 . . . . 74.44 111.046 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.562 ' HA ' ' CD2' ' A' ' 164' ' ' TYR . 4.6 m-85 -113.84 5.04 16.12 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.471 0.748 . . . . 72.42 110.928 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.46 ' CG2' ' HA ' ' A' ' 209' ' ' VAL . 18.4 m -140.47 162.14 24.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.49 1.119 . . . . 72.23 109.26 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.8 t -144.97 144.18 30.92 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.502 1.126 . . . . 73.34 110.008 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.461 HG13 ' CG2' ' A' ' 227' ' ' VAL . 36.0 mm -96.13 105.95 17.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.478 1.111 . . . . 62.52 109.303 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 1.9 pt -151.5 177.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.497 1.123 . . . . 74.41 109.256 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.91 48.31 2.39 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.447 1.092 . . . . 72.11 109.293 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 2.8 pt -125.75 -46.23 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.522 1.139 . . . . 75.02 109.333 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -108.67 -45.34 3.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.527 1.142 . . . . 63.52 109.282 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.459 HG23 ' CE2' ' A' ' 221' ' ' TYR . 3.3 m -128.56 177.66 6.86 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.514 1.134 . . . . 74.31 110.378 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -75.44 -5.98 79.25 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.509 1.131 . . . . 73.41 110.995 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.459 ' CE2' HG23 ' A' ' 219' ' ' THR . 6.3 p90 -139.25 -176.97 4.71 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.502 0.766 . . . . 74.13 110.989 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -85.73 132.78 34.07 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.457 1.098 . . . . 73.13 109.339 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.446 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 11.0 p -92.17 -32.88 14.93 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.595 1.184 . . . . 75.51 110.411 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 138.99 -13.2 3.35 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.474 1.109 . . . . 63.23 110.979 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.446 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 2.6 p30 -54.4 168.51 0.25 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.505 0.768 . . . . 72.32 109.251 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -114.57 175.24 5.57 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.469 1.105 . . . . 73.32 109.311 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.491 HG23 ' CZ ' ' A' ' 193' ' ' PHE . 11.0 p -80.77 -33.17 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.459 1.099 . . . . 72.4 109.316 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.6 mp -60.58 -51.49 72.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.477 1.111 . . . . 75.12 109.338 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -61.96 -22.66 65.83 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.49 1.118 . . . . 74.53 110.268 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.468 ' O ' ' CG2' ' A' ' 234' ' ' VAL . 2.9 m-20 -83.6 -35.91 24.31 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.454 1.096 . . . . 64.41 109.257 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.501 ' CG2' ' HB3' ' A' ' 236' ' ' LEU . 12.2 mt -59.87 -29.99 44.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 74.31 109.287 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -84.08 -11.52 56.55 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.445 1.09 . . . . 72.34 109.257 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.03 -11.85 29.87 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.478 1.111 . . . . 71.12 109.988 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' A' ' 230' ' ' ASP . 0.0 OUTLIER -132.56 10.69 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.525 1.14 . . . . 65.13 109.295 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 236' ' ' LEU . 74.0 m-20 52.95 20.74 1.76 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 63.32 109.327 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.501 ' HB3' ' CG2' ' A' ' 231' ' ' ILE . 0.0 OUTLIER -39.55 100.51 0.21 Allowed Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.476 1.11 . . . . 74.45 109.311 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.89 142.94 28.83 Favored 'Trans proline' 0 C--N 1.359 1.099 0 O-C-N 124.445 1.76 . . . . 71.21 111.012 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' THR . . . . . 0.444 HG23 ' CE1' ' A' ' 187' ' ' HIS . 7.1 p -60.23 148.08 37.8 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.547 1.154 . . . . 73.53 110.434 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 1.4 p -52.82 -25.8 9.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.497 1.123 . . . . 73.41 109.281 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.437 HE21 ' CE1' ' A' ' 188' ' ' HIS . 98.3 mm-40 -75.5 -39.38 58.59 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.561 1.163 . . . . 74.15 110.37 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -76.99 -23.1 52.28 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.454 1.096 . . . . 74.12 110.326 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.585 ' CZ2' ' CD1' ' A' ' 246' ' ' ILE . 4.7 t90 -79.93 -61.69 1.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.541 1.151 . . . . 74.22 107.978 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.31 -25.03 5.21 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.49 1.119 . . . . 72.13 109.291 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 29.5 t -72.55 -35.7 68.07 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.128 . . . . 61.4 109.997 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -77.05 -38.09 53.37 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.542 1.151 . . . . 70.41 109.306 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.585 ' CD1' ' CZ2' ' A' ' 242' ' ' TRP . 21.1 mt -42.13 -64.88 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.54 1.15 . . . . 74.12 109.283 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -146.62 120.52 9.33 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.522 1.139 . . . . 75.13 109.323 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.28 3.26 5.16 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.571 1.17 . . . . 74.33 110.318 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 57.37 51.26 10.17 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.495 1.122 . . . . 73.02 111.031 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -157.66 162.84 38.67 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.522 1.139 . . . . 75.33 109.248 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -72.86 -75.16 0.15 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.544 1.153 . . . . 65.2 109.284 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 26.7 m 46.53 34.86 2.58 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.528 1.143 . . . . 74.23 109.985 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -60.42 104.37 0.32 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.541 1.15 . . . . 74.31 109.288 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 22.8 pt -134.31 143.69 37.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.54 1.15 . . . . 74.13 109.34 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 28.6 t -126.0 138.36 53.74 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.501 1.126 . . . . 64.23 109.983 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.487 ' C ' ' CD2' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -98.23 178.95 4.91 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.505 1.128 . . . . 74.22 109.286 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -166.83 173.81 42.16 Favored Glycine 0 CA--C 1.531 1.057 0 O-C-N 124.578 1.174 . . . . 64.45 110.981 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 7.7 p -125.26 151.02 46.49 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.576 0.809 . . . . 71.34 109.998 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -110.8 153.74 12.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.513 1.133 . . . . 75.12 109.309 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 . . . . . 0 C--N 1.324 -0.507 0 O-C-N 124.527 1.142 . . . . 75.44 110.292 -179.99 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.984 0 N-CA-C 110.973 -0.851 . . . . 72.11 110.973 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 87.54 1.32 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.451 1.764 . . . . 70.24 111.003 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 40.1 mt -97.67 77.79 2.58 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.598 1.186 . . . . 75.32 109.219 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.459 ' HA2' ' CG2' ' A' ' 234' ' ' VAL . . . -175.49 52.28 0.12 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.498 1.124 . . . . 73.35 111.043 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.4 m -174.33 122.2 0.28 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.503 0.767 . . . . 75.04 110.038 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.7 tp -138.5 158.79 43.58 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.539 1.149 . . . . 75.24 109.348 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.53 ' CE2' ' O ' ' A' ' 215' ' ' ILE . 2.4 p90 -152.01 152.26 32.22 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.518 1.136 . . . . 73.34 110.974 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.47 ' HB2' ' CG1' ' A' ' 184' ' ' ILE . . . -122.39 141.27 51.76 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.513 1.133 . . . . 52.41 109.232 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.51 128.38 55.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.472 1.107 . . . . 75.12 109.255 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 179' ' ' GLY . 43.4 t -84.56 92.54 3.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.547 1.155 . . . . 74.45 109.332 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.565 HD13 ' CE2' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -92.51 25.09 3.16 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 72.31 109.321 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.565 ' CE2' HD13 ' A' ' 163' ' ' LEU . 37.3 m-85 -165.18 141.11 5.44 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.481 1.113 . . . . 74.22 111.014 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -67.22 98.66 0.62 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.493 1.121 . . . . 64.15 109.257 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.578 ' CE2' ' O ' ' A' ' 174' ' ' LEU . 0.6 OUTLIER -80.3 123.53 28.05 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.436 1.085 . . . . 75.03 111.017 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.515 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 7.8 mmmm -93.25 138.93 31.16 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.454 1.096 . . . . 73.2 109.341 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.489 ' CB ' ' OE1' ' A' ' 173' ' ' GLU . . . -82.0 122.1 27.37 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.415 1.072 . . . . 75.44 109.275 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -126.97 -34.93 2.31 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.562 1.164 . . . . 73.12 110.27 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 4.8 mttp -58.56 -164.09 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.423 1.077 . . . . 73.5 109.357 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.31 -51.28 5.65 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.578 1.174 . . . . 74.33 109.306 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -105.36 29.48 6.43 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.503 1.127 . . . . 74.11 109.262 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.492 ' O ' ' CD2' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -59.02 172.5 0.56 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.531 1.144 . . . . 70.43 110.325 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.578 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 1.7 mm? -146.95 108.07 4.22 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.417 1.073 . . . . 75.35 109.278 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.09 143.28 54.24 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.461 1.1 . . . . 75.22 110.361 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.8 m -139.9 -169.01 2.63 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.525 1.14 . . . . 70.52 110.378 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -130.94 147.43 52.58 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.448 1.092 . . . . 63.42 111.021 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.9 p -59.15 155.55 2.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.576 1.172 . . . . 71.53 109.285 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 61.51 41.39 99.55 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.444 1.09 . . . . 43.14 110.972 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -121.84 171.33 8.98 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.428 0.723 . . . . 62.23 110.273 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -119.03 131.57 55.99 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.494 1.121 . . . . 75.24 109.318 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 18.2 mt -140.61 124.38 17.16 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.501 1.126 . . . . 73.42 109.332 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -79.25 128.32 33.16 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.471 1.107 . . . . 75.45 111.01 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.47 ' CG1' ' HB2' ' A' ' 160' ' ' ALA . 15.6 mm -77.68 121.29 30.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.453 1.096 . . . . 74.44 109.359 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 62.9 m -95.73 -31.37 13.25 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.494 1.121 . . . . 73.11 108.248 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.462 ' HA ' ' CD2' ' A' ' 236' ' ' LEU . . . -164.03 161.66 22.73 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.498 1.124 . . . . 70.24 109.247 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.569 ' CE1' HG21 ' A' ' 231' ' ' ILE . 9.0 p80 -128.74 147.4 50.77 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.552 1.157 . . . . 74.04 109.577 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.594 ' CD2' ' CG1' ' A' ' 239' ' ' VAL . 1.0 OUTLIER -120.91 119.17 31.85 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.51 1.131 . . . . 74.13 109.542 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.436 ' O ' ' C ' ' A' ' 190' ' ' CYS . 5.5 m-80 48.62 37.92 10.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 73.05 109.302 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.5 p 38.72 38.77 0.29 Allowed 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.501 1.125 . . . . 63.33 108.251 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.491 ' O ' ' CG2' ' A' ' 209' ' ' VAL . 11.6 pt-20 -132.52 -37.52 1.06 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.509 1.131 . . . . 70.12 110.289 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.476 ' N ' ' HG3' ' A' ' 191' ' ' GLU . 20.8 m95 -113.51 163.1 15.35 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.482 1.114 . . . . 75.41 108.088 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.57 ' CE2' HG21 ' A' ' 209' ' ' VAL . 13.7 m-85 -133.59 161.72 33.87 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 74.11 111.002 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.459 ' CG1' ' HB ' ' A' ' 239' ' ' VAL . 20.0 mm -111.92 95.38 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.145 . . . . 70.21 109.248 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.44 ' CB ' HG13 ' A' ' 207' ' ' VAL . . . -86.3 -175.18 5.39 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.532 1.145 . . . . 71.31 109.364 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.4 pttp -162.27 155.45 17.28 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 73.24 109.266 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 149.05 36.31 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.489 1.784 . . . . 63.14 110.987 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.9 pt -126.2 15.57 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 73.45 109.337 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -124.32 -47.16 0.24 Allowed Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.523 1.139 . . . . 74.42 111.01 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -130.01 178.03 6.85 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.468 0.746 . . . . 74.45 110.299 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 5.4 mt -79.42 120.96 24.56 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.546 1.154 . . . . 64.53 109.319 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -168.43 -143.56 3.87 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.443 1.089 . . . . 65.43 110.964 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 51.1 176.74 0.02 OUTLIER Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.926 -0.87 . . . . 62.44 110.926 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.462 ' HG3' ' CH2' ' A' ' 242' ' ' TRP . 18.5 Cg_endo -74.89 144.95 82.57 Favored 'Cis proline' 0 C--N 1.361 1.2 0 C-N-CA 120.967 -2.514 . . . . 72.22 111.095 -0.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.469 ' HA3' ' CD2' ' A' ' 174' ' ' LEU . . . -106.99 160.06 14.38 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.509 1.13 . . . . 72.4 110.981 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.481 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 2.6 mt -103.55 139.63 38.61 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.465 0.744 . . . . 74.01 109.271 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.541 ' CG2' ' CG1' ' A' ' 212' ' ' VAL . 0.2 OUTLIER -143.89 127.52 9.03 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.49 1.119 . . . . 74.11 109.244 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 207' ' ' VAL . 18.4 Cg_endo -74.98 157.72 42.7 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.493 1.786 . . . . 75.53 111.043 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.57 HG21 ' CE2' ' A' ' 193' ' ' PHE . 21.3 t -80.94 3.26 2.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.547 1.154 . . . . 74.14 109.311 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . 0.431 ' O ' ' CD1' ' A' ' 211' ' ' PHE . . . -89.16 -3.01 76.56 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.467 1.105 . . . . 71.35 110.942 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.431 ' CD1' ' O ' ' A' ' 210' ' ' GLY . 21.4 m-85 -136.69 14.59 3.15 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.474 0.749 . . . . 75.32 110.972 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.541 ' CG1' ' CG2' ' A' ' 207' ' ' VAL . 8.7 m -142.4 146.94 21.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.464 1.102 . . . . 72.13 109.324 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' SER . . . . . 0.409 ' CB ' HD23 ' A' ' 163' ' ' LEU . 26.0 t -129.33 160.76 32.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.551 1.157 . . . . 71.52 110.011 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.486 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 16.6 mm -102.65 145.75 11.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 75.22 109.306 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.53 ' O ' ' CE2' ' A' ' 159' ' ' TYR . 44.3 pt -156.27 128.5 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.571 1.17 . . . . 71.2 109.205 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 218' ' ' ALA . 11.6 t0 -87.96 -177.71 5.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.568 1.168 . . . . 70.31 109.322 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 9.1 mm -41.6 99.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.424 1.078 . . . . 73.52 109.378 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -157.59 168.4 27.39 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.455 1.097 . . . . 74.22 109.292 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 12.7 t -93.23 28.88 2.05 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.148 . . . . 73.43 110.392 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 114.66 -1.85 23.28 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.536 1.147 . . . . 53.41 111.006 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -88.35 179.31 6.36 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.517 0.775 . . . . 74.0 111.038 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -134.29 153.52 51.83 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.518 1.137 . . . . 73.24 109.308 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 32.3 p -90.71 -24.0 20.55 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.565 1.165 . . . . 72.35 110.402 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 106.88 -0.58 36.0 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.51 1.132 . . . . 72.43 111.037 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.419 ' N ' HD21 ' A' ' 225' ' ' ASN . 1.7 m-80 -70.02 -175.92 1.03 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.528 0.781 . . . . 71.33 109.3 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -114.08 173.22 6.55 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.493 1.12 . . . . 74.13 109.352 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.468 ' CG2' HG13 ' A' ' 214' ' ' ILE . 2.8 p -84.16 -33.56 9.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.371 1.044 . . . . 75.05 109.329 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 1.8 mp -61.24 -50.87 78.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.498 1.123 . . . . 74.15 109.363 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -58.28 -31.42 67.45 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 64.01 110.351 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.54 -35.74 52.96 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.497 1.123 . . . . 64.14 109.354 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.569 HG21 ' CE1' ' A' ' 187' ' ' HIS . 29.7 mt -68.34 -38.43 79.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.131 . . . . 74.25 109.29 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.29 -33.85 59.08 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.536 1.147 . . . . 74.54 109.336 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.7 m -58.79 -38.24 78.1 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.561 1.163 . . . . 73.41 109.989 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.459 ' CG2' ' HA2' ' A' ' 156' ' ' GLY . 2.0 p -112.6 6.93 8.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.494 1.121 . . . . 74.53 109.325 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 231' ' ' ILE . 9.2 p30 40.46 51.72 2.91 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.471 1.107 . . . . 74.3 109.269 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.462 ' CD2' ' HA ' ' A' ' 186' ' ' ALA . 1.1 tt -50.79 140.72 19.3 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.554 1.159 . . . . 75.34 109.369 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 129.45 12.3 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.55 1.816 . . . . 64.11 111.002 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 3.0 p -67.17 152.39 45.84 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.479 1.112 . . . . 73.42 110.353 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.594 ' CG1' ' CD2' ' A' ' 188' ' ' HIS . 1.7 p -46.99 -25.58 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.544 1.153 . . . . 71.15 109.286 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -86.63 -50.43 6.81 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 74.11 110.337 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -57.1 -25.15 58.3 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.548 1.155 . . . . 74.54 110.249 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.462 ' CH2' ' HG3' ' A' ' 204' ' ' PRO . 26.9 t90 -85.77 -61.85 1.66 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 74.44 108.022 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -50.88 -23.2 2.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.433 1.083 . . . . 74.52 109.284 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.9 t -86.85 -61.81 1.64 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.413 1.071 . . . . 75.21 110.007 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -41.62 -54.8 3.13 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.518 1.136 . . . . 73.41 109.289 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 63.6 mt -42.62 106.91 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.524 1.14 . . . . 72.32 109.26 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -137.79 173.64 11.42 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.485 1.116 . . . . 73.32 109.271 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -84.98 112.26 20.44 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.425 1.078 . . . . 74.52 110.31 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 249' ' ' TYR . 1.0 OUTLIER 50.64 38.92 20.29 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.495 1.122 . . . . 73.53 110.971 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -44.77 132.62 6.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.483 1.114 . . . . 74.13 109.246 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -82.17 159.04 23.38 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.528 1.142 . . . . 65.34 109.287 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 4.2 p -126.21 162.63 24.98 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.481 1.113 . . . . 61.43 109.99 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -133.49 84.75 2.15 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.505 1.128 . . . . 65.43 109.36 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 2.7 mm -53.93 106.63 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.499 1.125 . . . . 73.41 109.265 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.4 t -57.84 99.1 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 74.44 109.992 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 11.5 tp -60.53 103.51 0.25 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.468 1.105 . . . . 74.42 109.344 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -164.24 72.09 0.19 Allowed Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.529 1.143 . . . . 75.33 110.98 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 24.5 m -113.63 22.92 13.62 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.392 0.701 . . . . 75.04 109.971 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 35.3 t -81.37 94.47 2.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.501 1.126 . . . . 73.31 109.305 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.324 -0.503 0 O-C-N 124.465 1.103 . . . . 74.34 110.253 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.03 0 N-CA-C 110.972 -0.851 . . . . 33.2 110.972 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 118.53 5.31 Favored 'Trans proline' 0 C--N 1.361 1.209 0 O-C-N 124.449 1.762 . . . . 71.13 110.982 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 14.4 mt -108.87 134.28 51.76 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.526 1.141 . . . . 74.4 109.318 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -160.05 27.05 0.33 Allowed Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.551 1.157 . . . . 74.22 111.025 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.9 m -160.14 107.4 1.62 Allowed 'General case' 0 C--N 1.326 -0.423 0 O-C-N 124.498 0.764 . . . . 73.21 110.014 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.4 tp -98.08 124.7 42.72 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 74.22 109.3 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.477 ' HB3' ' CE2' ' A' ' 183' ' ' PHE . 33.8 p90 -103.65 144.11 31.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.512 1.132 . . . . 75.22 110.998 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -140.83 141.83 34.67 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.557 1.161 . . . . 74.42 109.315 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.5 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -109.07 133.73 53.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 74.45 109.329 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.4 t -86.05 125.1 40.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.452 1.095 . . . . 73.45 109.378 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.54 ' N ' ' CD2' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -112.88 12.88 19.53 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.538 1.149 . . . . 72.43 109.317 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.408 ' CG ' ' O ' ' A' ' 163' ' ' LEU . 97.4 m-85 -158.24 145.14 17.73 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.467 1.105 . . . . 74.21 111.02 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -79.92 103.01 9.52 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.406 1.066 . . . . 63.35 109.277 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.545 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 7.4 t80 -83.1 137.82 33.94 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 73.14 111.015 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.486 ' HA ' ' CE ' ' A' ' 167' ' ' LYS . 0.5 OUTLIER -105.47 123.54 48.06 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.532 1.145 . . . . 73.12 109.304 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.425 ' CB ' ' OE1' ' A' ' 173' ' ' GLU . . . -71.0 123.26 21.64 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.595 1.185 . . . . 75.14 109.313 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -126.78 -34.16 2.42 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.541 1.151 . . . . 72.41 110.309 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 0.4 OUTLIER -58.62 -164.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 O-C-N 124.435 1.084 . . . . 74.34 109.316 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.34 -51.22 5.67 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.487 1.117 . . . . 73.52 109.266 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.64 29.42 6.96 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.521 1.138 . . . . 74.01 109.287 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.464 ' CD ' ' N ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -58.95 -178.42 0.05 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.561 1.163 . . . . 75.25 110.251 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.525 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -147.54 119.97 8.46 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.544 1.153 . . . . 71.32 109.277 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.53 130.41 35.95 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.555 1.159 . . . . 74.31 110.439 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.7 m -126.91 -176.08 3.6 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.593 1.183 . . . . 75.51 110.435 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 177' ' ' TYR . 23.9 m-85 -136.09 143.35 44.56 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.558 1.161 . . . . 64.44 110.987 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.5 p -56.24 147.28 4.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.469 1.106 . . . . 71.21 109.291 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.81 58.07 13.85 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.495 1.122 . . . . 75.41 111.034 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.5 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 10.9 tp10 -121.83 166.16 14.8 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.547 0.792 . . . . 74.53 110.303 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.415 ' N ' HD21 ' A' ' 181' ' ' ASN . 2.3 m-80 -119.35 133.44 55.72 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.442 1.089 . . . . 71.31 109.292 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.457 ' C ' ' CD1' ' A' ' 182' ' ' LEU . 1.2 pp -166.93 -175.45 3.05 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.546 1.154 . . . . 74.22 109.309 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.477 ' CE2' ' HB3' ' A' ' 159' ' ' TYR . 22.4 m-85 -134.07 139.91 46.29 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.474 1.109 . . . . 72.2 110.998 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.453 ' CD1' ' HB3' ' A' ' 193' ' ' PHE . 27.9 mm -77.7 138.08 21.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.487 1.117 . . . . 75.4 109.337 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.456 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 0.6 OUTLIER -95.1 -28.13 15.24 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.102 . . . . 73.1 108.338 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.403 ' N ' ' HB ' ' A' ' 194' ' ' ILE . . . -172.41 179.56 2.49 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.497 1.123 . . . . 72.42 109.325 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.565 ' CD2' HG23 ' A' ' 231' ' ' ILE . 8.5 p80 -136.56 154.32 50.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.486 1.116 . . . . 75.32 109.607 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.487 ' O ' ' CG ' ' A' ' 191' ' ' GLU . 0.0 OUTLIER -126.97 117.94 23.51 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.469 1.106 . . . . 64.25 109.511 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 2.2 m120 50.85 33.91 9.41 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.479 1.112 . . . . 73.0 109.292 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.464 ' HB3' ' CG1' ' A' ' 228' ' ' ILE . 99.2 m 43.77 38.16 1.93 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.473 1.108 . . . . 62.12 108.286 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 188' ' ' HIS . 8.3 pt-20 -135.26 -40.51 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.562 1.164 . . . . 71.42 110.318 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -107.23 165.78 11.12 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.989 -1.115 . . . . 74.22 107.989 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.562 ' CZ ' HG23 ' A' ' 209' ' ' VAL . 12.4 m-85 -137.79 159.03 43.11 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.499 1.124 . . . . 74.22 110.978 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.456 ' CG2' ' HB3' ' A' ' 185' ' ' CYS . 21.1 mm -100.37 114.43 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.504 1.127 . . . . 74.13 109.288 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.46 ' CB ' HG13 ' A' ' 207' ' ' VAL . . . -92.59 168.07 11.49 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.543 1.152 . . . . 75.23 109.273 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.496 ' CG ' ' O ' ' A' ' 196' ' ' LYS . 1.8 pttt -174.91 91.09 0.3 Allowed Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.128 . . . . 73.25 109.34 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.445 ' HG3' ' CD1' ' A' ' 174' ' ' LEU . 18.4 Cg_endo -74.96 94.59 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.528 1.804 . . . . 75.34 111.039 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 5.2 tt -59.31 153.84 3.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 72.14 109.301 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 89.63 -34.43 4.04 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.486 1.116 . . . . 73.32 111.028 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -124.24 120.17 31.45 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.494 0.761 . . . . 71.43 110.274 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 5.7 mp -57.1 153.91 10.81 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.464 1.102 . . . . 74.12 109.305 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 148.37 -52.1 0.55 Allowed Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.553 1.158 . . . . 72.41 111.07 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -78.52 -178.48 50.0 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.014 -0.834 . . . . 62.24 111.014 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 145.22 83.34 Favored 'Cis proline' 0 C--N 1.359 1.118 0 C-N-CA 121.048 -2.48 . . . . 73.12 111.017 0.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.467 ' HA3' ' CD2' ' A' ' 174' ' ' LEU . . . -119.09 -166.01 13.31 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.597 1.186 . . . . 65.51 111.006 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.454 HD23 ' CD1' ' A' ' 194' ' ' ILE . 3.1 mt -119.69 142.74 48.22 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.422 0.719 . . . . 73.2 109.302 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.46 HG13 ' CB ' ' A' ' 195' ' ' ALA . 1.6 m -143.9 155.06 59.32 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.487 1.117 . . . . 75.01 109.323 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.515 ' HD3' ' CE1' ' A' ' 166' ' ' PHE . 18.4 Cg_endo -74.93 160.44 40.35 Favored 'Trans proline' 0 C--N 1.359 1.108 0 O-C-N 124.53 1.805 . . . . 74.33 111.055 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.562 HG23 ' CZ ' ' A' ' 193' ' ' PHE . 10.1 p -84.97 -19.04 8.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 74.05 109.349 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -82.83 9.33 60.05 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.487 1.117 . . . . 70.12 110.994 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.545 ' CE2' ' HA ' ' A' ' 166' ' ' PHE . 11.2 m-85 -128.46 18.67 6.35 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 0.768 . . . . 71.53 111.009 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.514 HG23 ' CD2' ' A' ' 193' ' ' PHE . 31.7 m -156.9 144.5 10.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.496 1.123 . . . . 65.13 109.333 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' SER . . . . . 0.453 ' CB ' HD21 ' A' ' 163' ' ' LEU . 22.3 t -134.73 140.19 45.76 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 72.54 110.03 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.444 ' CG2' ' CG ' ' A' ' 230' ' ' ASP . 11.0 mm -86.82 89.3 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.53 1.144 . . . . 74.13 109.339 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.426 ' CG2' ' C ' ' A' ' 214' ' ' ILE . 0.3 OUTLIER -149.87 165.93 3.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.501 1.125 . . . . 72.43 109.262 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.56 138.37 43.9 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.499 1.124 . . . . 71.14 109.227 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 218' ' ' ALA . 35.7 pt -54.88 -42.35 62.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.453 1.096 . . . . 72.33 109.309 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 220' ' ' GLY . . . -46.53 165.64 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.524 1.14 . . . . 74.03 109.298 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 218' ' ' ALA . 52.0 m -38.85 -30.08 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.483 1.114 . . . . 73.21 110.329 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 218' ' ' ALA . . . -62.81 89.32 0.06 OUTLIER Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.537 1.148 . . . . 72.21 110.975 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -97.38 -171.76 2.27 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.537 0.786 . . . . 72.35 111.068 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -42.29 109.32 0.12 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.512 1.132 . . . . 71.1 109.361 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 73.3 p -88.08 -16.38 33.7 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.441 1.088 . . . . 71.12 110.453 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 113.21 13.54 10.72 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.531 1.145 . . . . 70.55 111.008 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -88.49 -176.81 5.44 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.5 0.765 . . . . 64.41 109.331 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -130.1 171.28 13.0 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.526 1.141 . . . . 63.4 109.25 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 12.6 p -78.25 -40.88 25.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.478 1.111 . . . . 74.23 109.318 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.464 ' CG1' ' HB3' ' A' ' 190' ' ' CYS . 2.1 mp -50.7 -53.41 13.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.519 1.137 . . . . 72.43 109.386 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -61.82 -33.08 73.49 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.458 1.099 . . . . 74.2 110.286 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.444 ' CG ' ' CG2' ' A' ' 214' ' ' ILE . 1.1 m-20 -70.86 -30.5 66.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.492 1.12 . . . . 71.41 109.294 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.565 HG23 ' CD2' ' A' ' 187' ' ' HIS . 19.2 mt -68.93 -36.25 73.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.529 1.143 . . . . 74.15 109.305 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -74.61 -20.53 59.88 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.53 1.144 . . . . 74.44 109.295 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 6.7 p -68.64 -34.66 76.11 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.44 1.087 . . . . 71.32 110.014 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.419 ' C ' ' N ' ' A' ' 236' ' ' LEU . 6.8 p -114.75 19.0 7.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.549 1.155 . . . . 73.3 109.267 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 43.06 28.17 0.13 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.567 1.167 . . . . 63.35 109.341 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.419 ' N ' ' C ' ' A' ' 234' ' ' VAL . 18.8 tp -51.55 109.95 1.61 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.48 1.112 . . . . 74.34 109.321 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.93 137.21 21.59 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.519 1.799 . . . . 75.25 110.966 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' THR . . . . . 0.529 HG21 ' CE1' ' A' ' 187' ' ' HIS . 10.2 p -57.04 157.97 5.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 71.42 110.37 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.445 ' HB ' ' CG1' ' A' ' 194' ' ' ILE . 1.5 p -54.04 -27.99 16.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.443 1.089 . . . . 74.42 109.261 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -80.03 -30.7 39.54 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.454 1.096 . . . . 74.5 110.327 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -81.78 -24.06 36.22 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.517 1.136 . . . . 71.5 110.282 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.443 ' O ' ' N ' ' A' ' 245' ' ' ASN . 9.5 t90 -83.3 -66.39 0.9 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.12 . . . . 74.33 108.046 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.5 -29.86 0.1 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.514 1.134 . . . . 74.42 109.282 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.433 ' N ' ' C ' ' A' ' 242' ' ' TRP . 47.4 t -64.16 -52.85 57.05 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.439 1.087 . . . . 64.44 110.004 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 242' ' ' TRP . 22.3 m-80 -54.65 -45.19 73.77 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.479 1.112 . . . . 74.24 109.355 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.434 HD12 ' CE2' ' A' ' 242' ' ' TRP . 7.8 mt -47.75 110.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.418 1.074 . . . . 61.44 109.292 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -102.85 132.36 49.1 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.484 1.115 . . . . 64.34 109.301 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -113.37 -54.33 2.62 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.482 1.114 . . . . 74.34 110.26 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -113.12 172.54 6.88 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.538 1.149 . . . . 74.24 110.93 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.96 106.84 5.84 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.538 1.149 . . . . 74.34 109.264 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -56.05 127.81 32.29 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.567 1.167 . . . . 73.43 109.257 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 15.3 m -64.59 178.74 0.71 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.509 1.131 . . . . 72.1 110.006 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -124.56 142.54 51.28 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.483 1.114 . . . . 65.44 109.283 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.412 HD11 ' N ' ' A' ' 254' ' ' ILE . 0.0 OUTLIER -119.59 145.12 26.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.429 1.08 . . . . 74.55 109.332 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.2 m -41.41 145.84 0.24 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.475 1.109 . . . . 70.51 109.951 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 8.5 tt -43.71 134.74 4.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 73.33 109.258 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -89.17 137.25 14.06 Favored Glycine 0 CA--C 1.531 1.057 0 O-C-N 124.563 1.164 . . . . 74.15 110.992 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 53.9 p -86.56 156.13 20.19 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.49 0.759 . . . . 63.13 109.967 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -80.94 -16.57 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.533 1.146 . . . . 74.14 109.294 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 . . . . . 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 72.51 110.289 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.006 0 N-CA-C 110.926 -0.87 . . . . 53.11 110.926 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -74.98 109.57 2.95 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.497 1.788 . . . . 71.22 110.972 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.459 ' CD1' ' O ' ' A' ' 233' ' ' SER . 10.4 mt -127.69 102.99 7.06 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.449 1.093 . . . . 71.44 109.335 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -153.38 36.39 0.75 Allowed Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.47 1.106 . . . . 71.03 111.067 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 39.7 t -158.36 150.1 21.37 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.484 0.755 . . . . 50.41 110.024 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.584 ' C ' ' CD1' ' A' ' 159' ' ' TYR . 8.2 mt -144.42 172.52 12.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 73.05 109.262 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.584 ' CD1' ' C ' ' A' ' 158' ' ' LEU . 36.4 m-85 -157.56 115.06 3.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.493 1.121 . . . . 74.43 111.031 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.506 ' CB ' ' CD1' ' A' ' 214' ' ' ILE . . . -114.79 133.21 56.11 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.471 1.107 . . . . 74.43 109.292 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.448 HG22 ' CD1' ' A' ' 215' ' ' ILE . 0.4 OUTLIER -100.62 130.78 49.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.449 1.093 . . . . 64.14 109.27 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 179' ' ' GLY . 2.0 t -88.84 127.72 41.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.512 1.133 . . . . 74.23 109.365 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -107.39 -5.97 17.41 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.477 1.111 . . . . 71.32 109.379 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -147.05 147.34 30.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 73.22 111.059 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.452 ' N ' HG11 ' A' ' 178' ' ' VAL . 0.2 OUTLIER -79.4 111.71 15.92 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.47 1.106 . . . . 71.42 109.325 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.629 ' CG ' ' CD ' ' A' ' 208' ' ' PRO . 7.9 t80 -80.51 150.17 29.74 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.597 1.185 . . . . 75.11 111.002 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.545 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 0.1 OUTLIER -108.26 132.4 53.71 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.412 1.07 . . . . 73.23 109.272 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.501 ' CB ' ' OE2' ' A' ' 173' ' ' GLU . . . -78.47 127.51 32.28 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.598 1.186 . . . . 73.33 109.282 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -130.35 -33.18 1.71 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.498 1.124 . . . . 75.54 110.263 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -58.04 -166.15 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.567 1.167 . . . . 70.5 109.304 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.96 -45.35 9.26 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.497 1.123 . . . . 64.14 109.333 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -111.23 28.66 8.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 1.117 . . . . 74.2 109.326 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.501 ' OE2' ' CB ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -63.44 -176.76 0.17 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.442 1.089 . . . . 74.34 110.298 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.8 mt -157.25 133.15 9.43 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.509 1.131 . . . . 75.13 109.22 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.72 130.97 35.24 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.498 1.124 . . . . 72.22 110.387 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.6 m -111.11 -176.82 3.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.505 1.128 . . . . 75.05 110.373 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 177' ' ' TYR . 15.5 m-85 -130.12 157.25 42.93 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.517 1.136 . . . . 73.43 110.944 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.452 HG11 ' N ' ' A' ' 165' ' ' ASP . 1.0 OUTLIER -67.33 162.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.405 1.065 . . . . 63.42 109.252 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 37.28 61.34 1.01 Allowed Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.456 1.098 . . . . 72.02 110.997 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -121.2 176.82 5.42 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 0.778 . . . . 64.14 110.298 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -146.71 134.48 21.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.458 1.099 . . . . 75.21 109.28 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.45 ' CD2' ' C ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -166.48 160.32 15.31 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.494 1.121 . . . . 75.14 109.284 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.434 ' CE1' ' O ' ' A' ' 184' ' ' ILE . 5.5 t80 -92.07 137.21 32.55 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.593 1.183 . . . . 75.34 111.04 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.434 ' O ' ' CE1' ' A' ' 183' ' ' PHE . 42.7 mm -77.54 124.78 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.496 1.122 . . . . 74.4 109.291 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.429 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 10.2 t -79.94 -26.24 40.15 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 64.12 108.274 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -176.84 166.95 2.56 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 71.43 109.312 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.564 ' CE1' HG23 ' A' ' 238' ' ' THR . 8.2 p80 -123.42 151.01 43.07 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.497 1.123 . . . . 74.14 109.545 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.593 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 3.8 t-160 -124.76 112.95 17.31 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.498 1.124 . . . . 75.52 109.556 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.401 ' C ' ' N ' ' A' ' 191' ' ' GLU . 8.4 t-20 57.26 23.45 8.78 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.547 1.154 . . . . 64.12 109.32 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 6.8 m 53.08 21.46 2.13 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.484 1.115 . . . . 51.54 108.235 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.401 ' N ' ' C ' ' A' ' 189' ' ' ASN . 5.0 pt-20 -116.95 -31.95 5.24 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.465 1.103 . . . . 75.44 110.27 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -118.92 166.45 12.83 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.923 -1.14 . . . . 74.12 107.923 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.551 ' CZ ' HG23 ' A' ' 227' ' ' VAL . 36.3 m-85 -140.44 162.07 36.2 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.454 1.096 . . . . 73.14 111.021 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.473 ' CD1' ' HG ' ' A' ' 206' ' ' LEU . 34.6 mm -103.16 124.38 57.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.433 1.083 . . . . 72.45 109.343 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -112.56 174.9 5.67 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.493 1.12 . . . . 73.23 109.29 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.411 ' N ' ' HD3' ' A' ' 197' ' ' PRO . 19.1 tptp -166.46 64.44 0.84 Allowed Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.573 1.17 . . . . 73.21 109.326 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 196' ' ' LYS . 18.3 Cg_endo -75.05 167.51 26.85 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.552 1.817 . . . . 62.25 110.989 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 200' ' ' ARG . 2.5 mm 40.47 69.26 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.478 1.112 . . . . 73.32 109.317 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -46.61 94.02 0.01 OUTLIER Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.495 1.122 . . . . 64.23 111.019 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 198' ' ' ILE . 12.5 ptp180 -147.46 -170.6 3.6 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.571 0.806 . . . . 70.32 110.262 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.26 89.54 0.13 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 75.25 109.267 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 172.51 -155.66 23.69 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.463 1.102 . . . . 71.31 110.93 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 48.84 -178.72 0.01 OUTLIER Glycine 0 CA--C 1.531 1.075 0 N-CA-C 110.952 -0.859 . . . . 63.24 110.952 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.1 165.92 84.6 Favored 'Cis proline' 0 C--N 1.36 1.174 0 C-N-CA 121.012 -2.495 . . . . 64.11 110.975 0.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -122.46 179.72 16.11 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.545 1.153 . . . . 64.21 110.993 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.473 ' HG ' ' CD1' ' A' ' 194' ' ' ILE . 3.8 mp -117.59 168.49 10.37 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.439 0.729 . . . . 73.34 109.318 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.526 HG22 ' CD2' ' A' ' 166' ' ' PHE . 6.1 p -159.81 140.18 8.78 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.519 1.137 . . . . 64.31 109.223 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.629 ' CD ' ' CG ' ' A' ' 166' ' ' PHE . 18.1 Cg_endo -75.0 152.2 40.48 Favored 'Trans proline' 0 C--N 1.361 1.21 0 O-C-N 124.505 1.792 . . . . 64.31 110.997 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.459 ' HA ' ' CG2' ' A' ' 212' ' ' VAL . 11.6 p -78.83 -18.94 13.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.539 1.149 . . . . 73.2 109.26 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -73.83 -2.38 61.08 Favored Glycine 0 CA--C 1.531 1.091 0 O-C-N 124.539 1.149 . . . . 61.24 110.947 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -126.52 -0.3 6.87 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.56 0.8 . . . . 73.21 110.976 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.48 HG23 ' CD2' ' A' ' 193' ' ' PHE . 11.8 m -133.5 153.01 36.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 73.13 109.326 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.7 t -143.2 155.91 44.64 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.5 1.125 . . . . 74.5 110.05 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.506 ' CD1' ' CB ' ' A' ' 160' ' ' ALA . 18.9 mm -111.41 154.26 13.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.507 1.129 . . . . 75.33 109.308 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.448 ' CD1' HG22 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -152.86 146.36 14.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.513 1.133 . . . . 74.34 109.247 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -88.37 157.36 18.73 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.134 . . . . 70.42 109.304 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 22.8 mm 50.41 28.32 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.529 1.143 . . . . 74.13 109.31 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 40.7 40.63 0.98 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.486 1.116 . . . . 73.14 109.272 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.628 ' CG2' ' CZ ' ' A' ' 221' ' ' TYR . 54.3 m -59.78 150.87 26.85 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.54 1.15 . . . . 70.32 110.401 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -74.18 -2.9 63.64 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.567 1.167 . . . . 75.31 110.995 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.628 ' CZ ' ' CG2' ' A' ' 219' ' ' THR . 1.5 p90 -140.37 -174.86 4.07 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.519 0.776 . . . . 71.31 111.01 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -90.88 134.83 34.15 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.125 . . . . 60.03 109.362 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 16.4 p -91.97 -25.53 18.82 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.521 1.138 . . . . 75.43 110.43 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 119.65 8.09 9.29 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.583 1.177 . . . . 75.35 110.982 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.704 ' N ' HD21 ' A' ' 225' ' ' ASN . 0.8 OUTLIER -85.44 -178.56 6.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.576 0.809 . . . . 75.55 109.289 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.2 172.58 10.45 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.5 1.125 . . . . 74.2 109.298 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.551 HG23 ' CZ ' ' A' ' 193' ' ' PHE . 13.2 p -81.1 -37.76 16.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.548 1.155 . . . . 62.41 109.319 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.6 mp -54.69 -53.58 30.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.49 1.119 . . . . 75.43 109.268 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -55.44 -31.01 61.56 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.575 1.172 . . . . 70.54 110.306 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.43 ' CG ' ' CG2' ' A' ' 214' ' ' ILE . 0.5 OUTLIER -77.29 -34.9 55.47 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.509 1.131 . . . . 62.32 109.332 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.559 HG21 ' CD2' ' A' ' 187' ' ' HIS . 21.3 mt -67.6 -35.13 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.486 1.116 . . . . 73.2 109.3 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -82.39 -26.97 32.35 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.511 1.132 . . . . 74.01 109.245 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.459 ' O ' ' CD1' ' A' ' 155' ' ' LEU . 46.8 p -60.06 -32.66 71.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.533 1.146 . . . . 74.31 109.991 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.448 ' O ' ' CG2' ' A' ' 234' ' ' VAL . 2.6 p -118.06 10.65 7.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.135 . . . . 75.03 109.327 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 4.4 m120 40.51 35.79 0.32 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.505 1.128 . . . . 65.31 109.272 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.49 144.04 12.84 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.472 1.107 . . . . 73.24 109.314 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.97 151.45 39.66 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.474 1.776 . . . . 75.44 111.02 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' THR . . . . . 0.564 HG23 ' CE1' ' A' ' 187' ' ' HIS . 2.1 p -86.17 141.29 29.46 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.517 1.136 . . . . 74.33 110.386 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.593 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 4.4 p -42.76 -28.31 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.556 1.16 . . . . 75.24 109.323 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.474 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 14.7 mm-40 -78.78 -46.32 19.07 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.522 1.139 . . . . 62.13 110.249 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 238' ' ' THR . 17.3 mt-10 -66.3 -19.79 65.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.448 1.092 . . . . 74.22 110.273 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.423 ' C ' ' N ' ' A' ' 244' ' ' SER . 2.0 t90 -81.37 -70.37 0.54 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 73.43 107.979 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -40.39 -29.93 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.398 1.061 . . . . 72.32 109.301 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.423 ' N ' ' C ' ' A' ' 242' ' ' TRP . 5.2 t -84.32 -59.24 2.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 61.41 110.044 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 246' ' ' ILE . 10.0 t-20 -40.37 -40.35 1.16 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.493 1.121 . . . . 75.11 109.254 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 245' ' ' ASN . 15.9 mm -40.51 132.1 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.488 1.117 . . . . 73.21 109.32 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -40.61 124.98 2.14 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.542 1.152 . . . . 73.14 109.233 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -118.02 -62.39 1.55 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.468 1.105 . . . . 75.32 110.322 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -120.97 154.49 35.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.463 1.102 . . . . 65.34 111.029 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -99.51 103.75 15.52 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.491 1.119 . . . . 73.34 109.306 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -164.9 142.62 6.27 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.543 1.152 . . . . 75.04 109.332 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 21.1 p -45.58 98.21 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 73.15 110.035 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -41.24 -76.23 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 74.43 109.309 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 2.8 pp -126.65 16.67 3.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.483 1.114 . . . . 72.31 109.298 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.9 m -96.27 47.67 1.09 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.532 1.145 . . . . 63.02 109.966 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.485 ' C ' ' CD2' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -86.81 -16.37 36.42 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.555 1.159 . . . . 71.53 109.305 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 118.34 170.52 14.93 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.499 1.124 . . . . 72.15 110.992 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 3.8 t -101.32 178.43 4.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.516 0.774 . . . . 72.52 110.04 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.77 113.28 38.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.127 . . . . 75.44 109.302 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.521 0 O-C-N 124.533 1.146 . . . . 54.54 110.302 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.02 0 N-CA-C 110.981 -0.847 . . . . 74.14 110.981 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.86 -162.83 0.16 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.504 1.792 . . . . 73.33 111.048 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.91 163.56 18.91 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.496 1.122 . . . . 74.51 109.325 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -170.51 49.51 0.2 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.586 1.179 . . . . 74.21 110.992 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.9 t -175.46 110.37 0.11 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.486 0.757 . . . . 71.33 110.037 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 11.4 tp -97.63 165.62 11.89 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.546 1.154 . . . . 74.21 109.275 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -132.04 130.58 41.53 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.466 1.104 . . . . 75.2 110.97 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.58 151.01 38.42 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.127 . . . . 74.13 109.259 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.63 129.19 74.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.54 1.15 . . . . 74.43 109.322 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.577 ' CG2' ' CD2' ' A' ' 182' ' ' LEU . 1.9 t -76.96 132.64 32.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.557 1.161 . . . . 71.31 109.302 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.461 ' O ' ' CG2' ' A' ' 178' ' ' VAL . 0.2 OUTLIER -111.56 -7.38 14.31 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.572 1.17 . . . . 74.32 109.317 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -142.23 143.56 32.95 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.548 1.155 . . . . 71.14 111.019 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.435 ' O ' ' NZ ' ' A' ' 167' ' ' LYS . 4.6 t0 -73.26 108.17 5.99 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.532 1.145 . . . . 75.02 109.326 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.604 ' CZ ' ' O ' ' A' ' 206' ' ' LEU . 3.8 t80 -80.41 147.31 31.05 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.533 1.146 . . . . 72.1 110.948 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.435 ' NZ ' ' O ' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -107.06 137.9 44.25 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.503 1.127 . . . . 72.33 109.29 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.467 ' CB ' ' OE1' ' A' ' 173' ' ' GLU . . . -89.45 122.74 32.93 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.547 1.154 . . . . 71.24 109.301 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -126.3 -29.42 2.99 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.484 1.115 . . . . 74.1 110.294 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 4.2 tttp -59.09 -173.34 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.463 1.102 . . . . 74.24 109.263 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.82 -29.49 17.54 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.394 1.059 . . . . 73.24 109.267 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.47 28.36 6.65 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.601 1.188 . . . . 74.11 109.323 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.467 ' OE1' ' CB ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -68.49 -176.37 0.77 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.541 1.151 . . . . 74.15 110.319 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.49 110.67 2.51 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.457 1.098 . . . . 72.33 109.329 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.1 t -68.29 136.2 53.1 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.465 1.103 . . . . 71.35 110.379 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 3.2 m -120.38 -164.3 1.08 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.567 1.167 . . . . 70.43 110.437 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.479 ' CB ' ' OE1' ' A' ' 180' ' ' GLU . 31.3 m-85 -128.47 173.61 10.08 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.433 1.083 . . . . 70.0 111.008 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 163' ' ' LEU . 1.4 p -93.67 137.46 22.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.469 1.106 . . . . 64.11 109.349 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 67.16 52.58 31.12 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.451 1.094 . . . . 75.31 110.972 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.479 ' OE1' ' CB ' ' A' ' 177' ' ' TYR . 2.4 mp0 -121.9 165.67 15.58 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.542 0.789 . . . . 73.22 110.293 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.456 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.4 OUTLIER -115.85 126.82 54.46 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.501 1.126 . . . . 74.52 109.369 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.577 ' CD2' ' CG2' ' A' ' 162' ' ' VAL . 0.4 OUTLIER -148.97 177.79 9.26 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.473 1.108 . . . . 63.54 109.327 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -122.85 131.13 53.61 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.532 1.145 . . . . 75.33 111.044 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 38.3 mm -77.52 122.63 32.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.488 1.117 . . . . 74.11 109.344 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 3.6 m -85.42 -28.97 24.75 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.122 . . . . 71.41 108.302 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -167.22 179.58 5.02 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.484 1.115 . . . . 73.24 109.252 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.421 ' NE2' HG21 ' A' ' 231' ' ' ILE . 7.5 p80 -136.26 154.65 50.84 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 75.34 109.605 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.466 ' C ' ' CD2' ' A' ' 188' ' ' HIS . 0.2 OUTLIER -128.98 111.91 13.51 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.536 1.147 . . . . 72.23 109.596 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.65 21.53 8.87 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.544 1.152 . . . . 61.41 109.36 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 69.9 m 56.33 19.2 3.82 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.495 1.122 . . . . 74.24 108.332 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 192' ' ' TRP . 6.7 pt-20 -116.52 -31.74 5.45 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.566 1.166 . . . . 73.52 110.325 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.425 ' N ' ' HG3' ' A' ' 191' ' ' GLU . 16.7 m0 -115.33 165.12 13.31 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.613 1.196 . . . . 64.55 108.012 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.474 ' CE2' ' HB ' ' A' ' 209' ' ' VAL . 9.0 m-85 -143.87 159.16 43.03 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.518 1.136 . . . . 74.43 111.006 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.468 ' CG1' ' HB ' ' A' ' 239' ' ' VAL . 19.9 mm -100.9 121.91 52.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.525 1.141 . . . . 71.41 109.341 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -118.78 170.83 8.66 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.572 1.17 . . . . 71.21 109.336 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -169.03 144.79 2.75 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.498 1.123 . . . . 73.52 109.271 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.44 ' CB ' HD13 ' A' ' 201' ' ' LEU . 18.0 Cg_endo -75.07 140.63 25.48 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.483 1.78 . . . . 71.43 110.958 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.407 HG23 ' N ' ' A' ' 199' ' ' GLY . 0.0 OUTLIER -41.54 -54.19 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.522 1.139 . . . . 73.42 109.223 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.407 ' N ' HG23 ' A' ' 198' ' ' ILE . . . -70.31 -130.15 0.07 OUTLIER Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.519 1.137 . . . . 63.22 111.049 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 35.4 mmm-85 -142.64 117.01 9.61 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.515 0.773 . . . . 74.41 110.32 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.44 HD13 ' CB ' ' A' ' 197' ' ' PRO . 5.0 mp -122.45 -43.63 2.28 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.455 1.097 . . . . 75.42 109.339 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 171.49 -76.09 0.1 OUTLIER Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.442 1.089 . . . . 74.41 111.045 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 53.25 177.19 0.07 OUTLIER Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.994 -0.842 . . . . 75.45 110.994 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 145.06 82.88 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 120.951 -2.52 . . . . 75.12 111.015 0.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 194' ' ' ILE . . . -90.61 156.73 24.97 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.531 1.145 . . . . 55.42 111.021 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.604 ' O ' ' CZ ' ' A' ' 166' ' ' PHE . 1.5 mt -119.94 135.74 54.79 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 0.763 . . . . 74.35 109.269 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.527 HG12 ' CG ' ' A' ' 166' ' ' PHE . 0.6 OUTLIER -148.17 139.37 13.64 Favored Pre-proline 0 C--N 1.323 -0.547 0 O-C-N 124.519 1.137 . . . . 71.02 109.34 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.43 ' HD3' ' CD1' ' A' ' 166' ' ' PHE . 18.3 Cg_endo -75.03 152.98 41.27 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.51 1.795 . . . . 75.54 110.979 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.474 ' HB ' ' CE2' ' A' ' 193' ' ' PHE . 3.9 p -67.57 -25.16 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.481 1.113 . . . . 75.13 109.314 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -67.51 -8.07 49.8 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.505 1.128 . . . . 52.51 111.016 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.446 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 8.0 m-85 -120.08 15.57 12.4 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.5 0.765 . . . . 75.22 111.008 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.426 ' CG1' ' O ' ' A' ' 211' ' ' PHE . 17.7 m -154.3 144.49 13.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.497 1.123 . . . . 61.0 109.291 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 42.0 t -128.27 147.91 50.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.495 1.122 . . . . 70.11 110.018 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.472 HG13 ' CG2' ' A' ' 227' ' ' VAL . 23.0 mm -91.81 146.54 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.413 1.071 . . . . 63.31 109.258 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.466 HG21 ' CB ' ' A' ' 222' ' ' ALA . 2.7 pp -157.8 141.92 7.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.464 1.102 . . . . 71.15 109.291 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -55.75 -174.3 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.135 . . . . 74.45 109.325 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 10.3 pt -90.86 15.94 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.498 1.124 . . . . 71.12 109.335 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -64.28 -175.68 0.18 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.488 1.117 . . . . 72.34 109.272 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.613 ' CG2' ' CE2' ' A' ' 221' ' ' TYR . 2.9 t -49.43 -23.45 1.53 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.139 . . . . 65.54 110.4 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 135.39 59.92 0.06 OUTLIER Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.516 1.135 . . . . 71.14 110.967 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.613 ' CE2' ' CG2' ' A' ' 219' ' ' THR . 21.5 m-85 -139.75 170.51 15.75 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.538 0.787 . . . . 74.3 111.006 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.466 ' CB ' HG21 ' A' ' 215' ' ' ILE . . . -124.69 148.96 47.7 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.451 1.094 . . . . 73.13 109.306 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.445 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 11.5 p -92.14 -36.05 13.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.476 1.11 . . . . 71.24 110.376 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 137.88 -11.8 3.65 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.5 1.125 . . . . 73.21 111.036 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.445 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 2.6 p30 -51.74 179.86 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.518 0.775 . . . . 74.43 109.353 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -118.74 172.48 7.48 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.484 1.115 . . . . 72.31 109.223 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.472 ' CG2' HG13 ' A' ' 214' ' ' ILE . 11.1 p -83.18 -40.49 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.459 1.099 . . . . 74.41 109.28 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 3.6 mp -55.14 -43.84 72.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.547 1.154 . . . . 72.23 109.28 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -66.04 -35.12 79.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.517 1.135 . . . . 72.32 110.311 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.01 -21.43 46.97 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.515 1.135 . . . . 75.54 109.355 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 227' ' ' VAL . 21.6 mt -69.14 -36.74 74.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.485 1.116 . . . . 71.34 109.33 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -78.03 -28.67 49.08 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.553 1.158 . . . . 72.53 109.314 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.3 m -56.14 -40.14 73.35 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.459 1.1 . . . . 71.03 110.003 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.428 ' C ' ' N ' ' A' ' 236' ' ' LEU . 7.2 p -111.65 21.29 5.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.521 1.138 . . . . 75.42 109.235 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 40.85 29.67 0.08 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.439 1.087 . . . . 75.44 109.251 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.428 ' N ' ' C ' ' A' ' 234' ' ' VAL . 38.7 tp -44.25 110.24 0.97 Allowed Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 73.22 109.3 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.07 140.88 25.79 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.589 1.836 . . . . 70.53 111.011 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 5.8 p -57.52 150.08 19.73 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.503 1.127 . . . . 73.42 110.367 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.468 ' HB ' ' CG1' ' A' ' 194' ' ' ILE . 0.9 OUTLIER -47.26 -25.6 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.474 1.109 . . . . 73.3 109.351 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -83.51 -49.63 9.06 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 72.34 110.319 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -56.94 -28.86 62.6 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.566 1.166 . . . . 74.13 110.361 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -78.13 -70.58 0.48 Allowed 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.478 1.111 . . . . 65.31 108.067 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.1 ptmm? -41.8 -33.75 0.55 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.435 1.084 . . . . 75.12 109.348 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 27.0 t -61.4 -59.0 5.93 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.476 1.11 . . . . 74.3 110.032 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -50.37 -38.31 41.8 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.465 1.103 . . . . 70.23 109.325 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 7.1 mm -57.43 119.12 2.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.521 1.138 . . . . 71.42 109.27 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -154.1 179.04 9.31 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.502 1.126 . . . . 72.15 109.29 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . 0.41 ' NE ' ' O ' ' A' ' 248' ' ' ARG . 0.0 OUTLIER -52.69 -49.59 65.0 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.52 1.138 . . . . 70.43 110.292 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -84.8 104.84 15.12 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.522 1.139 . . . . 75.14 111.011 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 17.3 mtmm -115.58 163.91 15.1 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.432 1.083 . . . . 64.15 109.273 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -154.29 140.37 18.4 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.506 1.129 . . . . 64.33 109.351 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 48.3 t -161.04 161.27 31.33 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.448 1.093 . . . . 65.14 109.983 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -169.47 126.79 0.92 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.474 1.109 . . . . 74.12 109.301 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 2.5 tp -127.64 126.52 67.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.493 1.12 . . . . 64.3 109.288 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 45.7 p -106.54 147.89 28.88 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.521 1.138 . . . . 75.45 109.941 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 8.0 tp -155.71 125.86 6.64 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.489 1.118 . . . . 75.13 109.265 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -115.07 150.29 18.74 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.469 1.106 . . . . 74.54 110.974 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 51.4 p -144.77 148.32 33.95 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.492 0.76 . . . . 73.22 109.933 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 59.3 t -102.56 123.7 56.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.459 1.099 . . . . 74.22 109.311 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.553 1.158 . . . . 74.32 110.329 -179.993 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.939 0 N-CA-C 111.073 -0.811 . . . . 74.15 111.073 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 170.36 20.59 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.498 1.788 . . . . 71.01 111.021 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.3 mp -83.31 -85.61 0.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.499 1.124 . . . . 73.21 109.254 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.29 -7.0 82.87 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.531 1.145 . . . . 70.11 110.977 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.4 m -139.24 127.64 22.87 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.528 0.781 . . . . 74.31 109.98 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.435 ' C ' ' CD1' ' A' ' 159' ' ' TYR . 33.9 tp -117.0 161.67 19.01 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.556 1.16 . . . . 74.03 109.283 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.435 ' CD1' ' C ' ' A' ' 158' ' ' LEU . 3.0 m-85 -136.43 136.55 39.62 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.519 1.137 . . . . 74.21 111.004 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -125.92 136.76 53.4 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.419 1.074 . . . . 73.23 109.316 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.409 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.0 OUTLIER -99.09 126.69 52.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.568 1.168 . . . . 72.31 109.303 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.465 HG21 ' CG2' ' A' ' 176' ' ' THR . 2.1 t -81.99 125.89 39.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.472 1.107 . . . . 73.53 109.292 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.426 ' C ' ' CD1' ' A' ' 164' ' ' TYR . 0.5 OUTLIER -93.08 -28.04 16.59 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 70.0 109.316 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.426 ' CD1' ' C ' ' A' ' 163' ' ' LEU . 2.1 m-85 -128.07 -171.93 2.57 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.513 1.133 . . . . 74.5 110.973 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.457 ' N ' HG12 ' A' ' 178' ' ' VAL . 12.3 t0 -111.27 139.56 46.57 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.516 1.135 . . . . 74.24 109.363 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.58 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 4.8 t80 -113.11 132.31 55.48 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 75.14 111.024 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -99.97 101.59 12.73 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.517 1.136 . . . . 71.03 109.312 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.421 ' HB1' ' N ' ' A' ' 175' ' ' THR . . . -55.16 119.21 5.16 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.503 1.127 . . . . 73.54 109.232 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -115.63 -36.84 4.12 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.419 1.074 . . . . 65.2 110.341 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -74.82 152.81 38.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.453 1.096 . . . . 75.41 109.323 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.34 -28.78 67.15 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.523 1.139 . . . . 74.0 109.332 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -109.45 28.35 8.62 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.53 1.144 . . . . 72.11 109.361 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.475 ' HG3' ' CE2' ' A' ' 166' ' ' PHE . 5.6 tp10 -100.61 148.02 25.31 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.463 1.102 . . . . 73.42 110.247 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.7 mt -121.24 141.99 50.35 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 74.51 109.306 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.499 ' O ' ' CD1' ' A' ' 198' ' ' ILE . 3.3 m -84.86 155.01 21.92 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.534 1.146 . . . . 63.23 110.421 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.47 ' C ' ' CD1' ' A' ' 177' ' ' TYR . 2.4 m -142.12 -175.04 4.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.474 1.109 . . . . 74.12 110.415 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.47 ' CD1' ' C ' ' A' ' 176' ' ' THR . 13.0 m-85 -139.87 158.33 44.25 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.534 1.146 . . . . 73.4 111.047 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.0 OUTLIER -67.72 153.64 8.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.49 1.119 . . . . 73.54 109.354 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 37.2 56.71 1.43 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.547 1.155 . . . . 73.14 110.983 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -120.71 172.33 7.95 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.523 0.778 . . . . 75.0 110.261 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -111.28 119.78 40.04 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.473 1.108 . . . . 74.53 109.319 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.7 tp -135.88 159.75 40.7 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.422 1.076 . . . . 74.24 109.283 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 0.4 OUTLIER -122.76 124.78 44.12 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.46 1.1 . . . . 75.35 110.957 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 23.1 mm -77.54 132.8 31.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.557 1.161 . . . . 75.33 109.275 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 33.9 t -99.65 -27.91 13.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.443 1.089 . . . . 74.24 108.313 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.457 ' HA ' ' CD1' ' A' ' 236' ' ' LEU . . . -163.9 177.47 8.54 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.482 1.114 . . . . 45.13 109.268 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -143.54 156.76 44.7 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.431 1.082 . . . . 73.33 109.632 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.602 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 1.7 t-160 -131.92 116.4 17.11 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.567 1.167 . . . . 74.23 109.602 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 58.31 20.7 7.49 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.465 1.103 . . . . 64.41 109.327 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.442 ' HB3' ' CG1' ' A' ' 228' ' ' ILE . 42.5 m 55.79 19.87 3.73 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.438 1.086 . . . . 72.32 108.331 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -117.02 -32.86 4.91 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.48 1.112 . . . . 73.4 110.29 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -112.4 160.26 17.91 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.542 1.151 . . . . 75.41 107.999 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.56 ' CD2' HG22 ' A' ' 212' ' ' VAL . 16.1 m-85 -132.78 161.45 34.05 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.121 . . . . 72.4 110.94 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.458 HD12 ' CG2' ' A' ' 239' ' ' VAL . 35.5 mm -109.46 120.32 60.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.56 1.162 . . . . 73.13 109.37 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -96.93 122.85 40.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.12 . . . . 74.54 109.332 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.522 ' CB ' ' HD3' ' A' ' 197' ' ' PRO . 0.0 OUTLIER -87.59 -60.33 0.25 Allowed Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.536 1.148 . . . . 74.31 109.222 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.522 ' HD3' ' CB ' ' A' ' 196' ' ' LYS . 18.2 Cg_endo -75.03 173.36 14.65 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.516 1.798 . . . . 74.1 111.022 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.499 ' CD1' ' O ' ' A' ' 175' ' ' THR . 9.9 tp -175.18 160.5 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.537 1.148 . . . . 74.22 109.239 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.423 ' N ' HG13 ' A' ' 198' ' ' ILE . . . -82.09 8.64 59.97 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.467 1.104 . . . . 70.01 111.071 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.455 ' O ' ' CG2' ' A' ' 198' ' ' ILE . 12.0 tpt180 -151.47 126.69 9.9 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 0.764 . . . . 72.2 110.341 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 15.4 mt -40.27 98.22 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.455 1.097 . . . . 75.45 109.314 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 200' ' ' ARG . . . -165.95 -140.47 2.89 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.61 1.194 . . . . 74.34 110.982 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 54.43 175.47 0.1 OUTLIER Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.995 -0.842 . . . . 45.42 110.995 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.9 151.97 97.61 Favored 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 120.947 -2.522 . . . . 71.22 111.033 -0.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.93 -164.5 11.08 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.454 1.096 . . . . 71.51 110.995 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.449 HD22 ' CD1' ' A' ' 194' ' ' ILE . 1.3 mt -109.19 164.6 12.31 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.508 0.769 . . . . 73.23 109.318 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -155.24 137.46 9.95 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.428 1.08 . . . . 73.15 109.291 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.58 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.2 Cg_endo -75.03 144.32 30.0 Favored 'Trans proline' 0 C--N 1.362 1.243 0 O-C-N 124.44 1.758 . . . . 75.33 110.991 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.449 HG22 ' CZ ' ' A' ' 193' ' ' PHE . 12.6 p -73.41 -16.91 17.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.505 1.128 . . . . 75.01 109.333 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -77.37 2.35 62.47 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.525 1.141 . . . . 63.02 110.994 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.482 ' O ' ' CG1' ' A' ' 212' ' ' VAL . 20.4 m-85 -133.46 23.85 4.06 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.435 0.726 . . . . 74.24 110.99 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.56 HG22 ' CD2' ' A' ' 193' ' ' PHE . 33.1 m -156.94 148.49 10.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.534 1.146 . . . . 72.14 109.251 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.1 t -133.65 159.29 40.95 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.488 1.117 . . . . 61.4 109.98 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.435 ' CG2' ' CG ' ' A' ' 230' ' ' ASP . 24.2 mm -110.83 102.42 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 73.45 109.276 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.485 ' CD1' ' C ' ' A' ' 215' ' ' ILE . 0.8 OUTLIER -142.77 151.45 17.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.539 1.149 . . . . 74.43 109.321 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -79.85 111.57 16.29 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.531 1.144 . . . . 74.34 109.327 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 9.5 mm -51.78 -24.26 4.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 124.466 1.104 . . . . 74.53 109.257 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.26 99.14 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.433 1.083 . . . . 75.41 109.373 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 13.7 m -83.68 -71.99 0.48 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.513 1.133 . . . . 71.45 110.388 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 109.35 13.42 17.28 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.504 1.127 . . . . 73.44 111.043 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -139.58 -175.6 4.25 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 0.769 . . . . 72.5 111.0 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -118.17 137.8 52.73 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.532 1.145 . . . . 64.22 109.208 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 77.8 p -91.45 -16.2 27.68 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.518 1.136 . . . . 74.21 110.435 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.53 6.06 17.97 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.534 1.146 . . . . 70.35 110.995 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -79.43 -179.2 6.67 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.583 0.814 . . . . 73.43 109.291 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.86 179.98 4.78 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.466 1.104 . . . . 72.12 109.292 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.435 ' CG2' HG13 ' A' ' 214' ' ' ILE . 5.6 p -82.1 -32.42 10.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 74.43 109.296 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.442 ' CG1' ' HB3' ' A' ' 190' ' ' CYS . 3.0 mp -62.02 -51.36 73.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.41 1.068 . . . . 63.2 109.323 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -62.1 -19.06 62.58 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.46 1.1 . . . . 72.14 110.392 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.435 ' CG ' ' CG2' ' A' ' 214' ' ' ILE . 0.8 OUTLIER -88.89 -34.68 16.87 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.49 1.119 . . . . 63.44 109.263 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 19.5 mt -61.35 -26.39 39.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.534 1.146 . . . . 74.32 109.284 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -83.57 -11.49 57.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.448 1.092 . . . . 74.22 109.317 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.7 m -93.21 -5.49 49.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.517 1.136 . . . . 71.31 109.986 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.411 ' C ' ' N ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -130.8 7.54 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.429 1.081 . . . . 74.43 109.317 -179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 4.1 m120 44.44 26.99 0.2 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.463 1.102 . . . . 64.35 109.288 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.457 ' CD1' ' HA ' ' A' ' 186' ' ' ALA . 3.5 tp -55.8 113.53 5.86 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.497 1.123 . . . . 73.12 109.317 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 145.08 31.1 Favored 'Trans proline' 0 C--N 1.361 1.231 0 O-C-N 124.505 1.792 . . . . 72.14 111.034 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 3.9 p -57.42 161.12 3.62 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.434 1.083 . . . . 73.3 110.367 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.602 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.8 p -61.32 -24.37 33.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.459 1.1 . . . . 72.11 109.317 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.513 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 4.4 mm100 -80.85 -36.64 31.19 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.119 . . . . 72.42 110.31 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -75.4 -25.77 57.88 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.498 1.124 . . . . 70.42 110.291 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.545 ' CE2' ' CD1' ' A' ' 246' ' ' ILE . 8.1 t90 -82.99 -63.61 1.33 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.003 -1.11 . . . . 71.51 108.003 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -44.04 -30.79 0.78 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.477 1.111 . . . . 72.35 109.315 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 22.7 t -72.99 -48.16 38.89 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.474 1.109 . . . . 62.32 110.01 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.58 -37.38 65.43 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.508 1.13 . . . . 75.55 109.26 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.545 ' CD1' ' CE2' ' A' ' 242' ' ' TRP . 50.6 mt -62.77 118.35 4.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.485 1.116 . . . . 73.43 109.267 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -137.27 164.66 28.02 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.474 1.109 . . . . 54.25 109.31 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . 0.43 ' CD ' ' O ' ' A' ' 248' ' ' ARG . 0.0 OUTLIER -61.33 -34.11 74.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.505 1.128 . . . . 75.33 110.276 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.475 ' CD1' ' C ' ' A' ' 249' ' ' TYR . 6.7 p90 -174.78 159.17 2.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.478 1.111 . . . . 74.24 111.0 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -140.17 174.53 10.42 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 72.51 109.35 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.23 -68.01 0.6 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.526 1.141 . . . . 70.44 109.308 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 69.2 m -117.22 154.86 30.43 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.534 1.146 . . . . 62.32 110.032 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -174.63 -176.99 1.11 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.543 1.152 . . . . 75.15 109.282 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.479 ' CD1' ' C ' ' A' ' 254' ' ' ILE . 1.7 pp -130.11 176.34 8.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 75.21 109.276 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 47.5 t -163.85 132.82 3.83 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.501 1.126 . . . . 75.45 110.01 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 90.5 mt -104.47 87.29 2.68 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.446 1.091 . . . . 75.54 109.359 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -95.14 121.47 6.84 Favored Glycine 0 CA--C 1.531 1.073 0 O-C-N 124.544 1.152 . . . . 71.53 110.97 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.86 148.58 21.9 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 124.546 0.792 . . . . 70.14 110.031 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 54.8 t -102.44 134.6 42.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.546 1.153 . . . . 72.44 109.304 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.324 -0.504 0 O-C-N 124.45 1.094 . . . . 70.52 110.299 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.937 0 N-CA-C 111.021 -0.832 . . . . 61.45 111.021 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 145.92 32.25 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.5 1.789 . . . . 71.55 111.047 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.406 HD11 ' N ' ' A' ' 156' ' ' GLY . 3.0 pp -113.48 163.38 14.98 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.478 1.111 . . . . 70.11 109.234 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.406 ' N ' HD11 ' A' ' 155' ' ' LEU . . . 113.04 -21.01 18.84 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.523 1.139 . . . . 65.11 110.991 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.58 109.12 0.51 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.477 0.751 . . . . 73.52 110.039 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.468 ' CD2' HG12 ' A' ' 234' ' ' VAL . 0.2 OUTLIER -97.54 135.22 39.69 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.489 1.118 . . . . 54.42 109.277 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -105.97 126.55 52.32 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.439 1.087 . . . . 75.42 111.06 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -105.66 162.74 13.25 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 62.5 109.273 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.406 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.0 OUTLIER -130.62 127.51 62.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.471 1.107 . . . . 72.54 109.26 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.512 ' CG2' ' CD2' ' A' ' 182' ' ' LEU . 4.9 t -86.14 122.55 38.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.488 1.118 . . . . 64.03 109.318 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.477 ' O ' ' CG2' ' A' ' 178' ' ' VAL . 0.3 OUTLIER -107.07 -9.42 16.19 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.13 . . . . 75.33 109.273 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -135.13 145.1 47.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.542 1.151 . . . . 75.33 110.992 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -82.58 104.59 12.96 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.56 1.162 . . . . 75.32 109.331 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -85.99 122.75 30.48 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.513 1.133 . . . . 74.32 111.007 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.78 99.94 11.3 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.454 1.096 . . . . 75.05 109.287 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.424 ' HB2' ' CA ' ' A' ' 174' ' ' LEU . . . -47.68 125.45 8.56 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.435 1.084 . . . . 74.12 109.324 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -120.38 -40.68 2.66 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.496 1.122 . . . . 64.21 110.289 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.88 170.57 10.88 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.523 1.139 . . . . 73.21 109.275 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.66 -38.09 62.56 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.497 1.123 . . . . 63.41 109.299 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -100.07 27.45 5.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.477 1.111 . . . . 63.45 109.353 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.593 ' OE2' ' CH2' ' A' ' 192' ' ' TRP . 3.5 mm-40 -108.57 153.17 23.76 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 74.41 110.317 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.443 ' CG ' ' HA3' ' A' ' 205' ' ' GLY . 17.3 mt -125.77 159.94 31.07 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.468 1.105 . . . . 73.04 109.313 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 15.1 t -101.55 154.04 19.2 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.538 1.149 . . . . 64.21 110.439 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.3 m -138.25 -168.98 2.48 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.454 1.096 . . . . 74.02 110.366 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -138.82 134.33 33.23 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.522 1.139 . . . . 74.43 111.014 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 163' ' ' LEU . 1.6 p -58.09 146.65 7.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.41 1.069 . . . . 72.1 109.28 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 58.74 47.17 91.72 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.457 1.098 . . . . 62.53 110.971 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -121.9 172.37 8.24 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.488 0.758 . . . . 63.11 110.306 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.414 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.4 OUTLIER -123.25 137.57 54.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.446 1.092 . . . . 72.04 109.374 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.512 ' CD2' ' CG2' ' A' ' 162' ' ' VAL . 3.1 pp -158.74 168.19 27.51 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 71.13 109.25 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.598 ' CE1' ' O ' ' A' ' 184' ' ' ILE . 4.2 t80 -112.13 148.24 34.4 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.487 1.117 . . . . 63.31 110.997 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.598 ' O ' ' CE1' ' A' ' 183' ' ' PHE . 26.4 mm -90.51 134.12 30.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.394 1.059 . . . . 75.44 109.327 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 16.5 t -101.59 -26.02 13.68 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.483 1.114 . . . . 72.31 108.325 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -164.27 179.38 6.87 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.135 . . . . 74.14 109.306 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.674 ' CD2' ' CG2' ' A' ' 231' ' ' ILE . 9.5 p80 -138.3 148.71 44.93 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 75.01 109.566 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.437 ' ND1' ' C ' ' A' ' 188' ' ' HIS . 0.0 OUTLIER -122.17 114.48 20.92 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.507 1.129 . . . . 61.11 109.555 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.45 ' O ' ' SG ' ' A' ' 190' ' ' CYS . 2.4 m-20 55.8 27.42 10.83 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.541 1.151 . . . . 73.01 109.272 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 1.5 p 50.81 20.04 0.71 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.569 1.168 . . . . 72.33 108.303 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.438 ' N ' ' C ' ' A' ' 189' ' ' ASN . 1.3 pt-20 -125.0 -10.45 7.14 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.497 1.123 . . . . 71.21 110.335 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.593 ' CH2' ' OE2' ' A' ' 173' ' ' GLU . 6.8 m95 -130.68 166.58 20.42 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.961 -1.126 . . . . 75.25 107.961 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.563 ' CE2' ' HB ' ' A' ' 209' ' ' VAL . 31.3 m-85 -139.59 163.31 32.89 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.427 1.079 . . . . 73.43 110.994 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.468 ' CG1' ' HB ' ' A' ' 239' ' ' VAL . 30.0 mm -109.35 117.67 55.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.506 1.129 . . . . 74.11 109.283 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.43 145.29 28.42 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 74.11 109.336 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.22 162.66 34.51 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.534 1.146 . . . . 75.44 109.228 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 108.82 2.81 Favored 'Trans proline' 0 C--N 1.361 1.222 0 O-C-N 124.442 1.759 . . . . 75.35 111.03 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 7.6 tt -114.98 27.62 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.475 1.109 . . . . 74.22 109.287 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -165.11 -43.23 0.02 OUTLIER Glycine 0 CA--C 1.531 1.074 0 O-C-N 124.527 1.142 . . . . 75.14 110.985 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -137.63 127.26 25.2 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.571 0.807 . . . . 71.11 110.263 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 7.7 tt -40.61 138.0 1.04 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.521 1.138 . . . . 74.33 109.27 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 145.55 109.6 0.63 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.543 1.152 . . . . 70.45 110.957 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 166.93 175.77 37.34 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.04 -0.824 . . . . 65.25 111.04 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 170.47 71.76 Favored 'Cis proline' 0 C--N 1.359 1.101 0 C-N-CA 121.008 -2.497 . . . . 71.12 110.986 -0.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.443 ' HA3' ' CG ' ' A' ' 174' ' ' LEU . . . -134.9 167.06 24.17 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.502 1.126 . . . . 52.44 110.976 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.576 ' HB3' ' CE3' ' A' ' 192' ' ' TRP . 3.2 mt -108.68 155.32 20.85 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.483 0.755 . . . . 63.34 109.311 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.471 ' CG2' HG11 ' A' ' 212' ' ' VAL . 0.2 OUTLIER -156.42 118.28 2.21 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.57 1.169 . . . . 74.42 109.294 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.508 ' HD3' ' CZ3' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -75.04 137.94 22.28 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.544 1.813 . . . . 61.12 111.0 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.563 ' HB ' ' CE2' ' A' ' 193' ' ' PHE . 13.3 p -58.26 -17.32 9.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.516 1.135 . . . . 73.23 109.314 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -71.44 -3.87 55.13 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 124.453 1.096 . . . . 72.1 111.047 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -128.73 2.39 5.45 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.405 0.709 . . . . 71.44 111.063 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.471 HG11 ' CG2' ' A' ' 207' ' ' VAL . 14.8 m -143.34 163.88 16.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.439 1.087 . . . . 75.2 109.246 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' SER . . . . . 0.408 ' N ' HD12 ' A' ' 163' ' ' LEU . 1.4 t -144.87 160.61 41.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.133 . . . . 72.31 109.981 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.466 HG13 ' CG2' ' A' ' 227' ' ' VAL . 28.1 mm -109.23 138.24 37.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.464 1.103 . . . . 75.34 109.349 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.73 167.26 3.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.514 1.134 . . . . 72.44 109.269 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -87.71 -57.82 2.8 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.571 1.169 . . . . 72.32 109.285 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 22.9 mm -87.72 153.27 3.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.479 1.112 . . . . 74.24 109.292 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -79.94 55.48 2.12 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.493 1.121 . . . . 73.3 109.293 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.5 p -126.9 -177.11 3.91 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.51 1.131 . . . . 72.45 110.388 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -91.13 20.62 38.99 Favored Glycine 0 CA--C 1.529 0.925 0 O-C-N 124.487 1.117 . . . . 73.34 111.024 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -106.17 -179.66 4.0 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.409 0.711 . . . . 73.14 110.978 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -141.42 149.79 41.49 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.443 1.09 . . . . 73.14 109.332 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 69.1 p -91.65 -21.38 20.82 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.546 1.154 . . . . 75.44 110.462 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 105.42 0.53 40.53 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.578 1.174 . . . . 72.12 111.014 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.537 ' N ' HD21 ' A' ' 225' ' ' ASN . 1.2 m-80 -74.97 -176.15 2.83 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.541 0.789 . . . . 75.3 109.345 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.22 158.57 38.67 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.493 1.121 . . . . 70.21 109.285 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.472 HG23 ' CZ ' ' A' ' 193' ' ' PHE . 8.6 p -77.46 -34.86 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.504 1.127 . . . . 74.2 109.334 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.44 ' CD1' ' N ' ' A' ' 228' ' ' ILE . 1.1 mp -52.1 -47.6 43.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 124.502 1.126 . . . . 72.14 109.227 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 233' ' ' SER . 7.0 mt-10 -66.75 -35.32 79.83 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.573 1.17 . . . . 73.01 110.268 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.24 -27.8 65.78 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.565 1.166 . . . . 70.24 109.309 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.674 ' CG2' ' CD2' ' A' ' 187' ' ' HIS . 26.8 mt -74.49 -40.96 49.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.387 1.054 . . . . 74.13 109.261 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 26.4 mmtt -83.77 -19.98 34.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.389 1.055 . . . . 71.14 109.296 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 229' ' ' GLU . 8.7 m -60.59 -23.35 64.61 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.489 1.118 . . . . 72.2 110.027 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.468 HG12 ' CD2' ' A' ' 158' ' ' LEU . 6.3 p -126.39 21.81 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.549 1.156 . . . . 70.54 109.29 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 53.0 t30 47.36 28.46 1.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.532 1.145 . . . . 73.3 109.301 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 10.4 tp -58.45 112.15 4.55 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.135 . . . . 74.14 109.307 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 149.34 36.66 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.493 1.786 . . . . 74.03 111.012 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' THR . . . . . 0.465 ' CG2' ' CE1' ' A' ' 187' ' ' HIS . 2.3 p -57.15 149.54 19.37 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.522 1.139 . . . . 75.44 110.342 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.468 ' HB ' ' CG1' ' A' ' 194' ' ' ILE . 0.4 OUTLIER -41.18 -31.02 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.109 . . . . 64.32 109.337 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.444 ' O ' ' CB ' ' A' ' 244' ' ' SER . 58.4 mm-40 -81.37 -49.34 10.79 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.455 1.097 . . . . 73.02 110.296 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -59.09 -21.84 59.84 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.449 1.093 . . . . 74.33 110.287 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.422 ' O ' ' N ' ' A' ' 246' ' ' ILE . 4.2 t90 -83.33 -71.17 0.51 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.507 1.129 . . . . 72.33 108.008 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.9 -24.51 1.5 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.455 1.097 . . . . 74.01 109.246 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 240' ' ' GLN . 43.9 t -77.4 -39.86 45.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.557 1.16 . . . . 70.24 110.004 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 242' ' ' TRP . 4.0 t-20 -92.18 -71.19 0.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.46 1.1 . . . . 65.31 109.264 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.422 ' N ' ' O ' ' A' ' 242' ' ' TRP . 14.1 mt 64.47 97.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.591 1.182 . . . . 72.2 109.269 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -122.92 5.13 9.36 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.566 1.166 . . . . 72.44 109.332 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -40.26 -45.42 2.08 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.474 1.109 . . . . 75.42 110.282 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -132.79 145.88 51.37 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.541 1.15 . . . . 63.42 110.981 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 252' ' ' SER . 0.0 OUTLIER -73.41 -64.24 1.03 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.39 1.056 . . . . 72.43 109.316 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -66.95 76.48 0.12 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.466 1.103 . . . . 74.32 109.332 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 250' ' ' LYS . 45.8 m -108.72 -72.74 0.71 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.52 1.137 . . . . 74.03 110.007 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -49.98 -26.76 4.56 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.567 1.167 . . . . 60.02 109.329 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 1.7 pp -127.5 165.22 26.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.492 1.12 . . . . 73.41 109.259 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 5.6 m 52.84 34.65 16.97 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 74.43 109.981 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -44.35 155.6 0.09 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.493 1.121 . . . . 75.43 109.257 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -66.12 -103.11 0.02 OUTLIER Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.522 1.139 . . . . 73.55 110.984 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 54.2 m -69.42 158.0 35.99 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.487 0.757 . . . . 73.52 110.037 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.5 134.54 54.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.476 1.11 . . . . 63.33 109.312 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 . . . . . 0 C--N 1.325 -0.495 0 O-C-N 124.468 1.105 . . . . 75.21 110.239 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.031 0 N-CA-C 110.977 -0.849 . . . . 70.02 110.977 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.03 164.64 32.91 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.586 1.834 . . . . 74.24 110.966 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.1 mp -100.61 169.74 8.84 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.477 1.111 . . . . 74.33 109.294 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.78 -23.67 1.03 Allowed Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.41 1.069 . . . . 51.42 111.021 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.1 p -122.65 163.74 19.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.52 0.776 . . . . 75.23 110.022 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.427 HD12 ' CG1' ' A' ' 234' ' ' VAL . 9.0 mt -154.16 -175.75 5.54 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.119 . . . . 71.45 109.297 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -160.7 139.78 10.47 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.466 1.104 . . . . 74.2 111.039 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.467 ' HB1' ' CD1' ' A' ' 214' ' ' ILE . . . -132.85 162.28 31.96 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.467 1.105 . . . . 72.13 109.298 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.466 HG21 ' CD1' ' A' ' 215' ' ' ILE . 0.7 OUTLIER -127.95 121.16 55.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.478 1.111 . . . . 74.33 109.271 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.452 HG22 ' CD1' ' A' ' 182' ' ' LEU . 55.9 t -79.11 98.02 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 74.32 109.323 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.525 ' O ' ' CG ' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -92.05 35.08 0.99 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.576 1.172 . . . . 73.13 109.306 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.556 ' HB3' ' CD2' ' A' ' 211' ' ' PHE . 18.2 m-85 -170.98 133.4 0.9 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.469 1.106 . . . . 75.23 111.014 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.13 102.99 3.16 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.524 1.14 . . . . 73.11 109.3 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.6 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 7.3 t80 -80.35 153.04 28.61 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.488 1.118 . . . . 74.4 110.937 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.6 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 11.4 mmmm -112.04 135.21 52.97 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.55 1.156 . . . . 74.25 109.297 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.475 ' CB ' ' OE1' ' A' ' 173' ' ' GLU . . . -84.25 123.81 30.53 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.484 1.115 . . . . 52.05 109.278 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -126.4 -30.62 2.85 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.544 1.153 . . . . 75.32 110.328 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.483 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 3.7 tttt -59.03 -173.72 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.594 1.184 . . . . 71.23 109.293 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.5 -27.82 17.99 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.523 1.139 . . . . 72.13 109.319 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.54 28.75 6.49 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.517 1.135 . . . . 74.33 109.354 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -71.13 -176.4 1.42 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.448 1.092 . . . . 72.12 110.271 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.428 ' CB ' ' HA3' ' A' ' 205' ' ' GLY . 1.6 tp -157.62 113.94 2.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 71.0 109.285 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 2.0 t -68.95 145.29 53.75 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.562 1.164 . . . . 73.04 110.394 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.7 m -129.25 -169.5 2.11 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.103 . . . . 70.32 110.405 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.418 ' O ' ' CG ' ' A' ' 180' ' ' GLU . 29.3 m-85 -138.4 133.73 33.23 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.438 1.087 . . . . 75.45 111.011 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' ' 177' ' ' TYR . 0.2 OUTLIER -39.41 156.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.515 1.134 . . . . 75.45 109.354 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 51.02 48.37 46.12 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.441 1.088 . . . . 64.33 110.991 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.452 ' HB3' ' CD1' ' A' ' 182' ' ' LEU . 7.6 mm-40 -107.36 151.49 25.43 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.53 0.782 . . . . 71.33 110.202 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.486 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.3 OUTLIER -108.27 127.28 53.71 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.56 1.162 . . . . 71.55 109.282 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.452 ' CD1' HG22 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -158.81 168.7 26.12 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.477 1.11 . . . . 64.21 109.311 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 184' ' ' ILE . 2.0 t80 -114.2 144.34 43.35 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.589 1.18 . . . . 75.15 111.002 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.493 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 9.3 mm -77.68 100.74 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.503 1.127 . . . . 70.05 109.308 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.426 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 1.3 t -73.6 -28.9 62.06 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.475 1.11 . . . . 75.25 108.246 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.414 ' HB2' ' N ' ' A' ' 239' ' ' VAL . . . -174.36 170.85 3.53 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.539 1.15 . . . . 65.34 109.352 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.411 ' NE2' HG21 ' A' ' 231' ' ' ILE . 6.4 p80 -129.16 149.51 50.94 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.559 1.162 . . . . 75.24 109.629 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.526 ' CE1' ' CD ' ' A' ' 240' ' ' GLN . 2.3 t-160 -124.54 114.94 20.08 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.441 1.088 . . . . 72.23 109.591 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.451 ' C ' ' N ' ' A' ' 191' ' ' GLU . 2.3 m120 53.85 32.8 15.75 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.491 1.12 . . . . 73.14 109.301 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 12.7 p 42.96 28.23 0.13 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 73.44 108.314 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.451 ' N ' ' C ' ' A' ' 189' ' ' ASN . 5.0 pt-20 -121.57 -34.79 3.36 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.465 1.103 . . . . 74.4 110.331 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.47 ' CE3' ' HB3' ' A' ' 206' ' ' LEU . 7.8 m0 -118.04 165.56 13.59 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.534 1.146 . . . . 75.42 107.945 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.47 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 20.3 m-85 -143.53 157.4 44.46 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 73.23 111.002 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.426 ' CG2' ' HB3' ' A' ' 185' ' ' CYS . 31.3 mm -95.62 101.93 12.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.497 1.123 . . . . 72.25 109.317 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.449 ' HB1' ' CG2' ' A' ' 207' ' ' VAL . . . -84.82 168.4 15.15 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.521 1.138 . . . . 63.03 109.245 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -140.54 162.11 51.05 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 63.42 109.262 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 176.24 10.16 Favored 'Trans proline' 0 C--N 1.361 1.203 0 O-C-N 124.473 1.775 . . . . 75.14 110.934 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 9.4 tt -91.97 -48.11 13.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.577 1.173 . . . . 75.41 109.24 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -169.19 46.99 0.22 Allowed Glycine 0 CA--C 1.529 0.934 0 O-C-N 124.474 1.108 . . . . 43.22 111.003 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -138.53 129.38 26.64 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.419 0.717 . . . . 75.41 110.271 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.4 tt -48.91 112.14 0.57 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.397 1.061 . . . . 71.04 109.306 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 160.89 -171.63 37.02 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.481 1.113 . . . . 73.35 111.035 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.01 -179.57 13.45 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 110.958 -0.857 . . . . 74.35 110.958 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.05 -178.72 24.31 Favored 'Cis proline' 0 C--N 1.36 1.153 0 C-N-CA 121.073 -2.47 . . . . 75.33 111.034 0.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 174' ' ' LEU . . . -133.8 172.38 21.67 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 124.475 1.11 . . . . 74.2 111.047 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.6 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 2.7 mt -106.41 129.6 54.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 0.754 . . . . 73.03 109.283 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.527 HG11 ' CG ' ' A' ' 166' ' ' PHE . 0.2 OUTLIER -135.88 145.82 54.36 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.471 1.107 . . . . 75.42 109.308 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.564 ' HD3' ' CD1' ' A' ' 166' ' ' PHE . 18.2 Cg_endo -75.03 157.68 42.49 Favored 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.515 1.797 . . . . 64.34 110.977 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.2 p -76.23 -20.27 15.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 124.416 1.072 . . . . 75.23 109.338 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -84.5 5.99 78.9 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.534 1.146 . . . . 50.01 110.977 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.556 ' CD2' ' HB3' ' A' ' 164' ' ' TYR . 11.5 m-85 -130.17 12.21 5.56 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.507 0.769 . . . . 72.51 111.023 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.4 m -149.4 148.04 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 75.32 109.309 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 10.6 t -126.87 147.43 50.06 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.514 1.134 . . . . 72.42 110.037 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.467 ' CD1' ' HB1' ' A' ' 160' ' ' ALA . 22.2 mm -94.12 133.66 34.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.557 1.161 . . . . 74.05 109.351 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.466 ' CD1' HG21 ' A' ' 161' ' ' ILE . 9.6 pt -155.02 115.56 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.442 1.089 . . . . 74.55 109.273 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.03 38.12 4.15 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.494 1.121 . . . . 70.21 109.255 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 2.2 pt -107.8 21.52 4.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 124.438 1.086 . . . . 75.32 109.245 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 49.89 44.29 25.21 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 71.15 109.358 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.1 t -161.35 179.7 8.09 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.592 1.182 . . . . 71.52 110.405 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -103.9 47.26 1.11 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.514 1.134 . . . . 52.11 110.994 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -139.08 177.18 8.08 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.501 0.765 . . . . 72.33 111.031 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -135.5 141.77 45.36 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.531 1.144 . . . . 73.35 109.236 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.441 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 11.5 p -88.97 -37.63 15.08 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.537 1.148 . . . . 71.41 110.423 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 145.26 -18.47 1.9 Allowed Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.472 1.107 . . . . 63.4 111.021 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.441 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 2.3 p30 -47.8 172.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.449 0.735 . . . . 74.41 109.324 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.67 165.31 18.13 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.531 1.144 . . . . 72.54 109.269 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.47 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 12.3 p -75.55 -44.94 40.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.466 1.104 . . . . 74.41 109.267 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 1.7 mp -49.42 -54.47 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.42 1.075 . . . . 75.14 109.324 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.11 -28.67 69.26 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.554 1.159 . . . . 72.11 110.293 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.11 -14.96 58.09 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.475 1.109 . . . . 73.24 109.307 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.411 HG21 ' NE2' ' A' ' 187' ' ' HIS . 38.3 mt -83.87 -30.45 7.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.534 1.146 . . . . 72.54 109.267 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -82.97 -20.72 34.64 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.507 1.129 . . . . 74.34 109.332 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 36.8 m -66.41 -39.17 88.83 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.566 1.166 . . . . 72.12 110.004 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.427 ' CG1' HD12 ' A' ' 158' ' ' LEU . 4.2 p -114.82 15.56 8.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.518 1.136 . . . . 72.25 109.326 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 41.41 29.4 0.1 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.496 1.123 . . . . 72.03 109.337 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.423 ' N ' ' C ' ' A' ' 234' ' ' VAL . 6.1 tp -41.37 121.01 2.04 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.524 1.14 . . . . 71.42 109.293 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 135.65 19.28 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.559 1.82 . . . . 73.12 111.002 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 2.3 p -57.97 152.36 16.48 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.508 1.13 . . . . 63.42 110.395 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.414 ' N ' ' HB2' ' A' ' 186' ' ' ALA . 1.3 p -51.2 -22.9 2.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.544 1.153 . . . . 65.03 109.322 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.526 ' CD ' ' CE1' ' A' ' 188' ' ' HIS . 8.8 mm100 -86.63 -45.54 10.92 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.465 1.103 . . . . 74.45 110.366 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -63.86 -25.52 68.2 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.465 1.103 . . . . 74.0 110.29 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.567 ' CD1' HD12 ' A' ' 246' ' ' ILE . 11.2 t90 -77.43 -65.87 0.9 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.553 1.158 . . . . 74.5 107.968 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -52.08 -25.36 8.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 1.13 . . . . 70.11 109.26 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 43.9 t -76.89 -50.37 13.48 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.552 1.158 . . . . 71.34 110.009 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -51.97 -39.33 59.15 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.496 1.122 . . . . 73.25 109.331 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.567 HD12 ' CD1' ' A' ' 242' ' ' TRP . 13.2 mt -72.22 158.12 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.477 1.111 . . . . 64.42 109.279 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 246' ' ' ILE . . . 78.3 8.96 2.2 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.466 1.104 . . . . 74.5 109.282 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -125.63 -176.62 3.65 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.429 1.08 . . . . 74.23 110.264 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.425 ' O ' ' C ' ' A' ' 250' ' ' LYS . 4.3 t80 -36.57 -63.37 0.41 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 75.41 111.014 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 249' ' ' TYR . 7.3 ttpp -38.77 -66.81 0.25 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.534 1.146 . . . . 74.2 109.294 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -47.12 171.35 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.484 1.115 . . . . 63.35 109.331 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 3.9 m -39.96 132.43 1.8 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.484 1.115 . . . . 71.13 110.022 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -57.03 109.22 0.61 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.475 1.109 . . . . 74.45 109.323 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 34.2 mt -117.67 149.79 19.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.484 1.115 . . . . 74.03 109.329 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.9 p -44.22 133.01 5.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.474 1.109 . . . . 74.43 110.024 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.67 162.92 26.73 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.522 1.139 . . . . 73.34 109.266 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -164.67 146.06 10.94 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.474 1.109 . . . . 34.14 111.024 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 9.0 t -88.11 128.25 35.42 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.533 0.784 . . . . 72.33 110.01 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.9 t -136.94 141.97 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.461 1.101 . . . . 73.23 109.306 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 . . . . . 0 C--N 1.324 -0.519 0 O-C-N 124.481 1.113 . . . . 64.11 110.314 -179.991 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.989 0 N-CA-C 111.002 -0.839 . . . . 71.51 111.002 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 155.72 42.79 Favored 'Trans proline' 0 C--N 1.361 1.204 0 O-C-N 124.528 1.804 . . . . 70.21 110.964 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 12.5 mt -64.82 148.02 52.1 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 75.1 109.293 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 163.51 48.62 0.02 OUTLIER Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.484 1.115 . . . . 71.51 111.02 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.2 m -166.29 105.58 0.65 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.46 0.741 . . . . 63.1 110.013 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.467 ' CD2' HG13 ' A' ' 234' ' ' VAL . 1.6 mm? -110.25 129.55 55.71 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.518 1.136 . . . . 72.04 109.274 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -138.52 122.71 18.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.485 1.116 . . . . 74.5 111.02 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -103.87 174.52 5.83 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.495 1.122 . . . . 74.44 109.299 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.462 HG22 ' CD1' ' A' ' 215' ' ' ILE . 0.0 OUTLIER -135.98 128.79 46.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.442 1.089 . . . . 74.12 109.251 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.45 ' CG2' HG22 ' A' ' 176' ' ' THR . 80.9 t -88.95 122.61 40.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.511 1.132 . . . . 74.11 109.252 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.8 2.73 23.79 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.469 1.105 . . . . 73.05 109.278 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -153.96 131.59 11.44 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.446 1.091 . . . . 74.21 110.999 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -63.45 104.82 0.67 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.537 1.148 . . . . 74.34 109.261 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.578 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 7.3 t80 -80.42 139.46 36.48 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.556 1.16 . . . . 74.42 110.963 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.489 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 26.7 mmmt -98.31 141.92 30.6 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.128 . . . . 75.23 109.298 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.492 ' CB ' ' OE1' ' A' ' 173' ' ' GLU . . . -92.02 123.39 35.34 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.422 1.076 . . . . 72.33 109.313 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -125.61 -29.35 3.18 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.527 1.142 . . . . 72.24 110.297 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.443 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 3.9 tttp -59.15 -173.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.566 1.166 . . . . 74.03 109.332 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.19 -31.07 17.2 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.43 1.081 . . . . 72.31 109.332 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.91 27.93 7.04 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.51 1.131 . . . . 73.43 109.312 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.492 ' OE1' ' CB ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -67.97 -176.24 0.66 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.478 1.111 . . . . 61.24 110.302 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.466 ' CG ' ' HA3' ' A' ' 205' ' ' GLY . 12.3 mt -151.85 132.36 13.86 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.467 1.104 . . . . 74.55 109.269 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 12.4 t -78.96 127.88 32.57 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.543 1.152 . . . . 74.02 110.426 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.45 HG22 ' CG2' ' A' ' 162' ' ' VAL . 2.5 m -106.47 -172.67 2.13 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.444 1.09 . . . . 63.02 110.374 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.4 ' O ' ' CB ' ' A' ' 180' ' ' GLU . 52.0 m-85 -143.86 133.56 23.72 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.509 1.131 . . . . 74.35 110.972 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.435 ' CG2' ' N ' ' A' ' 179' ' ' GLY . 1.3 p -51.84 161.37 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.468 1.105 . . . . 75.01 109.249 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 37.56 51.47 1.86 Allowed Glycine 0 CA--C 1.531 1.057 0 O-C-N 124.533 1.146 . . . . 75.14 111.005 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 177' ' ' TYR . 20.3 tt0 -121.85 167.59 12.84 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.555 0.797 . . . . 74.15 110.288 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.444 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.4 OUTLIER -119.58 120.99 38.32 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.508 1.13 . . . . 71.01 109.302 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.02 156.9 47.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.417 1.073 . . . . 45.33 109.319 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -102.77 129.24 49.36 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.474 1.109 . . . . 73.33 111.035 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 25.1 mm -77.65 121.32 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 73.23 109.298 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -88.66 -26.77 21.68 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.557 1.161 . . . . 74.41 108.299 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -171.8 176.94 3.48 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.461 1.101 . . . . 74.45 109.272 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.555 ' CE1' HG23 ' A' ' 231' ' ' ILE . 8.3 p80 -137.27 151.89 49.19 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.495 1.122 . . . . 75.34 109.565 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.638 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.3 t-160 -124.61 114.72 19.74 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.129 . . . . 74.43 109.566 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.449 ' C ' ' N ' ' A' ' 191' ' ' GLU . 2.7 t30 54.18 33.21 17.51 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.484 1.115 . . . . 70.3 109.283 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.417 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 12.8 p 43.06 28.43 0.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.595 1.185 . . . . 75.54 108.237 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.449 ' N ' ' C ' ' A' ' 189' ' ' ASN . 5.3 pt-20 -122.17 -34.88 3.24 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.539 1.149 . . . . 72.31 110.257 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.438 ' CD1' ' HG3' ' A' ' 191' ' ' GLU . 11.9 m0 -116.32 164.73 14.09 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.572 1.17 . . . . 74.34 108.005 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.531 ' CE2' ' HB ' ' A' ' 209' ' ' VAL . 16.6 m-85 -135.5 159.66 40.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.509 1.131 . . . . 72.4 111.002 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.469 ' CD1' HD23 ' A' ' 206' ' ' LEU . 20.2 mm -103.49 119.57 52.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.508 1.13 . . . . 73.11 109.303 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.405 ' CB ' HG11 ' A' ' 207' ' ' VAL . . . -100.77 175.98 5.45 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.489 1.118 . . . . 73.04 109.307 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -151.07 156.05 35.17 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.524 1.14 . . . . 73.45 109.305 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.402 ' HG3' ' CA ' ' A' ' 202' ' ' GLY . 18.2 Cg_endo -74.94 161.29 39.16 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.536 1.808 . . . . 74.02 111.048 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.8 tp -136.25 114.21 14.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 124.505 1.128 . . . . 74.31 109.287 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 95.13 -17.38 59.43 Favored Glycine 0 CA--C 1.529 0.943 0 O-C-N 124.461 1.101 . . . . 74.13 111.006 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.588 ' NH2' ' H ' ' A' ' 201' ' ' LEU . 0.0 OUTLIER -133.25 154.86 50.3 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.467 0.745 . . . . 74.43 110.289 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.588 ' H ' ' NH2' ' A' ' 200' ' ' ARG . 0.6 OUTLIER -85.02 128.19 34.53 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 74.44 109.3 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.402 ' CA ' ' HG3' ' A' ' 197' ' ' PRO . . . -175.23 -140.74 3.45 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.55 1.156 . . . . 73.24 111.02 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 52.6 -178.13 0.1 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.995 -0.842 . . . . 72.21 110.995 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.99 153.3 99.09 Favored 'Cis proline' 0 C--N 1.36 1.174 0 C-N-CA 121.033 -2.486 . . . . 62.12 110.97 0.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.466 ' HA3' ' CG ' ' A' ' 174' ' ' LEU . . . -117.25 178.33 17.03 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.503 1.127 . . . . 72.11 110.963 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.469 HD23 ' CD1' ' A' ' 194' ' ' ILE . 1.3 mt -118.88 165.19 14.36 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.437 0.728 . . . . 73.43 109.334 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.459 ' CG2' HG11 ' A' ' 212' ' ' VAL . 0.2 OUTLIER -162.66 129.96 2.6 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.443 1.089 . . . . 74.33 109.317 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.578 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.4 Cg_endo -74.9 137.58 22.14 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.488 1.783 . . . . 74.02 110.991 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.531 ' HB ' ' CE2' ' A' ' 193' ' ' PHE . 7.3 p -67.14 -27.16 38.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.515 1.134 . . . . 72.55 109.251 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -68.81 -13.36 66.11 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.538 1.149 . . . . 74.52 111.017 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 7.8 m-30 -113.11 3.16 15.96 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.486 0.757 . . . . 71.31 111.007 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.468 ' CG2' ' HA ' ' A' ' 209' ' ' VAL . 15.0 m -140.08 173.78 9.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.541 1.15 . . . . 74.42 109.319 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.9 t -152.09 160.76 43.35 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.519 1.137 . . . . 72.23 109.995 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.466 HG13 ' CG2' ' A' ' 227' ' ' VAL . 19.1 mm -104.05 96.59 4.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.55 1.156 . . . . 63.32 109.314 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.462 ' CD1' HG22 ' A' ' 161' ' ' ILE . 1.2 pt -137.29 -174.2 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.504 1.128 . . . . 74.34 109.353 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -123.45 153.46 40.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.527 1.142 . . . . 70.03 109.332 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 5.4 mm -67.8 -23.65 29.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.51 1.131 . . . . 73.13 109.299 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -70.62 -56.02 7.44 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.49 1.119 . . . . 75.11 109.254 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.453 HG23 ' CG2' ' A' ' 223' ' ' THR . 3.5 m -62.63 -70.41 0.2 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.545 1.153 . . . . 71.34 110.452 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.52 -17.54 53.06 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.435 1.084 . . . . 71.51 111.04 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.403 ' CD1' HG21 ' A' ' 219' ' ' THR . 24.1 p90 -132.88 -176.51 4.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.489 0.758 . . . . 71.25 111.004 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -94.58 119.86 33.91 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.508 1.13 . . . . 65.45 109.3 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.453 ' CG2' HG23 ' A' ' 219' ' ' THR . 12.6 p -82.95 -27.19 30.7 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.517 1.136 . . . . 74.34 110.424 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 139.65 -19.06 2.99 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.54 1.15 . . . . 71.2 111.052 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.425 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 2.2 p30 -50.08 176.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.465 0.744 . . . . 72.34 109.263 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -134.63 157.76 45.79 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.494 1.121 . . . . 65.5 109.312 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.466 ' CG2' HG13 ' A' ' 214' ' ' ILE . 2.5 p -77.67 -34.49 20.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.493 1.121 . . . . 73.25 109.298 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.21 -44.87 92.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 124.531 1.145 . . . . 75.43 109.284 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.95 -45.81 90.69 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.551 1.157 . . . . 75.34 110.291 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -67.97 -26.0 65.72 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.396 1.06 . . . . 72.23 109.33 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.555 HG23 ' CE1' ' A' ' 187' ' ' HIS . 16.8 mt -67.69 -41.56 85.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.507 1.129 . . . . 75.22 109.332 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -83.94 -20.16 33.43 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.558 1.161 . . . . 75.13 109.237 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 41.9 m -61.07 -25.73 67.15 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.49 1.119 . . . . 73.23 110.005 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.467 HG13 ' CD2' ' A' ' 158' ' ' LEU . 7.5 p -126.39 20.73 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.424 1.077 . . . . 72.31 109.351 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 40.55 30.12 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.504 1.128 . . . . 74.23 109.33 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 234' ' ' VAL . 12.7 tp -46.88 120.31 6.25 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.426 1.079 . . . . 75.52 109.277 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.93 131.05 13.92 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.486 1.782 . . . . 72.12 110.99 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 2.7 p -57.04 157.07 6.18 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.107 . . . . 74.35 110.418 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.638 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.1 p -46.29 -27.11 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.477 1.111 . . . . 74.31 109.272 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.402 ' NE2' ' HD3' ' A' ' 243' ' ' LYS . 37.6 mm-40 -86.77 -47.02 9.45 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.514 1.134 . . . . 75.33 110.39 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -61.4 -20.47 63.09 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.409 1.068 . . . . 71.44 110.308 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.442 ' C ' ' N ' ' A' ' 244' ' ' SER . 13.9 t90 -88.12 -65.51 1.01 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.958 -1.127 . . . . 75.44 107.958 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.402 ' HD3' ' NE2' ' A' ' 240' ' ' GLN . 2.9 ptmm? -41.79 -28.87 0.17 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.514 1.134 . . . . 72.53 109.333 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.442 ' N ' ' C ' ' A' ' 242' ' ' TRP . 1.2 t -73.36 -65.83 0.76 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.453 1.096 . . . . 72.34 109.994 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 246' ' ' ILE . 4.7 t-20 -45.04 -38.92 5.26 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.563 1.165 . . . . 65.22 109.346 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.407 ' C ' ' O ' ' A' ' 245' ' ' ASN . 31.3 mt -40.03 -60.18 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.533 1.146 . . . . 74.1 109.332 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 248' ' ' ARG . . . -153.49 -56.77 0.12 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.561 1.163 . . . . 61.43 109.272 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 247' ' ' ALA . 4.2 mmm180 -39.01 155.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 74.23 110.276 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 54.22 56.97 6.32 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.521 1.138 . . . . 74.54 110.982 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.84 116.93 2.59 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.532 1.145 . . . . 74.25 109.313 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.11 144.43 52.08 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.526 1.141 . . . . 74.33 109.293 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 90.6 p -71.36 175.67 5.24 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.558 1.161 . . . . 54.51 110.007 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -99.49 -174.42 2.72 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.564 1.165 . . . . 64.02 109.315 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 2.7 tp 43.16 38.26 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.459 1.099 . . . . 75.34 109.265 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 63.4 p -106.75 177.19 4.93 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.527 1.142 . . . . 72.4 110.061 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 57.1 tp -48.36 121.09 4.09 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.459 1.099 . . . . 70.11 109.308 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 131.19 86.85 0.39 Allowed Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.52 1.137 . . . . 64.54 111.065 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.7 m -57.1 -61.33 2.54 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.463 0.743 . . . . 71.24 110.02 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 24.3 t -54.2 111.0 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.493 1.121 . . . . 74.31 109.324 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 . . . . . 0 C--N 1.325 -0.476 0 O-C-N 124.433 1.083 . . . . 73.05 110.198 -179.925 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.046 0 N-CA-C 111.04 -0.824 . . . . 73.21 111.04 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 84.76 1.61 Allowed 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.548 1.814 . . . . 75.32 111.034 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -54.6 158.75 2.4 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.499 1.125 . . . . 74.04 109.281 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 138.65 -14.63 3.39 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.556 1.16 . . . . 72.23 110.964 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 32.4 t -154.95 138.08 15.62 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.551 0.794 . . . . 70.54 110.027 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.584 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -97.9 120.2 37.88 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.488 1.117 . . . . 73.15 109.236 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.418 ' N ' HD12 ' A' ' 158' ' ' LEU . 26.7 m-85 -120.01 141.87 49.32 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 74.0 110.993 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.401 ' O ' ' O ' ' A' ' 182' ' ' LEU . . . -140.14 143.21 36.06 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.419 1.075 . . . . 75.45 109.393 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.494 ' CG1' ' O ' ' A' ' 180' ' ' GLU . 0.8 OUTLIER -121.65 136.0 59.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.463 1.102 . . . . 75.52 109.313 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.501 ' CG1' ' O ' ' A' ' 211' ' ' PHE . 2.5 t -85.58 127.36 40.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.546 1.154 . . . . 72.11 109.313 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.8 -17.06 20.48 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.563 1.164 . . . . 72.35 109.338 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.422 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 42.9 m-85 -137.94 148.46 45.28 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.502 1.127 . . . . 74.23 111.039 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.02 100.1 0.11 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.54 1.15 . . . . 73.01 109.299 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.559 ' CE2' ' O ' ' A' ' 174' ' ' LEU . 26.5 t80 -81.34 126.1 31.18 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.137 . . . . 75.41 111.009 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.39 129.63 55.53 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.539 1.149 . . . . 73.41 109.273 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.6 122.63 15.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.102 . . . . 64.43 109.332 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.447 ' CG ' ' N ' ' A' ' 170' ' ' LYS . 9.0 pt-20 -107.85 -43.73 4.39 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.543 1.152 . . . . 71.01 110.277 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.447 ' N ' ' CG ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -70.0 -176.07 1.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.137 . . . . 72.32 109.306 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.43 -19.01 30.26 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.515 1.135 . . . . 73.01 109.317 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -123.52 27.82 7.25 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.496 1.123 . . . . 55.23 109.327 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -91.88 155.88 17.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.453 1.096 . . . . 71.14 110.271 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.559 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 0.3 OUTLIER -112.45 159.97 18.23 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.484 1.115 . . . . 70.31 109.316 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 13.1 t -118.58 122.8 43.49 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.495 1.122 . . . . 74.11 110.423 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.428 ' CG2' HG23 ' A' ' 162' ' ' VAL . 2.2 m -114.61 -168.82 1.43 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.521 1.138 . . . . 74.1 110.47 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 177' ' ' TYR . 14.3 m-85 -134.44 143.6 47.65 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.404 1.065 . . . . 74.43 110.97 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 179' ' ' GLY . 0.3 OUTLIER -40.46 152.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.478 1.111 . . . . 72.25 109.321 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 36.93 64.87 0.61 Allowed Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.565 1.165 . . . . 64.34 110.999 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.494 ' O ' ' CG1' ' A' ' 161' ' ' ILE . 18.3 tt0 -121.72 148.58 44.43 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.48 0.753 . . . . 74.1 110.328 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.404 ' ND2' ' N ' ' A' ' 181' ' ' ASN . 0.2 OUTLIER -100.82 139.42 36.53 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.493 1.121 . . . . 71.32 109.301 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.457 HD21 ' CG2' ' A' ' 162' ' ' VAL . 4.5 pp -166.95 163.28 16.05 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.468 1.105 . . . . 65.34 109.272 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.584 ' CD2' ' O ' ' A' ' 158' ' ' LEU . 1.0 OUTLIER -115.29 134.13 55.4 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.479 1.112 . . . . 72.45 110.98 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.498 ' O ' ' CE1' ' A' ' 183' ' ' PHE . 36.9 mm -78.21 134.0 29.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.506 1.128 . . . . 72.41 109.242 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.495 ' O ' ' CD1' ' A' ' 236' ' ' LEU . 3.3 m -96.09 -35.0 11.51 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.517 1.136 . . . . 71.41 108.297 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.432 ' HB2' ' N ' ' A' ' 239' ' ' VAL . . . -154.0 179.79 8.58 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.471 1.107 . . . . 73.12 109.28 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.565 ' CE1' HG22 ' A' ' 231' ' ' ILE . 12.7 p80 -147.38 138.53 23.73 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.464 1.102 . . . . 74.13 109.566 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.552 ' NE2' ' CG ' ' A' ' 240' ' ' GLN . 2.6 t-80 -114.21 116.42 29.02 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.485 1.116 . . . . 74.45 109.572 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.422 ' C ' ' N ' ' A' ' 191' ' ' GLU . 37.7 m-20 55.69 26.69 9.64 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.483 1.114 . . . . 62.12 109.276 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.436 ' HB3' ' CD1' ' A' ' 228' ' ' ILE . 3.6 m 49.83 22.8 0.9 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.51 1.131 . . . . 74.51 108.353 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.508 ' HG3' ' CD1' ' A' ' 192' ' ' TRP . 5.1 pt-20 -116.81 -32.49 5.1 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.375 1.047 . . . . 73.31 110.335 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.508 ' CD1' ' HG3' ' A' ' 191' ' ' GLU . 19.2 m0 -117.08 159.34 22.71 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.468 1.105 . . . . 72.42 108.027 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.66 ' CE2' ' CG2' ' A' ' 209' ' ' VAL . 43.7 m-85 -138.4 156.77 47.28 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 71.13 111.004 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 194' ' ' ILE . 0.5 OUTLIER -102.35 107.18 21.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.461 1.101 . . . . 71.15 109.247 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.43 ' CB ' HG11 ' A' ' 207' ' ' VAL . . . -97.85 151.61 20.04 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.476 1.11 . . . . 74.34 109.298 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.455 ' CD ' ' HB3' ' A' ' 204' ' ' PRO . 8.8 mtpp -145.32 103.94 4.35 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.525 1.14 . . . . 72.04 109.261 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 198' ' ' ILE . 18.3 Cg_endo -75.0 166.48 29.12 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.454 1.765 . . . . 73.5 110.934 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 197' ' ' PRO . 44.7 pt -40.05 154.29 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.521 1.138 . . . . 74.0 109.294 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 40.16 -121.1 1.61 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.495 1.122 . . . . 70.42 110.993 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -148.92 115.62 5.95 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.53 0.782 . . . . 74.15 110.286 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 4.0 pp -141.7 16.07 2.15 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.522 1.139 . . . . 70.51 109.252 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 155.05 -52.83 0.44 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.51 1.131 . . . . 74.11 110.978 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.494 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . -48.28 156.76 1.07 Allowed Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.001 -0.84 . . . . 71.34 111.001 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.494 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.5 Cg_endo -74.99 134.74 37.3 Favored 'Cis proline' 0 C--N 1.359 1.113 0 C-N-CA 121.003 -2.499 . . . . 73.42 111.049 -0.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.422 ' HA3' ' CD2' ' A' ' 174' ' ' LEU . . . -126.86 158.22 20.78 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.431 1.082 . . . . 60.33 111.045 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.474 ' CD2' HD13 ' A' ' 194' ' ' ILE . 4.6 mt -81.07 147.55 30.07 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.546 0.792 . . . . 75.34 109.318 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.442 HG21 ' CG1' ' A' ' 212' ' ' VAL . 0.2 OUTLIER -146.36 125.39 6.53 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.531 1.144 . . . . 72.3 109.286 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.492 ' CD ' ' CE1' ' A' ' 166' ' ' PHE . 18.5 Cg_endo -74.96 147.51 34.22 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.524 1.802 . . . . 74.05 110.997 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.66 ' CG2' ' CE2' ' A' ' 193' ' ' PHE . 3.5 t -63.83 -18.31 22.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.517 1.136 . . . . 73.32 109.265 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -74.07 -1.8 60.58 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.477 1.111 . . . . 70.42 111.08 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.501 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 30.2 m-85 -128.66 2.37 5.5 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.562 0.801 . . . . 70.02 110.961 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.442 ' CG1' HG21 ' A' ' 207' ' ' VAL . 35.4 m -148.95 154.41 9.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.578 1.174 . . . . 74.42 109.251 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 42.3 t -139.63 160.27 40.25 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.491 1.12 . . . . 71.25 110.043 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.484 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 8.4 mm -109.14 164.8 5.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.495 1.122 . . . . 62.25 109.267 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.484 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 0.2 OUTLIER -155.82 145.02 12.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.488 1.117 . . . . 75.13 109.264 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -75.87 70.45 2.62 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.462 1.101 . . . . 53.33 109.295 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 7.7 tt 41.54 44.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.492 1.12 . . . . 73.23 109.33 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -80.09 -175.86 5.23 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.457 1.098 . . . . 65.33 109.289 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.493 ' CG2' ' O ' ' A' ' 219' ' ' THR . 1.1 m -83.67 8.33 14.76 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.499 1.124 . . . . 71.24 110.367 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 129.61 -3.61 6.15 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 124.551 1.157 . . . . 71.1 111.008 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -106.7 176.32 5.21 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.44 0.729 . . . . 75.42 111.02 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -119.64 146.98 45.07 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.549 1.156 . . . . 73.34 109.3 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.441 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 11.0 p -91.61 -29.86 16.68 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.49 1.118 . . . . 74.31 110.468 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 141.93 -17.44 2.57 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.5 1.125 . . . . 63.41 111.021 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.441 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 1.5 p30 -51.02 174.23 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 0.746 . . . . 71.11 109.341 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.77 172.96 7.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 71.43 109.296 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.564 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 12.3 p -78.94 -30.9 14.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.133 . . . . 74.51 109.291 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.436 ' CD1' ' HB3' ' A' ' 190' ' ' CYS . 1.4 mp -60.82 -46.49 96.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 64.15 109.339 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.73 -43.02 99.89 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.558 1.162 . . . . 75.11 110.304 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.98 -34.32 77.83 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.554 1.159 . . . . 64.43 109.282 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.565 HG22 ' CE1' ' A' ' 187' ' ' HIS . 38.8 mt -63.25 -46.22 96.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.141 . . . . 74.32 109.309 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -76.56 -15.73 59.78 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.499 1.125 . . . . 75.13 109.315 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.0 p -69.55 -40.03 77.06 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.429 1.081 . . . . 72.31 110.029 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.42 ' CG1' HD21 ' A' ' 158' ' ' LEU . 11.3 p -109.4 14.03 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.511 1.132 . . . . 70.25 109.333 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 234' ' ' VAL . 7.5 t-20 40.35 43.1 1.39 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 71.42 109.287 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.495 ' CD1' ' O ' ' A' ' 185' ' ' CYS . 3.3 tp -66.79 132.2 93.98 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.462 1.101 . . . . 71.01 109.284 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.03 156.43 42.85 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.478 1.778 . . . . 75.21 110.997 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' THR . . . . . 0.401 ' C ' ' N ' ' A' ' 240' ' ' GLN . 4.2 p -77.98 148.41 34.44 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.492 1.12 . . . . 75.42 110.336 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.45 ' CG1' ' CD2' ' A' ' 188' ' ' HIS . 2.5 p -49.68 -23.57 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.45 1.093 . . . . 73.32 109.266 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.552 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 75.6 mm-40 -83.98 -41.71 17.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.476 1.11 . . . . 74.22 110.257 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -70.49 -23.16 62.63 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.432 1.082 . . . . 75.33 110.33 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -78.52 -59.99 2.56 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.501 1.125 . . . . 74.44 108.013 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.437 ' HA ' ' CG1' ' A' ' 246' ' ' ILE . 7.0 ptmm? -59.62 -17.44 33.48 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.116 . . . . 64.02 109.27 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.5 t -77.99 -26.51 48.69 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.59 1.181 . . . . 65.12 109.947 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -94.67 -26.06 16.48 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.48 1.113 . . . . 73.31 109.25 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.437 ' CG1' ' HA ' ' A' ' 243' ' ' LYS . 14.2 mm -40.68 -82.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.51 1.131 . . . . 74.44 109.351 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -130.67 7.23 4.8 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.539 1.149 . . . . 75.53 109.336 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 250' ' ' LYS . 0.2 OUTLIER -101.6 -153.6 0.46 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.439 1.087 . . . . 74.24 110.29 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -47.14 94.85 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.481 1.113 . . . . 73.43 111.022 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 248' ' ' ARG . 0.0 OUTLIER -76.56 104.3 6.99 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.542 1.151 . . . . 75.14 109.268 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.22 124.7 20.32 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.492 1.12 . . . . 52.21 109.353 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 3.6 t -57.54 113.45 1.8 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.502 1.126 . . . . 75.32 109.956 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -171.15 170.14 6.21 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.47 1.106 . . . . 70.23 109.276 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.476 ' CG2' ' O ' ' A' ' 254' ' ' ILE . 6.5 tt -60.22 94.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.492 1.12 . . . . 71.44 109.25 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.72 135.81 35.13 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.562 1.164 . . . . 73.13 109.99 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 12.2 tp -95.03 -27.49 15.59 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.474 1.109 . . . . 74.14 109.327 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 106.17 -145.89 16.0 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.48 1.113 . . . . 72.23 110.972 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 7.6 t -163.25 134.83 4.95 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.547 0.793 . . . . 72.31 110.012 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.4 p -93.12 -176.3 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.439 1.087 . . . . 74.31 109.282 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.451 1.094 . . . . 74.41 110.256 -179.986 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 N-CA-C 111.023 -0.831 . . . . 73.21 111.023 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 112.91 3.67 Favored 'Trans proline' 0 C--N 1.361 1.203 0 O-C-N 124.528 1.804 . . . . 71.43 111.017 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 7.0 mt -48.15 121.75 4.59 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.536 1.147 . . . . 71.14 109.411 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -160.02 49.72 0.38 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.539 1.15 . . . . 62.3 111.026 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.2 p -174.22 161.69 3.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.511 0.771 . . . . 72.34 110.076 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.401 ' O ' ' CG ' ' A' ' 159' ' ' TYR . 9.2 mt -148.46 -171.08 3.76 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.549 1.155 . . . . 75.22 109.317 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.401 ' CG ' ' O ' ' A' ' 158' ' ' LEU . 25.0 m-85 -163.7 118.4 1.58 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.48 1.113 . . . . 75.34 110.975 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.402 ' O ' ' O ' ' A' ' 182' ' ' LEU . . . -106.25 167.35 9.88 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.505 1.128 . . . . 65.12 109.361 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.49 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -137.48 129.24 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.44 1.087 . . . . 73.11 109.317 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.534 ' CG2' ' CD2' ' A' ' 182' ' ' LEU . 2.7 t -81.72 117.73 28.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.538 1.149 . . . . 75.3 109.273 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.431 HD13 ' CB ' ' A' ' 213' ' ' SER . 0.2 OUTLIER -96.18 -3.86 43.61 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.545 1.153 . . . . 73.53 109.268 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.489 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 53.4 m-85 -153.6 153.88 33.17 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.472 1.108 . . . . 72.44 110.968 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.423 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 11.0 t0 -83.47 103.58 12.94 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.433 1.083 . . . . 74.24 109.287 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.583 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 1.9 t80 -85.25 125.22 32.71 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.119 . . . . 73.11 111.0 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.87 115.79 29.64 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.455 1.097 . . . . 72.42 109.335 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -40.31 140.55 0.61 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.456 1.098 . . . . 64.31 109.342 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.467 ' CG ' ' N ' ' A' ' 170' ' ' LYS . 7.9 pt-20 -136.88 -45.28 0.58 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.427 1.079 . . . . 75.35 110.236 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.467 ' N ' ' CG ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -64.47 -170.7 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.506 1.129 . . . . 73.33 109.307 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.62 -33.25 20.21 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.432 1.083 . . . . 74.45 109.273 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.39 9.3 29.83 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.509 1.13 . . . . 73.5 109.254 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -75.43 159.89 30.86 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.524 1.14 . . . . 75.34 110.249 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.8 tp -138.33 159.6 41.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.457 1.098 . . . . 74.12 109.299 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.2 t -91.64 153.46 19.68 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.496 1.123 . . . . 74.13 110.389 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 3.3 m -139.19 -164.39 1.65 Allowed 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.514 1.134 . . . . 71.2 110.345 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -136.8 138.04 40.42 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.546 1.154 . . . . 75.11 110.972 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.463 ' CG2' ' N ' ' A' ' 179' ' ' GLY . 1.4 p -56.57 163.41 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.452 1.095 . . . . 73.53 109.285 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.463 ' N ' ' CG2' ' A' ' 178' ' ' VAL . . . 37.59 59.47 1.3 Allowed Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.474 1.109 . . . . 64.11 110.961 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.49 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 13.2 tp10 -121.4 166.9 13.43 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.557 0.798 . . . . 74.21 110.338 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -120.51 122.29 40.3 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.455 1.097 . . . . 74.31 109.352 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.534 ' CD2' ' CG2' ' A' ' 162' ' ' VAL . 0.6 OUTLIER -147.0 163.65 35.53 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.103 . . . . 74.54 109.362 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.591 ' CE1' ' O ' ' A' ' 184' ' ' ILE . 2.2 t80 -110.63 139.12 46.19 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.457 1.098 . . . . 75.2 111.023 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.591 ' O ' ' CE1' ' A' ' 183' ' ' PHE . 9.6 mm -77.7 120.92 29.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.471 1.107 . . . . 73.55 109.227 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 5.6 t -91.45 -24.42 19.7 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.432 1.082 . . . . 75.45 108.27 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.443 ' HA ' ' CD2' ' A' ' 236' ' ' LEU . . . -164.8 179.65 6.39 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.501 1.126 . . . . 75.02 109.253 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.568 ' CD2' HG23 ' A' ' 231' ' ' ILE . 9.3 p80 -149.38 129.86 13.91 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.466 1.104 . . . . 74.1 109.571 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.651 ' CD2' ' CB ' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -111.0 119.03 37.69 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.536 1.148 . . . . 72.51 109.633 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.433 ' C ' ' N ' ' A' ' 191' ' ' GLU . 3.5 m120 54.0 32.82 16.21 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.48 1.112 . . . . 71.25 109.325 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.411 ' SG ' ' CE1' ' A' ' 187' ' ' HIS . 49.9 m 42.1 29.04 0.12 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 74.21 108.3 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.575 ' HG3' ' CD1' ' A' ' 192' ' ' TRP . 6.4 pt-20 -120.94 -38.04 2.89 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.509 1.131 . . . . 74.13 110.312 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.651 ' CB ' ' CD2' ' A' ' 188' ' ' HIS . 27.7 m0 -116.87 164.42 14.7 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.126 . . . . 74.25 107.987 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.456 ' N ' ' O ' ' A' ' 207' ' ' VAL . 39.5 m-85 -141.94 168.93 18.58 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.542 1.151 . . . . 75.4 110.995 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.566 ' CD1' ' CD2' ' A' ' 206' ' ' LEU . 47.0 mm -103.55 109.07 25.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.544 1.153 . . . . 71.21 109.324 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.428 ' CB ' HG11 ' A' ' 207' ' ' VAL . . . -116.57 163.78 15.58 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.488 1.117 . . . . 72.13 109.321 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.76 78.71 0.24 Allowed Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.483 1.114 . . . . 75.43 109.267 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 -165.67 0.3 Allowed 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.499 1.789 . . . . 71.22 110.987 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 96.7 mt -90.1 89.82 3.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.47 1.106 . . . . 72.15 109.363 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -140.26 -62.82 0.04 OUTLIER Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.571 1.17 . . . . 73.25 111.036 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 9.5 ttt85 -126.28 172.4 10.13 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.536 0.786 . . . . 72.13 110.278 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.85 -19.2 32.76 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.482 1.114 . . . . 74.33 109.231 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -60.56 -152.48 0.02 OUTLIER Glycine 0 CA--C 1.529 0.935 0 O-C-N 124.537 1.148 . . . . 71.31 111.03 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 94.68 175.61 38.43 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.98 -0.848 . . . . 74.23 110.98 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.95 179.42 30.67 Favored 'Cis proline' 0 C--N 1.36 1.181 0 C-N-CA 121.02 -2.492 . . . . 73.22 110.983 0.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -129.64 161.62 22.85 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.531 1.145 . . . . 54.14 110.967 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.566 ' CD2' ' CD1' ' A' ' 194' ' ' ILE . 9.3 mt -92.91 149.14 21.45 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.514 0.773 . . . . 70.42 109.272 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.533 ' CG2' ' CG1' ' A' ' 212' ' ' VAL . 0.6 OUTLIER -148.5 122.6 4.81 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.123 . . . . 75.54 109.32 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.583 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.6 Cg_endo -74.91 149.87 37.79 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.502 1.791 . . . . 62.44 111.026 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.415 ' HB ' ' CE2' ' A' ' 193' ' ' PHE . 5.0 p -63.71 -20.88 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 73.44 109.293 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -74.57 -0.91 60.01 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.446 1.091 . . . . 75.13 110.956 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -129.8 3.32 4.93 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.491 0.759 . . . . 74.32 111.008 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.533 ' CG1' ' CG2' ' A' ' 207' ' ' VAL . 32.9 m -151.89 149.67 13.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 74.53 109.311 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' SER . . . . . 0.431 ' CB ' HD13 ' A' ' 163' ' ' LEU . 1.6 t -131.54 160.93 33.82 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.513 1.133 . . . . 75.52 109.966 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.468 HG13 ' CG2' ' A' ' 227' ' ' VAL . 32.1 mm -100.53 106.82 19.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.524 1.14 . . . . 75.35 109.295 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.419 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 11.0 pt -153.18 147.06 14.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.53 1.144 . . . . 75.32 109.275 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -61.32 -173.58 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.121 . . . . 60.02 109.235 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 41.2 mt -102.18 -39.96 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.563 1.164 . . . . 73.34 109.348 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -73.18 -173.82 1.41 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.464 1.102 . . . . 64.54 109.306 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 221' ' ' TYR . 25.8 m -47.91 -23.89 0.89 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.558 1.161 . . . . 75.41 110.432 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -53.17 88.75 0.01 OUTLIER Glycine 0 CA--C 1.531 1.075 0 O-C-N 124.446 1.091 . . . . 75.55 110.965 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.449 ' N ' ' O ' ' A' ' 219' ' ' THR . 2.8 m-85 -95.0 -171.17 2.36 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 124.604 0.826 . . . . 72.44 111.033 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 221' ' ' TYR . . . -40.41 111.45 0.2 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.45 1.093 . . . . 74.13 109.318 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 69.2 p -85.1 -16.99 38.71 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.458 1.099 . . . . 72.22 110.402 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 123.86 -18.03 7.6 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.64 1.212 . . . . 72.21 110.956 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -75.71 177.08 7.12 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.527 0.781 . . . . 72.32 109.288 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.15 -178.65 3.72 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.524 1.14 . . . . 75.41 109.332 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.468 ' CG2' HG13 ' A' ' 214' ' ' ILE . 3.0 p -79.02 -34.25 16.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.531 1.145 . . . . 71.24 109.336 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.1 mp -65.44 -56.85 13.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.483 1.114 . . . . 74.4 109.334 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -58.29 -21.43 48.89 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.489 1.118 . . . . 71.33 110.283 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -86.8 -34.96 19.38 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.426 1.079 . . . . 72.34 109.29 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.568 HG23 ' CD2' ' A' ' 187' ' ' HIS . 18.8 mt -64.81 -27.42 42.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.576 1.172 . . . . 74.11 109.338 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -83.99 -11.59 56.58 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.46 1.1 . . . . 74.31 109.318 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 68.5 m -95.12 -8.9 35.14 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.464 1.103 . . . . 70.21 110.019 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.13 5.98 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.465 1.103 . . . . 72.21 109.27 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.437 ' N ' ' OD1' ' A' ' 235' ' ' ASN . 0.6 OUTLIER 47.91 30.33 1.94 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.45 1.093 . . . . 72.14 109.275 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.443 ' CD2' ' HA ' ' A' ' 186' ' ' ALA . 0.7 OUTLIER -43.95 118.4 2.96 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.408 1.068 . . . . 71.43 109.261 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 135.57 19.16 Favored 'Trans proline' 0 C--N 1.361 1.211 0 O-C-N 124.453 1.765 . . . . 64.44 110.977 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' THR . . . . . 0.405 ' OG1' ' CG ' ' A' ' 241' ' ' GLU . 2.0 p -69.51 144.07 53.27 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.521 1.138 . . . . 74.43 110.376 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.548 HG13 ' CG ' ' A' ' 188' ' ' HIS . 7.6 p -51.0 -31.23 10.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.556 1.16 . . . . 70.31 109.298 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -76.76 -32.07 57.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.127 . . . . 63.33 110.305 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.405 ' CG ' ' OG1' ' A' ' 238' ' ' THR . 69.0 mt-10 -76.71 -30.01 56.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.517 1.136 . . . . 75.22 110.274 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.486 ' CD1' HD13 ' A' ' 246' ' ' ILE . 9.9 t90 -72.88 -54.89 7.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.499 1.124 . . . . 74.44 108.046 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.88 -29.02 69.29 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.547 1.154 . . . . 72.5 109.302 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 18.3 t -77.26 -41.25 41.72 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.563 1.164 . . . . 74.44 110.057 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -64.29 -31.86 73.23 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.529 1.143 . . . . 74.23 109.323 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.486 HD13 ' CD1' ' A' ' 242' ' ' TRP . 80.2 mt -71.45 -72.93 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.536 1.147 . . . . 74.42 109.264 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.454 ' O ' ' CB ' ' A' ' 248' ' ' ARG . . . -169.98 130.84 1.0 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.533 1.146 . . . . 65.01 109.258 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . 0.454 ' CB ' ' O ' ' A' ' 247' ' ' ALA . 0.8 OUTLIER 161.99 -167.74 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.45 1.094 . . . . 74.32 110.238 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 250' ' ' LYS . 0.3 OUTLIER -102.75 175.84 5.36 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.498 1.124 . . . . 71.42 111.054 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.576 ' N ' ' CD1' ' A' ' 249' ' ' TYR . 12.7 tttp -151.55 161.61 42.39 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.488 1.117 . . . . 70.45 109.267 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.451 ' N ' ' CG ' ' A' ' 250' ' ' LYS . . . -161.77 140.33 9.41 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.422 1.076 . . . . 74.54 109.279 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 1.4 t -81.84 157.78 24.28 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 61.41 110.049 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -169.36 143.25 2.83 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.454 1.096 . . . . 71.15 109.317 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 3.1 tp -113.54 104.85 17.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.496 1.122 . . . . 74.03 109.255 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.7 t -124.93 48.35 2.01 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.485 1.116 . . . . 74.22 109.972 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 7.1 tt -147.65 118.68 7.69 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.441 1.088 . . . . 73.14 109.31 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -128.03 -164.0 11.49 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.581 1.176 . . . . 65.11 110.99 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.5 t -65.13 114.79 4.89 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.452 0.736 . . . . 71.41 110.059 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.7 p -109.84 75.74 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.487 1.117 . . . . 71.34 109.264 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 . . . . . 0 C--N 1.326 -0.444 0 O-C-N 124.535 1.147 . . . . 61.41 110.362 179.908 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.995 0 N-CA-C 111.017 -0.833 . . . . 64.34 111.017 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.01 -91.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.499 1.789 . . . . 62.31 110.991 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.76 -174.01 2.55 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.443 1.089 . . . . 75.22 109.308 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 126.71 -8.18 7.32 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.498 1.124 . . . . 71.41 110.995 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 36.6 t -131.66 161.53 32.53 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.514 0.773 . . . . 71.14 109.955 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.2 mt -138.56 131.35 29.4 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.449 1.093 . . . . 74.52 109.332 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.411 ' CD2' ' CE2' ' A' ' 183' ' ' PHE . 1.7 t80 -121.47 122.82 40.59 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.475 1.11 . . . . 72.35 111.021 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -117.82 170.84 8.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.564 1.165 . . . . 73.54 109.318 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.407 ' N ' ' O ' ' A' ' 213' ' ' SER . 0.1 OUTLIER -142.29 126.69 16.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.479 1.112 . . . . 74.34 109.352 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.662 ' CG2' ' CE1' ' A' ' 211' ' ' PHE . 18.1 t -72.04 133.99 30.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.546 1.154 . . . . 74.42 109.28 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.9 0.33 14.39 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.441 1.088 . . . . 74.41 109.287 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.497 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 70.1 m-85 -144.66 147.02 32.57 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.581 1.175 . . . . 74.42 111.023 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -77.58 94.4 4.35 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.477 1.111 . . . . 73.43 109.298 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.502 ' CZ ' ' OE2' ' A' ' 173' ' ' GLU . 3.9 t80 -88.0 137.72 32.08 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.523 1.139 . . . . 74.54 110.97 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -119.85 103.38 9.3 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.469 1.106 . . . . 75.54 109.32 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -40.27 139.65 0.71 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.478 1.111 . . . . 52.23 109.278 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -123.73 -41.43 2.25 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.441 1.088 . . . . 71.4 110.236 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.32 -169.81 1.29 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.509 1.131 . . . . 74.33 109.304 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.29 -45.35 11.34 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.531 1.144 . . . . 65.25 109.279 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -94.43 26.59 3.33 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.455 1.097 . . . . 75.35 109.34 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.502 ' OE2' ' CZ ' ' A' ' 166' ' ' PHE . 2.9 mm-40 -96.82 140.88 30.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.473 1.108 . . . . 64.51 110.303 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.456 ' CD2' ' HA3' ' A' ' 205' ' ' GLY . 0.2 OUTLIER -102.53 160.07 14.88 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.545 1.153 . . . . 72.24 109.297 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.408 ' C ' ' OG1' ' A' ' 176' ' ' THR . 9.9 t -124.16 150.7 44.85 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.541 1.151 . . . . 61.43 110.426 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.408 ' OG1' ' C ' ' A' ' 175' ' ' THR . 11.6 m -157.34 -177.11 6.36 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.516 1.135 . . . . 72.43 110.366 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 177' ' ' TYR . 7.6 m-85 -121.03 156.7 31.62 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.46 1.1 . . . . 72.34 111.057 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.8 p -59.83 131.25 24.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.559 1.162 . . . . 72.52 109.28 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 71.76 59.21 4.89 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.465 1.103 . . . . 54.21 111.032 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 162' ' ' VAL . 5.4 tp10 -122.16 165.76 15.64 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.563 0.802 . . . . 73.54 110.281 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.447 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.7 OUTLIER -115.63 119.53 36.43 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 64.05 109.273 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.424 ' N ' HD13 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -152.35 158.63 42.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.533 1.146 . . . . 73.13 109.318 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.411 ' CE2' ' CD2' ' A' ' 159' ' ' TYR . 4.6 m-85 -107.04 170.64 7.83 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 73.2 110.996 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.451 ' CD1' ' HB3' ' A' ' 193' ' ' PHE . 32.5 mm -107.9 147.31 12.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.534 1.146 . . . . 74.44 109.241 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.404 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 0.1 OUTLIER -106.26 -19.46 13.69 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.535 1.147 . . . . 73.23 108.313 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.451 ' HA ' ' CD1' ' A' ' 236' ' ' LEU . . . 179.64 179.63 0.48 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.554 1.159 . . . . 71.14 109.309 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.561 ' CD2' HG23 ' A' ' 231' ' ' ILE . 6.2 p80 -137.39 152.98 50.23 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.549 1.156 . . . . 75.05 109.583 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.637 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 1.0 OUTLIER -129.45 112.8 14.15 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.463 1.102 . . . . 75.52 109.584 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 3.1 m120 57.97 21.24 7.52 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.436 1.085 . . . . 73.12 109.343 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 87.1 m 55.34 19.74 3.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 1.139 . . . . 71.42 108.336 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -115.94 -30.94 5.91 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.548 1.155 . . . . 62.25 110.299 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -116.25 158.99 22.49 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.959 -1.126 . . . . 74.4 107.959 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 12.8 m-85 -133.92 161.33 35.08 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.534 1.146 . . . . 65.3 110.96 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.421 ' HB ' ' N ' ' A' ' 186' ' ' ALA . 17.7 mm -105.56 85.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.486 1.116 . . . . 74.42 109.323 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.53 ' CB ' ' CG1' ' A' ' 207' ' ' VAL . . . -67.48 160.16 28.12 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.481 1.113 . . . . 72.51 109.345 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.38 152.54 3.33 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.558 1.161 . . . . 72.22 109.306 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -164.33 0.23 Allowed 'Trans proline' 0 C--N 1.359 1.103 0 O-C-N 124.479 1.779 . . . . 74.23 110.994 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.9 tp -110.39 -20.71 6.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.496 1.123 . . . . 72.32 109.275 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -167.54 47.76 0.24 Allowed Glycine 0 CA--C 1.529 0.931 0 O-C-N 124.455 1.097 . . . . 73.12 111.027 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.7 tpp85 -138.14 159.36 42.23 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.403 0.708 . . . . 72.31 110.295 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.498 ' C ' ' CD2' ' A' ' 201' ' ' LEU . 0.0 OUTLIER -91.57 17.44 8.73 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.525 1.14 . . . . 74.42 109.241 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -69.88 -51.16 25.63 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 124.531 1.145 . . . . 74.23 111.078 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -88.8 -179.54 46.04 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 111.019 -0.833 . . . . 74.43 111.019 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 172.31 63.61 Favored 'Cis proline' 0 C--N 1.36 1.171 0 C-N-CA 120.95 -2.521 . . . . 73.34 111.011 -0.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -157.59 156.35 27.22 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.471 1.107 . . . . 73.34 110.947 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.1 mt -83.94 134.02 34.68 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.524 0.779 . . . . 73.43 109.262 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.53 ' CG1' ' CB ' ' A' ' 195' ' ' ALA . 2.0 m -143.34 151.92 56.04 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.544 1.153 . . . . 74.23 109.313 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 159.5 41.15 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.488 1.783 . . . . 53.03 111.003 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 3.0 p -84.85 -20.51 8.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.517 1.136 . . . . 70.43 109.22 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -82.47 11.84 49.22 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.5 1.125 . . . . 73.12 110.994 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.684 ' CD2' ' CG1' ' A' ' 212' ' ' VAL . 0.0 OUTLIER -130.33 2.22 4.64 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.434 0.726 . . . . 73.02 110.943 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.684 ' CG1' ' CD2' ' A' ' 211' ' ' PHE . 14.3 m -137.8 145.8 28.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.456 1.098 . . . . 72.02 109.271 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' SER . . . . . 0.407 ' O ' ' N ' ' A' ' 161' ' ' ILE . 12.5 t -132.78 131.75 41.47 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 61.44 110.06 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.46 HG13 ' CG2' ' A' ' 227' ' ' VAL . 15.6 mm -83.77 149.73 4.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.113 . . . . 74.44 109.304 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.9 pt -154.2 116.69 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 74.43 109.302 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -48.17 172.9 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.493 1.121 . . . . 54.2 109.261 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 8.8 tp -71.24 109.4 3.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.512 1.132 . . . . 74.21 109.347 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -161.1 170.53 20.25 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.522 1.138 . . . . 74.34 109.343 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.427 ' CG2' ' CE2' ' A' ' 221' ' ' TYR . 1.7 t -55.16 -27.01 42.51 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 72.31 110.389 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 142.88 61.56 0.02 OUTLIER Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.531 1.144 . . . . 72.25 110.993 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.427 ' CE2' ' CG2' ' A' ' 219' ' ' THR . 17.3 m-85 -132.5 169.91 15.9 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 0.765 . . . . 74.54 110.992 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -117.15 129.4 55.93 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.51 1.131 . . . . 70.13 109.332 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 17.6 p -88.58 -34.3 17.38 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.454 1.096 . . . . 73.34 110.465 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 114.19 21.24 5.64 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.487 1.117 . . . . 63.21 110.957 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.487 ' N ' ' ND2' ' A' ' 225' ' ' ASN . 0.6 OUTLIER -84.16 171.95 12.36 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.488 0.758 . . . . 73.01 109.32 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.72 166.62 11.19 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.481 1.113 . . . . 75.23 109.335 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.498 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 11.2 p -78.92 -44.36 24.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.454 1.096 . . . . 73.25 109.278 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.3 mp -51.3 -53.25 16.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.607 1.192 . . . . 75.14 109.31 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -62.54 -32.76 73.76 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 64.44 110.275 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -73.91 -25.89 60.23 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.42 1.075 . . . . 71.01 109.255 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.561 HG23 ' CD2' ' A' ' 187' ' ' HIS . 42.0 mt -72.05 -34.79 51.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.519 1.137 . . . . 71.23 109.272 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -78.53 -29.84 46.69 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.466 1.104 . . . . 74.34 109.332 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.8 m -53.92 -40.78 67.0 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.472 1.108 . . . . 74.32 109.999 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.436 ' C ' ' N ' ' A' ' 236' ' ' LEU . 4.0 p -107.63 20.19 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.505 1.128 . . . . 74.43 109.287 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 41.94 28.86 0.1 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.532 1.145 . . . . 72.33 109.329 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.451 ' CD1' ' HA ' ' A' ' 186' ' ' ALA . 12.2 tp -47.16 115.53 3.56 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 75.43 109.281 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.01 147.15 33.51 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.551 1.816 . . . . 72.32 111.036 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 2.7 p -57.09 149.36 19.5 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.526 1.141 . . . . 73.35 110.411 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.637 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.4 p -48.78 -28.58 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.528 1.142 . . . . 75.44 109.291 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.404 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 76.6 mm-40 -80.17 -45.83 17.42 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.489 1.118 . . . . 71.54 110.311 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -58.46 -30.07 66.67 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.451 1.094 . . . . 75.14 110.285 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -76.91 -62.22 1.72 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.511 1.132 . . . . 71.15 108.003 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.38 -25.8 6.72 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 73.41 109.319 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 45.8 t -76.89 -36.47 56.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.444 1.09 . . . . 70.42 110.052 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -75.08 -31.92 61.35 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.469 1.105 . . . . 71.03 109.302 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 42.5 mt -45.16 110.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.431 1.082 . . . . 75.22 109.31 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -150.17 -177.02 5.69 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.463 1.102 . . . . 72.05 109.318 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . 0.507 ' O ' ' C ' ' A' ' 249' ' ' TYR . 1.4 tpt85 -160.78 166.07 29.26 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 74.53 110.292 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.507 ' C ' ' O ' ' A' ' 248' ' ' ARG . 5.9 m-85 -29.1 96.31 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.418 1.074 . . . . 73.24 111.008 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 248' ' ' ARG . 16.8 mtpp -134.41 115.35 13.9 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.463 1.102 . . . . 73.44 109.279 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.07 112.35 0.66 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.536 1.147 . . . . 72.23 109.311 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 88.4 p -153.68 162.87 40.86 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 74.41 110.029 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -130.39 112.01 12.86 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.488 1.118 . . . . 74.54 109.304 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -95.1 -35.95 6.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.409 1.068 . . . . 73.44 109.3 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 87.7 p -97.51 97.16 8.84 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.438 1.086 . . . . 74.35 109.998 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.88 122.73 47.81 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.541 1.151 . . . . 72.4 109.274 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 62.04 143.36 0.01 OUTLIER Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.451 1.095 . . . . 65.04 110.966 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 3.1 m -149.26 125.59 10.85 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.511 0.771 . . . . 64.2 109.945 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -174.74 167.33 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.452 1.095 . . . . 75.3 109.355 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 . . . . . 0 C--N 1.325 -0.488 0 O-C-N 124.469 1.106 . . . . 64.11 110.271 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.681 HD11 ' HB3' ' A' ' 230' ' ' ASP . 6.0 tp . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 109.301 -0.629 . . . . 72.109999999999999 109.301 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.581 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 0.6 OUTLIER -147.8 160.57 42.6 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.521 1.138 . . . . 74.329999999999998 111.023 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.51 ' HB2' ' CD1' ' A' ' 214' ' ' ILE . . . -132.14 175.59 9.12 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 64.310000000000002 109.345 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.496 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -137.41 129.72 42.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.473 1.108 . . . . 60.539999999999999 109.334 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 164' ' ' TYR . 4.1 t -80.86 121.07 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.474 1.109 . . . . 63.32 109.329 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.466 HD11 ' CB ' ' A' ' 213' ' ' SER . 0.7 OUTLIER -100.33 -6.36 25.97 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.534 1.146 . . . . 70.219999999999999 109.28 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.64 ' O ' HG12 ' A' ' 162' ' ' VAL . 88.9 m-85 -148.58 151.65 35.42 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.115 . . . . 73.219999999999999 111.033 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -78.84 112.16 15.72 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.533 1.145 . . . . 52.299999999999997 109.328 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.557 ' CZ ' ' HD3' ' A' ' 208' ' ' PRO . 11.6 t80 -83.27 152.67 25.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.532 1.145 . . . . 72.450000000000003 111.032 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -125.75 116.35 21.48 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.483 1.114 . . . . 75.219999999999999 109.292 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.15 121.42 12.47 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.556 1.16 . . . . 64.200000000000003 109.256 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 170' ' ' LYS . 9.9 pt-20 -110.63 -46.15 3.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.509 1.131 . . . . 73.319999999999993 110.309 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -63.42 179.51 0.44 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.534 1.146 . . . . 74.430000000000007 109.31 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.11 -15.18 41.96 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.551 1.157 . . . . 75.239999999999995 109.317 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.82 10.19 10.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.471 1.107 . . . . 73.400000000000006 109.378 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -77.63 151.34 34.39 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.508 1.13 . . . . 44.409999999999997 110.348 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.642 HD11 ' HA2' ' A' ' 203' ' ' GLY . 14.4 mt -120.75 145.74 47.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.449 1.093 . . . . 65.209999999999994 109.247 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.2 m -88.03 154.33 20.57 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.47 1.107 . . . . 43.420000000000002 110.396 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.69 HG22 ' H ' ' A' ' 177' ' ' TYR . 5.8 m -135.92 -174.57 3.7 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.555 1.159 . . . . 73.109999999999999 110.372 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.69 ' H ' HG22 ' A' ' 176' ' ' THR . 24.5 m-85 -134.13 138.43 45.22 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.461 1.101 . . . . 75.209999999999994 111.01 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 163' ' ' LEU . 1.5 p -55.25 158.32 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.438 1.086 . . . . 55.530000000000001 109.228 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 38.94 57.63 1.99 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.508 1.13 . . . . 42.219999999999999 111.01 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 15.0 tp10 -121.83 166.34 14.52 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.423 0.719 . . . . 53.340000000000003 110.287 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -118.58 130.22 55.77 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.438 1.086 . . . . 61.350000000000001 109.268 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.62 HD21 ' CG2' ' A' ' 162' ' ' VAL . 1.8 pp -157.0 -179.73 8.49 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 75.239999999999995 109.297 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -131.45 142.28 49.97 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.428 1.08 . . . . 62.509999999999998 111.024 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.766 HD12 ' HB3' ' A' ' 193' ' ' PHE . 23.3 mm -78.53 141.44 15.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.452 1.095 . . . . 75.340000000000003 109.337 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 3.4 t -103.49 -24.71 13.42 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.504 1.128 . . . . 64.510000000000005 108.294 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.853 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -170.11 179.53 3.5 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.505 1.128 . . . . 72.319999999999993 109.33 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 238' ' ' THR . 7.7 p80 -145.53 142.24 29.01 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 74.420000000000002 109.581 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.637 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.6 t-160 -123.72 120.66 33.34 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.475 1.109 . . . . 63.310000000000002 109.599 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.453 ' C ' ' N ' ' A' ' 191' ' ' GLU . 14.8 m-20 54.14 30.1 11.55 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.119 . . . . 75.540000000000006 109.256 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 11.9 p 43.51 28.29 0.19 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.502 1.126 . . . . 55.25 108.29 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.453 ' N ' ' C ' ' A' ' 189' ' ' ASN . 8.7 pt-20 -123.88 -36.76 2.68 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.491 1.119 . . . . 62.43 110.28 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.53 ' HZ3' HD13 ' A' ' 206' ' ' LEU . 9.0 m0 -110.55 158.52 18.45 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.443 1.089 . . . . 74.420000000000002 108.1 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.766 ' HB3' HD12 ' A' ' 184' ' ' ILE . 8.5 m-85 -131.12 148.49 52.73 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.502 1.126 . . . . 50.229999999999997 110.983 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.864 ' CD1' HD23 ' A' ' 206' ' ' LEU . 12.7 mm -96.34 88.89 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.495 1.122 . . . . 73.109999999999999 109.291 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.469 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -71.04 164.1 26.23 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.506 1.129 . . . . 71.209999999999994 109.315 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.586 1.179 . . . . 74.349999999999994 109.311 179.92 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.642 ' HA2' HD11 ' A' ' 174' ' ' LEU . . . . . . . . 0 CA--C 1.531 1.033 0 N-CA-C 110.949 -0.86 . . . . 61.399999999999999 110.949 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -178.65 24.09 Favored 'Cis proline' 0 C--N 1.361 1.201 0 C-N-CA 121.013 -2.495 . . . . 75.530000000000001 110.941 0.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -149.13 166.13 29.42 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 124.499 1.124 . . . . 62.340000000000003 110.977 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.864 HD23 ' CD1' ' A' ' 194' ' ' ILE . 6.6 mt -93.51 134.34 35.89 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.61 0.829 . . . . 75.049999999999997 109.253 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.469 HG11 ' HB2' ' A' ' 195' ' ' ALA . 1.8 m -139.1 153.9 71.86 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.537 1.148 . . . . 70.150000000000006 109.284 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.568 ' HG2' ' CD2' ' A' ' 211' ' ' PHE . 18.2 Cg_endo -74.98 155.33 43.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.526 1.803 . . . . 72.099999999999994 110.974 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.678 HG23 ' HE2' ' A' ' 193' ' ' PHE . 3.6 p -81.39 -33.66 12.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.409 1.068 . . . . 64.310000000000002 109.263 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -64.77 -11.03 48.26 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.5 1.125 . . . . 40.43 110.949 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.568 ' CD2' ' HG2' ' A' ' 208' ' ' PRO . 8.2 m-30 -109.89 19.74 18.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.493 0.76 . . . . 74.019999999999996 110.974 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.595 HG21 ' CD2' ' A' ' 193' ' ' PHE . 26.9 m -156.16 141.95 10.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.442 1.089 . . . . 73.010000000000005 109.275 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.466 ' CB ' HD11 ' A' ' 163' ' ' LEU . 1.0 OUTLIER -131.06 148.86 52.79 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.475 1.109 . . . . 73.109999999999999 110.017 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.758 HG13 HG23 ' A' ' 227' ' ' VAL . 12.1 mm -103.95 128.25 57.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.527 1.142 . . . . 75.430000000000007 109.346 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.429 ' O ' ' CE2' ' A' ' 159' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.11 . . . . 54.509999999999998 109.277 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 17.9 p . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 110.382 -0.229 . . . . 61.340000000000003 110.382 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 116.23 4.93 17.69 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 124.481 1.113 . . . . 65.340000000000003 110.928 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -78.19 -176.32 4.56 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.432 0.724 . . . . 61.32 109.292 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.1 169.88 14.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.554 1.159 . . . . 73.109999999999999 109.273 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.758 HG23 HG13 ' A' ' 214' ' ' ILE . 12.1 p -80.77 -35.28 14.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.474 1.109 . . . . 61.350000000000001 109.254 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.572 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.4 mp -54.16 -50.37 55.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.517 1.136 . . . . 61.100000000000001 109.301 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -59.55 -35.61 74.55 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 74.219999999999999 110.295 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.681 ' HB3' HD11 ' A' ' 158' ' ' LEU . 5.0 m-20 -78.1 -22.93 48.21 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.468 1.105 . . . . 75.019999999999996 109.299 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.745 HG23 ' HB3' ' A' ' 236' ' ' LEU . 35.5 mt -70.61 -36.8 67.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.585 1.178 . . . . 62.210000000000001 109.266 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.625 ' HE2' HG22 ' A' ' 231' ' ' ILE . 6.1 mmpt? -80.72 -13.98 58.52 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.572 1.17 . . . . 73.400000000000006 109.309 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.7 t -81.18 -44.39 17.91 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.526 1.141 . . . . 72.019999999999996 109.998 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.646 HG12 ' O ' ' A' ' 230' ' ' ASP . 7.7 p -99.17 24.25 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.494 1.121 . . . . 40.240000000000002 109.343 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 41.36 29.13 0.08 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.534 1.146 . . . . 73.310000000000002 109.338 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.745 ' HB3' HG23 ' A' ' 231' ' ' ILE . 1.1 tp -45.21 103.75 0.36 Allowed Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.106 . . . . 73.209999999999994 109.286 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 138.19 22.64 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.561 1.822 . . . . 62.25 111.049 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 7.4 p -57.01 148.88 20.27 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 72.409999999999997 110.411 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.637 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 3.5 p -53.99 -25.43 12.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.535 1.147 . . . . 63.219999999999999 109.323 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.547 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 3.8 mm100 -77.82 -34.36 51.99 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.407 1.067 . . . . 51.229999999999997 110.319 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -82.74 -20.87 35.11 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.553 1.158 . . . . 75.319999999999993 110.303 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -80.09 -53.25 6.88 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.516 1.135 . . . . 72.430000000000007 108.022 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -51.61 -28.17 13.42 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.527 1.142 . . . . 62.100000000000001 109.272 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.7 t -73.64 -35.2 65.26 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.451 1.094 . . . . 73.310000000000002 109.999 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 2.7 m120 . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.497 1.123 . . . . 74.219999999999999 109.281 -179.989 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.812 ' HG ' HG11 ' A' ' 234' ' ' VAL . 6.5 mt . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 109.301 -0.629 . . . . 64.329999999999998 109.301 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.43 ' CG ' ' C ' ' A' ' 158' ' ' LEU . 35.9 m-85 -154.65 116.73 4.22 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.466 1.104 . . . . 75.040000000000006 111.053 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.481 ' HB2' HD13 ' A' ' 214' ' ' ILE . . . -126.19 168.05 14.59 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.564 1.165 . . . . 51.149999999999999 109.382 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.543 HG21 HD11 ' A' ' 215' ' ' ILE . 0.1 OUTLIER -133.76 130.14 55.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.557 1.16 . . . . 74.010000000000005 109.385 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.843 HG23 HD11 ' A' ' 182' ' ' LEU . 39.7 t -89.66 111.22 22.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 53.200000000000003 109.304 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.64 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.2 OUTLIER -101.97 14.09 32.94 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.551 1.157 . . . . 52.030000000000001 109.287 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.57 ' HB3' ' CD2' ' A' ' 211' ' ' PHE . 63.5 m-85 -152.54 137.9 17.57 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.492 1.12 . . . . 73.049999999999997 111.031 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.417 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 25.8 t0 -80.16 107.96 13.37 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.482 1.114 . . . . 71.239999999999995 109.365 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.598 ' CE2' ' O ' ' A' ' 206' ' ' LEU . 17.1 t80 -80.33 136.58 36.43 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.517 1.136 . . . . 62.509999999999998 111.082 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.26 95.31 6.44 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.502 1.126 . . . . 62.439999999999998 109.316 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.777 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -57.86 133.4 55.4 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.563 1.164 . . . . 60.229999999999997 109.276 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -119.84 -38.63 2.94 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.523 1.139 . . . . 64.019999999999996 110.301 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.1 -177.96 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.517 1.135 . . . . 44.140000000000001 109.291 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.21 -29.95 22.78 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.459 1.099 . . . . 72.209999999999994 109.337 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.73 -11.62 28.76 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.423 1.077 . . . . 61.329999999999998 109.25 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.564 ' C ' ' HB1' ' A' ' 168' ' ' ALA . 8.6 mt-10 -74.74 134.4 41.88 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 75.329999999999998 110.263 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.777 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 5.4 mp -112.67 154.24 26.39 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.544 1.152 . . . . 72.409999999999997 109.329 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 175' ' ' THR . 14.9 t -91.65 115.82 28.37 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.503 1.127 . . . . 62.439999999999998 110.389 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.687 HG22 ' H ' ' A' ' 177' ' ' TYR . 6.0 m -94.0 -173.64 3.18 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.483 1.114 . . . . 71.209999999999994 110.384 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.687 ' H ' HG22 ' A' ' 176' ' ' THR . 37.3 m-85 -136.35 134.34 37.78 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.487 1.117 . . . . 72.430000000000007 110.996 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.625 HG23 ' C ' ' A' ' 163' ' ' LEU . 1.8 p -59.59 149.95 6.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.418 1.074 . . . . 74.340000000000003 109.286 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 68.22 36.77 85.71 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.505 1.128 . . . . 62.020000000000003 111.002 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.494 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 21.7 tp10 -113.42 165.02 12.86 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.527 0.781 . . . . 73.310000000000002 110.295 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.693 ' C ' HD13 ' A' ' 182' ' ' LEU . 5.5 m120 -129.24 134.68 48.09 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.414 1.071 . . . . 73.549999999999997 109.332 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.843 HD11 HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -167.2 164.48 15.57 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.542 1.151 . . . . 74.109999999999999 109.363 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.566 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 0.6 OUTLIER -99.69 148.08 24.73 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.592 1.183 . . . . 70.25 110.958 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.625 HD12 ' HB3' ' A' ' 193' ' ' PHE . 24.2 mm -77.7 112.9 16.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.49 1.119 . . . . 53.240000000000002 109.296 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.459 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 0.5 OUTLIER -73.87 -27.56 61.13 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.476 1.11 . . . . 33.439999999999998 108.261 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.829 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -171.3 179.58 2.93 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.533 1.146 . . . . 73.150000000000006 109.289 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.522 ' NE2' HG21 ' A' ' 231' ' ' ILE . 9.2 p80 -143.28 143.58 31.77 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.545 1.153 . . . . 61.420000000000002 109.594 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.469 ' HB2' ' CG1' ' A' ' 239' ' ' VAL . 0.1 OUTLIER -124.01 121.58 35.64 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.483 1.115 . . . . 74.140000000000001 109.628 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.466 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 0.1 OUTLIER 53.6 30.59 11.08 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.484 1.115 . . . . 74.409999999999997 109.309 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 13.1 p 42.68 29.0 0.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.125 . . . . 73.319999999999993 108.269 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.604 ' O ' HG12 ' A' ' 209' ' ' VAL . 13.3 pt-20 -123.38 -37.49 2.67 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 75.019999999999996 110.245 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.469 ' CD1' ' HG3' ' A' ' 191' ' ' GLU . 15.8 m0 -112.37 160.48 17.66 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.546 1.154 . . . . 73.439999999999998 107.989 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.859 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 21.0 m-85 -136.81 161.16 36.74 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.502 1.126 . . . . 74.219999999999999 111.016 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.829 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 9.5 mm -97.77 108.53 21.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.456 1.098 . . . . 73.010000000000005 109.317 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.681 ' CB ' HG21 ' A' ' 207' ' ' VAL . . . -99.42 167.98 10.28 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.525 1.14 . . . . 54.420000000000002 109.271 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? . . . . . 0 C--N 1.325 -0.468 0 O-C-N 124.429 1.081 . . . . 73.549999999999997 109.287 179.961 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.004 0 N-CA-C 111.091 -0.803 . . . . 70.120000000000005 111.091 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.472 ' CB ' ' O ' ' A' ' 195' ' ' ALA . 18.4 Cg_endo -75.03 -173.7 12.81 Favored 'Cis proline' 0 C--N 1.36 1.176 0 C-N-CA 121.0 -2.5 . . . . 72.420000000000002 111.027 -0.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.13 172.38 20.71 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.503 1.127 . . . . 73.530000000000001 110.988 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.598 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 6.5 mt -99.4 134.8 41.75 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.484 0.755 . . . . 74.109999999999999 109.316 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.78 HG12 ' HD2' ' A' ' 208' ' ' PRO . 0.7 OUTLIER -134.43 144.27 50.31 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.504 1.128 . . . . 71.099999999999994 109.309 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.78 ' HD2' HG12 ' A' ' 207' ' ' VAL . 18.2 Cg_endo -74.94 138.84 23.73 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.51 1.795 . . . . 62.219999999999999 111.005 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.721 ' HA ' HG22 ' A' ' 212' ' ' VAL . 7.5 p -61.13 -34.78 61.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.46 1.1 . . . . 63.32 109.301 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -61.27 -13.01 34.11 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.557 1.16 . . . . 52.039999999999999 111.031 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 164' ' ' TYR . 4.4 m-85 -113.51 18.41 17.67 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.546 0.792 . . . . 73.099999999999994 111.026 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.721 HG22 ' HA ' ' A' ' 209' ' ' VAL . 11.3 m -153.62 153.58 8.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.499 1.124 . . . . 75.25 109.336 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.64 ' HB2' HD21 ' A' ' 163' ' ' LEU . 1.7 t -139.27 141.55 37.79 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.458 1.098 . . . . 72.129999999999995 110.018 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.63 HG13 HG23 ' A' ' 227' ' ' VAL . 17.6 mm -82.34 91.71 2.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.535 1.147 . . . . 73.409999999999997 109.27 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.543 HD11 HG21 ' A' ' 161' ' ' ILE . 1.6 pt . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.125 . . . . 54.509999999999998 109.364 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 72.0 p . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 120.562 0.22 . . . . 73.420000000000002 110.428 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.08 -1.22 22.7 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.467 1.104 . . . . 32.409999999999997 111.01 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -82.25 176.17 9.69 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.475 0.75 . . . . 63.210000000000001 109.261 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.44 171.73 9.72 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.458 1.099 . . . . 72.329999999999998 109.333 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.859 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 12.0 p -80.52 -40.27 19.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.47 1.106 . . . . 70.439999999999998 109.239 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.872 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.4 mp -51.04 -48.51 29.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.156 . . . . 73.340000000000003 109.301 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.03 -33.15 74.82 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.491 1.12 . . . . 55.520000000000003 110.25 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.626 ' O ' HD21 ' A' ' 158' ' ' LEU . 0.6 OUTLIER -76.89 -14.29 59.9 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.574 1.171 . . . . 71.099999999999994 109.292 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.872 HD12 ' HA ' ' A' ' 228' ' ' ILE . 34.6 mt -84.29 -32.4 8.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.483 1.114 . . . . 61.43 109.354 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -84.01 -18.73 36.12 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.421 1.076 . . . . 62.009999999999998 109.288 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 6.8 p -68.66 -29.01 67.39 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.527 1.142 . . . . 63.450000000000003 109.967 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.812 HG11 ' HG ' ' A' ' 158' ' ' LEU . 6.2 p -126.53 21.34 3.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.506 1.129 . . . . 72.299999999999997 109.318 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.3 m120 40.68 29.74 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.559 1.162 . . . . 73.019999999999996 109.334 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.746 HD22 HD13 ' A' ' 158' ' ' LEU . 22.9 tp -42.11 113.34 1.2 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.521 1.138 . . . . 72.219999999999999 109.325 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 133.72 16.91 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.519 1.799 . . . . 71.239999999999995 110.956 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.522 HG22 ' CE1' ' A' ' 187' ' ' HIS . 9.4 p -57.12 151.56 15.1 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.513 1.133 . . . . 73.230000000000004 110.42 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.469 ' CG1' ' HB2' ' A' ' 188' ' ' HIS . 2.7 p -59.72 -24.89 30.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.549 1.156 . . . . 73.409999999999997 109.281 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -80.05 -28.59 39.22 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.455 1.097 . . . . 74.219999999999999 110.28 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -86.9 -25.06 24.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 74.099999999999994 110.233 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -76.75 -52.9 8.73 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.48 1.113 . . . . 63.399999999999999 108.001 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 32.5 pttt -48.1 -28.83 3.11 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.504 1.127 . . . . 65.310000000000002 109.35 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.6 t -81.32 -44.78 17.15 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.457 1.098 . . . . 32.229999999999997 109.98 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.1 m120 . . . . . 0 C--N 1.325 -0.458 0 O-C-N 124.543 1.152 . . . . 70.450000000000003 109.26 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 1.075 HD12 HD12 ' A' ' 236' ' ' LEU . 8.2 mt . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 109.3 -0.63 . . . . 62.509999999999998 109.3 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.54 ' CG ' ' O ' ' A' ' 158' ' ' LEU . 76.3 m-85 -164.69 141.62 6.2 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.588 1.18 . . . . 73.120000000000005 111.064 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.731 ' HB3' HD11 ' A' ' 184' ' ' ILE . . . -135.44 130.26 34.5 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.539 1.149 . . . . 35.420000000000002 109.297 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.463 ' CG1' ' O ' ' A' ' 180' ' ' GLU . 1.3 tt -100.83 138.85 23.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.519 1.137 . . . . 73.25 109.28 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 164' ' ' TYR . 2.9 t -90.88 114.21 27.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.456 1.097 . . . . 72.420000000000002 109.275 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.653 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.1 OUTLIER -94.32 12.99 25.02 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.481 1.113 . . . . 63.149999999999999 109.296 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.614 ' O ' HG12 ' A' ' 162' ' ' VAL . 35.3 m-85 -157.98 131.27 7.61 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.562 1.163 . . . . 62.210000000000001 110.969 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -54.06 108.67 0.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 72.040000000000006 109.236 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.586 ' CE2' ' O ' ' A' ' 174' ' ' LEU . 5.7 t80 -80.46 136.71 36.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.447 1.092 . . . . 73.219999999999999 110.992 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -113.68 111.75 22.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.458 1.099 . . . . 61.140000000000001 109.259 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.682 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -63.53 121.65 14.37 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.534 1.146 . . . . 53.439999999999998 109.301 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.452 ' CG ' ' N ' ' A' ' 170' ' ' LYS . 14.7 pt-20 -116.62 -44.41 2.85 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.543 1.152 . . . . 64.310000000000002 110.256 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.473 ' CB ' ' HB2' ' A' ' 173' ' ' GLU . 0.8 OUTLIER -59.78 161.71 6.06 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.537 1.148 . . . . 72.409999999999997 109.324 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.76 -19.61 64.33 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.441 1.088 . . . . 63.219999999999999 109.262 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -124.44 25.22 7.71 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.415 1.072 . . . . 62.039999999999999 109.393 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.473 ' HB2' ' CB ' ' A' ' 170' ' ' LYS . 6.3 tp10 -85.11 157.92 20.55 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 1.118 . . . . 73.519999999999996 110.33 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.682 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -115.86 149.83 38.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.153 . . . . 72.010000000000005 109.335 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 11.6 t -107.72 137.97 44.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.511 1.132 . . . . 74.530000000000001 110.402 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.622 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.5 m -136.54 -164.39 1.56 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.551 1.157 . . . . 65.299999999999997 110.463 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.622 ' H ' HG22 ' A' ' 176' ' ' THR . 76.3 m-85 -140.62 150.49 43.64 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.433 1.083 . . . . 71.319999999999993 111.039 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.428 ' H ' HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -45.81 156.47 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.436 1.085 . . . . 65.519999999999996 109.313 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 37.51 63.81 0.79 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.518 1.136 . . . . 71.150000000000006 111.025 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.463 ' O ' ' CG1' ' A' ' 161' ' ' ILE . 26.5 tp10 -121.85 155.93 34.34 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.541 0.789 . . . . 70.040000000000006 110.321 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.418 ' N ' ' HG3' ' A' ' 180' ' ' GLU . 0.5 OUTLIER -101.5 126.99 48.37 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.534 1.146 . . . . 71.219999999999999 109.335 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.444 HD12 HG21 ' A' ' 176' ' ' THR . 11.1 mt -146.79 153.21 39.93 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.463 1.102 . . . . 72.230000000000004 109.3 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -111.56 131.73 55.04 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.546 1.154 . . . . 73.439999999999998 111.016 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.731 HD11 ' HB3' ' A' ' 160' ' ' ALA . 31.7 mm -77.71 129.59 37.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 71.040000000000006 109.238 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 1.3 t -103.78 -25.45 13.1 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.457 1.098 . . . . 64.340000000000003 108.288 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.769 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -164.49 171.95 13.94 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.484 1.115 . . . . 63.130000000000003 109.298 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.423 ' CE1' HG21 ' A' ' 231' ' ' ILE . 8.5 p80 -140.23 145.27 37.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.519 1.137 . . . . 72.5 109.616 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.649 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.6 t-160 -122.97 118.28 27.44 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.569 1.168 . . . . 73.430000000000007 109.593 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.45 ' C ' ' N ' ' A' ' 191' ' ' GLU . 57.1 m-80 53.82 31.51 13.22 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.549 1.155 . . . . 52.210000000000001 109.258 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 12.7 p 42.96 28.62 0.14 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 72.400000000000006 108.244 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.45 ' N ' ' C ' ' A' ' 189' ' ' ASN . 6.1 pt-20 -122.54 -36.05 2.99 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.457 1.098 . . . . 72.549999999999997 110.279 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.467 ' HE3' HD22 ' A' ' 206' ' ' LEU . 9.1 m0 -114.07 159.91 19.48 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.486 1.116 . . . . 73.230000000000004 108.01 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.952 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 28.4 m-85 -130.35 157.38 42.73 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.423 1.077 . . . . 74.140000000000001 111.02 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.769 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 22.8 mm -103.44 111.56 33.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.459 1.099 . . . . 60.030000000000001 109.228 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 204' ' ' PRO . . . -98.08 154.85 17.44 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.589 1.181 . . . . 71.439999999999998 109.34 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt . . . . . 0 C--N 1.324 -0.503 0 O-C-N 124.467 1.104 . . . . 63.399999999999999 109.318 -179.953 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.962 0 N-CA-C 111.022 -0.831 . . . . 53.420000000000002 111.022 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 18.2 Cg_endo -75.03 125.38 11.24 Favored 'Cis proline' 0 C--N 1.362 1.241 0 C-N-CA 120.987 -2.506 . . . . 64.310000000000002 110.972 0.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -105.25 172.28 19.47 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.532 1.145 . . . . 62.539999999999999 110.972 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.65 HD23 ' CD1' ' A' ' 194' ' ' ILE . 3.8 mt -106.07 137.23 44.35 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.507 0.769 . . . . 70.349999999999994 109.258 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.76 HG21 HG11 ' A' ' 212' ' ' VAL . 0.1 OUTLIER -132.56 138.59 32.42 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.535 1.147 . . . . 70.049999999999997 109.327 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.57 ' HD3' ' CZ ' ' A' ' 166' ' ' PHE . 18.2 Cg_endo -75.01 144.58 30.37 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.463 1.77 . . . . 71.010000000000005 111.012 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.624 HG23 ' CE2' ' A' ' 193' ' ' PHE . 12.0 p -75.19 -21.84 16.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.545 1.153 . . . . 74.349999999999994 109.316 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -75.68 -7.8 83.7 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.488 1.118 . . . . 73.120000000000005 111.037 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -113.67 -11.2 12.99 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.447 0.733 . . . . 73.230000000000004 111.11 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.76 HG11 HG21 ' A' ' 207' ' ' VAL . 15.4 m -128.48 161.55 36.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.527 1.142 . . . . 73.450000000000003 109.302 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.653 ' HB2' HD21 ' A' ' 163' ' ' LEU . 6.3 t -149.88 153.17 36.25 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.47 1.106 . . . . 73.340000000000003 110.027 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.756 HG13 HG23 ' A' ' 227' ' ' VAL . 12.3 mm -96.46 121.42 46.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 124.546 1.154 . . . . 71.319999999999993 109.295 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.6 pt . . . . . 0 C--N 1.324 -0.535 0 O-C-N 124.514 1.134 . . . . 73.409999999999997 109.335 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 58.4 p . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 120.54 0.21 . . . . 64.239999999999995 110.447 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 154.08 -22.8 0.68 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.473 1.108 . . . . 71.299999999999997 111.033 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -62.88 -175.95 0.11 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.45 0.735 . . . . 61.020000000000003 109.318 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -135.04 176.98 8.17 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.47 1.106 . . . . 70.200000000000003 109.254 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.952 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 8.3 p -79.6 -32.95 14.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.524 1.14 . . . . 71.519999999999996 109.342 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.834 HD12 HG13 ' A' ' 227' ' ' VAL . 1.5 mp -57.75 -49.23 81.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.43 1.081 . . . . 72.129999999999995 109.258 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -59.92 -28.89 67.99 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.447 1.092 . . . . 74.140000000000001 110.298 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.44 ' O ' HD11 ' A' ' 158' ' ' LEU . 0.8 OUTLIER -80.75 -31.21 36.02 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.546 1.154 . . . . 42.219999999999999 109.277 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.572 HD11 HG22 ' A' ' 227' ' ' VAL . 24.3 mt -72.72 -39.03 59.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.459 1.099 . . . . 71.120000000000005 109.281 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -76.22 -32.7 59.08 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.536 1.147 . . . . 52.210000000000001 109.258 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.4 m -55.65 -39.86 71.45 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 74.129999999999995 110.04 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.62 HG11 ' HG ' ' A' ' 158' ' ' LEU . 11.8 p -118.58 13.54 7.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.501 1.126 . . . . 50.43 109.316 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 231' ' ' ILE . 8.5 m120 40.46 43.06 1.44 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.542 1.151 . . . . 73.200000000000003 109.321 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 1.075 HD12 HD12 ' A' ' 158' ' ' LEU . 2.1 tt -40.28 140.01 0.99 Allowed Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.525 1.14 . . . . 74.400000000000006 109.306 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.515 ' HD2' HD23 ' A' ' 236' ' ' LEU . 18.2 Cg_endo -75.01 139.23 24.02 Favored 'Trans proline' 0 C--N 1.361 1.207 0 O-C-N 124.566 1.824 . . . . 62.039999999999999 110.996 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.404 HG22 ' CE1' ' A' ' 187' ' ' HIS . 2.3 p -75.13 152.14 38.52 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.504 1.127 . . . . 64.230000000000004 110.41 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.649 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.7 p -53.32 -23.09 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.525 1.14 . . . . 63.149999999999999 109.33 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.498 ' O ' ' CB ' ' A' ' 244' ' ' SER . 99.3 mm-40 -86.06 -50.14 7.26 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.46 1.1 . . . . 63.240000000000002 110.254 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -59.01 -28.91 66.83 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.536 1.147 . . . . 63.350000000000001 110.327 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.645 ' HZ3' HG21 ' A' ' 194' ' ' ILE . 22.0 t90 -80.42 -68.0 0.72 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.98 -1.119 . . . . 75.25 107.98 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.8 pttp -50.41 -23.25 2.28 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.516 1.135 . . . . 72.219999999999999 109.254 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 240' ' ' GLN . 11.3 t -68.57 -59.67 2.97 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.64 1.213 . . . . 72.420000000000002 110.047 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 4.6 m120 . . . . . 0 C--N 1.325 -0.465 0 O-C-N 124.542 1.151 . . . . 64.340000000000003 109.381 179.925 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.684 HD21 ' OD2' ' A' ' 230' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 109.33 -0.619 . . . . 53.520000000000003 109.33 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.541 ' CD2' ' HB3' ' A' ' 183' ' ' PHE . 6.0 m-85 -137.41 165.82 25.31 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.493 1.121 . . . . 72.310000000000002 110.985 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.422 ' HB1' ' HB ' ' A' ' 212' ' ' VAL . . . -125.66 150.7 47.38 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.51 1.131 . . . . 65.310000000000002 109.291 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.82 HD12 ' O ' ' A' ' 180' ' ' GLU . 1.0 OUTLIER -113.19 122.74 67.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.514 1.134 . . . . 63.520000000000003 109.287 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.761 HG21 ' CG2' ' A' ' 176' ' ' THR . 19.8 t -76.73 132.31 33.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 64.099999999999994 109.293 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 1.015 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.4 OUTLIER -110.25 -12.38 14.46 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 55.149999999999999 109.294 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.483 ' HB2' ' CD2' ' A' ' 211' ' ' PHE . 85.1 m-85 -143.06 151.57 40.93 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 72.120000000000005 110.939 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.642 ' N ' HG12 ' A' ' 178' ' ' VAL . 0.9 OUTLIER -78.96 104.67 9.75 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.468 1.105 . . . . 64.430000000000007 109.273 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.513 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 1.1 t80 -80.87 109.45 15.45 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 1.127 . . . . 72.219999999999999 110.992 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.485 ' CE ' ' OD2' ' A' ' 165' ' ' ASP . 13.8 mmtp -81.55 94.41 6.88 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.53 1.143 . . . . 65.310000000000002 109.276 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.662 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -43.96 124.4 3.79 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.406 1.066 . . . . 71.439999999999998 109.244 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -119.72 -38.66 2.95 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.493 1.12 . . . . 71.299999999999997 110.269 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.414 ' CB ' ' HB2' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -63.75 165.01 8.99 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.53 1.144 . . . . 74.25 109.29 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.85 -22.57 62.29 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.509 1.131 . . . . 72.409999999999997 109.334 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -117.9 25.25 10.5 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.514 1.134 . . . . 61.140000000000001 109.297 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.529 ' O ' HD22 ' A' ' 174' ' ' LEU . 5.1 tp10 -91.91 147.5 22.92 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.527 1.142 . . . . 74.519999999999996 110.373 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.662 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 0.4 OUTLIER -120.02 143.61 47.98 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.403 1.065 . . . . 65.219999999999999 109.287 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.6 t -81.59 143.72 31.77 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.502 1.126 . . . . 63.409999999999997 110.414 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.761 ' CG2' HG21 ' A' ' 162' ' ' VAL . 2.6 m -131.37 -176.75 4.13 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.469 1.105 . . . . 73.25 110.399 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.563 ' H ' HG22 ' A' ' 176' ' ' THR . 6.1 m-85 -130.46 155.48 46.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.468 1.105 . . . . 75.209999999999994 111.017 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.642 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.0 OUTLIER -68.09 156.02 7.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.545 1.153 . . . . 73.549999999999997 109.309 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.47 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 37.45 55.1 1.66 Allowed Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.524 1.14 . . . . 54.119999999999997 111.011 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.82 ' O ' HD12 ' A' ' 161' ' ' ILE . 14.9 tt0 -114.75 165.94 12.28 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.513 0.772 . . . . 63.340000000000003 110.307 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -125.95 121.02 31.91 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.527 1.142 . . . . 72.319999999999993 109.269 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.423 ' C ' HD12 ' A' ' 182' ' ' LEU . 3.3 pp -140.63 168.27 20.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.462 1.101 . . . . 72.530000000000001 109.325 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.541 ' HB3' ' CD2' ' A' ' 159' ' ' TYR . 11.1 p90 -108.41 134.99 50.44 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.529 1.143 . . . . 63.450000000000003 110.965 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.708 HD12 ' HB3' ' A' ' 193' ' ' PHE . 22.9 mm -77.62 124.67 36.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.482 1.114 . . . . 75.450000000000003 109.304 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.464 ' HB2' HG22 ' A' ' 194' ' ' ILE . 39.7 m -88.59 -22.58 23.44 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.537 1.148 . . . . 71.430000000000007 108.316 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.774 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -172.6 179.19 2.5 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.522 1.139 . . . . 75.349999999999994 109.275 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.421 ' CE1' HG21 ' A' ' 231' ' ' ILE . 8.8 p80 -144.48 153.75 42.21 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.539 1.15 . . . . 73.319999999999993 109.616 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.463 ' HB2' ' CG1' ' A' ' 239' ' ' VAL . 0.2 OUTLIER -132.18 117.11 17.84 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 74.0 109.644 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 58.78 18.06 5.7 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.462 1.101 . . . . 71.430000000000007 109.319 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 4.0 m 57.92 18.62 5.16 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.452 1.095 . . . . 42.030000000000001 108.305 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.93 ' O ' HG23 ' A' ' 209' ' ' VAL . 11.6 pt-20 -115.97 -33.04 5.21 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.515 1.134 . . . . 71.140000000000001 110.284 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.472 ' HE3' HD22 ' A' ' 206' ' ' LEU . 12.9 m0 -112.58 158.47 19.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.568 1.167 . . . . 73.230000000000004 108.036 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 1.17 ' CE2' HG22 ' A' ' 209' ' ' VAL . 39.8 m-85 -134.44 163.55 29.43 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.466 1.104 . . . . 73.430000000000007 111.027 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.774 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 33.8 mm -105.97 120.67 57.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.596 1.185 . . . . 75.530000000000001 109.262 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.539 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -106.0 163.3 12.87 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.491 1.119 . . . . 74.540000000000006 109.353 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.418 ' HZ1' ' HD3' ' A' ' 204' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 74.25 109.295 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.03 0 N-CA-C 110.977 -0.849 . . . . 75.540000000000006 110.977 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.418 ' HD3' ' HZ1' ' A' ' 196' ' ' LYS . 18.1 Cg_endo -75.06 160.11 96.98 Favored 'Cis proline' 0 C--N 1.36 1.147 0 C-N-CA 121.006 -2.497 . . . . 73.340000000000003 110.926 0.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.428 ' HA3' ' CG ' ' A' ' 174' ' ' LEU . . . -120.13 -172.11 14.76 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.5 1.125 . . . . 45.340000000000003 111.006 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.577 HD23 ' CD1' ' A' ' 194' ' ' ILE . 4.4 mt -108.52 154.98 21.16 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.469 0.746 . . . . 53.340000000000003 109.321 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.746 HG21 HG11 ' A' ' 212' ' ' VAL . 0.2 OUTLIER -153.74 119.04 2.78 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.531 1.144 . . . . 54.329999999999998 109.241 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.513 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.5 Cg_endo -74.93 156.68 43.3 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.56 1.821 . . . . 74.109999999999999 111.027 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 1.17 HG22 ' CE2' ' A' ' 193' ' ' PHE . 7.1 t -68.68 -15.33 19.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.473 1.108 . . . . 61.25 109.319 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -72.88 -2.5 57.59 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.471 1.107 . . . . 61.240000000000002 110.998 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.483 ' CD2' ' HB2' ' A' ' 164' ' ' TYR . 29.0 m-85 -134.07 11.24 3.91 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.518 0.775 . . . . 73.409999999999997 111.024 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.746 HG11 HG21 ' A' ' 207' ' ' VAL . 14.9 m -148.26 143.99 19.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.508 1.13 . . . . 75.209999999999994 109.307 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' SER . . . . . 1.015 ' HB2' HD11 ' A' ' 163' ' ' LEU . 9.7 t -128.52 154.61 45.96 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.461 1.101 . . . . 53.420000000000002 110.024 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.689 HG13 HG23 ' A' ' 227' ' ' VAL . 31.6 mm -107.15 141.73 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.47 1.106 . . . . 65.310000000000002 109.279 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.457 1.098 . . . . 45.009999999999998 109.299 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 55.1 p . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.559 0.218 . . . . 75.25 110.427 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.87 -2.54 21.28 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.512 1.133 . . . . 74.099999999999994 111.06 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -69.47 171.93 8.01 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.535 0.785 . . . . 72.120000000000005 109.285 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.2 168.31 11.0 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.496 1.122 . . . . 71.409999999999997 109.281 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.883 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 10.4 p -78.47 -34.62 18.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.517 1.135 . . . . 63.43 109.293 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.748 HD12 HG13 ' A' ' 227' ' ' VAL . 1.3 mp -56.54 -50.94 71.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.585 1.178 . . . . 52.539999999999999 109.336 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -63.93 -31.95 73.31 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.541 1.151 . . . . 71.329999999999998 110.3 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.684 ' OD2' HD21 ' A' ' 158' ' ' LEU . 0.5 OUTLIER -70.33 -36.05 74.01 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.508 1.13 . . . . 72.120000000000005 109.307 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.421 HG21 ' CE1' ' A' ' 187' ' ' HIS . 23.0 mt -67.76 -43.03 86.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.496 1.123 . . . . 64.430000000000007 109.345 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 29.9 mmtt -74.36 -21.21 59.79 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.456 1.097 . . . . 64.530000000000001 109.251 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 36.9 m -66.75 -37.44 84.62 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.494 1.121 . . . . 74.099999999999994 109.985 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.468 HG11 ' HB2' ' A' ' 158' ' ' LEU . 14.5 p -116.46 11.67 7.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.527 1.142 . . . . 62.149999999999999 109.275 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 57.7 t30 40.48 43.95 1.62 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.549 1.156 . . . . 71.140000000000001 109.282 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.541 HD12 ' HD2' ' A' ' 237' ' ' PRO . 1.6 tp -52.07 142.87 25.94 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.54 1.15 . . . . 65.209999999999994 109.282 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.541 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.3 Cg_endo -74.97 154.1 42.4 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.473 1.775 . . . . 62.219999999999999 110.988 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.411 ' C ' ' N ' ' A' ' 240' ' ' GLN . 3.1 p -94.11 142.06 27.83 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.552 1.158 . . . . 75.329999999999998 110.375 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.463 ' CG1' ' HB2' ' A' ' 188' ' ' HIS . 2.7 p -47.04 -25.5 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.445 1.091 . . . . 62.200000000000003 109.301 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.411 ' N ' ' C ' ' A' ' 238' ' ' THR . 37.3 mm-40 -80.97 -40.92 23.63 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.524 1.14 . . . . 73.519999999999996 110.255 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 238' ' ' THR . 74.9 mt-10 -72.15 -23.44 61.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.526 1.141 . . . . 74.409999999999997 110.323 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.434 ' O ' ' N ' ' A' ' 245' ' ' ASN . 3.5 t90 -77.59 -71.59 0.41 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.532 1.145 . . . . 63.539999999999999 107.979 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.412 ' HB2' ' NZ ' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -44.02 -27.76 0.4 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.561 1.163 . . . . 74.049999999999997 109.259 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.42 ' N ' ' C ' ' A' ' 242' ' ' TRP . 3.0 t -73.58 -46.92 44.35 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 63.200000000000003 110.025 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 242' ' ' TRP . 16.5 t-20 . . . . . 0 C--N 1.326 -0.428 0 O-C-N 124.547 1.154 . . . . 72.140000000000001 109.254 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.779 HD11 HG11 ' A' ' 234' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 109.357 -0.609 . . . . 75.030000000000001 109.357 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -114.13 135.42 54.05 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.478 1.111 . . . . 72.540000000000006 111.011 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -124.31 163.91 20.71 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 71.200000000000003 109.291 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.655 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -132.69 128.75 57.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.52 1.137 . . . . 73.430000000000007 109.359 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 164' ' ' TYR . 3.0 t -86.93 109.51 19.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.478 1.111 . . . . 71.239999999999995 109.32 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.655 HD23 ' O ' ' A' ' 161' ' ' ILE . 0.1 OUTLIER -97.64 17.34 18.06 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.546 1.154 . . . . 70.219999999999999 109.308 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.691 ' O ' HG12 ' A' ' 162' ' ' VAL . 53.3 m-85 -164.56 147.67 8.93 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.557 1.161 . . . . 64.420000000000002 110.984 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.727 ' H ' HG22 ' A' ' 178' ' ' VAL . 0.2 OUTLIER -73.3 158.6 34.81 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.479 1.112 . . . . 74.409999999999997 109.304 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.602 ' CD1' ' N ' ' A' ' 167' ' ' LYS . 1.9 t80 -135.55 157.85 45.86 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.575 1.172 . . . . 73.109999999999999 111.041 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.602 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 21.5 mmtp -124.76 134.51 52.77 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.483 1.114 . . . . 53.020000000000003 109.294 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.74 ' HB1' ' HB3' ' A' ' 173' ' ' GLU . . . -99.98 124.07 44.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.487 1.117 . . . . 72.010000000000005 109.338 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -117.18 -34.37 4.38 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.496 1.123 . . . . 45.100000000000001 110.304 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -68.82 -179.79 1.55 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.447 1.092 . . . . 72.129999999999995 109.329 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.51 -29.68 22.54 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.474 1.109 . . . . 72.109999999999999 109.294 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.25 21.68 16.13 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.564 1.165 . . . . 71.519999999999996 109.278 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.812 ' O ' HD22 ' A' ' 174' ' ' LEU . 3.9 tt0 -93.44 159.27 15.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.446 1.091 . . . . 72.019999999999996 110.295 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.812 HD22 ' O ' ' A' ' 173' ' ' GLU . 4.6 mm? -133.0 147.18 52.28 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 74.439999999999998 109.289 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 12.2 t -98.21 145.74 26.31 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.484 1.115 . . . . 71.430000000000007 110.355 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.7 m -146.52 -178.11 5.99 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.49 1.119 . . . . 73.140000000000001 110.44 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.542 ' H ' HG22 ' A' ' 176' ' ' THR . 26.7 m-85 -128.97 -179.79 5.31 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.559 1.162 . . . . 74.409999999999997 111.038 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.727 HG22 ' H ' ' A' ' 165' ' ' ASP . 28.8 t -74.26 165.01 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.475 1.109 . . . . 73.319999999999993 109.316 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.464 ' N ' HG12 ' A' ' 178' ' ' VAL . . . 37.57 71.74 0.2 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.507 1.129 . . . . 53.299999999999997 111.023 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -121.91 154.2 37.44 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.488 0.758 . . . . 74.010000000000005 110.208 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -112.75 119.74 39.09 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.561 1.163 . . . . 75.400000000000006 109.327 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.561 ' C ' HD12 ' A' ' 182' ' ' LEU . 0.2 OUTLIER -160.64 -175.42 4.97 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.466 1.104 . . . . 74.099999999999994 109.343 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -133.1 147.2 52.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.134 . . . . 74.439999999999998 111.004 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.768 HD12 ' HB3' ' A' ' 193' ' ' PHE . 30.6 mm -77.62 128.35 38.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.487 1.117 . . . . 74.349999999999994 109.305 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.625 ' HB2' HG22 ' A' ' 194' ' ' ILE . 38.6 m -86.9 -34.38 19.42 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.541 1.151 . . . . 54.530000000000001 108.313 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.554 ' HA ' HD11 ' A' ' 236' ' ' LEU . . . -164.57 179.13 6.85 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.486 1.116 . . . . 73.450000000000003 109.239 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.429 ' CE1' HG21 ' A' ' 231' ' ' ILE . 6.1 p80 -139.85 148.69 42.47 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 73.109999999999999 109.604 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.645 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.8 t-160 -125.18 115.62 20.72 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.453 1.096 . . . . 74.200000000000003 109.569 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.437 ' C ' ' N ' ' A' ' 191' ' ' GLU . 79.6 m-20 53.72 33.1 15.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.438 1.086 . . . . 72.510000000000005 109.268 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 12.6 p 42.95 28.28 0.13 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.55 1.156 . . . . 61.200000000000003 108.297 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.437 ' N ' ' C ' ' A' ' 189' ' ' ASN . 4.4 pt-20 -121.81 -35.43 3.2 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.494 1.121 . . . . 74.109999999999999 110.324 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.825 ' HE3' HD22 ' A' ' 206' ' ' LEU . 10.7 m0 -115.9 165.94 12.53 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.497 1.123 . . . . 73.239999999999995 108.029 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.768 ' HB3' HD12 ' A' ' 184' ' ' ILE . 9.9 m-85 -137.75 155.66 48.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.556 1.16 . . . . 63.310000000000002 111.003 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.625 HG22 ' HB2' ' A' ' 185' ' ' CYS . 20.7 mm -102.14 83.73 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.512 1.132 . . . . 71.040000000000006 109.336 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.645 ' HB3' HG11 ' A' ' 207' ' ' VAL . . . -104.43 179.22 4.33 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.537 1.148 . . . . 62.439999999999998 109.317 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.438 ' HB3' ' CA ' ' A' ' 203' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.505 1.128 . . . . 73.140000000000001 109.323 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.438 ' CA ' ' HB3' ' A' ' 196' ' ' LYS . . . . . . . . 0 CA--C 1.531 1.035 0 N-CA-C 110.995 -0.842 . . . . 71.109999999999999 110.995 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 121.02 7.05 Favored 'Cis proline' 0 C--N 1.36 1.184 0 C-N-CA 121.039 -2.484 . . . . 73.400000000000006 110.977 -0.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.468 ' CA ' ' O ' ' A' ' 195' ' ' ALA . . . -96.92 132.37 10.97 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.537 1.148 . . . . 34.350000000000001 111.055 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.825 HD22 ' HE3' ' A' ' 192' ' ' TRP . 17.9 mt -88.72 125.43 34.85 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.488 0.758 . . . . 74.129999999999995 109.275 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.645 HG11 ' HB3' ' A' ' 195' ' ' ALA . 1.2 m -141.18 149.44 55.3 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.494 1.121 . . . . 73.140000000000001 109.293 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.515 ' HG2' ' CG ' ' A' ' 211' ' ' PHE . 18.2 Cg_endo -74.9 160.28 40.63 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.486 1.782 . . . . 73.340000000000003 111.043 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.675 HG23 ' HE2' ' A' ' 193' ' ' PHE . 3.3 p -81.9 -25.07 9.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.416 1.072 . . . . 72.040000000000006 109.282 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -73.78 -12.04 80.84 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.526 1.141 . . . . 63.140000000000001 111.026 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.515 ' CG ' ' HG2' ' A' ' 208' ' ' PRO . 8.6 m-30 -109.46 24.96 12.36 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.426 0.721 . . . . 75.430000000000007 111.019 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.603 HG21 ' CD2' ' A' ' 193' ' ' PHE . 32.6 m -157.0 145.06 11.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.488 1.118 . . . . 51.030000000000001 109.315 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.49 ' HB2' HD21 ' A' ' 163' ' ' LEU . 21.6 t -134.19 144.59 48.56 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.548 1.155 . . . . 64.519999999999996 109.962 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.478 HG13 HG23 ' A' ' 227' ' ' VAL . 16.3 mm -96.73 96.88 5.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.538 1.149 . . . . 74.519999999999996 109.266 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 1.8 pt . . . . . 0 C--N 1.325 -0.469 0 O-C-N 124.511 1.132 . . . . 62.439999999999998 109.327 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 61.1 p . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 110.395 -0.224 . . . . 72.120000000000005 110.395 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 105.32 -18.1 42.54 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.466 1.104 . . . . 72.239999999999995 111.003 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -58.15 -175.9 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.397 0.704 . . . . 71.340000000000003 109.312 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -123.74 172.68 8.66 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.492 1.12 . . . . 74.409999999999997 109.305 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.709 HG13 HD12 ' A' ' 228' ' ' ILE . 14.7 p -76.58 -38.61 31.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.468 1.105 . . . . 73.430000000000007 109.324 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.709 HD12 HG13 ' A' ' 227' ' ' VAL . 1.8 mp -53.59 -52.92 28.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 74.439999999999998 109.292 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -56.13 -34.93 66.55 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.476 1.11 . . . . 74.340000000000003 110.373 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.425 ' O ' HD21 ' A' ' 158' ' ' LEU . 0.6 OUTLIER -77.49 -26.96 51.75 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.431 1.082 . . . . 74.209999999999994 109.24 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.43 HD11 ' HE1' ' A' ' 193' ' ' PHE . 60.7 mt -71.5 -39.51 70.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.51 1.131 . . . . 60.109999999999999 109.326 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -29.56 60.21 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.477 1.111 . . . . 62.219999999999999 109.286 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 54.8 m -55.57 -44.87 77.28 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.491 1.119 . . . . 42.229999999999997 110.043 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.779 HG11 HD11 ' A' ' 158' ' ' LEU . 7.7 p -111.15 12.84 8.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.569 1.168 . . . . 71.239999999999995 109.309 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 13.7 m120 40.57 38.28 0.58 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.534 1.146 . . . . 70.239999999999995 109.313 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.933 HD12 ' HD2' ' A' ' 237' ' ' PRO . 3.9 tp -40.89 133.51 1.77 Allowed Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.405 1.066 . . . . 72.519999999999996 109.284 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.933 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.3 Cg_endo -75.06 131.89 14.74 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.479 1.779 . . . . 71.430000000000007 110.955 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.444 ' C ' ' N ' ' A' ' 240' ' ' GLN . 2.4 p -68.61 150.46 47.96 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.452 1.095 . . . . 71.109999999999999 110.348 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.645 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.1 p -40.41 -30.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.467 1.104 . . . . 62.450000000000003 109.281 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.444 ' N ' ' C ' ' A' ' 238' ' ' THR . 45.2 mm-40 -81.16 -56.12 4.29 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.474 1.109 . . . . 75.019999999999996 110.325 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -53.94 -22.03 9.32 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.531 1.145 . . . . 61.030000000000001 110.328 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -86.91 -60.46 1.98 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 64.140000000000001 108.046 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -23.48 2.78 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.573 1.171 . . . . 71.299999999999997 109.346 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 32.2 t -81.07 -62.25 1.72 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.491 1.119 . . . . 73.230000000000004 109.963 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.5 m120 . . . . . 0 C--N 1.325 -0.463 0 O-C-N 124.464 1.103 . . . . 63.530000000000001 109.315 179.992 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.729 HD11 HD13 ' A' ' 236' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.339 -0.615 . . . . 73.519999999999996 109.339 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.524 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 1.3 p90 -136.41 155.14 50.44 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.499 1.124 . . . . 74.340000000000003 110.948 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.835 ' HB3' HD11 ' A' ' 184' ' ' ILE . . . -121.59 142.16 50.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.468 1.105 . . . . 74.140000000000001 109.263 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.515 ' O ' ' CD2' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -110.29 133.72 54.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.557 1.161 . . . . 74.310000000000002 109.302 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.957 HG21 HG21 ' A' ' 176' ' ' THR . 2.0 t -76.27 132.17 33.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.511 1.132 . . . . 75.150000000000006 109.31 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.757 ' O ' HG23 ' A' ' 178' ' ' VAL . 0.2 OUTLIER -95.54 -31.56 13.26 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.495 1.122 . . . . 72.400000000000006 109.287 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.592 ' O ' HG12 ' A' ' 162' ' ' VAL . 15.4 m-85 -130.19 159.34 37.14 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.54 1.15 . . . . 74.349999999999994 110.983 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.64 97.49 5.12 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.531 1.144 . . . . 53.109999999999999 109.335 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.564 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 1.7 t80 -82.67 123.91 29.71 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.476 1.11 . . . . 64.329999999999998 110.967 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 168' ' ' ALA . 11.4 mmmm -101.93 105.47 16.27 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.493 1.12 . . . . 71.010000000000005 109.261 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.589 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -40.54 123.8 1.89 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.474 1.109 . . . . 70.409999999999997 109.321 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -113.72 -28.94 7.27 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.514 1.134 . . . . 64.230000000000004 110.302 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.52 177.79 8.61 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.498 1.124 . . . . 74.209999999999994 109.308 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.62 -14.06 43.84 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.582 1.176 . . . . 52.229999999999997 109.302 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -124.53 23.43 8.14 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.54 1.15 . . . . 73.219999999999999 109.233 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.458 ' HB3' ' HB1' ' A' ' 168' ' ' ALA . 3.3 tp10 -96.39 163.21 13.16 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 72.140000000000001 110.305 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.589 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 19.5 mt -127.46 153.48 46.25 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.515 1.134 . . . . 75.120000000000005 109.27 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.4 t -103.37 147.9 26.54 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.572 1.17 . . . . 74.019999999999996 110.448 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.957 HG21 HG21 ' A' ' 162' ' ' VAL . 2.4 m -138.44 -165.86 1.89 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.502 1.126 . . . . 73.519999999999996 110.378 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.638 ' H ' HG22 ' A' ' 176' ' ' THR . 69.7 m-85 -134.44 134.0 41.11 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.523 1.139 . . . . 71.299999999999997 111.001 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 163' ' ' LEU . 0.5 OUTLIER -41.42 143.33 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.487 1.117 . . . . 45.310000000000002 109.294 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 52.03 63.64 4.63 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.583 1.177 . . . . 64.329999999999998 111.019 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.436 ' CG ' ' HB2' ' A' ' 177' ' ' TYR . 6.0 mm-40 -122.15 160.93 24.08 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.433 0.725 . . . . 74.209999999999994 110.264 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -113.21 119.66 38.52 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.454 1.096 . . . . 62.210000000000001 109.345 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.451 ' CD2' ' HB1' ' A' ' 195' ' ' ALA . 1.2 mp -136.99 159.88 40.56 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.456 1.098 . . . . 74.129999999999995 109.322 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -108.09 128.89 55.08 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.561 1.163 . . . . 63.539999999999999 111.01 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.835 HD11 ' HB3' ' A' ' 160' ' ' ALA . 30.2 mm -77.62 128.53 38.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.527 1.142 . . . . 74.040000000000006 109.293 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 49.7 t -100.55 -23.15 14.76 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.48 1.112 . . . . 52.240000000000002 108.261 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.71 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -166.62 179.62 5.35 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.494 1.121 . . . . 72.319999999999993 109.306 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.431 ' CE1' HG21 ' A' ' 231' ' ' ILE . 8.2 p80 -146.28 157.81 43.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.452 1.095 . . . . 75.010000000000005 109.663 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.464 ' HB2' ' CG1' ' A' ' 239' ' ' VAL . 0.3 OUTLIER -134.48 115.3 13.8 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.463 1.102 . . . . 63.340000000000003 109.596 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.466 ' CB ' ' HG2' ' A' ' 191' ' ' GLU . 2.2 m-20 58.74 19.89 7.32 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.59 1.181 . . . . 72.340000000000003 109.31 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 23.4 m 57.36 18.78 4.59 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.551 1.157 . . . . 71.239999999999995 108.273 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.466 ' HG2' ' CB ' ' A' ' 189' ' ' ASN . 10.1 pt-20 -116.28 -33.0 5.12 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.122 . . . . 73.340000000000003 110.277 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.659 ' HE3' HD22 ' A' ' 206' ' ' LEU . 9.6 m0 -110.21 155.4 22.04 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 124.5 1.125 . . . . 73.129999999999995 108.004 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.811 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 24.9 m-85 -133.04 152.22 51.98 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.488 1.117 . . . . 75.109999999999999 111.06 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.71 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 27.8 mm -99.09 94.28 3.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.533 1.145 . . . . 64.209999999999994 109.315 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.496 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -75.38 154.73 37.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.436 1.085 . . . . 75.030000000000001 109.31 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm . . . . . 0 C--N 1.325 -0.493 0 O-C-N 124.406 1.066 . . . . 74.030000000000001 109.275 -179.982 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.432 ' HA2' HD11 ' A' ' 174' ' ' LEU . . . . . . . . 0 CA--C 1.53 0.986 0 N-CA-C 111.035 -0.826 . . . . 75.010000000000005 111.035 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.488 ' CB ' ' O ' ' A' ' 195' ' ' ALA . 18.3 Cg_endo -74.98 178.61 33.89 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 121.036 -2.485 . . . . 62.310000000000002 111.071 -0.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.56 ' N ' HD12 ' A' ' 174' ' ' LEU . . . -125.39 168.4 17.51 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.591 1.182 . . . . 71.219999999999999 111.016 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.659 HD22 ' HE3' ' A' ' 192' ' ' TRP . 2.5 mt -101.16 134.13 44.66 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.451 0.736 . . . . 44.439999999999998 109.223 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.798 HG21 HG11 ' A' ' 212' ' ' VAL . 0.1 OUTLIER -135.14 137.72 27.51 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.586 1.179 . . . . 61.119999999999997 109.299 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.568 ' HG2' ' CD1' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.92 148.85 36.24 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.542 1.811 . . . . 75.129999999999995 111.077 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.606 ' HA ' HG22 ' A' ' 212' ' ' VAL . 11.5 p -74.43 -14.06 15.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.504 1.128 . . . . 51.109999999999999 109.334 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLY . . . . . 0.52 ' C ' ' CD1' ' A' ' 211' ' ' PHE . . . -84.09 10.47 60.62 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.499 1.124 . . . . 45.43 111.053 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.568 ' CD1' ' HG2' ' A' ' 208' ' ' PRO . 17.3 m-85 -143.85 19.06 1.81 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.541 0.789 . . . . 70.310000000000002 111.001 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.798 HG11 HG21 ' A' ' 207' ' ' VAL . 30.8 m -145.68 147.94 17.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.524 1.14 . . . . 70.129999999999995 109.333 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 161' ' ' ILE . 46.5 t -130.74 152.44 50.09 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.594 1.184 . . . . 63.530000000000001 110.001 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.616 HG13 HG23 ' A' ' 227' ' ' VAL . 42.3 mm -106.26 161.07 5.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.527 1.142 . . . . 70.450000000000003 109.28 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.458 HG23 ' C ' ' A' ' 214' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.438 0 O-C-N 124.483 1.114 . . . . 74.209999999999994 109.235 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 18.1 p . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 110.399 -0.222 . . . . 51.210000000000001 110.399 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.52 10.21 11.85 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.466 1.103 . . . . 74.420000000000002 111.008 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -74.62 -177.02 2.99 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 0.755 . . . . 64.140000000000001 109.312 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.41 159.05 35.67 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.592 1.182 . . . . 55.020000000000003 109.291 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.811 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 12.6 p -78.05 -40.57 26.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 124.45 1.093 . . . . 73.310000000000002 109.337 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.687 HD12 HG13 ' A' ' 227' ' ' VAL . 2.1 mp -61.46 -46.39 96.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.496 1.122 . . . . 64.340000000000003 109.391 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -64.99 -20.37 66.46 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.587 1.18 . . . . 74.150000000000006 110.314 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -89.73 -31.65 17.35 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.125 . . . . 73.239999999999995 109.313 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.683 HD12 ' HA ' ' A' ' 228' ' ' ILE . 15.1 mt -66.49 -39.02 82.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.439 1.087 . . . . 75.209999999999994 109.261 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.484 ' HE2' HG22 ' A' ' 231' ' ' ILE . 6.1 mmpt? -76.33 -31.86 58.37 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.513 1.133 . . . . 72.510000000000005 109.283 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 6.6 p -57.0 -44.94 83.25 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.455 1.097 . . . . 70.150000000000006 110.032 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.678 HG12 HD21 ' A' ' 158' ' ' LEU . 3.4 p -106.11 13.13 8.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 124.518 1.136 . . . . 75.420000000000002 109.26 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 40.52 32.46 0.14 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.555 1.16 . . . . 71.420000000000002 109.247 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.729 HD13 HD11 ' A' ' 158' ' ' LEU . 2.1 tp -40.49 142.65 0.74 Allowed Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.498 1.124 . . . . 63.240000000000002 109.229 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.1 Cg_endo -75.03 170.74 19.75 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.624 1.855 . . . . 63.549999999999997 110.936 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 241' ' ' GLU . 1.4 p -113.21 143.14 44.9 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.461 1.101 . . . . 75.109999999999999 110.4 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 188' ' ' HIS . 2.5 p -45.33 -26.36 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.489 1.118 . . . . 64.310000000000002 109.266 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.402 ' N ' ' C ' ' A' ' 238' ' ' THR . 86.6 mm-40 -76.23 -43.36 42.48 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.477 1.111 . . . . 62.039999999999999 110.26 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 238' ' ' THR . 5.2 mm-40 -74.41 -21.7 59.51 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.528 1.142 . . . . 71.200000000000003 110.253 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.444 ' O ' ' N ' ' A' ' 245' ' ' ASN . 9.4 t90 -75.26 -62.36 1.59 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.958 -1.127 . . . . 71.340000000000003 107.958 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.7 pttm -50.45 -24.32 3.03 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.465 1.103 . . . . 71.439999999999998 109.275 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 2.6 t -88.07 -29.21 20.82 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.494 1.121 . . . . 70.340000000000003 110.007 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 242' ' ' TRP . 1.9 t30 . . . . . 0 C--N 1.325 -0.478 0 O-C-N 124.45 1.093 . . . . 75.540000000000006 109.246 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.475 ' HG ' HG11 ' A' ' 234' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 109.295 -0.631 . . . . 73.519999999999996 109.295 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.459 ' CG ' ' O ' ' A' ' 158' ' ' LEU . 10.3 m-85 -168.31 107.98 0.52 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.385 1.053 . . . . 72.340000000000003 111.041 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.409 ' HB2' HG12 ' A' ' 184' ' ' ILE . . . -106.58 129.44 54.51 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.518 1.136 . . . . 71.409999999999997 109.248 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.554 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -99.2 127.38 51.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.121 . . . . 63.399999999999999 109.319 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.594 ' CG2' ' CD2' ' A' ' 182' ' ' LEU . 2.2 t -87.25 119.31 34.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.54 1.15 . . . . 75.140000000000001 109.328 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.704 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.1 OUTLIER -112.33 17.67 19.19 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.428 1.08 . . . . 71.430000000000007 109.203 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.656 ' CE2' HD12 ' A' ' 163' ' ' LEU . 95.6 m-85 -155.89 148.91 24.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.437 1.086 . . . . 75.329999999999998 111.041 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.429 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 0.6 OUTLIER -87.47 106.74 18.19 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.475 1.11 . . . . 72.409999999999997 109.322 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.66 ' CD2' HG13 ' A' ' 207' ' ' VAL . 3.7 t80 -80.41 153.04 28.52 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.578 1.174 . . . . 74.239999999999995 110.965 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.531 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.9 mptt -115.51 115.39 26.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 72.049999999999997 109.316 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.811 ' HB1' ' OE1' ' A' ' 173' ' ' GLU . . . -56.47 126.59 27.17 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 1.138 . . . . 71.129999999999995 109.335 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.4 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 7.5 pt-20 -130.36 -35.53 1.53 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.481 1.113 . . . . 75.430000000000007 110.307 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.879 ' HD3' HD13 ' A' ' 206' ' ' LEU . 10.9 tttt -58.37 -163.26 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.448 1.093 . . . . 73.099999999999994 109.265 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.78 -50.65 5.93 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.526 1.141 . . . . 64.510000000000005 109.345 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.09 28.99 7.12 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.528 1.142 . . . . 73.340000000000003 109.324 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.811 ' OE1' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -60.27 -176.9 0.05 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.491 1.119 . . . . 74.239999999999995 110.325 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 174' ' ' LEU . 13.1 mt -151.8 132.54 14.05 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 72.019999999999996 109.269 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 175' ' ' THR . 15.2 t -78.82 114.1 17.47 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.504 1.128 . . . . 73.129999999999995 110.394 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.717 HG22 ' H ' ' A' ' 177' ' ' TYR . 5.6 m -102.34 -172.14 2.08 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.505 1.128 . . . . 74.040000000000006 110.382 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.717 ' H ' HG22 ' A' ' 176' ' ' THR . 11.1 m-85 -133.3 175.54 9.31 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.429 1.081 . . . . 64.349999999999994 110.979 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 163' ' ' LEU . 1.3 p -97.47 110.65 25.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 124.474 1.109 . . . . 62.509999999999998 109.287 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.46 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 99.23 51.12 1.37 Allowed Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.495 1.122 . . . . 72.340000000000003 111.028 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.404 ' HA ' ' OE1' ' A' ' 180' ' ' GLU . 3.4 mm-40 -115.6 169.38 9.23 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.49 0.759 . . . . 72.319999999999993 110.313 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.94 128.1 43.06 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 60.439999999999998 109.358 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.655 ' CD1' ' HB1' ' A' ' 195' ' ' ALA . 0.6 OUTLIER -167.02 172.7 9.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.454 1.097 . . . . 73.310000000000002 109.267 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -112.41 151.15 30.18 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.52 1.138 . . . . 72.129999999999995 110.97 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.813 HD12 ' HB3' ' A' ' 193' ' ' PHE . 48.1 mm -79.7 136.79 22.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.468 1.105 . . . . 72.310000000000002 109.275 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 9.1 t -101.5 -22.86 14.41 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.499 1.125 . . . . 73.310000000000002 108.328 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.885 ' HB3' HG13 ' A' ' 194' ' ' ILE . . . -173.7 172.26 3.61 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.497 1.123 . . . . 75.120000000000005 109.309 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.718 ' CE1' HG22 ' A' ' 238' ' ' THR . 6.6 p80 -133.67 145.48 49.97 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.475 1.11 . . . . 73.450000000000003 109.588 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.643 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.1 t-160 -123.02 116.33 23.35 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.53 1.144 . . . . 73.439999999999998 109.629 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.45 ' C ' ' N ' ' A' ' 191' ' ' GLU . 71.3 m-20 53.79 32.22 14.49 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.465 1.103 . . . . 53.329999999999998 109.275 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 12.8 p 42.96 28.41 0.13 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.53 1.143 . . . . 74.219999999999999 108.339 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.716 ' O ' HG12 ' A' ' 209' ' ' VAL . 5.6 pt-20 -121.99 -35.3 3.19 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.482 1.113 . . . . 72.010000000000005 110.294 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.437 ' N ' ' HG2' ' A' ' 191' ' ' GLU . 7.2 m0 -118.1 167.29 11.61 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.922 -1.14 . . . . 71.140000000000001 107.922 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.927 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 23.7 m-85 -141.78 161.58 37.59 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.492 1.12 . . . . 73.530000000000001 111.031 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.885 HG13 ' HB3' ' A' ' 186' ' ' ALA . 20.8 mm -99.65 122.9 52.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.51 1.131 . . . . 61.219999999999999 109.258 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.655 ' HB1' ' CD1' ' A' ' 182' ' ' LEU . . . -106.24 153.09 22.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.548 1.155 . . . . 42.450000000000003 109.281 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.4 tttp . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 71.420000000000002 109.255 179.982 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.992 0 N-CA-C 111.028 -0.829 . . . . 64.439999999999998 111.028 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 174.41 52.88 Favored 'Cis proline' 0 C--N 1.36 1.134 0 C-N-CA 121.013 -2.495 . . . . 63.240000000000002 111.026 0.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 194' ' ' ILE . . . -123.13 -173.68 14.11 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.491 1.119 . . . . 61.119999999999997 110.985 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.879 HD13 ' HD3' ' A' ' 170' ' ' LYS . 3.3 mp -115.06 156.08 25.83 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.566 0.803 . . . . 53.340000000000003 109.29 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.875 HG12 ' HD2' ' A' ' 208' ' ' PRO . 0.2 OUTLIER -150.99 147.27 20.37 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.455 1.097 . . . . 71.239999999999995 109.297 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.875 ' HD2' HG12 ' A' ' 207' ' ' VAL . 18.3 Cg_endo -75.02 141.49 26.65 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.551 1.816 . . . . 73.450000000000003 110.968 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.755 HG23 ' HE2' ' A' ' 193' ' ' PHE . 7.2 p -64.48 -37.72 80.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.563 1.164 . . . . 73.129999999999995 109.322 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -60.06 -13.93 29.55 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.483 1.114 . . . . 45.219999999999999 111.004 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 164' ' ' TYR . 5.9 m-85 -112.19 18.53 18.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.519 0.776 . . . . 73.209999999999994 110.94 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.736 HG22 ' HA ' ' A' ' 209' ' ' VAL . 10.5 m -153.43 143.63 14.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.52 1.137 . . . . 41.109999999999999 109.292 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.704 ' HB2' HD21 ' A' ' 163' ' ' LEU . 3.5 t -129.5 148.08 51.37 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.476 1.11 . . . . 64.400000000000006 110.006 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.723 HG13 HG23 ' A' ' 227' ' ' VAL . 25.8 mm -98.87 119.1 46.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.577 1.173 . . . . 71.040000000000006 109.327 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 4.0 pt . . . . . 0 C--N 1.325 -0.495 0 O-C-N 124.507 1.129 . . . . 72.219999999999999 109.358 179.986 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 60.9 p . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 120.54 0.209 . . . . 74.329999999999998 110.467 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 111.53 18.03 8.29 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.479 1.112 . . . . 73.530000000000001 110.993 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -79.93 175.39 10.67 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 0.758 . . . . 54.149999999999999 109.322 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -131.1 162.42 29.89 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.408 1.068 . . . . 74.319999999999993 109.307 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.927 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 11.4 p -77.92 -45.01 28.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.56 1.162 . . . . 74.409999999999997 109.278 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.835 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.0 mp -54.09 -44.85 64.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.5 1.125 . . . . 60.530000000000001 109.345 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -63.76 -28.78 70.11 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.481 1.113 . . . . 64.400000000000006 110.237 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.41 -19.87 35.2 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 74.310000000000002 109.328 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.91 HG23 ' HB3' ' A' ' 236' ' ' LEU . 37.8 mt -76.76 -36.53 26.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.511 1.132 . . . . 53.509999999999998 109.279 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.583 ' HE2' HG22 ' A' ' 231' ' ' ILE . 6.0 mmpt? -83.97 -12.02 55.95 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.107 . . . . 73.409999999999997 109.282 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.8 p -78.86 -41.67 29.35 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 71.25 109.961 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.475 HG11 ' HG ' ' A' ' 158' ' ' LEU . 7.7 p -108.72 26.28 2.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.527 1.142 . . . . 73.140000000000001 109.266 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 12.6 m120 45.6 26.21 0.31 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.518 1.136 . . . . 74.510000000000005 109.331 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.91 ' HB3' HG23 ' A' ' 231' ' ' ILE . 0.8 OUTLIER -43.91 103.8 0.34 Allowed Pre-proline 0 C--N 1.326 -0.433 0 O-C-N 124.484 1.115 . . . . 72.219999999999999 109.299 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 140.49 25.48 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.507 1.793 . . . . 64.319999999999993 111.0 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.718 HG22 ' CE1' ' A' ' 187' ' ' HIS . 15.7 p -57.66 155.69 9.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.551 1.157 . . . . 64.430000000000007 110.326 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.643 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 1.9 p -61.83 -21.04 24.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.458 1.099 . . . . 60.539999999999999 109.358 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.469 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 40.2 mm-40 -85.58 -26.23 26.25 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 75.549999999999997 110.286 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -84.3 -35.55 23.24 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.513 1.133 . . . . 73.219999999999999 110.291 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 245' ' ' ASN . 1.2 t90 -65.49 -52.07 55.42 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.001 -1.111 . . . . 72.439999999999998 108.001 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.484 ' HZ3' ' HB2' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -49.04 -33.32 11.13 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.435 1.084 . . . . 75.420000000000002 109.258 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.4 t -78.88 -30.23 44.88 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.441 1.088 . . . . 42.210000000000001 110.03 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 242' ' ' TRP . 5.4 t-20 . . . . . 0 C--N 1.324 -0.503 0 O-C-N 124.46 1.1 . . . . 43.329999999999998 109.223 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.718 ' HG ' HG11 ' A' ' 234' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 109.266 -0.642 . . . . 70.430000000000007 109.266 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 1.1 p90 -129.95 116.43 18.6 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.507 1.13 . . . . 75.109999999999999 111.003 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.483 ' CB ' HD11 ' A' ' 184' ' ' ILE . . . -95.23 132.37 40.27 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.529 1.143 . . . . 65.019999999999996 109.297 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.44 HD12 ' OD1' ' A' ' 181' ' ' ASN . 0.1 OUTLIER -108.43 130.41 61.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.119 . . . . 54.439999999999998 109.322 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 211' ' ' PHE . 2.2 t -81.33 122.11 35.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.499 1.124 . . . . 74.150000000000006 109.265 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.697 ' O ' HG23 ' A' ' 178' ' ' VAL . 0.7 OUTLIER -90.44 -26.14 19.99 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.485 1.115 . . . . 73.450000000000003 109.295 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.648 ' O ' HG12 ' A' ' 162' ' ' VAL . 44.6 m-85 -130.67 147.83 52.39 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.517 1.136 . . . . 71.530000000000001 111.023 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -61.06 108.42 0.88 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 75.540000000000006 109.309 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.605 ' CE2' ' O ' ' A' ' 174' ' ' LEU . 1.7 t80 -80.95 132.31 35.39 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.434 1.084 . . . . 74.109999999999999 110.983 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.602 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 0.4 OUTLIER -103.66 140.96 36.87 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.433 1.083 . . . . 44.350000000000001 109.322 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.822 ' HB1' ' CG ' ' A' ' 173' ' ' GLU . . . -84.34 126.58 33.34 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.514 1.134 . . . . 42.32 109.322 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.411 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 6.9 pt-20 -127.67 -33.65 2.27 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.506 1.129 . . . . 74.319999999999993 110.299 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.471 ' HD2' ' CD1' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -58.09 -164.43 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.504 1.128 . . . . 61.329999999999998 109.283 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.16 -51.56 5.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.469 1.106 . . . . 71.120000000000005 109.323 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -107.57 28.64 7.95 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.427 1.08 . . . . 71.329999999999998 109.288 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.822 ' CG ' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -59.73 177.94 0.19 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.503 1.127 . . . . 74.400000000000006 110.313 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.769 HD11 ' HA2' ' A' ' 203' ' ' GLY . 12.4 mt -145.09 133.2 21.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 1.137 . . . . 71.049999999999997 109.277 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.8 t -81.47 154.92 26.08 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 71.049999999999997 110.44 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.751 HG21 HG21 ' A' ' 162' ' ' VAL . 2.6 m -142.46 -165.44 2.04 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.529 1.143 . . . . 74.129999999999995 110.393 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.64 ' H ' HG22 ' A' ' 176' ' ' THR . 20.7 m-85 -143.86 137.92 28.27 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.525 1.141 . . . . 73.439999999999998 111.011 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 163' ' ' LEU . 0.7 OUTLIER -44.53 146.52 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.46 1.1 . . . . 72.109999999999999 109.315 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.455 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 52.67 60.55 7.77 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.494 1.121 . . . . 73.239999999999995 111.04 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 161' ' ' ILE . 7.0 mm-40 -118.51 166.21 12.97 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.518 0.775 . . . . 72.099999999999994 110.322 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.44 ' OD1' HD12 ' A' ' 161' ' ' ILE . 0.5 OUTLIER -126.09 136.37 52.83 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.483 1.114 . . . . 71.010000000000005 109.257 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.547 ' CD1' ' HB1' ' A' ' 195' ' ' ALA . 0.5 OUTLIER -167.19 157.83 11.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.452 1.095 . . . . 64.439999999999998 109.329 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.459 ' CD1' ' C ' ' A' ' 183' ' ' PHE . 6.8 p90 -99.54 150.48 22.18 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.447 1.092 . . . . 60.030000000000001 111.059 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.914 HD12 ' HB3' ' A' ' 193' ' ' PHE . 19.6 mm -88.93 133.41 31.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 124.489 1.118 . . . . 73.340000000000003 109.334 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.463 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 3.6 t -97.56 -27.73 14.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.409 1.068 . . . . 73.099999999999994 108.249 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.891 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -160.62 179.44 8.57 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.568 1.168 . . . . 72.030000000000001 109.342 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.437 ' HB3' HD12 ' A' ' 236' ' ' LEU . 32.8 p-80 -147.05 120.63 9.12 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.475 1.109 . . . . 74.239999999999995 109.58 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -99.7 114.53 27.7 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.451 1.094 . . . . 64.549999999999997 109.619 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.428 ' C ' ' N ' ' A' ' 191' ' ' GLU . 5.3 t-20 53.69 34.19 18.33 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.543 1.152 . . . . 75.109999999999999 109.356 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 13.4 p 42.53 28.47 0.12 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.482 1.114 . . . . 60.020000000000003 108.299 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.466 ' O ' HG12 ' A' ' 209' ' ' VAL . 3.8 pt-20 -121.64 -33.97 3.5 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.563 1.165 . . . . 54.210000000000001 110.297 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.473 ' HE3' HD22 ' A' ' 206' ' ' LEU . 8.2 m0 -117.22 157.48 25.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.518 1.136 . . . . 73.319999999999993 108.009 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 1.007 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 36.6 m-85 -130.66 159.14 38.11 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.478 1.111 . . . . 75.439999999999998 110.98 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.891 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 31.0 mm -102.7 96.0 4.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.456 1.098 . . . . 74.430000000000007 109.298 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.617 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -79.38 166.09 22.42 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.157 . . . . 45.530000000000001 109.233 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.1 tptp . . . . . 0 C--N 1.326 -0.434 0 O-C-N 124.514 1.134 . . . . 53.420000000000002 109.275 -179.978 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.769 ' HA2' HD11 ' A' ' 174' ' ' LEU . . . . . . . . 0 CA--C 1.531 1.053 0 N-CA-C 110.969 -0.852 . . . . 52.520000000000003 110.969 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 162.46 92.8 Favored 'Cis proline' 0 C--N 1.359 1.129 0 C-N-CA 120.973 -2.511 . . . . 73.209999999999994 110.935 0.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.416 ' HA3' ' CG ' ' A' ' 174' ' ' LEU . . . -133.64 160.28 23.97 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.545 1.153 . . . . 74.239999999999995 111.022 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.526 HD23 ' CD1' ' A' ' 194' ' ' ILE . 3.8 mt -99.61 137.27 38.32 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.531 0.783 . . . . 73.030000000000001 109.317 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.843 HG21 HG11 ' A' ' 212' ' ' VAL . 0.1 OUTLIER -133.94 136.78 27.02 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.583 1.177 . . . . 75.230000000000004 109.319 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.56 ' HD3' ' CE1' ' A' ' 166' ' ' PHE . 18.5 Cg_endo -74.93 138.12 22.79 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.491 1.785 . . . . 73.010000000000005 111.006 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.662 HG23 ' CE2' ' A' ' 193' ' ' PHE . 13.7 p -65.2 -15.66 18.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.525 1.14 . . . . 71.140000000000001 109.295 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -83.87 10.86 58.98 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.485 1.116 . . . . 73.129999999999995 111.052 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.805 ' O ' HG13 ' A' ' 162' ' ' VAL . 19.0 m-85 -140.7 15.53 2.33 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.501 0.765 . . . . 64.010000000000005 111.009 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.843 HG11 HG21 ' A' ' 207' ' ' VAL . 21.9 m -147.53 149.55 15.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.475 1.11 . . . . 74.319999999999993 109.283 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.456 ' HB3' HD11 ' A' ' 163' ' ' LEU . 0.3 OUTLIER -130.42 152.44 49.82 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.453 1.096 . . . . 71.319999999999993 109.952 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.692 HG13 HG23 ' A' ' 227' ' ' VAL . 31.0 mm -111.09 95.66 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 72.010000000000005 109.349 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 27.8 pt . . . . . 0 C--N 1.324 -0.504 0 O-C-N 124.455 1.097 . . . . 71.120000000000005 109.349 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 39.1 p . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 110.405 -0.22 . . . . 51.549999999999997 110.405 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 122.09 3.71 9.66 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.558 1.161 . . . . 52.409999999999997 111.017 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -83.1 -177.6 6.82 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.433 0.725 . . . . 74.310000000000002 109.306 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.23 178.61 6.84 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.564 1.165 . . . . 72.430000000000007 109.288 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 1.007 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 2.5 p -82.99 -34.37 11.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.522 1.139 . . . . 75.230000000000004 109.329 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.821 HD12 HG13 ' A' ' 227' ' ' VAL . 1.6 mp -59.87 -37.48 72.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.463 1.102 . . . . 62.140000000000001 109.241 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -67.15 -42.72 83.9 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.477 1.111 . . . . 74.140000000000001 110.266 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.408 ' CG ' HG21 ' A' ' 214' ' ' ILE . 0.6 OUTLIER -67.42 -32.99 74.24 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.496 1.123 . . . . 72.120000000000005 109.279 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.864 HG23 ' HB3' ' A' ' 236' ' ' LEU . 24.7 mt -63.61 -43.69 98.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.477 1.111 . . . . 60.310000000000002 109.311 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -78.46 -11.98 59.98 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 73.120000000000005 109.273 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.7 m -76.9 -44.89 30.05 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.526 1.141 . . . . 71.200000000000003 110.05 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.718 HG11 ' HG ' ' A' ' 158' ' ' LEU . 9.9 p -109.26 30.06 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.488 1.118 . . . . 73.109999999999999 109.31 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 42.41 28.46 0.11 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.516 1.135 . . . . 74.549999999999997 109.281 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.864 ' HB3' HG23 ' A' ' 231' ' ' ILE . 1.6 tm? -42.77 102.38 0.27 Allowed Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.587 1.179 . . . . 23.530000000000001 109.288 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.424 ' HD2' HD22 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -75.03 152.9 41.17 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.523 1.802 . . . . 72.519999999999996 111.02 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 8.8 p -67.17 151.41 47.6 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.549 1.155 . . . . 61.039999999999999 110.386 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.598 ' N ' ' HB1' ' A' ' 186' ' ' ALA . 1.3 p -50.79 -23.91 2.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.464 1.103 . . . . 71.439999999999998 109.318 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -83.82 -46.7 11.9 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.536 1.147 . . . . 71.140000000000001 110.342 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -63.25 -23.83 67.6 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.514 1.134 . . . . 74.049999999999997 110.343 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -80.14 -65.87 0.95 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.509 1.131 . . . . 75.349999999999994 107.98 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.39 -28.74 1.43 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.578 1.174 . . . . 75.140000000000001 109.28 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.4 t -71.49 -51.59 22.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.536 1.147 . . . . 72.439999999999998 109.973 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.425 1.078 . . . . 61.219999999999999 109.346 179.968 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.411 HD13 HG21 ' A' ' 234' ' ' VAL . 14.1 tp . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 109.271 -0.64 . . . . 74.329999999999998 109.271 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -137.38 115.92 12.02 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.556 1.16 . . . . 74.349999999999994 111.012 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.438 ' HB2' ' CD1' ' A' ' 214' ' ' ILE . . . -115.51 152.18 33.46 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.521 1.138 . . . . 71.319999999999993 109.325 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.834 HD12 ' O ' ' A' ' 180' ' ' GLU . 1.4 tp -120.12 128.88 75.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.487 1.117 . . . . 65.239999999999995 109.264 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.779 HG23 HD11 ' A' ' 182' ' ' LEU . 18.2 t -92.83 112.17 25.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.529 1.143 . . . . 65.230000000000004 109.359 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.879 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.1 OUTLIER -101.03 28.95 4.91 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.496 1.123 . . . . 75.310000000000002 109.327 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.599 ' CD2' ' O ' ' A' ' 163' ' ' LEU . 78.9 m-85 -164.57 131.07 2.98 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.555 1.159 . . . . 73.299999999999997 110.958 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.547 ' H ' HG22 ' A' ' 178' ' ' VAL . 2.7 t0 -79.59 101.19 8.17 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 74.010000000000005 109.329 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.568 ' CD1' ' HD3' ' A' ' 208' ' ' PRO . 60.9 t80 -83.21 152.67 25.11 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 74.049999999999997 111.024 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.561 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 6.9 mmmm -110.69 154.82 23.31 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.514 1.134 . . . . 63.049999999999997 109.25 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.694 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -95.49 125.0 39.8 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.539 1.149 . . . . 63.439999999999998 109.287 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -121.68 -40.31 2.56 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.477 1.11 . . . . 73.030000000000001 110.365 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -174.56 0.23 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.573 1.171 . . . . 73.030000000000001 109.284 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.38 -34.05 20.32 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.546 1.154 . . . . 52.310000000000002 109.307 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.5 10.35 33.21 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.626 1.204 . . . . 73.400000000000006 109.264 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 173' ' ' GLU . 1.2 mm-40 -75.12 172.87 11.6 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.125 . . . . 70.219999999999999 110.296 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.694 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 1.3 tp -155.56 157.68 37.22 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.53 1.144 . . . . 74.219999999999999 109.265 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.0 t -102.89 137.08 41.57 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.496 1.122 . . . . 74.409999999999997 110.407 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.684 HG22 ' H ' ' A' ' 177' ' ' TYR . 3.4 m -113.71 -166.01 1.05 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.547 1.154 . . . . 60.219999999999999 110.366 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.684 ' H ' HG22 ' A' ' 176' ' ' THR . 54.4 m-85 -138.57 150.69 46.58 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.456 1.097 . . . . 74.400000000000006 110.965 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.547 HG22 ' H ' ' A' ' 165' ' ' ASP . 60.8 t -60.84 163.66 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.133 . . . . 72.439999999999998 109.301 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.461 ' N ' HG12 ' A' ' 178' ' ' VAL . . . 37.74 57.73 1.54 Allowed Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.45 1.094 . . . . 55.210000000000001 110.995 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.834 ' O ' HD12 ' A' ' 161' ' ' ILE . 12.7 mm-40 -114.19 155.89 25.26 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.485 0.756 . . . . 71.519999999999996 110.326 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.595 ' C ' HD13 ' A' ' 182' ' ' LEU . 4.9 m120 -123.32 125.09 44.38 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.531 1.144 . . . . 53.43 109.349 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.779 HD11 HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -162.53 162.65 27.47 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.51 1.131 . . . . 74.420000000000002 109.308 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 184' ' ' ILE . 2.7 t80 -98.96 147.93 24.49 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.433 1.083 . . . . 73.140000000000001 111.007 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.527 HD12 ' HB3' ' A' ' 193' ' ' PHE . 8.9 mm -77.67 112.49 15.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.472 1.108 . . . . 71.420000000000002 109.325 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.522 ' HB3' HG22 ' A' ' 194' ' ' ILE . 10.9 t -78.71 -22.73 46.19 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.525 1.141 . . . . 62.350000000000001 108.285 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.8 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -171.9 179.65 2.67 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.58 1.175 . . . . 63.25 109.308 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.46 ' CE1' HG22 ' A' ' 238' ' ' THR . 8.0 p80 -148.05 151.25 35.37 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.526 1.141 . . . . 61.340000000000003 109.522 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.461 ' HB2' HG11 ' A' ' 239' ' ' VAL . 1.8 t-160 -132.48 122.45 24.92 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.493 1.12 . . . . 63.329999999999998 109.597 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.444 ' C ' ' N ' ' A' ' 191' ' ' GLU . 3.0 m-20 54.15 30.4 12.08 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.477 1.111 . . . . 74.209999999999994 109.281 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 12.7 p 42.95 28.95 0.15 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 72.430000000000007 108.299 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.444 ' N ' ' C ' ' A' ' 189' ' ' ASN . 9.8 pt-20 -124.5 -37.18 2.54 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.564 1.165 . . . . 73.25 110.257 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.693 ' HE3' HD22 ' A' ' 206' ' ' LEU . 11.2 m0 -109.71 158.2 18.34 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.492 1.12 . . . . 74.040000000000006 108.004 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.98 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 44.7 m-85 -137.56 157.16 47.12 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.532 1.145 . . . . 72.319999999999993 111.005 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.8 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 30.8 mm -96.83 98.85 8.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.543 1.152 . . . . 72.25 109.266 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.407 ' HB3' HG21 ' A' ' 207' ' ' VAL . . . -94.92 158.02 15.66 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.557 1.161 . . . . 72.530000000000001 109.267 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt . . . . . 0 C--N 1.325 -0.47 0 O-C-N 124.527 1.142 . . . . 65.430000000000007 109.297 179.924 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.675 ' HA2' HD22 ' A' ' 174' ' ' LEU . . . . . . . . 0 CA--C 1.53 0.975 0 N-CA-C 111.027 -0.829 . . . . 64.109999999999999 111.027 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.528 ' HB2' HG23 ' A' ' 194' ' ' ILE . 18.2 Cg_endo -75.02 -170.45 8.28 Favored 'Cis proline' 0 C--N 1.359 1.124 0 C-N-CA 120.953 -2.52 . . . . 65.109999999999999 110.951 0.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -150.32 156.17 26.59 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.438 1.086 . . . . 74.409999999999997 110.983 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.693 HD22 ' HE3' ' A' ' 192' ' ' TRP . 1.7 mt -97.26 127.45 43.23 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.543 0.79 . . . . 73.219999999999999 109.343 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.812 HG12 ' HD2' ' A' ' 208' ' ' PRO . 0.3 OUTLIER -129.54 145.47 57.07 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.466 1.104 . . . . 72.230000000000004 109.35 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.812 ' HD2' HG12 ' A' ' 207' ' ' VAL . 18.6 Cg_endo -74.96 148.11 35.04 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.436 1.756 . . . . 74.230000000000004 110.994 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.709 ' HA ' HG22 ' A' ' 212' ' ' VAL . 8.0 p -66.79 -32.06 56.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.469 1.105 . . . . 64.230000000000004 109.297 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -66.01 -9.1 45.83 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.478 1.111 . . . . 74.439999999999998 111.046 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.575 ' HA ' ' CD2' ' A' ' 164' ' ' TYR . 4.6 m-85 -113.84 5.04 16.12 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.471 0.748 . . . . 71.019999999999996 110.928 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.709 HG22 ' HA ' ' A' ' 209' ' ' VAL . 18.4 m -140.47 162.14 24.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.49 1.119 . . . . 61.5 109.26 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.879 ' HB2' HD21 ' A' ' 163' ' ' LEU . 1.8 t -144.97 144.18 30.92 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.502 1.126 . . . . 72.030000000000001 110.008 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.761 HG13 HG23 ' A' ' 227' ' ' VAL . 36.0 mm -96.13 105.95 17.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.478 1.111 . . . . 62.450000000000003 109.303 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.409 HG23 ' C ' ' A' ' 214' ' ' ILE . 1.9 pt . . . . . 0 C--N 1.325 -0.463 0 O-C-N 124.497 1.123 . . . . 74.109999999999999 109.256 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 110.411 -0.218 . . . . 74.400000000000006 110.411 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 138.99 -13.2 3.35 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.474 1.109 . . . . 32.229999999999997 110.979 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -54.4 168.51 0.25 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.505 0.768 . . . . 62.420000000000002 109.251 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -114.57 175.24 5.57 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.469 1.105 . . . . 73.319999999999993 109.311 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.98 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 11.0 p -80.77 -33.17 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.459 1.099 . . . . 72.400000000000006 109.316 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.711 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.6 mp -60.58 -51.49 72.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.477 1.111 . . . . 73.109999999999999 109.338 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -61.96 -22.66 65.83 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.49 1.118 . . . . 74.530000000000001 110.268 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.748 ' O ' HG22 ' A' ' 234' ' ' VAL . 2.9 m-20 -83.6 -35.91 24.31 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.454 1.096 . . . . 64.409999999999997 109.257 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.863 HG23 ' HB3' ' A' ' 236' ' ' LEU . 12.2 mt -59.87 -29.99 44.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 74.310000000000002 109.287 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -84.08 -11.52 56.55 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.445 1.09 . . . . 72.010000000000005 109.257 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.03 -11.85 29.87 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.478 1.111 . . . . 64.540000000000006 109.988 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.748 HG22 ' O ' ' A' ' 230' ' ' ASP . 0.0 OUTLIER -132.56 10.69 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.525 1.14 . . . . 53.32 109.295 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 236' ' ' LEU . 74.0 m-20 52.95 20.74 1.76 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 52.140000000000001 109.327 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.863 ' HB3' HG23 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -39.55 100.51 0.21 Allowed Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.476 1.11 . . . . 63.100000000000001 109.311 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.449 ' HD2' HD13 ' A' ' 236' ' ' LEU . 18.6 Cg_endo -74.89 142.94 28.83 Favored 'Trans proline' 0 C--N 1.359 1.099 0 O-C-N 124.445 1.76 . . . . 71.209999999999994 111.012 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.46 HG22 ' CE1' ' A' ' 187' ' ' HIS . 7.1 p -60.23 148.08 37.8 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.547 1.154 . . . . 73.530000000000001 110.434 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' A' ' 188' ' ' HIS . 1.4 p -52.82 -25.8 9.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.497 1.123 . . . . 73.409999999999997 109.281 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -75.5 -39.38 58.59 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.561 1.163 . . . . 74.150000000000006 110.37 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -76.99 -23.1 52.28 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.454 1.096 . . . . 74.120000000000005 110.326 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -79.93 -61.69 1.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.541 1.151 . . . . 74.219999999999999 107.978 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.407 ' HB2' ' NZ ' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -51.31 -25.03 5.21 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.49 1.119 . . . . 72.129999999999995 109.291 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 29.5 t -72.55 -35.7 68.07 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.128 . . . . 61.399999999999999 109.997 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 1.9 t30 . . . . . 0 C--N 1.324 -0.521 0 O-C-N 124.542 1.151 . . . . 41.109999999999999 109.306 179.976 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 230' ' ' ASP . 2.7 tp . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 109.348 -0.612 . . . . 73.450000000000003 109.348 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.53 ' CE2' ' O ' ' A' ' 215' ' ' ILE . 2.4 p90 -152.01 152.26 32.22 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.518 1.136 . . . . 73.340000000000003 110.974 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.771 ' HB3' HD11 ' A' ' 184' ' ' ILE . . . -122.39 141.27 51.76 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.513 1.133 . . . . 52.409999999999997 109.232 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.51 128.38 55.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.472 1.107 . . . . 73.430000000000007 109.255 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.809 HG21 HD12 ' A' ' 182' ' ' LEU . 43.4 t -84.56 92.54 3.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.547 1.155 . . . . 72.510000000000005 109.332 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.898 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.2 OUTLIER -92.51 25.09 3.16 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 52.450000000000003 109.321 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.832 ' CD2' HD13 ' A' ' 163' ' ' LEU . 37.3 m-85 -165.18 141.11 5.44 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.481 1.113 . . . . 71.439999999999998 111.014 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -67.22 98.66 0.62 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.493 1.121 . . . . 53.420000000000002 109.257 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.578 ' CE2' ' O ' ' A' ' 174' ' ' LEU . 0.6 OUTLIER -80.3 123.53 28.05 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.436 1.085 . . . . 75.030000000000001 111.017 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.515 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 7.8 mmmm -93.25 138.93 31.16 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.454 1.096 . . . . 73.200000000000003 109.341 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.816 ' HB1' ' OE1' ' A' ' 173' ' ' GLU . . . -82.0 122.1 27.37 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.415 1.072 . . . . 74.510000000000005 109.275 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -126.97 -34.93 2.31 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.562 1.164 . . . . 72.150000000000006 110.27 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.91 ' HD2' HD13 ' A' ' 206' ' ' LEU . 4.8 mttp -58.56 -164.09 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.423 1.077 . . . . 62.409999999999997 109.357 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.31 -51.28 5.65 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.578 1.174 . . . . 73.140000000000001 109.306 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -105.36 29.48 6.43 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.503 1.127 . . . . 74.109999999999999 109.262 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 1.005 ' O ' HD22 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -59.02 172.5 0.56 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.531 1.144 . . . . 70.430000000000007 110.325 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 1.005 HD22 ' O ' ' A' ' 173' ' ' GLU . 1.7 mm? -146.95 108.07 4.22 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.417 1.073 . . . . 75.340000000000003 109.278 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.09 143.28 54.24 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.461 1.1 . . . . 64.420000000000002 110.361 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.627 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.8 m -139.9 -169.01 2.63 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.525 1.14 . . . . 70.519999999999996 110.378 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.627 ' H ' HG22 ' A' ' 176' ' ' THR . 77.9 m-85 -130.94 147.43 52.58 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.448 1.092 . . . . 63.420000000000002 111.021 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.467 HG23 ' C ' ' A' ' 163' ' ' LEU . 1.9 p -59.15 155.55 2.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.576 1.172 . . . . 71.530000000000001 109.285 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 61.51 41.39 99.55 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.444 1.09 . . . . 43.140000000000001 110.972 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -121.84 171.33 8.98 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.428 0.723 . . . . 43.329999999999998 110.273 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -119.03 131.57 55.99 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.494 1.121 . . . . 75.239999999999995 109.318 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.809 HD12 HG21 ' A' ' 162' ' ' VAL . 18.2 mt -140.61 124.38 17.16 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.501 1.126 . . . . 70.349999999999994 109.332 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -79.25 128.32 33.16 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.471 1.107 . . . . 75.450000000000003 111.01 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.771 HD11 ' HB3' ' A' ' 160' ' ' ALA . 15.6 mm -77.68 121.29 30.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.453 1.096 . . . . 74.439999999999998 109.359 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.43 ' HB2' HG22 ' A' ' 194' ' ' ILE . 62.9 m -95.73 -31.37 13.25 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.494 1.121 . . . . 71.319999999999993 108.248 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.57 ' HB1' ' N ' ' A' ' 239' ' ' VAL . . . -164.03 161.66 22.73 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.498 1.124 . . . . 62.049999999999997 109.247 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.566 ' CE1' HG21 ' A' ' 231' ' ' ILE . 9.0 p80 -128.74 147.4 50.77 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.552 1.157 . . . . 74.040000000000006 109.577 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.574 ' CG ' HG11 ' A' ' 239' ' ' VAL . 0.7 OUTLIER -120.91 119.17 31.85 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.51 1.131 . . . . 70.400000000000006 109.542 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.554 ' CB ' ' HG2' ' A' ' 191' ' ' GLU . 5.5 m-80 48.62 37.92 10.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 73.049999999999997 109.302 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.5 p 38.72 38.77 0.29 Allowed 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.501 1.125 . . . . 63.329999999999998 108.251 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 1.002 ' O ' HG23 ' A' ' 209' ' ' VAL . 11.6 pt-20 -132.52 -37.52 1.06 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.509 1.131 . . . . 61.310000000000002 110.289 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.476 ' N ' ' HG3' ' A' ' 191' ' ' GLU . 20.8 m95 -113.51 163.1 15.35 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.482 1.114 . . . . 75.409999999999997 108.088 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.892 ' CE2' HG22 ' A' ' 209' ' ' VAL . 13.7 m-85 -133.59 161.72 33.87 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 74.109999999999999 111.002 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.602 HG21 ' CZ3' ' A' ' 242' ' ' TRP . 20.0 mm -111.92 95.38 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.145 . . . . 61.549999999999997 109.248 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.573 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -86.3 -175.18 5.39 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.532 1.145 . . . . 71.310000000000002 109.364 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.4 pttp . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 72.510000000000005 109.266 -179.938 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.041 0 N-CA-C 110.926 -0.87 . . . . 60.439999999999998 110.926 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.549 ' HB2' HG23 ' A' ' 194' ' ' ILE . 18.5 Cg_endo -74.89 144.95 82.57 Favored 'Cis proline' 0 C--N 1.361 1.2 0 C-N-CA 120.967 -2.514 . . . . 72.219999999999999 111.095 -0.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.993 ' CA ' HD23 ' A' ' 174' ' ' LEU . . . -106.99 160.06 14.38 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.509 1.13 . . . . 72.400000000000006 110.981 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.91 HD13 ' HD2' ' A' ' 170' ' ' LYS . 2.6 mt -103.55 139.63 38.61 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.465 0.744 . . . . 74.010000000000005 109.271 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.791 HG21 HG11 ' A' ' 212' ' ' VAL . 0.2 OUTLIER -143.89 127.52 9.03 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.49 1.119 . . . . 74.109999999999999 109.244 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.497 ' HG2' ' CD2' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.98 157.72 42.7 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.493 1.786 . . . . 75.530000000000001 111.043 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 1.002 HG23 ' O ' ' A' ' 191' ' ' GLU . 21.3 t -80.94 3.26 2.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.547 1.154 . . . . 62.109999999999999 109.311 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLY . . . . . 0.431 ' O ' ' CD1' ' A' ' 211' ' ' PHE . . . -89.16 -3.01 76.56 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.467 1.105 . . . . 52.399999999999999 110.942 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.497 ' CD2' ' HG2' ' A' ' 208' ' ' PRO . 21.4 m-85 -136.69 14.59 3.15 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.474 0.749 . . . . 55.140000000000001 110.972 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.791 HG11 HG21 ' A' ' 207' ' ' VAL . 8.7 m -142.4 146.94 21.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.464 1.102 . . . . 72.129999999999995 109.324 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.898 ' HB2' HD21 ' A' ' 163' ' ' LEU . 26.0 t -129.33 160.76 32.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.551 1.157 . . . . 71.519999999999996 110.011 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.6 HG13 HG23 ' A' ' 227' ' ' VAL . 16.6 mm -102.65 145.75 11.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 75.219999999999999 109.306 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.53 ' O ' ' CE2' ' A' ' 159' ' ' TYR . 44.3 pt . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.571 1.17 . . . . 63.240000000000002 109.205 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 110.402 -0.222 . . . . 72.349999999999994 110.402 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 106.88 -0.58 36.0 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.51 1.132 . . . . 61.350000000000001 111.037 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -70.02 -175.92 1.03 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.528 0.781 . . . . 71.329999999999998 109.3 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -114.08 173.22 6.55 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.493 1.12 . . . . 64.420000000000002 109.352 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.854 HG13 HD12 ' A' ' 228' ' ' ILE . 2.8 p -84.16 -33.56 9.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.371 1.044 . . . . 64.109999999999999 109.329 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.854 HD12 HG13 ' A' ' 227' ' ' VAL . 1.8 mp -61.24 -50.87 78.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.498 1.123 . . . . 74.150000000000006 109.363 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -58.28 -31.42 67.45 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 61.439999999999998 110.351 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.449 ' HB3' HD11 ' A' ' 158' ' ' LEU . 1.0 OUTLIER -77.54 -35.74 52.96 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.497 1.123 . . . . 64.140000000000001 109.354 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.647 ' CD1' HG22 ' A' ' 227' ' ' VAL . 29.7 mt -68.34 -38.43 79.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.131 . . . . 73.540000000000006 109.29 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.29 -33.85 59.08 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.536 1.147 . . . . 74.540000000000006 109.336 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.7 m -58.79 -38.24 78.1 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.561 1.163 . . . . 73.409999999999997 109.989 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.0 p -112.6 6.93 8.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.494 1.121 . . . . 74.530000000000001 109.325 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 235' ' ' ASN . 2.4 p-10 40.46 51.72 2.91 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.471 1.107 . . . . 74.299999999999997 109.269 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.534 HD23 ' HD2' ' A' ' 237' ' ' PRO . 1.1 tt -50.79 140.72 19.3 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.554 1.159 . . . . 71.230000000000004 109.369 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.534 ' HD2' HD23 ' A' ' 236' ' ' LEU . 18.1 Cg_endo -75.06 129.45 12.3 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.55 1.816 . . . . 64.109999999999999 111.002 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 3.0 p -67.17 152.39 45.84 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.479 1.112 . . . . 72.439999999999998 110.353 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.574 HG11 ' CG ' ' A' ' 188' ' ' HIS . 1.7 p -46.99 -25.58 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.544 1.153 . . . . 62.450000000000003 109.286 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -86.63 -50.43 6.81 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 71.299999999999997 110.337 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -57.1 -25.15 58.3 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.548 1.155 . . . . 74.540000000000006 110.249 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.602 ' CZ3' HG21 ' A' ' 194' ' ' ILE . 26.9 t90 -85.77 -61.85 1.66 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 74.439999999999998 108.022 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -50.88 -23.2 2.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.433 1.083 . . . . 70.010000000000005 109.284 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.9 t -86.85 -61.81 1.64 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.413 1.071 . . . . 75.209999999999994 110.007 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 C--N 1.324 -0.507 0 O-C-N 124.518 1.136 . . . . 73.409999999999997 109.289 179.946 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.723 ' HB2' HG11 ' A' ' 234' ' ' VAL . 61.4 tp . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.3 -0.63 . . . . 74.219999999999999 109.3 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.476 ' HB3' ' CE2' ' A' ' 183' ' ' PHE . 33.8 p90 -103.65 144.11 31.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.512 1.132 . . . . 75.219999999999999 110.998 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.458 ' CB ' HG12 ' A' ' 184' ' ' ILE . . . -140.83 141.83 34.67 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.557 1.161 . . . . 45.229999999999997 109.315 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.5 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -109.07 133.73 53.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 72.439999999999998 109.329 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.752 HG13 ' O ' ' A' ' 211' ' ' PHE . 3.4 t -86.05 125.1 40.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.452 1.095 . . . . 73.450000000000003 109.378 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.778 HD23 ' N ' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -112.88 12.88 19.53 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.538 1.149 . . . . 63.329999999999998 109.317 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.462 ' O ' HG12 ' A' ' 162' ' ' VAL . 97.4 m-85 -158.24 145.14 17.73 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.467 1.105 . . . . 73.140000000000001 111.02 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -79.92 103.01 9.52 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.406 1.066 . . . . 63.350000000000001 109.277 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.526 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 7.4 t80 -83.1 137.82 33.94 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 73.140000000000001 111.015 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.474 ' CE ' ' HA ' ' A' ' 167' ' ' LYS . 0.5 OUTLIER -105.47 123.54 48.06 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.532 1.145 . . . . 70.219999999999999 109.304 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.814 ' HB1' ' CG ' ' A' ' 173' ' ' GLU . . . -71.0 123.26 21.64 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.595 1.185 . . . . 75.140000000000001 109.313 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -126.78 -34.16 2.42 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.541 1.151 . . . . 72.409999999999997 110.309 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 0.4 OUTLIER -58.62 -164.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 O-C-N 124.435 1.084 . . . . 72.299999999999997 109.316 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.34 -51.22 5.67 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.487 1.117 . . . . 73.519999999999996 109.266 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.64 29.42 6.96 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.521 1.138 . . . . 72.150000000000006 109.287 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.814 ' CG ' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -58.95 -178.42 0.05 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.561 1.163 . . . . 75.25 110.251 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.834 HD23 ' HA3' ' A' ' 205' ' ' GLY . 0.0 OUTLIER -147.54 119.97 8.46 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.544 1.153 . . . . 71.319999999999993 109.277 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.53 130.41 35.95 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.555 1.159 . . . . 62.109999999999999 110.439 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.573 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.7 m -126.91 -176.08 3.6 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.593 1.183 . . . . 75.510000000000005 110.435 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.573 ' H ' HG22 ' A' ' 176' ' ' THR . 23.9 m-85 -136.09 143.35 44.56 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.558 1.161 . . . . 64.219999999999999 110.987 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.5 p -56.24 147.28 4.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.469 1.106 . . . . 64.510000000000005 109.291 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.81 58.07 13.85 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.495 1.122 . . . . 51.119999999999997 111.034 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.5 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 10.9 tp10 -121.83 166.16 14.8 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.547 0.792 . . . . 74.530000000000001 110.303 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -119.35 133.44 55.72 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.442 1.089 . . . . 71.310000000000002 109.292 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.666 ' C ' HD12 ' A' ' 182' ' ' LEU . 1.2 pp -166.93 -175.45 3.05 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.546 1.154 . . . . 71.209999999999994 109.309 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 159' ' ' TYR . 22.4 m-85 -134.07 139.91 46.29 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.474 1.109 . . . . 72.200000000000003 110.998 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.904 HD12 ' HB3' ' A' ' 193' ' ' PHE . 27.9 mm -77.7 138.08 21.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.487 1.117 . . . . 65.319999999999993 109.337 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.561 ' O ' HD11 ' A' ' 236' ' ' LEU . 0.6 OUTLIER -95.1 -28.13 15.24 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.102 . . . . 62.229999999999997 108.338 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.583 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -172.41 179.56 2.49 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.497 1.123 . . . . 70.230000000000004 109.325 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.814 ' CD2' HG21 ' A' ' 231' ' ' ILE . 8.5 p80 -136.56 154.32 50.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.486 1.116 . . . . 73.030000000000001 109.607 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.521 ' CD2' ' HB2' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -126.97 117.94 23.51 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.469 1.106 . . . . 64.25 109.511 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.568 ' CB ' ' HG2' ' A' ' 191' ' ' GLU . 2.2 m120 50.85 33.91 9.41 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.479 1.112 . . . . 73.0 109.292 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.465 ' HB3' ' CG1' ' A' ' 228' ' ' ILE . 99.2 m 43.77 38.16 1.93 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.473 1.108 . . . . 54.109999999999999 108.286 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.568 ' HG2' ' CB ' ' A' ' 189' ' ' ASN . 8.3 pt-20 -135.26 -40.51 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.562 1.164 . . . . 71.420000000000002 110.318 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.521 ' HB2' ' CD2' ' A' ' 188' ' ' HIS . 24.9 m95 -107.23 165.78 11.12 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.989 -1.115 . . . . 74.219999999999999 107.989 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.924 ' CE2' HG23 ' A' ' 209' ' ' VAL . 12.4 m-85 -137.79 159.03 43.11 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.499 1.124 . . . . 74.219999999999999 110.978 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.583 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 21.1 mm -100.37 114.43 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.504 1.127 . . . . 74.129999999999995 109.288 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.737 ' HB2' ' CG1' ' A' ' 207' ' ' VAL . . . -92.59 168.07 11.49 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.543 1.152 . . . . 75.230000000000004 109.273 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.496 ' CG ' ' O ' ' A' ' 196' ' ' LYS . 1.8 pttt . . . . . 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.128 . . . . 73.25 109.34 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.032 0 N-CA-C 111.014 -0.834 . . . . 62.240000000000002 111.014 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 18.3 Cg_endo -74.98 145.22 83.34 Favored 'Cis proline' 0 C--N 1.359 1.118 0 C-N-CA 121.048 -2.48 . . . . 73.120000000000005 111.017 0.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.834 ' HA3' HD23 ' A' ' 174' ' ' LEU . . . -119.09 -166.01 13.31 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.597 1.186 . . . . 65.510000000000005 111.006 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.486 HD23 HD13 ' A' ' 194' ' ' ILE . 3.1 mt -119.69 142.74 48.22 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.422 0.719 . . . . 43.219999999999999 109.302 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.737 ' CG1' ' HB2' ' A' ' 195' ' ' ALA . 1.6 m -143.9 155.06 59.32 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.487 1.117 . . . . 73.439999999999998 109.323 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.579 ' HG2' ' CD1' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.93 160.44 40.35 Favored 'Trans proline' 0 C--N 1.359 1.108 0 O-C-N 124.53 1.805 . . . . 74.319999999999993 111.055 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.924 HG23 ' CE2' ' A' ' 193' ' ' PHE . 10.1 p -84.97 -19.04 8.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 51.25 109.349 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -82.83 9.33 60.05 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.487 1.117 . . . . 70.120000000000005 110.994 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.752 ' O ' HG13 ' A' ' 162' ' ' VAL . 11.2 m-85 -128.46 18.67 6.35 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 0.768 . . . . 71.530000000000001 111.009 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.565 HG21 ' CD2' ' A' ' 193' ' ' PHE . 31.7 m -156.9 144.5 10.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.496 1.123 . . . . 65.0 109.333 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 22.3 t -134.73 140.19 45.76 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 72.540000000000006 110.03 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.868 HG21 ' CG ' ' A' ' 230' ' ' ASP . 11.0 mm -86.82 89.3 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.53 1.144 . . . . 73.010000000000005 109.339 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.426 ' CG2' ' C ' ' A' ' 214' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.501 1.125 . . . . 72.430000000000007 109.262 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 73.3 p . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 110.453 -0.203 . . . . 71.120000000000005 110.453 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 113.21 13.54 10.72 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.531 1.145 . . . . 70.549999999999997 111.008 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -88.49 -176.81 5.44 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.5 0.765 . . . . 63.140000000000001 109.331 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -130.1 171.28 13.0 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.526 1.141 . . . . 63.100000000000001 109.25 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.774 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 12.6 p -78.25 -40.88 25.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.478 1.111 . . . . 74.230000000000004 109.318 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.838 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.1 mp -50.7 -53.41 13.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.519 1.137 . . . . 72.430000000000007 109.386 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -61.82 -33.08 73.49 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.458 1.099 . . . . 74.200000000000003 110.286 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.868 ' CG ' HG21 ' A' ' 214' ' ' ILE . 1.1 m-20 -70.86 -30.5 66.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.492 1.12 . . . . 61.43 109.294 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 228' ' ' ILE . 19.2 mt -68.93 -36.25 73.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.529 1.143 . . . . 65.519999999999996 109.305 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -74.61 -20.53 59.88 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.53 1.144 . . . . 74.439999999999998 109.295 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 6.7 p -68.64 -34.66 76.11 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.44 1.087 . . . . 71.319999999999993 110.014 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.723 HG11 ' HB2' ' A' ' 158' ' ' LEU . 6.8 p -114.75 19.0 7.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.549 1.155 . . . . 72.129999999999995 109.267 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 43.06 28.17 0.13 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.567 1.167 . . . . 63.350000000000001 109.341 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.717 ' HB3' HG23 ' A' ' 231' ' ' ILE . 18.8 tp -51.55 109.95 1.61 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.48 1.112 . . . . 72.310000000000002 109.321 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.93 137.21 21.59 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.519 1.799 . . . . 75.25 110.966 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.617 HG22 ' CE1' ' A' ' 187' ' ' HIS . 10.2 p -57.04 157.97 5.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 71.420000000000002 110.37 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.473 ' CG1' ' HB2' ' A' ' 188' ' ' HIS . 1.5 p -54.04 -27.99 16.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.443 1.089 . . . . 72.340000000000003 109.261 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -80.03 -30.7 39.54 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.454 1.096 . . . . 63.530000000000001 110.327 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -81.78 -24.06 36.22 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.517 1.136 . . . . 71.5 110.282 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.443 ' O ' ' N ' ' A' ' 245' ' ' ASN . 9.5 t90 -83.3 -66.39 0.9 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.12 . . . . 73.040000000000006 108.046 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.5 -29.86 0.1 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.514 1.134 . . . . 74.420000000000002 109.282 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.433 ' N ' ' C ' ' A' ' 242' ' ' TRP . 47.4 t -64.16 -52.85 57.05 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.439 1.087 . . . . 64.439999999999998 110.004 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 242' ' ' TRP . 22.3 m-80 . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.479 1.112 . . . . 74.239999999999995 109.355 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.867 ' HG ' HG11 ' A' ' 234' ' ' VAL . 8.2 mt . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 109.262 -0.644 . . . . 73.049999999999997 109.262 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.584 ' CD1' ' C ' ' A' ' 158' ' ' LEU . 36.4 m-85 -157.56 115.06 3.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.493 1.121 . . . . 72.430000000000007 111.031 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.522 ' HB2' HD11 ' A' ' 214' ' ' ILE . . . -114.79 133.21 56.11 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.471 1.107 . . . . 74.430000000000007 109.292 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.565 HD12 ' O ' ' A' ' 180' ' ' GLU . 0.4 OUTLIER -100.62 130.78 49.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.449 1.093 . . . . 64.140000000000001 109.27 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.587 HG13 HG12 ' A' ' 212' ' ' VAL . 2.0 t -88.84 127.72 41.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.512 1.133 . . . . 72.430000000000007 109.365 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.728 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.1 OUTLIER -107.39 -5.97 17.41 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.477 1.111 . . . . 63.310000000000002 109.379 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.636 ' HE2' HD12 ' A' ' 163' ' ' LEU . 96.3 m-85 -147.05 147.34 30.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 73.219999999999999 111.059 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.676 ' N ' HG12 ' A' ' 178' ' ' VAL . 0.2 OUTLIER -79.4 111.71 15.92 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.47 1.106 . . . . 71.420000000000002 109.325 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.629 ' CG ' ' CD ' ' A' ' 208' ' ' PRO . 7.9 t80 -80.51 150.17 29.74 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.597 1.185 . . . . 75.109999999999999 111.002 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.545 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 0.1 OUTLIER -108.26 132.4 53.71 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.412 1.07 . . . . 73.230000000000004 109.272 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.822 ' HB1' ' OE2' ' A' ' 173' ' ' GLU . . . -78.47 127.51 32.28 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.598 1.186 . . . . 71.549999999999997 109.282 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.412 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 17.2 pt-20 -130.35 -33.18 1.71 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.498 1.124 . . . . 75.540000000000006 110.263 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -58.04 -166.15 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.567 1.167 . . . . 63.020000000000003 109.304 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.96 -45.35 9.26 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.497 1.123 . . . . 61.009999999999998 109.333 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -111.23 28.66 8.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 1.117 . . . . 74.200000000000003 109.326 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.822 ' OE2' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -63.44 -176.76 0.17 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.442 1.089 . . . . 74.340000000000003 110.298 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 174' ' ' LEU . 13.8 mt -157.25 133.15 9.43 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.509 1.131 . . . . 74.299999999999997 109.22 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.72 130.97 35.24 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.498 1.124 . . . . 61.520000000000003 110.387 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.6 m -111.11 -176.82 3.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.505 1.128 . . . . 75.049999999999997 110.373 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.543 ' H ' HG22 ' A' ' 176' ' ' THR . 15.5 m-85 -130.12 157.25 42.93 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.517 1.136 . . . . 73.430000000000007 110.944 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.676 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.0 OUTLIER -67.33 162.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.405 1.065 . . . . 60.350000000000001 109.252 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 37.28 61.34 1.01 Allowed Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.456 1.098 . . . . 64.319999999999993 110.997 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.565 ' O ' HD12 ' A' ' 161' ' ' ILE . 2.9 mm-40 -121.2 176.82 5.42 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 0.778 . . . . 64.140000000000001 110.298 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.464 ' C ' HD13 ' A' ' 182' ' ' LEU . 7.1 t30 -146.71 134.48 21.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.458 1.099 . . . . 75.209999999999994 109.28 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.62 ' O ' HD22 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -166.48 160.32 15.31 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.494 1.121 . . . . 75.140000000000001 109.284 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.434 ' CE1' ' O ' ' A' ' 184' ' ' ILE . 5.5 t80 -92.07 137.21 32.55 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.593 1.183 . . . . 73.510000000000005 111.04 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.912 HD12 ' HB3' ' A' ' 193' ' ' PHE . 42.7 mm -77.54 124.78 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.496 1.122 . . . . 73.439999999999998 109.291 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.429 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 10.2 t -79.94 -26.24 40.15 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 50.149999999999999 108.274 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.571 ' HB3' HG13 ' A' ' 194' ' ' ILE . . . -176.84 166.95 2.56 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 43.409999999999997 109.312 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.6 ' CE1' HG22 ' A' ' 238' ' ' THR . 8.2 p80 -123.42 151.01 43.07 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.497 1.123 . . . . 71.010000000000005 109.545 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.619 ' HB2' HG11 ' A' ' 239' ' ' VAL . 3.8 t-160 -124.76 112.95 17.31 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.498 1.124 . . . . 75.519999999999996 109.556 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.401 ' C ' ' N ' ' A' ' 191' ' ' GLU . 8.4 t-20 57.26 23.45 8.78 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.547 1.154 . . . . 64.120000000000005 109.32 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.481 ' HG ' ' CE1' ' A' ' 187' ' ' HIS . 6.8 m 53.08 21.46 2.13 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.484 1.115 . . . . 51.539999999999999 108.235 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.484 ' O ' HG12 ' A' ' 209' ' ' VAL . 5.0 pt-20 -116.95 -31.95 5.24 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.465 1.103 . . . . 75.439999999999998 110.27 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.413 ' N ' ' HG2' ' A' ' 191' ' ' GLU . 4.3 m0 -118.92 166.45 12.83 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.923 -1.14 . . . . 74.120000000000005 107.923 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.912 ' HB3' HD12 ' A' ' 184' ' ' ILE . 36.3 m-85 -140.44 162.07 36.2 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.454 1.096 . . . . 73.140000000000001 111.021 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.571 HG13 ' HB3' ' A' ' 186' ' ' ALA . 34.6 mm -103.16 124.38 57.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.433 1.083 . . . . 63.219999999999999 109.343 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -112.56 174.9 5.67 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.493 1.12 . . . . 63.229999999999997 109.29 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.1 tptp . . . . . 0 C--N 1.324 -0.517 0 O-C-N 124.573 1.17 . . . . 73.209999999999994 109.326 179.96 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.075 0 N-CA-C 110.952 -0.859 . . . . 42.219999999999999 110.952 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.57 ' HG2' ' CH2' ' A' ' 242' ' ' TRP . 18.2 Cg_endo -75.1 165.92 84.6 Favored 'Cis proline' 0 C--N 1.36 1.174 0 C-N-CA 121.012 -2.495 . . . . 64.109999999999999 110.975 0.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.429 ' O ' HG23 ' A' ' 194' ' ' ILE . . . -122.46 179.72 16.11 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.545 1.153 . . . . 64.209999999999994 110.993 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.472 ' HG ' ' CD1' ' A' ' 194' ' ' ILE . 3.8 mp -117.59 168.49 10.37 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.439 0.729 . . . . 64.230000000000004 109.318 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.476 HG23 ' CD2' ' A' ' 166' ' ' PHE . 6.1 p -159.81 140.18 8.78 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.519 1.137 . . . . 64.310000000000002 109.223 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.629 ' CD ' ' CG ' ' A' ' 166' ' ' PHE . 18.1 Cg_endo -75.0 152.2 40.48 Favored 'Trans proline' 0 C--N 1.361 1.21 0 O-C-N 124.505 1.792 . . . . 64.310000000000002 110.997 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.729 ' HA ' HG22 ' A' ' 212' ' ' VAL . 11.6 p -78.83 -18.94 13.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.539 1.149 . . . . 65.219999999999999 109.26 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -73.83 -2.38 61.08 Favored Glycine 0 CA--C 1.531 1.091 0 O-C-N 124.539 1.149 . . . . 61.240000000000002 110.947 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.47 ' CD1' ' HG2' ' A' ' 208' ' ' PRO . 10.3 m-85 -126.52 -0.3 6.87 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.56 0.8 . . . . 73.209999999999994 110.976 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.729 HG22 ' HA ' ' A' ' 209' ' ' VAL . 11.8 m -133.5 153.01 36.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 71.310000000000002 109.326 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.728 ' HB2' HD21 ' A' ' 163' ' ' LEU . 1.7 t -143.2 155.91 44.64 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.5 1.125 . . . . 53.340000000000003 110.05 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.914 HG13 HG23 ' A' ' 227' ' ' VAL . 18.9 mm -111.41 154.26 13.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.507 1.129 . . . . 61.030000000000001 109.308 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.457 HD12 HG21 ' A' ' 161' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 O-C-N 124.513 1.133 . . . . 74.340000000000003 109.247 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 16.4 p . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 110.43 -0.211 . . . . 75.129999999999995 110.43 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 119.65 8.09 9.29 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.583 1.177 . . . . 45.130000000000003 110.982 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -85.44 -178.56 6.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.576 0.809 . . . . 74.420000000000002 109.289 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.2 172.58 10.45 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.5 1.125 . . . . 74.200000000000003 109.298 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.914 HG23 HG13 ' A' ' 214' ' ' ILE . 13.2 p -81.1 -37.76 16.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.548 1.155 . . . . 55.539999999999999 109.319 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.676 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.6 mp -54.69 -53.58 30.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.49 1.119 . . . . 75.430000000000007 109.268 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -55.44 -31.01 61.56 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.575 1.172 . . . . 70.540000000000006 110.306 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.761 ' CG ' HG21 ' A' ' 214' ' ' ILE . 0.5 OUTLIER -77.29 -34.9 55.47 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.509 1.131 . . . . 62.32 109.332 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' A' ' 228' ' ' ILE . 21.3 mt -67.6 -35.13 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.486 1.116 . . . . 73.200000000000003 109.3 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -82.39 -26.97 32.35 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.511 1.132 . . . . 74.010000000000005 109.245 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 46.8 p -60.06 -32.66 71.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.533 1.146 . . . . 74.310000000000002 109.991 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.867 HG11 ' HG ' ' A' ' 158' ' ' LEU . 2.6 p -118.06 10.65 7.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.135 . . . . 62.009999999999998 109.327 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 4.4 m120 40.51 35.79 0.32 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.505 1.128 . . . . 62.009999999999998 109.272 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.559 HD12 ' HD2' ' A' ' 237' ' ' PRO . 0.6 OUTLIER -50.49 144.04 12.84 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.472 1.107 . . . . 70.099999999999994 109.314 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.559 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.5 Cg_endo -74.97 151.45 39.66 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.474 1.776 . . . . 75.439999999999998 111.02 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.6 HG22 ' CE1' ' A' ' 187' ' ' HIS . 2.1 p -86.17 141.29 29.46 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.517 1.136 . . . . 74.329999999999998 110.386 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.619 HG11 ' HB2' ' A' ' 188' ' ' HIS . 4.4 p -42.76 -28.31 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.556 1.16 . . . . 63.200000000000003 109.323 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.474 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 13.0 mm100 -78.78 -46.32 19.07 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.522 1.139 . . . . 50.210000000000001 110.249 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 238' ' ' THR . 17.3 mt-10 -66.3 -19.79 65.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.448 1.092 . . . . 72.310000000000002 110.273 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.57 ' CH2' ' HG2' ' A' ' 204' ' ' PRO . 2.0 t90 -81.37 -70.37 0.54 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 73.430000000000007 107.979 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -40.39 -29.93 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.398 1.061 . . . . 72.319999999999993 109.301 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.423 ' N ' ' C ' ' A' ' 242' ' ' TRP . 5.2 t -84.32 -59.24 2.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 60.210000000000001 110.044 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 . . . . . 0 C--N 1.326 -0.456 0 O-C-N 124.493 1.121 . . . . 71.319999999999993 109.254 179.97 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.437 HD11 ' HB3' ' A' ' 230' ' ' ASP . 11.4 tp . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 109.275 -0.639 . . . . 74.209999999999994 109.275 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -132.04 130.58 41.53 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.466 1.104 . . . . 75.200000000000003 110.97 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.491 ' O ' HD12 ' A' ' 182' ' ' LEU . . . -144.58 151.01 38.42 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.127 . . . . 55.210000000000001 109.259 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.63 129.19 74.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.54 1.15 . . . . 71.540000000000006 109.322 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.959 ' CG2' HD21 ' A' ' 182' ' ' LEU . 1.9 t -76.96 132.64 32.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.557 1.161 . . . . 61.399999999999999 109.302 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.932 ' O ' HG23 ' A' ' 178' ' ' VAL . 0.2 OUTLIER -111.56 -7.38 14.31 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.572 1.17 . . . . 73.219999999999999 109.317 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.435 ' HB2' ' CD2' ' A' ' 211' ' ' PHE . 90.0 m-85 -142.23 143.56 32.95 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.548 1.155 . . . . 61.149999999999999 111.019 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.41 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 4.6 t0 -73.26 108.17 5.99 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.532 1.145 . . . . 75.019999999999996 109.326 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.684 ' CG ' HG13 ' A' ' 207' ' ' VAL . 3.8 t80 -80.41 147.31 31.05 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.533 1.146 . . . . 72.099999999999994 110.948 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.06 137.9 44.25 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.503 1.127 . . . . 71.219999999999999 109.29 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.828 ' HB1' ' OE1' ' A' ' 173' ' ' GLU . . . -89.45 122.74 32.93 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.547 1.154 . . . . 41.520000000000003 109.301 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.426 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 10.0 pt-20 -126.3 -29.42 2.99 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.484 1.115 . . . . 73.030000000000001 110.294 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 4.2 tttp -59.09 -173.34 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.463 1.102 . . . . 72.530000000000001 109.263 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.82 -29.49 17.54 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.394 1.059 . . . . 72.409999999999997 109.267 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.47 28.36 6.65 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.601 1.188 . . . . 74.109999999999999 109.323 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.828 ' OE1' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -68.49 -176.37 0.77 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.541 1.151 . . . . 74.150000000000006 110.319 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.433 ' HB2' ' CA ' ' A' ' 205' ' ' GLY . 0.1 OUTLIER -157.49 110.67 2.51 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.457 1.098 . . . . 72.329999999999998 109.329 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.1 t -68.29 136.2 53.1 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.465 1.103 . . . . 63.439999999999998 110.379 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.692 HG22 ' H ' ' A' ' 177' ' ' TYR . 3.2 m -120.38 -164.3 1.08 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.567 1.167 . . . . 64.340000000000003 110.437 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.692 ' H ' HG22 ' A' ' 176' ' ' THR . 31.3 m-85 -128.47 173.61 10.08 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.433 1.083 . . . . 63.409999999999997 111.008 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 163' ' ' LEU . 1.4 p -93.67 137.46 22.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.469 1.106 . . . . 63.240000000000002 109.349 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 67.16 52.58 31.12 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.451 1.094 . . . . 32.350000000000001 110.972 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.479 ' OE1' ' CB ' ' A' ' 177' ' ' TYR . 2.4 mp0 -121.9 165.67 15.58 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.542 0.789 . . . . 73.219999999999999 110.293 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.85 126.82 54.46 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.501 1.126 . . . . 72.420000000000002 109.369 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.959 HD21 ' CG2' ' A' ' 162' ' ' VAL . 0.4 OUTLIER -148.97 177.79 9.26 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.473 1.108 . . . . 63.420000000000002 109.327 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -122.85 131.13 53.61 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.532 1.145 . . . . 75.329999999999998 111.044 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.907 HD12 ' HB3' ' A' ' 193' ' ' PHE . 38.3 mm -77.52 122.63 32.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.488 1.117 . . . . 73.400000000000006 109.344 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.556 ' C ' HD11 ' A' ' 236' ' ' LEU . 3.6 m -85.42 -28.97 24.75 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.122 . . . . 71.409999999999997 108.302 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -167.22 179.58 5.02 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.484 1.115 . . . . 71.319999999999993 109.252 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.468 ' NE2' HG21 ' A' ' 231' ' ' ILE . 7.5 p80 -136.26 154.65 50.84 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 75.340000000000003 109.605 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.471 ' CD2' ' HB2' ' A' ' 189' ' ' ASN . 0.2 OUTLIER -128.98 111.91 13.51 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.536 1.147 . . . . 71.109999999999999 109.596 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.471 ' HB2' ' CD2' ' A' ' 188' ' ' HIS . 1.2 m-20 58.65 21.53 8.87 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.544 1.152 . . . . 61.109999999999999 109.36 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 69.9 m 56.33 19.2 3.82 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.495 1.122 . . . . 54.530000000000001 108.332 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.462 ' HG2' ' CB ' ' A' ' 189' ' ' ASN . 6.7 pt-20 -116.52 -31.74 5.45 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.566 1.166 . . . . 73.519999999999996 110.325 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.425 ' N ' ' HG3' ' A' ' 191' ' ' GLU . 16.7 m0 -115.33 165.12 13.31 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.613 1.196 . . . . 64.549999999999997 108.012 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.907 ' HB3' HD12 ' A' ' 184' ' ' ILE . 9.0 m-85 -143.87 159.16 43.03 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.518 1.136 . . . . 74.430000000000007 111.006 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.468 ' CG1' ' HB ' ' A' ' 239' ' ' VAL . 19.9 mm -100.9 121.91 52.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.525 1.141 . . . . 71.409999999999997 109.341 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -118.78 170.83 8.66 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.572 1.17 . . . . 64.430000000000007 109.336 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.498 1.123 . . . . 73.519999999999996 109.271 -179.999 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.971 0 N-CA-C 110.994 -0.842 . . . . 74.349999999999994 110.994 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 145.06 82.88 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 120.951 -2.52 . . . . 70.150000000000006 111.015 0.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 194' ' ' ILE . . . -90.61 156.73 24.97 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.531 1.145 . . . . 54.43 111.021 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.604 ' O ' ' CZ ' ' A' ' 166' ' ' PHE . 1.5 mt -119.94 135.74 54.79 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 0.763 . . . . 74.349999999999994 109.269 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.684 HG13 ' CG ' ' A' ' 166' ' ' PHE . 0.6 OUTLIER -148.17 139.37 13.64 Favored Pre-proline 0 C--N 1.323 -0.547 0 O-C-N 124.519 1.137 . . . . 71.019999999999996 109.34 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.573 ' HD2' HG12 ' A' ' 207' ' ' VAL . 18.3 Cg_endo -75.03 152.98 41.27 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.51 1.795 . . . . 74.310000000000002 110.979 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.615 ' HA ' HG22 ' A' ' 212' ' ' VAL . 3.9 p -67.57 -25.16 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.481 1.113 . . . . 71.049999999999997 109.314 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -67.51 -8.07 49.8 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.505 1.128 . . . . 43.210000000000001 111.016 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.609 ' O ' HG13 ' A' ' 162' ' ' VAL . 8.0 m-85 -120.08 15.57 12.4 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.5 0.765 . . . . 74.319999999999993 111.008 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.615 HG22 ' HA ' ' A' ' 209' ' ' VAL . 17.7 m -154.3 144.49 13.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.497 1.123 . . . . 43.009999999999998 109.291 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 42.0 t -128.27 147.91 50.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.495 1.122 . . . . 70.109999999999999 110.018 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 215' ' ' ILE . 23.0 mm -91.81 146.54 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.413 1.071 . . . . 62.119999999999997 109.258 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 214' ' ' ILE . 2.7 pp . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.464 1.102 . . . . 71.150000000000006 109.291 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.5 p . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 110.376 -0.231 . . . . 71.239999999999995 110.376 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 137.88 -11.8 3.65 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.5 1.125 . . . . 60.119999999999997 111.036 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.74 179.86 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.518 0.775 . . . . 74.430000000000007 109.353 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -118.74 172.48 7.48 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.484 1.115 . . . . 54.450000000000003 109.223 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.73 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 11.1 p -83.18 -40.49 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.459 1.099 . . . . 74.409999999999997 109.28 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.596 ' HA ' HD12 ' A' ' 231' ' ' ILE . 3.6 mp -55.14 -43.84 72.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.547 1.154 . . . . 64.439999999999998 109.28 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -66.04 -35.12 79.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.517 1.135 . . . . 52.140000000000001 110.311 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.437 ' HB3' HD11 ' A' ' 158' ' ' LEU . 1.1 m-20 -79.01 -21.43 46.97 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.515 1.135 . . . . 75.540000000000006 109.355 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 228' ' ' ILE . 21.6 mt -69.14 -36.74 74.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.485 1.116 . . . . 64.340000000000003 109.33 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -78.03 -28.67 49.08 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.553 1.158 . . . . 72.530000000000001 109.314 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.3 m -56.14 -40.14 73.35 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.459 1.1 . . . . 71.030000000000001 110.003 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.593 ' O ' HG22 ' A' ' 234' ' ' VAL . 7.2 p -111.65 21.29 5.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.521 1.138 . . . . 74.349999999999994 109.235 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 40.85 29.67 0.08 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.439 1.087 . . . . 73.030000000000001 109.251 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.581 ' HB2' HG13 ' A' ' 234' ' ' VAL . 38.7 tp -44.25 110.24 0.97 Allowed Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 73.219999999999999 109.3 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.07 140.88 25.79 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.589 1.836 . . . . 64.510000000000005 111.011 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 5.8 p -57.52 150.08 19.73 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.503 1.127 . . . . 72.349999999999994 110.367 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.468 ' HB ' ' CG1' ' A' ' 194' ' ' ILE . 0.9 OUTLIER -47.26 -25.6 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.474 1.109 . . . . 53.030000000000001 109.351 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -83.51 -49.63 9.06 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 72.340000000000003 110.319 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -56.94 -28.86 62.6 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.566 1.166 . . . . 73.109999999999999 110.361 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -78.13 -70.58 0.48 Allowed 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.478 1.111 . . . . 64.150000000000006 108.067 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.1 ptmm? -41.8 -33.75 0.55 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.435 1.084 . . . . 60.219999999999999 109.348 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 27.0 t -61.4 -59.0 5.93 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.476 1.11 . . . . 71.310000000000002 110.032 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.465 1.103 . . . . 70.230000000000004 109.325 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.784 HD22 HG21 ' A' ' 234' ' ' VAL . 33.9 tp . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.283 -0.636 . . . . 73.120000000000005 109.283 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.435 ' CD1' ' C ' ' A' ' 158' ' ' LEU . 3.0 m-85 -136.43 136.55 39.62 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.519 1.137 . . . . 74.209999999999994 111.004 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.469 ' HB2' ' CD1' ' A' ' 214' ' ' ILE . . . -125.92 136.76 53.4 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.419 1.074 . . . . 72.140000000000001 109.316 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.409 HD13 ' C ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -99.09 126.69 52.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.568 1.168 . . . . 72.310000000000002 109.303 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.74 HG13 ' O ' ' A' ' 211' ' ' PHE . 2.1 t -81.99 125.89 39.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.472 1.107 . . . . 71.310000000000002 109.292 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.491 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.5 OUTLIER -93.08 -28.04 16.59 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 65.340000000000003 109.316 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.66 ' O ' HG12 ' A' ' 162' ' ' VAL . 2.1 m-85 -128.07 -171.93 2.57 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.513 1.133 . . . . 74.409999999999997 110.973 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.524 ' N ' HG12 ' A' ' 178' ' ' VAL . 12.3 t0 -111.27 139.56 46.57 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.516 1.135 . . . . 74.239999999999995 109.363 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.58 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 4.8 t80 -113.11 132.31 55.48 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 73.099999999999994 111.024 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -99.97 101.59 12.73 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.517 1.136 . . . . 71.030000000000001 109.312 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.517 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -55.16 119.21 5.16 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.503 1.127 . . . . 73.540000000000006 109.232 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -115.63 -36.84 4.12 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.419 1.074 . . . . 65.200000000000003 110.341 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.429 ' CB ' ' HB2' ' A' ' 173' ' ' GLU . 5.1 tptt -74.82 152.81 38.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.453 1.096 . . . . 74.409999999999997 109.323 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.34 -28.78 67.15 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.523 1.139 . . . . 64.310000000000002 109.332 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -109.45 28.35 8.62 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.53 1.144 . . . . 72.109999999999999 109.361 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.473 ' HG3' ' CE2' ' A' ' 166' ' ' PHE . 5.6 tp10 -100.61 148.02 25.31 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.463 1.102 . . . . 73.420000000000002 110.247 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.619 HD11 ' HA3' ' A' ' 203' ' ' GLY . 7.7 mt -121.24 141.99 50.35 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 65.200000000000003 109.306 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 166' ' ' PHE . 3.3 m -84.86 155.01 21.92 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.534 1.146 . . . . 63.229999999999997 110.421 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.4 m -142.12 -175.04 4.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.474 1.109 . . . . 74.120000000000005 110.415 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.549 ' H ' HG22 ' A' ' 176' ' ' THR . 13.0 m-85 -139.87 158.33 44.25 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.534 1.146 . . . . 71.120000000000005 111.047 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.0 OUTLIER -67.72 153.64 8.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.49 1.119 . . . . 53.25 109.354 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 37.2 56.71 1.43 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.547 1.155 . . . . 73.140000000000001 110.983 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -120.71 172.33 7.95 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.523 0.778 . . . . 75.0 110.261 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -111.28 119.78 40.04 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.473 1.108 . . . . 74.530000000000001 109.319 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.7 tp -135.88 159.75 40.7 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.422 1.076 . . . . 73.209999999999994 109.283 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 0.4 OUTLIER -122.76 124.78 44.12 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.46 1.1 . . . . 75.349999999999994 110.957 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.773 HD12 ' HB3' ' A' ' 193' ' ' PHE . 23.1 mm -77.54 132.8 31.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.557 1.161 . . . . 75.329999999999998 109.275 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.492 ' C ' HD11 ' A' ' 236' ' ' LEU . 33.9 t -99.65 -27.91 13.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.443 1.089 . . . . 74.239999999999995 108.313 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.818 ' HB3' HG13 ' A' ' 194' ' ' ILE . . . -163.9 177.47 8.54 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.482 1.114 . . . . 41.329999999999998 109.268 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.442 ' NE2' HG21 ' A' ' 231' ' ' ILE . 10.3 p80 -143.54 156.76 44.7 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.431 1.082 . . . . 73.329999999999998 109.632 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.602 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 1.7 t-160 -131.92 116.4 17.11 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.567 1.167 . . . . 74.230000000000004 109.602 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 58.31 20.7 7.49 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.465 1.103 . . . . 64.409999999999997 109.327 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.442 ' HB3' ' CG1' ' A' ' 228' ' ' ILE . 42.5 m 55.79 19.87 3.73 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.438 1.086 . . . . 72.319999999999993 108.331 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 192' ' ' TRP . 4.4 pt-20 -117.02 -32.86 4.91 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.48 1.112 . . . . 73.400000000000006 110.29 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.619 ' HE3' HD22 ' A' ' 206' ' ' LEU . 7.7 m0 -112.4 160.26 17.91 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.542 1.151 . . . . 45.420000000000002 107.999 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.794 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 16.1 m-85 -132.78 161.45 34.05 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.121 . . . . 72.400000000000006 110.94 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.818 HG13 ' HB3' ' A' ' 186' ' ' ALA . 35.5 mm -109.46 120.32 60.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.56 1.162 . . . . 64.010000000000005 109.37 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -96.93 122.85 40.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.12 . . . . 70.5 109.332 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.513 0 O-C-N 124.536 1.148 . . . . 74.310000000000002 109.222 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.619 ' HA3' HD11 ' A' ' 174' ' ' LEU . . . . . . . . 0 CA--C 1.53 0.979 0 N-CA-C 110.995 -0.842 . . . . 41.450000000000003 110.995 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.9 151.97 97.61 Favored 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 120.947 -2.522 . . . . 53.32 111.033 -0.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.93 -164.5 11.08 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.454 1.096 . . . . 71.510000000000005 110.995 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.619 HD22 ' HE3' ' A' ' 192' ' ' TRP . 1.3 mt -109.19 164.6 12.31 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.508 0.769 . . . . 73.230000000000004 109.318 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.62 HG13 ' HB2' ' A' ' 193' ' ' PHE . 0.1 OUTLIER -155.24 137.46 9.95 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.428 1.08 . . . . 64.319999999999993 109.291 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.58 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.2 Cg_endo -75.03 144.32 30.0 Favored 'Trans proline' 0 C--N 1.362 1.243 0 O-C-N 124.44 1.758 . . . . 75.329999999999998 110.991 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.732 HG23 ' CE2' ' A' ' 193' ' ' PHE . 12.6 p -73.41 -16.91 17.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.505 1.128 . . . . 75.010000000000005 109.333 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -77.37 2.35 62.47 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.525 1.141 . . . . 53.020000000000003 110.994 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.74 ' O ' HG13 ' A' ' 162' ' ' VAL . 20.4 m-85 -133.46 23.85 4.06 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.435 0.726 . . . . 74.219999999999999 110.99 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.634 HG21 ' CD2' ' A' ' 193' ' ' PHE . 33.1 m -156.94 148.49 10.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.534 1.146 . . . . 63.210000000000001 109.251 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.491 ' HB2' HD11 ' A' ' 163' ' ' LEU . 3.1 t -133.65 159.29 40.95 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.488 1.117 . . . . 61.009999999999998 109.98 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.868 HG13 HG23 ' A' ' 227' ' ' VAL . 24.2 mm -110.83 102.42 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 72.200000000000003 109.276 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.763 ' C ' HD12 ' A' ' 215' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.324 -0.521 0 O-C-N 124.539 1.149 . . . . 72.549999999999997 109.321 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 77.8 p . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 110.435 -0.209 . . . . 72.310000000000002 110.435 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.53 6.06 17.97 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.534 1.146 . . . . 70.349999999999994 110.995 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -79.43 -179.2 6.67 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.583 0.814 . . . . 73.430000000000007 109.291 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.86 179.98 4.78 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.466 1.104 . . . . 71.120000000000005 109.292 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.868 HG23 HG13 ' A' ' 214' ' ' ILE . 5.6 p -82.1 -32.42 10.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 74.430000000000007 109.296 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.708 ' HA ' HD12 ' A' ' 231' ' ' ILE . 3.0 mp -62.02 -51.36 73.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.41 1.068 . . . . 54.409999999999997 109.323 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -62.1 -19.06 62.58 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.46 1.1 . . . . 64.510000000000005 110.392 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.653 ' O ' HG22 ' A' ' 234' ' ' VAL . 0.8 OUTLIER -88.89 -34.68 16.87 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.49 1.119 . . . . 63.439999999999998 109.263 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.708 HD12 ' HA ' ' A' ' 228' ' ' ILE . 19.5 mt -61.35 -26.39 39.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.534 1.146 . . . . 74.319999999999993 109.284 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -83.57 -11.49 57.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.448 1.092 . . . . 73.25 109.317 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.7 m -93.21 -5.49 49.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.517 1.136 . . . . 71.310000000000002 109.986 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.784 HG21 HD22 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -130.8 7.54 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.429 1.081 . . . . 50.240000000000002 109.317 -179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 4.1 m120 44.44 26.99 0.2 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.463 1.102 . . . . 64.349999999999994 109.288 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.666 HD11 ' HA ' ' A' ' 186' ' ' ALA . 3.5 tp -55.8 113.53 5.86 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.497 1.123 . . . . 71.239999999999995 109.317 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 145.08 31.1 Favored 'Trans proline' 0 C--N 1.361 1.231 0 O-C-N 124.505 1.792 . . . . 72.140000000000001 111.034 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 3.9 p -57.42 161.12 3.62 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.434 1.083 . . . . 73.299999999999997 110.367 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.602 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.8 p -61.32 -24.37 33.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.459 1.1 . . . . 64.200000000000003 109.317 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.513 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 4.4 mm100 -80.85 -36.64 31.19 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.119 . . . . 72.420000000000002 110.31 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -75.4 -25.77 57.88 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.498 1.124 . . . . 61.020000000000003 110.291 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -82.99 -63.61 1.33 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.003 -1.11 . . . . 71.140000000000001 108.003 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -44.04 -30.79 0.78 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.477 1.111 . . . . 61.299999999999997 109.315 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 22.7 t -72.99 -48.16 38.89 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.474 1.109 . . . . 62.32 110.01 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 C--N 1.324 -0.532 0 O-C-N 124.508 1.13 . . . . 60.549999999999997 109.26 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.711 ' CD2' HG11 ' A' ' 234' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 109.277 -0.638 . . . . 51.219999999999999 109.277 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -105.97 126.55 52.32 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.439 1.087 . . . . 75.420000000000002 111.06 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.499 ' HA ' HD13 ' A' ' 214' ' ' ILE . . . -105.66 162.74 13.25 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 51.520000000000003 109.273 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.433 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.0 OUTLIER -130.62 127.51 62.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.471 1.107 . . . . 72.239999999999995 109.26 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.705 ' CG2' HD23 ' A' ' 182' ' ' LEU . 4.9 t -86.14 122.55 38.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.488 1.118 . . . . 62.43 109.318 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.956 ' O ' HG23 ' A' ' 178' ' ' VAL . 0.3 OUTLIER -107.07 -9.42 16.19 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.13 . . . . 75.329999999999998 109.273 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.445 ' O ' HG12 ' A' ' 162' ' ' VAL . 66.7 m-85 -135.13 145.1 47.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.542 1.151 . . . . 75.329999999999998 110.992 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -82.58 104.59 12.96 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.56 1.162 . . . . 75.319999999999993 109.331 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 175' ' ' THR . 1.5 t80 -85.99 122.75 30.48 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.513 1.133 . . . . 62.25 111.007 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.78 99.94 11.3 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.454 1.096 . . . . 75.049999999999997 109.287 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.959 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -47.68 125.45 8.56 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.435 1.084 . . . . 74.120000000000005 109.324 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -120.38 -40.68 2.66 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.496 1.122 . . . . 64.209999999999994 110.289 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.88 170.57 10.88 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.523 1.139 . . . . 62.219999999999999 109.275 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.66 -38.09 62.56 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.497 1.123 . . . . 63.409999999999997 109.299 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -100.07 27.45 5.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.477 1.111 . . . . 63.450000000000003 109.353 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.593 ' OE2' ' CH2' ' A' ' 192' ' ' TRP . 3.5 mm-40 -108.57 153.17 23.76 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 74.409999999999997 110.317 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.959 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 17.3 mt -125.77 159.94 31.07 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.468 1.105 . . . . 63.140000000000001 109.313 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.522 ' N ' ' HB2' ' A' ' 168' ' ' ALA . 15.1 t -101.55 154.04 19.2 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.538 1.149 . . . . 62.310000000000002 110.439 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.3 m -138.25 -168.98 2.48 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.454 1.096 . . . . 74.019999999999996 110.366 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.613 ' H ' HG22 ' A' ' 176' ' ' THR . 54.5 m-85 -138.82 134.33 33.23 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.522 1.139 . . . . 74.430000000000007 111.014 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.956 HG23 ' O ' ' A' ' 163' ' ' LEU . 1.6 p -58.09 146.65 7.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.41 1.069 . . . . 64.129999999999995 109.28 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 58.74 47.17 91.72 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.457 1.098 . . . . 62.530000000000001 110.971 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -121.9 172.37 8.24 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.488 0.758 . . . . 63.109999999999999 110.306 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.25 137.57 54.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.446 1.092 . . . . 64.510000000000005 109.374 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.705 HD23 ' CG2' ' A' ' 162' ' ' VAL . 3.1 pp -158.74 168.19 27.51 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 70.310000000000002 109.25 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.598 ' CE1' ' O ' ' A' ' 184' ' ' ILE . 4.2 t80 -112.13 148.24 34.4 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.487 1.117 . . . . 60.109999999999999 110.997 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.955 HD12 ' HB3' ' A' ' 193' ' ' PHE . 26.4 mm -90.51 134.12 30.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.394 1.059 . . . . 75.439999999999998 109.327 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.49 ' O ' HD11 ' A' ' 236' ' ' LEU . 16.5 t -101.59 -26.02 13.68 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.483 1.114 . . . . 51.310000000000002 108.325 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.707 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -164.27 179.38 6.87 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.135 . . . . 73.099999999999994 109.306 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.624 ' CE1' HG21 ' A' ' 231' ' ' ILE . 44.1 p-80 -138.3 148.71 44.93 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 60.130000000000003 109.566 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.526 ' CG ' ' HB2' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -122.17 114.48 20.92 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.507 1.129 . . . . 54.310000000000002 109.555 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.438 ' C ' ' N ' ' A' ' 191' ' ' GLU . 2.4 m-20 55.8 27.42 10.83 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.541 1.151 . . . . 73.010000000000005 109.272 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 1.5 p 50.81 20.04 0.71 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.569 1.168 . . . . 72.329999999999998 108.303 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.445 ' O ' HG12 ' A' ' 209' ' ' VAL . 1.3 pt-20 -125.0 -10.45 7.14 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.497 1.123 . . . . 71.209999999999994 110.335 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.593 ' CH2' ' OE2' ' A' ' 173' ' ' GLU . 6.8 m95 -130.68 166.58 20.42 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.961 -1.126 . . . . 75.25 107.961 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.955 ' HB3' HD12 ' A' ' 184' ' ' ILE . 31.3 m-85 -139.59 163.31 32.89 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.427 1.079 . . . . 73.430000000000007 110.994 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.707 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 30.0 mm -109.35 117.67 55.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.506 1.129 . . . . 74.109999999999999 109.283 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.505 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -100.43 145.29 28.42 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 64.209999999999994 109.336 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.618 ' HD3' HG22 ' A' ' 194' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 O-C-N 124.534 1.146 . . . . 72.230000000000004 109.228 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.748 ' HA2' HD11 ' A' ' 174' ' ' LEU . . . . . . . . 0 CA--C 1.53 0.975 0 N-CA-C 111.04 -0.824 . . . . 65.25 111.04 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 170.47 71.76 Favored 'Cis proline' 0 C--N 1.359 1.101 0 C-N-CA 121.008 -2.497 . . . . 71.120000000000005 110.986 -0.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.473 ' HA3' HD12 ' A' ' 174' ' ' LEU . . . -134.9 167.06 24.17 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.502 1.126 . . . . 42.420000000000002 110.976 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.575 ' HB3' ' CE3' ' A' ' 192' ' ' TRP . 3.2 mt -108.68 155.32 20.85 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.483 0.755 . . . . 63.340000000000003 109.311 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.731 HG21 HG11 ' A' ' 212' ' ' VAL . 0.2 OUTLIER -156.42 118.28 2.21 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.57 1.169 . . . . 74.420000000000002 109.294 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.509 ' HD3' ' CZ3' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -75.04 137.94 22.28 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.544 1.813 . . . . 61.119999999999997 111.0 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.562 ' HB ' ' CE2' ' A' ' 193' ' ' PHE . 13.3 p -58.26 -17.32 9.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.516 1.135 . . . . 71.319999999999993 109.314 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -71.44 -3.87 55.13 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 124.453 1.096 . . . . 53.340000000000003 111.047 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -128.73 2.39 5.45 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.405 0.709 . . . . 71.439999999999998 111.063 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.731 HG11 HG21 ' A' ' 207' ' ' VAL . 14.8 m -143.34 163.88 16.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.439 1.087 . . . . 74.230000000000004 109.246 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.624 ' HB2' HD11 ' A' ' 163' ' ' LEU . 1.4 t -144.87 160.61 41.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.133 . . . . 71.319999999999993 109.981 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.696 HG13 HG23 ' A' ' 227' ' ' VAL . 28.1 mm -109.23 138.24 37.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.464 1.103 . . . . 62.539999999999999 109.349 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.514 1.134 . . . . 62.119999999999997 109.269 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 69.1 p . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 110.462 -0.199 . . . . 75.439999999999998 110.462 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 105.42 0.53 40.53 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.578 1.174 . . . . 51.43 111.014 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -74.97 -176.15 2.83 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.541 0.789 . . . . 75.299999999999997 109.345 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.22 158.57 38.67 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.493 1.121 . . . . 64.209999999999994 109.285 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.816 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 8.6 p -77.46 -34.86 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.504 1.127 . . . . 74.200000000000003 109.334 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.619 ' HA ' HD12 ' A' ' 231' ' ' ILE . 1.1 mp -52.1 -47.6 43.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 124.502 1.126 . . . . 72.140000000000001 109.227 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 233' ' ' SER . 7.0 mt-10 -66.75 -35.32 79.83 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.573 1.17 . . . . 62.0 110.268 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.24 -27.8 65.78 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.565 1.166 . . . . 70.239999999999995 109.309 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.629 HG23 HD23 ' A' ' 236' ' ' LEU . 26.8 mt -74.49 -40.96 49.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.387 1.054 . . . . 54.350000000000001 109.261 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 26.4 mmtt -83.77 -19.98 34.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.389 1.055 . . . . 71.140000000000001 109.296 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 229' ' ' GLU . 8.7 m -60.59 -23.35 64.61 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.489 1.118 . . . . 62.210000000000001 110.027 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.711 HG11 ' CD2' ' A' ' 158' ' ' LEU . 6.3 p -126.39 21.81 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.549 1.156 . . . . 60.25 109.29 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 53.0 t30 47.36 28.46 1.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.532 1.145 . . . . 73.109999999999999 109.301 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.629 HD23 HG23 ' A' ' 231' ' ' ILE . 10.4 tp -58.45 112.15 4.55 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.135 . . . . 60.119999999999997 109.307 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 149.34 36.66 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.493 1.786 . . . . 74.030000000000001 111.012 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.419 ' C ' ' N ' ' A' ' 240' ' ' GLN . 2.3 p -57.15 149.54 19.37 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.522 1.139 . . . . 75.439999999999998 110.342 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.495 HG11 ' HB2' ' A' ' 188' ' ' HIS . 0.4 OUTLIER -41.18 -31.02 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.109 . . . . 61.140000000000001 109.337 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.444 ' O ' ' CB ' ' A' ' 244' ' ' SER . 58.4 mm-40 -81.37 -49.34 10.79 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.455 1.097 . . . . 73.019999999999996 110.296 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -59.09 -21.84 59.84 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.449 1.093 . . . . 74.329999999999998 110.287 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.402 ' O ' ' N ' ' A' ' 245' ' ' ASN . 4.2 t90 -83.33 -71.17 0.51 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.507 1.129 . . . . 64.329999999999998 108.008 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.9 -24.51 1.5 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.455 1.097 . . . . 74.010000000000005 109.246 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 240' ' ' GLN . 43.9 t -77.4 -39.86 45.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.557 1.16 . . . . 70.239999999999995 110.004 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 242' ' ' TRP . 13.6 t30 . . . . . 0 C--N 1.325 -0.485 0 O-C-N 124.46 1.1 . . . . 65.310000000000002 109.264 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 158' ' ' LEU . 9.0 mt . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 109.297 -0.631 . . . . 71.450000000000003 109.297 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -160.7 139.78 10.47 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.466 1.104 . . . . 73.510000000000005 111.039 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.411 ' HB2' HG12 ' A' ' 184' ' ' ILE . . . -132.85 162.28 31.96 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.467 1.105 . . . . 44.340000000000003 109.298 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.711 HG21 HD13 ' A' ' 215' ' ' ILE . 0.7 OUTLIER -127.95 121.16 55.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.478 1.111 . . . . 70.329999999999998 109.271 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.979 HG23 HD21 ' A' ' 182' ' ' LEU . 55.9 t -79.11 98.02 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 72.209999999999994 109.323 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.818 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.2 OUTLIER -92.05 35.08 0.99 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.576 1.172 . . . . 73.129999999999995 109.306 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.556 ' HB3' ' CD2' ' A' ' 211' ' ' PHE . 18.2 m-85 -170.98 133.4 0.9 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.469 1.106 . . . . 75.230000000000004 111.014 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.13 102.99 3.16 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.524 1.14 . . . . 62.219999999999999 109.3 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.6 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 7.3 t80 -80.35 153.04 28.61 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.488 1.118 . . . . 74.400000000000006 110.937 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.6 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 11.4 mmmm -112.04 135.21 52.97 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.55 1.156 . . . . 74.25 109.297 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.828 ' HB1' ' OE1' ' A' ' 173' ' ' GLU . . . -84.25 123.81 30.53 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.484 1.115 . . . . 52.049999999999997 109.278 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.439 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 6.5 pt-20 -126.4 -30.62 2.85 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.544 1.153 . . . . 75.319999999999993 110.328 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 3.7 tttt -59.03 -173.72 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.594 1.184 . . . . 70.349999999999994 109.293 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.5 -27.82 17.99 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.523 1.139 . . . . 72.129999999999995 109.319 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.54 28.75 6.49 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.517 1.135 . . . . 71.040000000000006 109.354 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.828 ' OE1' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -71.13 -176.4 1.42 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.448 1.092 . . . . 72.120000000000005 110.271 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.725 HD22 ' HA2' ' A' ' 203' ' ' GLY . 1.6 tp -157.62 113.94 2.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 62.140000000000001 109.285 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 2.0 t -68.95 145.29 53.75 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.562 1.164 . . . . 62.32 110.394 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.645 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.7 m -129.25 -169.5 2.11 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.103 . . . . 65.400000000000006 110.405 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.645 ' H ' HG22 ' A' ' 176' ' ' THR . 29.3 m-85 -138.4 133.73 33.23 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.438 1.087 . . . . 75.450000000000003 111.011 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' ' 177' ' ' TYR . 0.2 OUTLIER -39.41 156.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.515 1.134 . . . . 75.450000000000003 109.354 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 51.02 48.37 46.12 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.441 1.088 . . . . 53.229999999999997 110.991 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.452 ' HB3' ' CD1' ' A' ' 182' ' ' LEU . 7.6 mm-40 -107.36 151.49 25.43 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.53 0.782 . . . . 71.329999999999998 110.202 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.877 ' C ' HD13 ' A' ' 182' ' ' LEU . 0.3 OUTLIER -108.27 127.28 53.71 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.56 1.162 . . . . 53.420000000000002 109.282 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.979 HD21 HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -158.81 168.7 26.12 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.477 1.11 . . . . 64.209999999999994 109.311 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 184' ' ' ILE . 2.0 t80 -114.2 144.34 43.35 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.589 1.18 . . . . 73.409999999999997 111.002 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.501 HD12 ' HB3' ' A' ' 193' ' ' PHE . 9.3 mm -77.68 100.74 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.503 1.127 . . . . 62.25 109.308 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.425 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 1.3 t -73.6 -28.9 62.06 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.475 1.11 . . . . 70.329999999999998 108.246 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.412 ' HB1' ' N ' ' A' ' 239' ' ' VAL . . . -174.36 170.85 3.53 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.539 1.15 . . . . 65.340000000000003 109.352 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.49 ' NE2' HG21 ' A' ' 231' ' ' ILE . 6.4 p80 -129.16 149.51 50.94 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.559 1.162 . . . . 75.239999999999995 109.629 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.637 ' CE1' ' CG ' ' A' ' 240' ' ' GLN . 0.8 OUTLIER -124.54 114.94 20.08 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.441 1.088 . . . . 72.230000000000004 109.591 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.451 ' C ' ' N ' ' A' ' 191' ' ' GLU . 6.0 m-20 53.85 32.8 15.75 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.491 1.12 . . . . 72.230000000000004 109.301 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 12.7 p 42.96 28.23 0.13 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 71.129999999999995 108.314 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.451 ' N ' ' C ' ' A' ' 189' ' ' ASN . 5.0 pt-20 -121.57 -34.79 3.36 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.465 1.103 . . . . 74.400000000000006 110.331 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.47 ' CE3' ' HB3' ' A' ' 206' ' ' LEU . 7.8 m0 -118.04 165.56 13.59 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.534 1.146 . . . . 75.349999999999994 107.945 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.749 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 20.3 m-85 -143.53 157.4 44.46 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 70.120000000000005 111.002 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.441 ' CG2' ' HB2' ' A' ' 204' ' ' PRO . 31.3 mm -95.62 101.93 12.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.497 1.123 . . . . 72.25 109.317 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.577 ' HB2' HG21 ' A' ' 207' ' ' VAL . . . -84.82 168.4 15.15 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.521 1.138 . . . . 54.32 109.245 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 63.119999999999997 109.262 -179.993 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.725 ' HA2' HD22 ' A' ' 174' ' ' LEU . . . . . . . . 0 CA--C 1.531 1.072 0 N-CA-C 110.958 -0.857 . . . . 74.349999999999994 110.958 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.441 ' HB2' ' CG2' ' A' ' 194' ' ' ILE . 18.4 Cg_endo -75.05 -178.72 24.31 Favored 'Cis proline' 0 C--N 1.36 1.153 0 C-N-CA 121.073 -2.47 . . . . 65.430000000000007 111.034 0.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 174' ' ' LEU . . . -133.8 172.38 21.67 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 124.475 1.11 . . . . 74.200000000000003 111.047 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.6 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 2.7 mt -106.41 129.6 54.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 0.754 . . . . 42.43 109.283 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.809 HG12 ' HD2' ' A' ' 208' ' ' PRO . 0.2 OUTLIER -135.88 145.82 54.36 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.471 1.107 . . . . 75.420000000000002 109.308 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.809 ' HD2' HG12 ' A' ' 207' ' ' VAL . 18.2 Cg_endo -75.03 157.68 42.49 Favored 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.515 1.797 . . . . 64.340000000000003 110.977 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.719 HG23 ' HE2' ' A' ' 193' ' ' PHE . 11.2 p -76.23 -20.27 15.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 124.416 1.072 . . . . 75.230000000000004 109.338 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -84.5 5.99 78.9 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.534 1.146 . . . . 32.420000000000002 110.977 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.572 ' CD1' ' HG2' ' A' ' 208' ' ' PRO . 11.5 m-85 -130.17 12.21 5.56 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.507 0.769 . . . . 72.510000000000005 111.023 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.696 HG12 HG22 ' A' ' 162' ' ' VAL . 2.4 m -149.4 148.04 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 62.109999999999999 109.309 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.818 ' HB2' HD21 ' A' ' 163' ' ' LEU . 10.6 t -126.87 147.43 50.06 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.514 1.134 . . . . 72.420000000000002 110.037 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.756 HG13 HG23 ' A' ' 227' ' ' VAL . 22.2 mm -94.12 133.66 34.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.557 1.161 . . . . 74.049999999999997 109.351 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.711 HD13 HG21 ' A' ' 161' ' ' ILE . 9.6 pt . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.442 1.089 . . . . 71.299999999999997 109.273 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.5 p . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 110.423 -0.214 . . . . 71.120000000000005 110.423 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 145.26 -18.47 1.9 Allowed Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.472 1.107 . . . . 20.129999999999999 111.021 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -47.8 172.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.449 0.735 . . . . 74.409999999999997 109.324 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.67 165.31 18.13 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.531 1.144 . . . . 72.540000000000006 109.269 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.756 HG23 HG13 ' A' ' 214' ' ' ILE . 12.3 p -75.55 -44.94 40.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.466 1.104 . . . . 74.409999999999997 109.267 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.779 ' HA ' HD12 ' A' ' 231' ' ' ILE . 1.7 mp -49.42 -54.47 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.42 1.075 . . . . 75.140000000000001 109.324 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.11 -28.67 69.26 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.554 1.159 . . . . 72.109999999999999 110.293 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.11 -14.96 58.09 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.475 1.109 . . . . 73.239999999999995 109.307 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.779 HD12 ' HA ' ' A' ' 228' ' ' ILE . 38.3 mt -83.87 -30.45 7.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.534 1.146 . . . . 72.129999999999995 109.267 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.52 ' CE ' HG22 ' A' ' 231' ' ' ILE . 7.5 mmpt? -82.97 -20.72 34.64 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.507 1.129 . . . . 74.340000000000003 109.332 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 36.8 m -66.41 -39.17 88.83 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.566 1.166 . . . . 72.120000000000005 110.004 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.634 ' O ' HG22 ' A' ' 234' ' ' VAL . 4.2 p -114.82 15.56 8.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.518 1.136 . . . . 42.420000000000002 109.326 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 41.41 29.4 0.1 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.496 1.123 . . . . 72.030000000000001 109.337 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.425 HD21 HG22 ' A' ' 184' ' ' ILE . 6.1 tp -41.37 121.01 2.04 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.524 1.14 . . . . 33.350000000000001 109.293 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 135.65 19.28 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.559 1.82 . . . . 62.009999999999998 111.002 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 2.3 p -57.97 152.36 16.48 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.508 1.13 . . . . 62.25 110.395 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.432 HG11 ' HB2' ' A' ' 188' ' ' HIS . 1.3 p -51.2 -22.9 2.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.544 1.153 . . . . 65.030000000000001 109.322 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.637 ' CG ' ' CE1' ' A' ' 188' ' ' HIS . 8.8 mm100 -86.63 -45.54 10.92 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.465 1.103 . . . . 74.450000000000003 110.366 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -63.86 -25.52 68.2 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.465 1.103 . . . . 72.510000000000005 110.29 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -77.43 -65.87 0.9 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.553 1.158 . . . . 74.5 107.968 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -52.08 -25.36 8.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 1.13 . . . . 70.109999999999999 109.26 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 43.9 t -76.89 -50.37 13.48 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.552 1.158 . . . . 70.510000000000005 110.009 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 . . . . . 0 C--N 1.325 -0.458 0 O-C-N 124.496 1.122 . . . . 73.25 109.331 179.961 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.741 ' CD2' HG11 ' A' ' 234' ' ' VAL . 1.6 mm? . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.274 -0.639 . . . . 72.040000000000006 109.274 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -138.52 122.71 18.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.485 1.116 . . . . 70.430000000000007 111.02 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.621 ' HB2' HG12 ' A' ' 184' ' ' ILE . . . -103.87 174.52 5.83 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.495 1.122 . . . . 74.439999999999998 109.299 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.522 HG21 ' CD1' ' A' ' 215' ' ' ILE . 0.0 OUTLIER -135.98 128.79 46.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.442 1.089 . . . . 72.209999999999994 109.251 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.897 HG21 ' CG2' ' A' ' 176' ' ' THR . 80.9 t -88.95 122.61 40.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.511 1.132 . . . . 74.109999999999999 109.252 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.2 OUTLIER -107.8 2.73 23.79 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.469 1.105 . . . . 73.049999999999997 109.278 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -153.96 131.59 11.44 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.446 1.091 . . . . 73.349999999999994 110.999 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -63.45 104.82 0.67 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.537 1.148 . . . . 74.340000000000003 109.261 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.578 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 7.3 t80 -80.42 139.46 36.48 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.556 1.16 . . . . 74.420000000000002 110.963 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.489 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 26.7 mmmt -98.31 141.92 30.6 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.128 . . . . 54.020000000000003 109.298 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.822 ' HB1' ' OE1' ' A' ' 173' ' ' GLU . . . -92.02 123.39 35.34 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.422 1.076 . . . . 62.32 109.313 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.448 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 5.9 pt-20 -125.61 -29.35 3.18 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.527 1.142 . . . . 72.239999999999995 110.297 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.45 ' HD3' HD13 ' A' ' 206' ' ' LEU . 3.9 tttp -59.15 -173.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.566 1.166 . . . . 74.030000000000001 109.332 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.19 -31.07 17.2 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.43 1.081 . . . . 63.420000000000002 109.332 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.91 27.93 7.04 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.51 1.131 . . . . 73.430000000000007 109.312 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.822 ' OE1' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -67.97 -176.24 0.66 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.478 1.111 . . . . 61.240000000000002 110.302 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.589 HD12 ' HA3' ' A' ' 205' ' ' GLY . 12.3 mt -151.85 132.36 13.86 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.467 1.104 . . . . 74.549999999999997 109.269 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 12.4 t -78.96 127.88 32.57 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.543 1.152 . . . . 74.019999999999996 110.426 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.897 ' CG2' HG21 ' A' ' 162' ' ' VAL . 2.5 m -106.47 -172.67 2.13 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.444 1.09 . . . . 61.229999999999997 110.374 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.603 ' H ' HG22 ' A' ' 176' ' ' THR . 52.0 m-85 -143.86 133.56 23.72 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.509 1.131 . . . . 74.349999999999994 110.972 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.435 ' CG2' ' N ' ' A' ' 179' ' ' GLY . 1.3 p -51.84 161.37 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.468 1.105 . . . . 75.010000000000005 109.249 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 37.56 51.47 1.86 Allowed Glycine 0 CA--C 1.531 1.057 0 O-C-N 124.533 1.146 . . . . 75.140000000000001 111.005 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.513 ' HG2' HD12 ' A' ' 182' ' ' LEU . 20.3 tt0 -121.85 167.59 12.84 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.555 0.797 . . . . 72.150000000000006 110.288 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.58 120.99 38.32 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.508 1.13 . . . . 43.420000000000002 109.302 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.513 HD12 ' HG2' ' A' ' 180' ' ' GLU . 0.6 OUTLIER -138.02 156.9 47.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.417 1.073 . . . . 45.329999999999998 109.319 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -102.77 129.24 49.36 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.474 1.109 . . . . 71.540000000000006 111.035 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.686 HD12 ' HB3' ' A' ' 193' ' ' PHE . 25.1 mm -77.65 121.32 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 73.230000000000004 109.298 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.499 ' O ' HD11 ' A' ' 236' ' ' LEU . 0.9 OUTLIER -88.66 -26.77 21.68 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.557 1.161 . . . . 63.130000000000003 108.299 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -171.8 176.94 3.48 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.461 1.101 . . . . 74.450000000000003 109.272 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.598 ' CE1' HG21 ' A' ' 231' ' ' ILE . 8.3 p80 -137.27 151.89 49.19 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.495 1.122 . . . . 75.340000000000003 109.565 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.638 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.3 t-160 -124.61 114.72 19.74 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.129 . . . . 74.430000000000007 109.566 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.449 ' C ' ' N ' ' A' ' 191' ' ' GLU . 2.7 t30 54.18 33.21 17.51 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.484 1.115 . . . . 54.149999999999999 109.283 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 12.8 p 43.06 28.43 0.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.595 1.185 . . . . 75.540000000000006 108.237 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.8 ' O ' HG12 ' A' ' 209' ' ' VAL . 5.3 pt-20 -122.17 -34.88 3.24 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.539 1.149 . . . . 64.310000000000002 110.257 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.545 ' HE3' HD22 ' A' ' 206' ' ' LEU . 11.9 m0 -116.32 164.73 14.09 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.572 1.17 . . . . 74.340000000000003 108.005 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.736 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 16.6 m-85 -135.5 159.66 40.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.509 1.131 . . . . 72.400000000000006 111.002 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.469 ' CG1' ' HB ' ' A' ' 239' ' ' VAL . 20.2 mm -103.49 119.57 52.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.508 1.13 . . . . 73.109999999999999 109.303 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.77 175.98 5.45 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.489 1.118 . . . . 72.209999999999994 109.307 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.524 1.14 . . . . 70.209999999999994 109.305 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.948 0 N-CA-C 110.995 -0.842 . . . . 72.209999999999994 110.995 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.99 153.3 99.09 Favored 'Cis proline' 0 C--N 1.36 1.174 0 C-N-CA 121.033 -2.486 . . . . 62.119999999999997 110.97 0.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.589 ' HA3' HD12 ' A' ' 174' ' ' LEU . . . -117.25 178.33 17.03 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.503 1.127 . . . . 71.310000000000002 110.963 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.545 HD22 ' HE3' ' A' ' 192' ' ' TRP . 1.3 mt -118.88 165.19 14.36 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.437 0.728 . . . . 73.400000000000006 109.334 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.735 HG21 HG11 ' A' ' 212' ' ' VAL . 0.2 OUTLIER -162.66 129.96 2.6 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.443 1.089 . . . . 74.120000000000005 109.317 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.578 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.4 Cg_endo -74.9 137.58 22.14 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.488 1.783 . . . . 71.349999999999994 110.991 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.8 HG12 ' O ' ' A' ' 191' ' ' GLU . 7.3 p -67.14 -27.16 38.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.515 1.134 . . . . 71.299999999999997 109.251 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -68.81 -13.36 66.11 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.538 1.149 . . . . 34.240000000000002 111.017 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 7.8 m-30 -113.11 3.16 15.96 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.486 0.757 . . . . 71.310000000000002 111.007 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.842 HG12 HG22 ' A' ' 162' ' ' VAL . 15.0 m -140.08 173.78 9.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.541 1.15 . . . . 64.25 109.319 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.686 ' HB2' HD11 ' A' ' 163' ' ' LEU . 2.9 t -152.09 160.76 43.35 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.519 1.137 . . . . 34.009999999999998 109.995 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.682 HG13 HG23 ' A' ' 227' ' ' VAL . 19.1 mm -104.05 96.59 4.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.55 1.156 . . . . 62.219999999999999 109.314 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.522 ' CD1' HG21 ' A' ' 161' ' ' ILE . 1.2 pt . . . . . 0 C--N 1.324 -0.504 0 O-C-N 124.504 1.128 . . . . 74.340000000000003 109.353 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 110.424 -0.213 . . . . 51.520000000000003 110.424 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 139.65 -19.06 2.99 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.54 1.15 . . . . 54.329999999999998 111.052 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -50.08 176.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.465 0.744 . . . . 72.340000000000003 109.263 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -134.63 157.76 45.79 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.494 1.121 . . . . 65.5 109.312 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.737 HG13 HD12 ' A' ' 228' ' ' ILE . 2.5 p -77.67 -34.49 20.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.493 1.121 . . . . 73.25 109.298 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.737 HD12 HG13 ' A' ' 227' ' ' VAL . 1.9 mp -59.21 -44.87 92.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 124.531 1.145 . . . . 64.340000000000003 109.284 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.95 -45.81 90.69 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.551 1.157 . . . . 63.149999999999999 110.291 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -67.97 -26.0 65.72 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.396 1.06 . . . . 64.540000000000006 109.33 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.718 HD11 HG22 ' A' ' 227' ' ' VAL . 16.8 mt -67.69 -41.56 85.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.507 1.129 . . . . 72.329999999999998 109.332 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.426 ' HE3' HG22 ' A' ' 231' ' ' ILE . 3.4 mmtp -83.94 -20.16 33.43 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.558 1.161 . . . . 75.129999999999995 109.237 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 41.9 m -61.07 -25.73 67.15 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.49 1.119 . . . . 73.230000000000004 110.005 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.741 HG11 ' CD2' ' A' ' 158' ' ' LEU . 7.5 p -126.39 20.73 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.424 1.077 . . . . 72.310000000000002 109.351 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 40.55 30.12 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.504 1.128 . . . . 64.25 109.33 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.502 HD12 ' HD2' ' A' ' 237' ' ' PRO . 12.7 tp -46.88 120.31 6.25 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.426 1.079 . . . . 75.519999999999996 109.277 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.502 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -74.93 131.05 13.92 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.486 1.782 . . . . 72.120000000000005 110.99 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 2.7 p -57.04 157.07 6.18 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.107 . . . . 34.130000000000003 110.418 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.638 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.1 p -46.29 -27.11 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.477 1.111 . . . . 71.329999999999998 109.272 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.402 ' NE2' ' HD3' ' A' ' 243' ' ' LYS . 37.6 mm-40 -86.77 -47.02 9.45 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.514 1.134 . . . . 75.329999999999998 110.39 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -61.4 -20.47 63.09 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.409 1.068 . . . . 71.439999999999998 110.308 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.442 ' C ' ' N ' ' A' ' 244' ' ' SER . 13.9 t90 -88.12 -65.51 1.01 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.958 -1.127 . . . . 75.209999999999994 107.958 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.402 ' HD3' ' NE2' ' A' ' 240' ' ' GLN . 2.9 ptmm? -41.79 -28.87 0.17 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.514 1.134 . . . . 72.129999999999995 109.333 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.442 ' N ' ' C ' ' A' ' 242' ' ' TRP . 1.2 t -73.36 -65.83 0.76 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.453 1.096 . . . . 62.329999999999998 109.994 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.563 1.165 . . . . 54.329999999999998 109.346 179.997 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.584 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 109.236 -0.653 . . . . 71.25 109.236 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -120.01 141.87 49.32 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 74.0 110.993 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.454 ' CB ' HG12 ' A' ' 184' ' ' ILE . . . -140.14 143.21 36.06 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.419 1.075 . . . . 75.450000000000003 109.393 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.494 ' CG1' ' O ' ' A' ' 180' ' ' GLU . 0.8 OUTLIER -121.65 136.0 59.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.463 1.102 . . . . 75.519999999999996 109.313 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.955 HG21 HG21 ' A' ' 176' ' ' THR . 2.5 t -85.58 127.36 40.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.546 1.154 . . . . 45.020000000000003 109.313 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.484 ' O ' HG23 ' A' ' 178' ' ' VAL . 0.1 OUTLIER -96.8 -17.06 20.48 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.563 1.164 . . . . 72.349999999999994 109.338 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.654 ' O ' HG12 ' A' ' 162' ' ' VAL . 42.9 m-85 -137.94 148.46 45.28 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.502 1.127 . . . . 74.230000000000004 111.039 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.02 100.1 0.11 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.54 1.15 . . . . 63.149999999999999 109.299 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.559 ' CE2' ' O ' ' A' ' 174' ' ' LEU . 26.5 t80 -81.34 126.1 31.18 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.137 . . . . 65.140000000000001 111.009 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.39 129.63 55.53 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.539 1.149 . . . . 73.409999999999997 109.273 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.6 122.63 15.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.102 . . . . 64.430000000000007 109.332 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.447 ' CG ' ' N ' ' A' ' 170' ' ' LYS . 9.0 pt-20 -107.85 -43.73 4.39 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.543 1.152 . . . . 71.010000000000005 110.277 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.447 ' N ' ' CG ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -70.0 -176.07 1.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.137 . . . . 70.140000000000001 109.306 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.43 -19.01 30.26 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.515 1.135 . . . . 73.010000000000005 109.317 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -123.52 27.82 7.25 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.496 1.123 . . . . 45.219999999999999 109.327 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -91.88 155.88 17.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.453 1.096 . . . . 61.200000000000003 110.271 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.716 HD23 ' HA3' ' A' ' 205' ' ' GLY . 0.3 OUTLIER -112.45 159.97 18.23 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.484 1.115 . . . . 70.310000000000002 109.316 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 166' ' ' PHE . 13.1 t -118.58 122.8 43.49 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.495 1.122 . . . . 74.109999999999999 110.423 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.955 HG21 HG21 ' A' ' 162' ' ' VAL . 2.2 m -114.61 -168.82 1.43 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.521 1.138 . . . . 65.530000000000001 110.47 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.61 ' H ' HG22 ' A' ' 176' ' ' THR . 14.3 m-85 -134.44 143.6 47.65 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.404 1.065 . . . . 74.430000000000007 110.97 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 163' ' ' LEU . 0.3 OUTLIER -40.46 152.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.478 1.111 . . . . 70.299999999999997 109.321 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 36.93 64.87 0.61 Allowed Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.565 1.165 . . . . 52.520000000000003 110.999 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.494 ' O ' ' CG1' ' A' ' 161' ' ' ILE . 18.3 tt0 -121.72 148.58 44.43 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.48 0.753 . . . . 65.120000000000005 110.328 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.82 139.42 36.53 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.493 1.121 . . . . 71.319999999999993 109.301 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.471 HD21 ' CG2' ' A' ' 162' ' ' VAL . 4.5 pp -166.95 163.28 16.05 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.468 1.105 . . . . 65.340000000000003 109.272 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.584 ' CD2' ' O ' ' A' ' 158' ' ' LEU . 1.0 OUTLIER -115.29 134.13 55.4 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.479 1.112 . . . . 72.450000000000003 110.98 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.895 HD12 ' HB3' ' A' ' 193' ' ' PHE . 36.9 mm -78.21 134.0 29.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.506 1.128 . . . . 72.409999999999997 109.242 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.741 ' O ' HD11 ' A' ' 236' ' ' LEU . 3.3 m -96.09 -35.0 11.51 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.517 1.136 . . . . 71.409999999999997 108.297 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.602 ' HB1' ' N ' ' A' ' 239' ' ' VAL . . . -154.0 179.79 8.58 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.471 1.107 . . . . 73.120000000000005 109.28 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.621 ' CE1' HG21 ' A' ' 231' ' ' ILE . 12.7 p80 -147.38 138.53 23.73 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.464 1.102 . . . . 74.129999999999995 109.566 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.552 ' NE2' ' CG ' ' A' ' 240' ' ' GLN . 2.6 t-80 -114.21 116.42 29.02 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.485 1.116 . . . . 74.450000000000003 109.572 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.422 ' C ' ' N ' ' A' ' 191' ' ' GLU . 37.7 m-20 55.69 26.69 9.64 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.483 1.114 . . . . 62.119999999999997 109.276 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.436 ' HB3' ' CD1' ' A' ' 228' ' ' ILE . 3.6 m 49.83 22.8 0.9 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.51 1.131 . . . . 74.510000000000005 108.353 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.927 ' O ' HG23 ' A' ' 209' ' ' VAL . 5.1 pt-20 -116.81 -32.49 5.1 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.375 1.047 . . . . 63.130000000000003 110.335 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.508 ' CD1' ' HG3' ' A' ' 191' ' ' GLU . 19.2 m0 -117.08 159.34 22.71 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.468 1.105 . . . . 72.420000000000002 108.027 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 1.186 ' CE2' HG22 ' A' ' 209' ' ' VAL . 43.7 m-85 -138.4 156.77 47.28 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 52.030000000000001 111.004 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.944 HD11 HD23 ' A' ' 206' ' ' LEU . 0.5 OUTLIER -102.35 107.18 21.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.461 1.101 . . . . 60.240000000000002 109.247 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.676 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -97.85 151.61 20.04 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.476 1.11 . . . . 74.340000000000003 109.298 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.459 ' CG ' ' HA ' ' A' ' 204' ' ' PRO . 8.8 mtpp . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.525 1.14 . . . . 72.040000000000006 109.261 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.665 ' N ' HD11 ' A' ' 174' ' ' LEU . . . . . . . . 0 CA--C 1.531 1.059 0 N-CA-C 111.001 -0.84 . . . . 71.340000000000003 111.001 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.494 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.5 Cg_endo -74.99 134.74 37.3 Favored 'Cis proline' 0 C--N 1.359 1.113 0 C-N-CA 121.003 -2.499 . . . . 73.420000000000002 111.049 -0.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.716 ' HA3' HD23 ' A' ' 174' ' ' LEU . . . -126.86 158.22 20.78 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.431 1.082 . . . . 60.329999999999998 111.045 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.944 HD23 HD11 ' A' ' 194' ' ' ILE . 4.6 mt -81.07 147.55 30.07 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.546 0.792 . . . . 75.340000000000003 109.318 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.676 HG11 ' HB2' ' A' ' 195' ' ' ALA . 0.2 OUTLIER -146.36 125.39 6.53 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.531 1.144 . . . . 64.409999999999997 109.286 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.56 ' HG2' ' CD1' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.96 147.51 34.22 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.524 1.802 . . . . 74.049999999999997 110.997 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 1.186 HG22 ' CE2' ' A' ' 193' ' ' PHE . 3.5 t -63.83 -18.31 22.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.517 1.136 . . . . 73.319999999999993 109.265 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -74.07 -1.8 60.58 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.477 1.111 . . . . 70.420000000000002 111.08 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.829 ' O ' HG13 ' A' ' 162' ' ' VAL . 30.2 m-85 -128.66 2.37 5.5 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.562 0.801 . . . . 60.340000000000003 110.961 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.676 HG12 HG22 ' A' ' 162' ' ' VAL . 35.4 m -148.95 154.41 9.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.578 1.174 . . . . 74.420000000000002 109.251 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 42.3 t -139.63 160.27 40.25 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.491 1.12 . . . . 71.25 110.043 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.745 HG13 HG23 ' A' ' 227' ' ' VAL . 8.4 mm -109.14 164.8 5.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.495 1.122 . . . . 62.25 109.267 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.484 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.421 0 O-C-N 124.488 1.117 . . . . 72.329999999999998 109.264 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 120.559 0.219 . . . . 74.310000000000002 110.468 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 141.93 -17.44 2.57 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.5 1.125 . . . . 63.409999999999997 111.021 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -51.02 174.23 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 0.746 . . . . 71.109999999999999 109.341 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.77 172.96 7.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 54.329999999999998 109.296 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 1.02 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 12.3 p -78.94 -30.9 14.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.133 . . . . 63.210000000000001 109.291 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.77 HD12 HG13 ' A' ' 227' ' ' VAL . 1.4 mp -60.82 -46.49 96.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 63.119999999999997 109.339 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.73 -43.02 99.89 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.558 1.162 . . . . 75.109999999999999 110.304 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.98 -34.32 77.83 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.554 1.159 . . . . 64.430000000000007 109.282 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.621 HG21 ' CE1' ' A' ' 187' ' ' HIS . 38.8 mt -63.25 -46.22 96.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.141 . . . . 74.319999999999993 109.309 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -76.56 -15.73 59.78 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.499 1.125 . . . . 75.129999999999995 109.315 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.0 p -69.55 -40.03 77.06 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.429 1.081 . . . . 72.310000000000002 110.029 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.428 ' O ' HG22 ' A' ' 234' ' ' VAL . 11.3 p -109.4 14.03 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.511 1.132 . . . . 61.409999999999997 109.333 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 234' ' ' VAL . 7.5 t-20 40.35 43.1 1.39 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 71.420000000000002 109.287 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.973 HD12 ' HD2' ' A' ' 237' ' ' PRO . 3.3 tp -66.79 132.2 93.98 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.462 1.101 . . . . 71.010000000000005 109.284 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.973 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -75.03 156.43 42.85 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.478 1.778 . . . . 75.209999999999994 110.997 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 4.2 p -77.98 148.41 34.44 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.492 1.12 . . . . 75.420000000000002 110.336 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.602 ' N ' ' HB1' ' A' ' 186' ' ' ALA . 2.5 p -49.68 -23.57 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.45 1.093 . . . . 73.319999999999993 109.266 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.552 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 75.6 mm-40 -83.98 -41.71 17.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.476 1.11 . . . . 74.219999999999999 110.257 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -70.49 -23.16 62.63 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.432 1.082 . . . . 75.329999999999998 110.33 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -78.52 -59.99 2.56 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.501 1.125 . . . . 74.439999999999998 108.013 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.0 ptmm? -59.62 -17.44 33.48 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.116 . . . . 51.530000000000001 109.27 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.5 t -77.99 -26.51 48.69 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.59 1.181 . . . . 65.120000000000005 109.947 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.5 t30 . . . . . 0 C--N 1.325 -0.497 0 O-C-N 124.48 1.113 . . . . 73.310000000000002 109.25 -179.995 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.751 ' HG ' HG11 ' A' ' 234' ' ' VAL . 9.2 mt . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 109.317 -0.623 . . . . 75.219999999999999 109.317 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.401 ' CG ' ' O ' ' A' ' 158' ' ' LEU . 25.0 m-85 -163.7 118.4 1.58 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.48 1.113 . . . . 73.030000000000001 110.975 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.574 ' HB2' HG12 ' A' ' 184' ' ' ILE . . . -106.25 167.35 9.88 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.505 1.128 . . . . 60.200000000000003 109.361 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.597 HG21 HD11 ' A' ' 215' ' ' ILE . 0.1 OUTLIER -137.48 129.24 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.44 1.087 . . . . 73.109999999999999 109.317 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.803 ' CG2' HD21 ' A' ' 182' ' ' LEU . 2.7 t -81.72 117.73 28.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.538 1.149 . . . . 73.439999999999998 109.273 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.553 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -96.18 -3.86 43.61 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.545 1.153 . . . . 44.310000000000002 109.268 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.731 ' O ' HG12 ' A' ' 162' ' ' VAL . 53.4 m-85 -153.6 153.88 33.17 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.472 1.108 . . . . 71.430000000000007 110.968 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.424 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 11.0 t0 -83.47 103.58 12.94 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.433 1.083 . . . . 74.120000000000005 109.287 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.584 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 1.9 t80 -85.25 125.22 32.71 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.119 . . . . 73.109999999999999 111.0 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.87 115.79 29.64 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.455 1.097 . . . . 64.400000000000006 109.335 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.669 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -40.31 140.55 0.61 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.456 1.098 . . . . 24.449999999999999 109.342 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.467 ' CG ' ' N ' ' A' ' 170' ' ' LYS . 7.9 pt-20 -136.88 -45.28 0.58 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.427 1.079 . . . . 73.430000000000007 110.236 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.467 ' N ' ' CG ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -64.47 -170.7 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.506 1.129 . . . . 73.329999999999998 109.307 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.62 -33.25 20.21 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.432 1.083 . . . . 62.549999999999997 109.273 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.39 9.3 29.83 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.509 1.13 . . . . 73.5 109.254 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.402 ' HB2' ' N ' ' A' ' 170' ' ' LYS . 3.2 mm-40 -75.43 159.89 30.86 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.524 1.14 . . . . 75.340000000000003 110.249 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.669 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 2.8 tp -138.33 159.6 41.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.457 1.098 . . . . 72.120000000000005 109.299 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.2 t -91.64 153.46 19.68 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.496 1.123 . . . . 73.439999999999998 110.389 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 177' ' ' TYR . 3.3 m -139.19 -164.39 1.65 Allowed 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.514 1.134 . . . . 64.140000000000001 110.345 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.685 ' H ' HG22 ' A' ' 176' ' ' THR . 30.9 m-85 -136.8 138.04 40.42 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.546 1.154 . . . . 71.239999999999995 110.972 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.463 ' CG2' ' N ' ' A' ' 179' ' ' GLY . 1.4 p -56.57 163.41 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.452 1.095 . . . . 73.530000000000001 109.285 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.463 ' N ' ' CG2' ' A' ' 178' ' ' VAL . . . 37.59 59.47 1.3 Allowed Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.474 1.109 . . . . 64.109999999999999 110.961 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.491 ' O ' HD13 ' A' ' 161' ' ' ILE . 13.2 tp10 -121.4 166.9 13.43 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.557 0.798 . . . . 73.349999999999994 110.338 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -120.51 122.29 40.3 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.455 1.097 . . . . 62.119999999999997 109.352 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.803 HD21 ' CG2' ' A' ' 162' ' ' VAL . 0.6 OUTLIER -147.0 163.65 35.53 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.103 . . . . 74.540000000000006 109.362 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.591 ' CE1' ' O ' ' A' ' 184' ' ' ILE . 2.2 t80 -110.63 139.12 46.19 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.457 1.098 . . . . 62.039999999999999 111.023 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.591 ' O ' ' CE1' ' A' ' 183' ' ' PHE . 9.6 mm -77.7 120.92 29.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.471 1.107 . . . . 73.549999999999997 109.227 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 5.6 t -91.45 -24.42 19.7 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.432 1.082 . . . . 75.450000000000003 108.27 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.782 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -164.8 179.65 6.39 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.501 1.126 . . . . 75.019999999999996 109.253 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.526 ' CE1' ' HG ' ' A' ' 190' ' ' CYS . 9.3 p80 -149.38 129.86 13.91 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.466 1.104 . . . . 74.099999999999994 109.571 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.655 ' CG ' HG11 ' A' ' 239' ' ' VAL . 0.0 OUTLIER -111.0 119.03 37.69 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.536 1.148 . . . . 72.510000000000005 109.633 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.433 ' C ' ' N ' ' A' ' 191' ' ' GLU . 3.5 m120 54.0 32.82 16.21 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.48 1.112 . . . . 71.129999999999995 109.325 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.526 ' HG ' ' CE1' ' A' ' 187' ' ' HIS . 49.9 m 42.1 29.04 0.12 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 74.209999999999994 108.3 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.575 ' HG3' ' CD1' ' A' ' 192' ' ' TRP . 6.4 pt-20 -120.94 -38.04 2.89 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.509 1.131 . . . . 73.120000000000005 110.312 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.651 ' CB ' ' CD2' ' A' ' 188' ' ' HIS . 27.7 m0 -116.87 164.42 14.7 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.126 . . . . 74.25 107.987 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.724 ' HB2' HG13 ' A' ' 207' ' ' VAL . 39.5 m-85 -141.94 168.93 18.58 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.542 1.151 . . . . 75.400000000000006 110.995 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.782 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 47.0 mm -103.55 109.07 25.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.544 1.153 . . . . 53.439999999999998 109.324 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.748 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -116.57 163.78 15.58 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.488 1.117 . . . . 65.329999999999998 109.321 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 O-C-N 124.483 1.114 . . . . 75.430000000000007 109.267 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.012 0 N-CA-C 110.98 -0.848 . . . . 74.230000000000004 110.98 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.605 ' HB2' HG23 ' A' ' 194' ' ' ILE . 18.2 Cg_endo -74.95 179.42 30.67 Favored 'Cis proline' 0 C--N 1.36 1.181 0 C-N-CA 121.02 -2.492 . . . . 73.219999999999999 110.983 0.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -129.64 161.62 22.85 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.531 1.145 . . . . 52.43 110.967 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.566 ' CD2' ' CD1' ' A' ' 194' ' ' ILE . 9.3 mt -92.91 149.14 21.45 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.514 0.773 . . . . 64.219999999999999 109.272 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.91 HG21 HG11 ' A' ' 212' ' ' VAL . 0.6 OUTLIER -148.5 122.6 4.81 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.123 . . . . 73.430000000000007 109.32 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.584 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.6 Cg_endo -74.91 149.87 37.79 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.502 1.791 . . . . 62.439999999999998 111.026 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.417 ' HB ' ' CE2' ' A' ' 193' ' ' PHE . 5.0 p -63.71 -20.88 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 71.420000000000002 109.293 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -74.57 -0.91 60.01 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.446 1.091 . . . . 75.129999999999995 110.956 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.562 ' CD2' ' HB2' ' A' ' 166' ' ' PHE . 15.8 m-85 -129.8 3.32 4.93 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.491 0.759 . . . . 72.5 111.008 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.91 HG11 HG21 ' A' ' 207' ' ' VAL . 32.9 m -151.89 149.67 13.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 71.120000000000005 109.311 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.44 ' CB ' HD11 ' A' ' 163' ' ' LEU . 1.6 t -131.54 160.93 33.82 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.513 1.133 . . . . 75.519999999999996 109.966 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.827 HG13 HG23 ' A' ' 227' ' ' VAL . 32.1 mm -100.53 106.82 19.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.524 1.14 . . . . 75.349999999999994 109.295 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.597 HD11 HG21 ' A' ' 161' ' ' ILE . 11.0 pt . . . . . 0 C--N 1.324 -0.515 0 O-C-N 124.53 1.144 . . . . 75.140000000000001 109.275 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 69.2 p . . . . . 0 N--CA 1.453 -0.321 0 N-CA-C 110.402 -0.221 . . . . 71.140000000000001 110.402 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 123.86 -18.03 7.6 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.64 1.212 . . . . 43.549999999999997 110.956 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -75.71 177.08 7.12 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.527 0.781 . . . . 71.140000000000001 109.288 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.15 -178.65 3.72 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.524 1.14 . . . . 44.340000000000003 109.332 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.936 HG13 HD12 ' A' ' 228' ' ' ILE . 3.0 p -79.02 -34.25 16.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.531 1.145 . . . . 61.140000000000001 109.336 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.936 HD12 HG13 ' A' ' 227' ' ' VAL . 2.1 mp -65.44 -56.85 13.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.483 1.114 . . . . 52.32 109.334 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -58.29 -21.43 48.89 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.489 1.118 . . . . 71.329999999999998 110.283 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.663 ' O ' HG13 ' A' ' 234' ' ' VAL . 59.0 m-20 -86.8 -34.96 19.38 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.426 1.079 . . . . 72.340000000000003 109.29 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.778 HG23 ' HB3' ' A' ' 236' ' ' LEU . 18.8 mt -64.81 -27.42 42.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.576 1.172 . . . . 61.32 109.338 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.445 ' HE2' HG22 ' A' ' 231' ' ' ILE . 6.3 mmpt? -83.99 -11.59 56.58 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.46 1.1 . . . . 71.310000000000002 109.318 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 68.5 m -95.12 -8.9 35.14 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.464 1.103 . . . . 70.209999999999994 110.019 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.751 HG11 ' HG ' ' A' ' 158' ' ' LEU . 1.0 OUTLIER -127.13 5.98 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.465 1.103 . . . . 72.209999999999994 109.27 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.437 ' N ' ' OD1' ' A' ' 235' ' ' ASN . 0.6 OUTLIER 47.91 30.33 1.94 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.45 1.093 . . . . 72.140000000000001 109.275 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.778 ' HB3' HG23 ' A' ' 231' ' ' ILE . 0.7 OUTLIER -43.95 118.4 2.96 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.408 1.068 . . . . 71.430000000000007 109.261 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 135.57 19.16 Favored 'Trans proline' 0 C--N 1.361 1.211 0 O-C-N 124.453 1.765 . . . . 64.439999999999998 110.977 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 187' ' ' HIS . 2.0 p -69.51 144.07 53.27 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.521 1.138 . . . . 74.430000000000007 110.376 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.655 HG11 ' CG ' ' A' ' 188' ' ' HIS . 7.6 p -51.0 -31.23 10.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.556 1.16 . . . . 70.310000000000002 109.298 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -76.76 -32.07 57.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.127 . . . . 63.329999999999998 110.305 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.405 ' CG ' ' OG1' ' A' ' 238' ' ' THR . 69.0 mt-10 -76.71 -30.01 56.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.517 1.136 . . . . 75.219999999999999 110.274 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -72.88 -54.89 7.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.499 1.124 . . . . 70.340000000000003 108.046 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.88 -29.02 69.29 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.547 1.154 . . . . 64.030000000000001 109.302 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 18.3 t -77.26 -41.25 41.72 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.563 1.164 . . . . 74.439999999999998 110.057 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 . . . . . 0 C--N 1.324 -0.5 0 O-C-N 124.529 1.143 . . . . 74.230000000000004 109.323 179.932 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.665 ' HG ' HG11 ' A' ' 234' ' ' VAL . 13.2 mt . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 109.332 -0.618 . . . . 74.519999999999996 109.332 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.411 ' CD2' ' CE2' ' A' ' 183' ' ' PHE . 1.7 t80 -121.47 122.82 40.59 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.475 1.11 . . . . 72.349999999999994 111.021 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.655 ' HB2' HD13 ' A' ' 214' ' ' ILE . . . -117.82 170.84 8.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.564 1.165 . . . . 63.409999999999997 109.318 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.501 HG21 HD13 ' A' ' 215' ' ' ILE . 0.1 OUTLIER -142.29 126.69 16.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.479 1.112 . . . . 74.340000000000003 109.352 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.766 HG22 ' CZ ' ' A' ' 211' ' ' PHE . 18.1 t -72.04 133.99 30.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.546 1.154 . . . . 74.140000000000001 109.28 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.983 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.5 OUTLIER -113.9 0.33 14.39 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.441 1.088 . . . . 74.109999999999999 109.287 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.497 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 70.1 m-85 -144.66 147.02 32.57 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.581 1.175 . . . . 64.409999999999997 111.023 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -77.58 94.4 4.35 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.477 1.111 . . . . 71.209999999999994 109.298 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.502 ' CZ ' ' OE2' ' A' ' 173' ' ' GLU . 3.9 t80 -88.0 137.72 32.08 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.523 1.139 . . . . 71.120000000000005 110.97 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -119.85 103.38 9.3 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.469 1.106 . . . . 75.540000000000006 109.32 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.549 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -40.27 139.65 0.71 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.478 1.111 . . . . 51.420000000000002 109.278 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -123.73 -41.43 2.25 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.441 1.088 . . . . 63.340000000000003 110.236 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.32 -169.81 1.29 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.509 1.131 . . . . 74.329999999999998 109.304 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.29 -45.35 11.34 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.531 1.144 . . . . 54.509999999999998 109.279 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -94.43 26.59 3.33 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.455 1.097 . . . . 75.349999999999994 109.34 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.502 ' OE2' ' CZ ' ' A' ' 166' ' ' PHE . 2.9 mm-40 -96.82 140.88 30.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.473 1.108 . . . . 63.009999999999998 110.303 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.708 HD23 ' HA3' ' A' ' 205' ' ' GLY . 0.2 OUTLIER -102.53 160.07 14.88 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.545 1.153 . . . . 71.310000000000002 109.297 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.408 ' C ' ' OG1' ' A' ' 176' ' ' THR . 9.9 t -124.16 150.7 44.85 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.541 1.151 . . . . 61.43 110.426 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.684 HG22 ' H ' ' A' ' 177' ' ' TYR . 11.6 m -157.34 -177.11 6.36 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.516 1.135 . . . . 41.409999999999997 110.366 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.684 ' H ' HG22 ' A' ' 176' ' ' THR . 7.6 m-85 -121.03 156.7 31.62 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.46 1.1 . . . . 72.340000000000003 111.057 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 163' ' ' LEU . 1.8 p -59.83 131.25 24.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.559 1.162 . . . . 33.149999999999999 109.28 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 71.76 59.21 4.89 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.465 1.103 . . . . 51.539999999999999 111.032 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 162' ' ' VAL . 5.4 tp10 -122.16 165.76 15.64 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.563 0.802 . . . . 73.540000000000006 110.281 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.63 119.53 36.43 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 51.310000000000002 109.273 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.551 HD13 ' O ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -152.35 158.63 42.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.533 1.146 . . . . 44.219999999999999 109.318 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.42 ' O ' HD22 ' A' ' 182' ' ' LEU . 4.6 m-85 -107.04 170.64 7.83 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 44.210000000000001 110.996 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.934 HD12 ' HB3' ' A' ' 193' ' ' PHE . 32.5 mm -107.9 147.31 12.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.534 1.146 . . . . 62.030000000000001 109.241 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 186' ' ' ALA . 0.1 OUTLIER -106.26 -19.46 13.69 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.535 1.147 . . . . 73.230000000000004 108.313 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.646 ' HA ' HD11 ' A' ' 236' ' ' LEU . . . 179.64 179.63 0.48 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.554 1.159 . . . . 52.329999999999998 109.309 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.687 ' CD2' HG21 ' A' ' 231' ' ' ILE . 6.2 p80 -137.39 152.98 50.23 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.549 1.156 . . . . 75.049999999999997 109.583 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.637 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 1.0 OUTLIER -129.45 112.8 14.15 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.463 1.102 . . . . 75.519999999999996 109.584 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 3.1 m120 57.97 21.24 7.52 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.436 1.085 . . . . 73.120000000000005 109.343 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.583 ' HG ' ' CE1' ' A' ' 187' ' ' HIS . 87.1 m 55.34 19.74 3.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 1.139 . . . . 62.520000000000003 108.336 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 192' ' ' TRP . 3.9 pt-20 -115.94 -30.94 5.91 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.548 1.155 . . . . 62.25 110.299 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.574 ' HE3' HD22 ' A' ' 206' ' ' LEU . 8.5 m0 -116.25 158.99 22.49 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.959 -1.126 . . . . 74.400000000000006 107.959 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.934 ' HB3' HD12 ' A' ' 184' ' ' ILE . 12.8 m-85 -133.92 161.33 35.08 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.534 1.146 . . . . 64.340000000000003 110.96 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.586 HG13 ' HB3' ' A' ' 186' ' ' ALA . 17.7 mm -105.56 85.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.486 1.116 . . . . 55.530000000000001 109.323 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.736 ' CB ' HG11 ' A' ' 207' ' ' VAL . . . -67.48 160.16 28.12 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.481 1.113 . . . . 43.140000000000001 109.345 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.407 ' HB2' ' NZ ' ' A' ' 196' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.465 0 O-C-N 124.558 1.161 . . . . 72.219999999999999 109.306 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.036 0 N-CA-C 111.019 -0.833 . . . . 74.430000000000007 111.019 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.474 ' HB2' ' CG2' ' A' ' 194' ' ' ILE . 18.4 Cg_endo -74.96 172.31 63.61 Favored 'Cis proline' 0 C--N 1.36 1.171 0 C-N-CA 120.95 -2.521 . . . . 32.329999999999998 111.011 -0.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.708 ' HA3' HD23 ' A' ' 174' ' ' LEU . . . -157.59 156.35 27.22 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.471 1.107 . . . . 73.340000000000003 110.947 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.574 HD22 ' HE3' ' A' ' 192' ' ' TRP . 3.1 mt -83.94 134.02 34.68 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.524 0.779 . . . . 73.430000000000007 109.262 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.736 HG11 ' CB ' ' A' ' 195' ' ' ALA . 2.0 m -143.34 151.92 56.04 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.544 1.153 . . . . 74.230000000000004 109.313 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.459 ' HG2' ' HB3' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -75.04 159.5 41.15 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.488 1.783 . . . . 53.030000000000001 111.003 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.69 HG23 ' HE2' ' A' ' 193' ' ' PHE . 3.0 p -84.85 -20.51 8.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.517 1.136 . . . . 65.400000000000006 109.22 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -82.47 11.84 49.22 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.5 1.125 . . . . 73.120000000000005 110.994 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.974 ' CD2' HG13 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -130.33 2.22 4.64 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.434 0.726 . . . . 73.019999999999996 110.943 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.974 HG13 ' CD2' ' A' ' 211' ' ' PHE . 14.3 m -137.8 145.8 28.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.456 1.098 . . . . 63.020000000000003 109.271 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.983 ' HB2' HD11 ' A' ' 163' ' ' LEU . 12.5 t -132.78 131.75 41.47 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 61.439999999999998 110.06 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.823 HG13 HG23 ' A' ' 227' ' ' VAL . 15.6 mm -83.77 149.73 4.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.113 . . . . 72.409999999999997 109.304 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 214' ' ' ILE . 18.9 pt . . . . . 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 73.109999999999999 109.302 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 17.6 p . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.549 0.214 . . . . 73.340000000000003 110.465 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 114.19 21.24 5.64 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.487 1.117 . . . . 63.210000000000001 110.957 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.487 ' ND2' ' N ' ' A' ' 225' ' ' ASN . 0.6 OUTLIER -84.16 171.95 12.36 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.488 0.758 . . . . 52.399999999999999 109.32 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.72 166.62 11.19 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.481 1.113 . . . . 72.439999999999998 109.335 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.823 HG23 HG13 ' A' ' 214' ' ' ILE . 11.2 p -78.92 -44.36 24.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.454 1.096 . . . . 73.219999999999999 109.278 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.637 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.3 mp -51.3 -53.25 16.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.607 1.192 . . . . 75.140000000000001 109.31 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -62.54 -32.76 73.76 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 64.439999999999998 110.275 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -73.91 -25.89 60.23 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.42 1.075 . . . . 71.010000000000005 109.255 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.687 HG21 ' CD2' ' A' ' 187' ' ' HIS . 42.0 mt -72.05 -34.79 51.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.519 1.137 . . . . 62.399999999999999 109.272 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.401 ' HE2' HG22 ' A' ' 231' ' ' ILE . 6.5 mmpt? -78.53 -29.84 46.69 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.466 1.104 . . . . 72.019999999999996 109.332 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.8 m -53.92 -40.78 67.0 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.472 1.108 . . . . 74.319999999999993 109.999 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.665 HG11 ' HG ' ' A' ' 158' ' ' LEU . 4.0 p -107.63 20.19 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.505 1.128 . . . . 74.430000000000007 109.287 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 41.94 28.86 0.1 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.532 1.145 . . . . 72.329999999999998 109.329 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.646 HD11 ' HA ' ' A' ' 186' ' ' ALA . 12.2 tp -47.16 115.53 3.56 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 75.430000000000007 109.281 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.01 147.15 33.51 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.551 1.816 . . . . 72.319999999999993 111.036 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 2.7 p -57.09 149.36 19.5 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.526 1.141 . . . . 71.109999999999999 110.411 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.637 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.4 p -48.78 -28.58 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.528 1.142 . . . . 70.150000000000006 109.291 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.412 ' HG2' ' NE2' ' A' ' 188' ' ' HIS . 76.6 mm-40 -80.17 -45.83 17.42 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.489 1.118 . . . . 71.540000000000006 110.311 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -58.46 -30.07 66.67 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.451 1.094 . . . . 60.329999999999998 110.285 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -76.91 -62.22 1.72 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.511 1.132 . . . . 71.150000000000006 108.003 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.38 -25.8 6.72 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 73.409999999999997 109.319 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 45.8 t -76.89 -36.47 56.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.444 1.09 . . . . 70.420000000000002 110.052 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.469 1.105 . . . . 60.109999999999999 109.302 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.987 0 N-CA-C 111.022 -0.831 . . . . 54.219999999999999 111.022 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.4 ' C ' HD23 ' A' ' 155' ' ' LEU . 18.4 Cg_endo -74.99 143.29 28.89 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.554 1.818 . . . . 60.130000000000003 111.018 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.755 HD23 ' N ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -126.92 -175.27 3.37 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.524 1.14 . . . . 71.519999999999996 109.279 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.43 -10.35 9.24 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.436 1.085 . . . . 62.130000000000003 111.018 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.7 p -150.65 114.52 5.01 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.5 0.765 . . . . 54.030000000000001 110.005 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.681 HD11 ' HB3' ' A' ' 230' ' ' ASP . 6.0 tp -110.96 153.48 25.46 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.445 1.091 . . . . 72.109999999999999 109.301 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.581 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 0.6 OUTLIER -147.8 160.57 42.6 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.521 1.138 . . . . 74.329999999999998 111.023 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.51 ' HB2' ' CD1' ' A' ' 214' ' ' ILE . . . -132.14 175.59 9.12 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 64.310000000000002 109.345 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.496 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -137.41 129.72 42.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.473 1.108 . . . . 60.539999999999999 109.334 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 164' ' ' TYR . 4.1 t -80.86 121.07 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.474 1.109 . . . . 63.32 109.329 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.466 HD11 ' CB ' ' A' ' 213' ' ' SER . 0.7 OUTLIER -100.33 -6.36 25.97 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.534 1.146 . . . . 70.219999999999999 109.28 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.64 ' O ' HG12 ' A' ' 162' ' ' VAL . 88.9 m-85 -148.58 151.65 35.42 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.115 . . . . 73.219999999999999 111.033 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -78.84 112.16 15.72 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.533 1.145 . . . . 52.299999999999997 109.328 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.557 ' CZ ' ' HD3' ' A' ' 208' ' ' PRO . 11.6 t80 -83.27 152.67 25.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.532 1.145 . . . . 72.450000000000003 111.032 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -125.75 116.35 21.48 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.483 1.114 . . . . 75.219999999999999 109.292 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.15 121.42 12.47 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.556 1.16 . . . . 64.200000000000003 109.256 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 170' ' ' LYS . 9.9 pt-20 -110.63 -46.15 3.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.509 1.131 . . . . 73.319999999999993 110.309 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -63.42 179.51 0.44 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.534 1.146 . . . . 74.430000000000007 109.31 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.11 -15.18 41.96 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.551 1.157 . . . . 75.239999999999995 109.317 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.82 10.19 10.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.471 1.107 . . . . 73.400000000000006 109.378 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -77.63 151.34 34.39 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.508 1.13 . . . . 44.409999999999997 110.348 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.642 HD11 ' HA2' ' A' ' 203' ' ' GLY . 14.4 mt -120.75 145.74 47.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.449 1.093 . . . . 65.209999999999994 109.247 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.2 m -88.03 154.33 20.57 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.47 1.107 . . . . 43.420000000000002 110.396 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.69 HG22 ' H ' ' A' ' 177' ' ' TYR . 5.8 m -135.92 -174.57 3.7 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.555 1.159 . . . . 73.109999999999999 110.372 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.69 ' H ' HG22 ' A' ' 176' ' ' THR . 24.5 m-85 -134.13 138.43 45.22 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.461 1.101 . . . . 75.209999999999994 111.01 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 163' ' ' LEU . 1.5 p -55.25 158.32 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.438 1.086 . . . . 55.530000000000001 109.228 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 38.94 57.63 1.99 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.508 1.13 . . . . 42.219999999999999 111.01 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 15.0 tp10 -121.83 166.34 14.52 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.423 0.719 . . . . 53.340000000000003 110.287 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -118.58 130.22 55.77 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.438 1.086 . . . . 61.350000000000001 109.268 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.62 HD21 ' CG2' ' A' ' 162' ' ' VAL . 1.8 pp -157.0 -179.73 8.49 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 75.239999999999995 109.297 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -131.45 142.28 49.97 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.428 1.08 . . . . 62.509999999999998 111.024 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.766 HD12 ' HB3' ' A' ' 193' ' ' PHE . 23.3 mm -78.53 141.44 15.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.452 1.095 . . . . 75.340000000000003 109.337 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 3.4 t -103.49 -24.71 13.42 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.504 1.128 . . . . 64.510000000000005 108.294 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.853 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -170.11 179.53 3.5 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.505 1.128 . . . . 72.319999999999993 109.33 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 238' ' ' THR . 7.7 p80 -145.53 142.24 29.01 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 74.420000000000002 109.581 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.637 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.6 t-160 -123.72 120.66 33.34 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.475 1.109 . . . . 63.310000000000002 109.599 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.453 ' C ' ' N ' ' A' ' 191' ' ' GLU . 14.8 m-20 54.14 30.1 11.55 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.119 . . . . 75.540000000000006 109.256 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 11.9 p 43.51 28.29 0.19 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.502 1.126 . . . . 55.25 108.29 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.453 ' N ' ' C ' ' A' ' 189' ' ' ASN . 8.7 pt-20 -123.88 -36.76 2.68 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.491 1.119 . . . . 62.43 110.28 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.53 ' HZ3' HD13 ' A' ' 206' ' ' LEU . 9.0 m0 -110.55 158.52 18.45 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.443 1.089 . . . . 74.420000000000002 108.1 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.766 ' HB3' HD12 ' A' ' 184' ' ' ILE . 8.5 m-85 -131.12 148.49 52.73 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.502 1.126 . . . . 50.229999999999997 110.983 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.864 ' CD1' HD23 ' A' ' 206' ' ' LEU . 12.7 mm -96.34 88.89 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.495 1.122 . . . . 73.109999999999999 109.291 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.469 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -71.04 164.1 26.23 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.506 1.129 . . . . 71.209999999999994 109.315 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -164.82 82.75 1.2 Allowed Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.586 1.179 . . . . 74.349999999999994 109.311 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 152.99 41.19 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.512 1.796 . . . . 73.420000000000002 111.016 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 14.8 pt -103.53 -21.98 5.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.57 1.169 . . . . 71.329999999999998 109.294 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -46.93 -29.4 4.44 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.503 1.127 . . . . 55.310000000000002 111.038 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -138.94 140.34 38.27 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.483 0.755 . . . . 74.239999999999995 110.241 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 49.0 tp -71.04 98.25 1.6 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.569 1.168 . . . . 63.450000000000003 109.311 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -172.04 -135.12 1.9 Allowed Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.475 1.11 . . . . 74.099999999999994 110.959 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.642 ' HA2' HD11 ' A' ' 174' ' ' LEU . . . 51.43 178.3 0.04 OUTLIER Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.949 -0.86 . . . . 61.399999999999999 110.949 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -178.65 24.09 Favored 'Cis proline' 0 C--N 1.361 1.201 0 C-N-CA 121.013 -2.495 . . . . 75.530000000000001 110.941 0.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -149.13 166.13 29.42 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 124.499 1.124 . . . . 62.340000000000003 110.977 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.864 HD23 ' CD1' ' A' ' 194' ' ' ILE . 6.6 mt -93.51 134.34 35.89 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.61 0.829 . . . . 75.049999999999997 109.253 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.469 HG11 ' HB2' ' A' ' 195' ' ' ALA . 1.8 m -139.1 153.9 71.86 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.537 1.148 . . . . 70.150000000000006 109.284 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.568 ' HG2' ' CD2' ' A' ' 211' ' ' PHE . 18.2 Cg_endo -74.98 155.33 43.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.526 1.803 . . . . 72.099999999999994 110.974 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.678 HG23 ' HE2' ' A' ' 193' ' ' PHE . 3.6 p -81.39 -33.66 12.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.409 1.068 . . . . 64.310000000000002 109.263 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -64.77 -11.03 48.26 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.5 1.125 . . . . 40.43 110.949 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.568 ' CD2' ' HG2' ' A' ' 208' ' ' PRO . 8.2 m-30 -109.89 19.74 18.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.493 0.76 . . . . 74.019999999999996 110.974 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.595 HG21 ' CD2' ' A' ' 193' ' ' PHE . 26.9 m -156.16 141.95 10.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.442 1.089 . . . . 73.010000000000005 109.275 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.466 ' CB ' HD11 ' A' ' 163' ' ' LEU . 1.0 OUTLIER -131.06 148.86 52.79 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.475 1.109 . . . . 73.109999999999999 110.017 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.758 HG13 HG23 ' A' ' 227' ' ' VAL . 12.1 mm -103.95 128.25 57.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.527 1.142 . . . . 75.430000000000007 109.346 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.429 ' O ' ' CE2' ' A' ' 159' ' ' TYR . 0.2 OUTLIER -151.86 156.85 5.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.11 . . . . 54.509999999999998 109.277 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' A' ' 217' ' ' ILE . 12.6 t70 -86.35 167.56 14.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.532 1.145 . . . . 74.430000000000007 109.296 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.416 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 9.6 tt -53.11 113.85 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 71.219999999999999 109.303 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.504 ' HB1' ' CE2' ' A' ' 221' ' ' TYR . . . -172.87 -175.54 1.27 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.558 1.161 . . . . 52.539999999999999 109.296 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 5.1 t -54.61 -45.27 73.63 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.595 1.184 . . . . 73.120000000000005 110.428 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 133.99 79.28 0.13 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.442 1.089 . . . . 74.409999999999997 111.069 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.504 ' CE2' ' HB1' ' A' ' 218' ' ' ALA . 2.7 p90 -139.76 171.01 14.83 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.522 0.778 . . . . 63.329999999999998 110.983 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -107.89 114.18 27.93 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.471 1.107 . . . . 71.120000000000005 109.275 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 17.9 p -72.7 -26.25 61.53 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 61.340000000000003 110.382 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 116.23 4.93 17.69 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 124.481 1.113 . . . . 65.340000000000003 110.928 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -78.19 -176.32 4.56 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.432 0.724 . . . . 61.32 109.292 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.1 169.88 14.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.554 1.159 . . . . 73.109999999999999 109.273 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.758 HG23 HG13 ' A' ' 214' ' ' ILE . 12.1 p -80.77 -35.28 14.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.474 1.109 . . . . 61.350000000000001 109.254 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.572 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.4 mp -54.16 -50.37 55.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.517 1.136 . . . . 61.100000000000001 109.301 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -59.55 -35.61 74.55 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 74.219999999999999 110.295 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.681 ' HB3' HD11 ' A' ' 158' ' ' LEU . 5.0 m-20 -78.1 -22.93 48.21 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.468 1.105 . . . . 75.019999999999996 109.299 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.745 HG23 ' HB3' ' A' ' 236' ' ' LEU . 35.5 mt -70.61 -36.8 67.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.585 1.178 . . . . 62.210000000000001 109.266 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.625 ' HE2' HG22 ' A' ' 231' ' ' ILE . 6.1 mmpt? -80.72 -13.98 58.52 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.572 1.17 . . . . 73.400000000000006 109.309 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.562 ' O ' HD12 ' A' ' 155' ' ' LEU . 2.7 t -81.18 -44.39 17.91 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.526 1.141 . . . . 72.019999999999996 109.998 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.646 HG12 ' O ' ' A' ' 230' ' ' ASP . 7.7 p -99.17 24.25 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.494 1.121 . . . . 40.240000000000002 109.343 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 41.36 29.13 0.08 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.534 1.146 . . . . 73.310000000000002 109.338 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.745 ' HB3' HG23 ' A' ' 231' ' ' ILE . 1.1 tp -45.21 103.75 0.36 Allowed Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.106 . . . . 73.209999999999994 109.286 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 138.19 22.64 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.561 1.822 . . . . 62.25 111.049 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 7.4 p -57.01 148.88 20.27 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 72.409999999999997 110.411 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.637 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 3.5 p -53.99 -25.43 12.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.535 1.147 . . . . 63.219999999999999 109.323 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.547 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 3.8 mm100 -77.82 -34.36 51.99 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.407 1.067 . . . . 51.229999999999997 110.319 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -82.74 -20.87 35.11 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.553 1.158 . . . . 75.319999999999993 110.303 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.457 ' HE1' HD11 ' A' ' 246' ' ' ILE . 4.3 t90 -80.09 -53.25 6.88 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.516 1.135 . . . . 72.430000000000007 108.022 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -51.61 -28.17 13.42 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.527 1.142 . . . . 62.100000000000001 109.272 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.7 t -73.64 -35.2 65.26 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.451 1.094 . . . . 73.310000000000002 109.999 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -76.11 -24.06 54.95 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.497 1.123 . . . . 74.219999999999999 109.281 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.562 ' O ' ' HB3' ' A' ' 247' ' ' ALA . 8.3 mm -68.93 129.14 33.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.528 1.142 . . . . 64.200000000000003 109.261 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 246' ' ' ILE . . . 74.85 3.89 4.25 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.536 1.148 . . . . 74.219999999999999 109.362 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.04 -59.98 1.85 Allowed 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.499 1.124 . . . . 52.530000000000001 110.366 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -93.5 177.57 5.98 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.477 1.111 . . . . 73.200000000000003 110.955 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -130.87 152.19 50.46 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.445 1.091 . . . . 73.530000000000001 109.273 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -44.54 122.34 3.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.472 1.107 . . . . 51.439999999999998 109.325 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 87.0 p -139.65 179.32 6.64 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.518 1.136 . . . . 70.099999999999994 109.994 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.87 141.49 51.99 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.495 1.122 . . . . 74.140000000000001 109.336 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 19.5 tt -127.96 155.86 39.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.526 1.141 . . . . 64.109999999999999 109.264 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 13.6 t -57.96 144.19 40.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.544 1.152 . . . . 74.239999999999995 110.004 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 34.6 tp -137.58 142.62 41.31 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.513 1.133 . . . . 74.129999999999995 109.302 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -80.34 -161.76 25.18 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.537 1.148 . . . . 54.32 111.042 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.4 t -168.14 134.42 1.98 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.507 0.769 . . . . 74.140000000000001 109.979 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 259' ' ' VAL . 13.7 p -171.41 113.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.482 1.114 . . . . 73.329999999999998 109.283 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 C--N 1.324 -0.523 0 O-C-N 124.524 1.14 . . . . 75.540000000000006 110.258 -179.961 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.058 0 N-CA-C 110.96 -0.856 . . . . 70.030000000000001 110.96 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.95 149.48 36.98 Favored 'Trans proline' 0 C--N 1.359 1.113 0 O-C-N 124.489 1.784 . . . . 53.399999999999999 111.001 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.403 ' H ' HD12 ' A' ' 155' ' ' LEU . 2.4 mp -91.23 -176.4 4.57 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.528 1.143 . . . . 72.25 109.304 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 102.2 6.49 48.14 Favored Glycine 0 CA--C 1.531 1.057 0 O-C-N 124.544 1.153 . . . . 72.230000000000004 111.034 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.0 t -159.71 151.0 19.7 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.559 0.799 . . . . 73.239999999999995 109.973 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.812 ' HG ' HG11 ' A' ' 234' ' ' VAL . 6.5 mt -114.42 165.95 12.2 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.485 1.116 . . . . 64.329999999999998 109.301 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.43 ' CG ' ' C ' ' A' ' 158' ' ' LEU . 35.9 m-85 -154.65 116.73 4.22 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.466 1.104 . . . . 75.040000000000006 111.053 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.481 ' HB2' HD13 ' A' ' 214' ' ' ILE . . . -126.19 168.05 14.59 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.564 1.165 . . . . 51.149999999999999 109.382 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.543 HG21 HD11 ' A' ' 215' ' ' ILE . 0.1 OUTLIER -133.76 130.14 55.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.557 1.16 . . . . 74.010000000000005 109.385 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.843 HG23 HD11 ' A' ' 182' ' ' LEU . 39.7 t -89.66 111.22 22.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 53.200000000000003 109.304 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.64 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.2 OUTLIER -101.97 14.09 32.94 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.551 1.157 . . . . 52.030000000000001 109.287 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.57 ' HB3' ' CD2' ' A' ' 211' ' ' PHE . 63.5 m-85 -152.54 137.9 17.57 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.492 1.12 . . . . 73.049999999999997 111.031 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.417 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 25.8 t0 -80.16 107.96 13.37 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.482 1.114 . . . . 71.239999999999995 109.365 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.598 ' CE2' ' O ' ' A' ' 206' ' ' LEU . 17.1 t80 -80.33 136.58 36.43 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.517 1.136 . . . . 62.509999999999998 111.082 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.26 95.31 6.44 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.502 1.126 . . . . 62.439999999999998 109.316 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.777 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -57.86 133.4 55.4 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.563 1.164 . . . . 60.229999999999997 109.276 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -119.84 -38.63 2.94 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.523 1.139 . . . . 64.019999999999996 110.301 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.1 -177.96 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.517 1.135 . . . . 44.140000000000001 109.291 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.21 -29.95 22.78 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.459 1.099 . . . . 72.209999999999994 109.337 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.73 -11.62 28.76 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.423 1.077 . . . . 61.329999999999998 109.25 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.564 ' C ' ' HB1' ' A' ' 168' ' ' ALA . 8.6 mt-10 -74.74 134.4 41.88 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 75.329999999999998 110.263 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.777 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 5.4 mp -112.67 154.24 26.39 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.544 1.152 . . . . 72.409999999999997 109.329 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 175' ' ' THR . 14.9 t -91.65 115.82 28.37 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.503 1.127 . . . . 62.439999999999998 110.389 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.687 HG22 ' H ' ' A' ' 177' ' ' TYR . 6.0 m -94.0 -173.64 3.18 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.483 1.114 . . . . 71.209999999999994 110.384 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.687 ' H ' HG22 ' A' ' 176' ' ' THR . 37.3 m-85 -136.35 134.34 37.78 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.487 1.117 . . . . 72.430000000000007 110.996 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.625 HG23 ' C ' ' A' ' 163' ' ' LEU . 1.8 p -59.59 149.95 6.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.418 1.074 . . . . 74.340000000000003 109.286 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 68.22 36.77 85.71 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.505 1.128 . . . . 62.020000000000003 111.002 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.494 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 21.7 tp10 -113.42 165.02 12.86 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.527 0.781 . . . . 73.310000000000002 110.295 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.693 ' C ' HD13 ' A' ' 182' ' ' LEU . 5.5 m120 -129.24 134.68 48.09 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.414 1.071 . . . . 73.549999999999997 109.332 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.843 HD11 HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -167.2 164.48 15.57 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.542 1.151 . . . . 74.109999999999999 109.363 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.566 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 0.6 OUTLIER -99.69 148.08 24.73 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.592 1.183 . . . . 70.25 110.958 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.625 HD12 ' HB3' ' A' ' 193' ' ' PHE . 24.2 mm -77.7 112.9 16.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.49 1.119 . . . . 53.240000000000002 109.296 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.459 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 0.5 OUTLIER -73.87 -27.56 61.13 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.476 1.11 . . . . 33.439999999999998 108.261 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.829 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -171.3 179.58 2.93 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.533 1.146 . . . . 73.150000000000006 109.289 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.522 ' NE2' HG21 ' A' ' 231' ' ' ILE . 9.2 p80 -143.28 143.58 31.77 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.545 1.153 . . . . 61.420000000000002 109.594 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.469 ' HB2' ' CG1' ' A' ' 239' ' ' VAL . 0.1 OUTLIER -124.01 121.58 35.64 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.483 1.115 . . . . 74.140000000000001 109.628 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.466 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 0.1 OUTLIER 53.6 30.59 11.08 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.484 1.115 . . . . 74.409999999999997 109.309 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 13.1 p 42.68 29.0 0.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.125 . . . . 73.319999999999993 108.269 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.604 ' O ' HG12 ' A' ' 209' ' ' VAL . 13.3 pt-20 -123.38 -37.49 2.67 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 75.019999999999996 110.245 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.469 ' CD1' ' HG3' ' A' ' 191' ' ' GLU . 15.8 m0 -112.37 160.48 17.66 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.546 1.154 . . . . 73.439999999999998 107.989 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.859 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 21.0 m-85 -136.81 161.16 36.74 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.502 1.126 . . . . 74.219999999999999 111.016 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.829 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 9.5 mm -97.77 108.53 21.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.456 1.098 . . . . 73.010000000000005 109.317 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.681 ' CB ' HG21 ' A' ' 207' ' ' VAL . . . -99.42 167.98 10.28 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.525 1.14 . . . . 54.420000000000002 109.271 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -153.94 91.79 3.15 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.429 1.081 . . . . 73.549999999999997 109.287 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -162.47 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.198 0 O-C-N 124.518 1.799 . . . . 54.009999999999998 111.004 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.537 ' N ' HD13 ' A' ' 198' ' ' ILE . 0.1 OUTLIER -40.14 126.51 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 75.450000000000003 109.291 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -37.77 115.33 0.35 Allowed Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.546 1.154 . . . . 64.019999999999996 110.975 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 202' ' ' GLY . 44.5 ttt180 -151.23 115.99 5.19 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.451 0.736 . . . . 74.150000000000006 110.337 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 14.8 mt -49.21 94.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.501 1.126 . . . . 32.119999999999997 109.321 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 200' ' ' ARG . . . 165.84 -31.28 0.22 Allowed Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.468 1.105 . . . . 74.129999999999995 111.033 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -72.15 176.05 41.45 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.58 0.812 . . . . 70.120000000000005 111.091 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.472 ' CB ' ' O ' ' A' ' 195' ' ' ALA . 18.4 Cg_endo -75.03 -173.7 12.81 Favored 'Cis proline' 0 C--N 1.36 1.176 0 C-N-CA 121.0 -2.5 . . . . 72.420000000000002 111.027 -0.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.13 172.38 20.71 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.503 1.127 . . . . 73.530000000000001 110.988 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.598 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 6.5 mt -99.4 134.8 41.75 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.484 0.755 . . . . 74.109999999999999 109.316 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.78 HG12 ' HD2' ' A' ' 208' ' ' PRO . 0.7 OUTLIER -134.43 144.27 50.31 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.504 1.128 . . . . 71.099999999999994 109.309 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.78 ' HD2' HG12 ' A' ' 207' ' ' VAL . 18.2 Cg_endo -74.94 138.84 23.73 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.51 1.795 . . . . 62.219999999999999 111.005 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.721 ' HA ' HG22 ' A' ' 212' ' ' VAL . 7.5 p -61.13 -34.78 61.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.46 1.1 . . . . 63.32 109.301 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -61.27 -13.01 34.11 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.557 1.16 . . . . 52.039999999999999 111.031 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 164' ' ' TYR . 4.4 m-85 -113.51 18.41 17.67 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.546 0.792 . . . . 73.099999999999994 111.026 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.721 HG22 ' HA ' ' A' ' 209' ' ' VAL . 11.3 m -153.62 153.58 8.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.499 1.124 . . . . 75.25 109.336 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.64 ' HB2' HD21 ' A' ' 163' ' ' LEU . 1.7 t -139.27 141.55 37.79 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.458 1.098 . . . . 72.129999999999995 110.018 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.63 HG13 HG23 ' A' ' 227' ' ' VAL . 17.6 mm -82.34 91.71 2.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.535 1.147 . . . . 73.409999999999997 109.27 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.543 HD11 HG21 ' A' ' 161' ' ' ILE . 1.6 pt -148.6 131.86 7.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.125 . . . . 54.509999999999998 109.364 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -112.12 17.99 19.08 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.507 1.129 . . . . 71.450000000000003 109.318 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.56 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 61.1 mt -87.9 -35.13 7.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.511 1.132 . . . . 61.109999999999999 109.294 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 217' ' ' ILE . . . 74.51 49.21 0.11 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.499 1.124 . . . . 74.25 109.292 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.522 ' HB ' ' CE2' ' A' ' 221' ' ' TYR . 10.1 p -133.47 -49.48 0.84 Allowed 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.513 1.133 . . . . 70.109999999999999 110.411 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 129.19 -6.61 6.36 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.524 1.14 . . . . 50.109999999999999 110.973 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.522 ' CE2' ' HB ' ' A' ' 219' ' ' THR . 4.9 m-85 -85.8 -179.93 6.92 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.48 0.753 . . . . 54.119999999999997 111.009 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -139.71 155.73 47.2 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.472 1.108 . . . . 62.43 109.336 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 72.0 p -91.94 -17.85 24.57 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.517 1.135 . . . . 73.420000000000002 110.428 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.08 -1.22 22.7 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.467 1.104 . . . . 32.409999999999997 111.01 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -82.25 176.17 9.69 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.475 0.75 . . . . 63.210000000000001 109.261 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.44 171.73 9.72 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.458 1.099 . . . . 72.329999999999998 109.333 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.859 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 12.0 p -80.52 -40.27 19.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.47 1.106 . . . . 70.439999999999998 109.239 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.872 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.4 mp -51.04 -48.51 29.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.156 . . . . 73.340000000000003 109.301 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.03 -33.15 74.82 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.491 1.12 . . . . 55.520000000000003 110.25 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.626 ' O ' HD21 ' A' ' 158' ' ' LEU . 0.6 OUTLIER -76.89 -14.29 59.9 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.574 1.171 . . . . 71.099999999999994 109.292 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.872 HD12 ' HA ' ' A' ' 228' ' ' ILE . 34.6 mt -84.29 -32.4 8.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.483 1.114 . . . . 61.43 109.354 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -84.01 -18.73 36.12 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.421 1.076 . . . . 62.009999999999998 109.288 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 6.8 p -68.66 -29.01 67.39 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.527 1.142 . . . . 63.450000000000003 109.967 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.812 HG11 ' HG ' ' A' ' 158' ' ' LEU . 6.2 p -126.53 21.34 3.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.506 1.129 . . . . 72.299999999999997 109.318 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.3 m120 40.68 29.74 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.559 1.162 . . . . 73.019999999999996 109.334 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.746 HD22 HD13 ' A' ' 158' ' ' LEU . 22.9 tp -42.11 113.34 1.2 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.521 1.138 . . . . 72.219999999999999 109.325 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 133.72 16.91 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.519 1.799 . . . . 71.239999999999995 110.956 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.522 HG22 ' CE1' ' A' ' 187' ' ' HIS . 9.4 p -57.12 151.56 15.1 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.513 1.133 . . . . 73.230000000000004 110.42 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.469 ' CG1' ' HB2' ' A' ' 188' ' ' HIS . 2.7 p -59.72 -24.89 30.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.549 1.156 . . . . 73.409999999999997 109.281 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -80.05 -28.59 39.22 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.455 1.097 . . . . 74.219999999999999 110.28 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -86.9 -25.06 24.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 74.099999999999994 110.233 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.687 ' CE2' HD11 ' A' ' 246' ' ' ILE . 4.0 t90 -76.75 -52.9 8.73 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.48 1.113 . . . . 63.399999999999999 108.001 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.707 ' HA ' HD12 ' A' ' 246' ' ' ILE . 32.5 pttt -48.1 -28.83 3.11 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.504 1.127 . . . . 65.310000000000002 109.35 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.6 t -81.32 -44.78 17.15 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.457 1.098 . . . . 32.229999999999997 109.98 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -63.07 -16.39 59.76 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.543 1.152 . . . . 70.450000000000003 109.26 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.707 HD12 ' HA ' ' A' ' 243' ' ' LYS . 55.5 mt -69.06 129.53 33.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 O-C-N 124.591 1.182 . . . . 64.310000000000002 109.299 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.03 153.71 40.77 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.486 1.116 . . . . 73.329999999999998 109.248 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -162.61 175.49 11.35 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.462 1.101 . . . . 74.219999999999999 110.304 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' ' 248' ' ' ARG . 25.1 t80 -35.07 112.57 0.16 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.128 . . . . 72.200000000000003 110.95 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -115.87 132.72 56.56 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.505 1.128 . . . . 75.140000000000001 109.3 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.99 176.77 7.6 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.477 1.111 . . . . 62.020000000000003 109.264 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 1.5 t -63.88 133.61 53.63 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.554 1.159 . . . . 73.230000000000004 110.07 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -152.82 -177.03 6.01 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.567 1.167 . . . . 74.129999999999995 109.28 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 255' ' ' SER . 19.6 mm -110.14 164.6 6.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.539 1.149 . . . . 74.010000000000005 109.363 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.466 ' N ' HG22 ' A' ' 254' ' ' ILE . 61.2 p -96.76 -175.88 3.42 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.548 1.155 . . . . 71.040000000000006 109.974 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.98 -66.7 0.98 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.528 1.142 . . . . 62.329999999999998 109.281 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 165.28 -170.79 40.38 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.573 1.17 . . . . 74.439999999999998 110.955 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.3 p -125.03 131.37 53.39 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.442 0.73 . . . . 70.019999999999996 109.978 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.8 m -54.55 177.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.547 1.154 . . . . 74.219999999999999 109.351 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 . . . . . 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 73.319999999999993 110.29 179.972 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.94 0 N-CA-C 111.07 -0.812 . . . . 63.009999999999998 111.07 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 107.97 2.61 Favored 'Trans proline' 0 C--N 1.361 1.205 0 O-C-N 124.466 1.772 . . . . 61.420000000000002 111.025 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 16.3 mt -87.51 -27.69 22.47 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.545 1.153 . . . . 75.219999999999999 109.271 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.442 ' H ' HG23 ' A' ' 234' ' ' VAL . . . 52.16 20.22 6.52 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.546 1.154 . . . . 60.32 110.99 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.2 p -166.32 153.49 9.62 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.474 0.75 . . . . 64.439999999999998 110.044 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 1.075 HD12 HD12 ' A' ' 236' ' ' LEU . 8.2 mt -146.64 -178.65 6.28 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.514 1.134 . . . . 62.509999999999998 109.3 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.54 ' CG ' ' O ' ' A' ' 158' ' ' LEU . 76.3 m-85 -164.69 141.62 6.2 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.588 1.18 . . . . 73.120000000000005 111.064 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.731 ' HB3' HD11 ' A' ' 184' ' ' ILE . . . -135.44 130.26 34.5 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.539 1.149 . . . . 35.420000000000002 109.297 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.463 ' CG1' ' O ' ' A' ' 180' ' ' GLU . 1.3 tt -100.83 138.85 23.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.519 1.137 . . . . 73.25 109.28 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 164' ' ' TYR . 2.9 t -90.88 114.21 27.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.456 1.097 . . . . 72.420000000000002 109.275 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.653 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.1 OUTLIER -94.32 12.99 25.02 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.481 1.113 . . . . 63.149999999999999 109.296 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.614 ' O ' HG12 ' A' ' 162' ' ' VAL . 35.3 m-85 -157.98 131.27 7.61 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.562 1.163 . . . . 62.210000000000001 110.969 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -54.06 108.67 0.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 72.040000000000006 109.236 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.586 ' CE2' ' O ' ' A' ' 174' ' ' LEU . 5.7 t80 -80.46 136.71 36.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.447 1.092 . . . . 73.219999999999999 110.992 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -113.68 111.75 22.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.458 1.099 . . . . 61.140000000000001 109.259 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.682 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -63.53 121.65 14.37 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.534 1.146 . . . . 53.439999999999998 109.301 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.452 ' CG ' ' N ' ' A' ' 170' ' ' LYS . 14.7 pt-20 -116.62 -44.41 2.85 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.543 1.152 . . . . 64.310000000000002 110.256 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.473 ' CB ' ' HB2' ' A' ' 173' ' ' GLU . 0.8 OUTLIER -59.78 161.71 6.06 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.537 1.148 . . . . 72.409999999999997 109.324 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.76 -19.61 64.33 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.441 1.088 . . . . 63.219999999999999 109.262 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -124.44 25.22 7.71 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.415 1.072 . . . . 62.039999999999999 109.393 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.473 ' HB2' ' CB ' ' A' ' 170' ' ' LYS . 6.3 tp10 -85.11 157.92 20.55 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 1.118 . . . . 73.519999999999996 110.33 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.682 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -115.86 149.83 38.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.153 . . . . 72.010000000000005 109.335 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 11.6 t -107.72 137.97 44.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.511 1.132 . . . . 74.530000000000001 110.402 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.622 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.5 m -136.54 -164.39 1.56 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.551 1.157 . . . . 65.299999999999997 110.463 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.622 ' H ' HG22 ' A' ' 176' ' ' THR . 76.3 m-85 -140.62 150.49 43.64 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.433 1.083 . . . . 71.319999999999993 111.039 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.428 ' H ' HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -45.81 156.47 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.436 1.085 . . . . 65.519999999999996 109.313 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 37.51 63.81 0.79 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.518 1.136 . . . . 71.150000000000006 111.025 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.463 ' O ' ' CG1' ' A' ' 161' ' ' ILE . 26.5 tp10 -121.85 155.93 34.34 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.541 0.789 . . . . 70.040000000000006 110.321 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.418 ' N ' ' HG3' ' A' ' 180' ' ' GLU . 0.5 OUTLIER -101.5 126.99 48.37 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.534 1.146 . . . . 71.219999999999999 109.335 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.444 HD12 HG21 ' A' ' 176' ' ' THR . 11.1 mt -146.79 153.21 39.93 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.463 1.102 . . . . 72.230000000000004 109.3 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -111.56 131.73 55.04 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.546 1.154 . . . . 73.439999999999998 111.016 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.731 HD11 ' HB3' ' A' ' 160' ' ' ALA . 31.7 mm -77.71 129.59 37.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 71.040000000000006 109.238 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 1.3 t -103.78 -25.45 13.1 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.457 1.098 . . . . 64.340000000000003 108.288 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.769 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -164.49 171.95 13.94 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.484 1.115 . . . . 63.130000000000003 109.298 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.423 ' CE1' HG21 ' A' ' 231' ' ' ILE . 8.5 p80 -140.23 145.27 37.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.519 1.137 . . . . 72.5 109.616 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.649 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.6 t-160 -122.97 118.28 27.44 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.569 1.168 . . . . 73.430000000000007 109.593 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.45 ' C ' ' N ' ' A' ' 191' ' ' GLU . 57.1 m-80 53.82 31.51 13.22 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.549 1.155 . . . . 52.210000000000001 109.258 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 12.7 p 42.96 28.62 0.14 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 72.400000000000006 108.244 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.45 ' N ' ' C ' ' A' ' 189' ' ' ASN . 6.1 pt-20 -122.54 -36.05 2.99 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.457 1.098 . . . . 72.549999999999997 110.279 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.467 ' HE3' HD22 ' A' ' 206' ' ' LEU . 9.1 m0 -114.07 159.91 19.48 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.486 1.116 . . . . 73.230000000000004 108.01 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.952 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 28.4 m-85 -130.35 157.38 42.73 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.423 1.077 . . . . 74.140000000000001 111.02 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.769 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 22.8 mm -103.44 111.56 33.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.459 1.099 . . . . 60.030000000000001 109.228 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 204' ' ' PRO . . . -98.08 154.85 17.44 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.589 1.181 . . . . 71.439999999999998 109.34 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -142.9 154.64 62.37 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.467 1.104 . . . . 63.399999999999999 109.318 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 163.1 36.01 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.435 1.755 . . . . 75.140000000000001 111.034 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 18.2 tt -70.78 -21.21 22.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.481 1.113 . . . . 75.239999999999995 109.311 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 159.86 53.75 0.01 OUTLIER Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.462 1.101 . . . . 14.109999999999999 111.01 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 48.0 mmm-85 -150.01 -175.87 5.22 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.545 0.791 . . . . 73.420000000000002 110.279 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.25 123.47 30.17 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.503 1.127 . . . . 73.340000000000003 109.279 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 175.57 -96.21 0.1 Allowed Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.475 1.109 . . . . 63.149999999999999 111.005 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -50.14 -178.88 0.02 OUTLIER Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.022 -0.831 . . . . 53.420000000000002 111.022 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 18.2 Cg_endo -75.03 125.38 11.24 Favored 'Cis proline' 0 C--N 1.362 1.241 0 C-N-CA 120.987 -2.506 . . . . 64.310000000000002 110.972 0.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -105.25 172.28 19.47 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.532 1.145 . . . . 62.539999999999999 110.972 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.65 HD23 ' CD1' ' A' ' 194' ' ' ILE . 3.8 mt -106.07 137.23 44.35 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.507 0.769 . . . . 70.349999999999994 109.258 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.76 HG21 HG11 ' A' ' 212' ' ' VAL . 0.1 OUTLIER -132.56 138.59 32.42 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.535 1.147 . . . . 70.049999999999997 109.327 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.57 ' HD3' ' CZ ' ' A' ' 166' ' ' PHE . 18.2 Cg_endo -75.01 144.58 30.37 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.463 1.77 . . . . 71.010000000000005 111.012 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.624 HG23 ' CE2' ' A' ' 193' ' ' PHE . 12.0 p -75.19 -21.84 16.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.545 1.153 . . . . 74.349999999999994 109.316 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -75.68 -7.8 83.7 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.488 1.118 . . . . 73.120000000000005 111.037 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -113.67 -11.2 12.99 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.447 0.733 . . . . 73.230000000000004 111.11 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.76 HG11 HG21 ' A' ' 207' ' ' VAL . 15.4 m -128.48 161.55 36.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.527 1.142 . . . . 73.450000000000003 109.302 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.653 ' HB2' HD21 ' A' ' 163' ' ' LEU . 6.3 t -149.88 153.17 36.25 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.47 1.106 . . . . 73.340000000000003 110.027 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.756 HG13 HG23 ' A' ' 227' ' ' VAL . 12.3 mm -96.46 121.42 46.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 124.546 1.154 . . . . 71.319999999999993 109.295 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.894 HD12 ' HB3' ' A' ' 218' ' ' ALA . 7.6 pt -149.89 156.48 7.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.514 1.134 . . . . 73.409999999999997 109.335 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -85.94 -58.75 2.52 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.533 1.146 . . . . 62.299999999999997 109.311 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.6 mt -152.17 112.64 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.53 1.144 . . . . 73.540000000000006 109.295 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.894 ' HB3' HD12 ' A' ' 215' ' ' ILE . . . -174.33 132.62 0.39 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.43 1.081 . . . . 70.230000000000004 109.368 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 9.5 t -58.14 -30.84 66.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.577 1.173 . . . . 54.409999999999997 110.409 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 173.53 65.7 0.05 OUTLIER Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.524 1.14 . . . . 45.520000000000003 111.038 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.49 ' HB2' ' HB1' ' A' ' 218' ' ' ALA . 65.3 m-85 -137.11 -175.14 3.94 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 0.783 . . . . 75.310000000000002 111.069 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -155.64 109.62 2.83 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.483 1.115 . . . . 75.129999999999995 109.354 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 58.4 p -45.68 -48.33 15.0 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.485 1.115 . . . . 64.239999999999995 110.447 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 154.08 -22.8 0.68 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.473 1.108 . . . . 71.299999999999997 111.033 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -62.88 -175.95 0.11 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.45 0.735 . . . . 61.020000000000003 109.318 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -135.04 176.98 8.17 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.47 1.106 . . . . 70.200000000000003 109.254 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.952 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 8.3 p -79.6 -32.95 14.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.524 1.14 . . . . 71.519999999999996 109.342 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.834 HD12 HG13 ' A' ' 227' ' ' VAL . 1.5 mp -57.75 -49.23 81.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.43 1.081 . . . . 72.129999999999995 109.258 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -59.92 -28.89 67.99 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.447 1.092 . . . . 74.140000000000001 110.298 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.44 ' O ' HD11 ' A' ' 158' ' ' LEU . 0.8 OUTLIER -80.75 -31.21 36.02 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.546 1.154 . . . . 42.219999999999999 109.277 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.572 HD11 HG22 ' A' ' 227' ' ' VAL . 24.3 mt -72.72 -39.03 59.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.459 1.099 . . . . 71.120000000000005 109.281 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -76.22 -32.7 59.08 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.536 1.147 . . . . 52.210000000000001 109.258 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.4 m -55.65 -39.86 71.45 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 74.129999999999995 110.04 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.62 HG11 ' HG ' ' A' ' 158' ' ' LEU . 11.8 p -118.58 13.54 7.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.501 1.126 . . . . 50.43 109.316 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 231' ' ' ILE . 8.5 m120 40.46 43.06 1.44 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.542 1.151 . . . . 73.200000000000003 109.321 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 1.075 HD12 HD12 ' A' ' 158' ' ' LEU . 2.1 tt -40.28 140.01 0.99 Allowed Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.525 1.14 . . . . 74.400000000000006 109.306 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.515 ' HD2' HD23 ' A' ' 236' ' ' LEU . 18.2 Cg_endo -75.01 139.23 24.02 Favored 'Trans proline' 0 C--N 1.361 1.207 0 O-C-N 124.566 1.824 . . . . 62.039999999999999 110.996 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.404 HG22 ' CE1' ' A' ' 187' ' ' HIS . 2.3 p -75.13 152.14 38.52 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.504 1.127 . . . . 64.230000000000004 110.41 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.649 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.7 p -53.32 -23.09 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.525 1.14 . . . . 63.149999999999999 109.33 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.498 ' O ' ' CB ' ' A' ' 244' ' ' SER . 99.3 mm-40 -86.06 -50.14 7.26 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.46 1.1 . . . . 63.240000000000002 110.254 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -59.01 -28.91 66.83 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.536 1.147 . . . . 63.350000000000001 110.327 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.645 ' HZ3' HG21 ' A' ' 194' ' ' ILE . 22.0 t90 -80.42 -68.0 0.72 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.98 -1.119 . . . . 75.25 107.98 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.8 pttp -50.41 -23.25 2.28 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.516 1.135 . . . . 72.219999999999999 109.254 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 240' ' ' GLN . 11.3 t -68.57 -59.67 2.97 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.64 1.213 . . . . 72.420000000000002 110.047 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -59.27 -24.33 63.14 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.542 1.151 . . . . 64.340000000000003 109.381 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 3.3 mm -78.47 155.06 5.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 63.329999999999998 109.216 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -43.75 155.91 0.07 Allowed 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.462 1.101 . . . . 65.219999999999999 109.32 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.431 ' C ' ' CD ' ' A' ' 248' ' ' ARG . 0.0 OUTLIER 175.06 -174.4 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.441 1.088 . . . . 75.109999999999999 110.322 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.413 ' N ' ' HD2' ' A' ' 248' ' ' ARG . 0.4 OUTLIER -125.89 172.26 10.04 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.456 1.097 . . . . 75.530000000000001 110.969 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -92.7 -40.66 10.59 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.558 1.161 . . . . 63.25 109.314 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -144.72 145.08 31.53 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.505 1.128 . . . . 52.119999999999997 109.35 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 55.0 m -116.7 163.13 16.59 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.477 1.111 . . . . 62.439999999999998 110.015 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -100.12 18.83 17.62 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.467 1.104 . . . . 74.019999999999996 109.246 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 3.8 pt -93.83 17.8 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.485 1.116 . . . . 73.530000000000001 109.288 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.7 t -97.43 138.32 35.06 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.484 1.115 . . . . 71.219999999999999 109.949 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 256' ' ' LEU . 13.8 mt -123.53 150.44 43.99 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.525 1.14 . . . . 45.32 109.318 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.94 71.79 2.35 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.503 1.127 . . . . 73.200000000000003 110.977 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.5 t -82.72 135.93 34.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.49 0.759 . . . . 54.020000000000003 109.997 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.65 130.25 16.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.433 1.083 . . . . 75.430000000000007 109.326 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.506 0 O-C-N 124.468 1.105 . . . . 72.310000000000002 110.277 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.047 0 N-CA-C 111.016 -0.834 . . . . 41.119999999999997 111.016 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 177.79 8.12 Favored 'Trans proline' 0 C--N 1.361 1.208 0 O-C-N 124.487 1.783 . . . . 73.329999999999998 110.984 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 233' ' ' SER . 7.0 mt -126.15 138.15 53.64 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.582 1.176 . . . . 72.400000000000006 109.368 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 169.03 58.21 0.03 OUTLIER Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.551 1.157 . . . . 54.109999999999999 111.009 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.8 m -166.13 121.36 1.22 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 0.769 . . . . 63.140000000000001 109.997 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.684 HD21 ' OD2' ' A' ' 230' ' ' ASP . 0.5 OUTLIER -164.32 122.68 1.81 Allowed 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.502 1.126 . . . . 53.520000000000003 109.33 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.541 ' CD2' ' HB3' ' A' ' 183' ' ' PHE . 6.0 m-85 -137.41 165.82 25.31 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.493 1.121 . . . . 72.310000000000002 110.985 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.422 ' HB1' ' HB ' ' A' ' 212' ' ' VAL . . . -125.66 150.7 47.38 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.51 1.131 . . . . 65.310000000000002 109.291 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.82 HD12 ' O ' ' A' ' 180' ' ' GLU . 1.0 OUTLIER -113.19 122.74 67.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.514 1.134 . . . . 63.520000000000003 109.287 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.761 HG21 ' CG2' ' A' ' 176' ' ' THR . 19.8 t -76.73 132.31 33.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 64.099999999999994 109.293 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 1.015 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.4 OUTLIER -110.25 -12.38 14.46 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 55.149999999999999 109.294 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.483 ' HB2' ' CD2' ' A' ' 211' ' ' PHE . 85.1 m-85 -143.06 151.57 40.93 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 72.120000000000005 110.939 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.642 ' N ' HG12 ' A' ' 178' ' ' VAL . 0.9 OUTLIER -78.96 104.67 9.75 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.468 1.105 . . . . 64.430000000000007 109.273 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.513 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 1.1 t80 -80.87 109.45 15.45 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 1.127 . . . . 72.219999999999999 110.992 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.485 ' CE ' ' OD2' ' A' ' 165' ' ' ASP . 13.8 mmtp -81.55 94.41 6.88 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.53 1.143 . . . . 65.310000000000002 109.276 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.662 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -43.96 124.4 3.79 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.406 1.066 . . . . 71.439999999999998 109.244 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -119.72 -38.66 2.95 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.493 1.12 . . . . 71.299999999999997 110.269 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.414 ' CB ' ' HB2' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -63.75 165.01 8.99 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.53 1.144 . . . . 74.25 109.29 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.85 -22.57 62.29 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.509 1.131 . . . . 72.409999999999997 109.334 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -117.9 25.25 10.5 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.514 1.134 . . . . 61.140000000000001 109.297 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.529 ' O ' HD22 ' A' ' 174' ' ' LEU . 5.1 tp10 -91.91 147.5 22.92 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.527 1.142 . . . . 74.519999999999996 110.373 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.868 HD12 ' CG ' ' A' ' 197' ' ' PRO . 0.4 OUTLIER -120.02 143.61 47.98 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.403 1.065 . . . . 65.219999999999999 109.287 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.6 t -81.59 143.72 31.77 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.502 1.126 . . . . 63.409999999999997 110.414 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.761 ' CG2' HG21 ' A' ' 162' ' ' VAL . 2.6 m -131.37 -176.75 4.13 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.469 1.105 . . . . 73.25 110.399 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.563 ' H ' HG22 ' A' ' 176' ' ' THR . 6.1 m-85 -130.46 155.48 46.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.468 1.105 . . . . 75.209999999999994 111.017 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.642 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.0 OUTLIER -68.09 156.02 7.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.545 1.153 . . . . 73.549999999999997 109.309 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.47 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 37.45 55.1 1.66 Allowed Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.524 1.14 . . . . 54.119999999999997 111.011 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.82 ' O ' HD12 ' A' ' 161' ' ' ILE . 14.9 tt0 -114.75 165.94 12.28 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.513 0.772 . . . . 63.340000000000003 110.307 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -125.95 121.02 31.91 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.527 1.142 . . . . 72.319999999999993 109.269 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.423 ' C ' HD12 ' A' ' 182' ' ' LEU . 3.3 pp -140.63 168.27 20.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.462 1.101 . . . . 72.530000000000001 109.325 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.541 ' HB3' ' CD2' ' A' ' 159' ' ' TYR . 11.1 p90 -108.41 134.99 50.44 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.529 1.143 . . . . 63.450000000000003 110.965 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.708 HD12 ' HB3' ' A' ' 193' ' ' PHE . 22.9 mm -77.62 124.67 36.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.482 1.114 . . . . 75.450000000000003 109.304 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.464 ' HB2' HG22 ' A' ' 194' ' ' ILE . 39.7 m -88.59 -22.58 23.44 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.537 1.148 . . . . 71.430000000000007 108.316 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.774 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -172.6 179.19 2.5 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.522 1.139 . . . . 75.349999999999994 109.275 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.421 ' CE1' HG21 ' A' ' 231' ' ' ILE . 8.8 p80 -144.48 153.75 42.21 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.539 1.15 . . . . 73.319999999999993 109.616 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.463 ' HB2' ' CG1' ' A' ' 239' ' ' VAL . 0.2 OUTLIER -132.18 117.11 17.84 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 74.0 109.644 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 58.78 18.06 5.7 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.462 1.101 . . . . 71.430000000000007 109.319 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 4.0 m 57.92 18.62 5.16 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.452 1.095 . . . . 42.030000000000001 108.305 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.93 ' O ' HG23 ' A' ' 209' ' ' VAL . 11.6 pt-20 -115.97 -33.04 5.21 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.515 1.134 . . . . 71.140000000000001 110.284 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.472 ' HE3' HD22 ' A' ' 206' ' ' LEU . 12.9 m0 -112.58 158.47 19.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.568 1.167 . . . . 73.230000000000004 108.036 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 1.17 ' CE2' HG22 ' A' ' 209' ' ' VAL . 39.8 m-85 -134.44 163.55 29.43 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.466 1.104 . . . . 73.430000000000007 111.027 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.774 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 33.8 mm -105.97 120.67 57.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.596 1.185 . . . . 75.530000000000001 109.262 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.539 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -106.0 163.3 12.87 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.491 1.119 . . . . 74.540000000000006 109.353 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.418 ' HZ1' ' HD3' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -154.94 87.7 3.3 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 74.25 109.295 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.868 ' CG ' HD12 ' A' ' 174' ' ' LEU . 18.2 Cg_endo -75.06 95.03 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.488 1.783 . . . . 72.340000000000003 110.967 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 198' ' ' ILE . 7.8 tp -65.4 163.5 2.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.449 1.093 . . . . 60.240000000000002 109.317 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 113.11 -41.09 2.31 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.506 1.129 . . . . 74.430000000000007 111.015 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 60.3 mmt-85 -125.29 179.86 4.9 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.482 0.754 . . . . 72.310000000000002 110.32 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 11.7 mt -96.68 74.57 2.74 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.481 1.113 . . . . 72.239999999999995 109.32 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -156.01 113.8 0.58 Allowed Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.557 1.161 . . . . 43.229999999999997 110.995 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 133.67 177.4 14.91 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.977 -0.849 . . . . 75.540000000000006 110.977 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.418 ' HD3' ' HZ1' ' A' ' 196' ' ' LYS . 18.1 Cg_endo -75.06 160.11 96.98 Favored 'Cis proline' 0 C--N 1.36 1.147 0 C-N-CA 121.006 -2.497 . . . . 73.340000000000003 110.926 0.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.428 ' HA3' ' CG ' ' A' ' 174' ' ' LEU . . . -120.13 -172.11 14.76 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.5 1.125 . . . . 45.340000000000003 111.006 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.577 HD23 ' CD1' ' A' ' 194' ' ' ILE . 4.4 mt -108.52 154.98 21.16 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.469 0.746 . . . . 53.340000000000003 109.321 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.746 HG21 HG11 ' A' ' 212' ' ' VAL . 0.2 OUTLIER -153.74 119.04 2.78 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.531 1.144 . . . . 54.329999999999998 109.241 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.513 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.5 Cg_endo -74.93 156.68 43.3 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.56 1.821 . . . . 74.109999999999999 111.027 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 1.17 HG22 ' CE2' ' A' ' 193' ' ' PHE . 7.1 t -68.68 -15.33 19.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.473 1.108 . . . . 61.25 109.319 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -72.88 -2.5 57.59 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.471 1.107 . . . . 61.240000000000002 110.998 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.483 ' CD2' ' HB2' ' A' ' 164' ' ' TYR . 29.0 m-85 -134.07 11.24 3.91 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.518 0.775 . . . . 73.409999999999997 111.024 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.746 HG11 HG21 ' A' ' 207' ' ' VAL . 14.9 m -148.26 143.99 19.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.508 1.13 . . . . 75.209999999999994 109.307 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' SER . . . . . 1.015 ' HB2' HD11 ' A' ' 163' ' ' LEU . 9.7 t -128.52 154.61 45.96 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.461 1.101 . . . . 53.420000000000002 110.024 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.689 HG13 HG23 ' A' ' 227' ' ' VAL . 31.6 mm -107.15 141.73 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.47 1.106 . . . . 65.310000000000002 109.279 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.66 157.63 18.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.457 1.098 . . . . 45.009999999999998 109.299 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -136.23 127.47 28.18 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.481 1.113 . . . . 54.32 109.345 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 21.2 tt 42.15 44.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.477 1.111 . . . . 73.430000000000007 109.345 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -134.78 136.37 42.54 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.524 1.14 . . . . 44.130000000000003 109.282 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 219' ' ' THR . 8.8 t -89.09 76.13 7.81 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.486 1.116 . . . . 72.319999999999993 110.394 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.71 -28.51 8.38 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 124.511 1.132 . . . . 61.149999999999999 111.043 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -80.05 -176.41 5.51 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.505 0.768 . . . . 75.540000000000006 111.011 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -131.86 148.93 52.58 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.491 1.12 . . . . 75.109999999999999 109.289 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 55.1 p -92.11 -17.51 24.86 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.43 1.081 . . . . 75.25 110.427 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.87 -2.54 21.28 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.512 1.133 . . . . 74.099999999999994 111.06 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -69.47 171.93 8.01 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.535 0.785 . . . . 72.120000000000005 109.285 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.2 168.31 11.0 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.496 1.122 . . . . 71.409999999999997 109.281 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.883 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 10.4 p -78.47 -34.62 18.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.517 1.135 . . . . 63.43 109.293 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.748 HD12 HG13 ' A' ' 227' ' ' VAL . 1.3 mp -56.54 -50.94 71.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.585 1.178 . . . . 52.539999999999999 109.336 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -63.93 -31.95 73.31 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.541 1.151 . . . . 71.329999999999998 110.3 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.684 ' OD2' HD21 ' A' ' 158' ' ' LEU . 0.5 OUTLIER -70.33 -36.05 74.01 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.508 1.13 . . . . 72.120000000000005 109.307 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.421 HG21 ' CE1' ' A' ' 187' ' ' HIS . 23.0 mt -67.76 -43.03 86.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.496 1.123 . . . . 64.430000000000007 109.345 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 29.9 mmtt -74.36 -21.21 59.79 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.456 1.097 . . . . 64.530000000000001 109.251 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.448 ' O ' HD13 ' A' ' 155' ' ' LEU . 36.9 m -66.75 -37.44 84.62 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.494 1.121 . . . . 74.099999999999994 109.985 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.468 HG11 ' HB2' ' A' ' 158' ' ' LEU . 14.5 p -116.46 11.67 7.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.527 1.142 . . . . 62.149999999999999 109.275 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 57.7 t30 40.48 43.95 1.62 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.549 1.156 . . . . 71.140000000000001 109.282 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.541 HD12 ' HD2' ' A' ' 237' ' ' PRO . 1.6 tp -52.07 142.87 25.94 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.54 1.15 . . . . 65.209999999999994 109.282 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.541 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.3 Cg_endo -74.97 154.1 42.4 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.473 1.775 . . . . 62.219999999999999 110.988 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.411 ' C ' ' N ' ' A' ' 240' ' ' GLN . 3.1 p -94.11 142.06 27.83 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.552 1.158 . . . . 75.329999999999998 110.375 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.463 ' CG1' ' HB2' ' A' ' 188' ' ' HIS . 2.7 p -47.04 -25.5 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.445 1.091 . . . . 62.200000000000003 109.301 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.411 ' N ' ' C ' ' A' ' 238' ' ' THR . 37.3 mm-40 -80.97 -40.92 23.63 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.524 1.14 . . . . 73.519999999999996 110.255 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 238' ' ' THR . 74.9 mt-10 -72.15 -23.44 61.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.526 1.141 . . . . 74.409999999999997 110.323 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.434 ' O ' ' N ' ' A' ' 245' ' ' ASN . 3.5 t90 -77.59 -71.59 0.41 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.532 1.145 . . . . 63.539999999999999 107.979 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.412 ' HB2' ' NZ ' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -44.02 -27.76 0.4 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.561 1.163 . . . . 74.049999999999997 109.259 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.42 ' N ' ' C ' ' A' ' 242' ' ' TRP . 3.0 t -73.58 -46.92 44.35 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 63.200000000000003 110.025 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 242' ' ' TRP . 16.5 t-20 -56.25 -26.32 51.09 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.547 1.154 . . . . 72.140000000000001 109.254 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 16.4 mm -79.26 92.79 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.527 1.142 . . . . 52.439999999999998 109.269 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -174.48 116.06 0.19 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.529 1.143 . . . . 74.140000000000001 109.232 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 13.2 mmm-85 -84.5 174.41 10.06 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.52 1.138 . . . . 75.030000000000001 110.311 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 42.49 42.37 2.7 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.446 1.091 . . . . 73.319999999999993 110.975 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -112.75 -70.0 0.83 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.138 . . . . 74.010000000000005 109.252 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -158.6 145.46 17.45 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.496 1.122 . . . . 63.329999999999998 109.34 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 2.2 p -58.13 149.04 24.72 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.514 1.134 . . . . 71.019999999999996 110.007 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -134.5 109.39 8.68 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 72.120000000000005 109.251 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 29.6 mt -134.22 123.85 44.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.468 1.105 . . . . 71.230000000000004 109.278 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 5.4 t -55.16 159.19 2.63 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.465 1.103 . . . . 73.129999999999995 110.012 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 4.7 tp -127.58 94.7 4.03 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.548 1.155 . . . . 55.299999999999997 109.294 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -81.38 158.44 39.73 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.521 1.138 . . . . 70.420000000000002 110.998 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.2 m -116.03 -9.98 11.64 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.548 0.793 . . . . 62.549999999999997 110.017 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 259' ' ' VAL . 2.7 p -64.42 142.37 16.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.502 1.126 . . . . 70.450000000000003 109.325 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.125 . . . . 72.510000000000005 110.302 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.996 0 N-CA-C 110.994 -0.842 . . . . 75.510000000000005 110.994 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 148.32 35.32 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.498 1.788 . . . . 70.409999999999997 110.991 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.4 mt -110.99 162.96 14.32 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.523 1.14 . . . . 64.010000000000005 109.322 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.81 -16.74 6.89 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.519 1.137 . . . . 72.319999999999993 111.001 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.0 p -173.55 153.42 2.31 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.478 0.752 . . . . 72.219999999999999 110.02 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.779 HD11 HG11 ' A' ' 234' ' ' VAL . 0.0 OUTLIER -126.62 158.94 34.99 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.482 1.114 . . . . 75.030000000000001 109.357 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -114.13 135.42 54.05 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.478 1.111 . . . . 72.540000000000006 111.011 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -124.31 163.91 20.71 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 71.200000000000003 109.291 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.655 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -132.69 128.75 57.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.52 1.137 . . . . 73.430000000000007 109.359 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 164' ' ' TYR . 3.0 t -86.93 109.51 19.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.478 1.111 . . . . 71.239999999999995 109.32 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.655 HD23 ' O ' ' A' ' 161' ' ' ILE . 0.1 OUTLIER -97.64 17.34 18.06 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.546 1.154 . . . . 70.219999999999999 109.308 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.691 ' O ' HG12 ' A' ' 162' ' ' VAL . 53.3 m-85 -164.56 147.67 8.93 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.557 1.161 . . . . 64.420000000000002 110.984 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.727 ' H ' HG22 ' A' ' 178' ' ' VAL . 0.2 OUTLIER -73.3 158.6 34.81 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.479 1.112 . . . . 74.409999999999997 109.304 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.602 ' CD1' ' N ' ' A' ' 167' ' ' LYS . 1.9 t80 -135.55 157.85 45.86 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.575 1.172 . . . . 73.109999999999999 111.041 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.602 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 21.5 mmtp -124.76 134.51 52.77 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.483 1.114 . . . . 53.020000000000003 109.294 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.74 ' HB1' ' HB3' ' A' ' 173' ' ' GLU . . . -99.98 124.07 44.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.487 1.117 . . . . 72.010000000000005 109.338 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -117.18 -34.37 4.38 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.496 1.123 . . . . 45.100000000000001 110.304 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -68.82 -179.79 1.55 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.447 1.092 . . . . 72.129999999999995 109.329 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.51 -29.68 22.54 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.474 1.109 . . . . 72.109999999999999 109.294 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.25 21.68 16.13 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.564 1.165 . . . . 71.519999999999996 109.278 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.812 ' O ' HD22 ' A' ' 174' ' ' LEU . 3.9 tt0 -93.44 159.27 15.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.446 1.091 . . . . 72.019999999999996 110.295 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.812 HD22 ' O ' ' A' ' 173' ' ' GLU . 4.6 mm? -133.0 147.18 52.28 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 74.439999999999998 109.289 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 12.2 t -98.21 145.74 26.31 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.484 1.115 . . . . 71.430000000000007 110.355 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.7 m -146.52 -178.11 5.99 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.49 1.119 . . . . 73.140000000000001 110.44 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.542 ' H ' HG22 ' A' ' 176' ' ' THR . 26.7 m-85 -128.97 -179.79 5.31 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.559 1.162 . . . . 74.409999999999997 111.038 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.727 HG22 ' H ' ' A' ' 165' ' ' ASP . 28.8 t -74.26 165.01 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.475 1.109 . . . . 73.319999999999993 109.316 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.464 ' N ' HG12 ' A' ' 178' ' ' VAL . . . 37.57 71.74 0.2 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.507 1.129 . . . . 53.299999999999997 111.023 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -121.91 154.2 37.44 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.488 0.758 . . . . 74.010000000000005 110.208 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -112.75 119.74 39.09 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.561 1.163 . . . . 75.400000000000006 109.327 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.561 ' C ' HD12 ' A' ' 182' ' ' LEU . 0.2 OUTLIER -160.64 -175.42 4.97 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.466 1.104 . . . . 74.099999999999994 109.343 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -133.1 147.2 52.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.134 . . . . 74.439999999999998 111.004 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.768 HD12 ' HB3' ' A' ' 193' ' ' PHE . 30.6 mm -77.62 128.35 38.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.487 1.117 . . . . 74.349999999999994 109.305 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.625 ' HB2' HG22 ' A' ' 194' ' ' ILE . 38.6 m -86.9 -34.38 19.42 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.541 1.151 . . . . 54.530000000000001 108.313 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.554 ' HA ' HD11 ' A' ' 236' ' ' LEU . . . -164.57 179.13 6.85 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.486 1.116 . . . . 73.450000000000003 109.239 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.429 ' CE1' HG21 ' A' ' 231' ' ' ILE . 6.1 p80 -139.85 148.69 42.47 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 73.109999999999999 109.604 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.645 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.8 t-160 -125.18 115.62 20.72 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.453 1.096 . . . . 74.200000000000003 109.569 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.437 ' C ' ' N ' ' A' ' 191' ' ' GLU . 79.6 m-20 53.72 33.1 15.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.438 1.086 . . . . 72.510000000000005 109.268 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 12.6 p 42.95 28.28 0.13 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.55 1.156 . . . . 61.200000000000003 108.297 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.437 ' N ' ' C ' ' A' ' 189' ' ' ASN . 4.4 pt-20 -121.81 -35.43 3.2 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.494 1.121 . . . . 74.109999999999999 110.324 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.825 ' HE3' HD22 ' A' ' 206' ' ' LEU . 10.7 m0 -115.9 165.94 12.53 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.497 1.123 . . . . 73.239999999999995 108.029 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.768 ' HB3' HD12 ' A' ' 184' ' ' ILE . 9.9 m-85 -137.75 155.66 48.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.556 1.16 . . . . 63.310000000000002 111.003 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.625 HG22 ' HB2' ' A' ' 185' ' ' CYS . 20.7 mm -102.14 83.73 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.512 1.132 . . . . 71.040000000000006 109.336 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.645 ' HB3' HG11 ' A' ' 207' ' ' VAL . . . -104.43 179.22 4.33 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.537 1.148 . . . . 62.439999999999998 109.317 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.438 ' HB3' ' CA ' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -177.94 155.72 1.05 Allowed Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.505 1.128 . . . . 73.140000000000001 109.323 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 147.78 34.26 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.592 1.838 . . . . 71.319999999999993 110.996 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 8.7 pt -81.8 173.14 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.539 1.15 . . . . 75.510000000000005 109.326 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 104.41 -56.64 0.55 Allowed Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.476 1.11 . . . . 35.420000000000002 111.038 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 -147.0 145.56 29.77 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.569 0.805 . . . . 75.230000000000004 110.3 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.519 ' C ' HD23 ' A' ' 201' ' ' LEU . 7.9 tt -43.16 112.09 0.33 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.514 1.134 . . . . 52.340000000000003 109.332 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.494 ' O ' HD21 ' A' ' 174' ' ' LEU . . . -118.01 -44.48 0.53 Allowed Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.428 1.08 . . . . 63.229999999999997 110.965 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.438 ' CA ' ' HB3' ' A' ' 196' ' ' LYS . . . -56.51 -178.46 0.41 Allowed Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.995 -0.842 . . . . 71.109999999999999 110.995 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 121.02 7.05 Favored 'Cis proline' 0 C--N 1.36 1.184 0 C-N-CA 121.039 -2.484 . . . . 73.400000000000006 110.977 -0.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.468 ' CA ' ' O ' ' A' ' 195' ' ' ALA . . . -96.92 132.37 10.97 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.537 1.148 . . . . 34.350000000000001 111.055 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.825 HD22 ' HE3' ' A' ' 192' ' ' TRP . 17.9 mt -88.72 125.43 34.85 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.488 0.758 . . . . 74.129999999999995 109.275 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.645 HG11 ' HB3' ' A' ' 195' ' ' ALA . 1.2 m -141.18 149.44 55.3 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.494 1.121 . . . . 73.140000000000001 109.293 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.515 ' HG2' ' CG ' ' A' ' 211' ' ' PHE . 18.2 Cg_endo -74.9 160.28 40.63 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.486 1.782 . . . . 73.340000000000003 111.043 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.675 HG23 ' HE2' ' A' ' 193' ' ' PHE . 3.3 p -81.9 -25.07 9.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.416 1.072 . . . . 72.040000000000006 109.282 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -73.78 -12.04 80.84 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.526 1.141 . . . . 63.140000000000001 111.026 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.515 ' CG ' ' HG2' ' A' ' 208' ' ' PRO . 8.6 m-30 -109.46 24.96 12.36 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.426 0.721 . . . . 75.430000000000007 111.019 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.603 HG21 ' CD2' ' A' ' 193' ' ' PHE . 32.6 m -157.0 145.06 11.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.488 1.118 . . . . 51.030000000000001 109.315 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.49 ' HB2' HD21 ' A' ' 163' ' ' LEU . 21.6 t -134.19 144.59 48.56 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.548 1.155 . . . . 64.519999999999996 109.962 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.478 HG13 HG23 ' A' ' 227' ' ' VAL . 16.3 mm -96.73 96.88 5.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.538 1.149 . . . . 74.519999999999996 109.266 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 1.8 pt -141.16 150.39 20.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.511 1.132 . . . . 62.439999999999998 109.327 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -58.22 -178.73 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.496 1.122 . . . . 73.019999999999996 109.268 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.486 ' N ' HD13 ' A' ' 217' ' ' ILE . 0.0 OUTLIER -100.46 67.39 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.492 1.12 . . . . 73.400000000000006 109.268 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -120.0 -179.34 3.89 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.437 1.086 . . . . 43.439999999999998 109.339 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.405 HG22 ' CE2' ' A' ' 221' ' ' TYR . 6.2 t -42.37 -40.32 2.47 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.539 1.149 . . . . 51.009999999999998 110.381 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 152.07 87.64 0.06 OUTLIER Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.568 1.168 . . . . 61.229999999999997 110.997 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.405 ' CE2' HG22 ' A' ' 219' ' ' THR . 35.4 m-85 -131.65 178.71 6.54 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.463 0.743 . . . . 64.450000000000003 111.022 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -159.22 110.13 2.03 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.462 1.101 . . . . 74.230000000000004 109.3 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 61.1 p -52.04 -25.27 8.18 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.434 1.084 . . . . 72.120000000000005 110.395 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 105.32 -18.1 42.54 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.466 1.104 . . . . 72.239999999999995 111.003 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -58.15 -175.9 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.397 0.704 . . . . 71.340000000000003 109.312 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -123.74 172.68 8.66 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.492 1.12 . . . . 74.409999999999997 109.305 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.709 HG13 HD12 ' A' ' 228' ' ' ILE . 14.7 p -76.58 -38.61 31.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.468 1.105 . . . . 73.430000000000007 109.324 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.709 HD12 HG13 ' A' ' 227' ' ' VAL . 1.8 mp -53.59 -52.92 28.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 74.439999999999998 109.292 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -56.13 -34.93 66.55 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.476 1.11 . . . . 74.340000000000003 110.373 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.425 ' O ' HD21 ' A' ' 158' ' ' LEU . 0.6 OUTLIER -77.49 -26.96 51.75 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.431 1.082 . . . . 74.209999999999994 109.24 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.43 HD11 ' HE1' ' A' ' 193' ' ' PHE . 60.7 mt -71.5 -39.51 70.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.51 1.131 . . . . 60.109999999999999 109.326 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -29.56 60.21 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.477 1.111 . . . . 62.219999999999999 109.286 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 54.8 m -55.57 -44.87 77.28 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.491 1.119 . . . . 42.229999999999997 110.043 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.779 HG11 HD11 ' A' ' 158' ' ' LEU . 7.7 p -111.15 12.84 8.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.569 1.168 . . . . 71.239999999999995 109.309 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 13.7 m120 40.57 38.28 0.58 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.534 1.146 . . . . 70.239999999999995 109.313 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.933 HD12 ' HD2' ' A' ' 237' ' ' PRO . 3.9 tp -40.89 133.51 1.77 Allowed Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.405 1.066 . . . . 72.519999999999996 109.284 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.933 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.3 Cg_endo -75.06 131.89 14.74 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.479 1.779 . . . . 71.430000000000007 110.955 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.444 ' C ' ' N ' ' A' ' 240' ' ' GLN . 2.4 p -68.61 150.46 47.96 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.452 1.095 . . . . 71.109999999999999 110.348 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.645 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.1 p -40.41 -30.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.467 1.104 . . . . 62.450000000000003 109.281 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.444 ' N ' ' C ' ' A' ' 238' ' ' THR . 45.2 mm-40 -81.16 -56.12 4.29 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.474 1.109 . . . . 75.019999999999996 110.325 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -53.94 -22.03 9.32 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.531 1.145 . . . . 61.030000000000001 110.328 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.942 ' CE2' HD11 ' A' ' 246' ' ' ILE . 26.9 t90 -86.91 -60.46 1.98 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 64.140000000000001 108.046 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.722 ' HA ' HD12 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -50.81 -23.48 2.78 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.573 1.171 . . . . 71.299999999999997 109.346 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 32.2 t -81.07 -62.25 1.72 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.491 1.119 . . . . 73.230000000000004 109.963 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -46.15 -48.05 17.43 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.464 1.103 . . . . 63.530000000000001 109.315 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.942 HD11 ' CE2' ' A' ' 242' ' ' TRP . 62.4 mt -42.27 120.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.548 1.155 . . . . 75.25 109.348 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -86.3 -39.15 16.79 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.529 1.143 . . . . 55.350000000000001 109.269 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.408 ' O ' HG22 ' A' ' 246' ' ' ILE . 0.9 OUTLIER -68.93 159.83 31.92 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.487 1.117 . . . . 73.430000000000007 110.319 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 50.57 54.31 11.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 75.140000000000001 110.958 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -96.82 -32.31 12.17 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.458 1.099 . . . . 73.400000000000006 109.3 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -100.99 145.48 28.63 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.527 1.142 . . . . 75.400000000000006 109.242 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 48.5 t -97.86 57.25 1.3 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.525 1.141 . . . . 63.240000000000002 109.905 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -147.96 113.58 5.68 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.494 1.121 . . . . 61.210000000000001 109.262 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 14.6 tt -127.39 21.41 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.453 1.096 . . . . 73.430000000000007 109.237 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 47.8 t -171.51 128.19 0.66 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.462 1.101 . . . . 75.450000000000003 110.016 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 17.5 tp -98.33 -21.94 16.37 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.566 1.167 . . . . 72.129999999999995 109.294 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 126.48 -91.34 0.38 Allowed Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.487 1.117 . . . . 33.409999999999997 111.011 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 88.7 p 43.22 48.03 5.56 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.472 0.748 . . . . 61.539999999999999 109.998 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 49.4 t -92.83 140.97 15.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.462 1.101 . . . . 64.239999999999995 109.286 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 . . . . . 0 C--N 1.324 -0.526 0 O-C-N 124.494 1.122 . . . . 75.549999999999997 110.326 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.989 0 N-CA-C 111.073 -0.811 . . . . 64.420000000000002 111.073 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 119.21 5.56 Favored 'Trans proline' 0 C--N 1.359 1.095 0 O-C-N 124.491 1.785 . . . . 75.209999999999994 111.028 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.48 ' O ' HD12 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -42.82 134.82 3.17 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.454 1.096 . . . . 75.519999999999996 109.304 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.618 ' HA2' HG23 ' A' ' 234' ' ' VAL . . . -169.44 35.19 0.18 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.447 1.092 . . . . 75.319999999999993 110.947 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -177.94 149.7 0.59 Allowed 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.478 0.752 . . . . 75.519999999999996 109.966 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.729 HD11 HD13 ' A' ' 236' ' ' LEU . 0.4 OUTLIER -150.39 154.0 36.99 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.518 1.136 . . . . 73.519999999999996 109.339 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.524 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 1.3 p90 -136.41 155.14 50.44 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.499 1.124 . . . . 74.340000000000003 110.948 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.835 ' HB3' HD11 ' A' ' 184' ' ' ILE . . . -121.59 142.16 50.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.468 1.105 . . . . 74.140000000000001 109.263 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.515 ' O ' ' CD2' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -110.29 133.72 54.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.557 1.161 . . . . 74.310000000000002 109.302 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.957 HG21 HG21 ' A' ' 176' ' ' THR . 2.0 t -76.27 132.17 33.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.511 1.132 . . . . 75.150000000000006 109.31 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.757 ' O ' HG23 ' A' ' 178' ' ' VAL . 0.2 OUTLIER -95.54 -31.56 13.26 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.495 1.122 . . . . 72.400000000000006 109.287 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.592 ' O ' HG12 ' A' ' 162' ' ' VAL . 15.4 m-85 -130.19 159.34 37.14 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.54 1.15 . . . . 74.349999999999994 110.983 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.64 97.49 5.12 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.531 1.144 . . . . 53.109999999999999 109.335 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.564 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 1.7 t80 -82.67 123.91 29.71 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.476 1.11 . . . . 64.329999999999998 110.967 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 168' ' ' ALA . 11.4 mmmm -101.93 105.47 16.27 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.493 1.12 . . . . 71.010000000000005 109.261 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.589 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -40.54 123.8 1.89 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.474 1.109 . . . . 70.409999999999997 109.321 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -113.72 -28.94 7.27 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.514 1.134 . . . . 64.230000000000004 110.302 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.52 177.79 8.61 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.498 1.124 . . . . 74.209999999999994 109.308 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.62 -14.06 43.84 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.582 1.176 . . . . 52.229999999999997 109.302 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -124.53 23.43 8.14 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.54 1.15 . . . . 73.219999999999999 109.233 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.458 ' HB3' ' HB1' ' A' ' 168' ' ' ALA . 3.3 tp10 -96.39 163.21 13.16 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 72.140000000000001 110.305 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.589 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 19.5 mt -127.46 153.48 46.25 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.515 1.134 . . . . 75.120000000000005 109.27 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.4 t -103.37 147.9 26.54 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.572 1.17 . . . . 74.019999999999996 110.448 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.957 HG21 HG21 ' A' ' 162' ' ' VAL . 2.4 m -138.44 -165.86 1.89 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.502 1.126 . . . . 73.519999999999996 110.378 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.638 ' H ' HG22 ' A' ' 176' ' ' THR . 69.7 m-85 -134.44 134.0 41.11 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.523 1.139 . . . . 71.299999999999997 111.001 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 163' ' ' LEU . 0.5 OUTLIER -41.42 143.33 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.487 1.117 . . . . 45.310000000000002 109.294 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 52.03 63.64 4.63 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.583 1.177 . . . . 64.329999999999998 111.019 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.436 ' CG ' ' HB2' ' A' ' 177' ' ' TYR . 6.0 mm-40 -122.15 160.93 24.08 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.433 0.725 . . . . 74.209999999999994 110.264 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -113.21 119.66 38.52 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.454 1.096 . . . . 62.210000000000001 109.345 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.451 ' CD2' ' HB1' ' A' ' 195' ' ' ALA . 1.2 mp -136.99 159.88 40.56 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.456 1.098 . . . . 74.129999999999995 109.322 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -108.09 128.89 55.08 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.561 1.163 . . . . 63.539999999999999 111.01 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.835 HD11 ' HB3' ' A' ' 160' ' ' ALA . 30.2 mm -77.62 128.53 38.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.527 1.142 . . . . 74.040000000000006 109.293 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 49.7 t -100.55 -23.15 14.76 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.48 1.112 . . . . 52.240000000000002 108.261 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.71 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -166.62 179.62 5.35 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.494 1.121 . . . . 72.319999999999993 109.306 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.431 ' CE1' HG21 ' A' ' 231' ' ' ILE . 8.2 p80 -146.28 157.81 43.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.452 1.095 . . . . 75.010000000000005 109.663 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.464 ' HB2' ' CG1' ' A' ' 239' ' ' VAL . 0.3 OUTLIER -134.48 115.3 13.8 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.463 1.102 . . . . 63.340000000000003 109.596 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.466 ' CB ' ' HG2' ' A' ' 191' ' ' GLU . 2.2 m-20 58.74 19.89 7.32 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.59 1.181 . . . . 72.340000000000003 109.31 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 23.4 m 57.36 18.78 4.59 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.551 1.157 . . . . 71.239999999999995 108.273 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.466 ' HG2' ' CB ' ' A' ' 189' ' ' ASN . 10.1 pt-20 -116.28 -33.0 5.12 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.122 . . . . 73.340000000000003 110.277 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.659 ' HE3' HD22 ' A' ' 206' ' ' LEU . 9.6 m0 -110.21 155.4 22.04 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 124.5 1.125 . . . . 73.129999999999995 108.004 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.811 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 24.9 m-85 -133.04 152.22 51.98 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.488 1.117 . . . . 75.109999999999999 111.06 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.71 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 27.8 mm -99.09 94.28 3.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.533 1.145 . . . . 64.209999999999994 109.315 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.496 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -75.38 154.73 37.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.436 1.085 . . . . 75.030000000000001 109.31 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -148.54 78.89 9.03 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.406 1.066 . . . . 74.030000000000001 109.275 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 152.87 41.23 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.578 1.831 . . . . 74.129999999999995 110.972 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 198' ' ' ILE . 5.2 mp -112.8 143.31 22.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.385 1.053 . . . . 73.129999999999995 109.312 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 128.52 -26.52 4.6 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.49 1.119 . . . . 51.340000000000003 110.965 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -130.8 118.84 21.4 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.489 0.758 . . . . 74.209999999999994 110.295 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 8.8 mp -55.83 99.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.528 1.143 . . . . 71.409999999999997 109.279 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 172.49 -177.45 45.08 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.473 1.108 . . . . 75.129999999999995 111.015 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.432 ' HA2' HD11 ' A' ' 174' ' ' LEU . . . 92.46 -178.89 40.14 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.035 -0.826 . . . . 75.010000000000005 111.035 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.488 ' CB ' ' O ' ' A' ' 195' ' ' ALA . 18.3 Cg_endo -74.98 178.61 33.89 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 121.036 -2.485 . . . . 62.310000000000002 111.071 -0.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.56 ' N ' HD12 ' A' ' 174' ' ' LEU . . . -125.39 168.4 17.51 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.591 1.182 . . . . 71.219999999999999 111.016 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.659 HD22 ' HE3' ' A' ' 192' ' ' TRP . 2.5 mt -101.16 134.13 44.66 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.451 0.736 . . . . 44.439999999999998 109.223 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.798 HG21 HG11 ' A' ' 212' ' ' VAL . 0.1 OUTLIER -135.14 137.72 27.51 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.586 1.179 . . . . 61.119999999999997 109.299 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.568 ' HG2' ' CD1' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.92 148.85 36.24 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.542 1.811 . . . . 75.129999999999995 111.077 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.606 ' HA ' HG22 ' A' ' 212' ' ' VAL . 11.5 p -74.43 -14.06 15.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.504 1.128 . . . . 51.109999999999999 109.334 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLY . . . . . 0.52 ' C ' ' CD1' ' A' ' 211' ' ' PHE . . . -84.09 10.47 60.62 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.499 1.124 . . . . 45.43 111.053 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.568 ' CD1' ' HG2' ' A' ' 208' ' ' PRO . 17.3 m-85 -143.85 19.06 1.81 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.541 0.789 . . . . 70.310000000000002 111.001 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.798 HG11 HG21 ' A' ' 207' ' ' VAL . 30.8 m -145.68 147.94 17.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.524 1.14 . . . . 70.129999999999995 109.333 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 161' ' ' ILE . 46.5 t -130.74 152.44 50.09 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.594 1.184 . . . . 63.530000000000001 110.001 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.616 HG13 HG23 ' A' ' 227' ' ' VAL . 42.3 mm -106.26 161.07 5.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.527 1.142 . . . . 70.450000000000003 109.28 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.458 HG23 ' C ' ' A' ' 214' ' ' ILE . 0.2 OUTLIER -153.8 170.11 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.483 1.114 . . . . 74.209999999999994 109.235 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.742 ' C ' HD12 ' A' ' 217' ' ' ILE . 8.0 t0 -129.27 -59.3 1.1 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.419 1.075 . . . . 63.549999999999997 109.323 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.742 HD12 ' C ' ' A' ' 216' ' ' ASP . 2.8 mp -132.5 89.5 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.531 1.144 . . . . 73.319999999999993 109.334 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.671 ' HB1' ' HB2' ' A' ' 221' ' ' TYR . . . -172.45 155.47 3.45 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.425 1.078 . . . . 72.010000000000005 109.35 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 13.1 t -102.42 34.78 2.64 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.563 1.164 . . . . 74.129999999999995 110.417 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 139.0 -17.15 3.21 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.49 1.119 . . . . 71.200000000000003 111.04 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.671 ' HB2' ' HB1' ' A' ' 218' ' ' ALA . 61.9 m-85 -84.54 178.35 7.74 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.523 0.778 . . . . 70.140000000000001 110.982 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -129.37 131.4 46.85 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.487 1.117 . . . . 63.109999999999999 109.288 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 18.1 p -73.57 -25.26 60.29 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.494 1.121 . . . . 51.210000000000001 110.399 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.52 10.21 11.85 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.466 1.103 . . . . 74.420000000000002 111.008 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -74.62 -177.02 2.99 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 0.755 . . . . 64.140000000000001 109.312 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.41 159.05 35.67 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.592 1.182 . . . . 55.020000000000003 109.291 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.811 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 12.6 p -78.05 -40.57 26.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 124.45 1.093 . . . . 73.310000000000002 109.337 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.687 HD12 HG13 ' A' ' 227' ' ' VAL . 2.1 mp -61.46 -46.39 96.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.496 1.122 . . . . 64.340000000000003 109.391 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -64.99 -20.37 66.46 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.587 1.18 . . . . 74.150000000000006 110.314 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -89.73 -31.65 17.35 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.125 . . . . 73.239999999999995 109.313 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.683 HD12 ' HA ' ' A' ' 228' ' ' ILE . 15.1 mt -66.49 -39.02 82.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.439 1.087 . . . . 75.209999999999994 109.261 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.484 ' HE2' HG22 ' A' ' 231' ' ' ILE . 6.1 mmpt? -76.33 -31.86 58.37 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.513 1.133 . . . . 72.510000000000005 109.283 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 6.6 p -57.0 -44.94 83.25 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.455 1.097 . . . . 70.150000000000006 110.032 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.678 HG12 HD21 ' A' ' 158' ' ' LEU . 3.4 p -106.11 13.13 8.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 124.518 1.136 . . . . 75.420000000000002 109.26 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 40.52 32.46 0.14 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.555 1.16 . . . . 71.420000000000002 109.247 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.729 HD13 HD11 ' A' ' 158' ' ' LEU . 2.1 tp -40.49 142.65 0.74 Allowed Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.498 1.124 . . . . 63.240000000000002 109.229 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.1 Cg_endo -75.03 170.74 19.75 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.624 1.855 . . . . 63.549999999999997 110.936 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 241' ' ' GLU . 1.4 p -113.21 143.14 44.9 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.461 1.101 . . . . 75.109999999999999 110.4 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 188' ' ' HIS . 2.5 p -45.33 -26.36 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.489 1.118 . . . . 64.310000000000002 109.266 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.402 ' N ' ' C ' ' A' ' 238' ' ' THR . 86.6 mm-40 -76.23 -43.36 42.48 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.477 1.111 . . . . 62.039999999999999 110.26 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 238' ' ' THR . 5.2 mm-40 -74.41 -21.7 59.51 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.528 1.142 . . . . 71.200000000000003 110.253 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.444 ' O ' ' N ' ' A' ' 245' ' ' ASN . 9.4 t90 -75.26 -62.36 1.59 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.958 -1.127 . . . . 71.340000000000003 107.958 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.7 pttm -50.45 -24.32 3.03 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.465 1.103 . . . . 71.439999999999998 109.275 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 2.6 t -88.07 -29.21 20.82 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.494 1.121 . . . . 70.340000000000003 110.007 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 242' ' ' TRP . 1.9 t30 -72.08 -39.79 68.72 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.45 1.093 . . . . 75.540000000000006 109.246 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 5.6 mt -40.28 152.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.524 1.14 . . . . 65.349999999999994 109.321 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.585 ' O ' ' CE2' ' A' ' 249' ' ' TYR . . . -41.03 -78.69 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.52 1.137 . . . . 71.140000000000001 109.296 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.482 ' CB ' ' O ' ' A' ' 247' ' ' ALA . 1.8 tmm_? 83.79 22.01 0.15 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.464 1.103 . . . . 70.409999999999997 110.305 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.585 ' CE2' ' O ' ' A' ' 247' ' ' ALA . 5.2 p90 179.74 179.18 0.52 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.518 1.136 . . . . 70.040000000000006 110.996 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? 61.98 37.89 14.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.547 1.154 . . . . 71.109999999999999 109.253 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -119.99 170.13 9.55 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.492 1.12 . . . . 74.109999999999999 109.3 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 1.4 m -44.19 154.8 0.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.464 1.102 . . . . 74.420000000000002 110.007 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -75.63 96.71 3.62 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.41 1.069 . . . . 75.219999999999999 109.285 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.604 ' H ' HD13 ' A' ' 254' ' ' ILE . 0.2 OUTLIER -119.56 136.14 57.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.487 1.117 . . . . 74.319999999999993 109.295 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 36.2 t 45.43 40.27 5.38 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.441 1.088 . . . . 53.32 110.055 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.568 ' C ' HD13 ' A' ' 256' ' ' LEU . 2.5 tm? -46.85 -48.9 20.87 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.53 1.144 . . . . 73.230000000000004 109.329 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -52.16 98.67 0.03 OUTLIER Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.485 1.116 . . . . 53.32 111.02 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 10.4 m -161.67 165.62 27.93 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.547 0.792 . . . . 70.230000000000004 109.981 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 259' ' ' VAL . 28.9 m -133.98 57.96 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.471 1.107 . . . . 75.430000000000007 109.263 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 . . . . . 0 C--N 1.324 -0.521 0 O-C-N 124.591 1.182 . . . . 54.439999999999998 110.248 179.942 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.025 0 N-CA-C 110.953 -0.859 . . . . 63.039999999999999 110.953 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 129.69 12.52 Favored 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.43 1.752 . . . . 62.530000000000001 111.046 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.484 HD13 ' O ' ' A' ' 233' ' ' SER . 6.8 mt -78.45 158.36 28.69 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.522 1.139 . . . . 74.209999999999994 109.285 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 116.3 34.91 1.26 Allowed Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.469 1.106 . . . . 54.310000000000002 110.974 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 76.5 p -135.5 76.3 1.61 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.495 0.762 . . . . 74.329999999999998 109.976 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.475 ' HG ' HG11 ' A' ' 234' ' ' VAL . 0.5 OUTLIER -98.56 156.55 16.74 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.58 1.175 . . . . 73.519999999999996 109.295 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.459 ' CG ' ' O ' ' A' ' 158' ' ' LEU . 10.3 m-85 -168.31 107.98 0.52 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.385 1.053 . . . . 72.340000000000003 111.041 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.409 ' HB2' HG12 ' A' ' 184' ' ' ILE . . . -106.58 129.44 54.51 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.518 1.136 . . . . 71.409999999999997 109.248 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.554 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -99.2 127.38 51.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.121 . . . . 63.399999999999999 109.319 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.594 ' CG2' ' CD2' ' A' ' 182' ' ' LEU . 2.2 t -87.25 119.31 34.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.54 1.15 . . . . 75.140000000000001 109.328 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.704 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.1 OUTLIER -112.33 17.67 19.19 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.428 1.08 . . . . 71.430000000000007 109.203 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.656 ' CE2' HD12 ' A' ' 163' ' ' LEU . 95.6 m-85 -155.89 148.91 24.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.437 1.086 . . . . 75.329999999999998 111.041 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.429 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 0.6 OUTLIER -87.47 106.74 18.19 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.475 1.11 . . . . 72.409999999999997 109.322 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.66 ' CD2' HG13 ' A' ' 207' ' ' VAL . 3.7 t80 -80.41 153.04 28.52 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.578 1.174 . . . . 74.239999999999995 110.965 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.531 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.9 mptt -115.51 115.39 26.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 72.049999999999997 109.316 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.811 ' HB1' ' OE1' ' A' ' 173' ' ' GLU . . . -56.47 126.59 27.17 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 1.138 . . . . 71.129999999999995 109.335 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.4 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 7.5 pt-20 -130.36 -35.53 1.53 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.481 1.113 . . . . 75.430000000000007 110.307 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.879 ' HD3' HD13 ' A' ' 206' ' ' LEU . 10.9 tttt -58.37 -163.26 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.448 1.093 . . . . 73.099999999999994 109.265 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.78 -50.65 5.93 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.526 1.141 . . . . 64.510000000000005 109.345 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.09 28.99 7.12 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.528 1.142 . . . . 73.340000000000003 109.324 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.811 ' OE1' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -60.27 -176.9 0.05 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.491 1.119 . . . . 74.239999999999995 110.325 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 174' ' ' LEU . 13.1 mt -151.8 132.54 14.05 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 72.019999999999996 109.269 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 175' ' ' THR . 15.2 t -78.82 114.1 17.47 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.504 1.128 . . . . 73.129999999999995 110.394 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.717 HG22 ' H ' ' A' ' 177' ' ' TYR . 5.6 m -102.34 -172.14 2.08 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.505 1.128 . . . . 74.040000000000006 110.382 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.717 ' H ' HG22 ' A' ' 176' ' ' THR . 11.1 m-85 -133.3 175.54 9.31 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.429 1.081 . . . . 64.349999999999994 110.979 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 163' ' ' LEU . 1.3 p -97.47 110.65 25.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 124.474 1.109 . . . . 62.509999999999998 109.287 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.46 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 99.23 51.12 1.37 Allowed Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.495 1.122 . . . . 72.340000000000003 111.028 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.404 ' HA ' ' OE1' ' A' ' 180' ' ' GLU . 3.4 mm-40 -115.6 169.38 9.23 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.49 0.759 . . . . 72.319999999999993 110.313 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.94 128.1 43.06 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 60.439999999999998 109.358 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.655 ' CD1' ' HB1' ' A' ' 195' ' ' ALA . 0.6 OUTLIER -167.02 172.7 9.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.454 1.097 . . . . 73.310000000000002 109.267 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -112.41 151.15 30.18 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.52 1.138 . . . . 72.129999999999995 110.97 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.813 HD12 ' HB3' ' A' ' 193' ' ' PHE . 48.1 mm -79.7 136.79 22.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.468 1.105 . . . . 72.310000000000002 109.275 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 9.1 t -101.5 -22.86 14.41 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.499 1.125 . . . . 73.310000000000002 108.328 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.885 ' HB3' HG13 ' A' ' 194' ' ' ILE . . . -173.7 172.26 3.61 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.497 1.123 . . . . 75.120000000000005 109.309 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.718 ' CE1' HG22 ' A' ' 238' ' ' THR . 6.6 p80 -133.67 145.48 49.97 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.475 1.11 . . . . 73.450000000000003 109.588 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.643 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.1 t-160 -123.02 116.33 23.35 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.53 1.144 . . . . 73.439999999999998 109.629 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.45 ' C ' ' N ' ' A' ' 191' ' ' GLU . 71.3 m-20 53.79 32.22 14.49 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.465 1.103 . . . . 53.329999999999998 109.275 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 12.8 p 42.96 28.41 0.13 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.53 1.143 . . . . 74.219999999999999 108.339 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.716 ' O ' HG12 ' A' ' 209' ' ' VAL . 5.6 pt-20 -121.99 -35.3 3.19 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.482 1.113 . . . . 72.010000000000005 110.294 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.437 ' N ' ' HG2' ' A' ' 191' ' ' GLU . 7.2 m0 -118.1 167.29 11.61 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.922 -1.14 . . . . 71.140000000000001 107.922 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.927 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 23.7 m-85 -141.78 161.58 37.59 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.492 1.12 . . . . 73.530000000000001 111.031 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.885 HG13 ' HB3' ' A' ' 186' ' ' ALA . 20.8 mm -99.65 122.9 52.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.51 1.131 . . . . 61.219999999999999 109.258 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.655 ' HB1' ' CD1' ' A' ' 182' ' ' LEU . . . -106.24 153.09 22.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.548 1.155 . . . . 42.450000000000003 109.281 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.465 ' CG ' ' HD2' ' A' ' 197' ' ' PRO . 15.4 tttp -137.49 143.74 42.26 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 71.420000000000002 109.255 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.526 ' CB ' HD11 ' A' ' 201' ' ' LEU . 18.2 Cg_endo -74.98 -174.52 1.96 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 O-C-N 124.444 1.76 . . . . 70.239999999999995 111.024 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 10.6 mm -91.18 -69.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.136 . . . . 71.5 109.309 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -60.82 -120.24 0.01 OUTLIER Glycine 0 CA--C 1.529 0.947 0 O-C-N 124.476 1.11 . . . . 72.049999999999997 111.059 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -151.34 115.72 5.08 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.479 0.752 . . . . 73.340000000000003 110.318 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.892 ' O ' HD22 ' A' ' 201' ' ' LEU . 0.0 OUTLIER -170.8 111.46 0.37 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.456 1.098 . . . . 61.350000000000001 109.296 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 44.38 -127.87 6.85 Favored Glycine 0 CA--C 1.531 1.059 0 O-C-N 124.553 1.158 . . . . 4.4000000000000004 110.956 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 50.33 177.59 0.02 OUTLIER Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.028 -0.829 . . . . 64.439999999999998 111.028 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 174.41 52.88 Favored 'Cis proline' 0 C--N 1.36 1.134 0 C-N-CA 121.013 -2.495 . . . . 63.240000000000002 111.026 0.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 194' ' ' ILE . . . -123.13 -173.68 14.11 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.491 1.119 . . . . 61.119999999999997 110.985 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.879 HD13 ' HD3' ' A' ' 170' ' ' LYS . 3.3 mp -115.06 156.08 25.83 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.566 0.803 . . . . 53.340000000000003 109.29 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.875 HG12 ' HD2' ' A' ' 208' ' ' PRO . 0.2 OUTLIER -150.99 147.27 20.37 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.455 1.097 . . . . 71.239999999999995 109.297 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.875 ' HD2' HG12 ' A' ' 207' ' ' VAL . 18.3 Cg_endo -75.02 141.49 26.65 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.551 1.816 . . . . 73.450000000000003 110.968 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.755 HG23 ' HE2' ' A' ' 193' ' ' PHE . 7.2 p -64.48 -37.72 80.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.563 1.164 . . . . 73.129999999999995 109.322 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -60.06 -13.93 29.55 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.483 1.114 . . . . 45.219999999999999 111.004 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 164' ' ' TYR . 5.9 m-85 -112.19 18.53 18.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.519 0.776 . . . . 73.209999999999994 110.94 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.736 HG22 ' HA ' ' A' ' 209' ' ' VAL . 10.5 m -153.43 143.63 14.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.52 1.137 . . . . 41.109999999999999 109.292 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.704 ' HB2' HD21 ' A' ' 163' ' ' LEU . 3.5 t -129.5 148.08 51.37 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.476 1.11 . . . . 64.400000000000006 110.006 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.723 HG13 HG23 ' A' ' 227' ' ' VAL . 25.8 mm -98.87 119.1 46.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.577 1.173 . . . . 71.040000000000006 109.327 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 4.0 pt -145.89 116.96 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.507 1.129 . . . . 72.219999999999999 109.358 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.619 ' OD1' ' HB3' ' A' ' 218' ' ' ALA . 25.6 p-10 -57.89 142.22 46.79 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.516 1.135 . . . . 72.030000000000001 109.335 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 14.0 tt -60.19 -27.52 39.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.43 1.081 . . . . 45.439999999999998 109.29 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.619 ' HB3' ' OD1' ' A' ' 216' ' ' ASP . . . -49.88 -62.41 1.58 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 35.130000000000003 109.253 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.691 ' CG2' ' CE2' ' A' ' 221' ' ' TYR . 4.2 m -88.12 165.72 14.92 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 65.239999999999995 110.435 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -114.43 7.51 22.66 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.414 1.072 . . . . 70.329999999999998 110.948 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.691 ' CE2' ' CG2' ' A' ' 219' ' ' THR . 25.5 p90 -138.03 -177.26 4.75 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.569 0.805 . . . . 73.340000000000003 111.002 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -85.4 114.28 22.34 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.5 1.125 . . . . 70.400000000000006 109.336 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 60.9 p -81.48 -19.82 41.52 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.503 1.127 . . . . 74.329999999999998 110.467 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 111.53 18.03 8.29 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.479 1.112 . . . . 73.530000000000001 110.993 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -79.93 175.39 10.67 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 0.758 . . . . 54.149999999999999 109.322 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -131.1 162.42 29.89 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.408 1.068 . . . . 74.319999999999993 109.307 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.927 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 11.4 p -77.92 -45.01 28.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.56 1.162 . . . . 74.409999999999997 109.278 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.835 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.0 mp -54.09 -44.85 64.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.5 1.125 . . . . 60.530000000000001 109.345 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -63.76 -28.78 70.11 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.481 1.113 . . . . 64.400000000000006 110.237 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.41 -19.87 35.2 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 74.310000000000002 109.328 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.91 HG23 ' HB3' ' A' ' 236' ' ' LEU . 37.8 mt -76.76 -36.53 26.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.511 1.132 . . . . 53.509999999999998 109.279 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.583 ' HE2' HG22 ' A' ' 231' ' ' ILE . 6.0 mmpt? -83.97 -12.02 55.95 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.107 . . . . 73.409999999999997 109.282 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.484 ' O ' HD13 ' A' ' 155' ' ' LEU . 3.8 p -78.86 -41.67 29.35 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 71.25 109.961 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.475 HG11 ' HG ' ' A' ' 158' ' ' LEU . 7.7 p -108.72 26.28 2.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.527 1.142 . . . . 73.140000000000001 109.266 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 12.6 m120 45.6 26.21 0.31 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.518 1.136 . . . . 74.510000000000005 109.331 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.91 ' HB3' HG23 ' A' ' 231' ' ' ILE . 0.8 OUTLIER -43.91 103.8 0.34 Allowed Pre-proline 0 C--N 1.326 -0.433 0 O-C-N 124.484 1.115 . . . . 72.219999999999999 109.299 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 140.49 25.48 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.507 1.793 . . . . 64.319999999999993 111.0 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.718 HG22 ' CE1' ' A' ' 187' ' ' HIS . 15.7 p -57.66 155.69 9.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.551 1.157 . . . . 64.430000000000007 110.326 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.643 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 1.9 p -61.83 -21.04 24.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.458 1.099 . . . . 60.539999999999999 109.358 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.469 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 40.2 mm-40 -85.58 -26.23 26.25 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 75.549999999999997 110.286 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -84.3 -35.55 23.24 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.513 1.133 . . . . 73.219999999999999 110.291 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 245' ' ' ASN . 1.2 t90 -65.49 -52.07 55.42 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.001 -1.111 . . . . 72.439999999999998 108.001 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.484 ' HZ3' ' HB2' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -49.04 -33.32 11.13 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.435 1.084 . . . . 75.420000000000002 109.258 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.4 t -78.88 -30.23 44.88 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.441 1.088 . . . . 42.210000000000001 110.03 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 242' ' ' TRP . 5.4 t-20 -68.99 -36.7 78.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.46 1.1 . . . . 43.329999999999998 109.223 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.578 ' O ' ' HB3' ' A' ' 247' ' ' ALA . 96.6 mt -42.4 150.67 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.556 1.16 . . . . 71.120000000000005 109.278 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 246' ' ' ILE . . . 75.74 4.45 3.91 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.45 1.094 . . . . 73.299999999999997 109.321 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.537 ' CD ' ' CD2' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -46.55 141.18 3.86 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 74.340000000000003 110.376 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.537 ' CD2' ' CD ' ' A' ' 248' ' ' ARG . 8.6 m-85 44.77 46.01 8.51 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 72.439999999999998 110.935 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.91 151.54 50.08 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.532 1.145 . . . . 74.140000000000001 109.312 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -42.4 106.96 0.07 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.562 1.164 . . . . 74.239999999999995 109.331 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -175.32 157.28 2.16 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.526 1.141 . . . . 70.400000000000006 110.06 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -79.32 103.34 9.18 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.465 1.103 . . . . 75.030000000000001 109.29 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.89 HD12 ' N ' ' A' ' 255' ' ' SER . 1.0 OUTLIER -106.33 177.98 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.531 1.144 . . . . 70.540000000000006 109.244 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.89 ' N ' HD12 ' A' ' 254' ' ' ILE . 33.2 t -151.87 175.12 12.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.536 1.147 . . . . 34.140000000000001 110.033 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 3.5 tt -112.53 139.5 48.06 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.494 1.122 . . . . 73.5 109.312 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -73.81 -150.72 1.8 Allowed Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.472 1.108 . . . . 51.210000000000001 110.986 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 85.5 p -119.33 173.38 6.99 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.519 0.776 . . . . 54.109999999999999 109.958 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 13.6 m -123.86 -178.87 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.503 1.127 . . . . 65.409999999999997 109.316 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.472 1.108 . . . . 72.299999999999997 110.288 -179.99 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.963 0 N-CA-C 111.046 -0.822 . . . . 61.43 111.046 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 165.93 30.26 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.469 1.773 . . . . 73.109999999999999 110.965 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.1 mp -92.45 179.37 5.55 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.499 1.124 . . . . 74.420000000000002 109.336 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -119.49 0.91 14.12 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.523 1.14 . . . . 71.329999999999998 111.006 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.4 p -169.74 160.62 8.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.496 0.762 . . . . 72.430000000000007 110.003 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.718 ' HG ' HG11 ' A' ' 234' ' ' VAL . 0.2 OUTLIER -136.4 149.07 48.13 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.557 1.161 . . . . 70.430000000000007 109.266 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.988 ' OH ' HG23 ' A' ' 217' ' ' ILE . 1.1 p90 -129.95 116.43 18.6 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.507 1.13 . . . . 75.109999999999999 111.003 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.483 ' CB ' HD11 ' A' ' 184' ' ' ILE . . . -95.23 132.37 40.27 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.529 1.143 . . . . 65.019999999999996 109.297 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.44 HD12 ' OD1' ' A' ' 181' ' ' ASN . 0.1 OUTLIER -108.43 130.41 61.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.119 . . . . 54.439999999999998 109.322 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 211' ' ' PHE . 2.2 t -81.33 122.11 35.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.499 1.124 . . . . 74.150000000000006 109.265 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.697 ' O ' HG23 ' A' ' 178' ' ' VAL . 0.7 OUTLIER -90.44 -26.14 19.99 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.485 1.115 . . . . 73.450000000000003 109.295 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.648 ' O ' HG12 ' A' ' 162' ' ' VAL . 44.6 m-85 -130.67 147.83 52.39 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.517 1.136 . . . . 71.530000000000001 111.023 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -61.06 108.42 0.88 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 75.540000000000006 109.309 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.605 ' CE2' ' O ' ' A' ' 174' ' ' LEU . 1.7 t80 -80.95 132.31 35.39 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.434 1.084 . . . . 74.109999999999999 110.983 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.602 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 0.4 OUTLIER -103.66 140.96 36.87 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.433 1.083 . . . . 44.350000000000001 109.322 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.822 ' HB1' ' CG ' ' A' ' 173' ' ' GLU . . . -84.34 126.58 33.34 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.514 1.134 . . . . 42.32 109.322 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.411 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 6.9 pt-20 -127.67 -33.65 2.27 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.506 1.129 . . . . 74.319999999999993 110.299 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.471 ' HD2' ' CD1' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -58.09 -164.43 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.504 1.128 . . . . 61.329999999999998 109.283 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.16 -51.56 5.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.469 1.106 . . . . 71.120000000000005 109.323 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -107.57 28.64 7.95 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.427 1.08 . . . . 71.329999999999998 109.288 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.822 ' CG ' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -59.73 177.94 0.19 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.503 1.127 . . . . 74.400000000000006 110.313 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.769 HD11 ' HA2' ' A' ' 203' ' ' GLY . 12.4 mt -145.09 133.2 21.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 1.137 . . . . 71.049999999999997 109.277 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.8 t -81.47 154.92 26.08 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 71.049999999999997 110.44 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.751 HG21 HG21 ' A' ' 162' ' ' VAL . 2.6 m -142.46 -165.44 2.04 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.529 1.143 . . . . 74.129999999999995 110.393 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.64 ' H ' HG22 ' A' ' 176' ' ' THR . 20.7 m-85 -143.86 137.92 28.27 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.525 1.141 . . . . 73.439999999999998 111.011 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 163' ' ' LEU . 0.7 OUTLIER -44.53 146.52 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.46 1.1 . . . . 72.109999999999999 109.315 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.455 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 52.67 60.55 7.77 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.494 1.121 . . . . 73.239999999999995 111.04 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 161' ' ' ILE . 7.0 mm-40 -118.51 166.21 12.97 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.518 0.775 . . . . 72.099999999999994 110.322 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.44 ' OD1' HD12 ' A' ' 161' ' ' ILE . 0.5 OUTLIER -126.09 136.37 52.83 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.483 1.114 . . . . 71.010000000000005 109.257 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.547 ' CD1' ' HB1' ' A' ' 195' ' ' ALA . 0.5 OUTLIER -167.19 157.83 11.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.452 1.095 . . . . 64.439999999999998 109.329 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.459 ' CD1' ' C ' ' A' ' 183' ' ' PHE . 6.8 p90 -99.54 150.48 22.18 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.447 1.092 . . . . 60.030000000000001 111.059 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.914 HD12 ' HB3' ' A' ' 193' ' ' PHE . 19.6 mm -88.93 133.41 31.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 124.489 1.118 . . . . 73.340000000000003 109.334 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.463 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 3.6 t -97.56 -27.73 14.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.409 1.068 . . . . 73.099999999999994 108.249 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.891 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -160.62 179.44 8.57 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.568 1.168 . . . . 72.030000000000001 109.342 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.437 ' HB3' HD12 ' A' ' 236' ' ' LEU . 32.8 p-80 -147.05 120.63 9.12 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.475 1.109 . . . . 74.239999999999995 109.58 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -99.7 114.53 27.7 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.451 1.094 . . . . 64.549999999999997 109.619 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.428 ' C ' ' N ' ' A' ' 191' ' ' GLU . 5.3 t-20 53.69 34.19 18.33 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.543 1.152 . . . . 75.109999999999999 109.356 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 13.4 p 42.53 28.47 0.12 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.482 1.114 . . . . 60.020000000000003 108.299 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.466 ' O ' HG12 ' A' ' 209' ' ' VAL . 3.8 pt-20 -121.64 -33.97 3.5 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.563 1.165 . . . . 54.210000000000001 110.297 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.473 ' HE3' HD22 ' A' ' 206' ' ' LEU . 8.2 m0 -117.22 157.48 25.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.518 1.136 . . . . 73.319999999999993 108.009 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 1.007 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 36.6 m-85 -130.66 159.14 38.11 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.478 1.111 . . . . 75.439999999999998 110.98 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.891 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 31.0 mm -102.7 96.0 4.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.456 1.098 . . . . 74.430000000000007 109.298 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.617 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -79.38 166.09 22.42 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.157 . . . . 45.530000000000001 109.233 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -166.36 90.48 0.82 Allowed Pre-proline 0 C--N 1.326 -0.434 0 O-C-N 124.514 1.134 . . . . 53.420000000000002 109.275 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.09 155.54 42.53 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.467 1.772 . . . . 62.210000000000001 110.968 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 27.1 mt -108.16 149.84 11.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.51 1.131 . . . . 74.140000000000001 109.321 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 125.23 -33.68 3.59 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.498 1.124 . . . . 62.420000000000002 111.034 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -151.22 117.82 5.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.52 0.776 . . . . 73.230000000000004 110.238 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 10.8 tp -54.18 101.06 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.541 1.151 . . . . 52.43 109.274 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -135.55 -52.25 0.07 OUTLIER Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.481 1.113 . . . . 64.150000000000006 110.991 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.769 ' HA2' HD11 ' A' ' 174' ' ' LEU . . . -49.17 179.55 0.01 OUTLIER Glycine 0 CA--C 1.531 1.053 0 N-CA-C 110.969 -0.852 . . . . 52.520000000000003 110.969 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 162.46 92.8 Favored 'Cis proline' 0 C--N 1.359 1.129 0 C-N-CA 120.973 -2.511 . . . . 73.209999999999994 110.935 0.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.416 ' HA3' ' CG ' ' A' ' 174' ' ' LEU . . . -133.64 160.28 23.97 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.545 1.153 . . . . 74.239999999999995 111.022 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.526 HD23 ' CD1' ' A' ' 194' ' ' ILE . 3.8 mt -99.61 137.27 38.32 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.531 0.783 . . . . 73.030000000000001 109.317 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.843 HG21 HG11 ' A' ' 212' ' ' VAL . 0.1 OUTLIER -133.94 136.78 27.02 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.583 1.177 . . . . 75.230000000000004 109.319 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.56 ' HD3' ' CE1' ' A' ' 166' ' ' PHE . 18.5 Cg_endo -74.93 138.12 22.79 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.491 1.785 . . . . 73.010000000000005 111.006 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.662 HG23 ' CE2' ' A' ' 193' ' ' PHE . 13.7 p -65.2 -15.66 18.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.525 1.14 . . . . 71.140000000000001 109.295 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -83.87 10.86 58.98 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.485 1.116 . . . . 73.129999999999995 111.052 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.805 ' O ' HG13 ' A' ' 162' ' ' VAL . 19.0 m-85 -140.7 15.53 2.33 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.501 0.765 . . . . 64.010000000000005 111.009 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.843 HG11 HG21 ' A' ' 207' ' ' VAL . 21.9 m -147.53 149.55 15.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.475 1.11 . . . . 74.319999999999993 109.283 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.456 ' HB3' HD11 ' A' ' 163' ' ' LEU . 0.3 OUTLIER -130.42 152.44 49.82 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.453 1.096 . . . . 71.319999999999993 109.952 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.692 HG13 HG23 ' A' ' 227' ' ' VAL . 31.0 mm -111.09 95.66 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 72.010000000000005 109.349 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 27.8 pt -99.81 171.33 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.455 1.097 . . . . 71.120000000000005 109.349 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -109.37 170.01 8.33 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.513 1.133 . . . . 72.219999999999999 109.285 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.988 HG23 ' OH ' ' A' ' 159' ' ' TYR . 2.0 pp -89.19 -44.72 15.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.555 1.159 . . . . 75.340000000000003 109.378 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.699 ' N ' HD12 ' A' ' 217' ' ' ILE . . . -41.08 -29.54 0.12 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.54 1.15 . . . . 64.310000000000002 109.28 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.644 ' CG2' ' CZ ' ' A' ' 221' ' ' TYR . 4.3 m -126.87 173.5 9.54 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.487 1.117 . . . . 74.25 110.369 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.423 ' H ' HG22 ' A' ' 219' ' ' THR . . . -112.32 3.62 26.66 Favored Glycine 0 CA--C 1.529 0.939 0 O-C-N 124.516 1.135 . . . . 65.319999999999993 111.032 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.644 ' CZ ' ' CG2' ' A' ' 219' ' ' THR . 3.0 p90 -140.73 -175.89 4.46 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.464 0.744 . . . . 73.129999999999995 111.053 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.25 117.03 6.6 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.478 1.111 . . . . 72.439999999999998 109.326 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 39.1 p -83.49 -24.04 31.9 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.449 1.093 . . . . 51.549999999999997 110.405 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 122.09 3.71 9.66 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.558 1.161 . . . . 52.409999999999997 111.017 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -83.1 -177.6 6.82 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.433 0.725 . . . . 74.310000000000002 109.306 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.23 178.61 6.84 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.564 1.165 . . . . 72.430000000000007 109.288 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 1.007 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 2.5 p -82.99 -34.37 11.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.522 1.139 . . . . 75.230000000000004 109.329 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.821 HD12 HG13 ' A' ' 227' ' ' VAL . 1.6 mp -59.87 -37.48 72.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.463 1.102 . . . . 62.140000000000001 109.241 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -67.15 -42.72 83.9 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.477 1.111 . . . . 74.140000000000001 110.266 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.408 ' CG ' HG21 ' A' ' 214' ' ' ILE . 0.6 OUTLIER -67.42 -32.99 74.24 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.496 1.123 . . . . 72.120000000000005 109.279 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.864 HG23 ' HB3' ' A' ' 236' ' ' LEU . 24.7 mt -63.61 -43.69 98.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.477 1.111 . . . . 60.310000000000002 109.311 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -78.46 -11.98 59.98 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 73.120000000000005 109.273 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.7 m -76.9 -44.89 30.05 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.526 1.141 . . . . 71.200000000000003 110.05 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.718 HG11 ' HG ' ' A' ' 158' ' ' LEU . 9.9 p -109.26 30.06 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.488 1.118 . . . . 73.109999999999999 109.31 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 42.41 28.46 0.11 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.516 1.135 . . . . 74.549999999999997 109.281 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.864 ' HB3' HG23 ' A' ' 231' ' ' ILE . 1.6 tm? -42.77 102.38 0.27 Allowed Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.587 1.179 . . . . 23.530000000000001 109.288 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.424 ' HD2' HD22 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -75.03 152.9 41.17 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.523 1.802 . . . . 72.519999999999996 111.02 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 8.8 p -67.17 151.41 47.6 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.549 1.155 . . . . 61.039999999999999 110.386 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.598 ' N ' ' HB1' ' A' ' 186' ' ' ALA . 1.3 p -50.79 -23.91 2.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.464 1.103 . . . . 71.439999999999998 109.318 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -83.82 -46.7 11.9 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.536 1.147 . . . . 71.140000000000001 110.342 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -63.25 -23.83 67.6 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.514 1.134 . . . . 74.049999999999997 110.343 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -80.14 -65.87 0.95 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.509 1.131 . . . . 75.349999999999994 107.98 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.39 -28.74 1.43 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.578 1.174 . . . . 75.140000000000001 109.28 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.4 t -71.49 -51.59 22.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.536 1.147 . . . . 72.439999999999998 109.973 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -61.95 -24.0 66.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.425 1.078 . . . . 61.219999999999999 109.346 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 3.4 mm -74.15 93.61 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.512 1.132 . . . . 73.319999999999993 109.349 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.529 ' HB3' ' CD ' ' A' ' 250' ' ' LYS . . . -154.64 163.82 39.66 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.549 1.155 . . . . 60.329999999999998 109.299 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -76.17 160.74 29.43 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.474 1.109 . . . . 61.039999999999999 110.252 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 52.45 42.8 31.35 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.552 1.157 . . . . 72.329999999999998 110.935 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.529 ' CD ' ' HB3' ' A' ' 247' ' ' ALA . 0.2 OUTLIER -102.52 104.1 14.49 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.485 1.116 . . . . 70.310000000000002 109.289 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -115.28 16.68 16.81 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.493 1.121 . . . . 65.519999999999996 109.257 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 2.1 p -60.2 106.29 0.5 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.436 1.085 . . . . 74.439999999999998 109.972 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.792 ' C ' HD13 ' A' ' 254' ' ' ILE . 14.9 t-20 -89.86 -21.86 22.34 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.474 1.109 . . . . 73.030000000000001 109.349 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.792 HD13 ' C ' ' A' ' 253' ' ' ASN . 0.2 OUTLIER 40.51 34.94 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 124.469 1.105 . . . . 73.439999999999998 109.374 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.5 p -51.48 104.21 0.08 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.465 1.103 . . . . 50.039999999999999 109.931 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 2.8 pp -147.87 137.11 22.26 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 74.420000000000002 109.282 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 164.26 148.25 5.37 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.505 1.128 . . . . 61.299999999999997 110.971 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 15.1 p -172.12 148.3 2.18 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.474 0.75 . . . . 71.439999999999998 110.082 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.483 HG22 ' N ' ' A' ' 260' ' ' GLU . 14.7 p -161.88 167.04 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.467 1.104 . . . . 71.239999999999995 109.305 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.483 ' N ' HG22 ' A' ' 259' ' ' VAL . 57.9 tt0 . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.441 1.088 . . . . 72.120000000000005 110.314 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.976 0 N-CA-C 110.981 -0.847 . . . . 63.0 110.981 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 136.74 20.73 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.455 1.766 . . . . 53.439999999999998 110.951 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.42 HD22 ' O ' ' A' ' 233' ' ' SER . 8.5 mt 40.15 47.17 2.01 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.529 1.143 . . . . 64.230000000000004 109.282 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -147.28 17.9 1.52 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.468 1.105 . . . . 72.540000000000006 110.999 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 68.2 p -135.42 115.08 12.78 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.536 0.786 . . . . 74.219999999999999 109.98 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.411 HD13 HG21 ' A' ' 234' ' ' VAL . 14.1 tp -132.31 160.34 36.53 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.445 1.091 . . . . 74.329999999999998 109.271 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -137.38 115.92 12.02 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.556 1.16 . . . . 74.349999999999994 111.012 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.438 ' HB2' ' CD1' ' A' ' 214' ' ' ILE . . . -115.51 152.18 33.46 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.521 1.138 . . . . 71.319999999999993 109.325 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.834 HD12 ' O ' ' A' ' 180' ' ' GLU . 1.4 tp -120.12 128.88 75.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.487 1.117 . . . . 65.239999999999995 109.264 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.779 HG23 HD11 ' A' ' 182' ' ' LEU . 18.2 t -92.83 112.17 25.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.529 1.143 . . . . 65.230000000000004 109.359 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.879 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.1 OUTLIER -101.03 28.95 4.91 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.496 1.123 . . . . 75.310000000000002 109.327 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.599 ' CD2' ' O ' ' A' ' 163' ' ' LEU . 78.9 m-85 -164.57 131.07 2.98 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.555 1.159 . . . . 73.299999999999997 110.958 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.547 ' H ' HG22 ' A' ' 178' ' ' VAL . 2.7 t0 -79.59 101.19 8.17 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 74.010000000000005 109.329 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.568 ' CD1' ' HD3' ' A' ' 208' ' ' PRO . 60.9 t80 -83.21 152.67 25.11 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 74.049999999999997 111.024 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.561 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 6.9 mmmm -110.69 154.82 23.31 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.514 1.134 . . . . 63.049999999999997 109.25 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.694 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -95.49 125.0 39.8 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.539 1.149 . . . . 63.439999999999998 109.287 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -121.68 -40.31 2.56 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.477 1.11 . . . . 73.030000000000001 110.365 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -174.56 0.23 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.573 1.171 . . . . 73.030000000000001 109.284 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.38 -34.05 20.32 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.546 1.154 . . . . 52.310000000000002 109.307 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.5 10.35 33.21 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.626 1.204 . . . . 73.400000000000006 109.264 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 173' ' ' GLU . 1.2 mm-40 -75.12 172.87 11.6 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.125 . . . . 70.219999999999999 110.296 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.694 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 1.3 tp -155.56 157.68 37.22 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.53 1.144 . . . . 74.219999999999999 109.265 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.0 t -102.89 137.08 41.57 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.496 1.122 . . . . 74.409999999999997 110.407 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.684 HG22 ' H ' ' A' ' 177' ' ' TYR . 3.4 m -113.71 -166.01 1.05 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.547 1.154 . . . . 60.219999999999999 110.366 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.684 ' H ' HG22 ' A' ' 176' ' ' THR . 54.4 m-85 -138.57 150.69 46.58 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.456 1.097 . . . . 74.400000000000006 110.965 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.547 HG22 ' H ' ' A' ' 165' ' ' ASP . 60.8 t -60.84 163.66 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.133 . . . . 72.439999999999998 109.301 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.461 ' N ' HG12 ' A' ' 178' ' ' VAL . . . 37.74 57.73 1.54 Allowed Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.45 1.094 . . . . 55.210000000000001 110.995 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.834 ' O ' HD12 ' A' ' 161' ' ' ILE . 12.7 mm-40 -114.19 155.89 25.26 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.485 0.756 . . . . 71.519999999999996 110.326 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.595 ' C ' HD13 ' A' ' 182' ' ' LEU . 4.9 m120 -123.32 125.09 44.38 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.531 1.144 . . . . 53.43 109.349 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.779 HD11 HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -162.53 162.65 27.47 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.51 1.131 . . . . 74.420000000000002 109.308 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 184' ' ' ILE . 2.7 t80 -98.96 147.93 24.49 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.433 1.083 . . . . 73.140000000000001 111.007 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.527 HD12 ' HB3' ' A' ' 193' ' ' PHE . 8.9 mm -77.67 112.49 15.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.472 1.108 . . . . 71.420000000000002 109.325 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.522 ' HB3' HG22 ' A' ' 194' ' ' ILE . 10.9 t -78.71 -22.73 46.19 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.525 1.141 . . . . 62.350000000000001 108.285 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.8 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -171.9 179.65 2.67 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.58 1.175 . . . . 63.25 109.308 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.46 ' CE1' HG22 ' A' ' 238' ' ' THR . 8.0 p80 -148.05 151.25 35.37 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.526 1.141 . . . . 61.340000000000003 109.522 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.461 ' HB2' HG11 ' A' ' 239' ' ' VAL . 1.8 t-160 -132.48 122.45 24.92 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.493 1.12 . . . . 63.329999999999998 109.597 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.444 ' C ' ' N ' ' A' ' 191' ' ' GLU . 3.0 m-20 54.15 30.4 12.08 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.477 1.111 . . . . 74.209999999999994 109.281 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 12.7 p 42.95 28.95 0.15 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 72.430000000000007 108.299 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.444 ' N ' ' C ' ' A' ' 189' ' ' ASN . 9.8 pt-20 -124.5 -37.18 2.54 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.564 1.165 . . . . 73.25 110.257 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.693 ' HE3' HD22 ' A' ' 206' ' ' LEU . 11.2 m0 -109.71 158.2 18.34 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.492 1.12 . . . . 74.040000000000006 108.004 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.98 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 44.7 m-85 -137.56 157.16 47.12 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.532 1.145 . . . . 72.319999999999993 111.005 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.8 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 30.8 mm -96.83 98.85 8.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.543 1.152 . . . . 72.25 109.266 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.407 ' HB3' HG21 ' A' ' 207' ' ' VAL . . . -94.92 158.02 15.66 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.557 1.161 . . . . 72.530000000000001 109.267 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -152.42 157.61 33.66 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.527 1.142 . . . . 65.430000000000007 109.297 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.94 -167.33 0.41 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.564 1.823 . . . . 64.329999999999998 111.038 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 5.1 tp -85.6 -21.62 7.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.474 1.109 . . . . 72.209999999999994 109.368 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 166.03 85.28 0.06 OUTLIER Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.563 1.164 . . . . 33.530000000000001 110.967 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -150.94 131.47 13.85 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.492 0.76 . . . . 74.319999999999993 110.31 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.471 ' HA ' HD22 ' A' ' 201' ' ' LEU . 0.6 OUTLIER -68.87 72.72 0.25 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.477 1.11 . . . . 73.049999999999997 109.28 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -149.03 -59.19 0.01 OUTLIER Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.462 1.101 . . . . 74.349999999999994 110.92 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.675 ' HA2' HD22 ' A' ' 174' ' ' LEU . . . -55.67 -178.54 0.29 Allowed Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.027 -0.829 . . . . 64.109999999999999 111.027 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.528 ' HB2' HG23 ' A' ' 194' ' ' ILE . 18.2 Cg_endo -75.02 -170.45 8.28 Favored 'Cis proline' 0 C--N 1.359 1.124 0 C-N-CA 120.953 -2.52 . . . . 65.109999999999999 110.951 0.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -150.32 156.17 26.59 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.438 1.086 . . . . 74.409999999999997 110.983 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.693 HD22 ' HE3' ' A' ' 192' ' ' TRP . 1.7 mt -97.26 127.45 43.23 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.543 0.79 . . . . 73.219999999999999 109.343 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.812 HG12 ' HD2' ' A' ' 208' ' ' PRO . 0.3 OUTLIER -129.54 145.47 57.07 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.466 1.104 . . . . 72.230000000000004 109.35 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.812 ' HD2' HG12 ' A' ' 207' ' ' VAL . 18.6 Cg_endo -74.96 148.11 35.04 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.436 1.756 . . . . 74.230000000000004 110.994 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.709 ' HA ' HG22 ' A' ' 212' ' ' VAL . 8.0 p -66.79 -32.06 56.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.469 1.105 . . . . 64.230000000000004 109.297 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -66.01 -9.1 45.83 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.478 1.111 . . . . 74.439999999999998 111.046 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.575 ' HA ' ' CD2' ' A' ' 164' ' ' TYR . 4.6 m-85 -113.84 5.04 16.12 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.471 0.748 . . . . 71.019999999999996 110.928 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.709 HG22 ' HA ' ' A' ' 209' ' ' VAL . 18.4 m -140.47 162.14 24.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.49 1.119 . . . . 61.5 109.26 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.879 ' HB2' HD21 ' A' ' 163' ' ' LEU . 1.8 t -144.97 144.18 30.92 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.502 1.126 . . . . 72.030000000000001 110.008 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.761 HG13 HG23 ' A' ' 227' ' ' VAL . 36.0 mm -96.13 105.95 17.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.478 1.111 . . . . 62.450000000000003 109.303 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.409 HG23 ' C ' ' A' ' 214' ' ' ILE . 1.9 pt -151.5 177.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.497 1.123 . . . . 74.109999999999999 109.256 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.91 48.31 2.39 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.447 1.092 . . . . 72.109999999999999 109.293 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 2.8 pt -125.75 -46.23 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.522 1.139 . . . . 75.019999999999996 109.333 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -108.67 -45.34 3.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.527 1.142 . . . . 63.520000000000003 109.282 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.655 HG21 ' CZ ' ' A' ' 221' ' ' TYR . 3.3 m -128.56 177.66 6.86 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.514 1.134 . . . . 60.329999999999998 110.378 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.48 ' H ' HG22 ' A' ' 219' ' ' THR . . . -75.44 -5.98 79.25 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.509 1.131 . . . . 53.119999999999997 110.995 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.655 ' CZ ' HG21 ' A' ' 219' ' ' THR . 6.3 p90 -139.25 -176.97 4.71 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.502 0.766 . . . . 74.129999999999995 110.989 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -85.73 132.78 34.07 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.457 1.098 . . . . 73.129999999999995 109.339 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.0 p -92.17 -32.88 14.93 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.595 1.184 . . . . 74.400000000000006 110.411 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 138.99 -13.2 3.35 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.474 1.109 . . . . 32.229999999999997 110.979 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -54.4 168.51 0.25 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.505 0.768 . . . . 62.420000000000002 109.251 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -114.57 175.24 5.57 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.469 1.105 . . . . 73.319999999999993 109.311 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.98 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 11.0 p -80.77 -33.17 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.459 1.099 . . . . 72.400000000000006 109.316 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.711 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.6 mp -60.58 -51.49 72.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.477 1.111 . . . . 73.109999999999999 109.338 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -61.96 -22.66 65.83 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.49 1.118 . . . . 74.530000000000001 110.268 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.748 ' O ' HG22 ' A' ' 234' ' ' VAL . 2.9 m-20 -83.6 -35.91 24.31 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.454 1.096 . . . . 64.409999999999997 109.257 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.863 HG23 ' HB3' ' A' ' 236' ' ' LEU . 12.2 mt -59.87 -29.99 44.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 74.310000000000002 109.287 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -84.08 -11.52 56.55 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.445 1.09 . . . . 72.010000000000005 109.257 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.42 ' O ' HD22 ' A' ' 155' ' ' LEU . 0.8 OUTLIER -94.03 -11.85 29.87 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.478 1.111 . . . . 64.540000000000006 109.988 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.748 HG22 ' O ' ' A' ' 230' ' ' ASP . 0.0 OUTLIER -132.56 10.69 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.525 1.14 . . . . 53.32 109.295 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 236' ' ' LEU . 74.0 m-20 52.95 20.74 1.76 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 52.140000000000001 109.327 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.863 ' HB3' HG23 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -39.55 100.51 0.21 Allowed Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.476 1.11 . . . . 63.100000000000001 109.311 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.449 ' HD2' HD13 ' A' ' 236' ' ' LEU . 18.6 Cg_endo -74.89 142.94 28.83 Favored 'Trans proline' 0 C--N 1.359 1.099 0 O-C-N 124.445 1.76 . . . . 71.209999999999994 111.012 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.46 HG22 ' CE1' ' A' ' 187' ' ' HIS . 7.1 p -60.23 148.08 37.8 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.547 1.154 . . . . 73.530000000000001 110.434 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' A' ' 188' ' ' HIS . 1.4 p -52.82 -25.8 9.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.497 1.123 . . . . 73.409999999999997 109.281 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -75.5 -39.38 58.59 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.561 1.163 . . . . 74.150000000000006 110.37 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -76.99 -23.1 52.28 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.454 1.096 . . . . 74.120000000000005 110.326 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 1.069 ' CE2' HD11 ' A' ' 246' ' ' ILE . 4.7 t90 -79.93 -61.69 1.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.541 1.151 . . . . 74.219999999999999 107.978 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.407 ' HB2' ' NZ ' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -51.31 -25.03 5.21 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.49 1.119 . . . . 72.129999999999995 109.291 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 29.5 t -72.55 -35.7 68.07 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.128 . . . . 61.399999999999999 109.997 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -77.05 -38.09 53.37 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.542 1.151 . . . . 41.109999999999999 109.306 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 1.069 HD11 ' CE2' ' A' ' 242' ' ' TRP . 21.1 mt -42.13 -64.88 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.54 1.15 . . . . 64.430000000000007 109.283 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -146.62 120.52 9.33 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.522 1.139 . . . . 75.129999999999995 109.323 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -129.28 3.26 5.16 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.571 1.17 . . . . 73.409999999999997 110.318 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 248' ' ' ARG . 4.4 m-30 57.37 51.26 10.17 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.495 1.122 . . . . 73.019999999999996 111.031 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -157.66 162.84 38.67 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.522 1.139 . . . . 75.329999999999998 109.248 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -72.86 -75.16 0.15 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.544 1.153 . . . . 51.149999999999999 109.284 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 26.7 m 46.53 34.86 2.58 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.528 1.143 . . . . 74.230000000000004 109.985 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -60.42 104.37 0.32 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.541 1.15 . . . . 74.310000000000002 109.288 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 22.8 pt -134.31 143.69 37.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.54 1.15 . . . . 74.129999999999995 109.34 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 28.6 t -126.0 138.36 53.74 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.501 1.126 . . . . 54.210000000000001 109.983 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.623 ' H ' HD13 ' A' ' 256' ' ' LEU . 0.0 OUTLIER -98.23 178.95 4.91 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.505 1.128 . . . . 74.219999999999999 109.286 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -166.83 173.81 42.16 Favored Glycine 0 CA--C 1.531 1.057 0 O-C-N 124.578 1.174 . . . . 61.509999999999998 110.981 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 7.7 p -125.26 151.02 46.49 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.576 0.809 . . . . 71.340000000000003 109.998 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -110.8 153.74 12.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.513 1.133 . . . . 75.120000000000005 109.309 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 . . . . . 0 C--N 1.324 -0.507 0 O-C-N 124.527 1.142 . . . . 75.439999999999998 110.292 -179.99 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.984 0 N-CA-C 110.973 -0.851 . . . . 72.109999999999999 110.973 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 87.54 1.32 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.451 1.764 . . . . 55.549999999999997 111.003 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.424 ' C ' HG23 ' A' ' 234' ' ' VAL . 40.1 mt -97.67 77.79 2.58 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.598 1.186 . . . . 64.510000000000005 109.219 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.459 ' HA2' ' CG2' ' A' ' 234' ' ' VAL . . . -175.49 52.28 0.12 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.498 1.124 . . . . 70.239999999999995 111.043 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.4 m -174.33 122.2 0.28 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.503 0.767 . . . . 75.040000000000006 110.038 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 230' ' ' ASP . 2.7 tp -138.5 158.79 43.58 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.539 1.149 . . . . 73.450000000000003 109.348 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.53 ' CE2' ' O ' ' A' ' 215' ' ' ILE . 2.4 p90 -152.01 152.26 32.22 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.518 1.136 . . . . 73.340000000000003 110.974 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.771 ' HB3' HD11 ' A' ' 184' ' ' ILE . . . -122.39 141.27 51.76 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.513 1.133 . . . . 52.409999999999997 109.232 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.51 128.38 55.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.472 1.107 . . . . 73.430000000000007 109.255 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.809 HG21 HD12 ' A' ' 182' ' ' LEU . 43.4 t -84.56 92.54 3.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.547 1.155 . . . . 72.510000000000005 109.332 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.898 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.2 OUTLIER -92.51 25.09 3.16 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 52.450000000000003 109.321 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.832 ' CD2' HD13 ' A' ' 163' ' ' LEU . 37.3 m-85 -165.18 141.11 5.44 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.481 1.113 . . . . 71.439999999999998 111.014 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -67.22 98.66 0.62 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.493 1.121 . . . . 53.420000000000002 109.257 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.578 ' CE2' ' O ' ' A' ' 174' ' ' LEU . 0.6 OUTLIER -80.3 123.53 28.05 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.436 1.085 . . . . 75.030000000000001 111.017 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.515 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 7.8 mmmm -93.25 138.93 31.16 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.454 1.096 . . . . 73.200000000000003 109.341 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.816 ' HB1' ' OE1' ' A' ' 173' ' ' GLU . . . -82.0 122.1 27.37 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.415 1.072 . . . . 74.510000000000005 109.275 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -126.97 -34.93 2.31 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.562 1.164 . . . . 72.150000000000006 110.27 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.91 ' HD2' HD13 ' A' ' 206' ' ' LEU . 4.8 mttp -58.56 -164.09 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.423 1.077 . . . . 62.409999999999997 109.357 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.31 -51.28 5.65 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.578 1.174 . . . . 73.140000000000001 109.306 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -105.36 29.48 6.43 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.503 1.127 . . . . 74.109999999999999 109.262 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 1.005 ' O ' HD22 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -59.02 172.5 0.56 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.531 1.144 . . . . 70.430000000000007 110.325 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 1.005 HD22 ' O ' ' A' ' 173' ' ' GLU . 1.7 mm? -146.95 108.07 4.22 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.417 1.073 . . . . 75.340000000000003 109.278 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.09 143.28 54.24 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.461 1.1 . . . . 64.420000000000002 110.361 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.627 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.8 m -139.9 -169.01 2.63 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.525 1.14 . . . . 70.519999999999996 110.378 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.627 ' H ' HG22 ' A' ' 176' ' ' THR . 77.9 m-85 -130.94 147.43 52.58 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.448 1.092 . . . . 63.420000000000002 111.021 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.467 HG23 ' C ' ' A' ' 163' ' ' LEU . 1.9 p -59.15 155.55 2.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.576 1.172 . . . . 71.530000000000001 109.285 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 61.51 41.39 99.55 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.444 1.09 . . . . 43.140000000000001 110.972 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -121.84 171.33 8.98 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.428 0.723 . . . . 43.329999999999998 110.273 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -119.03 131.57 55.99 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.494 1.121 . . . . 75.239999999999995 109.318 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.809 HD12 HG21 ' A' ' 162' ' ' VAL . 18.2 mt -140.61 124.38 17.16 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.501 1.126 . . . . 70.349999999999994 109.332 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -79.25 128.32 33.16 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.471 1.107 . . . . 75.450000000000003 111.01 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.771 HD11 ' HB3' ' A' ' 160' ' ' ALA . 15.6 mm -77.68 121.29 30.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.453 1.096 . . . . 74.439999999999998 109.359 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.43 ' HB2' HG22 ' A' ' 194' ' ' ILE . 62.9 m -95.73 -31.37 13.25 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.494 1.121 . . . . 71.319999999999993 108.248 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.57 ' HB1' ' N ' ' A' ' 239' ' ' VAL . . . -164.03 161.66 22.73 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.498 1.124 . . . . 62.049999999999997 109.247 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.566 ' CE1' HG21 ' A' ' 231' ' ' ILE . 9.0 p80 -128.74 147.4 50.77 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.552 1.157 . . . . 74.040000000000006 109.577 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.574 ' CG ' HG11 ' A' ' 239' ' ' VAL . 0.7 OUTLIER -120.91 119.17 31.85 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.51 1.131 . . . . 70.400000000000006 109.542 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.554 ' CB ' ' HG2' ' A' ' 191' ' ' GLU . 5.5 m-80 48.62 37.92 10.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 73.049999999999997 109.302 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.5 p 38.72 38.77 0.29 Allowed 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.501 1.125 . . . . 63.329999999999998 108.251 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 1.002 ' O ' HG23 ' A' ' 209' ' ' VAL . 11.6 pt-20 -132.52 -37.52 1.06 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.509 1.131 . . . . 61.310000000000002 110.289 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.476 ' N ' ' HG3' ' A' ' 191' ' ' GLU . 20.8 m95 -113.51 163.1 15.35 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.482 1.114 . . . . 75.409999999999997 108.088 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.892 ' CE2' HG22 ' A' ' 209' ' ' VAL . 13.7 m-85 -133.59 161.72 33.87 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 74.109999999999999 111.002 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.602 HG21 ' CZ3' ' A' ' 242' ' ' TRP . 20.0 mm -111.92 95.38 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.145 . . . . 61.549999999999997 109.248 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.573 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -86.3 -175.18 5.39 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.532 1.145 . . . . 71.310000000000002 109.364 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.4 pttp -162.27 155.45 17.28 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 72.510000000000005 109.266 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 149.05 36.31 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.489 1.784 . . . . 63.140000000000001 110.987 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.9 pt -126.2 15.57 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 72.510000000000005 109.337 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -124.32 -47.16 0.24 Allowed Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.523 1.139 . . . . 52.420000000000002 111.01 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -130.01 178.03 6.85 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.468 0.746 . . . . 73.140000000000001 110.299 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.439 HD23 ' N ' ' A' ' 201' ' ' LEU . 5.4 mt -79.42 120.96 24.56 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.546 1.154 . . . . 64.530000000000001 109.319 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -168.43 -143.56 3.87 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.443 1.089 . . . . 45.200000000000003 110.964 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 51.1 176.74 0.02 OUTLIER Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.926 -0.87 . . . . 60.439999999999998 110.926 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.549 ' HB2' HG23 ' A' ' 194' ' ' ILE . 18.5 Cg_endo -74.89 144.95 82.57 Favored 'Cis proline' 0 C--N 1.361 1.2 0 C-N-CA 120.967 -2.514 . . . . 72.219999999999999 111.095 -0.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.993 ' CA ' HD23 ' A' ' 174' ' ' LEU . . . -106.99 160.06 14.38 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.509 1.13 . . . . 72.400000000000006 110.981 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.91 HD13 ' HD2' ' A' ' 170' ' ' LYS . 2.6 mt -103.55 139.63 38.61 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.465 0.744 . . . . 74.010000000000005 109.271 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.791 HG21 HG11 ' A' ' 212' ' ' VAL . 0.2 OUTLIER -143.89 127.52 9.03 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.49 1.119 . . . . 74.109999999999999 109.244 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.497 ' HG2' ' CD2' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.98 157.72 42.7 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.493 1.786 . . . . 75.530000000000001 111.043 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 1.002 HG23 ' O ' ' A' ' 191' ' ' GLU . 21.3 t -80.94 3.26 2.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.547 1.154 . . . . 62.109999999999999 109.311 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLY . . . . . 0.431 ' O ' ' CD1' ' A' ' 211' ' ' PHE . . . -89.16 -3.01 76.56 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.467 1.105 . . . . 52.399999999999999 110.942 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.497 ' CD2' ' HG2' ' A' ' 208' ' ' PRO . 21.4 m-85 -136.69 14.59 3.15 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.474 0.749 . . . . 55.140000000000001 110.972 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.791 HG11 HG21 ' A' ' 207' ' ' VAL . 8.7 m -142.4 146.94 21.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.464 1.102 . . . . 72.129999999999995 109.324 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.898 ' HB2' HD21 ' A' ' 163' ' ' LEU . 26.0 t -129.33 160.76 32.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.551 1.157 . . . . 71.519999999999996 110.011 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.6 HG13 HG23 ' A' ' 227' ' ' VAL . 16.6 mm -102.65 145.75 11.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 75.219999999999999 109.306 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.53 ' O ' ' CE2' ' A' ' 159' ' ' TYR . 44.3 pt -156.27 128.5 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.571 1.17 . . . . 63.240000000000002 109.205 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 218' ' ' ALA . 11.6 t0 -87.96 -177.71 5.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.568 1.168 . . . . 70.310000000000002 109.322 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 9.1 mm -41.6 99.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.424 1.078 . . . . 73.519999999999996 109.378 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -157.59 168.4 27.39 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.455 1.097 . . . . 44.119999999999997 109.292 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.418 HG22 ' HD2' ' A' ' 221' ' ' TYR . 12.7 t -93.23 28.88 2.05 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.148 . . . . 63.009999999999998 110.392 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 114.66 -1.85 23.28 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.536 1.147 . . . . 33.009999999999998 111.006 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.418 ' HD2' HG22 ' A' ' 219' ' ' THR . 33.4 m-85 -88.35 179.31 6.36 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.517 0.775 . . . . 74.0 111.038 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -134.29 153.52 51.83 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.518 1.137 . . . . 73.239999999999995 109.308 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 32.3 p -90.71 -24.0 20.55 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.565 1.165 . . . . 72.349999999999994 110.402 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 106.88 -0.58 36.0 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.51 1.132 . . . . 61.350000000000001 111.037 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -70.02 -175.92 1.03 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.528 0.781 . . . . 71.329999999999998 109.3 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -114.08 173.22 6.55 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.493 1.12 . . . . 64.420000000000002 109.352 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.854 HG13 HD12 ' A' ' 228' ' ' ILE . 2.8 p -84.16 -33.56 9.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.371 1.044 . . . . 64.109999999999999 109.329 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.854 HD12 HG13 ' A' ' 227' ' ' VAL . 1.8 mp -61.24 -50.87 78.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.498 1.123 . . . . 74.150000000000006 109.363 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -58.28 -31.42 67.45 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 61.439999999999998 110.351 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.449 ' HB3' HD11 ' A' ' 158' ' ' LEU . 1.0 OUTLIER -77.54 -35.74 52.96 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.497 1.123 . . . . 64.140000000000001 109.354 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.647 ' CD1' HG22 ' A' ' 227' ' ' VAL . 29.7 mt -68.34 -38.43 79.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.131 . . . . 73.540000000000006 109.29 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.29 -33.85 59.08 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.536 1.147 . . . . 74.540000000000006 109.336 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.7 m -58.79 -38.24 78.1 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.561 1.163 . . . . 73.409999999999997 109.989 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.459 ' CG2' ' HA2' ' A' ' 156' ' ' GLY . 2.0 p -112.6 6.93 8.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.494 1.121 . . . . 74.530000000000001 109.325 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 235' ' ' ASN . 2.4 p-10 40.46 51.72 2.91 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.471 1.107 . . . . 74.299999999999997 109.269 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.534 HD23 ' HD2' ' A' ' 237' ' ' PRO . 1.1 tt -50.79 140.72 19.3 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.554 1.159 . . . . 71.230000000000004 109.369 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.534 ' HD2' HD23 ' A' ' 236' ' ' LEU . 18.1 Cg_endo -75.06 129.45 12.3 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.55 1.816 . . . . 64.109999999999999 111.002 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 3.0 p -67.17 152.39 45.84 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.479 1.112 . . . . 72.439999999999998 110.353 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.574 HG11 ' CG ' ' A' ' 188' ' ' HIS . 1.7 p -46.99 -25.58 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.544 1.153 . . . . 62.450000000000003 109.286 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -86.63 -50.43 6.81 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 71.299999999999997 110.337 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -57.1 -25.15 58.3 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.548 1.155 . . . . 74.540000000000006 110.249 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.801 ' NE1' HD11 ' A' ' 246' ' ' ILE . 26.9 t90 -85.77 -61.85 1.66 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 74.439999999999998 108.022 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -50.88 -23.2 2.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.433 1.083 . . . . 70.010000000000005 109.284 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.9 t -86.85 -61.81 1.64 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.413 1.071 . . . . 75.209999999999994 110.007 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -41.62 -54.8 3.13 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.518 1.136 . . . . 73.409999999999997 109.289 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.801 HD11 ' NE1' ' A' ' 242' ' ' TRP . 63.6 mt -42.62 106.91 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.524 1.14 . . . . 61.450000000000003 109.26 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.686 ' HB3' ' HB2' ' A' ' 250' ' ' LYS . . . -137.79 173.64 11.42 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.485 1.116 . . . . 71.310000000000002 109.271 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -84.98 112.26 20.44 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.425 1.078 . . . . 74.519999999999996 110.31 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 249' ' ' TYR . 1.0 OUTLIER 50.64 38.92 20.29 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.495 1.122 . . . . 73.530000000000001 110.971 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.686 ' HB2' ' HB3' ' A' ' 247' ' ' ALA . 48.8 tttm -44.77 132.62 6.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.483 1.114 . . . . 74.129999999999995 109.246 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -82.17 159.04 23.38 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.528 1.142 . . . . 52.109999999999999 109.287 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 4.2 p -126.21 162.63 24.98 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.481 1.113 . . . . 61.43 109.99 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -133.49 84.75 2.15 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.505 1.128 . . . . 65.430000000000007 109.36 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 2.7 mm -53.93 106.63 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.499 1.125 . . . . 73.409999999999997 109.265 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.4 t -57.84 99.1 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 74.439999999999998 109.992 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 11.5 tp -60.53 103.51 0.25 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.468 1.105 . . . . 74.420000000000002 109.344 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -164.24 72.09 0.19 Allowed Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.529 1.143 . . . . 75.329999999999998 110.98 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 24.5 m -113.63 22.92 13.62 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.392 0.701 . . . . 75.040000000000006 109.971 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 35.3 t -81.37 94.47 2.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.501 1.126 . . . . 60.409999999999997 109.305 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.324 -0.503 0 O-C-N 124.465 1.103 . . . . 73.450000000000003 110.253 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.03 0 N-CA-C 110.972 -0.851 . . . . 33.200000000000003 110.972 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 118.53 5.31 Favored 'Trans proline' 0 C--N 1.361 1.209 0 O-C-N 124.449 1.762 . . . . 71.129999999999995 110.982 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 14.4 mt -108.87 134.28 51.76 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.526 1.141 . . . . 74.400000000000006 109.318 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -160.05 27.05 0.33 Allowed Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.551 1.157 . . . . 62.039999999999999 111.025 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.9 m -160.14 107.4 1.62 Allowed 'General case' 0 C--N 1.326 -0.423 0 O-C-N 124.498 0.764 . . . . 73.209999999999994 110.014 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.723 ' HB2' HG11 ' A' ' 234' ' ' VAL . 61.4 tp -98.08 124.7 42.72 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 74.219999999999999 109.3 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.476 ' HB3' ' CE2' ' A' ' 183' ' ' PHE . 33.8 p90 -103.65 144.11 31.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.512 1.132 . . . . 75.219999999999999 110.998 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.458 ' CB ' HG12 ' A' ' 184' ' ' ILE . . . -140.83 141.83 34.67 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.557 1.161 . . . . 45.229999999999997 109.315 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.5 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -109.07 133.73 53.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 72.439999999999998 109.329 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.752 HG13 ' O ' ' A' ' 211' ' ' PHE . 3.4 t -86.05 125.1 40.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.452 1.095 . . . . 73.450000000000003 109.378 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.778 HD23 ' N ' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -112.88 12.88 19.53 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.538 1.149 . . . . 63.329999999999998 109.317 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.462 ' O ' HG12 ' A' ' 162' ' ' VAL . 97.4 m-85 -158.24 145.14 17.73 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.467 1.105 . . . . 73.140000000000001 111.02 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -79.92 103.01 9.52 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.406 1.066 . . . . 63.350000000000001 109.277 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.526 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 7.4 t80 -83.1 137.82 33.94 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 73.140000000000001 111.015 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.474 ' CE ' ' HA ' ' A' ' 167' ' ' LYS . 0.5 OUTLIER -105.47 123.54 48.06 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.532 1.145 . . . . 70.219999999999999 109.304 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.814 ' HB1' ' CG ' ' A' ' 173' ' ' GLU . . . -71.0 123.26 21.64 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.595 1.185 . . . . 75.140000000000001 109.313 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -126.78 -34.16 2.42 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.541 1.151 . . . . 72.409999999999997 110.309 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 0.4 OUTLIER -58.62 -164.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 O-C-N 124.435 1.084 . . . . 72.299999999999997 109.316 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.34 -51.22 5.67 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.487 1.117 . . . . 73.519999999999996 109.266 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.64 29.42 6.96 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.521 1.138 . . . . 72.150000000000006 109.287 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.814 ' CG ' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -58.95 -178.42 0.05 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.561 1.163 . . . . 75.25 110.251 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.834 HD23 ' HA3' ' A' ' 205' ' ' GLY . 0.0 OUTLIER -147.54 119.97 8.46 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.544 1.153 . . . . 71.319999999999993 109.277 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.53 130.41 35.95 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.555 1.159 . . . . 62.109999999999999 110.439 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.573 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.7 m -126.91 -176.08 3.6 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.593 1.183 . . . . 75.510000000000005 110.435 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.573 ' H ' HG22 ' A' ' 176' ' ' THR . 23.9 m-85 -136.09 143.35 44.56 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.558 1.161 . . . . 64.219999999999999 110.987 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.5 p -56.24 147.28 4.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.469 1.106 . . . . 64.510000000000005 109.291 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.81 58.07 13.85 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.495 1.122 . . . . 51.119999999999997 111.034 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.5 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 10.9 tp10 -121.83 166.16 14.8 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.547 0.792 . . . . 74.530000000000001 110.303 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.428 HD22 ' N ' ' A' ' 181' ' ' ASN . 2.3 m-80 -119.35 133.44 55.72 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.442 1.089 . . . . 71.310000000000002 109.292 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.666 ' C ' HD12 ' A' ' 182' ' ' LEU . 1.2 pp -166.93 -175.45 3.05 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.546 1.154 . . . . 71.209999999999994 109.309 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 159' ' ' TYR . 22.4 m-85 -134.07 139.91 46.29 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.474 1.109 . . . . 72.200000000000003 110.998 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.904 HD12 ' HB3' ' A' ' 193' ' ' PHE . 27.9 mm -77.7 138.08 21.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.487 1.117 . . . . 65.319999999999993 109.337 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.561 ' O ' HD11 ' A' ' 236' ' ' LEU . 0.6 OUTLIER -95.1 -28.13 15.24 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.102 . . . . 62.229999999999997 108.338 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.583 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -172.41 179.56 2.49 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.497 1.123 . . . . 70.230000000000004 109.325 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.814 ' CD2' HG21 ' A' ' 231' ' ' ILE . 8.5 p80 -136.56 154.32 50.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.486 1.116 . . . . 73.030000000000001 109.607 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.521 ' CD2' ' HB2' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -126.97 117.94 23.51 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.469 1.106 . . . . 64.25 109.511 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.568 ' CB ' ' HG2' ' A' ' 191' ' ' GLU . 2.2 m120 50.85 33.91 9.41 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.479 1.112 . . . . 73.0 109.292 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.465 ' HB3' ' CG1' ' A' ' 228' ' ' ILE . 99.2 m 43.77 38.16 1.93 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.473 1.108 . . . . 54.109999999999999 108.286 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.568 ' HG2' ' CB ' ' A' ' 189' ' ' ASN . 8.3 pt-20 -135.26 -40.51 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.562 1.164 . . . . 71.420000000000002 110.318 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.521 ' HB2' ' CD2' ' A' ' 188' ' ' HIS . 24.9 m95 -107.23 165.78 11.12 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.989 -1.115 . . . . 74.219999999999999 107.989 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.924 ' CE2' HG23 ' A' ' 209' ' ' VAL . 12.4 m-85 -137.79 159.03 43.11 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.499 1.124 . . . . 74.219999999999999 110.978 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.583 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 21.1 mm -100.37 114.43 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.504 1.127 . . . . 74.129999999999995 109.288 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.737 ' HB2' ' CG1' ' A' ' 207' ' ' VAL . . . -92.59 168.07 11.49 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.543 1.152 . . . . 75.230000000000004 109.273 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.496 ' CG ' ' O ' ' A' ' 196' ' ' LYS . 1.8 pttt -174.91 91.09 0.3 Allowed Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.128 . . . . 73.25 109.34 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.777 ' HG3' HD11 ' A' ' 174' ' ' LEU . 18.4 Cg_endo -74.96 94.59 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.528 1.804 . . . . 62.219999999999999 111.039 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 5.2 tt -59.31 153.84 3.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 72.140000000000001 109.301 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 89.63 -34.43 4.04 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.486 1.116 . . . . 73.319999999999993 111.028 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -124.24 120.17 31.45 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.494 0.761 . . . . 71.430000000000007 110.274 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.592 ' H ' HD12 ' A' ' 201' ' ' LEU . 5.7 mp -57.1 153.91 10.81 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.464 1.102 . . . . 71.019999999999996 109.305 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 148.37 -52.1 0.55 Allowed Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.553 1.158 . . . . 15.23 111.07 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -78.52 -178.48 50.0 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.014 -0.834 . . . . 62.240000000000002 111.014 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 18.3 Cg_endo -74.98 145.22 83.34 Favored 'Cis proline' 0 C--N 1.359 1.118 0 C-N-CA 121.048 -2.48 . . . . 73.120000000000005 111.017 0.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.834 ' HA3' HD23 ' A' ' 174' ' ' LEU . . . -119.09 -166.01 13.31 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.597 1.186 . . . . 65.510000000000005 111.006 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.486 HD23 HD13 ' A' ' 194' ' ' ILE . 3.1 mt -119.69 142.74 48.22 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.422 0.719 . . . . 43.219999999999999 109.302 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.737 ' CG1' ' HB2' ' A' ' 195' ' ' ALA . 1.6 m -143.9 155.06 59.32 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.487 1.117 . . . . 73.439999999999998 109.323 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.579 ' HG2' ' CD1' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.93 160.44 40.35 Favored 'Trans proline' 0 C--N 1.359 1.108 0 O-C-N 124.53 1.805 . . . . 74.319999999999993 111.055 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.924 HG23 ' CE2' ' A' ' 193' ' ' PHE . 10.1 p -84.97 -19.04 8.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 51.25 109.349 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -82.83 9.33 60.05 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.487 1.117 . . . . 70.120000000000005 110.994 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.752 ' O ' HG13 ' A' ' 162' ' ' VAL . 11.2 m-85 -128.46 18.67 6.35 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 0.768 . . . . 71.530000000000001 111.009 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.565 HG21 ' CD2' ' A' ' 193' ' ' PHE . 31.7 m -156.9 144.5 10.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.496 1.123 . . . . 65.0 109.333 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 22.3 t -134.73 140.19 45.76 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 72.540000000000006 110.03 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.868 HG21 ' CG ' ' A' ' 230' ' ' ASP . 11.0 mm -86.82 89.3 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.53 1.144 . . . . 73.010000000000005 109.339 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.426 ' CG2' ' C ' ' A' ' 214' ' ' ILE . 0.3 OUTLIER -149.87 165.93 3.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.501 1.125 . . . . 72.430000000000007 109.262 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.56 138.37 43.9 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.499 1.124 . . . . 71.140000000000001 109.227 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 218' ' ' ALA . 35.7 pt -54.88 -42.35 62.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.453 1.096 . . . . 63.240000000000002 109.309 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 220' ' ' GLY . . . -46.53 165.64 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.524 1.14 . . . . 72.319999999999993 109.298 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 218' ' ' ALA . 52.0 m -38.85 -30.08 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.483 1.114 . . . . 71.120000000000005 110.329 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 218' ' ' ALA . . . -62.81 89.32 0.06 OUTLIER Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.537 1.148 . . . . 34.0 110.975 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -97.38 -171.76 2.27 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.537 0.786 . . . . 72.349999999999994 111.068 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -42.29 109.32 0.12 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.512 1.132 . . . . 42.420000000000002 109.361 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 73.3 p -88.08 -16.38 33.7 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.441 1.088 . . . . 71.120000000000005 110.453 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 113.21 13.54 10.72 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.531 1.145 . . . . 70.549999999999997 111.008 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -88.49 -176.81 5.44 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.5 0.765 . . . . 63.140000000000001 109.331 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -130.1 171.28 13.0 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.526 1.141 . . . . 63.100000000000001 109.25 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.774 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 12.6 p -78.25 -40.88 25.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.478 1.111 . . . . 74.230000000000004 109.318 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.838 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.1 mp -50.7 -53.41 13.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.519 1.137 . . . . 72.430000000000007 109.386 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -61.82 -33.08 73.49 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.458 1.099 . . . . 74.200000000000003 110.286 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.868 ' CG ' HG21 ' A' ' 214' ' ' ILE . 1.1 m-20 -70.86 -30.5 66.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.492 1.12 . . . . 61.43 109.294 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 228' ' ' ILE . 19.2 mt -68.93 -36.25 73.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.529 1.143 . . . . 65.519999999999996 109.305 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -74.61 -20.53 59.88 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.53 1.144 . . . . 74.439999999999998 109.295 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 6.7 p -68.64 -34.66 76.11 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.44 1.087 . . . . 71.319999999999993 110.014 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.723 HG11 ' HB2' ' A' ' 158' ' ' LEU . 6.8 p -114.75 19.0 7.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.549 1.155 . . . . 72.129999999999995 109.267 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 43.06 28.17 0.13 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.567 1.167 . . . . 63.350000000000001 109.341 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.717 ' HB3' HG23 ' A' ' 231' ' ' ILE . 18.8 tp -51.55 109.95 1.61 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.48 1.112 . . . . 72.310000000000002 109.321 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.93 137.21 21.59 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.519 1.799 . . . . 75.25 110.966 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.617 HG22 ' CE1' ' A' ' 187' ' ' HIS . 10.2 p -57.04 157.97 5.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 71.420000000000002 110.37 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.473 ' CG1' ' HB2' ' A' ' 188' ' ' HIS . 1.5 p -54.04 -27.99 16.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.443 1.089 . . . . 72.340000000000003 109.261 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -80.03 -30.7 39.54 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.454 1.096 . . . . 63.530000000000001 110.327 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -81.78 -24.06 36.22 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.517 1.136 . . . . 71.5 110.282 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.591 ' CE2' HD11 ' A' ' 246' ' ' ILE . 9.5 t90 -83.3 -66.39 0.9 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.12 . . . . 73.040000000000006 108.046 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.5 -29.86 0.1 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.514 1.134 . . . . 74.420000000000002 109.282 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.433 ' N ' ' C ' ' A' ' 242' ' ' TRP . 47.4 t -64.16 -52.85 57.05 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.439 1.087 . . . . 64.439999999999998 110.004 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 242' ' ' TRP . 22.3 m-80 -54.65 -45.19 73.77 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.479 1.112 . . . . 74.239999999999995 109.355 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.591 HD11 ' CE2' ' A' ' 242' ' ' TRP . 7.8 mt -47.75 110.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.418 1.074 . . . . 61.439999999999998 109.292 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -102.85 132.36 49.1 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.484 1.115 . . . . 62.039999999999999 109.301 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -113.37 -54.33 2.62 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.482 1.114 . . . . 74.340000000000003 110.26 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -113.12 172.54 6.88 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.538 1.149 . . . . 74.239999999999995 110.93 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.96 106.84 5.84 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.538 1.149 . . . . 74.340000000000003 109.264 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -56.05 127.81 32.29 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.567 1.167 . . . . 65.329999999999998 109.257 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 15.3 m -64.59 178.74 0.71 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.509 1.131 . . . . 64.310000000000002 110.006 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -124.56 142.54 51.28 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.483 1.114 . . . . 65.439999999999998 109.283 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.468 ' N ' HD13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -119.59 145.12 26.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.429 1.08 . . . . 74.230000000000004 109.332 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.2 m -41.41 145.84 0.24 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.475 1.109 . . . . 70.510000000000005 109.951 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 8.5 tt -43.71 134.74 4.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 63.409999999999997 109.258 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -89.17 137.25 14.06 Favored Glycine 0 CA--C 1.531 1.057 0 O-C-N 124.563 1.164 . . . . 63.039999999999999 110.992 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 53.9 p -86.56 156.13 20.19 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.49 0.759 . . . . 33.350000000000001 109.967 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -80.94 -16.57 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.533 1.146 . . . . 73.030000000000001 109.294 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 . . . . . 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 72.510000000000005 110.289 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.006 0 N-CA-C 110.926 -0.87 . . . . 53.109999999999999 110.926 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -74.98 109.57 2.95 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.497 1.788 . . . . 71.219999999999999 110.972 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.941 HD13 ' O ' ' A' ' 233' ' ' SER . 10.4 mt -127.69 102.99 7.06 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.449 1.093 . . . . 64.010000000000005 109.335 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -153.38 36.39 0.75 Allowed Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.47 1.106 . . . . 64.439999999999998 111.067 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 39.7 t -158.36 150.1 21.37 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.484 0.755 . . . . 50.409999999999997 110.024 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.867 ' HG ' HG11 ' A' ' 234' ' ' VAL . 8.2 mt -144.42 172.52 12.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 73.049999999999997 109.262 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.584 ' CD1' ' C ' ' A' ' 158' ' ' LEU . 36.4 m-85 -157.56 115.06 3.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.493 1.121 . . . . 72.430000000000007 111.031 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.522 ' HB2' HD11 ' A' ' 214' ' ' ILE . . . -114.79 133.21 56.11 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.471 1.107 . . . . 74.430000000000007 109.292 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.565 HD12 ' O ' ' A' ' 180' ' ' GLU . 0.4 OUTLIER -100.62 130.78 49.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.449 1.093 . . . . 64.140000000000001 109.27 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.587 HG13 HG12 ' A' ' 212' ' ' VAL . 2.0 t -88.84 127.72 41.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.512 1.133 . . . . 72.430000000000007 109.365 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.728 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.1 OUTLIER -107.39 -5.97 17.41 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.477 1.111 . . . . 63.310000000000002 109.379 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.636 ' HE2' HD12 ' A' ' 163' ' ' LEU . 96.3 m-85 -147.05 147.34 30.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 73.219999999999999 111.059 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.676 ' N ' HG12 ' A' ' 178' ' ' VAL . 0.2 OUTLIER -79.4 111.71 15.92 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.47 1.106 . . . . 71.420000000000002 109.325 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.629 ' CG ' ' CD ' ' A' ' 208' ' ' PRO . 7.9 t80 -80.51 150.17 29.74 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.597 1.185 . . . . 75.109999999999999 111.002 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.545 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 0.1 OUTLIER -108.26 132.4 53.71 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.412 1.07 . . . . 73.230000000000004 109.272 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.822 ' HB1' ' OE2' ' A' ' 173' ' ' GLU . . . -78.47 127.51 32.28 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.598 1.186 . . . . 71.549999999999997 109.282 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.412 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 17.2 pt-20 -130.35 -33.18 1.71 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.498 1.124 . . . . 75.540000000000006 110.263 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -58.04 -166.15 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.567 1.167 . . . . 63.020000000000003 109.304 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.96 -45.35 9.26 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.497 1.123 . . . . 61.009999999999998 109.333 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -111.23 28.66 8.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 1.117 . . . . 74.200000000000003 109.326 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.822 ' OE2' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -63.44 -176.76 0.17 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.442 1.089 . . . . 74.340000000000003 110.298 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.677 HD13 ' HD2' ' A' ' 197' ' ' PRO . 13.8 mt -157.25 133.15 9.43 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.509 1.131 . . . . 74.299999999999997 109.22 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.72 130.97 35.24 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.498 1.124 . . . . 61.520000000000003 110.387 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.6 m -111.11 -176.82 3.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.505 1.128 . . . . 75.049999999999997 110.373 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.543 ' H ' HG22 ' A' ' 176' ' ' THR . 15.5 m-85 -130.12 157.25 42.93 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.517 1.136 . . . . 73.430000000000007 110.944 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.676 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.0 OUTLIER -67.33 162.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.405 1.065 . . . . 60.350000000000001 109.252 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 37.28 61.34 1.01 Allowed Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.456 1.098 . . . . 64.319999999999993 110.997 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.565 ' O ' HD12 ' A' ' 161' ' ' ILE . 2.9 mm-40 -121.2 176.82 5.42 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 0.778 . . . . 64.140000000000001 110.298 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.464 ' C ' HD13 ' A' ' 182' ' ' LEU . 7.1 t30 -146.71 134.48 21.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.458 1.099 . . . . 75.209999999999994 109.28 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.62 ' O ' HD22 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -166.48 160.32 15.31 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.494 1.121 . . . . 75.140000000000001 109.284 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.434 ' CE1' ' O ' ' A' ' 184' ' ' ILE . 5.5 t80 -92.07 137.21 32.55 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.593 1.183 . . . . 73.510000000000005 111.04 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.912 HD12 ' HB3' ' A' ' 193' ' ' PHE . 42.7 mm -77.54 124.78 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.496 1.122 . . . . 73.439999999999998 109.291 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.429 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 10.2 t -79.94 -26.24 40.15 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 50.149999999999999 108.274 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.571 ' HB3' HG13 ' A' ' 194' ' ' ILE . . . -176.84 166.95 2.56 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 43.409999999999997 109.312 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.6 ' CE1' HG22 ' A' ' 238' ' ' THR . 8.2 p80 -123.42 151.01 43.07 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.497 1.123 . . . . 71.010000000000005 109.545 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.619 ' HB2' HG11 ' A' ' 239' ' ' VAL . 3.8 t-160 -124.76 112.95 17.31 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.498 1.124 . . . . 75.519999999999996 109.556 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.401 ' C ' ' N ' ' A' ' 191' ' ' GLU . 8.4 t-20 57.26 23.45 8.78 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.547 1.154 . . . . 64.120000000000005 109.32 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.481 ' HG ' ' CE1' ' A' ' 187' ' ' HIS . 6.8 m 53.08 21.46 2.13 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.484 1.115 . . . . 51.539999999999999 108.235 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.484 ' O ' HG12 ' A' ' 209' ' ' VAL . 5.0 pt-20 -116.95 -31.95 5.24 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.465 1.103 . . . . 75.439999999999998 110.27 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.413 ' N ' ' HG2' ' A' ' 191' ' ' GLU . 4.3 m0 -118.92 166.45 12.83 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.923 -1.14 . . . . 74.120000000000005 107.923 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.912 ' HB3' HD12 ' A' ' 184' ' ' ILE . 36.3 m-85 -140.44 162.07 36.2 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.454 1.096 . . . . 73.140000000000001 111.021 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.571 HG13 ' HB3' ' A' ' 186' ' ' ALA . 34.6 mm -103.16 124.38 57.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.433 1.083 . . . . 63.219999999999999 109.343 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -112.56 174.9 5.67 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.493 1.12 . . . . 63.229999999999997 109.29 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.411 ' N ' ' HD3' ' A' ' 197' ' ' PRO . 19.1 tptp -166.46 64.44 0.84 Allowed Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.573 1.17 . . . . 73.209999999999994 109.326 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.677 ' HD2' HD13 ' A' ' 174' ' ' LEU . 18.3 Cg_endo -75.05 167.51 26.85 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.552 1.817 . . . . 44.229999999999997 110.989 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.518 ' H ' HD13 ' A' ' 198' ' ' ILE . 2.5 mm 40.47 69.26 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.478 1.112 . . . . 54.329999999999998 109.317 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -46.61 94.02 0.01 OUTLIER Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.495 1.122 . . . . 64.230000000000004 111.019 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.428 ' HE ' HG22 ' A' ' 198' ' ' ILE . 12.5 ptp180 -147.46 -170.6 3.6 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.571 0.806 . . . . 52.340000000000003 110.262 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.26 89.54 0.13 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 75.25 109.267 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 172.51 -155.66 23.69 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.463 1.102 . . . . 71.310000000000002 110.93 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 48.84 -178.72 0.01 OUTLIER Glycine 0 CA--C 1.531 1.075 0 N-CA-C 110.952 -0.859 . . . . 42.219999999999999 110.952 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.57 ' HG2' ' CH2' ' A' ' 242' ' ' TRP . 18.2 Cg_endo -75.1 165.92 84.6 Favored 'Cis proline' 0 C--N 1.36 1.174 0 C-N-CA 121.012 -2.495 . . . . 64.109999999999999 110.975 0.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.429 ' O ' HG23 ' A' ' 194' ' ' ILE . . . -122.46 179.72 16.11 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.545 1.153 . . . . 64.209999999999994 110.993 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.472 ' HG ' ' CD1' ' A' ' 194' ' ' ILE . 3.8 mp -117.59 168.49 10.37 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.439 0.729 . . . . 64.230000000000004 109.318 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.476 HG23 ' CD2' ' A' ' 166' ' ' PHE . 6.1 p -159.81 140.18 8.78 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.519 1.137 . . . . 64.310000000000002 109.223 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.629 ' CD ' ' CG ' ' A' ' 166' ' ' PHE . 18.1 Cg_endo -75.0 152.2 40.48 Favored 'Trans proline' 0 C--N 1.361 1.21 0 O-C-N 124.505 1.792 . . . . 64.310000000000002 110.997 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.729 ' HA ' HG22 ' A' ' 212' ' ' VAL . 11.6 p -78.83 -18.94 13.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.539 1.149 . . . . 65.219999999999999 109.26 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -73.83 -2.38 61.08 Favored Glycine 0 CA--C 1.531 1.091 0 O-C-N 124.539 1.149 . . . . 61.240000000000002 110.947 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.47 ' CD1' ' HG2' ' A' ' 208' ' ' PRO . 10.3 m-85 -126.52 -0.3 6.87 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.56 0.8 . . . . 73.209999999999994 110.976 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.729 HG22 ' HA ' ' A' ' 209' ' ' VAL . 11.8 m -133.5 153.01 36.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 71.310000000000002 109.326 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.728 ' HB2' HD21 ' A' ' 163' ' ' LEU . 1.7 t -143.2 155.91 44.64 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.5 1.125 . . . . 53.340000000000003 110.05 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.914 HG13 HG23 ' A' ' 227' ' ' VAL . 18.9 mm -111.41 154.26 13.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.507 1.129 . . . . 61.030000000000001 109.308 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.457 HD12 HG21 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -152.86 146.36 14.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.513 1.133 . . . . 74.340000000000003 109.247 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.678 ' CG ' HG21 ' A' ' 223' ' ' THR . 2.2 p30 -88.37 157.36 18.73 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.134 . . . . 64.129999999999995 109.304 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 217' ' ' ILE . 22.8 mm 50.41 28.32 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.529 1.143 . . . . 74.129999999999995 109.31 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 40.7 40.63 0.98 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.486 1.116 . . . . 73.140000000000001 109.272 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.699 HG22 ' H ' ' A' ' 221' ' ' TYR . 54.3 m -59.78 150.87 26.85 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.54 1.15 . . . . 70.319999999999993 110.401 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -74.18 -2.9 63.64 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.567 1.167 . . . . 43.310000000000002 110.995 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.699 ' H ' HG22 ' A' ' 219' ' ' THR . 1.5 p90 -140.37 -174.86 4.07 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.519 0.776 . . . . 71.310000000000002 111.01 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -90.88 134.83 34.15 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.125 . . . . 60.030000000000001 109.362 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.678 HG21 ' CG ' ' A' ' 216' ' ' ASP . 16.4 p -91.97 -25.53 18.82 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.521 1.138 . . . . 75.129999999999995 110.43 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 119.65 8.09 9.29 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.583 1.177 . . . . 45.130000000000003 110.982 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -85.44 -178.56 6.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.576 0.809 . . . . 74.420000000000002 109.289 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.2 172.58 10.45 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.5 1.125 . . . . 74.200000000000003 109.298 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.914 HG23 HG13 ' A' ' 214' ' ' ILE . 13.2 p -81.1 -37.76 16.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.548 1.155 . . . . 55.539999999999999 109.319 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.676 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.6 mp -54.69 -53.58 30.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.49 1.119 . . . . 75.430000000000007 109.268 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -55.44 -31.01 61.56 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.575 1.172 . . . . 70.540000000000006 110.306 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.761 ' CG ' HG21 ' A' ' 214' ' ' ILE . 0.5 OUTLIER -77.29 -34.9 55.47 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.509 1.131 . . . . 62.32 109.332 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' A' ' 228' ' ' ILE . 21.3 mt -67.6 -35.13 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.486 1.116 . . . . 73.200000000000003 109.3 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -82.39 -26.97 32.35 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.511 1.132 . . . . 74.010000000000005 109.245 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.941 ' O ' HD13 ' A' ' 155' ' ' LEU . 46.8 p -60.06 -32.66 71.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.533 1.146 . . . . 74.310000000000002 109.991 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.867 HG11 ' HG ' ' A' ' 158' ' ' LEU . 2.6 p -118.06 10.65 7.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.135 . . . . 62.009999999999998 109.327 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 4.4 m120 40.51 35.79 0.32 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.505 1.128 . . . . 62.009999999999998 109.272 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.559 HD12 ' HD2' ' A' ' 237' ' ' PRO . 0.6 OUTLIER -50.49 144.04 12.84 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.472 1.107 . . . . 70.099999999999994 109.314 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.559 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.5 Cg_endo -74.97 151.45 39.66 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.474 1.776 . . . . 75.439999999999998 111.02 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.6 HG22 ' CE1' ' A' ' 187' ' ' HIS . 2.1 p -86.17 141.29 29.46 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.517 1.136 . . . . 74.329999999999998 110.386 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.619 HG11 ' HB2' ' A' ' 188' ' ' HIS . 4.4 p -42.76 -28.31 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.556 1.16 . . . . 63.200000000000003 109.323 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.474 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 13.0 mm100 -78.78 -46.32 19.07 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.522 1.139 . . . . 50.210000000000001 110.249 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 238' ' ' THR . 17.3 mt-10 -66.3 -19.79 65.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.448 1.092 . . . . 72.310000000000002 110.273 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.57 ' CH2' ' HG2' ' A' ' 204' ' ' PRO . 2.0 t90 -81.37 -70.37 0.54 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 73.430000000000007 107.979 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -40.39 -29.93 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.398 1.061 . . . . 72.319999999999993 109.301 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.423 ' N ' ' C ' ' A' ' 242' ' ' TRP . 5.2 t -84.32 -59.24 2.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 60.210000000000001 110.044 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 246' ' ' ILE . 10.0 t-20 -40.37 -40.35 1.16 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.493 1.121 . . . . 71.319999999999993 109.254 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 245' ' ' ASN . 15.9 mm -40.51 132.1 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.488 1.117 . . . . 50.25 109.32 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -40.61 124.98 2.14 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.542 1.152 . . . . 73.140000000000001 109.233 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -118.02 -62.39 1.55 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.468 1.105 . . . . 75.319999999999993 110.322 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -120.97 154.49 35.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.463 1.102 . . . . 65.340000000000003 111.029 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -99.51 103.75 15.52 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.491 1.119 . . . . 72.0 109.306 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -164.9 142.62 6.27 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.543 1.152 . . . . 75.040000000000006 109.332 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 21.1 p -45.58 98.21 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 73.150000000000006 110.035 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -41.24 -76.23 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 65.230000000000004 109.309 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.485 ' C ' HD12 ' A' ' 254' ' ' ILE . 2.8 pp -126.65 16.67 3.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.483 1.114 . . . . 42.210000000000001 109.298 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.9 m -96.27 47.67 1.09 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.532 1.145 . . . . 61.310000000000002 109.966 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.765 ' C ' HD22 ' A' ' 256' ' ' LEU . 0.0 OUTLIER -86.81 -16.37 36.42 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.555 1.159 . . . . 54.140000000000001 109.305 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 118.34 170.52 14.93 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.499 1.124 . . . . 72.150000000000006 110.992 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 3.8 t -101.32 178.43 4.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.516 0.774 . . . . 72.519999999999996 110.04 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.77 113.28 38.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.127 . . . . 74.319999999999993 109.302 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.521 0 O-C-N 124.533 1.146 . . . . 54.539999999999999 110.302 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.02 0 N-CA-C 110.981 -0.847 . . . . 74.140000000000001 110.981 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.86 -162.83 0.16 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.504 1.792 . . . . 72.340000000000003 111.048 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.715 ' HB2' HG23 ' A' ' 234' ' ' VAL . 0.5 OUTLIER -84.91 163.56 18.91 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.496 1.122 . . . . 64.109999999999999 109.325 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -170.51 49.51 0.2 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.586 1.179 . . . . 73.510000000000005 110.992 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.518 ' H ' HG21 ' A' ' 234' ' ' VAL . 1.9 t -175.46 110.37 0.11 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.486 0.757 . . . . 71.329999999999998 110.037 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.437 HD11 ' HB3' ' A' ' 230' ' ' ASP . 11.4 tp -97.63 165.62 11.89 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.546 1.154 . . . . 74.209999999999994 109.275 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -132.04 130.58 41.53 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.466 1.104 . . . . 75.200000000000003 110.97 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.491 ' O ' HD12 ' A' ' 182' ' ' LEU . . . -144.58 151.01 38.42 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.127 . . . . 55.210000000000001 109.259 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.63 129.19 74.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.54 1.15 . . . . 71.540000000000006 109.322 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.959 ' CG2' HD21 ' A' ' 182' ' ' LEU . 1.9 t -76.96 132.64 32.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.557 1.161 . . . . 61.399999999999999 109.302 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.932 ' O ' HG23 ' A' ' 178' ' ' VAL . 0.2 OUTLIER -111.56 -7.38 14.31 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.572 1.17 . . . . 73.219999999999999 109.317 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.435 ' HB2' ' CD2' ' A' ' 211' ' ' PHE . 90.0 m-85 -142.23 143.56 32.95 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.548 1.155 . . . . 61.149999999999999 111.019 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.41 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 4.6 t0 -73.26 108.17 5.99 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.532 1.145 . . . . 75.019999999999996 109.326 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.684 ' CG ' HG13 ' A' ' 207' ' ' VAL . 3.8 t80 -80.41 147.31 31.05 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.533 1.146 . . . . 72.099999999999994 110.948 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.06 137.9 44.25 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.503 1.127 . . . . 71.219999999999999 109.29 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.828 ' HB1' ' OE1' ' A' ' 173' ' ' GLU . . . -89.45 122.74 32.93 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.547 1.154 . . . . 41.520000000000003 109.301 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.426 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 10.0 pt-20 -126.3 -29.42 2.99 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.484 1.115 . . . . 73.030000000000001 110.294 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 4.2 tttp -59.09 -173.34 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.463 1.102 . . . . 72.530000000000001 109.263 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.82 -29.49 17.54 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.394 1.059 . . . . 72.409999999999997 109.267 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.47 28.36 6.65 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.601 1.188 . . . . 74.109999999999999 109.323 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.828 ' OE1' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -68.49 -176.37 0.77 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.541 1.151 . . . . 74.150000000000006 110.319 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.433 ' HB2' ' CA ' ' A' ' 205' ' ' GLY . 0.1 OUTLIER -157.49 110.67 2.51 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.457 1.098 . . . . 72.329999999999998 109.329 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.1 t -68.29 136.2 53.1 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.465 1.103 . . . . 63.439999999999998 110.379 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.692 HG22 ' H ' ' A' ' 177' ' ' TYR . 3.2 m -120.38 -164.3 1.08 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.567 1.167 . . . . 64.340000000000003 110.437 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.692 ' H ' HG22 ' A' ' 176' ' ' THR . 31.3 m-85 -128.47 173.61 10.08 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.433 1.083 . . . . 63.409999999999997 111.008 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 163' ' ' LEU . 1.4 p -93.67 137.46 22.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.469 1.106 . . . . 63.240000000000002 109.349 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 67.16 52.58 31.12 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.451 1.094 . . . . 32.350000000000001 110.972 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.479 ' OE1' ' CB ' ' A' ' 177' ' ' TYR . 2.4 mp0 -121.9 165.67 15.58 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.542 0.789 . . . . 73.219999999999999 110.293 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.85 126.82 54.46 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.501 1.126 . . . . 72.420000000000002 109.369 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.959 HD21 ' CG2' ' A' ' 162' ' ' VAL . 0.4 OUTLIER -148.97 177.79 9.26 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.473 1.108 . . . . 63.420000000000002 109.327 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -122.85 131.13 53.61 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.532 1.145 . . . . 75.329999999999998 111.044 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.907 HD12 ' HB3' ' A' ' 193' ' ' PHE . 38.3 mm -77.52 122.63 32.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.488 1.117 . . . . 73.400000000000006 109.344 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.556 ' C ' HD11 ' A' ' 236' ' ' LEU . 3.6 m -85.42 -28.97 24.75 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.122 . . . . 71.409999999999997 108.302 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -167.22 179.58 5.02 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.484 1.115 . . . . 71.319999999999993 109.252 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.468 ' NE2' HG21 ' A' ' 231' ' ' ILE . 7.5 p80 -136.26 154.65 50.84 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 75.340000000000003 109.605 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.471 ' CD2' ' HB2' ' A' ' 189' ' ' ASN . 0.2 OUTLIER -128.98 111.91 13.51 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.536 1.147 . . . . 71.109999999999999 109.596 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.471 ' HB2' ' CD2' ' A' ' 188' ' ' HIS . 1.2 m-20 58.65 21.53 8.87 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.544 1.152 . . . . 61.109999999999999 109.36 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 69.9 m 56.33 19.2 3.82 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.495 1.122 . . . . 54.530000000000001 108.332 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.462 ' HG2' ' CB ' ' A' ' 189' ' ' ASN . 6.7 pt-20 -116.52 -31.74 5.45 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.566 1.166 . . . . 73.519999999999996 110.325 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.425 ' N ' ' HG3' ' A' ' 191' ' ' GLU . 16.7 m0 -115.33 165.12 13.31 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.613 1.196 . . . . 64.549999999999997 108.012 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.907 ' HB3' HD12 ' A' ' 184' ' ' ILE . 9.0 m-85 -143.87 159.16 43.03 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.518 1.136 . . . . 74.430000000000007 111.006 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.468 ' CG1' ' HB ' ' A' ' 239' ' ' VAL . 19.9 mm -100.9 121.91 52.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.525 1.141 . . . . 71.409999999999997 109.341 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -118.78 170.83 8.66 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.572 1.17 . . . . 64.430000000000007 109.336 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.457 ' CG ' ' HD2' ' A' ' 197' ' ' PRO . 1.5 ttpm? -169.03 144.79 2.75 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.498 1.123 . . . . 73.519999999999996 109.271 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.698 ' CG ' HD13 ' A' ' 201' ' ' LEU . 18.0 Cg_endo -75.07 140.63 25.48 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.483 1.78 . . . . 71.299999999999997 110.958 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.512 HG23 ' N ' ' A' ' 199' ' ' GLY . 0.0 OUTLIER -41.54 -54.19 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.522 1.139 . . . . 73.420000000000002 109.223 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.512 ' N ' HG23 ' A' ' 198' ' ' ILE . . . -70.31 -130.15 0.07 OUTLIER Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.519 1.137 . . . . 52.32 111.049 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 35.4 mmm-85 -142.64 117.01 9.61 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.515 0.773 . . . . 74.409999999999997 110.32 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.698 HD13 ' CG ' ' A' ' 197' ' ' PRO . 5.0 mp -122.45 -43.63 2.28 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.455 1.097 . . . . 75.420000000000002 109.339 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 171.49 -76.09 0.1 OUTLIER Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.442 1.089 . . . . 74.409999999999997 111.045 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 53.25 177.19 0.07 OUTLIER Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.994 -0.842 . . . . 74.349999999999994 110.994 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 145.06 82.88 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 120.951 -2.52 . . . . 70.150000000000006 111.015 0.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 194' ' ' ILE . . . -90.61 156.73 24.97 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.531 1.145 . . . . 54.43 111.021 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.604 ' O ' ' CZ ' ' A' ' 166' ' ' PHE . 1.5 mt -119.94 135.74 54.79 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 0.763 . . . . 74.349999999999994 109.269 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.684 HG13 ' CG ' ' A' ' 166' ' ' PHE . 0.6 OUTLIER -148.17 139.37 13.64 Favored Pre-proline 0 C--N 1.323 -0.547 0 O-C-N 124.519 1.137 . . . . 71.019999999999996 109.34 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.573 ' HD2' HG12 ' A' ' 207' ' ' VAL . 18.3 Cg_endo -75.03 152.98 41.27 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.51 1.795 . . . . 74.310000000000002 110.979 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.615 ' HA ' HG22 ' A' ' 212' ' ' VAL . 3.9 p -67.57 -25.16 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.481 1.113 . . . . 71.049999999999997 109.314 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -67.51 -8.07 49.8 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.505 1.128 . . . . 43.210000000000001 111.016 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.609 ' O ' HG13 ' A' ' 162' ' ' VAL . 8.0 m-85 -120.08 15.57 12.4 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.5 0.765 . . . . 74.319999999999993 111.008 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.615 HG22 ' HA ' ' A' ' 209' ' ' VAL . 17.7 m -154.3 144.49 13.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.497 1.123 . . . . 43.009999999999998 109.291 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 42.0 t -128.27 147.91 50.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.495 1.122 . . . . 70.109999999999999 110.018 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 215' ' ' ILE . 23.0 mm -91.81 146.54 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.413 1.071 . . . . 62.119999999999997 109.258 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 1.033 HG22 ' HB2' ' A' ' 222' ' ' ALA . 2.7 pp -157.8 141.92 7.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.464 1.102 . . . . 71.150000000000006 109.291 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.497 ' O ' HD12 ' A' ' 215' ' ' ILE . 19.4 m-20 -55.75 -174.3 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.135 . . . . 74.209999999999994 109.325 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 10.3 pt -90.86 15.94 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.498 1.124 . . . . 64.010000000000005 109.335 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -64.28 -175.68 0.18 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.488 1.117 . . . . 72.340000000000003 109.272 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.613 ' CG2' ' CE2' ' A' ' 221' ' ' TYR . 2.9 t -49.43 -23.45 1.53 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.139 . . . . 65.540000000000006 110.4 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 135.39 59.92 0.06 OUTLIER Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.516 1.135 . . . . 71.140000000000001 110.967 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.613 ' CE2' ' CG2' ' A' ' 219' ' ' THR . 21.5 m-85 -139.75 170.51 15.75 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.538 0.787 . . . . 74.299999999999997 111.006 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 1.033 ' HB2' HG22 ' A' ' 215' ' ' ILE . . . -124.69 148.96 47.7 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.451 1.094 . . . . 73.129999999999995 109.306 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.5 p -92.14 -36.05 13.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.476 1.11 . . . . 71.239999999999995 110.376 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 137.88 -11.8 3.65 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.5 1.125 . . . . 60.119999999999997 111.036 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.74 179.86 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.518 0.775 . . . . 74.430000000000007 109.353 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -118.74 172.48 7.48 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.484 1.115 . . . . 54.450000000000003 109.223 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.73 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 11.1 p -83.18 -40.49 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.459 1.099 . . . . 74.409999999999997 109.28 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.596 ' HA ' HD12 ' A' ' 231' ' ' ILE . 3.6 mp -55.14 -43.84 72.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.547 1.154 . . . . 64.439999999999998 109.28 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -66.04 -35.12 79.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.517 1.135 . . . . 52.140000000000001 110.311 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.437 ' HB3' HD11 ' A' ' 158' ' ' LEU . 1.1 m-20 -79.01 -21.43 46.97 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.515 1.135 . . . . 75.540000000000006 109.355 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 228' ' ' ILE . 21.6 mt -69.14 -36.74 74.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.485 1.116 . . . . 64.340000000000003 109.33 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -78.03 -28.67 49.08 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.553 1.158 . . . . 72.530000000000001 109.314 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.481 ' O ' HD13 ' A' ' 155' ' ' LEU . 50.3 m -56.14 -40.14 73.35 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.459 1.1 . . . . 71.030000000000001 110.003 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.715 HG23 ' HB2' ' A' ' 155' ' ' LEU . 7.2 p -111.65 21.29 5.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.521 1.138 . . . . 74.349999999999994 109.235 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 40.85 29.67 0.08 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.439 1.087 . . . . 73.030000000000001 109.251 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.581 ' HB2' HG13 ' A' ' 234' ' ' VAL . 38.7 tp -44.25 110.24 0.97 Allowed Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 73.219999999999999 109.3 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.07 140.88 25.79 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.589 1.836 . . . . 64.510000000000005 111.011 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 5.8 p -57.52 150.08 19.73 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.503 1.127 . . . . 72.349999999999994 110.367 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.468 ' HB ' ' CG1' ' A' ' 194' ' ' ILE . 0.9 OUTLIER -47.26 -25.6 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.474 1.109 . . . . 53.030000000000001 109.351 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -83.51 -49.63 9.06 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 72.340000000000003 110.319 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -56.94 -28.86 62.6 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.566 1.166 . . . . 73.109999999999999 110.361 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -78.13 -70.58 0.48 Allowed 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.478 1.111 . . . . 64.150000000000006 108.067 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.1 ptmm? -41.8 -33.75 0.55 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.435 1.084 . . . . 60.219999999999999 109.348 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 27.0 t -61.4 -59.0 5.93 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.476 1.11 . . . . 71.310000000000002 110.032 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -50.37 -38.31 41.8 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.465 1.103 . . . . 70.230000000000004 109.325 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 7.1 mm -57.43 119.12 2.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.521 1.138 . . . . 71.420000000000002 109.27 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -154.1 179.04 9.31 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.502 1.126 . . . . 70.329999999999998 109.29 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.41 ' NE ' ' O ' ' A' ' 248' ' ' ARG . 0.0 OUTLIER -52.69 -49.59 65.0 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.52 1.138 . . . . 70.430000000000007 110.292 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -84.8 104.84 15.12 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.522 1.139 . . . . 75.140000000000001 111.011 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 17.3 mtmm -115.58 163.91 15.1 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.432 1.083 . . . . 54.020000000000003 109.273 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -154.29 140.37 18.4 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.506 1.129 . . . . 64.329999999999998 109.351 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 48.3 t -161.04 161.27 31.33 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.448 1.093 . . . . 65.140000000000001 109.983 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -169.47 126.79 0.92 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.474 1.109 . . . . 73.109999999999999 109.301 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 2.5 tp -127.64 126.52 67.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.493 1.12 . . . . 51.009999999999998 109.288 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 45.7 p -106.54 147.89 28.88 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.521 1.138 . . . . 72.109999999999999 109.941 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 8.0 tp -155.71 125.86 6.64 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.489 1.118 . . . . 75.129999999999995 109.265 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -115.07 150.29 18.74 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.469 1.106 . . . . 74.540000000000006 110.974 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 51.4 p -144.77 148.32 33.95 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.492 0.76 . . . . 73.219999999999999 109.933 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 59.3 t -102.56 123.7 56.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.459 1.099 . . . . 72.230000000000004 109.311 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.553 1.158 . . . . 74.319999999999993 110.329 -179.993 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.939 0 N-CA-C 111.073 -0.811 . . . . 74.150000000000006 111.073 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 170.36 20.59 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.498 1.788 . . . . 65.409999999999997 111.021 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.8 HD13 ' O ' ' A' ' 233' ' ' SER . 4.3 mp -83.31 -85.61 0.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.499 1.124 . . . . 71.239999999999995 109.254 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.29 -7.0 82.87 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.531 1.145 . . . . 70.109999999999999 110.977 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.4 m -139.24 127.64 22.87 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.528 0.781 . . . . 72.140000000000001 109.98 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.784 HD22 HG21 ' A' ' 234' ' ' VAL . 33.9 tp -117.0 161.67 19.01 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.556 1.16 . . . . 73.120000000000005 109.283 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.435 ' CD1' ' C ' ' A' ' 158' ' ' LEU . 3.0 m-85 -136.43 136.55 39.62 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.519 1.137 . . . . 74.209999999999994 111.004 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.469 ' HB2' ' CD1' ' A' ' 214' ' ' ILE . . . -125.92 136.76 53.4 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.419 1.074 . . . . 72.140000000000001 109.316 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.409 HD13 ' C ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -99.09 126.69 52.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.568 1.168 . . . . 72.310000000000002 109.303 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.74 HG13 ' O ' ' A' ' 211' ' ' PHE . 2.1 t -81.99 125.89 39.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.472 1.107 . . . . 71.310000000000002 109.292 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.491 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.5 OUTLIER -93.08 -28.04 16.59 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 65.340000000000003 109.316 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.66 ' O ' HG12 ' A' ' 162' ' ' VAL . 2.1 m-85 -128.07 -171.93 2.57 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.513 1.133 . . . . 74.409999999999997 110.973 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.524 ' N ' HG12 ' A' ' 178' ' ' VAL . 12.3 t0 -111.27 139.56 46.57 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.516 1.135 . . . . 74.239999999999995 109.363 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.58 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 4.8 t80 -113.11 132.31 55.48 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 73.099999999999994 111.024 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -99.97 101.59 12.73 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.517 1.136 . . . . 71.030000000000001 109.312 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.517 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -55.16 119.21 5.16 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.503 1.127 . . . . 73.540000000000006 109.232 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -115.63 -36.84 4.12 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.419 1.074 . . . . 65.200000000000003 110.341 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.429 ' CB ' ' HB2' ' A' ' 173' ' ' GLU . 5.1 tptt -74.82 152.81 38.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.453 1.096 . . . . 74.409999999999997 109.323 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.34 -28.78 67.15 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.523 1.139 . . . . 64.310000000000002 109.332 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -109.45 28.35 8.62 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.53 1.144 . . . . 72.109999999999999 109.361 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.473 ' HG3' ' CE2' ' A' ' 166' ' ' PHE . 5.6 tp10 -100.61 148.02 25.31 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.463 1.102 . . . . 73.420000000000002 110.247 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.715 HD13 ' HB ' ' A' ' 198' ' ' ILE . 7.7 mt -121.24 141.99 50.35 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 65.200000000000003 109.306 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 166' ' ' PHE . 3.3 m -84.86 155.01 21.92 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.534 1.146 . . . . 63.229999999999997 110.421 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.4 m -142.12 -175.04 4.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.474 1.109 . . . . 74.120000000000005 110.415 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.549 ' H ' HG22 ' A' ' 176' ' ' THR . 13.0 m-85 -139.87 158.33 44.25 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.534 1.146 . . . . 71.120000000000005 111.047 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.0 OUTLIER -67.72 153.64 8.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.49 1.119 . . . . 53.25 109.354 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 37.2 56.71 1.43 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.547 1.155 . . . . 73.140000000000001 110.983 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -120.71 172.33 7.95 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.523 0.778 . . . . 75.0 110.261 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -111.28 119.78 40.04 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.473 1.108 . . . . 74.530000000000001 109.319 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.7 tp -135.88 159.75 40.7 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.422 1.076 . . . . 73.209999999999994 109.283 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 0.4 OUTLIER -122.76 124.78 44.12 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.46 1.1 . . . . 75.349999999999994 110.957 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.773 HD12 ' HB3' ' A' ' 193' ' ' PHE . 23.1 mm -77.54 132.8 31.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.557 1.161 . . . . 75.329999999999998 109.275 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.492 ' C ' HD11 ' A' ' 236' ' ' LEU . 33.9 t -99.65 -27.91 13.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.443 1.089 . . . . 74.239999999999995 108.313 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.818 ' HB3' HG13 ' A' ' 194' ' ' ILE . . . -163.9 177.47 8.54 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.482 1.114 . . . . 41.329999999999998 109.268 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.442 ' NE2' HG21 ' A' ' 231' ' ' ILE . 10.3 p80 -143.54 156.76 44.7 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.431 1.082 . . . . 73.329999999999998 109.632 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.602 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 1.7 t-160 -131.92 116.4 17.11 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.567 1.167 . . . . 74.230000000000004 109.602 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 58.31 20.7 7.49 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.465 1.103 . . . . 64.409999999999997 109.327 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.442 ' HB3' ' CG1' ' A' ' 228' ' ' ILE . 42.5 m 55.79 19.87 3.73 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.438 1.086 . . . . 72.319999999999993 108.331 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 192' ' ' TRP . 4.4 pt-20 -117.02 -32.86 4.91 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.48 1.112 . . . . 73.400000000000006 110.29 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.619 ' HE3' HD22 ' A' ' 206' ' ' LEU . 7.7 m0 -112.4 160.26 17.91 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.542 1.151 . . . . 45.420000000000002 107.999 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.794 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 16.1 m-85 -132.78 161.45 34.05 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.121 . . . . 72.400000000000006 110.94 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.818 HG13 ' HB3' ' A' ' 186' ' ' ALA . 35.5 mm -109.46 120.32 60.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.56 1.162 . . . . 64.010000000000005 109.37 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -96.93 122.85 40.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.12 . . . . 70.5 109.332 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.522 ' CB ' ' HD3' ' A' ' 197' ' ' PRO . 0.0 OUTLIER -87.59 -60.33 0.25 Allowed Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.536 1.148 . . . . 74.310000000000002 109.222 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.522 ' HD3' ' CB ' ' A' ' 196' ' ' LYS . 18.2 Cg_endo -75.03 173.36 14.65 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.516 1.798 . . . . 72.349999999999994 111.022 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.715 ' HB ' HD13 ' A' ' 174' ' ' LEU . 9.9 tp -175.18 160.5 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.537 1.148 . . . . 74.219999999999999 109.239 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.423 ' N ' HG13 ' A' ' 198' ' ' ILE . . . -82.09 8.64 59.97 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.467 1.104 . . . . 35.32 111.071 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.578 ' O ' HG23 ' A' ' 198' ' ' ILE . 12.0 tpt180 -151.47 126.69 9.9 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 0.764 . . . . 72.200000000000003 110.341 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 15.4 mt -40.27 98.22 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.455 1.097 . . . . 75.450000000000003 109.314 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 200' ' ' ARG . . . -165.95 -140.47 2.89 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.61 1.194 . . . . 74.340000000000003 110.982 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.619 ' HA3' HD11 ' A' ' 174' ' ' LEU . . . 54.43 175.47 0.1 OUTLIER Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.995 -0.842 . . . . 41.450000000000003 110.995 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.9 151.97 97.61 Favored 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 120.947 -2.522 . . . . 53.32 111.033 -0.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.93 -164.5 11.08 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.454 1.096 . . . . 71.510000000000005 110.995 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.619 HD22 ' HE3' ' A' ' 192' ' ' TRP . 1.3 mt -109.19 164.6 12.31 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.508 0.769 . . . . 73.230000000000004 109.318 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.62 HG13 ' HB2' ' A' ' 193' ' ' PHE . 0.1 OUTLIER -155.24 137.46 9.95 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.428 1.08 . . . . 64.319999999999993 109.291 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.58 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.2 Cg_endo -75.03 144.32 30.0 Favored 'Trans proline' 0 C--N 1.362 1.243 0 O-C-N 124.44 1.758 . . . . 75.329999999999998 110.991 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.732 HG23 ' CE2' ' A' ' 193' ' ' PHE . 12.6 p -73.41 -16.91 17.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.505 1.128 . . . . 75.010000000000005 109.333 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -77.37 2.35 62.47 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.525 1.141 . . . . 53.020000000000003 110.994 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.74 ' O ' HG13 ' A' ' 162' ' ' VAL . 20.4 m-85 -133.46 23.85 4.06 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.435 0.726 . . . . 74.219999999999999 110.99 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.634 HG21 ' CD2' ' A' ' 193' ' ' PHE . 33.1 m -156.94 148.49 10.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.534 1.146 . . . . 63.210000000000001 109.251 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.491 ' HB2' HD11 ' A' ' 163' ' ' LEU . 3.1 t -133.65 159.29 40.95 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.488 1.117 . . . . 61.009999999999998 109.98 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.868 HG13 HG23 ' A' ' 227' ' ' VAL . 24.2 mm -110.83 102.42 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 72.200000000000003 109.276 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.763 ' C ' HD12 ' A' ' 215' ' ' ILE . 0.8 OUTLIER -142.77 151.45 17.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.539 1.149 . . . . 72.549999999999997 109.321 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.431 ' N ' HD12 ' A' ' 215' ' ' ILE . 9.8 t0 -79.85 111.57 16.29 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.531 1.144 . . . . 74.340000000000003 109.327 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 217' ' ' ILE . 9.5 mm -51.78 -24.26 4.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 124.466 1.104 . . . . 74.530000000000001 109.257 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.26 99.14 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.433 1.083 . . . . 72.439999999999998 109.373 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 13.7 m -83.68 -71.99 0.48 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.513 1.133 . . . . 71.450000000000003 110.388 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 109.35 13.42 17.28 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.504 1.127 . . . . 73.439999999999998 111.043 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -139.58 -175.6 4.25 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 0.769 . . . . 72.5 111.0 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -118.17 137.8 52.73 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.532 1.145 . . . . 55.100000000000001 109.208 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 77.8 p -91.45 -16.2 27.68 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.518 1.136 . . . . 72.310000000000002 110.435 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.53 6.06 17.97 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.534 1.146 . . . . 70.349999999999994 110.995 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -79.43 -179.2 6.67 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.583 0.814 . . . . 73.430000000000007 109.291 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.86 179.98 4.78 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.466 1.104 . . . . 71.120000000000005 109.292 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.868 HG23 HG13 ' A' ' 214' ' ' ILE . 5.6 p -82.1 -32.42 10.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 74.430000000000007 109.296 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.708 ' HA ' HD12 ' A' ' 231' ' ' ILE . 3.0 mp -62.02 -51.36 73.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.41 1.068 . . . . 54.409999999999997 109.323 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -62.1 -19.06 62.58 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.46 1.1 . . . . 64.510000000000005 110.392 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.653 ' O ' HG22 ' A' ' 234' ' ' VAL . 0.8 OUTLIER -88.89 -34.68 16.87 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.49 1.119 . . . . 63.439999999999998 109.263 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.708 HD12 ' HA ' ' A' ' 228' ' ' ILE . 19.5 mt -61.35 -26.39 39.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.534 1.146 . . . . 74.319999999999993 109.284 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -83.57 -11.49 57.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.448 1.092 . . . . 73.25 109.317 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.8 ' O ' HD13 ' A' ' 155' ' ' LEU . 3.7 m -93.21 -5.49 49.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.517 1.136 . . . . 71.310000000000002 109.986 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.784 HG21 HD22 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -130.8 7.54 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.429 1.081 . . . . 50.240000000000002 109.317 -179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 4.1 m120 44.44 26.99 0.2 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.463 1.102 . . . . 64.349999999999994 109.288 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.666 HD11 ' HA ' ' A' ' 186' ' ' ALA . 3.5 tp -55.8 113.53 5.86 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.497 1.123 . . . . 71.239999999999995 109.317 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 145.08 31.1 Favored 'Trans proline' 0 C--N 1.361 1.231 0 O-C-N 124.505 1.792 . . . . 72.140000000000001 111.034 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 3.9 p -57.42 161.12 3.62 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.434 1.083 . . . . 73.299999999999997 110.367 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.602 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.8 p -61.32 -24.37 33.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.459 1.1 . . . . 64.200000000000003 109.317 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.513 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 4.4 mm100 -80.85 -36.64 31.19 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.119 . . . . 72.420000000000002 110.31 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -75.4 -25.77 57.88 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.498 1.124 . . . . 61.020000000000003 110.291 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 1.002 ' CE2' HD11 ' A' ' 246' ' ' ILE . 8.1 t90 -82.99 -63.61 1.33 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.003 -1.11 . . . . 71.140000000000001 108.003 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.658 ' HA ' HD12 ' A' ' 246' ' ' ILE . 8.6 ptmt -44.04 -30.79 0.78 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.477 1.111 . . . . 61.299999999999997 109.315 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 22.7 t -72.99 -48.16 38.89 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.474 1.109 . . . . 62.32 110.01 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -54.58 -37.38 65.43 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.508 1.13 . . . . 60.549999999999997 109.26 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 1.002 HD11 ' CE2' ' A' ' 242' ' ' TRP . 50.6 mt -62.77 118.35 4.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.485 1.116 . . . . 73.430000000000007 109.267 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -137.27 164.66 28.02 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.474 1.109 . . . . 54.25 109.31 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.43 ' CD ' ' O ' ' A' ' 248' ' ' ARG . 0.0 OUTLIER -61.33 -34.11 74.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.505 1.128 . . . . 75.329999999999998 110.276 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.475 ' C ' ' CD1' ' A' ' 249' ' ' TYR . 6.7 p90 -174.78 159.17 2.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.478 1.111 . . . . 74.239999999999995 111.0 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -140.17 174.53 10.42 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 64.219999999999999 109.35 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.23 -68.01 0.6 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.526 1.141 . . . . 52.409999999999997 109.308 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 69.2 m -117.22 154.86 30.43 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.534 1.146 . . . . 62.32 110.032 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -174.63 -176.99 1.11 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.543 1.152 . . . . 65.120000000000005 109.282 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.679 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.7 pp -130.11 176.34 8.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 72.439999999999998 109.276 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 47.5 t -163.85 132.82 3.83 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.501 1.126 . . . . 75.450000000000003 110.01 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 90.5 mt -104.47 87.29 2.68 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.446 1.091 . . . . 75.540000000000006 109.359 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -95.14 121.47 6.84 Favored Glycine 0 CA--C 1.531 1.073 0 O-C-N 124.544 1.152 . . . . 64.420000000000002 110.97 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.86 148.58 21.9 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 124.546 0.792 . . . . 65.439999999999998 110.031 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 54.8 t -102.44 134.6 42.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.546 1.153 . . . . 72.439999999999998 109.304 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.324 -0.504 0 O-C-N 124.45 1.094 . . . . 51.509999999999998 110.299 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.937 0 N-CA-C 111.021 -0.832 . . . . 61.450000000000003 111.021 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 145.92 32.25 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.5 1.789 . . . . 71.549999999999997 111.047 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.566 ' C ' HD12 ' A' ' 155' ' ' LEU . 3.0 pp -113.48 163.38 14.98 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.478 1.111 . . . . 62.539999999999999 109.234 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 113.04 -21.01 18.84 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.523 1.139 . . . . 65.109999999999999 110.991 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.58 109.12 0.51 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.477 0.751 . . . . 73.519999999999996 110.039 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.711 ' CD2' HG11 ' A' ' 234' ' ' VAL . 0.2 OUTLIER -97.54 135.22 39.69 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.489 1.118 . . . . 51.219999999999999 109.277 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -105.97 126.55 52.32 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.439 1.087 . . . . 75.420000000000002 111.06 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.499 ' HA ' HD13 ' A' ' 214' ' ' ILE . . . -105.66 162.74 13.25 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 51.520000000000003 109.273 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.433 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.0 OUTLIER -130.62 127.51 62.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.471 1.107 . . . . 72.239999999999995 109.26 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.705 ' CG2' HD23 ' A' ' 182' ' ' LEU . 4.9 t -86.14 122.55 38.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.488 1.118 . . . . 62.43 109.318 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.956 ' O ' HG23 ' A' ' 178' ' ' VAL . 0.3 OUTLIER -107.07 -9.42 16.19 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.13 . . . . 75.329999999999998 109.273 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.445 ' O ' HG12 ' A' ' 162' ' ' VAL . 66.7 m-85 -135.13 145.1 47.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.542 1.151 . . . . 75.329999999999998 110.992 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -82.58 104.59 12.96 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.56 1.162 . . . . 75.319999999999993 109.331 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 175' ' ' THR . 1.5 t80 -85.99 122.75 30.48 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.513 1.133 . . . . 62.25 111.007 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.78 99.94 11.3 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.454 1.096 . . . . 75.049999999999997 109.287 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.959 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -47.68 125.45 8.56 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.435 1.084 . . . . 74.120000000000005 109.324 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -120.38 -40.68 2.66 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.496 1.122 . . . . 64.209999999999994 110.289 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.88 170.57 10.88 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.523 1.139 . . . . 62.219999999999999 109.275 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.66 -38.09 62.56 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.497 1.123 . . . . 63.409999999999997 109.299 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -100.07 27.45 5.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.477 1.111 . . . . 63.450000000000003 109.353 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.593 ' OE2' ' CH2' ' A' ' 192' ' ' TRP . 3.5 mm-40 -108.57 153.17 23.76 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 74.409999999999997 110.317 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.959 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 17.3 mt -125.77 159.94 31.07 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.468 1.105 . . . . 63.140000000000001 109.313 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.522 ' N ' ' HB2' ' A' ' 168' ' ' ALA . 15.1 t -101.55 154.04 19.2 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.538 1.149 . . . . 62.310000000000002 110.439 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.3 m -138.25 -168.98 2.48 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.454 1.096 . . . . 74.019999999999996 110.366 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.613 ' H ' HG22 ' A' ' 176' ' ' THR . 54.5 m-85 -138.82 134.33 33.23 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.522 1.139 . . . . 74.430000000000007 111.014 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.956 HG23 ' O ' ' A' ' 163' ' ' LEU . 1.6 p -58.09 146.65 7.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.41 1.069 . . . . 64.129999999999995 109.28 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 58.74 47.17 91.72 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.457 1.098 . . . . 62.530000000000001 110.971 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -121.9 172.37 8.24 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.488 0.758 . . . . 63.109999999999999 110.306 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.25 137.57 54.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.446 1.092 . . . . 64.510000000000005 109.374 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.705 HD23 ' CG2' ' A' ' 162' ' ' VAL . 3.1 pp -158.74 168.19 27.51 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 70.310000000000002 109.25 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.598 ' CE1' ' O ' ' A' ' 184' ' ' ILE . 4.2 t80 -112.13 148.24 34.4 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.487 1.117 . . . . 60.109999999999999 110.997 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.955 HD12 ' HB3' ' A' ' 193' ' ' PHE . 26.4 mm -90.51 134.12 30.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.394 1.059 . . . . 75.439999999999998 109.327 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.49 ' O ' HD11 ' A' ' 236' ' ' LEU . 16.5 t -101.59 -26.02 13.68 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.483 1.114 . . . . 51.310000000000002 108.325 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.707 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -164.27 179.38 6.87 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.135 . . . . 73.099999999999994 109.306 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.624 ' CE1' HG21 ' A' ' 231' ' ' ILE . 44.1 p-80 -138.3 148.71 44.93 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 60.130000000000003 109.566 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.526 ' CG ' ' HB2' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -122.17 114.48 20.92 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.507 1.129 . . . . 54.310000000000002 109.555 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.438 ' C ' ' N ' ' A' ' 191' ' ' GLU . 2.4 m-20 55.8 27.42 10.83 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.541 1.151 . . . . 73.010000000000005 109.272 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 1.5 p 50.81 20.04 0.71 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.569 1.168 . . . . 72.329999999999998 108.303 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.445 ' O ' HG12 ' A' ' 209' ' ' VAL . 1.3 pt-20 -125.0 -10.45 7.14 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.497 1.123 . . . . 71.209999999999994 110.335 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.593 ' CH2' ' OE2' ' A' ' 173' ' ' GLU . 6.8 m95 -130.68 166.58 20.42 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.961 -1.126 . . . . 75.25 107.961 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.955 ' HB3' HD12 ' A' ' 184' ' ' ILE . 31.3 m-85 -139.59 163.31 32.89 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.427 1.079 . . . . 73.430000000000007 110.994 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.707 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 30.0 mm -109.35 117.67 55.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.506 1.129 . . . . 74.109999999999999 109.283 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.505 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -100.43 145.29 28.42 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 64.209999999999994 109.336 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.618 ' HD3' HG22 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -121.22 162.66 34.51 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.534 1.146 . . . . 72.230000000000004 109.228 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 108.82 2.81 Favored 'Trans proline' 0 C--N 1.361 1.222 0 O-C-N 124.442 1.759 . . . . 65.219999999999999 111.03 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 7.6 tt -114.98 27.62 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.475 1.109 . . . . 70.019999999999996 109.287 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -165.11 -43.23 0.02 OUTLIER Glycine 0 CA--C 1.531 1.074 0 O-C-N 124.527 1.142 . . . . 73.540000000000006 110.985 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -137.63 127.26 25.2 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.571 0.807 . . . . 65.329999999999998 110.263 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.527 ' C ' HD23 ' A' ' 201' ' ' LEU . 7.7 tt -40.61 138.0 1.04 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.521 1.138 . . . . 71.129999999999995 109.27 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.469 ' N ' HD23 ' A' ' 201' ' ' LEU . . . 145.55 109.6 0.63 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.543 1.152 . . . . 70.450000000000003 110.957 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.748 ' HA2' HD11 ' A' ' 174' ' ' LEU . . . 166.93 175.77 37.34 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.04 -0.824 . . . . 65.25 111.04 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 170.47 71.76 Favored 'Cis proline' 0 C--N 1.359 1.101 0 C-N-CA 121.008 -2.497 . . . . 71.120000000000005 110.986 -0.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.473 ' HA3' HD12 ' A' ' 174' ' ' LEU . . . -134.9 167.06 24.17 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.502 1.126 . . . . 42.420000000000002 110.976 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.575 ' HB3' ' CE3' ' A' ' 192' ' ' TRP . 3.2 mt -108.68 155.32 20.85 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.483 0.755 . . . . 63.340000000000003 109.311 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.731 HG21 HG11 ' A' ' 212' ' ' VAL . 0.2 OUTLIER -156.42 118.28 2.21 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.57 1.169 . . . . 74.420000000000002 109.294 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.509 ' HD3' ' CZ3' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -75.04 137.94 22.28 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.544 1.813 . . . . 61.119999999999997 111.0 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.562 ' HB ' ' CE2' ' A' ' 193' ' ' PHE . 13.3 p -58.26 -17.32 9.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.516 1.135 . . . . 71.319999999999993 109.314 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -71.44 -3.87 55.13 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 124.453 1.096 . . . . 53.340000000000003 111.047 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -128.73 2.39 5.45 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.405 0.709 . . . . 71.439999999999998 111.063 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.731 HG11 HG21 ' A' ' 207' ' ' VAL . 14.8 m -143.34 163.88 16.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.439 1.087 . . . . 74.230000000000004 109.246 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.624 ' HB2' HD11 ' A' ' 163' ' ' LEU . 1.4 t -144.87 160.61 41.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.133 . . . . 71.319999999999993 109.981 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.696 HG13 HG23 ' A' ' 227' ' ' VAL . 28.1 mm -109.23 138.24 37.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.464 1.103 . . . . 62.539999999999999 109.349 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.73 167.26 3.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.514 1.134 . . . . 62.119999999999997 109.269 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.558 ' HB2' HG21 ' A' ' 223' ' ' THR . 11.2 t70 -87.71 -57.82 2.8 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.571 1.169 . . . . 72.319999999999993 109.285 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.401 HG22 HG23 ' A' ' 219' ' ' THR . 22.9 mm -87.72 153.27 3.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.479 1.112 . . . . 74.239999999999995 109.292 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -79.94 55.48 2.12 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.493 1.121 . . . . 73.299999999999997 109.293 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.401 HG23 HG22 ' A' ' 217' ' ' ILE . 2.5 p -126.9 -177.11 3.91 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.51 1.131 . . . . 72.450000000000003 110.388 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -91.13 20.62 38.99 Favored Glycine 0 CA--C 1.529 0.925 0 O-C-N 124.487 1.117 . . . . 73.340000000000003 111.024 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -106.17 -179.66 4.0 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.409 0.711 . . . . 73.140000000000001 110.978 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -141.42 149.79 41.49 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.443 1.09 . . . . 61.039999999999999 109.332 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.558 HG21 ' HB2' ' A' ' 216' ' ' ASP . 69.1 p -91.65 -21.38 20.82 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.546 1.154 . . . . 75.439999999999998 110.462 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 105.42 0.53 40.53 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.578 1.174 . . . . 51.43 111.014 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -74.97 -176.15 2.83 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.541 0.789 . . . . 75.299999999999997 109.345 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.22 158.57 38.67 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.493 1.121 . . . . 64.209999999999994 109.285 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.816 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 8.6 p -77.46 -34.86 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.504 1.127 . . . . 74.200000000000003 109.334 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.619 ' HA ' HD12 ' A' ' 231' ' ' ILE . 1.1 mp -52.1 -47.6 43.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 124.502 1.126 . . . . 72.140000000000001 109.227 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 233' ' ' SER . 7.0 mt-10 -66.75 -35.32 79.83 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.573 1.17 . . . . 62.0 110.268 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.24 -27.8 65.78 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.565 1.166 . . . . 70.239999999999995 109.309 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.629 HG23 HD23 ' A' ' 236' ' ' LEU . 26.8 mt -74.49 -40.96 49.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.387 1.054 . . . . 54.350000000000001 109.261 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 26.4 mmtt -83.77 -19.98 34.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.389 1.055 . . . . 71.140000000000001 109.296 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 229' ' ' GLU . 8.7 m -60.59 -23.35 64.61 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.489 1.118 . . . . 62.210000000000001 110.027 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.711 HG11 ' CD2' ' A' ' 158' ' ' LEU . 6.3 p -126.39 21.81 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.549 1.156 . . . . 60.25 109.29 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 53.0 t30 47.36 28.46 1.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.532 1.145 . . . . 73.109999999999999 109.301 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.629 HD23 HG23 ' A' ' 231' ' ' ILE . 10.4 tp -58.45 112.15 4.55 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.135 . . . . 60.119999999999997 109.307 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 149.34 36.66 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.493 1.786 . . . . 74.030000000000001 111.012 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.419 ' C ' ' N ' ' A' ' 240' ' ' GLN . 2.3 p -57.15 149.54 19.37 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.522 1.139 . . . . 75.439999999999998 110.342 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.495 HG11 ' HB2' ' A' ' 188' ' ' HIS . 0.4 OUTLIER -41.18 -31.02 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.109 . . . . 61.140000000000001 109.337 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.444 ' O ' ' CB ' ' A' ' 244' ' ' SER . 58.4 mm-40 -81.37 -49.34 10.79 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.455 1.097 . . . . 73.019999999999996 110.296 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -59.09 -21.84 59.84 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.449 1.093 . . . . 74.329999999999998 110.287 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.422 ' O ' ' N ' ' A' ' 246' ' ' ILE . 4.2 t90 -83.33 -71.17 0.51 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.507 1.129 . . . . 64.329999999999998 108.008 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.9 -24.51 1.5 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.455 1.097 . . . . 74.010000000000005 109.246 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 240' ' ' GLN . 43.9 t -77.4 -39.86 45.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.557 1.16 . . . . 70.239999999999995 110.004 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 242' ' ' TRP . 4.0 t-20 -92.18 -71.19 0.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.46 1.1 . . . . 65.310000000000002 109.264 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.422 ' N ' ' O ' ' A' ' 242' ' ' TRP . 14.1 mt 64.47 97.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.591 1.182 . . . . 72.200000000000003 109.269 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -122.92 5.13 9.36 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.566 1.166 . . . . 71.430000000000007 109.332 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -40.26 -45.42 2.08 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.474 1.109 . . . . 72.209999999999994 110.282 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -132.79 145.88 51.37 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.541 1.15 . . . . 63.409999999999997 110.981 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 252' ' ' SER . 0.0 OUTLIER -73.41 -64.24 1.03 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.39 1.056 . . . . 72.430000000000007 109.316 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' A' ' 255' ' ' SER . . . -66.95 76.48 0.12 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.466 1.103 . . . . 74.319999999999993 109.332 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 250' ' ' LYS . 45.8 m -108.72 -72.74 0.71 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.52 1.137 . . . . 72.230000000000004 110.007 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -49.98 -26.76 4.56 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.567 1.167 . . . . 51.329999999999998 109.329 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.548 ' O ' HD12 ' A' ' 254' ' ' ILE . 1.7 pp -127.5 165.22 26.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.492 1.12 . . . . 62.43 109.259 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.51 ' HB2' ' HB1' ' A' ' 251' ' ' ALA . 5.6 m 52.84 34.65 16.97 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 74.430000000000007 109.981 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -44.35 155.6 0.09 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.493 1.121 . . . . 75.430000000000007 109.257 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -66.12 -103.11 0.02 OUTLIER Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.522 1.139 . . . . 73.549999999999997 110.984 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 54.2 m -69.42 158.0 35.99 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.487 0.757 . . . . 73.519999999999996 110.037 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.5 134.54 54.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.476 1.11 . . . . 63.219999999999999 109.312 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 . . . . . 0 C--N 1.325 -0.495 0 O-C-N 124.468 1.105 . . . . 75.209999999999994 110.239 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.031 0 N-CA-C 110.977 -0.849 . . . . 70.019999999999996 110.977 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.03 164.64 32.91 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.586 1.834 . . . . 64.230000000000004 110.966 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.467 HD22 ' O ' ' A' ' 233' ' ' SER . 1.1 mp -100.61 169.74 8.84 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.477 1.111 . . . . 61.340000000000003 109.294 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.499 ' HA2' HG23 ' A' ' 234' ' ' VAL . . . 150.78 -23.67 1.03 Allowed Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.41 1.069 . . . . 43.43 111.021 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.1 p -122.65 163.74 19.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.52 0.776 . . . . 62.140000000000001 110.022 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 158' ' ' LEU . 9.0 mt -154.16 -175.75 5.54 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.119 . . . . 71.450000000000003 109.297 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -160.7 139.78 10.47 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.466 1.104 . . . . 73.510000000000005 111.039 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.411 ' HB2' HG12 ' A' ' 184' ' ' ILE . . . -132.85 162.28 31.96 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.467 1.105 . . . . 44.340000000000003 109.298 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.711 HG21 HD13 ' A' ' 215' ' ' ILE . 0.7 OUTLIER -127.95 121.16 55.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.478 1.111 . . . . 70.329999999999998 109.271 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.979 HG23 HD21 ' A' ' 182' ' ' LEU . 55.9 t -79.11 98.02 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 72.209999999999994 109.323 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.818 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.2 OUTLIER -92.05 35.08 0.99 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.576 1.172 . . . . 73.129999999999995 109.306 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.556 ' HB3' ' CD2' ' A' ' 211' ' ' PHE . 18.2 m-85 -170.98 133.4 0.9 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.469 1.106 . . . . 75.230000000000004 111.014 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.13 102.99 3.16 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.524 1.14 . . . . 62.219999999999999 109.3 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.6 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 7.3 t80 -80.35 153.04 28.61 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.488 1.118 . . . . 74.400000000000006 110.937 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.6 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 11.4 mmmm -112.04 135.21 52.97 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.55 1.156 . . . . 74.25 109.297 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.828 ' HB1' ' OE1' ' A' ' 173' ' ' GLU . . . -84.25 123.81 30.53 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.484 1.115 . . . . 52.049999999999997 109.278 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.439 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 6.5 pt-20 -126.4 -30.62 2.85 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.544 1.153 . . . . 75.319999999999993 110.328 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 3.7 tttt -59.03 -173.72 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.594 1.184 . . . . 70.349999999999994 109.293 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.5 -27.82 17.99 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.523 1.139 . . . . 72.129999999999995 109.319 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.54 28.75 6.49 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.517 1.135 . . . . 71.040000000000006 109.354 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.828 ' OE1' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -71.13 -176.4 1.42 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.448 1.092 . . . . 72.120000000000005 110.271 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.725 HD22 ' HA2' ' A' ' 203' ' ' GLY . 1.6 tp -157.62 113.94 2.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 62.140000000000001 109.285 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 2.0 t -68.95 145.29 53.75 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.562 1.164 . . . . 62.32 110.394 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.645 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.7 m -129.25 -169.5 2.11 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.103 . . . . 65.400000000000006 110.405 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.645 ' H ' HG22 ' A' ' 176' ' ' THR . 29.3 m-85 -138.4 133.73 33.23 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.438 1.087 . . . . 75.450000000000003 111.011 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' ' 177' ' ' TYR . 0.2 OUTLIER -39.41 156.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.515 1.134 . . . . 75.450000000000003 109.354 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 51.02 48.37 46.12 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.441 1.088 . . . . 53.229999999999997 110.991 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.452 ' HB3' ' CD1' ' A' ' 182' ' ' LEU . 7.6 mm-40 -107.36 151.49 25.43 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.53 0.782 . . . . 71.329999999999998 110.202 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.877 ' C ' HD13 ' A' ' 182' ' ' LEU . 0.3 OUTLIER -108.27 127.28 53.71 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.56 1.162 . . . . 53.420000000000002 109.282 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.979 HD21 HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -158.81 168.7 26.12 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.477 1.11 . . . . 64.209999999999994 109.311 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 184' ' ' ILE . 2.0 t80 -114.2 144.34 43.35 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.589 1.18 . . . . 73.409999999999997 111.002 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.501 HD12 ' HB3' ' A' ' 193' ' ' PHE . 9.3 mm -77.68 100.74 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.503 1.127 . . . . 62.25 109.308 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.425 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 1.3 t -73.6 -28.9 62.06 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.475 1.11 . . . . 70.329999999999998 108.246 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.412 ' HB1' ' N ' ' A' ' 239' ' ' VAL . . . -174.36 170.85 3.53 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.539 1.15 . . . . 65.340000000000003 109.352 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.49 ' NE2' HG21 ' A' ' 231' ' ' ILE . 6.4 p80 -129.16 149.51 50.94 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.559 1.162 . . . . 75.239999999999995 109.629 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.637 ' CE1' ' CG ' ' A' ' 240' ' ' GLN . 0.8 OUTLIER -124.54 114.94 20.08 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.441 1.088 . . . . 72.230000000000004 109.591 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.451 ' C ' ' N ' ' A' ' 191' ' ' GLU . 6.0 m-20 53.85 32.8 15.75 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.491 1.12 . . . . 72.230000000000004 109.301 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 12.7 p 42.96 28.23 0.13 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 71.129999999999995 108.314 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.451 ' N ' ' C ' ' A' ' 189' ' ' ASN . 5.0 pt-20 -121.57 -34.79 3.36 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.465 1.103 . . . . 74.400000000000006 110.331 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.47 ' CE3' ' HB3' ' A' ' 206' ' ' LEU . 7.8 m0 -118.04 165.56 13.59 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.534 1.146 . . . . 75.349999999999994 107.945 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.749 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 20.3 m-85 -143.53 157.4 44.46 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 70.120000000000005 111.002 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.441 ' CG2' ' HB2' ' A' ' 204' ' ' PRO . 31.3 mm -95.62 101.93 12.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.497 1.123 . . . . 72.25 109.317 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.577 ' HB2' HG21 ' A' ' 207' ' ' VAL . . . -84.82 168.4 15.15 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.521 1.138 . . . . 54.32 109.245 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -140.54 162.11 51.05 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 63.119999999999997 109.262 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 176.24 10.16 Favored 'Trans proline' 0 C--N 1.361 1.203 0 O-C-N 124.473 1.775 . . . . 75.140000000000001 110.934 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 9.4 tt -91.97 -48.11 13.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.577 1.173 . . . . 75.409999999999997 109.24 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -169.19 46.99 0.22 Allowed Glycine 0 CA--C 1.529 0.934 0 O-C-N 124.474 1.108 . . . . 43.219999999999999 111.003 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -138.53 129.38 26.64 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.419 0.717 . . . . 75.409999999999997 110.271 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.4 tt -48.91 112.14 0.57 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.397 1.061 . . . . 71.010000000000005 109.306 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 160.89 -171.63 37.02 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.481 1.113 . . . . 43.439999999999998 111.035 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.725 ' HA2' HD22 ' A' ' 174' ' ' LEU . . . 67.01 -179.57 13.45 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 110.958 -0.857 . . . . 74.349999999999994 110.958 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.441 ' HB2' ' CG2' ' A' ' 194' ' ' ILE . 18.4 Cg_endo -75.05 -178.72 24.31 Favored 'Cis proline' 0 C--N 1.36 1.153 0 C-N-CA 121.073 -2.47 . . . . 65.430000000000007 111.034 0.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 174' ' ' LEU . . . -133.8 172.38 21.67 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 124.475 1.11 . . . . 74.200000000000003 111.047 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.6 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 2.7 mt -106.41 129.6 54.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 0.754 . . . . 42.43 109.283 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.809 HG12 ' HD2' ' A' ' 208' ' ' PRO . 0.2 OUTLIER -135.88 145.82 54.36 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.471 1.107 . . . . 75.420000000000002 109.308 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.809 ' HD2' HG12 ' A' ' 207' ' ' VAL . 18.2 Cg_endo -75.03 157.68 42.49 Favored 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.515 1.797 . . . . 64.340000000000003 110.977 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.719 HG23 ' HE2' ' A' ' 193' ' ' PHE . 11.2 p -76.23 -20.27 15.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 124.416 1.072 . . . . 75.230000000000004 109.338 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -84.5 5.99 78.9 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.534 1.146 . . . . 32.420000000000002 110.977 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.572 ' CD1' ' HG2' ' A' ' 208' ' ' PRO . 11.5 m-85 -130.17 12.21 5.56 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.507 0.769 . . . . 72.510000000000005 111.023 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.696 HG12 HG22 ' A' ' 162' ' ' VAL . 2.4 m -149.4 148.04 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 62.109999999999999 109.309 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.818 ' HB2' HD21 ' A' ' 163' ' ' LEU . 10.6 t -126.87 147.43 50.06 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.514 1.134 . . . . 72.420000000000002 110.037 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.756 HG13 HG23 ' A' ' 227' ' ' VAL . 22.2 mm -94.12 133.66 34.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.557 1.161 . . . . 74.049999999999997 109.351 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.711 HD13 HG21 ' A' ' 161' ' ' ILE . 9.6 pt -155.02 115.56 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.442 1.089 . . . . 71.299999999999997 109.273 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.03 38.12 4.15 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.494 1.121 . . . . 70.209999999999994 109.255 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.468 HD11 ' O ' ' A' ' 221' ' ' TYR . 2.2 pt -107.8 21.52 4.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 124.438 1.086 . . . . 64.540000000000006 109.245 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 49.89 44.29 25.21 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 71.150000000000006 109.358 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.1 t -161.35 179.7 8.09 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.592 1.182 . . . . 71.519999999999996 110.405 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -103.9 47.26 1.11 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.514 1.134 . . . . 52.109999999999999 110.994 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.468 ' O ' HD11 ' A' ' 217' ' ' ILE . 23.0 m-85 -139.08 177.18 8.08 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.501 0.765 . . . . 63.509999999999998 111.031 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -135.5 141.77 45.36 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.531 1.144 . . . . 73.349999999999994 109.236 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.5 p -88.97 -37.63 15.08 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.537 1.148 . . . . 71.120000000000005 110.423 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 145.26 -18.47 1.9 Allowed Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.472 1.107 . . . . 20.129999999999999 111.021 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -47.8 172.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.449 0.735 . . . . 74.409999999999997 109.324 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.67 165.31 18.13 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.531 1.144 . . . . 72.540000000000006 109.269 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.756 HG23 HG13 ' A' ' 214' ' ' ILE . 12.3 p -75.55 -44.94 40.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.466 1.104 . . . . 74.409999999999997 109.267 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.779 ' HA ' HD12 ' A' ' 231' ' ' ILE . 1.7 mp -49.42 -54.47 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.42 1.075 . . . . 75.140000000000001 109.324 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.11 -28.67 69.26 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.554 1.159 . . . . 72.109999999999999 110.293 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.11 -14.96 58.09 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.475 1.109 . . . . 73.239999999999995 109.307 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.779 HD12 ' HA ' ' A' ' 228' ' ' ILE . 38.3 mt -83.87 -30.45 7.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.534 1.146 . . . . 72.129999999999995 109.267 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.52 ' CE ' HG22 ' A' ' 231' ' ' ILE . 7.5 mmpt? -82.97 -20.72 34.64 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.507 1.129 . . . . 74.340000000000003 109.332 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.467 ' O ' HD22 ' A' ' 155' ' ' LEU . 36.8 m -66.41 -39.17 88.83 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.566 1.166 . . . . 72.120000000000005 110.004 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.634 ' O ' HG22 ' A' ' 234' ' ' VAL . 4.2 p -114.82 15.56 8.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.518 1.136 . . . . 42.420000000000002 109.326 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 41.41 29.4 0.1 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.496 1.123 . . . . 72.030000000000001 109.337 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.425 HD21 HG22 ' A' ' 184' ' ' ILE . 6.1 tp -41.37 121.01 2.04 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.524 1.14 . . . . 33.350000000000001 109.293 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 135.65 19.28 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.559 1.82 . . . . 62.009999999999998 111.002 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 2.3 p -57.97 152.36 16.48 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.508 1.13 . . . . 62.25 110.395 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.432 HG11 ' HB2' ' A' ' 188' ' ' HIS . 1.3 p -51.2 -22.9 2.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.544 1.153 . . . . 65.030000000000001 109.322 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.637 ' CG ' ' CE1' ' A' ' 188' ' ' HIS . 8.8 mm100 -86.63 -45.54 10.92 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.465 1.103 . . . . 74.450000000000003 110.366 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -63.86 -25.52 68.2 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.465 1.103 . . . . 72.510000000000005 110.29 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.957 ' NE1' HD11 ' A' ' 246' ' ' ILE . 11.2 t90 -77.43 -65.87 0.9 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.553 1.158 . . . . 74.5 107.968 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -52.08 -25.36 8.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 1.13 . . . . 70.109999999999999 109.26 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 43.9 t -76.89 -50.37 13.48 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.552 1.158 . . . . 70.510000000000005 110.009 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -51.97 -39.33 59.15 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.496 1.122 . . . . 73.25 109.331 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.957 HD11 ' NE1' ' A' ' 242' ' ' TRP . 13.2 mt -72.22 158.12 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.477 1.111 . . . . 64.420000000000002 109.279 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 246' ' ' ILE . . . 78.3 8.96 2.2 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.466 1.104 . . . . 74.5 109.282 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -125.63 -176.62 3.65 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.429 1.08 . . . . 74.230000000000004 110.264 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.425 ' O ' ' C ' ' A' ' 250' ' ' LYS . 4.3 t80 -36.57 -63.37 0.41 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 75.409999999999997 111.014 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 249' ' ' TYR . 7.3 ttpp -38.77 -66.81 0.25 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.534 1.146 . . . . 60.450000000000003 109.294 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.625 ' HB2' ' HA ' ' A' ' 246' ' ' ILE . . . -47.12 171.35 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.484 1.115 . . . . 63.350000000000001 109.331 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 3.9 m -39.96 132.43 1.8 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.484 1.115 . . . . 71.120000000000005 110.022 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -57.03 109.22 0.61 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.475 1.109 . . . . 74.450000000000003 109.323 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 34.2 mt -117.67 149.79 19.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.484 1.115 . . . . 74.030000000000001 109.329 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.9 p -44.22 133.01 5.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.474 1.109 . . . . 74.430000000000007 110.024 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.67 162.92 26.73 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.522 1.139 . . . . 73.340000000000003 109.266 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -164.67 146.06 10.94 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.474 1.109 . . . . 34.140000000000001 111.024 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 9.0 t -88.11 128.25 35.42 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.533 0.784 . . . . 65.450000000000003 110.01 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.9 t -136.94 141.97 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.461 1.101 . . . . 73.230000000000004 109.306 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 . . . . . 0 C--N 1.324 -0.519 0 O-C-N 124.481 1.113 . . . . 61.350000000000001 110.314 -179.991 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.989 0 N-CA-C 111.002 -0.839 . . . . 64.230000000000004 111.002 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 155.72 42.79 Favored 'Trans proline' 0 C--N 1.361 1.204 0 O-C-N 124.528 1.804 . . . . 70.209999999999994 110.964 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 12.5 mt -64.82 148.02 52.1 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 71.439999999999998 109.293 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 163.51 48.62 0.02 OUTLIER Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.484 1.115 . . . . 64.150000000000006 111.02 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.2 m -166.29 105.58 0.65 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.46 0.741 . . . . 63.100000000000001 110.013 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.741 ' CD2' HG11 ' A' ' 234' ' ' VAL . 1.6 mm? -110.25 129.55 55.71 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.518 1.136 . . . . 72.040000000000006 109.274 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -138.52 122.71 18.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.485 1.116 . . . . 70.430000000000007 111.02 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.621 ' HB2' HG12 ' A' ' 184' ' ' ILE . . . -103.87 174.52 5.83 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.495 1.122 . . . . 74.439999999999998 109.299 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.522 HG21 ' CD1' ' A' ' 215' ' ' ILE . 0.0 OUTLIER -135.98 128.79 46.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.442 1.089 . . . . 72.209999999999994 109.251 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.897 HG21 ' CG2' ' A' ' 176' ' ' THR . 80.9 t -88.95 122.61 40.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.511 1.132 . . . . 74.109999999999999 109.252 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.2 OUTLIER -107.8 2.73 23.79 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.469 1.105 . . . . 73.049999999999997 109.278 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -153.96 131.59 11.44 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.446 1.091 . . . . 73.349999999999994 110.999 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -63.45 104.82 0.67 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.537 1.148 . . . . 74.340000000000003 109.261 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.578 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 7.3 t80 -80.42 139.46 36.48 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.556 1.16 . . . . 74.420000000000002 110.963 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.489 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 26.7 mmmt -98.31 141.92 30.6 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.128 . . . . 54.020000000000003 109.298 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.822 ' HB1' ' OE1' ' A' ' 173' ' ' GLU . . . -92.02 123.39 35.34 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.422 1.076 . . . . 62.32 109.313 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.448 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 5.9 pt-20 -125.61 -29.35 3.18 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.527 1.142 . . . . 72.239999999999995 110.297 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.45 ' HD3' HD13 ' A' ' 206' ' ' LEU . 3.9 tttp -59.15 -173.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.566 1.166 . . . . 74.030000000000001 109.332 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.19 -31.07 17.2 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.43 1.081 . . . . 63.420000000000002 109.332 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.91 27.93 7.04 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.51 1.131 . . . . 73.430000000000007 109.312 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.822 ' OE1' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -67.97 -176.24 0.66 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.478 1.111 . . . . 61.240000000000002 110.302 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.589 HD12 ' HA3' ' A' ' 205' ' ' GLY . 12.3 mt -151.85 132.36 13.86 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.467 1.104 . . . . 74.549999999999997 109.269 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 12.4 t -78.96 127.88 32.57 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.543 1.152 . . . . 74.019999999999996 110.426 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.897 ' CG2' HG21 ' A' ' 162' ' ' VAL . 2.5 m -106.47 -172.67 2.13 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.444 1.09 . . . . 61.229999999999997 110.374 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.603 ' H ' HG22 ' A' ' 176' ' ' THR . 52.0 m-85 -143.86 133.56 23.72 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.509 1.131 . . . . 74.349999999999994 110.972 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.435 ' CG2' ' N ' ' A' ' 179' ' ' GLY . 1.3 p -51.84 161.37 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.468 1.105 . . . . 75.010000000000005 109.249 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 37.56 51.47 1.86 Allowed Glycine 0 CA--C 1.531 1.057 0 O-C-N 124.533 1.146 . . . . 75.140000000000001 111.005 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.513 ' HG2' HD12 ' A' ' 182' ' ' LEU . 20.3 tt0 -121.85 167.59 12.84 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.555 0.797 . . . . 72.150000000000006 110.288 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.58 120.99 38.32 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.508 1.13 . . . . 43.420000000000002 109.302 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.513 HD12 ' HG2' ' A' ' 180' ' ' GLU . 0.6 OUTLIER -138.02 156.9 47.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.417 1.073 . . . . 45.329999999999998 109.319 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -102.77 129.24 49.36 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.474 1.109 . . . . 71.540000000000006 111.035 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.686 HD12 ' HB3' ' A' ' 193' ' ' PHE . 25.1 mm -77.65 121.32 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 73.230000000000004 109.298 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.499 ' O ' HD11 ' A' ' 236' ' ' LEU . 0.9 OUTLIER -88.66 -26.77 21.68 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.557 1.161 . . . . 63.130000000000003 108.299 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -171.8 176.94 3.48 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.461 1.101 . . . . 74.450000000000003 109.272 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.598 ' CE1' HG21 ' A' ' 231' ' ' ILE . 8.3 p80 -137.27 151.89 49.19 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.495 1.122 . . . . 75.340000000000003 109.565 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.638 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.3 t-160 -124.61 114.72 19.74 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.129 . . . . 74.430000000000007 109.566 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.449 ' C ' ' N ' ' A' ' 191' ' ' GLU . 2.7 t30 54.18 33.21 17.51 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.484 1.115 . . . . 54.149999999999999 109.283 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 12.8 p 43.06 28.43 0.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.595 1.185 . . . . 75.540000000000006 108.237 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.8 ' O ' HG12 ' A' ' 209' ' ' VAL . 5.3 pt-20 -122.17 -34.88 3.24 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.539 1.149 . . . . 64.310000000000002 110.257 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.545 ' HE3' HD22 ' A' ' 206' ' ' LEU . 11.9 m0 -116.32 164.73 14.09 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.572 1.17 . . . . 74.340000000000003 108.005 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.736 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 16.6 m-85 -135.5 159.66 40.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.509 1.131 . . . . 72.400000000000006 111.002 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.469 ' CG1' ' HB ' ' A' ' 239' ' ' VAL . 20.2 mm -103.49 119.57 52.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.508 1.13 . . . . 73.109999999999999 109.303 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.77 175.98 5.45 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.489 1.118 . . . . 72.209999999999994 109.307 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -151.07 156.05 35.17 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.524 1.14 . . . . 70.209999999999994 109.305 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.401 ' HG3' ' CA ' ' A' ' 202' ' ' GLY . 18.2 Cg_endo -74.94 161.29 39.16 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.536 1.808 . . . . 74.019999999999996 111.048 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.8 tp -136.25 114.21 14.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 124.505 1.128 . . . . 74.310000000000002 109.287 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 95.13 -17.38 59.43 Favored Glycine 0 CA--C 1.529 0.943 0 O-C-N 124.461 1.101 . . . . 74.129999999999995 111.006 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.609 ' NH2' ' H ' ' A' ' 201' ' ' LEU . 0.0 OUTLIER -133.25 154.86 50.3 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.467 0.745 . . . . 74.430000000000007 110.289 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.609 ' H ' ' NH2' ' A' ' 200' ' ' ARG . 0.6 OUTLIER -85.02 128.19 34.53 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 74.439999999999998 109.3 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.401 ' CA ' ' HG3' ' A' ' 197' ' ' PRO . . . -175.23 -140.74 3.45 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.55 1.156 . . . . 73.239999999999995 111.02 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 52.6 -178.13 0.1 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.995 -0.842 . . . . 72.209999999999994 110.995 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.99 153.3 99.09 Favored 'Cis proline' 0 C--N 1.36 1.174 0 C-N-CA 121.033 -2.486 . . . . 62.119999999999997 110.97 0.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.589 ' HA3' HD12 ' A' ' 174' ' ' LEU . . . -117.25 178.33 17.03 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.503 1.127 . . . . 71.310000000000002 110.963 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.545 HD22 ' HE3' ' A' ' 192' ' ' TRP . 1.3 mt -118.88 165.19 14.36 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.437 0.728 . . . . 73.400000000000006 109.334 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.735 HG21 HG11 ' A' ' 212' ' ' VAL . 0.2 OUTLIER -162.66 129.96 2.6 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.443 1.089 . . . . 74.120000000000005 109.317 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.578 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.4 Cg_endo -74.9 137.58 22.14 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.488 1.783 . . . . 71.349999999999994 110.991 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.8 HG12 ' O ' ' A' ' 191' ' ' GLU . 7.3 p -67.14 -27.16 38.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.515 1.134 . . . . 71.299999999999997 109.251 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -68.81 -13.36 66.11 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.538 1.149 . . . . 34.240000000000002 111.017 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 7.8 m-30 -113.11 3.16 15.96 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.486 0.757 . . . . 71.310000000000002 111.007 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.842 HG12 HG22 ' A' ' 162' ' ' VAL . 15.0 m -140.08 173.78 9.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.541 1.15 . . . . 64.25 109.319 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.686 ' HB2' HD11 ' A' ' 163' ' ' LEU . 2.9 t -152.09 160.76 43.35 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.519 1.137 . . . . 34.009999999999998 109.995 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.682 HG13 HG23 ' A' ' 227' ' ' VAL . 19.1 mm -104.05 96.59 4.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.55 1.156 . . . . 62.219999999999999 109.314 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.522 ' CD1' HG21 ' A' ' 161' ' ' ILE . 1.2 pt -137.29 -174.2 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.504 1.128 . . . . 74.340000000000003 109.353 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -123.45 153.46 40.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.527 1.142 . . . . 70.030000000000001 109.332 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 5.4 mm -67.8 -23.65 29.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.51 1.131 . . . . 73.129999999999995 109.299 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -70.62 -56.02 7.44 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.49 1.119 . . . . 72.0 109.254 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.543 HG21 ' CG2' ' A' ' 223' ' ' THR . 3.5 m -62.63 -70.41 0.2 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.545 1.153 . . . . 71.340000000000003 110.452 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.52 -17.54 53.06 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.435 1.084 . . . . 71.510000000000005 111.04 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.498 ' CE1' HG22 ' A' ' 219' ' ' THR . 24.1 p90 -132.88 -176.51 4.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.489 0.758 . . . . 71.25 111.004 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -94.58 119.86 33.91 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.508 1.13 . . . . 60.109999999999999 109.3 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.543 ' CG2' HG21 ' A' ' 219' ' ' THR . 12.6 p -82.95 -27.19 30.7 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.517 1.136 . . . . 51.520000000000003 110.424 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 139.65 -19.06 2.99 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.54 1.15 . . . . 54.329999999999998 111.052 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -50.08 176.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.465 0.744 . . . . 72.340000000000003 109.263 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -134.63 157.76 45.79 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.494 1.121 . . . . 65.5 109.312 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.737 HG13 HD12 ' A' ' 228' ' ' ILE . 2.5 p -77.67 -34.49 20.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.493 1.121 . . . . 73.25 109.298 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.737 HD12 HG13 ' A' ' 227' ' ' VAL . 1.9 mp -59.21 -44.87 92.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 124.531 1.145 . . . . 64.340000000000003 109.284 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.95 -45.81 90.69 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.551 1.157 . . . . 63.149999999999999 110.291 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -67.97 -26.0 65.72 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.396 1.06 . . . . 64.540000000000006 109.33 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.718 HD11 HG22 ' A' ' 227' ' ' VAL . 16.8 mt -67.69 -41.56 85.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.507 1.129 . . . . 72.329999999999998 109.332 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.426 ' HE3' HG22 ' A' ' 231' ' ' ILE . 3.4 mmtp -83.94 -20.16 33.43 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.558 1.161 . . . . 75.129999999999995 109.237 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 41.9 m -61.07 -25.73 67.15 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.49 1.119 . . . . 73.230000000000004 110.005 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.741 HG11 ' CD2' ' A' ' 158' ' ' LEU . 7.5 p -126.39 20.73 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.424 1.077 . . . . 72.310000000000002 109.351 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 40.55 30.12 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.504 1.128 . . . . 64.25 109.33 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.502 HD12 ' HD2' ' A' ' 237' ' ' PRO . 12.7 tp -46.88 120.31 6.25 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.426 1.079 . . . . 75.519999999999996 109.277 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.502 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -74.93 131.05 13.92 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.486 1.782 . . . . 72.120000000000005 110.99 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 2.7 p -57.04 157.07 6.18 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.107 . . . . 34.130000000000003 110.418 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.638 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.1 p -46.29 -27.11 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.477 1.111 . . . . 71.329999999999998 109.272 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.402 ' NE2' ' HD3' ' A' ' 243' ' ' LYS . 37.6 mm-40 -86.77 -47.02 9.45 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.514 1.134 . . . . 75.329999999999998 110.39 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -61.4 -20.47 63.09 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.409 1.068 . . . . 71.439999999999998 110.308 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.442 ' C ' ' N ' ' A' ' 244' ' ' SER . 13.9 t90 -88.12 -65.51 1.01 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.958 -1.127 . . . . 75.209999999999994 107.958 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.739 ' HA ' HD12 ' A' ' 246' ' ' ILE . 2.9 ptmm? -41.79 -28.87 0.17 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.514 1.134 . . . . 72.129999999999995 109.333 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.442 ' N ' ' C ' ' A' ' 242' ' ' TRP . 1.2 t -73.36 -65.83 0.76 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.453 1.096 . . . . 62.329999999999998 109.994 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 246' ' ' ILE . 4.7 t-20 -45.04 -38.92 5.26 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.563 1.165 . . . . 54.329999999999998 109.346 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.739 HD12 ' HA ' ' A' ' 243' ' ' LYS . 31.3 mt -40.03 -60.18 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.533 1.146 . . . . 51.32 109.332 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 248' ' ' ARG . . . -153.49 -56.77 0.12 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.561 1.163 . . . . 61.43 109.272 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 247' ' ' ALA . 4.2 mmm180 -39.01 155.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 74.230000000000004 110.276 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 54.22 56.97 6.32 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.521 1.138 . . . . 72.209999999999994 110.982 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.84 116.93 2.59 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.532 1.145 . . . . 74.25 109.313 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.11 144.43 52.08 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.526 1.141 . . . . 74.209999999999994 109.293 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 90.6 p -71.36 175.67 5.24 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.558 1.161 . . . . 54.509999999999998 110.007 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -99.49 -174.42 2.72 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.564 1.165 . . . . 55.240000000000002 109.315 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 2.7 tp 43.16 38.26 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.459 1.099 . . . . 72.409999999999997 109.265 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 63.4 p -106.75 177.19 4.93 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.527 1.142 . . . . 72.400000000000006 110.061 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 57.1 tp -48.36 121.09 4.09 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.459 1.099 . . . . 70.109999999999999 109.308 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 131.19 86.85 0.39 Allowed Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.52 1.137 . . . . 64.540000000000006 111.065 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.7 m -57.1 -61.33 2.54 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.463 0.743 . . . . 71.239999999999995 110.02 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 24.3 t -54.2 111.0 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.493 1.121 . . . . 74.310000000000002 109.324 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 . . . . . 0 C--N 1.325 -0.476 0 O-C-N 124.433 1.083 . . . . 63.109999999999999 110.198 -179.925 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.046 0 N-CA-C 111.04 -0.824 . . . . 73.209999999999994 111.04 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 84.76 1.61 Allowed 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.548 1.814 . . . . 75.319999999999993 111.034 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 233' ' ' SER . 2.6 pp -54.6 158.75 2.4 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.499 1.125 . . . . 71.230000000000004 109.281 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 138.65 -14.63 3.39 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.556 1.16 . . . . 72.230000000000004 110.964 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 32.4 t -154.95 138.08 15.62 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.551 0.794 . . . . 70.540000000000006 110.027 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.584 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -97.9 120.2 37.88 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.488 1.117 . . . . 71.25 109.236 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -120.01 141.87 49.32 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 74.0 110.993 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.454 ' CB ' HG12 ' A' ' 184' ' ' ILE . . . -140.14 143.21 36.06 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.419 1.075 . . . . 75.450000000000003 109.393 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.494 ' CG1' ' O ' ' A' ' 180' ' ' GLU . 0.8 OUTLIER -121.65 136.0 59.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.463 1.102 . . . . 75.519999999999996 109.313 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.955 HG21 HG21 ' A' ' 176' ' ' THR . 2.5 t -85.58 127.36 40.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.546 1.154 . . . . 45.020000000000003 109.313 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.484 ' O ' HG23 ' A' ' 178' ' ' VAL . 0.1 OUTLIER -96.8 -17.06 20.48 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.563 1.164 . . . . 72.349999999999994 109.338 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.654 ' O ' HG12 ' A' ' 162' ' ' VAL . 42.9 m-85 -137.94 148.46 45.28 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.502 1.127 . . . . 74.230000000000004 111.039 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.02 100.1 0.11 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.54 1.15 . . . . 63.149999999999999 109.299 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.559 ' CE2' ' O ' ' A' ' 174' ' ' LEU . 26.5 t80 -81.34 126.1 31.18 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.137 . . . . 65.140000000000001 111.009 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.39 129.63 55.53 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.539 1.149 . . . . 73.409999999999997 109.273 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.6 122.63 15.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.102 . . . . 64.430000000000007 109.332 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.447 ' CG ' ' N ' ' A' ' 170' ' ' LYS . 9.0 pt-20 -107.85 -43.73 4.39 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.543 1.152 . . . . 71.010000000000005 110.277 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.447 ' N ' ' CG ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -70.0 -176.07 1.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.137 . . . . 70.140000000000001 109.306 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.43 -19.01 30.26 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.515 1.135 . . . . 73.010000000000005 109.317 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -123.52 27.82 7.25 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.496 1.123 . . . . 45.219999999999999 109.327 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -91.88 155.88 17.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.453 1.096 . . . . 61.200000000000003 110.271 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.904 HD21 ' C ' ' A' ' 202' ' ' GLY . 0.3 OUTLIER -112.45 159.97 18.23 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.484 1.115 . . . . 70.310000000000002 109.316 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 166' ' ' PHE . 13.1 t -118.58 122.8 43.49 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.495 1.122 . . . . 74.109999999999999 110.423 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.955 HG21 HG21 ' A' ' 162' ' ' VAL . 2.2 m -114.61 -168.82 1.43 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.521 1.138 . . . . 65.530000000000001 110.47 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.61 ' H ' HG22 ' A' ' 176' ' ' THR . 14.3 m-85 -134.44 143.6 47.65 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.404 1.065 . . . . 74.430000000000007 110.97 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 163' ' ' LEU . 0.3 OUTLIER -40.46 152.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.478 1.111 . . . . 70.299999999999997 109.321 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 36.93 64.87 0.61 Allowed Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.565 1.165 . . . . 52.520000000000003 110.999 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.494 ' O ' ' CG1' ' A' ' 161' ' ' ILE . 18.3 tt0 -121.72 148.58 44.43 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.48 0.753 . . . . 65.120000000000005 110.328 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.82 139.42 36.53 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.493 1.121 . . . . 71.319999999999993 109.301 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.471 HD21 ' CG2' ' A' ' 162' ' ' VAL . 4.5 pp -166.95 163.28 16.05 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.468 1.105 . . . . 65.340000000000003 109.272 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.584 ' CD2' ' O ' ' A' ' 158' ' ' LEU . 1.0 OUTLIER -115.29 134.13 55.4 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.479 1.112 . . . . 72.450000000000003 110.98 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.895 HD12 ' HB3' ' A' ' 193' ' ' PHE . 36.9 mm -78.21 134.0 29.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.506 1.128 . . . . 72.409999999999997 109.242 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.741 ' O ' HD11 ' A' ' 236' ' ' LEU . 3.3 m -96.09 -35.0 11.51 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.517 1.136 . . . . 71.409999999999997 108.297 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.602 ' HB1' ' N ' ' A' ' 239' ' ' VAL . . . -154.0 179.79 8.58 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.471 1.107 . . . . 73.120000000000005 109.28 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.621 ' CE1' HG21 ' A' ' 231' ' ' ILE . 12.7 p80 -147.38 138.53 23.73 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.464 1.102 . . . . 74.129999999999995 109.566 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.552 ' NE2' ' CG ' ' A' ' 240' ' ' GLN . 2.6 t-80 -114.21 116.42 29.02 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.485 1.116 . . . . 74.450000000000003 109.572 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.422 ' C ' ' N ' ' A' ' 191' ' ' GLU . 37.7 m-20 55.69 26.69 9.64 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.483 1.114 . . . . 62.119999999999997 109.276 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.436 ' HB3' ' CD1' ' A' ' 228' ' ' ILE . 3.6 m 49.83 22.8 0.9 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.51 1.131 . . . . 74.510000000000005 108.353 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.927 ' O ' HG23 ' A' ' 209' ' ' VAL . 5.1 pt-20 -116.81 -32.49 5.1 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.375 1.047 . . . . 63.130000000000003 110.335 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.508 ' CD1' ' HG3' ' A' ' 191' ' ' GLU . 19.2 m0 -117.08 159.34 22.71 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.468 1.105 . . . . 72.420000000000002 108.027 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 1.186 ' CE2' HG22 ' A' ' 209' ' ' VAL . 43.7 m-85 -138.4 156.77 47.28 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 52.030000000000001 111.004 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.944 HD11 HD23 ' A' ' 206' ' ' LEU . 0.5 OUTLIER -102.35 107.18 21.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.461 1.101 . . . . 60.240000000000002 109.247 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.676 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -97.85 151.61 20.04 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.476 1.11 . . . . 74.340000000000003 109.298 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.459 ' CG ' ' HA ' ' A' ' 204' ' ' PRO . 8.8 mtpp -145.32 103.94 4.35 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.525 1.14 . . . . 72.040000000000006 109.261 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.451 ' CG ' HD11 ' A' ' 201' ' ' LEU . 18.3 Cg_endo -75.0 166.48 29.12 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.454 1.765 . . . . 73.5 110.934 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 197' ' ' PRO . 44.7 pt -40.05 154.29 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.521 1.138 . . . . 64.140000000000001 109.294 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 40.16 -121.1 1.61 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.495 1.122 . . . . 62.219999999999999 110.993 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -148.92 115.62 5.95 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.53 0.782 . . . . 74.150000000000006 110.286 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.451 HD11 ' CG ' ' A' ' 197' ' ' PRO . 4.0 pp -141.7 16.07 2.15 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.522 1.139 . . . . 61.100000000000001 109.252 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.904 ' C ' HD21 ' A' ' 174' ' ' LEU . . . 155.05 -52.83 0.44 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.51 1.131 . . . . 74.109999999999999 110.978 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.684 ' H ' HD11 ' A' ' 174' ' ' LEU . . . -48.28 156.76 1.07 Allowed Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.001 -0.84 . . . . 71.340000000000003 111.001 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.494 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.5 Cg_endo -74.99 134.74 37.3 Favored 'Cis proline' 0 C--N 1.359 1.113 0 C-N-CA 121.003 -2.499 . . . . 73.420000000000002 111.049 -0.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.716 ' HA3' HD23 ' A' ' 174' ' ' LEU . . . -126.86 158.22 20.78 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.431 1.082 . . . . 60.329999999999998 111.045 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.944 HD23 HD11 ' A' ' 194' ' ' ILE . 4.6 mt -81.07 147.55 30.07 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.546 0.792 . . . . 75.340000000000003 109.318 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.676 HG11 ' HB2' ' A' ' 195' ' ' ALA . 0.2 OUTLIER -146.36 125.39 6.53 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.531 1.144 . . . . 64.409999999999997 109.286 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.56 ' HG2' ' CD1' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.96 147.51 34.22 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.524 1.802 . . . . 74.049999999999997 110.997 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 1.186 HG22 ' CE2' ' A' ' 193' ' ' PHE . 3.5 t -63.83 -18.31 22.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.517 1.136 . . . . 73.319999999999993 109.265 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -74.07 -1.8 60.58 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.477 1.111 . . . . 70.420000000000002 111.08 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.829 ' O ' HG13 ' A' ' 162' ' ' VAL . 30.2 m-85 -128.66 2.37 5.5 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.562 0.801 . . . . 60.340000000000003 110.961 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.676 HG12 HG22 ' A' ' 162' ' ' VAL . 35.4 m -148.95 154.41 9.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.578 1.174 . . . . 74.420000000000002 109.251 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 42.3 t -139.63 160.27 40.25 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.491 1.12 . . . . 71.25 110.043 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.745 HG13 HG23 ' A' ' 227' ' ' VAL . 8.4 mm -109.14 164.8 5.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.495 1.122 . . . . 62.25 109.267 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.484 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 0.2 OUTLIER -155.82 145.02 12.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.488 1.117 . . . . 72.329999999999998 109.264 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.603 ' OD2' HG21 ' A' ' 223' ' ' THR . 47.4 p-10 -75.87 70.45 2.62 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.462 1.101 . . . . 53.329999999999998 109.295 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 7.7 tt 41.54 44.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.492 1.12 . . . . 73.219999999999999 109.33 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -80.09 -175.86 5.23 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.457 1.098 . . . . 65.329999999999998 109.289 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.511 ' O ' HG22 ' A' ' 219' ' ' THR . 1.1 m -83.67 8.33 14.76 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.499 1.124 . . . . 70.409999999999997 110.367 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 129.61 -3.61 6.15 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 124.551 1.157 . . . . 71.099999999999994 111.008 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -106.7 176.32 5.21 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.44 0.729 . . . . 73.040000000000006 111.02 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -119.64 146.98 45.07 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.549 1.156 . . . . 52.32 109.3 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.603 HG21 ' OD2' ' A' ' 216' ' ' ASP . 11.0 p -91.61 -29.86 16.68 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.49 1.118 . . . . 74.310000000000002 110.468 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 141.93 -17.44 2.57 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.5 1.125 . . . . 63.409999999999997 111.021 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -51.02 174.23 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 0.746 . . . . 71.109999999999999 109.341 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.77 172.96 7.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 54.329999999999998 109.296 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 1.02 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 12.3 p -78.94 -30.9 14.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.133 . . . . 63.210000000000001 109.291 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.77 HD12 HG13 ' A' ' 227' ' ' VAL . 1.4 mp -60.82 -46.49 96.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 63.119999999999997 109.339 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.73 -43.02 99.89 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.558 1.162 . . . . 75.109999999999999 110.304 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.98 -34.32 77.83 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.554 1.159 . . . . 64.430000000000007 109.282 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.621 HG21 ' CE1' ' A' ' 187' ' ' HIS . 38.8 mt -63.25 -46.22 96.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.141 . . . . 74.319999999999993 109.309 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -76.56 -15.73 59.78 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.499 1.125 . . . . 75.129999999999995 109.315 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.492 ' O ' HD22 ' A' ' 155' ' ' LEU . 5.0 p -69.55 -40.03 77.06 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.429 1.081 . . . . 72.310000000000002 110.029 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.428 ' O ' HG22 ' A' ' 234' ' ' VAL . 11.3 p -109.4 14.03 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.511 1.132 . . . . 61.409999999999997 109.333 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 234' ' ' VAL . 7.5 t-20 40.35 43.1 1.39 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 71.420000000000002 109.287 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.973 HD12 ' HD2' ' A' ' 237' ' ' PRO . 3.3 tp -66.79 132.2 93.98 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.462 1.101 . . . . 71.010000000000005 109.284 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.973 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -75.03 156.43 42.85 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.478 1.778 . . . . 75.209999999999994 110.997 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 4.2 p -77.98 148.41 34.44 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.492 1.12 . . . . 75.420000000000002 110.336 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.602 ' N ' ' HB1' ' A' ' 186' ' ' ALA . 2.5 p -49.68 -23.57 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.45 1.093 . . . . 73.319999999999993 109.266 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.552 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 75.6 mm-40 -83.98 -41.71 17.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.476 1.11 . . . . 74.219999999999999 110.257 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -70.49 -23.16 62.63 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.432 1.082 . . . . 75.329999999999998 110.33 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.669 ' HE1' HD11 ' A' ' 246' ' ' ILE . 2.6 t90 -78.52 -59.99 2.56 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.501 1.125 . . . . 74.439999999999998 108.013 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.427 ' HA ' ' CG1' ' A' ' 246' ' ' ILE . 7.0 ptmm? -59.62 -17.44 33.48 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.116 . . . . 51.530000000000001 109.27 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.5 t -77.99 -26.51 48.69 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.59 1.181 . . . . 65.120000000000005 109.947 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -94.67 -26.06 16.48 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.48 1.113 . . . . 73.310000000000002 109.25 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.669 HD11 ' HE1' ' A' ' 242' ' ' TRP . 14.2 mm -40.68 -82.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.51 1.131 . . . . 73.409999999999997 109.351 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.545 ' N ' HG22 ' A' ' 246' ' ' ILE . . . -130.67 7.23 4.8 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.539 1.149 . . . . 71.109999999999999 109.336 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 250' ' ' LYS . 0.2 OUTLIER -101.6 -153.6 0.46 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.439 1.087 . . . . 74.239999999999995 110.29 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -47.14 94.85 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.481 1.113 . . . . 60.509999999999998 111.022 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 248' ' ' ARG . 0.0 OUTLIER -76.56 104.3 6.99 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.542 1.151 . . . . 75.140000000000001 109.268 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.22 124.7 20.32 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.492 1.12 . . . . 35.32 109.353 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 3.6 t -57.54 113.45 1.8 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.502 1.126 . . . . 75.319999999999993 109.956 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -171.15 170.14 6.21 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.47 1.106 . . . . 52.219999999999999 109.276 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 254' ' ' ILE . 6.5 tt -60.22 94.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.492 1.12 . . . . 71.439999999999998 109.25 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.72 135.81 35.13 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.562 1.164 . . . . 73.129999999999995 109.99 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 12.2 tp -95.03 -27.49 15.59 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.474 1.109 . . . . 54.229999999999997 109.327 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 106.17 -145.89 16.0 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.48 1.113 . . . . 72.140000000000001 110.972 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 7.6 t -163.25 134.83 4.95 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.547 0.793 . . . . 52.229999999999997 110.012 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.703 HG22 ' H ' ' A' ' 260' ' ' GLU . 2.4 p -93.12 -176.3 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.439 1.087 . . . . 74.310000000000002 109.282 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.703 ' H ' HG22 ' A' ' 259' ' ' VAL . 3.7 tm-20 . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.451 1.094 . . . . 74.409999999999997 110.256 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 N-CA-C 111.023 -0.831 . . . . 73.209999999999994 111.023 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 112.91 3.67 Favored 'Trans proline' 0 C--N 1.361 1.203 0 O-C-N 124.528 1.804 . . . . 71.430000000000007 111.017 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 7.0 mt -48.15 121.75 4.59 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.536 1.147 . . . . 65.349999999999994 109.411 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -160.02 49.72 0.38 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.539 1.15 . . . . 62.299999999999997 111.026 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.2 p -174.22 161.69 3.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.511 0.771 . . . . 65.329999999999998 110.076 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.751 ' HG ' HG11 ' A' ' 234' ' ' VAL . 9.2 mt -148.46 -171.08 3.76 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.549 1.155 . . . . 75.219999999999999 109.317 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.401 ' CG ' ' O ' ' A' ' 158' ' ' LEU . 25.0 m-85 -163.7 118.4 1.58 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.48 1.113 . . . . 73.030000000000001 110.975 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.574 ' HB2' HG12 ' A' ' 184' ' ' ILE . . . -106.25 167.35 9.88 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.505 1.128 . . . . 60.200000000000003 109.361 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.597 HG21 HD11 ' A' ' 215' ' ' ILE . 0.1 OUTLIER -137.48 129.24 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.44 1.087 . . . . 73.109999999999999 109.317 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.803 ' CG2' HD21 ' A' ' 182' ' ' LEU . 2.7 t -81.72 117.73 28.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.538 1.149 . . . . 73.439999999999998 109.273 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.553 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -96.18 -3.86 43.61 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.545 1.153 . . . . 44.310000000000002 109.268 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.731 ' O ' HG12 ' A' ' 162' ' ' VAL . 53.4 m-85 -153.6 153.88 33.17 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.472 1.108 . . . . 71.430000000000007 110.968 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.424 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 11.0 t0 -83.47 103.58 12.94 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.433 1.083 . . . . 74.120000000000005 109.287 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.584 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 1.9 t80 -85.25 125.22 32.71 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.119 . . . . 73.109999999999999 111.0 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.87 115.79 29.64 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.455 1.097 . . . . 64.400000000000006 109.335 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.669 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -40.31 140.55 0.61 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.456 1.098 . . . . 24.449999999999999 109.342 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.467 ' CG ' ' N ' ' A' ' 170' ' ' LYS . 7.9 pt-20 -136.88 -45.28 0.58 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.427 1.079 . . . . 73.430000000000007 110.236 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.467 ' N ' ' CG ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -64.47 -170.7 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.506 1.129 . . . . 73.329999999999998 109.307 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.62 -33.25 20.21 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.432 1.083 . . . . 62.549999999999997 109.273 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.39 9.3 29.83 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.509 1.13 . . . . 73.5 109.254 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.402 ' HB2' ' N ' ' A' ' 170' ' ' LYS . 3.2 mm-40 -75.43 159.89 30.86 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.524 1.14 . . . . 75.340000000000003 110.249 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.669 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 2.8 tp -138.33 159.6 41.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.457 1.098 . . . . 72.120000000000005 109.299 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.2 t -91.64 153.46 19.68 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.496 1.123 . . . . 73.439999999999998 110.389 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 177' ' ' TYR . 3.3 m -139.19 -164.39 1.65 Allowed 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.514 1.134 . . . . 64.140000000000001 110.345 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.685 ' H ' HG22 ' A' ' 176' ' ' THR . 30.9 m-85 -136.8 138.04 40.42 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.546 1.154 . . . . 71.239999999999995 110.972 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.463 ' CG2' ' N ' ' A' ' 179' ' ' GLY . 1.4 p -56.57 163.41 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.452 1.095 . . . . 73.530000000000001 109.285 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.463 ' N ' ' CG2' ' A' ' 178' ' ' VAL . . . 37.59 59.47 1.3 Allowed Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.474 1.109 . . . . 64.109999999999999 110.961 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.491 ' O ' HD13 ' A' ' 161' ' ' ILE . 13.2 tp10 -121.4 166.9 13.43 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.557 0.798 . . . . 73.349999999999994 110.338 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -120.51 122.29 40.3 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.455 1.097 . . . . 62.119999999999997 109.352 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.803 HD21 ' CG2' ' A' ' 162' ' ' VAL . 0.6 OUTLIER -147.0 163.65 35.53 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.103 . . . . 74.540000000000006 109.362 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.591 ' CE1' ' O ' ' A' ' 184' ' ' ILE . 2.2 t80 -110.63 139.12 46.19 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.457 1.098 . . . . 62.039999999999999 111.023 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.591 ' O ' ' CE1' ' A' ' 183' ' ' PHE . 9.6 mm -77.7 120.92 29.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.471 1.107 . . . . 73.549999999999997 109.227 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 5.6 t -91.45 -24.42 19.7 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.432 1.082 . . . . 75.450000000000003 108.27 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.782 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -164.8 179.65 6.39 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.501 1.126 . . . . 75.019999999999996 109.253 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.526 ' CE1' ' HG ' ' A' ' 190' ' ' CYS . 9.3 p80 -149.38 129.86 13.91 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.466 1.104 . . . . 74.099999999999994 109.571 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.655 ' CG ' HG11 ' A' ' 239' ' ' VAL . 0.0 OUTLIER -111.0 119.03 37.69 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.536 1.148 . . . . 72.510000000000005 109.633 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.433 ' C ' ' N ' ' A' ' 191' ' ' GLU . 3.5 m120 54.0 32.82 16.21 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.48 1.112 . . . . 71.129999999999995 109.325 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.526 ' HG ' ' CE1' ' A' ' 187' ' ' HIS . 49.9 m 42.1 29.04 0.12 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 74.209999999999994 108.3 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.575 ' HG3' ' CD1' ' A' ' 192' ' ' TRP . 6.4 pt-20 -120.94 -38.04 2.89 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.509 1.131 . . . . 73.120000000000005 110.312 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.651 ' CB ' ' CD2' ' A' ' 188' ' ' HIS . 27.7 m0 -116.87 164.42 14.7 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.126 . . . . 74.25 107.987 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.724 ' HB2' HG13 ' A' ' 207' ' ' VAL . 39.5 m-85 -141.94 168.93 18.58 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.542 1.151 . . . . 75.400000000000006 110.995 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.782 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 47.0 mm -103.55 109.07 25.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.544 1.153 . . . . 53.439999999999998 109.324 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.748 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -116.57 163.78 15.58 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.488 1.117 . . . . 65.329999999999998 109.321 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.76 78.71 0.24 Allowed Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.483 1.114 . . . . 75.430000000000007 109.267 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 -165.67 0.3 Allowed 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.499 1.789 . . . . 52.329999999999998 110.987 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 96.7 mt -90.1 89.82 3.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.47 1.106 . . . . 72.150000000000006 109.363 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -140.26 -62.82 0.04 OUTLIER Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.571 1.17 . . . . 73.25 111.036 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 9.5 ttt85 -126.28 172.4 10.13 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.536 0.786 . . . . 72.129999999999995 110.278 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.554 ' O ' HD13 ' A' ' 201' ' ' LEU . 0.8 OUTLIER -84.85 -19.2 32.76 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.482 1.114 . . . . 53.030000000000001 109.231 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -60.56 -152.48 0.02 OUTLIER Glycine 0 CA--C 1.529 0.935 0 O-C-N 124.537 1.148 . . . . 71.040000000000006 111.03 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 94.68 175.61 38.43 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.98 -0.848 . . . . 74.230000000000004 110.98 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.605 ' HB2' HG23 ' A' ' 194' ' ' ILE . 18.2 Cg_endo -74.95 179.42 30.67 Favored 'Cis proline' 0 C--N 1.36 1.181 0 C-N-CA 121.02 -2.492 . . . . 73.219999999999999 110.983 0.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -129.64 161.62 22.85 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.531 1.145 . . . . 52.43 110.967 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.566 ' CD2' ' CD1' ' A' ' 194' ' ' ILE . 9.3 mt -92.91 149.14 21.45 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.514 0.773 . . . . 64.219999999999999 109.272 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.91 HG21 HG11 ' A' ' 212' ' ' VAL . 0.6 OUTLIER -148.5 122.6 4.81 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.123 . . . . 73.430000000000007 109.32 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.584 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.6 Cg_endo -74.91 149.87 37.79 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.502 1.791 . . . . 62.439999999999998 111.026 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.417 ' HB ' ' CE2' ' A' ' 193' ' ' PHE . 5.0 p -63.71 -20.88 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 71.420000000000002 109.293 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -74.57 -0.91 60.01 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.446 1.091 . . . . 75.129999999999995 110.956 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.562 ' CD2' ' HB2' ' A' ' 166' ' ' PHE . 15.8 m-85 -129.8 3.32 4.93 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.491 0.759 . . . . 72.5 111.008 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.91 HG11 HG21 ' A' ' 207' ' ' VAL . 32.9 m -151.89 149.67 13.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 71.120000000000005 109.311 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.44 ' CB ' HD11 ' A' ' 163' ' ' LEU . 1.6 t -131.54 160.93 33.82 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.513 1.133 . . . . 75.519999999999996 109.966 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.827 HG13 HG23 ' A' ' 227' ' ' VAL . 32.1 mm -100.53 106.82 19.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.524 1.14 . . . . 75.349999999999994 109.295 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.597 HD11 HG21 ' A' ' 161' ' ' ILE . 11.0 pt -153.18 147.06 14.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.53 1.144 . . . . 75.140000000000001 109.275 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -61.32 -173.58 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.121 . . . . 60.020000000000003 109.235 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 41.2 mt -102.18 -39.96 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.563 1.164 . . . . 61.539999999999999 109.348 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -73.18 -173.82 1.41 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.464 1.102 . . . . 62.329999999999998 109.306 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 221' ' ' TYR . 25.8 m -47.91 -23.89 0.89 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.558 1.161 . . . . 75.409999999999997 110.432 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -53.17 88.75 0.01 OUTLIER Glycine 0 CA--C 1.531 1.075 0 O-C-N 124.446 1.091 . . . . 61.32 110.965 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.449 ' N ' ' O ' ' A' ' 219' ' ' THR . 2.8 m-85 -95.0 -171.17 2.36 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 124.604 0.826 . . . . 72.439999999999998 111.033 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 221' ' ' TYR . . . -40.41 111.45 0.2 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.45 1.093 . . . . 73.230000000000004 109.318 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 69.2 p -85.1 -16.99 38.71 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.458 1.099 . . . . 71.140000000000001 110.402 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 123.86 -18.03 7.6 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.64 1.212 . . . . 43.549999999999997 110.956 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -75.71 177.08 7.12 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.527 0.781 . . . . 71.140000000000001 109.288 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.15 -178.65 3.72 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.524 1.14 . . . . 44.340000000000003 109.332 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.936 HG13 HD12 ' A' ' 228' ' ' ILE . 3.0 p -79.02 -34.25 16.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.531 1.145 . . . . 61.140000000000001 109.336 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.936 HD12 HG13 ' A' ' 227' ' ' VAL . 2.1 mp -65.44 -56.85 13.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.483 1.114 . . . . 52.32 109.334 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -58.29 -21.43 48.89 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.489 1.118 . . . . 71.329999999999998 110.283 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.663 ' O ' HG13 ' A' ' 234' ' ' VAL . 59.0 m-20 -86.8 -34.96 19.38 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.426 1.079 . . . . 72.340000000000003 109.29 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.778 HG23 ' HB3' ' A' ' 236' ' ' LEU . 18.8 mt -64.81 -27.42 42.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.576 1.172 . . . . 61.32 109.338 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.445 ' HE2' HG22 ' A' ' 231' ' ' ILE . 6.3 mmpt? -83.99 -11.59 56.58 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.46 1.1 . . . . 71.310000000000002 109.318 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 68.5 m -95.12 -8.9 35.14 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.464 1.103 . . . . 70.209999999999994 110.019 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.751 HG11 ' HG ' ' A' ' 158' ' ' LEU . 1.0 OUTLIER -127.13 5.98 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.465 1.103 . . . . 72.209999999999994 109.27 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.437 ' N ' ' OD1' ' A' ' 235' ' ' ASN . 0.6 OUTLIER 47.91 30.33 1.94 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.45 1.093 . . . . 72.140000000000001 109.275 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.778 ' HB3' HG23 ' A' ' 231' ' ' ILE . 0.7 OUTLIER -43.95 118.4 2.96 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.408 1.068 . . . . 71.430000000000007 109.261 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 135.57 19.16 Favored 'Trans proline' 0 C--N 1.361 1.211 0 O-C-N 124.453 1.765 . . . . 64.439999999999998 110.977 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 187' ' ' HIS . 2.0 p -69.51 144.07 53.27 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.521 1.138 . . . . 74.430000000000007 110.376 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.655 HG11 ' CG ' ' A' ' 188' ' ' HIS . 7.6 p -51.0 -31.23 10.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.556 1.16 . . . . 70.310000000000002 109.298 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -76.76 -32.07 57.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.127 . . . . 63.329999999999998 110.305 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.405 ' CG ' ' OG1' ' A' ' 238' ' ' THR . 69.0 mt-10 -76.71 -30.01 56.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.517 1.136 . . . . 75.219999999999999 110.274 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.979 ' NE1' HD11 ' A' ' 246' ' ' ILE . 9.9 t90 -72.88 -54.89 7.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.499 1.124 . . . . 70.340000000000003 108.046 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.88 -29.02 69.29 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.547 1.154 . . . . 64.030000000000001 109.302 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 18.3 t -77.26 -41.25 41.72 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.563 1.164 . . . . 74.439999999999998 110.057 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -64.29 -31.86 73.23 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.529 1.143 . . . . 74.230000000000004 109.323 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.979 HD11 ' NE1' ' A' ' 242' ' ' TRP . 80.2 mt -71.45 -72.93 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.536 1.147 . . . . 74.420000000000002 109.264 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.454 ' O ' ' CB ' ' A' ' 248' ' ' ARG . . . -169.98 130.84 1.0 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.533 1.146 . . . . 65.010000000000005 109.258 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.454 ' CB ' ' O ' ' A' ' 247' ' ' ALA . 0.8 OUTLIER 161.99 -167.74 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.45 1.094 . . . . 54.219999999999999 110.238 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 250' ' ' LYS . 0.3 OUTLIER -102.75 175.84 5.36 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.498 1.124 . . . . 71.420000000000002 111.054 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.576 ' N ' ' CD1' ' A' ' 249' ' ' TYR . 12.7 tttp -151.55 161.61 42.39 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.488 1.117 . . . . 53.140000000000001 109.267 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.451 ' N ' ' CG ' ' A' ' 250' ' ' LYS . . . -161.77 140.33 9.41 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.422 1.076 . . . . 51.530000000000001 109.279 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 1.4 t -81.84 157.78 24.28 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 61.409999999999997 110.049 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -169.36 143.25 2.83 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.454 1.096 . . . . 71.010000000000005 109.317 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.537 HG23 ' O ' ' A' ' 254' ' ' ILE . 3.1 tp -113.54 104.85 17.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.496 1.122 . . . . 74.030000000000001 109.255 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.7 t -124.93 48.35 2.01 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.485 1.116 . . . . 74.219999999999999 109.972 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.549 HD23 ' C ' ' A' ' 256' ' ' LEU . 7.1 tt -147.65 118.68 7.69 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.441 1.088 . . . . 72.239999999999995 109.31 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -128.03 -164.0 11.49 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.581 1.176 . . . . 64.329999999999998 110.99 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.5 t -65.13 114.79 4.89 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.452 0.736 . . . . 71.409999999999997 110.059 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.7 p -109.84 75.74 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.487 1.117 . . . . 71.340000000000003 109.264 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 . . . . . 0 C--N 1.326 -0.444 0 O-C-N 124.535 1.147 . . . . 61.409999999999997 110.362 179.908 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.995 0 N-CA-C 111.017 -0.833 . . . . 63.409999999999997 111.017 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.572 ' HB2' HD12 ' A' ' 155' ' ' LEU . 18.5 Cg_endo -75.01 -91.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.499 1.789 . . . . 62.310000000000002 110.991 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.572 HD12 ' HB2' ' A' ' 154' ' ' PRO . 0.0 OUTLIER -117.76 -174.01 2.55 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.443 1.089 . . . . 75.219999999999999 109.308 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.515 ' HA2' HG23 ' A' ' 234' ' ' VAL . . . 126.71 -8.18 7.32 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.498 1.124 . . . . 71.409999999999997 110.995 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 36.6 t -131.66 161.53 32.53 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.514 0.773 . . . . 63.549999999999997 109.955 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.665 ' HG ' HG11 ' A' ' 234' ' ' VAL . 13.2 mt -138.56 131.35 29.4 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.449 1.093 . . . . 74.519999999999996 109.332 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.411 ' CD2' ' CE2' ' A' ' 183' ' ' PHE . 1.7 t80 -121.47 122.82 40.59 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.475 1.11 . . . . 72.349999999999994 111.021 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.655 ' HB2' HD13 ' A' ' 214' ' ' ILE . . . -117.82 170.84 8.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.564 1.165 . . . . 63.409999999999997 109.318 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.501 HG21 HD13 ' A' ' 215' ' ' ILE . 0.1 OUTLIER -142.29 126.69 16.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.479 1.112 . . . . 74.340000000000003 109.352 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.766 HG22 ' CZ ' ' A' ' 211' ' ' PHE . 18.1 t -72.04 133.99 30.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.546 1.154 . . . . 74.140000000000001 109.28 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.983 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.5 OUTLIER -113.9 0.33 14.39 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.441 1.088 . . . . 74.109999999999999 109.287 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.497 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 70.1 m-85 -144.66 147.02 32.57 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.581 1.175 . . . . 64.409999999999997 111.023 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -77.58 94.4 4.35 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.477 1.111 . . . . 71.209999999999994 109.298 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.502 ' CZ ' ' OE2' ' A' ' 173' ' ' GLU . 3.9 t80 -88.0 137.72 32.08 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.523 1.139 . . . . 71.120000000000005 110.97 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -119.85 103.38 9.3 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.469 1.106 . . . . 75.540000000000006 109.32 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.549 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -40.27 139.65 0.71 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.478 1.111 . . . . 51.420000000000002 109.278 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -123.73 -41.43 2.25 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.441 1.088 . . . . 63.340000000000003 110.236 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.32 -169.81 1.29 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.509 1.131 . . . . 74.329999999999998 109.304 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.29 -45.35 11.34 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.531 1.144 . . . . 54.509999999999998 109.279 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -94.43 26.59 3.33 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.455 1.097 . . . . 75.349999999999994 109.34 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.502 ' OE2' ' CZ ' ' A' ' 166' ' ' PHE . 2.9 mm-40 -96.82 140.88 30.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.473 1.108 . . . . 63.009999999999998 110.303 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.708 HD23 ' HA3' ' A' ' 205' ' ' GLY . 0.2 OUTLIER -102.53 160.07 14.88 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.545 1.153 . . . . 71.310000000000002 109.297 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.408 ' C ' ' OG1' ' A' ' 176' ' ' THR . 9.9 t -124.16 150.7 44.85 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.541 1.151 . . . . 61.43 110.426 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.684 HG22 ' H ' ' A' ' 177' ' ' TYR . 11.6 m -157.34 -177.11 6.36 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.516 1.135 . . . . 41.409999999999997 110.366 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.684 ' H ' HG22 ' A' ' 176' ' ' THR . 7.6 m-85 -121.03 156.7 31.62 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.46 1.1 . . . . 72.340000000000003 111.057 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 163' ' ' LEU . 1.8 p -59.83 131.25 24.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.559 1.162 . . . . 33.149999999999999 109.28 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 71.76 59.21 4.89 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.465 1.103 . . . . 51.539999999999999 111.032 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 162' ' ' VAL . 5.4 tp10 -122.16 165.76 15.64 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.563 0.802 . . . . 73.540000000000006 110.281 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.63 119.53 36.43 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 51.310000000000002 109.273 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.551 HD13 ' O ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -152.35 158.63 42.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.533 1.146 . . . . 44.219999999999999 109.318 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.42 ' O ' HD22 ' A' ' 182' ' ' LEU . 4.6 m-85 -107.04 170.64 7.83 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 44.210000000000001 110.996 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.934 HD12 ' HB3' ' A' ' 193' ' ' PHE . 32.5 mm -107.9 147.31 12.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.534 1.146 . . . . 62.030000000000001 109.241 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 186' ' ' ALA . 0.1 OUTLIER -106.26 -19.46 13.69 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.535 1.147 . . . . 73.230000000000004 108.313 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.646 ' HA ' HD11 ' A' ' 236' ' ' LEU . . . 179.64 179.63 0.48 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.554 1.159 . . . . 52.329999999999998 109.309 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.687 ' CD2' HG21 ' A' ' 231' ' ' ILE . 6.2 p80 -137.39 152.98 50.23 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.549 1.156 . . . . 75.049999999999997 109.583 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.637 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 1.0 OUTLIER -129.45 112.8 14.15 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.463 1.102 . . . . 75.519999999999996 109.584 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 3.1 m120 57.97 21.24 7.52 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.436 1.085 . . . . 73.120000000000005 109.343 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.583 ' HG ' ' CE1' ' A' ' 187' ' ' HIS . 87.1 m 55.34 19.74 3.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 1.139 . . . . 62.520000000000003 108.336 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 192' ' ' TRP . 3.9 pt-20 -115.94 -30.94 5.91 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.548 1.155 . . . . 62.25 110.299 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.574 ' HE3' HD22 ' A' ' 206' ' ' LEU . 8.5 m0 -116.25 158.99 22.49 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.959 -1.126 . . . . 74.400000000000006 107.959 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.934 ' HB3' HD12 ' A' ' 184' ' ' ILE . 12.8 m-85 -133.92 161.33 35.08 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.534 1.146 . . . . 64.340000000000003 110.96 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.586 HG13 ' HB3' ' A' ' 186' ' ' ALA . 17.7 mm -105.56 85.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.486 1.116 . . . . 55.530000000000001 109.323 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.736 ' CB ' HG11 ' A' ' 207' ' ' VAL . . . -67.48 160.16 28.12 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.481 1.113 . . . . 43.140000000000001 109.345 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.407 ' HB2' ' NZ ' ' A' ' 196' ' ' LYS . 0.0 OUTLIER -171.38 152.54 3.33 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.558 1.161 . . . . 72.219999999999999 109.306 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -164.33 0.23 Allowed 'Trans proline' 0 C--N 1.359 1.103 0 O-C-N 124.479 1.779 . . . . 52.329999999999998 110.994 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.9 tp -110.39 -20.71 6.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.496 1.123 . . . . 63.310000000000002 109.275 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -167.54 47.76 0.24 Allowed Glycine 0 CA--C 1.529 0.931 0 O-C-N 124.455 1.097 . . . . 61.130000000000003 111.027 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.7 tpp85 -138.14 159.36 42.23 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.403 0.708 . . . . 63.520000000000003 110.295 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.58 HD13 ' H ' ' A' ' 201' ' ' LEU . 0.0 OUTLIER -91.57 17.44 8.73 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.525 1.14 . . . . 45.439999999999998 109.241 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.406 ' O ' HD21 ' A' ' 174' ' ' LEU . . . -69.88 -51.16 25.63 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 124.531 1.145 . . . . 74.230000000000004 111.078 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -88.8 -179.54 46.04 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 111.019 -0.833 . . . . 74.430000000000007 111.019 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.474 ' HB2' ' CG2' ' A' ' 194' ' ' ILE . 18.4 Cg_endo -74.96 172.31 63.61 Favored 'Cis proline' 0 C--N 1.36 1.171 0 C-N-CA 120.95 -2.521 . . . . 32.329999999999998 111.011 -0.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.708 ' HA3' HD23 ' A' ' 174' ' ' LEU . . . -157.59 156.35 27.22 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.471 1.107 . . . . 73.340000000000003 110.947 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.574 HD22 ' HE3' ' A' ' 192' ' ' TRP . 3.1 mt -83.94 134.02 34.68 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.524 0.779 . . . . 73.430000000000007 109.262 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.736 HG11 ' CB ' ' A' ' 195' ' ' ALA . 2.0 m -143.34 151.92 56.04 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.544 1.153 . . . . 74.230000000000004 109.313 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.459 ' HG2' ' HB3' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -75.04 159.5 41.15 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.488 1.783 . . . . 53.030000000000001 111.003 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.69 HG23 ' HE2' ' A' ' 193' ' ' PHE . 3.0 p -84.85 -20.51 8.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.517 1.136 . . . . 65.400000000000006 109.22 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -82.47 11.84 49.22 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.5 1.125 . . . . 73.120000000000005 110.994 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.974 ' CD2' HG13 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -130.33 2.22 4.64 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.434 0.726 . . . . 73.019999999999996 110.943 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.974 HG13 ' CD2' ' A' ' 211' ' ' PHE . 14.3 m -137.8 145.8 28.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.456 1.098 . . . . 63.020000000000003 109.271 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.983 ' HB2' HD11 ' A' ' 163' ' ' LEU . 12.5 t -132.78 131.75 41.47 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 61.439999999999998 110.06 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.823 HG13 HG23 ' A' ' 227' ' ' VAL . 15.6 mm -83.77 149.73 4.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.113 . . . . 72.409999999999997 109.304 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 214' ' ' ILE . 18.9 pt -154.2 116.69 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 73.109999999999999 109.302 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -48.17 172.9 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.493 1.121 . . . . 51.219999999999999 109.261 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 217' ' ' ILE . 8.8 tp -71.24 109.4 3.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.512 1.132 . . . . 74.209999999999994 109.347 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -161.1 170.53 20.25 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.522 1.138 . . . . 74.329999999999998 109.343 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.427 ' CG2' ' CE2' ' A' ' 221' ' ' TYR . 1.7 t -55.16 -27.01 42.51 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 50.219999999999999 110.389 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 142.88 61.56 0.02 OUTLIER Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.531 1.144 . . . . 71.540000000000006 110.993 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.427 ' CE2' ' CG2' ' A' ' 219' ' ' THR . 17.3 m-85 -132.5 169.91 15.9 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 0.765 . . . . 74.540000000000006 110.992 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -117.15 129.4 55.93 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.51 1.131 . . . . 61.340000000000003 109.332 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 17.6 p -88.58 -34.3 17.38 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.454 1.096 . . . . 73.340000000000003 110.465 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 114.19 21.24 5.64 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.487 1.117 . . . . 63.210000000000001 110.957 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.487 ' ND2' ' N ' ' A' ' 225' ' ' ASN . 0.6 OUTLIER -84.16 171.95 12.36 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.488 0.758 . . . . 52.399999999999999 109.32 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.72 166.62 11.19 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.481 1.113 . . . . 72.439999999999998 109.335 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.823 HG23 HG13 ' A' ' 214' ' ' ILE . 11.2 p -78.92 -44.36 24.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.454 1.096 . . . . 73.219999999999999 109.278 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.637 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.3 mp -51.3 -53.25 16.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.607 1.192 . . . . 75.140000000000001 109.31 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -62.54 -32.76 73.76 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 64.439999999999998 110.275 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -73.91 -25.89 60.23 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.42 1.075 . . . . 71.010000000000005 109.255 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.687 HG21 ' CD2' ' A' ' 187' ' ' HIS . 42.0 mt -72.05 -34.79 51.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.519 1.137 . . . . 62.399999999999999 109.272 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.401 ' HE2' HG22 ' A' ' 231' ' ' ILE . 6.5 mmpt? -78.53 -29.84 46.69 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.466 1.104 . . . . 72.019999999999996 109.332 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.8 m -53.92 -40.78 67.0 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.472 1.108 . . . . 74.319999999999993 109.999 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.665 HG11 ' HG ' ' A' ' 158' ' ' LEU . 4.0 p -107.63 20.19 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.505 1.128 . . . . 74.430000000000007 109.287 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 41.94 28.86 0.1 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.532 1.145 . . . . 72.329999999999998 109.329 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.646 HD11 ' HA ' ' A' ' 186' ' ' ALA . 12.2 tp -47.16 115.53 3.56 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 75.430000000000007 109.281 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.01 147.15 33.51 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.551 1.816 . . . . 72.319999999999993 111.036 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 2.7 p -57.09 149.36 19.5 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.526 1.141 . . . . 71.109999999999999 110.411 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.637 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.4 p -48.78 -28.58 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.528 1.142 . . . . 70.150000000000006 109.291 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.412 ' HG2' ' NE2' ' A' ' 188' ' ' HIS . 76.6 mm-40 -80.17 -45.83 17.42 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.489 1.118 . . . . 71.540000000000006 110.311 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -58.46 -30.07 66.67 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.451 1.094 . . . . 60.329999999999998 110.285 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -76.91 -62.22 1.72 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.511 1.132 . . . . 71.150000000000006 108.003 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.536 ' HA ' HD12 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -51.38 -25.8 6.72 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 73.409999999999997 109.319 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 45.8 t -76.89 -36.47 56.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.444 1.09 . . . . 70.420000000000002 110.052 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -75.08 -31.92 61.35 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.469 1.105 . . . . 60.109999999999999 109.302 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 243' ' ' LYS . 42.5 mt -45.16 110.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.431 1.082 . . . . 75.219999999999999 109.31 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -150.17 -177.02 5.69 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.463 1.102 . . . . 60.130000000000003 109.318 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.507 ' O ' ' C ' ' A' ' 249' ' ' TYR . 1.4 tpt85 -160.78 166.07 29.26 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 62.140000000000001 110.292 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.507 ' C ' ' O ' ' A' ' 248' ' ' ARG . 5.9 m-85 -29.1 96.31 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.418 1.074 . . . . 64.230000000000004 111.008 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 248' ' ' ARG . 16.8 mtpp -134.41 115.35 13.9 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.463 1.102 . . . . 73.439999999999998 109.279 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.07 112.35 0.66 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.536 1.147 . . . . 52.240000000000002 109.311 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 88.4 p -153.68 162.87 40.86 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 74.409999999999997 110.029 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -130.39 112.01 12.86 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.488 1.118 . . . . 74.540000000000006 109.304 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.466 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.8 OUTLIER -95.1 -35.95 6.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.409 1.068 . . . . 63.340000000000003 109.3 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 87.7 p -97.51 97.16 8.84 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.438 1.086 . . . . 45.530000000000001 109.998 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.523 HD13 ' N ' ' A' ' 257' ' ' GLY . 0.2 OUTLIER -108.88 122.73 47.81 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.541 1.151 . . . . 72.230000000000004 109.274 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.523 ' N ' HD13 ' A' ' 256' ' ' LEU . . . 62.04 143.36 0.01 OUTLIER Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.451 1.095 . . . . 65.040000000000006 110.966 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 3.1 m -149.26 125.59 10.85 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.511 0.771 . . . . 35.340000000000003 109.945 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -174.74 167.33 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.452 1.095 . . . . 64.310000000000002 109.355 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 . . . . . 0 C--N 1.325 -0.488 0 O-C-N 124.469 1.106 . . . . 64.109999999999999 110.271 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.681 HD11 ' HB3' ' A' ' 230' ' ' ASP . 6.0 tp . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 109.301 -0.629 . . . . 72.109999999999999 109.301 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.581 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 0.6 OUTLIER -147.8 160.57 42.6 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.521 1.138 . . . . 74.329999999999998 111.023 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.51 ' HB2' ' CD1' ' A' ' 214' ' ' ILE . . . -132.14 175.59 9.12 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 64.310000000000002 109.345 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.496 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -137.41 129.72 42.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.473 1.108 . . . . 60.539999999999999 109.334 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 164' ' ' TYR . 4.1 t -80.86 121.07 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.474 1.109 . . . . 63.32 109.329 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.466 HD11 ' CB ' ' A' ' 213' ' ' SER . 0.7 OUTLIER -100.33 -6.36 25.97 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.534 1.146 . . . . 70.219999999999999 109.28 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.64 ' O ' HG12 ' A' ' 162' ' ' VAL . 88.9 m-85 -148.58 151.65 35.42 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.115 . . . . 73.219999999999999 111.033 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -78.84 112.16 15.72 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.533 1.145 . . . . 52.299999999999997 109.328 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.557 ' CZ ' ' HD3' ' A' ' 208' ' ' PRO . 11.6 t80 -83.27 152.67 25.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.532 1.145 . . . . 72.450000000000003 111.032 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -125.75 116.35 21.48 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.483 1.114 . . . . 75.219999999999999 109.292 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.15 121.42 12.47 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.556 1.16 . . . . 64.200000000000003 109.256 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 170' ' ' LYS . 9.9 pt-20 -110.63 -46.15 3.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.509 1.131 . . . . 73.319999999999993 110.309 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -63.42 179.51 0.44 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.534 1.146 . . . . 74.430000000000007 109.31 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.11 -15.18 41.96 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.551 1.157 . . . . 75.239999999999995 109.317 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.82 10.19 10.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.471 1.107 . . . . 73.400000000000006 109.378 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -77.63 151.34 34.39 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.508 1.13 . . . . 44.409999999999997 110.348 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.642 HD11 ' HA2' ' A' ' 203' ' ' GLY . 14.4 mt -120.75 145.74 47.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.449 1.093 . . . . 65.209999999999994 109.247 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.2 m -88.03 154.33 20.57 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.47 1.107 . . . . 43.420000000000002 110.396 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.69 HG22 ' H ' ' A' ' 177' ' ' TYR . 5.8 m -135.92 -174.57 3.7 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.555 1.159 . . . . 73.109999999999999 110.372 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.69 ' H ' HG22 ' A' ' 176' ' ' THR . 24.5 m-85 -134.13 138.43 45.22 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.461 1.101 . . . . 75.209999999999994 111.01 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 163' ' ' LEU . 1.5 p -55.25 158.32 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.438 1.086 . . . . 55.530000000000001 109.228 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 38.94 57.63 1.99 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.508 1.13 . . . . 42.219999999999999 111.01 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 15.0 tp10 -121.83 166.34 14.52 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.423 0.719 . . . . 53.340000000000003 110.287 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.546 HD22 ' N ' ' A' ' 181' ' ' ASN . 1.5 m-80 -118.58 130.22 55.77 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.438 1.086 . . . . 61.350000000000001 109.268 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.62 HD21 ' CG2' ' A' ' 162' ' ' VAL . 1.8 pp -157.0 -179.73 8.49 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 75.239999999999995 109.297 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -131.45 142.28 49.97 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.428 1.08 . . . . 62.509999999999998 111.024 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.766 HD12 ' HB3' ' A' ' 193' ' ' PHE . 23.3 mm -78.53 141.44 15.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.452 1.095 . . . . 75.340000000000003 109.337 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 3.4 t -103.49 -24.71 13.42 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.504 1.128 . . . . 64.510000000000005 108.294 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.853 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -170.11 179.53 3.5 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.505 1.128 . . . . 72.319999999999993 109.33 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 238' ' ' THR . 7.7 p80 -145.53 142.24 29.01 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 74.420000000000002 109.581 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.637 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.6 t-160 -123.72 120.66 33.34 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.475 1.109 . . . . 63.310000000000002 109.599 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.453 ' C ' ' N ' ' A' ' 191' ' ' GLU . 14.8 m-20 54.14 30.1 11.55 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.119 . . . . 75.540000000000006 109.256 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 11.9 p 43.51 28.29 0.19 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.502 1.126 . . . . 55.25 108.29 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.453 ' N ' ' C ' ' A' ' 189' ' ' ASN . 8.7 pt-20 -123.88 -36.76 2.68 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.491 1.119 . . . . 62.43 110.28 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.53 ' HZ3' HD13 ' A' ' 206' ' ' LEU . 9.0 m0 -110.55 158.52 18.45 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.443 1.089 . . . . 74.420000000000002 108.1 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.766 ' HB3' HD12 ' A' ' 184' ' ' ILE . 8.5 m-85 -131.12 148.49 52.73 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.502 1.126 . . . . 50.229999999999997 110.983 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.864 ' CD1' HD23 ' A' ' 206' ' ' LEU . 12.7 mm -96.34 88.89 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.495 1.122 . . . . 73.109999999999999 109.291 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.469 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -71.04 164.1 26.23 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.506 1.129 . . . . 71.209999999999994 109.315 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.586 1.179 . . . . 74.349999999999994 109.311 179.92 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.642 ' HA2' HD11 ' A' ' 174' ' ' LEU . . . . . . . . 0 CA--C 1.531 1.033 0 N-CA-C 110.949 -0.86 . . . . 61.399999999999999 110.949 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -178.65 24.09 Favored 'Cis proline' 0 C--N 1.361 1.201 0 C-N-CA 121.013 -2.495 . . . . 75.530000000000001 110.941 0.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -149.13 166.13 29.42 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 124.499 1.124 . . . . 62.340000000000003 110.977 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.864 HD23 ' CD1' ' A' ' 194' ' ' ILE . 6.6 mt -93.51 134.34 35.89 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.61 0.829 . . . . 75.049999999999997 109.253 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.469 HG11 ' HB2' ' A' ' 195' ' ' ALA . 1.8 m -139.1 153.9 71.86 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.537 1.148 . . . . 70.150000000000006 109.284 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.568 ' HG2' ' CD2' ' A' ' 211' ' ' PHE . 18.2 Cg_endo -74.98 155.33 43.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.526 1.803 . . . . 72.099999999999994 110.974 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.678 HG23 ' HE2' ' A' ' 193' ' ' PHE . 3.6 p -81.39 -33.66 12.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.409 1.068 . . . . 64.310000000000002 109.263 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -64.77 -11.03 48.26 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.5 1.125 . . . . 40.43 110.949 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.568 ' CD2' ' HG2' ' A' ' 208' ' ' PRO . 8.2 m-30 -109.89 19.74 18.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.493 0.76 . . . . 74.019999999999996 110.974 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.595 HG21 ' CD2' ' A' ' 193' ' ' PHE . 26.9 m -156.16 141.95 10.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.442 1.089 . . . . 73.010000000000005 109.275 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.466 ' CB ' HD11 ' A' ' 163' ' ' LEU . 1.0 OUTLIER -131.06 148.86 52.79 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.475 1.109 . . . . 73.109999999999999 110.017 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.758 HG13 HG23 ' A' ' 227' ' ' VAL . 12.1 mm -103.95 128.25 57.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.527 1.142 . . . . 75.430000000000007 109.346 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.429 ' O ' ' CE2' ' A' ' 159' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.11 . . . . 54.509999999999998 109.277 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 17.9 p . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 110.382 -0.229 . . . . 61.340000000000003 110.382 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 116.23 4.93 17.69 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 124.481 1.113 . . . . 65.340000000000003 110.928 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.652 ' N ' HD22 ' A' ' 225' ' ' ASN . 0.9 OUTLIER -78.19 -176.32 4.56 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.432 0.724 . . . . 61.32 109.292 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.1 169.88 14.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.554 1.159 . . . . 73.109999999999999 109.273 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.758 HG23 HG13 ' A' ' 214' ' ' ILE . 12.1 p -80.77 -35.28 14.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.474 1.109 . . . . 61.350000000000001 109.254 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.572 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.4 mp -54.16 -50.37 55.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.517 1.136 . . . . 61.100000000000001 109.301 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -59.55 -35.61 74.55 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 74.219999999999999 110.295 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.681 ' HB3' HD11 ' A' ' 158' ' ' LEU . 5.0 m-20 -78.1 -22.93 48.21 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.468 1.105 . . . . 75.019999999999996 109.299 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.745 HG23 ' HB3' ' A' ' 236' ' ' LEU . 35.5 mt -70.61 -36.8 67.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.585 1.178 . . . . 62.210000000000001 109.266 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.625 ' HE2' HG22 ' A' ' 231' ' ' ILE . 6.1 mmpt? -80.72 -13.98 58.52 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.572 1.17 . . . . 73.400000000000006 109.309 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.7 t -81.18 -44.39 17.91 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.526 1.141 . . . . 72.019999999999996 109.998 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.646 HG12 ' O ' ' A' ' 230' ' ' ASP . 7.7 p -99.17 24.25 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.494 1.121 . . . . 40.240000000000002 109.343 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 41.36 29.13 0.08 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.534 1.146 . . . . 73.310000000000002 109.338 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.745 ' HB3' HG23 ' A' ' 231' ' ' ILE . 1.1 tp -45.21 103.75 0.36 Allowed Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.106 . . . . 73.209999999999994 109.286 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 138.19 22.64 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.561 1.822 . . . . 62.25 111.049 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 7.4 p -57.01 148.88 20.27 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 72.409999999999997 110.411 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.637 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 3.5 p -53.99 -25.43 12.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.535 1.147 . . . . 63.219999999999999 109.323 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.547 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 3.8 mm100 -77.82 -34.36 51.99 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.407 1.067 . . . . 51.229999999999997 110.319 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -82.74 -20.87 35.11 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.553 1.158 . . . . 75.319999999999993 110.303 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -80.09 -53.25 6.88 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.516 1.135 . . . . 72.430000000000007 108.022 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -51.61 -28.17 13.42 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.527 1.142 . . . . 62.100000000000001 109.272 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.7 t -73.64 -35.2 65.26 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.451 1.094 . . . . 73.310000000000002 109.999 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.497 1.123 . . . . 74.219999999999999 109.281 -179.989 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.812 ' HG ' HG11 ' A' ' 234' ' ' VAL . 6.5 mt . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 109.301 -0.629 . . . . 64.329999999999998 109.301 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.43 ' CG ' ' C ' ' A' ' 158' ' ' LEU . 35.9 m-85 -154.65 116.73 4.22 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.466 1.104 . . . . 75.040000000000006 111.053 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.481 ' HB2' HD13 ' A' ' 214' ' ' ILE . . . -126.19 168.05 14.59 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.564 1.165 . . . . 51.149999999999999 109.382 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.543 HG21 HD11 ' A' ' 215' ' ' ILE . 0.1 OUTLIER -133.76 130.14 55.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.557 1.16 . . . . 74.010000000000005 109.385 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.843 HG23 HD11 ' A' ' 182' ' ' LEU . 39.7 t -89.66 111.22 22.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 53.200000000000003 109.304 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.64 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.2 OUTLIER -101.97 14.09 32.94 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.551 1.157 . . . . 52.030000000000001 109.287 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.57 ' HB3' ' CD2' ' A' ' 211' ' ' PHE . 63.5 m-85 -152.54 137.9 17.57 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.492 1.12 . . . . 73.049999999999997 111.031 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.417 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 25.8 t0 -80.16 107.96 13.37 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.482 1.114 . . . . 71.239999999999995 109.365 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.598 ' CE2' ' O ' ' A' ' 206' ' ' LEU . 17.1 t80 -80.33 136.58 36.43 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.517 1.136 . . . . 62.509999999999998 111.082 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.26 95.31 6.44 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.502 1.126 . . . . 62.439999999999998 109.316 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.777 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -57.86 133.4 55.4 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.563 1.164 . . . . 60.229999999999997 109.276 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -119.84 -38.63 2.94 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.523 1.139 . . . . 64.019999999999996 110.301 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.1 -177.96 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.517 1.135 . . . . 44.140000000000001 109.291 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.21 -29.95 22.78 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.459 1.099 . . . . 72.209999999999994 109.337 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.73 -11.62 28.76 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.423 1.077 . . . . 61.329999999999998 109.25 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.564 ' C ' ' HB1' ' A' ' 168' ' ' ALA . 8.6 mt-10 -74.74 134.4 41.88 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 75.329999999999998 110.263 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.777 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 5.4 mp -112.67 154.24 26.39 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.544 1.152 . . . . 72.409999999999997 109.329 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 175' ' ' THR . 14.9 t -91.65 115.82 28.37 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.503 1.127 . . . . 62.439999999999998 110.389 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.687 HG22 ' H ' ' A' ' 177' ' ' TYR . 6.0 m -94.0 -173.64 3.18 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.483 1.114 . . . . 71.209999999999994 110.384 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.687 ' H ' HG22 ' A' ' 176' ' ' THR . 37.3 m-85 -136.35 134.34 37.78 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.487 1.117 . . . . 72.430000000000007 110.996 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.625 HG23 ' C ' ' A' ' 163' ' ' LEU . 1.8 p -59.59 149.95 6.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.418 1.074 . . . . 74.340000000000003 109.286 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 68.22 36.77 85.71 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.505 1.128 . . . . 62.020000000000003 111.002 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.494 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 21.7 tp10 -113.42 165.02 12.86 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.527 0.781 . . . . 73.310000000000002 110.295 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.693 ' C ' HD13 ' A' ' 182' ' ' LEU . 2.7 m-80 -129.24 134.68 48.09 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.414 1.071 . . . . 73.549999999999997 109.332 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.843 HD11 HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -167.2 164.48 15.57 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.542 1.151 . . . . 74.109999999999999 109.363 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.566 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 0.6 OUTLIER -99.69 148.08 24.73 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.592 1.183 . . . . 70.25 110.958 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.625 HD12 ' HB3' ' A' ' 193' ' ' PHE . 24.2 mm -77.7 112.9 16.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.49 1.119 . . . . 53.240000000000002 109.296 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.459 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 0.5 OUTLIER -73.87 -27.56 61.13 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.476 1.11 . . . . 33.439999999999998 108.261 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.829 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -171.3 179.58 2.93 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.533 1.146 . . . . 73.150000000000006 109.289 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.522 ' NE2' HG21 ' A' ' 231' ' ' ILE . 9.2 p80 -143.28 143.58 31.77 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.545 1.153 . . . . 61.420000000000002 109.594 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.469 ' HB2' ' CG1' ' A' ' 239' ' ' VAL . 0.1 OUTLIER -124.01 121.58 35.64 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.483 1.115 . . . . 74.140000000000001 109.628 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.466 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 2.5 t-20 53.6 30.59 11.08 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.484 1.115 . . . . 74.409999999999997 109.309 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 13.1 p 42.68 29.0 0.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.125 . . . . 73.319999999999993 108.269 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.604 ' O ' HG12 ' A' ' 209' ' ' VAL . 13.3 pt-20 -123.38 -37.49 2.67 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 75.019999999999996 110.245 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.469 ' CD1' ' HG3' ' A' ' 191' ' ' GLU . 15.8 m0 -112.37 160.48 17.66 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.546 1.154 . . . . 73.439999999999998 107.989 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.859 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 21.0 m-85 -136.81 161.16 36.74 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.502 1.126 . . . . 74.219999999999999 111.016 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.829 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 9.5 mm -97.77 108.53 21.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.456 1.098 . . . . 73.010000000000005 109.317 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.681 ' CB ' HG21 ' A' ' 207' ' ' VAL . . . -99.42 167.98 10.28 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.525 1.14 . . . . 54.420000000000002 109.271 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? . . . . . 0 C--N 1.325 -0.468 0 O-C-N 124.429 1.081 . . . . 73.549999999999997 109.287 179.961 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.004 0 N-CA-C 111.091 -0.803 . . . . 70.120000000000005 111.091 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.472 ' CB ' ' O ' ' A' ' 195' ' ' ALA . 18.4 Cg_endo -75.03 -173.7 12.81 Favored 'Cis proline' 0 C--N 1.36 1.176 0 C-N-CA 121.0 -2.5 . . . . 72.420000000000002 111.027 -0.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.13 172.38 20.71 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.503 1.127 . . . . 73.530000000000001 110.988 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.598 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 6.5 mt -99.4 134.8 41.75 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.484 0.755 . . . . 74.109999999999999 109.316 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.78 HG12 ' HD2' ' A' ' 208' ' ' PRO . 0.7 OUTLIER -134.43 144.27 50.31 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.504 1.128 . . . . 71.099999999999994 109.309 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.78 ' HD2' HG12 ' A' ' 207' ' ' VAL . 18.2 Cg_endo -74.94 138.84 23.73 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.51 1.795 . . . . 62.219999999999999 111.005 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.721 ' HA ' HG22 ' A' ' 212' ' ' VAL . 7.5 p -61.13 -34.78 61.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.46 1.1 . . . . 63.32 109.301 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -61.27 -13.01 34.11 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.557 1.16 . . . . 52.039999999999999 111.031 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 164' ' ' TYR . 4.4 m-85 -113.51 18.41 17.67 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.546 0.792 . . . . 73.099999999999994 111.026 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.721 HG22 ' HA ' ' A' ' 209' ' ' VAL . 11.3 m -153.62 153.58 8.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.499 1.124 . . . . 75.25 109.336 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.64 ' HB2' HD21 ' A' ' 163' ' ' LEU . 1.7 t -139.27 141.55 37.79 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.458 1.098 . . . . 72.129999999999995 110.018 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.63 HG13 HG23 ' A' ' 227' ' ' VAL . 17.6 mm -82.34 91.71 2.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.535 1.147 . . . . 73.409999999999997 109.27 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.543 HD11 HG21 ' A' ' 161' ' ' ILE . 1.6 pt . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.125 . . . . 54.509999999999998 109.364 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 72.0 p . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 120.562 0.22 . . . . 73.420000000000002 110.428 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.08 -1.22 22.7 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.467 1.104 . . . . 32.409999999999997 111.01 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -82.25 176.17 9.69 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.475 0.75 . . . . 63.210000000000001 109.261 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.44 171.73 9.72 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.458 1.099 . . . . 72.329999999999998 109.333 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.859 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 12.0 p -80.52 -40.27 19.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.47 1.106 . . . . 70.439999999999998 109.239 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.872 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.4 mp -51.04 -48.51 29.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.156 . . . . 73.340000000000003 109.301 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.03 -33.15 74.82 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.491 1.12 . . . . 55.520000000000003 110.25 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.626 ' O ' HD21 ' A' ' 158' ' ' LEU . 0.6 OUTLIER -76.89 -14.29 59.9 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.574 1.171 . . . . 71.099999999999994 109.292 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.872 HD12 ' HA ' ' A' ' 228' ' ' ILE . 34.6 mt -84.29 -32.4 8.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.483 1.114 . . . . 61.43 109.354 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -84.01 -18.73 36.12 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.421 1.076 . . . . 62.009999999999998 109.288 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 6.8 p -68.66 -29.01 67.39 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.527 1.142 . . . . 63.450000000000003 109.967 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.812 HG11 ' HG ' ' A' ' 158' ' ' LEU . 6.2 p -126.53 21.34 3.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.506 1.129 . . . . 72.299999999999997 109.318 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 40.68 29.74 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.559 1.162 . . . . 73.019999999999996 109.334 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.746 HD22 HD13 ' A' ' 158' ' ' LEU . 22.9 tp -42.11 113.34 1.2 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.521 1.138 . . . . 72.219999999999999 109.325 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 133.72 16.91 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.519 1.799 . . . . 71.239999999999995 110.956 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.522 HG22 ' CE1' ' A' ' 187' ' ' HIS . 9.4 p -57.12 151.56 15.1 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.513 1.133 . . . . 73.230000000000004 110.42 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.469 ' CG1' ' HB2' ' A' ' 188' ' ' HIS . 2.7 p -59.72 -24.89 30.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.549 1.156 . . . . 73.409999999999997 109.281 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -80.05 -28.59 39.22 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.455 1.097 . . . . 74.219999999999999 110.28 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -86.9 -25.06 24.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 74.099999999999994 110.233 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -76.75 -52.9 8.73 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.48 1.113 . . . . 63.399999999999999 108.001 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 32.5 pttt -48.1 -28.83 3.11 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.504 1.127 . . . . 65.310000000000002 109.35 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.6 t -81.32 -44.78 17.15 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.457 1.098 . . . . 32.229999999999997 109.98 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . 0.433 ' N ' HD22 ' A' ' 245' ' ' ASN . 1.3 m-80 . . . . . 0 C--N 1.325 -0.458 0 O-C-N 124.543 1.152 . . . . 70.450000000000003 109.26 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 1.075 HD12 HD12 ' A' ' 236' ' ' LEU . 8.2 mt . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 109.3 -0.63 . . . . 62.509999999999998 109.3 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.54 ' CG ' ' O ' ' A' ' 158' ' ' LEU . 76.3 m-85 -164.69 141.62 6.2 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.588 1.18 . . . . 73.120000000000005 111.064 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.731 ' HB3' HD11 ' A' ' 184' ' ' ILE . . . -135.44 130.26 34.5 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.539 1.149 . . . . 35.420000000000002 109.297 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.463 ' CG1' ' O ' ' A' ' 180' ' ' GLU . 1.3 tt -100.83 138.85 23.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.519 1.137 . . . . 73.25 109.28 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 164' ' ' TYR . 2.9 t -90.88 114.21 27.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.456 1.097 . . . . 72.420000000000002 109.275 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.653 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.1 OUTLIER -94.32 12.99 25.02 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.481 1.113 . . . . 63.149999999999999 109.296 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.614 ' O ' HG12 ' A' ' 162' ' ' VAL . 35.3 m-85 -157.98 131.27 7.61 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.562 1.163 . . . . 62.210000000000001 110.969 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -54.06 108.67 0.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 72.040000000000006 109.236 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.586 ' CE2' ' O ' ' A' ' 174' ' ' LEU . 5.7 t80 -80.46 136.71 36.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.447 1.092 . . . . 73.219999999999999 110.992 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -113.68 111.75 22.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.458 1.099 . . . . 61.140000000000001 109.259 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.682 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -63.53 121.65 14.37 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.534 1.146 . . . . 53.439999999999998 109.301 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.452 ' CG ' ' N ' ' A' ' 170' ' ' LYS . 14.7 pt-20 -116.62 -44.41 2.85 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.543 1.152 . . . . 64.310000000000002 110.256 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.473 ' CB ' ' HB2' ' A' ' 173' ' ' GLU . 0.8 OUTLIER -59.78 161.71 6.06 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.537 1.148 . . . . 72.409999999999997 109.324 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.76 -19.61 64.33 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.441 1.088 . . . . 63.219999999999999 109.262 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -124.44 25.22 7.71 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.415 1.072 . . . . 62.039999999999999 109.393 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.473 ' HB2' ' CB ' ' A' ' 170' ' ' LYS . 6.3 tp10 -85.11 157.92 20.55 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 1.118 . . . . 73.519999999999996 110.33 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.682 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -115.86 149.83 38.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.153 . . . . 72.010000000000005 109.335 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 11.6 t -107.72 137.97 44.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.511 1.132 . . . . 74.530000000000001 110.402 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.622 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.5 m -136.54 -164.39 1.56 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.551 1.157 . . . . 65.299999999999997 110.463 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.622 ' H ' HG22 ' A' ' 176' ' ' THR . 76.3 m-85 -140.62 150.49 43.64 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.433 1.083 . . . . 71.319999999999993 111.039 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.428 ' H ' HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -45.81 156.47 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.436 1.085 . . . . 65.519999999999996 109.313 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 37.51 63.81 0.79 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.518 1.136 . . . . 71.150000000000006 111.025 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.463 ' O ' ' CG1' ' A' ' 161' ' ' ILE . 26.5 tp10 -121.85 155.93 34.34 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.541 0.789 . . . . 70.040000000000006 110.321 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.457 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.5 OUTLIER -101.5 126.99 48.37 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.534 1.146 . . . . 71.219999999999999 109.335 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.444 HD12 HG21 ' A' ' 176' ' ' THR . 11.1 mt -146.79 153.21 39.93 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.463 1.102 . . . . 72.230000000000004 109.3 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -111.56 131.73 55.04 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.546 1.154 . . . . 73.439999999999998 111.016 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.731 HD11 ' HB3' ' A' ' 160' ' ' ALA . 31.7 mm -77.71 129.59 37.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 71.040000000000006 109.238 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 1.3 t -103.78 -25.45 13.1 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.457 1.098 . . . . 64.340000000000003 108.288 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.769 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -164.49 171.95 13.94 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.484 1.115 . . . . 63.130000000000003 109.298 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.423 ' CE1' HG21 ' A' ' 231' ' ' ILE . 8.5 p80 -140.23 145.27 37.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.519 1.137 . . . . 72.5 109.616 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.649 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.6 t-160 -122.97 118.28 27.44 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.569 1.168 . . . . 73.430000000000007 109.593 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.45 ' C ' ' N ' ' A' ' 191' ' ' GLU . 57.1 m-80 53.82 31.51 13.22 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.549 1.155 . . . . 52.210000000000001 109.258 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 12.7 p 42.96 28.62 0.14 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 72.400000000000006 108.244 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.45 ' N ' ' C ' ' A' ' 189' ' ' ASN . 6.1 pt-20 -122.54 -36.05 2.99 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.457 1.098 . . . . 72.549999999999997 110.279 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.467 ' HE3' HD22 ' A' ' 206' ' ' LEU . 9.1 m0 -114.07 159.91 19.48 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.486 1.116 . . . . 73.230000000000004 108.01 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.952 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 28.4 m-85 -130.35 157.38 42.73 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.423 1.077 . . . . 74.140000000000001 111.02 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.769 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 22.8 mm -103.44 111.56 33.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.459 1.099 . . . . 60.030000000000001 109.228 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 204' ' ' PRO . . . -98.08 154.85 17.44 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.589 1.181 . . . . 71.439999999999998 109.34 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt . . . . . 0 C--N 1.324 -0.503 0 O-C-N 124.467 1.104 . . . . 63.399999999999999 109.318 -179.953 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.962 0 N-CA-C 111.022 -0.831 . . . . 53.420000000000002 111.022 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 18.2 Cg_endo -75.03 125.38 11.24 Favored 'Cis proline' 0 C--N 1.362 1.241 0 C-N-CA 120.987 -2.506 . . . . 64.310000000000002 110.972 0.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -105.25 172.28 19.47 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.532 1.145 . . . . 62.539999999999999 110.972 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.65 HD23 ' CD1' ' A' ' 194' ' ' ILE . 3.8 mt -106.07 137.23 44.35 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.507 0.769 . . . . 70.349999999999994 109.258 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.76 HG21 HG11 ' A' ' 212' ' ' VAL . 0.1 OUTLIER -132.56 138.59 32.42 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.535 1.147 . . . . 70.049999999999997 109.327 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.57 ' HD3' ' CZ ' ' A' ' 166' ' ' PHE . 18.2 Cg_endo -75.01 144.58 30.37 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.463 1.77 . . . . 71.010000000000005 111.012 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.624 HG23 ' CE2' ' A' ' 193' ' ' PHE . 12.0 p -75.19 -21.84 16.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.545 1.153 . . . . 74.349999999999994 109.316 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -75.68 -7.8 83.7 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.488 1.118 . . . . 73.120000000000005 111.037 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -113.67 -11.2 12.99 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.447 0.733 . . . . 73.230000000000004 111.11 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.76 HG11 HG21 ' A' ' 207' ' ' VAL . 15.4 m -128.48 161.55 36.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.527 1.142 . . . . 73.450000000000003 109.302 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.653 ' HB2' HD21 ' A' ' 163' ' ' LEU . 6.3 t -149.88 153.17 36.25 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.47 1.106 . . . . 73.340000000000003 110.027 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.756 HG13 HG23 ' A' ' 227' ' ' VAL . 12.3 mm -96.46 121.42 46.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 124.546 1.154 . . . . 71.319999999999993 109.295 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.6 pt . . . . . 0 C--N 1.324 -0.535 0 O-C-N 124.514 1.134 . . . . 73.409999999999997 109.335 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.426 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 58.4 p . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 120.54 0.21 . . . . 64.239999999999995 110.447 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 154.08 -22.8 0.68 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.473 1.108 . . . . 71.299999999999997 111.033 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.426 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 21.4 m-80 -62.88 -175.95 0.11 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.45 0.735 . . . . 61.020000000000003 109.318 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -135.04 176.98 8.17 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.47 1.106 . . . . 70.200000000000003 109.254 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.952 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 8.3 p -79.6 -32.95 14.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.524 1.14 . . . . 71.519999999999996 109.342 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.834 HD12 HG13 ' A' ' 227' ' ' VAL . 1.5 mp -57.75 -49.23 81.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.43 1.081 . . . . 72.129999999999995 109.258 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -59.92 -28.89 67.99 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.447 1.092 . . . . 74.140000000000001 110.298 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.44 ' O ' HD11 ' A' ' 158' ' ' LEU . 0.8 OUTLIER -80.75 -31.21 36.02 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.546 1.154 . . . . 42.219999999999999 109.277 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.572 HD11 HG22 ' A' ' 227' ' ' VAL . 24.3 mt -72.72 -39.03 59.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.459 1.099 . . . . 71.120000000000005 109.281 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -76.22 -32.7 59.08 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.536 1.147 . . . . 52.210000000000001 109.258 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.4 m -55.65 -39.86 71.45 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 74.129999999999995 110.04 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.62 HG11 ' HG ' ' A' ' 158' ' ' LEU . 11.8 p -118.58 13.54 7.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.501 1.126 . . . . 50.43 109.316 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 231' ' ' ILE . 8.5 m120 40.46 43.06 1.44 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.542 1.151 . . . . 73.200000000000003 109.321 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 1.075 HD12 HD12 ' A' ' 158' ' ' LEU . 2.1 tt -40.28 140.01 0.99 Allowed Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.525 1.14 . . . . 74.400000000000006 109.306 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.515 ' HD2' HD23 ' A' ' 236' ' ' LEU . 18.2 Cg_endo -75.01 139.23 24.02 Favored 'Trans proline' 0 C--N 1.361 1.207 0 O-C-N 124.566 1.824 . . . . 62.039999999999999 110.996 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.404 HG22 ' CE1' ' A' ' 187' ' ' HIS . 2.3 p -75.13 152.14 38.52 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.504 1.127 . . . . 64.230000000000004 110.41 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.649 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.7 p -53.32 -23.09 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.525 1.14 . . . . 63.149999999999999 109.33 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.498 ' O ' ' CB ' ' A' ' 244' ' ' SER . 99.3 mm-40 -86.06 -50.14 7.26 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.46 1.1 . . . . 63.240000000000002 110.254 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -59.01 -28.91 66.83 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.536 1.147 . . . . 63.350000000000001 110.327 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.645 ' HZ3' HG21 ' A' ' 194' ' ' ILE . 22.0 t90 -80.42 -68.0 0.72 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.98 -1.119 . . . . 75.25 107.98 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.8 pttp -50.41 -23.25 2.28 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.516 1.135 . . . . 72.219999999999999 109.254 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 240' ' ' GLN . 11.3 t -68.57 -59.67 2.97 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.64 1.213 . . . . 72.420000000000002 110.047 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 4.6 m120 . . . . . 0 C--N 1.325 -0.465 0 O-C-N 124.542 1.151 . . . . 64.340000000000003 109.381 179.925 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.684 HD21 ' OD2' ' A' ' 230' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 109.33 -0.619 . . . . 53.520000000000003 109.33 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.541 ' CD2' ' HB3' ' A' ' 183' ' ' PHE . 6.0 m-85 -137.41 165.82 25.31 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.493 1.121 . . . . 72.310000000000002 110.985 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.422 ' HB1' ' HB ' ' A' ' 212' ' ' VAL . . . -125.66 150.7 47.38 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.51 1.131 . . . . 65.310000000000002 109.291 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.82 HD12 ' O ' ' A' ' 180' ' ' GLU . 1.0 OUTLIER -113.19 122.74 67.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.514 1.134 . . . . 63.520000000000003 109.287 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.761 HG21 ' CG2' ' A' ' 176' ' ' THR . 19.8 t -76.73 132.31 33.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 64.099999999999994 109.293 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 1.015 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.4 OUTLIER -110.25 -12.38 14.46 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 55.149999999999999 109.294 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.483 ' HB2' ' CD2' ' A' ' 211' ' ' PHE . 85.1 m-85 -143.06 151.57 40.93 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 72.120000000000005 110.939 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.642 ' N ' HG12 ' A' ' 178' ' ' VAL . 0.9 OUTLIER -78.96 104.67 9.75 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.468 1.105 . . . . 64.430000000000007 109.273 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.513 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 1.1 t80 -80.87 109.45 15.45 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 1.127 . . . . 72.219999999999999 110.992 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.485 ' CE ' ' OD2' ' A' ' 165' ' ' ASP . 13.8 mmtp -81.55 94.41 6.88 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.53 1.143 . . . . 65.310000000000002 109.276 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.662 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -43.96 124.4 3.79 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.406 1.066 . . . . 71.439999999999998 109.244 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -119.72 -38.66 2.95 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.493 1.12 . . . . 71.299999999999997 110.269 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.414 ' CB ' ' HB2' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -63.75 165.01 8.99 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.53 1.144 . . . . 74.25 109.29 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.85 -22.57 62.29 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.509 1.131 . . . . 72.409999999999997 109.334 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -117.9 25.25 10.5 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.514 1.134 . . . . 61.140000000000001 109.297 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.529 ' O ' HD22 ' A' ' 174' ' ' LEU . 5.1 tp10 -91.91 147.5 22.92 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.527 1.142 . . . . 74.519999999999996 110.373 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.662 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 0.4 OUTLIER -120.02 143.61 47.98 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.403 1.065 . . . . 65.219999999999999 109.287 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.6 t -81.59 143.72 31.77 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.502 1.126 . . . . 63.409999999999997 110.414 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.761 ' CG2' HG21 ' A' ' 162' ' ' VAL . 2.6 m -131.37 -176.75 4.13 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.469 1.105 . . . . 73.25 110.399 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.563 ' H ' HG22 ' A' ' 176' ' ' THR . 6.1 m-85 -130.46 155.48 46.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.468 1.105 . . . . 75.209999999999994 111.017 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.642 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.0 OUTLIER -68.09 156.02 7.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.545 1.153 . . . . 73.549999999999997 109.309 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.47 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 37.45 55.1 1.66 Allowed Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.524 1.14 . . . . 54.119999999999997 111.011 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.82 ' O ' HD12 ' A' ' 161' ' ' ILE . 14.9 tt0 -114.75 165.94 12.28 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.513 0.772 . . . . 63.340000000000003 110.307 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.477 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.0 OUTLIER -125.95 121.02 31.91 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.527 1.142 . . . . 72.319999999999993 109.269 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.423 ' C ' HD12 ' A' ' 182' ' ' LEU . 3.3 pp -140.63 168.27 20.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.462 1.101 . . . . 72.530000000000001 109.325 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.541 ' HB3' ' CD2' ' A' ' 159' ' ' TYR . 11.1 p90 -108.41 134.99 50.44 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.529 1.143 . . . . 63.450000000000003 110.965 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.708 HD12 ' HB3' ' A' ' 193' ' ' PHE . 22.9 mm -77.62 124.67 36.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.482 1.114 . . . . 75.450000000000003 109.304 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.464 ' HB2' HG22 ' A' ' 194' ' ' ILE . 39.7 m -88.59 -22.58 23.44 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.537 1.148 . . . . 71.430000000000007 108.316 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.774 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -172.6 179.19 2.5 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.522 1.139 . . . . 75.349999999999994 109.275 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.421 ' CE1' HG21 ' A' ' 231' ' ' ILE . 8.8 p80 -144.48 153.75 42.21 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.539 1.15 . . . . 73.319999999999993 109.616 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.463 ' HB2' ' CG1' ' A' ' 239' ' ' VAL . 0.2 OUTLIER -132.18 117.11 17.84 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 74.0 109.644 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.78 18.06 5.7 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.462 1.101 . . . . 71.430000000000007 109.319 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 4.0 m 57.92 18.62 5.16 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.452 1.095 . . . . 42.030000000000001 108.305 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.93 ' O ' HG23 ' A' ' 209' ' ' VAL . 11.6 pt-20 -115.97 -33.04 5.21 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.515 1.134 . . . . 71.140000000000001 110.284 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.472 ' HE3' HD22 ' A' ' 206' ' ' LEU . 12.9 m0 -112.58 158.47 19.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.568 1.167 . . . . 73.230000000000004 108.036 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 1.17 ' CE2' HG22 ' A' ' 209' ' ' VAL . 39.8 m-85 -134.44 163.55 29.43 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.466 1.104 . . . . 73.430000000000007 111.027 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.774 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 33.8 mm -105.97 120.67 57.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.596 1.185 . . . . 75.530000000000001 109.262 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.539 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -106.0 163.3 12.87 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.491 1.119 . . . . 74.540000000000006 109.353 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.418 ' HZ1' ' HD3' ' A' ' 204' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 74.25 109.295 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.03 0 N-CA-C 110.977 -0.849 . . . . 75.540000000000006 110.977 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.418 ' HD3' ' HZ1' ' A' ' 196' ' ' LYS . 18.1 Cg_endo -75.06 160.11 96.98 Favored 'Cis proline' 0 C--N 1.36 1.147 0 C-N-CA 121.006 -2.497 . . . . 73.340000000000003 110.926 0.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.428 ' HA3' ' CG ' ' A' ' 174' ' ' LEU . . . -120.13 -172.11 14.76 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.5 1.125 . . . . 45.340000000000003 111.006 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.577 HD23 ' CD1' ' A' ' 194' ' ' ILE . 4.4 mt -108.52 154.98 21.16 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.469 0.746 . . . . 53.340000000000003 109.321 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.746 HG21 HG11 ' A' ' 212' ' ' VAL . 0.2 OUTLIER -153.74 119.04 2.78 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.531 1.144 . . . . 54.329999999999998 109.241 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.513 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.5 Cg_endo -74.93 156.68 43.3 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.56 1.821 . . . . 74.109999999999999 111.027 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 1.17 HG22 ' CE2' ' A' ' 193' ' ' PHE . 7.1 t -68.68 -15.33 19.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.473 1.108 . . . . 61.25 109.319 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -72.88 -2.5 57.59 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.471 1.107 . . . . 61.240000000000002 110.998 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.483 ' CD2' ' HB2' ' A' ' 164' ' ' TYR . 29.0 m-85 -134.07 11.24 3.91 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.518 0.775 . . . . 73.409999999999997 111.024 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.746 HG11 HG21 ' A' ' 207' ' ' VAL . 14.9 m -148.26 143.99 19.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.508 1.13 . . . . 75.209999999999994 109.307 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 1.015 ' HB2' HD11 ' A' ' 163' ' ' LEU . 9.7 t -128.52 154.61 45.96 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.461 1.101 . . . . 53.420000000000002 110.024 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.689 HG13 HG23 ' A' ' 227' ' ' VAL . 31.6 mm -107.15 141.73 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.47 1.106 . . . . 65.310000000000002 109.279 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.457 1.098 . . . . 45.009999999999998 109.299 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 55.1 p . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.559 0.218 . . . . 75.25 110.427 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.87 -2.54 21.28 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.512 1.133 . . . . 74.099999999999994 111.06 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -69.47 171.93 8.01 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.535 0.785 . . . . 72.120000000000005 109.285 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.2 168.31 11.0 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.496 1.122 . . . . 71.409999999999997 109.281 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.883 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 10.4 p -78.47 -34.62 18.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.517 1.135 . . . . 63.43 109.293 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.748 HD12 HG13 ' A' ' 227' ' ' VAL . 1.3 mp -56.54 -50.94 71.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.585 1.178 . . . . 52.539999999999999 109.336 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -63.93 -31.95 73.31 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.541 1.151 . . . . 71.329999999999998 110.3 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.684 ' OD2' HD21 ' A' ' 158' ' ' LEU . 0.5 OUTLIER -70.33 -36.05 74.01 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.508 1.13 . . . . 72.120000000000005 109.307 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.421 HG21 ' CE1' ' A' ' 187' ' ' HIS . 23.0 mt -67.76 -43.03 86.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.496 1.123 . . . . 64.430000000000007 109.345 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 29.9 mmtt -74.36 -21.21 59.79 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.456 1.097 . . . . 64.530000000000001 109.251 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 36.9 m -66.75 -37.44 84.62 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.494 1.121 . . . . 74.099999999999994 109.985 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.468 HG11 ' HB2' ' A' ' 158' ' ' LEU . 14.5 p -116.46 11.67 7.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.527 1.142 . . . . 62.149999999999999 109.275 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 57.7 t30 40.48 43.95 1.62 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.549 1.156 . . . . 71.140000000000001 109.282 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.541 HD12 ' HD2' ' A' ' 237' ' ' PRO . 1.6 tp -52.07 142.87 25.94 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.54 1.15 . . . . 65.209999999999994 109.282 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.541 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.3 Cg_endo -74.97 154.1 42.4 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.473 1.775 . . . . 62.219999999999999 110.988 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.411 ' C ' ' N ' ' A' ' 240' ' ' GLN . 3.1 p -94.11 142.06 27.83 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.552 1.158 . . . . 75.329999999999998 110.375 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.463 ' CG1' ' HB2' ' A' ' 188' ' ' HIS . 2.7 p -47.04 -25.5 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.445 1.091 . . . . 62.200000000000003 109.301 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.411 ' N ' ' C ' ' A' ' 238' ' ' THR . 37.3 mm-40 -80.97 -40.92 23.63 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.524 1.14 . . . . 73.519999999999996 110.255 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 238' ' ' THR . 74.9 mt-10 -72.15 -23.44 61.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.526 1.141 . . . . 74.409999999999997 110.323 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.434 ' O ' ' N ' ' A' ' 245' ' ' ASN . 3.5 t90 -77.59 -71.59 0.41 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.532 1.145 . . . . 63.539999999999999 107.979 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.412 ' HB2' ' NZ ' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -44.02 -27.76 0.4 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.561 1.163 . . . . 74.049999999999997 109.259 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.42 ' N ' ' C ' ' A' ' 242' ' ' TRP . 3.0 t -73.58 -46.92 44.35 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 63.200000000000003 110.025 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 242' ' ' TRP . 16.5 t-20 . . . . . 0 C--N 1.326 -0.428 0 O-C-N 124.547 1.154 . . . . 72.140000000000001 109.254 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.779 HD11 HG11 ' A' ' 234' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 109.357 -0.609 . . . . 75.030000000000001 109.357 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -114.13 135.42 54.05 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.478 1.111 . . . . 72.540000000000006 111.011 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -124.31 163.91 20.71 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 71.200000000000003 109.291 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.655 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -132.69 128.75 57.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.52 1.137 . . . . 73.430000000000007 109.359 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 164' ' ' TYR . 3.0 t -86.93 109.51 19.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.478 1.111 . . . . 71.239999999999995 109.32 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.655 HD23 ' O ' ' A' ' 161' ' ' ILE . 0.1 OUTLIER -97.64 17.34 18.06 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.546 1.154 . . . . 70.219999999999999 109.308 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.691 ' O ' HG12 ' A' ' 162' ' ' VAL . 53.3 m-85 -164.56 147.67 8.93 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.557 1.161 . . . . 64.420000000000002 110.984 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.727 ' H ' HG22 ' A' ' 178' ' ' VAL . 0.2 OUTLIER -73.3 158.6 34.81 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.479 1.112 . . . . 74.409999999999997 109.304 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.602 ' CD1' ' N ' ' A' ' 167' ' ' LYS . 1.9 t80 -135.55 157.85 45.86 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.575 1.172 . . . . 73.109999999999999 111.041 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.602 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 21.5 mmtp -124.76 134.51 52.77 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.483 1.114 . . . . 53.020000000000003 109.294 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.74 ' HB1' ' HB3' ' A' ' 173' ' ' GLU . . . -99.98 124.07 44.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.487 1.117 . . . . 72.010000000000005 109.338 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -117.18 -34.37 4.38 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.496 1.123 . . . . 45.100000000000001 110.304 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -68.82 -179.79 1.55 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.447 1.092 . . . . 72.129999999999995 109.329 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.51 -29.68 22.54 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.474 1.109 . . . . 72.109999999999999 109.294 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.25 21.68 16.13 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.564 1.165 . . . . 71.519999999999996 109.278 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.812 ' O ' HD22 ' A' ' 174' ' ' LEU . 3.9 tt0 -93.44 159.27 15.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.446 1.091 . . . . 72.019999999999996 110.295 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.812 HD22 ' O ' ' A' ' 173' ' ' GLU . 4.6 mm? -133.0 147.18 52.28 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 74.439999999999998 109.289 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 12.2 t -98.21 145.74 26.31 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.484 1.115 . . . . 71.430000000000007 110.355 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.7 m -146.52 -178.11 5.99 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.49 1.119 . . . . 73.140000000000001 110.44 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.542 ' H ' HG22 ' A' ' 176' ' ' THR . 26.7 m-85 -128.97 -179.79 5.31 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.559 1.162 . . . . 74.409999999999997 111.038 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.727 HG22 ' H ' ' A' ' 165' ' ' ASP . 28.8 t -74.26 165.01 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.475 1.109 . . . . 73.319999999999993 109.316 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.464 ' N ' HG12 ' A' ' 178' ' ' VAL . . . 37.57 71.74 0.2 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.507 1.129 . . . . 53.299999999999997 111.023 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -121.91 154.2 37.44 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.488 0.758 . . . . 74.010000000000005 110.208 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -112.75 119.74 39.09 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.561 1.163 . . . . 75.400000000000006 109.327 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.561 ' C ' HD12 ' A' ' 182' ' ' LEU . 0.2 OUTLIER -160.64 -175.42 4.97 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.466 1.104 . . . . 74.099999999999994 109.343 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -133.1 147.2 52.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.134 . . . . 74.439999999999998 111.004 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.768 HD12 ' HB3' ' A' ' 193' ' ' PHE . 30.6 mm -77.62 128.35 38.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.487 1.117 . . . . 74.349999999999994 109.305 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.625 ' HB2' HG22 ' A' ' 194' ' ' ILE . 38.6 m -86.9 -34.38 19.42 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.541 1.151 . . . . 54.530000000000001 108.313 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.554 ' HA ' HD11 ' A' ' 236' ' ' LEU . . . -164.57 179.13 6.85 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.486 1.116 . . . . 73.450000000000003 109.239 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.429 ' CE1' HG21 ' A' ' 231' ' ' ILE . 6.1 p80 -139.85 148.69 42.47 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 73.109999999999999 109.604 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.645 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.8 t-160 -125.18 115.62 20.72 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.453 1.096 . . . . 74.200000000000003 109.569 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.437 ' C ' ' N ' ' A' ' 191' ' ' GLU . 79.6 m-20 53.72 33.1 15.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.438 1.086 . . . . 72.510000000000005 109.268 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 12.6 p 42.95 28.28 0.13 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.55 1.156 . . . . 61.200000000000003 108.297 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.437 ' N ' ' C ' ' A' ' 189' ' ' ASN . 4.4 pt-20 -121.81 -35.43 3.2 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.494 1.121 . . . . 74.109999999999999 110.324 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.825 ' HE3' HD22 ' A' ' 206' ' ' LEU . 10.7 m0 -115.9 165.94 12.53 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.497 1.123 . . . . 73.239999999999995 108.029 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.768 ' HB3' HD12 ' A' ' 184' ' ' ILE . 9.9 m-85 -137.75 155.66 48.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.556 1.16 . . . . 63.310000000000002 111.003 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.625 HG22 ' HB2' ' A' ' 185' ' ' CYS . 20.7 mm -102.14 83.73 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.512 1.132 . . . . 71.040000000000006 109.336 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.645 ' HB3' HG11 ' A' ' 207' ' ' VAL . . . -104.43 179.22 4.33 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.537 1.148 . . . . 62.439999999999998 109.317 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.438 ' HB3' ' CA ' ' A' ' 203' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.505 1.128 . . . . 73.140000000000001 109.323 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.438 ' CA ' ' HB3' ' A' ' 196' ' ' LYS . . . . . . . . 0 CA--C 1.531 1.035 0 N-CA-C 110.995 -0.842 . . . . 71.109999999999999 110.995 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 121.02 7.05 Favored 'Cis proline' 0 C--N 1.36 1.184 0 C-N-CA 121.039 -2.484 . . . . 73.400000000000006 110.977 -0.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.468 ' CA ' ' O ' ' A' ' 195' ' ' ALA . . . -96.92 132.37 10.97 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.537 1.148 . . . . 34.350000000000001 111.055 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.825 HD22 ' HE3' ' A' ' 192' ' ' TRP . 17.9 mt -88.72 125.43 34.85 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.488 0.758 . . . . 74.129999999999995 109.275 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.645 HG11 ' HB3' ' A' ' 195' ' ' ALA . 1.2 m -141.18 149.44 55.3 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.494 1.121 . . . . 73.140000000000001 109.293 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.515 ' HG2' ' CG ' ' A' ' 211' ' ' PHE . 18.2 Cg_endo -74.9 160.28 40.63 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.486 1.782 . . . . 73.340000000000003 111.043 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.675 HG23 ' HE2' ' A' ' 193' ' ' PHE . 3.3 p -81.9 -25.07 9.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.416 1.072 . . . . 72.040000000000006 109.282 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -73.78 -12.04 80.84 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.526 1.141 . . . . 63.140000000000001 111.026 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.515 ' CG ' ' HG2' ' A' ' 208' ' ' PRO . 8.6 m-30 -109.46 24.96 12.36 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.426 0.721 . . . . 75.430000000000007 111.019 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.603 HG21 ' CD2' ' A' ' 193' ' ' PHE . 32.6 m -157.0 145.06 11.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.488 1.118 . . . . 51.030000000000001 109.315 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.49 ' HB2' HD21 ' A' ' 163' ' ' LEU . 21.6 t -134.19 144.59 48.56 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.548 1.155 . . . . 64.519999999999996 109.962 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.478 HG13 HG23 ' A' ' 227' ' ' VAL . 16.3 mm -96.73 96.88 5.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.538 1.149 . . . . 74.519999999999996 109.266 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 1.8 pt . . . . . 0 C--N 1.325 -0.469 0 O-C-N 124.511 1.132 . . . . 62.439999999999998 109.327 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 61.1 p . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 110.395 -0.224 . . . . 72.120000000000005 110.395 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 105.32 -18.1 42.54 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.466 1.104 . . . . 72.239999999999995 111.003 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -58.15 -175.9 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.397 0.704 . . . . 71.340000000000003 109.312 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -123.74 172.68 8.66 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.492 1.12 . . . . 74.409999999999997 109.305 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.709 HG13 HD12 ' A' ' 228' ' ' ILE . 14.7 p -76.58 -38.61 31.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.468 1.105 . . . . 73.430000000000007 109.324 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.709 HD12 HG13 ' A' ' 227' ' ' VAL . 1.8 mp -53.59 -52.92 28.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 74.439999999999998 109.292 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -56.13 -34.93 66.55 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.476 1.11 . . . . 74.340000000000003 110.373 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.425 ' O ' HD21 ' A' ' 158' ' ' LEU . 0.6 OUTLIER -77.49 -26.96 51.75 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.431 1.082 . . . . 74.209999999999994 109.24 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.43 HD11 ' HE1' ' A' ' 193' ' ' PHE . 60.7 mt -71.5 -39.51 70.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.51 1.131 . . . . 60.109999999999999 109.326 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -29.56 60.21 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.477 1.111 . . . . 62.219999999999999 109.286 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 54.8 m -55.57 -44.87 77.28 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.491 1.119 . . . . 42.229999999999997 110.043 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.779 HG11 HD11 ' A' ' 158' ' ' LEU . 7.7 p -111.15 12.84 8.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.569 1.168 . . . . 71.239999999999995 109.309 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 13.7 m120 40.57 38.28 0.58 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.534 1.146 . . . . 70.239999999999995 109.313 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.933 HD12 ' HD2' ' A' ' 237' ' ' PRO . 3.9 tp -40.89 133.51 1.77 Allowed Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.405 1.066 . . . . 72.519999999999996 109.284 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.933 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.3 Cg_endo -75.06 131.89 14.74 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.479 1.779 . . . . 71.430000000000007 110.955 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.444 ' C ' ' N ' ' A' ' 240' ' ' GLN . 2.4 p -68.61 150.46 47.96 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.452 1.095 . . . . 71.109999999999999 110.348 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.645 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.1 p -40.41 -30.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.467 1.104 . . . . 62.450000000000003 109.281 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.444 ' N ' ' C ' ' A' ' 238' ' ' THR . 45.2 mm-40 -81.16 -56.12 4.29 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.474 1.109 . . . . 75.019999999999996 110.325 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -53.94 -22.03 9.32 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.531 1.145 . . . . 61.030000000000001 110.328 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -86.91 -60.46 1.98 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 64.140000000000001 108.046 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -23.48 2.78 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.573 1.171 . . . . 71.299999999999997 109.346 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 32.2 t -81.07 -62.25 1.72 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.491 1.119 . . . . 73.230000000000004 109.963 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.5 m120 . . . . . 0 C--N 1.325 -0.463 0 O-C-N 124.464 1.103 . . . . 63.530000000000001 109.315 179.992 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.729 HD11 HD13 ' A' ' 236' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.339 -0.615 . . . . 73.519999999999996 109.339 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.524 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 1.3 p90 -136.41 155.14 50.44 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.499 1.124 . . . . 74.340000000000003 110.948 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.835 ' HB3' HD11 ' A' ' 184' ' ' ILE . . . -121.59 142.16 50.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.468 1.105 . . . . 74.140000000000001 109.263 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.515 ' O ' ' CD2' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -110.29 133.72 54.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.557 1.161 . . . . 74.310000000000002 109.302 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.957 HG21 HG21 ' A' ' 176' ' ' THR . 2.0 t -76.27 132.17 33.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.511 1.132 . . . . 75.150000000000006 109.31 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.757 ' O ' HG23 ' A' ' 178' ' ' VAL . 0.2 OUTLIER -95.54 -31.56 13.26 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.495 1.122 . . . . 72.400000000000006 109.287 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.592 ' O ' HG12 ' A' ' 162' ' ' VAL . 15.4 m-85 -130.19 159.34 37.14 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.54 1.15 . . . . 74.349999999999994 110.983 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.64 97.49 5.12 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.531 1.144 . . . . 53.109999999999999 109.335 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.564 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 1.7 t80 -82.67 123.91 29.71 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.476 1.11 . . . . 64.329999999999998 110.967 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 168' ' ' ALA . 11.4 mmmm -101.93 105.47 16.27 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.493 1.12 . . . . 71.010000000000005 109.261 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.589 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -40.54 123.8 1.89 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.474 1.109 . . . . 70.409999999999997 109.321 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -113.72 -28.94 7.27 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.514 1.134 . . . . 64.230000000000004 110.302 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.52 177.79 8.61 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.498 1.124 . . . . 74.209999999999994 109.308 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.62 -14.06 43.84 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.582 1.176 . . . . 52.229999999999997 109.302 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -124.53 23.43 8.14 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.54 1.15 . . . . 73.219999999999999 109.233 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.458 ' HB3' ' HB1' ' A' ' 168' ' ' ALA . 3.3 tp10 -96.39 163.21 13.16 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 72.140000000000001 110.305 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.589 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 19.5 mt -127.46 153.48 46.25 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.515 1.134 . . . . 75.120000000000005 109.27 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.4 t -103.37 147.9 26.54 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.572 1.17 . . . . 74.019999999999996 110.448 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.957 HG21 HG21 ' A' ' 162' ' ' VAL . 2.4 m -138.44 -165.86 1.89 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.502 1.126 . . . . 73.519999999999996 110.378 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.638 ' H ' HG22 ' A' ' 176' ' ' THR . 69.7 m-85 -134.44 134.0 41.11 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.523 1.139 . . . . 71.299999999999997 111.001 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 163' ' ' LEU . 0.5 OUTLIER -41.42 143.33 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.487 1.117 . . . . 45.310000000000002 109.294 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 52.03 63.64 4.63 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.583 1.177 . . . . 64.329999999999998 111.019 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.436 ' CG ' ' HB2' ' A' ' 177' ' ' TYR . 6.0 mm-40 -122.15 160.93 24.08 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.433 0.725 . . . . 74.209999999999994 110.264 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -113.21 119.66 38.52 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.454 1.096 . . . . 62.210000000000001 109.345 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.451 ' CD2' ' HB1' ' A' ' 195' ' ' ALA . 1.2 mp -136.99 159.88 40.56 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.456 1.098 . . . . 74.129999999999995 109.322 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -108.09 128.89 55.08 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.561 1.163 . . . . 63.539999999999999 111.01 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.835 HD11 ' HB3' ' A' ' 160' ' ' ALA . 30.2 mm -77.62 128.53 38.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.527 1.142 . . . . 74.040000000000006 109.293 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 49.7 t -100.55 -23.15 14.76 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.48 1.112 . . . . 52.240000000000002 108.261 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.71 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -166.62 179.62 5.35 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.494 1.121 . . . . 72.319999999999993 109.306 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.431 ' CE1' HG21 ' A' ' 231' ' ' ILE . 8.2 p80 -146.28 157.81 43.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.452 1.095 . . . . 75.010000000000005 109.663 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.464 ' HB2' ' CG1' ' A' ' 239' ' ' VAL . 0.6 OUTLIER -134.48 115.3 13.8 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.463 1.102 . . . . 63.340000000000003 109.596 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.466 ' CB ' ' HG2' ' A' ' 191' ' ' GLU . 2.2 m-20 58.74 19.89 7.32 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.59 1.181 . . . . 72.340000000000003 109.31 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 23.4 m 57.36 18.78 4.59 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.551 1.157 . . . . 71.239999999999995 108.273 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.466 ' HG2' ' CB ' ' A' ' 189' ' ' ASN . 10.1 pt-20 -116.28 -33.0 5.12 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.122 . . . . 73.340000000000003 110.277 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.659 ' HE3' HD22 ' A' ' 206' ' ' LEU . 9.6 m0 -110.21 155.4 22.04 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 124.5 1.125 . . . . 73.129999999999995 108.004 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.811 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 24.9 m-85 -133.04 152.22 51.98 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.488 1.117 . . . . 75.109999999999999 111.06 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.71 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 27.8 mm -99.09 94.28 3.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.533 1.145 . . . . 64.209999999999994 109.315 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.496 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -75.38 154.73 37.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.436 1.085 . . . . 75.030000000000001 109.31 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm . . . . . 0 C--N 1.325 -0.493 0 O-C-N 124.406 1.066 . . . . 74.030000000000001 109.275 -179.982 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.432 ' HA2' HD11 ' A' ' 174' ' ' LEU . . . . . . . . 0 CA--C 1.53 0.986 0 N-CA-C 111.035 -0.826 . . . . 75.010000000000005 111.035 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.488 ' CB ' ' O ' ' A' ' 195' ' ' ALA . 18.3 Cg_endo -74.98 178.61 33.89 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 121.036 -2.485 . . . . 62.310000000000002 111.071 -0.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.56 ' N ' HD12 ' A' ' 174' ' ' LEU . . . -125.39 168.4 17.51 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.591 1.182 . . . . 71.219999999999999 111.016 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.659 HD22 ' HE3' ' A' ' 192' ' ' TRP . 2.5 mt -101.16 134.13 44.66 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.451 0.736 . . . . 44.439999999999998 109.223 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.798 HG21 HG11 ' A' ' 212' ' ' VAL . 0.1 OUTLIER -135.14 137.72 27.51 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.586 1.179 . . . . 61.119999999999997 109.299 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.568 ' HG2' ' CD1' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.92 148.85 36.24 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.542 1.811 . . . . 75.129999999999995 111.077 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.606 ' HA ' HG22 ' A' ' 212' ' ' VAL . 11.5 p -74.43 -14.06 15.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.504 1.128 . . . . 51.109999999999999 109.334 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . 0.52 ' C ' ' CD1' ' A' ' 211' ' ' PHE . . . -84.09 10.47 60.62 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.499 1.124 . . . . 45.43 111.053 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.568 ' CD1' ' HG2' ' A' ' 208' ' ' PRO . 17.3 m-85 -143.85 19.06 1.81 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.541 0.789 . . . . 70.310000000000002 111.001 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.798 HG11 HG21 ' A' ' 207' ' ' VAL . 30.8 m -145.68 147.94 17.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.524 1.14 . . . . 70.129999999999995 109.333 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 161' ' ' ILE . 46.5 t -130.74 152.44 50.09 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.594 1.184 . . . . 63.530000000000001 110.001 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.616 HG13 HG23 ' A' ' 227' ' ' VAL . 42.3 mm -106.26 161.07 5.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.527 1.142 . . . . 70.450000000000003 109.28 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.458 HG23 ' C ' ' A' ' 214' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.438 0 O-C-N 124.483 1.114 . . . . 74.209999999999994 109.235 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.43 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 18.1 p . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 110.399 -0.222 . . . . 51.210000000000001 110.399 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.52 10.21 11.85 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.466 1.103 . . . . 74.420000000000002 111.008 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.439 ' N ' HD22 ' A' ' 225' ' ' ASN . 1.8 m-80 -74.62 -177.02 2.99 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 0.755 . . . . 64.140000000000001 109.312 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.41 159.05 35.67 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.592 1.182 . . . . 55.020000000000003 109.291 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.811 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 12.6 p -78.05 -40.57 26.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 124.45 1.093 . . . . 73.310000000000002 109.337 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.687 HD12 HG13 ' A' ' 227' ' ' VAL . 2.1 mp -61.46 -46.39 96.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.496 1.122 . . . . 64.340000000000003 109.391 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -64.99 -20.37 66.46 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.587 1.18 . . . . 74.150000000000006 110.314 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -89.73 -31.65 17.35 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.125 . . . . 73.239999999999995 109.313 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.683 HD12 ' HA ' ' A' ' 228' ' ' ILE . 15.1 mt -66.49 -39.02 82.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.439 1.087 . . . . 75.209999999999994 109.261 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.484 ' HE2' HG22 ' A' ' 231' ' ' ILE . 6.1 mmpt? -76.33 -31.86 58.37 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.513 1.133 . . . . 72.510000000000005 109.283 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 6.6 p -57.0 -44.94 83.25 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.455 1.097 . . . . 70.150000000000006 110.032 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.678 HG12 HD21 ' A' ' 158' ' ' LEU . 3.4 p -106.11 13.13 8.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 124.518 1.136 . . . . 75.420000000000002 109.26 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 40.52 32.46 0.14 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.555 1.16 . . . . 71.420000000000002 109.247 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.729 HD13 HD11 ' A' ' 158' ' ' LEU . 2.1 tp -40.49 142.65 0.74 Allowed Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.498 1.124 . . . . 63.240000000000002 109.229 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.1 Cg_endo -75.03 170.74 19.75 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.624 1.855 . . . . 63.549999999999997 110.936 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 241' ' ' GLU . 1.4 p -113.21 143.14 44.9 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.461 1.101 . . . . 75.109999999999999 110.4 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 188' ' ' HIS . 2.5 p -45.33 -26.36 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.489 1.118 . . . . 64.310000000000002 109.266 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.402 ' N ' ' C ' ' A' ' 238' ' ' THR . 86.6 mm-40 -76.23 -43.36 42.48 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.477 1.111 . . . . 62.039999999999999 110.26 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 238' ' ' THR . 5.2 mm-40 -74.41 -21.7 59.51 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.528 1.142 . . . . 71.200000000000003 110.253 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.444 ' O ' ' N ' ' A' ' 245' ' ' ASN . 9.4 t90 -75.26 -62.36 1.59 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.958 -1.127 . . . . 71.340000000000003 107.958 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.7 pttm -50.45 -24.32 3.03 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.465 1.103 . . . . 71.439999999999998 109.275 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 2.6 t -88.07 -29.21 20.82 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.494 1.121 . . . . 70.340000000000003 110.007 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 242' ' ' TRP . 1.9 t30 . . . . . 0 C--N 1.325 -0.478 0 O-C-N 124.45 1.093 . . . . 75.540000000000006 109.246 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.475 ' HG ' HG11 ' A' ' 234' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 109.295 -0.631 . . . . 73.519999999999996 109.295 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.459 ' CG ' ' O ' ' A' ' 158' ' ' LEU . 10.3 m-85 -168.31 107.98 0.52 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.385 1.053 . . . . 72.340000000000003 111.041 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.409 ' HB2' HG12 ' A' ' 184' ' ' ILE . . . -106.58 129.44 54.51 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.518 1.136 . . . . 71.409999999999997 109.248 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.554 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -99.2 127.38 51.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.121 . . . . 63.399999999999999 109.319 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.594 ' CG2' ' CD2' ' A' ' 182' ' ' LEU . 2.2 t -87.25 119.31 34.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.54 1.15 . . . . 75.140000000000001 109.328 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.704 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.1 OUTLIER -112.33 17.67 19.19 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.428 1.08 . . . . 71.430000000000007 109.203 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.656 ' CE2' HD12 ' A' ' 163' ' ' LEU . 95.6 m-85 -155.89 148.91 24.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.437 1.086 . . . . 75.329999999999998 111.041 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.429 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 0.6 OUTLIER -87.47 106.74 18.19 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.475 1.11 . . . . 72.409999999999997 109.322 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.66 ' CD2' HG13 ' A' ' 207' ' ' VAL . 3.7 t80 -80.41 153.04 28.52 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.578 1.174 . . . . 74.239999999999995 110.965 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.531 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.9 mptt -115.51 115.39 26.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 72.049999999999997 109.316 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.811 ' HB1' ' OE1' ' A' ' 173' ' ' GLU . . . -56.47 126.59 27.17 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 1.138 . . . . 71.129999999999995 109.335 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.4 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 7.5 pt-20 -130.36 -35.53 1.53 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.481 1.113 . . . . 75.430000000000007 110.307 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.879 ' HD3' HD13 ' A' ' 206' ' ' LEU . 10.9 tttt -58.37 -163.26 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.448 1.093 . . . . 73.099999999999994 109.265 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.78 -50.65 5.93 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.526 1.141 . . . . 64.510000000000005 109.345 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.09 28.99 7.12 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.528 1.142 . . . . 73.340000000000003 109.324 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.811 ' OE1' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -60.27 -176.9 0.05 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.491 1.119 . . . . 74.239999999999995 110.325 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 174' ' ' LEU . 13.1 mt -151.8 132.54 14.05 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 72.019999999999996 109.269 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 175' ' ' THR . 15.2 t -78.82 114.1 17.47 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.504 1.128 . . . . 73.129999999999995 110.394 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.717 HG22 ' H ' ' A' ' 177' ' ' TYR . 5.6 m -102.34 -172.14 2.08 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.505 1.128 . . . . 74.040000000000006 110.382 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.717 ' H ' HG22 ' A' ' 176' ' ' THR . 11.1 m-85 -133.3 175.54 9.31 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.429 1.081 . . . . 64.349999999999994 110.979 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 163' ' ' LEU . 1.3 p -97.47 110.65 25.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 124.474 1.109 . . . . 62.509999999999998 109.287 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.46 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 99.23 51.12 1.37 Allowed Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.495 1.122 . . . . 72.340000000000003 111.028 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.404 ' HA ' ' OE1' ' A' ' 180' ' ' GLU . 3.4 mm-40 -115.6 169.38 9.23 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.49 0.759 . . . . 72.319999999999993 110.313 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.94 128.1 43.06 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 60.439999999999998 109.358 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.655 ' CD1' ' HB1' ' A' ' 195' ' ' ALA . 0.6 OUTLIER -167.02 172.7 9.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.454 1.097 . . . . 73.310000000000002 109.267 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -112.41 151.15 30.18 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.52 1.138 . . . . 72.129999999999995 110.97 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.813 HD12 ' HB3' ' A' ' 193' ' ' PHE . 48.1 mm -79.7 136.79 22.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.468 1.105 . . . . 72.310000000000002 109.275 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 9.1 t -101.5 -22.86 14.41 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.499 1.125 . . . . 73.310000000000002 108.328 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.885 ' HB3' HG13 ' A' ' 194' ' ' ILE . . . -173.7 172.26 3.61 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.497 1.123 . . . . 75.120000000000005 109.309 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.718 ' CE1' HG22 ' A' ' 238' ' ' THR . 6.6 p80 -133.67 145.48 49.97 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.475 1.11 . . . . 73.450000000000003 109.588 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.643 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.1 t-160 -123.02 116.33 23.35 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.53 1.144 . . . . 73.439999999999998 109.629 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.45 ' C ' ' N ' ' A' ' 191' ' ' GLU . 71.3 m-20 53.79 32.22 14.49 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.465 1.103 . . . . 53.329999999999998 109.275 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 12.8 p 42.96 28.41 0.13 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.53 1.143 . . . . 74.219999999999999 108.339 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.716 ' O ' HG12 ' A' ' 209' ' ' VAL . 5.6 pt-20 -121.99 -35.3 3.19 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.482 1.113 . . . . 72.010000000000005 110.294 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.437 ' N ' ' HG2' ' A' ' 191' ' ' GLU . 7.2 m0 -118.1 167.29 11.61 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.922 -1.14 . . . . 71.140000000000001 107.922 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.927 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 23.7 m-85 -141.78 161.58 37.59 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.492 1.12 . . . . 73.530000000000001 111.031 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.885 HG13 ' HB3' ' A' ' 186' ' ' ALA . 20.8 mm -99.65 122.9 52.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.51 1.131 . . . . 61.219999999999999 109.258 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.655 ' HB1' ' CD1' ' A' ' 182' ' ' LEU . . . -106.24 153.09 22.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.548 1.155 . . . . 42.450000000000003 109.281 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.4 tttp . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 71.420000000000002 109.255 179.982 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.992 0 N-CA-C 111.028 -0.829 . . . . 64.439999999999998 111.028 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 174.41 52.88 Favored 'Cis proline' 0 C--N 1.36 1.134 0 C-N-CA 121.013 -2.495 . . . . 63.240000000000002 111.026 0.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 194' ' ' ILE . . . -123.13 -173.68 14.11 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.491 1.119 . . . . 61.119999999999997 110.985 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.879 HD13 ' HD3' ' A' ' 170' ' ' LYS . 3.3 mp -115.06 156.08 25.83 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.566 0.803 . . . . 53.340000000000003 109.29 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.875 HG12 ' HD2' ' A' ' 208' ' ' PRO . 0.2 OUTLIER -150.99 147.27 20.37 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.455 1.097 . . . . 71.239999999999995 109.297 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.875 ' HD2' HG12 ' A' ' 207' ' ' VAL . 18.3 Cg_endo -75.02 141.49 26.65 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.551 1.816 . . . . 73.450000000000003 110.968 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.755 HG23 ' HE2' ' A' ' 193' ' ' PHE . 7.2 p -64.48 -37.72 80.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.563 1.164 . . . . 73.129999999999995 109.322 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -60.06 -13.93 29.55 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.483 1.114 . . . . 45.219999999999999 111.004 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 164' ' ' TYR . 5.9 m-85 -112.19 18.53 18.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.519 0.776 . . . . 73.209999999999994 110.94 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.736 HG22 ' HA ' ' A' ' 209' ' ' VAL . 10.5 m -153.43 143.63 14.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.52 1.137 . . . . 41.109999999999999 109.292 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.704 ' HB2' HD21 ' A' ' 163' ' ' LEU . 3.5 t -129.5 148.08 51.37 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.476 1.11 . . . . 64.400000000000006 110.006 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.723 HG13 HG23 ' A' ' 227' ' ' VAL . 25.8 mm -98.87 119.1 46.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.577 1.173 . . . . 71.040000000000006 109.327 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 4.0 pt . . . . . 0 C--N 1.325 -0.495 0 O-C-N 124.507 1.129 . . . . 72.219999999999999 109.358 179.986 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 60.9 p . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 120.54 0.209 . . . . 74.329999999999998 110.467 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 111.53 18.03 8.29 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.479 1.112 . . . . 73.530000000000001 110.993 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.569 ' N ' HD22 ' A' ' 225' ' ' ASN . 1.0 OUTLIER -79.93 175.39 10.67 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 0.758 . . . . 54.149999999999999 109.322 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -131.1 162.42 29.89 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.408 1.068 . . . . 74.319999999999993 109.307 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.927 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 11.4 p -77.92 -45.01 28.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.56 1.162 . . . . 74.409999999999997 109.278 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.835 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.0 mp -54.09 -44.85 64.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.5 1.125 . . . . 60.530000000000001 109.345 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -63.76 -28.78 70.11 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.481 1.113 . . . . 64.400000000000006 110.237 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.41 -19.87 35.2 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 74.310000000000002 109.328 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.91 HG23 ' HB3' ' A' ' 236' ' ' LEU . 37.8 mt -76.76 -36.53 26.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.511 1.132 . . . . 53.509999999999998 109.279 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.583 ' HE2' HG22 ' A' ' 231' ' ' ILE . 6.0 mmpt? -83.97 -12.02 55.95 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.107 . . . . 73.409999999999997 109.282 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.8 p -78.86 -41.67 29.35 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 71.25 109.961 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.475 HG11 ' HG ' ' A' ' 158' ' ' LEU . 7.7 p -108.72 26.28 2.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.527 1.142 . . . . 73.140000000000001 109.266 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 12.6 m120 45.6 26.21 0.31 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.518 1.136 . . . . 74.510000000000005 109.331 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.91 ' HB3' HG23 ' A' ' 231' ' ' ILE . 0.8 OUTLIER -43.91 103.8 0.34 Allowed Pre-proline 0 C--N 1.326 -0.433 0 O-C-N 124.484 1.115 . . . . 72.219999999999999 109.299 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 140.49 25.48 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.507 1.793 . . . . 64.319999999999993 111.0 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.718 HG22 ' CE1' ' A' ' 187' ' ' HIS . 15.7 p -57.66 155.69 9.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.551 1.157 . . . . 64.430000000000007 110.326 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.643 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 1.9 p -61.83 -21.04 24.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.458 1.099 . . . . 60.539999999999999 109.358 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.469 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 40.2 mm-40 -85.58 -26.23 26.25 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 75.549999999999997 110.286 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -84.3 -35.55 23.24 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.513 1.133 . . . . 73.219999999999999 110.291 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 245' ' ' ASN . 1.2 t90 -65.49 -52.07 55.42 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.001 -1.111 . . . . 72.439999999999998 108.001 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.484 ' HZ3' ' HB2' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -49.04 -33.32 11.13 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.435 1.084 . . . . 75.420000000000002 109.258 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.4 t -78.88 -30.23 44.88 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.441 1.088 . . . . 42.210000000000001 110.03 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 242' ' ' TRP . 5.4 t-20 . . . . . 0 C--N 1.324 -0.503 0 O-C-N 124.46 1.1 . . . . 43.329999999999998 109.223 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.718 ' HG ' HG11 ' A' ' 234' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 109.266 -0.642 . . . . 70.430000000000007 109.266 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 1.1 p90 -129.95 116.43 18.6 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.507 1.13 . . . . 75.109999999999999 111.003 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.483 ' CB ' HD11 ' A' ' 184' ' ' ILE . . . -95.23 132.37 40.27 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.529 1.143 . . . . 65.019999999999996 109.297 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.59 HD12 ' ND2' ' A' ' 181' ' ' ASN . 0.1 OUTLIER -108.43 130.41 61.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.119 . . . . 54.439999999999998 109.322 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 211' ' ' PHE . 2.2 t -81.33 122.11 35.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.499 1.124 . . . . 74.150000000000006 109.265 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.697 ' O ' HG23 ' A' ' 178' ' ' VAL . 0.7 OUTLIER -90.44 -26.14 19.99 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.485 1.115 . . . . 73.450000000000003 109.295 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.648 ' O ' HG12 ' A' ' 162' ' ' VAL . 44.6 m-85 -130.67 147.83 52.39 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.517 1.136 . . . . 71.530000000000001 111.023 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -61.06 108.42 0.88 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 75.540000000000006 109.309 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.605 ' CE2' ' O ' ' A' ' 174' ' ' LEU . 1.7 t80 -80.95 132.31 35.39 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.434 1.084 . . . . 74.109999999999999 110.983 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.602 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 0.4 OUTLIER -103.66 140.96 36.87 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.433 1.083 . . . . 44.350000000000001 109.322 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.822 ' HB1' ' CG ' ' A' ' 173' ' ' GLU . . . -84.34 126.58 33.34 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.514 1.134 . . . . 42.32 109.322 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.411 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 6.9 pt-20 -127.67 -33.65 2.27 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.506 1.129 . . . . 74.319999999999993 110.299 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.471 ' HD2' ' CD1' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -58.09 -164.43 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.504 1.128 . . . . 61.329999999999998 109.283 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.16 -51.56 5.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.469 1.106 . . . . 71.120000000000005 109.323 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -107.57 28.64 7.95 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.427 1.08 . . . . 71.329999999999998 109.288 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.822 ' CG ' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -59.73 177.94 0.19 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.503 1.127 . . . . 74.400000000000006 110.313 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.769 HD11 ' HA2' ' A' ' 203' ' ' GLY . 12.4 mt -145.09 133.2 21.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 1.137 . . . . 71.049999999999997 109.277 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.8 t -81.47 154.92 26.08 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 71.049999999999997 110.44 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.751 HG21 HG21 ' A' ' 162' ' ' VAL . 2.6 m -142.46 -165.44 2.04 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.529 1.143 . . . . 74.129999999999995 110.393 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.64 ' H ' HG22 ' A' ' 176' ' ' THR . 20.7 m-85 -143.86 137.92 28.27 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.525 1.141 . . . . 73.439999999999998 111.011 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 163' ' ' LEU . 0.7 OUTLIER -44.53 146.52 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.46 1.1 . . . . 72.109999999999999 109.315 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.455 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 52.67 60.55 7.77 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.494 1.121 . . . . 73.239999999999995 111.04 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 161' ' ' ILE . 7.0 mm-40 -118.51 166.21 12.97 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.518 0.775 . . . . 72.099999999999994 110.322 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.59 ' ND2' HD12 ' A' ' 161' ' ' ILE . 0.5 OUTLIER -126.09 136.37 52.83 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.483 1.114 . . . . 71.010000000000005 109.257 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.547 ' CD1' ' HB1' ' A' ' 195' ' ' ALA . 0.5 OUTLIER -167.19 157.83 11.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.452 1.095 . . . . 64.439999999999998 109.329 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.459 ' CD1' ' C ' ' A' ' 183' ' ' PHE . 6.8 p90 -99.54 150.48 22.18 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.447 1.092 . . . . 60.030000000000001 111.059 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.914 HD12 ' HB3' ' A' ' 193' ' ' PHE . 19.6 mm -88.93 133.41 31.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 124.489 1.118 . . . . 73.340000000000003 109.334 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.463 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 3.6 t -97.56 -27.73 14.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.409 1.068 . . . . 73.099999999999994 108.249 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.891 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -160.62 179.44 8.57 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.568 1.168 . . . . 72.030000000000001 109.342 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.437 ' HB3' HD12 ' A' ' 236' ' ' LEU . 8.3 p80 -147.05 120.63 9.12 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.475 1.109 . . . . 74.239999999999995 109.58 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.414 ' CD2' ' CG1' ' A' ' 239' ' ' VAL . 0.9 OUTLIER -99.7 114.53 27.7 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.451 1.094 . . . . 64.549999999999997 109.619 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.428 ' C ' ' N ' ' A' ' 191' ' ' GLU . 9.6 t30 53.69 34.19 18.33 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.543 1.152 . . . . 75.109999999999999 109.356 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 13.4 p 42.53 28.47 0.12 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.482 1.114 . . . . 60.020000000000003 108.299 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.466 ' O ' HG12 ' A' ' 209' ' ' VAL . 3.8 pt-20 -121.64 -33.97 3.5 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.563 1.165 . . . . 54.210000000000001 110.297 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.473 ' HE3' HD22 ' A' ' 206' ' ' LEU . 8.2 m0 -117.22 157.48 25.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.518 1.136 . . . . 73.319999999999993 108.009 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 1.007 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 36.6 m-85 -130.66 159.14 38.11 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.478 1.111 . . . . 75.439999999999998 110.98 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.891 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 31.0 mm -102.7 96.0 4.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.456 1.098 . . . . 74.430000000000007 109.298 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.617 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -79.38 166.09 22.42 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.157 . . . . 45.530000000000001 109.233 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.1 tptp . . . . . 0 C--N 1.326 -0.434 0 O-C-N 124.514 1.134 . . . . 53.420000000000002 109.275 -179.978 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.769 ' HA2' HD11 ' A' ' 174' ' ' LEU . . . . . . . . 0 CA--C 1.531 1.053 0 N-CA-C 110.969 -0.852 . . . . 52.520000000000003 110.969 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 162.46 92.8 Favored 'Cis proline' 0 C--N 1.359 1.129 0 C-N-CA 120.973 -2.511 . . . . 73.209999999999994 110.935 0.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.416 ' HA3' ' CG ' ' A' ' 174' ' ' LEU . . . -133.64 160.28 23.97 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.545 1.153 . . . . 74.239999999999995 111.022 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.526 HD23 ' CD1' ' A' ' 194' ' ' ILE . 3.8 mt -99.61 137.27 38.32 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.531 0.783 . . . . 73.030000000000001 109.317 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.843 HG21 HG11 ' A' ' 212' ' ' VAL . 0.1 OUTLIER -133.94 136.78 27.02 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.583 1.177 . . . . 75.230000000000004 109.319 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.56 ' HD3' ' CE1' ' A' ' 166' ' ' PHE . 18.5 Cg_endo -74.93 138.12 22.79 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.491 1.785 . . . . 73.010000000000005 111.006 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.662 HG23 ' CE2' ' A' ' 193' ' ' PHE . 13.7 p -65.2 -15.66 18.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.525 1.14 . . . . 71.140000000000001 109.295 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -83.87 10.86 58.98 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.485 1.116 . . . . 73.129999999999995 111.052 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.805 ' O ' HG13 ' A' ' 162' ' ' VAL . 19.0 m-85 -140.7 15.53 2.33 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.501 0.765 . . . . 64.010000000000005 111.009 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.843 HG11 HG21 ' A' ' 207' ' ' VAL . 21.9 m -147.53 149.55 15.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.475 1.11 . . . . 74.319999999999993 109.283 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.456 ' HB3' HD11 ' A' ' 163' ' ' LEU . 0.3 OUTLIER -130.42 152.44 49.82 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.453 1.096 . . . . 71.319999999999993 109.952 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.692 HG13 HG23 ' A' ' 227' ' ' VAL . 31.0 mm -111.09 95.66 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 72.010000000000005 109.349 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 27.8 pt . . . . . 0 C--N 1.324 -0.504 0 O-C-N 124.455 1.097 . . . . 71.120000000000005 109.349 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 39.1 p . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 110.405 -0.22 . . . . 51.549999999999997 110.405 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 122.09 3.71 9.66 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.558 1.161 . . . . 52.409999999999997 111.017 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -83.1 -177.6 6.82 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.433 0.725 . . . . 74.310000000000002 109.306 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.23 178.61 6.84 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.564 1.165 . . . . 72.430000000000007 109.288 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 1.007 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 2.5 p -82.99 -34.37 11.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.522 1.139 . . . . 75.230000000000004 109.329 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.821 HD12 HG13 ' A' ' 227' ' ' VAL . 1.6 mp -59.87 -37.48 72.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.463 1.102 . . . . 62.140000000000001 109.241 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -67.15 -42.72 83.9 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.477 1.111 . . . . 74.140000000000001 110.266 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.408 ' CG ' HG21 ' A' ' 214' ' ' ILE . 0.6 OUTLIER -67.42 -32.99 74.24 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.496 1.123 . . . . 72.120000000000005 109.279 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.864 HG23 ' HB3' ' A' ' 236' ' ' LEU . 24.7 mt -63.61 -43.69 98.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.477 1.111 . . . . 60.310000000000002 109.311 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -78.46 -11.98 59.98 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 73.120000000000005 109.273 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.7 m -76.9 -44.89 30.05 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.526 1.141 . . . . 71.200000000000003 110.05 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.718 HG11 ' HG ' ' A' ' 158' ' ' LEU . 9.9 p -109.26 30.06 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.488 1.118 . . . . 73.109999999999999 109.31 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 42.41 28.46 0.11 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.516 1.135 . . . . 74.549999999999997 109.281 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.864 ' HB3' HG23 ' A' ' 231' ' ' ILE . 1.6 tm? -42.77 102.38 0.27 Allowed Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.587 1.179 . . . . 23.530000000000001 109.288 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.424 ' HD2' HD22 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -75.03 152.9 41.17 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.523 1.802 . . . . 72.519999999999996 111.02 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 8.8 p -67.17 151.41 47.6 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.549 1.155 . . . . 61.039999999999999 110.386 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.598 ' N ' ' HB1' ' A' ' 186' ' ' ALA . 1.3 p -50.79 -23.91 2.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.464 1.103 . . . . 71.439999999999998 109.318 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -83.82 -46.7 11.9 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.536 1.147 . . . . 71.140000000000001 110.342 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -63.25 -23.83 67.6 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.514 1.134 . . . . 74.049999999999997 110.343 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -80.14 -65.87 0.95 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.509 1.131 . . . . 75.349999999999994 107.98 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.39 -28.74 1.43 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.578 1.174 . . . . 75.140000000000001 109.28 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.4 t -71.49 -51.59 22.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.536 1.147 . . . . 72.439999999999998 109.973 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.425 1.078 . . . . 61.219999999999999 109.346 179.968 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.411 HD13 HG21 ' A' ' 234' ' ' VAL . 14.1 tp . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 109.271 -0.64 . . . . 74.329999999999998 109.271 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -137.38 115.92 12.02 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.556 1.16 . . . . 74.349999999999994 111.012 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.438 ' HB2' ' CD1' ' A' ' 214' ' ' ILE . . . -115.51 152.18 33.46 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.521 1.138 . . . . 71.319999999999993 109.325 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.834 HD12 ' O ' ' A' ' 180' ' ' GLU . 1.4 tp -120.12 128.88 75.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.487 1.117 . . . . 65.239999999999995 109.264 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.779 HG23 HD11 ' A' ' 182' ' ' LEU . 18.2 t -92.83 112.17 25.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.529 1.143 . . . . 65.230000000000004 109.359 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.879 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.1 OUTLIER -101.03 28.95 4.91 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.496 1.123 . . . . 75.310000000000002 109.327 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.599 ' CD2' ' O ' ' A' ' 163' ' ' LEU . 78.9 m-85 -164.57 131.07 2.98 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.555 1.159 . . . . 73.299999999999997 110.958 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.547 ' H ' HG22 ' A' ' 178' ' ' VAL . 2.7 t0 -79.59 101.19 8.17 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 74.010000000000005 109.329 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.568 ' CD1' ' HD3' ' A' ' 208' ' ' PRO . 60.9 t80 -83.21 152.67 25.11 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 74.049999999999997 111.024 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.561 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 6.9 mmmm -110.69 154.82 23.31 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.514 1.134 . . . . 63.049999999999997 109.25 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.694 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -95.49 125.0 39.8 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.539 1.149 . . . . 63.439999999999998 109.287 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -121.68 -40.31 2.56 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.477 1.11 . . . . 73.030000000000001 110.365 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -174.56 0.23 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.573 1.171 . . . . 73.030000000000001 109.284 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.38 -34.05 20.32 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.546 1.154 . . . . 52.310000000000002 109.307 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.5 10.35 33.21 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.626 1.204 . . . . 73.400000000000006 109.264 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 173' ' ' GLU . 1.2 mm-40 -75.12 172.87 11.6 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.125 . . . . 70.219999999999999 110.296 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.694 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 1.3 tp -155.56 157.68 37.22 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.53 1.144 . . . . 74.219999999999999 109.265 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.0 t -102.89 137.08 41.57 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.496 1.122 . . . . 74.409999999999997 110.407 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.684 HG22 ' H ' ' A' ' 177' ' ' TYR . 3.4 m -113.71 -166.01 1.05 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.547 1.154 . . . . 60.219999999999999 110.366 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.684 ' H ' HG22 ' A' ' 176' ' ' THR . 54.4 m-85 -138.57 150.69 46.58 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.456 1.097 . . . . 74.400000000000006 110.965 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.547 HG22 ' H ' ' A' ' 165' ' ' ASP . 60.8 t -60.84 163.66 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.133 . . . . 72.439999999999998 109.301 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.461 ' N ' HG12 ' A' ' 178' ' ' VAL . . . 37.74 57.73 1.54 Allowed Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.45 1.094 . . . . 55.210000000000001 110.995 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.834 ' O ' HD12 ' A' ' 161' ' ' ILE . 12.7 mm-40 -114.19 155.89 25.26 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.485 0.756 . . . . 71.519999999999996 110.326 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.595 ' C ' HD13 ' A' ' 182' ' ' LEU . 2.3 m-80 -123.32 125.09 44.38 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.531 1.144 . . . . 53.43 109.349 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.779 HD11 HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -162.53 162.65 27.47 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.51 1.131 . . . . 74.420000000000002 109.308 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 184' ' ' ILE . 2.7 t80 -98.96 147.93 24.49 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.433 1.083 . . . . 73.140000000000001 111.007 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.527 HD12 ' HB3' ' A' ' 193' ' ' PHE . 8.9 mm -77.67 112.49 15.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.472 1.108 . . . . 71.420000000000002 109.325 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.522 ' HB3' HG22 ' A' ' 194' ' ' ILE . 10.9 t -78.71 -22.73 46.19 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.525 1.141 . . . . 62.350000000000001 108.285 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.8 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -171.9 179.65 2.67 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.58 1.175 . . . . 63.25 109.308 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.46 ' CE1' HG22 ' A' ' 238' ' ' THR . 8.0 p80 -148.05 151.25 35.37 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.526 1.141 . . . . 61.340000000000003 109.522 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.461 ' HB2' HG11 ' A' ' 239' ' ' VAL . 1.8 t-160 -132.48 122.45 24.92 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.493 1.12 . . . . 63.329999999999998 109.597 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.444 ' C ' ' N ' ' A' ' 191' ' ' GLU . 3.0 m-20 54.15 30.4 12.08 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.477 1.111 . . . . 74.209999999999994 109.281 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 12.7 p 42.95 28.95 0.15 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 72.430000000000007 108.299 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.444 ' N ' ' C ' ' A' ' 189' ' ' ASN . 9.8 pt-20 -124.5 -37.18 2.54 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.564 1.165 . . . . 73.25 110.257 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.693 ' HE3' HD22 ' A' ' 206' ' ' LEU . 11.2 m0 -109.71 158.2 18.34 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.492 1.12 . . . . 74.040000000000006 108.004 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.98 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 44.7 m-85 -137.56 157.16 47.12 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.532 1.145 . . . . 72.319999999999993 111.005 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.8 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 30.8 mm -96.83 98.85 8.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.543 1.152 . . . . 72.25 109.266 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.407 ' HB3' HG21 ' A' ' 207' ' ' VAL . . . -94.92 158.02 15.66 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.557 1.161 . . . . 72.530000000000001 109.267 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt . . . . . 0 C--N 1.325 -0.47 0 O-C-N 124.527 1.142 . . . . 65.430000000000007 109.297 179.924 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.675 ' HA2' HD22 ' A' ' 174' ' ' LEU . . . . . . . . 0 CA--C 1.53 0.975 0 N-CA-C 111.027 -0.829 . . . . 64.109999999999999 111.027 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.528 ' HB2' HG23 ' A' ' 194' ' ' ILE . 18.2 Cg_endo -75.02 -170.45 8.28 Favored 'Cis proline' 0 C--N 1.359 1.124 0 C-N-CA 120.953 -2.52 . . . . 65.109999999999999 110.951 0.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -150.32 156.17 26.59 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.438 1.086 . . . . 74.409999999999997 110.983 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.693 HD22 ' HE3' ' A' ' 192' ' ' TRP . 1.7 mt -97.26 127.45 43.23 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.543 0.79 . . . . 73.219999999999999 109.343 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.812 HG12 ' HD2' ' A' ' 208' ' ' PRO . 0.3 OUTLIER -129.54 145.47 57.07 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.466 1.104 . . . . 72.230000000000004 109.35 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.812 ' HD2' HG12 ' A' ' 207' ' ' VAL . 18.6 Cg_endo -74.96 148.11 35.04 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.436 1.756 . . . . 74.230000000000004 110.994 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.709 ' HA ' HG22 ' A' ' 212' ' ' VAL . 8.0 p -66.79 -32.06 56.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.469 1.105 . . . . 64.230000000000004 109.297 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -66.01 -9.1 45.83 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.478 1.111 . . . . 74.439999999999998 111.046 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.575 ' HA ' ' CD2' ' A' ' 164' ' ' TYR . 4.6 m-85 -113.84 5.04 16.12 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.471 0.748 . . . . 71.019999999999996 110.928 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.709 HG22 ' HA ' ' A' ' 209' ' ' VAL . 18.4 m -140.47 162.14 24.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.49 1.119 . . . . 61.5 109.26 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.879 ' HB2' HD21 ' A' ' 163' ' ' LEU . 1.8 t -144.97 144.18 30.92 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.502 1.126 . . . . 72.030000000000001 110.008 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.761 HG13 HG23 ' A' ' 227' ' ' VAL . 36.0 mm -96.13 105.95 17.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.478 1.111 . . . . 62.450000000000003 109.303 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.409 HG23 ' C ' ' A' ' 214' ' ' ILE . 1.9 pt . . . . . 0 C--N 1.325 -0.463 0 O-C-N 124.497 1.123 . . . . 74.109999999999999 109.256 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.446 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 11.0 p . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 110.411 -0.218 . . . . 74.400000000000006 110.411 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 138.99 -13.2 3.35 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.474 1.109 . . . . 32.229999999999997 110.979 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.446 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 2.6 p30 -54.4 168.51 0.25 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.505 0.768 . . . . 62.420000000000002 109.251 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -114.57 175.24 5.57 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.469 1.105 . . . . 73.319999999999993 109.311 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.98 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 11.0 p -80.77 -33.17 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.459 1.099 . . . . 72.400000000000006 109.316 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.711 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.6 mp -60.58 -51.49 72.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.477 1.111 . . . . 73.109999999999999 109.338 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -61.96 -22.66 65.83 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.49 1.118 . . . . 74.530000000000001 110.268 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.748 ' O ' HG22 ' A' ' 234' ' ' VAL . 2.9 m-20 -83.6 -35.91 24.31 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.454 1.096 . . . . 64.409999999999997 109.257 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.863 HG23 ' HB3' ' A' ' 236' ' ' LEU . 12.2 mt -59.87 -29.99 44.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 74.310000000000002 109.287 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -84.08 -11.52 56.55 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.445 1.09 . . . . 72.010000000000005 109.257 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.03 -11.85 29.87 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.478 1.111 . . . . 64.540000000000006 109.988 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.748 HG22 ' O ' ' A' ' 230' ' ' ASP . 0.0 OUTLIER -132.56 10.69 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.525 1.14 . . . . 53.32 109.295 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 236' ' ' LEU . 74.0 m-20 52.95 20.74 1.76 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 52.140000000000001 109.327 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.863 ' HB3' HG23 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -39.55 100.51 0.21 Allowed Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.476 1.11 . . . . 63.100000000000001 109.311 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.449 ' HD2' HD13 ' A' ' 236' ' ' LEU . 18.6 Cg_endo -74.89 142.94 28.83 Favored 'Trans proline' 0 C--N 1.359 1.099 0 O-C-N 124.445 1.76 . . . . 71.209999999999994 111.012 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.46 HG22 ' CE1' ' A' ' 187' ' ' HIS . 7.1 p -60.23 148.08 37.8 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.547 1.154 . . . . 73.530000000000001 110.434 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' A' ' 188' ' ' HIS . 1.4 p -52.82 -25.8 9.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.497 1.123 . . . . 73.409999999999997 109.281 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.453 HE21 ' CE1' ' A' ' 188' ' ' HIS . 98.3 mm-40 -75.5 -39.38 58.59 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.561 1.163 . . . . 74.150000000000006 110.37 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -76.99 -23.1 52.28 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.454 1.096 . . . . 74.120000000000005 110.326 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -79.93 -61.69 1.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.541 1.151 . . . . 74.219999999999999 107.978 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.407 ' HB2' ' NZ ' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -51.31 -25.03 5.21 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.49 1.119 . . . . 72.129999999999995 109.291 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 29.5 t -72.55 -35.7 68.07 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.128 . . . . 61.399999999999999 109.997 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 1.9 t30 . . . . . 0 C--N 1.324 -0.521 0 O-C-N 124.542 1.151 . . . . 41.109999999999999 109.306 179.976 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 230' ' ' ASP . 2.7 tp . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 109.348 -0.612 . . . . 73.450000000000003 109.348 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.53 ' CE2' ' O ' ' A' ' 215' ' ' ILE . 2.4 p90 -152.01 152.26 32.22 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.518 1.136 . . . . 73.340000000000003 110.974 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.771 ' HB3' HD11 ' A' ' 184' ' ' ILE . . . -122.39 141.27 51.76 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.513 1.133 . . . . 52.409999999999997 109.232 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.51 128.38 55.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.472 1.107 . . . . 73.430000000000007 109.255 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.809 HG21 HD12 ' A' ' 182' ' ' LEU . 43.4 t -84.56 92.54 3.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.547 1.155 . . . . 72.510000000000005 109.332 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.898 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.2 OUTLIER -92.51 25.09 3.16 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 52.450000000000003 109.321 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.832 ' CD2' HD13 ' A' ' 163' ' ' LEU . 37.3 m-85 -165.18 141.11 5.44 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.481 1.113 . . . . 71.439999999999998 111.014 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -67.22 98.66 0.62 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.493 1.121 . . . . 53.420000000000002 109.257 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.578 ' CE2' ' O ' ' A' ' 174' ' ' LEU . 0.6 OUTLIER -80.3 123.53 28.05 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.436 1.085 . . . . 75.030000000000001 111.017 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.515 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 7.8 mmmm -93.25 138.93 31.16 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.454 1.096 . . . . 73.200000000000003 109.341 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.816 ' HB1' ' OE1' ' A' ' 173' ' ' GLU . . . -82.0 122.1 27.37 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.415 1.072 . . . . 74.510000000000005 109.275 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -126.97 -34.93 2.31 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.562 1.164 . . . . 72.150000000000006 110.27 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.91 ' HD2' HD13 ' A' ' 206' ' ' LEU . 4.8 mttp -58.56 -164.09 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.423 1.077 . . . . 62.409999999999997 109.357 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.31 -51.28 5.65 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.578 1.174 . . . . 73.140000000000001 109.306 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -105.36 29.48 6.43 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.503 1.127 . . . . 74.109999999999999 109.262 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 1.005 ' O ' HD22 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -59.02 172.5 0.56 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.531 1.144 . . . . 70.430000000000007 110.325 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 1.005 HD22 ' O ' ' A' ' 173' ' ' GLU . 1.7 mm? -146.95 108.07 4.22 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.417 1.073 . . . . 75.340000000000003 109.278 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.09 143.28 54.24 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.461 1.1 . . . . 64.420000000000002 110.361 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.627 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.8 m -139.9 -169.01 2.63 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.525 1.14 . . . . 70.519999999999996 110.378 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.627 ' H ' HG22 ' A' ' 176' ' ' THR . 77.9 m-85 -130.94 147.43 52.58 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.448 1.092 . . . . 63.420000000000002 111.021 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.467 HG23 ' C ' ' A' ' 163' ' ' LEU . 1.9 p -59.15 155.55 2.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.576 1.172 . . . . 71.530000000000001 109.285 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 61.51 41.39 99.55 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.444 1.09 . . . . 43.140000000000001 110.972 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -121.84 171.33 8.98 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.428 0.723 . . . . 43.329999999999998 110.273 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -119.03 131.57 55.99 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.494 1.121 . . . . 75.239999999999995 109.318 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.809 HD12 HG21 ' A' ' 162' ' ' VAL . 18.2 mt -140.61 124.38 17.16 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.501 1.126 . . . . 70.349999999999994 109.332 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -79.25 128.32 33.16 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.471 1.107 . . . . 75.450000000000003 111.01 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.771 HD11 ' HB3' ' A' ' 160' ' ' ALA . 15.6 mm -77.68 121.29 30.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.453 1.096 . . . . 74.439999999999998 109.359 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.43 ' HB2' HG22 ' A' ' 194' ' ' ILE . 62.9 m -95.73 -31.37 13.25 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.494 1.121 . . . . 71.319999999999993 108.248 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.57 ' HB1' ' N ' ' A' ' 239' ' ' VAL . . . -164.03 161.66 22.73 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.498 1.124 . . . . 62.049999999999997 109.247 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.566 ' CE1' HG21 ' A' ' 231' ' ' ILE . 9.0 p80 -128.74 147.4 50.77 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.552 1.157 . . . . 74.040000000000006 109.577 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.594 ' CD2' ' CG1' ' A' ' 239' ' ' VAL . 1.0 OUTLIER -120.91 119.17 31.85 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.51 1.131 . . . . 70.400000000000006 109.542 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.554 ' CB ' ' HG2' ' A' ' 191' ' ' GLU . 5.5 m-80 48.62 37.92 10.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 73.049999999999997 109.302 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.5 p 38.72 38.77 0.29 Allowed 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.501 1.125 . . . . 63.329999999999998 108.251 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 1.002 ' O ' HG23 ' A' ' 209' ' ' VAL . 11.6 pt-20 -132.52 -37.52 1.06 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.509 1.131 . . . . 61.310000000000002 110.289 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.476 ' N ' ' HG3' ' A' ' 191' ' ' GLU . 20.8 m95 -113.51 163.1 15.35 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.482 1.114 . . . . 75.409999999999997 108.088 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.892 ' CE2' HG22 ' A' ' 209' ' ' VAL . 13.7 m-85 -133.59 161.72 33.87 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 74.109999999999999 111.002 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.602 HG21 ' CZ3' ' A' ' 242' ' ' TRP . 20.0 mm -111.92 95.38 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.145 . . . . 61.549999999999997 109.248 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.573 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -86.3 -175.18 5.39 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.532 1.145 . . . . 71.310000000000002 109.364 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.4 pttp . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 72.510000000000005 109.266 -179.938 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.041 0 N-CA-C 110.926 -0.87 . . . . 60.439999999999998 110.926 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.549 ' HB2' HG23 ' A' ' 194' ' ' ILE . 18.5 Cg_endo -74.89 144.95 82.57 Favored 'Cis proline' 0 C--N 1.361 1.2 0 C-N-CA 120.967 -2.514 . . . . 72.219999999999999 111.095 -0.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.993 ' CA ' HD23 ' A' ' 174' ' ' LEU . . . -106.99 160.06 14.38 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.509 1.13 . . . . 72.400000000000006 110.981 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.91 HD13 ' HD2' ' A' ' 170' ' ' LYS . 2.6 mt -103.55 139.63 38.61 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.465 0.744 . . . . 74.010000000000005 109.271 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.791 HG21 HG11 ' A' ' 212' ' ' VAL . 0.2 OUTLIER -143.89 127.52 9.03 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.49 1.119 . . . . 74.109999999999999 109.244 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.497 ' HG2' ' CD2' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.98 157.72 42.7 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.493 1.786 . . . . 75.530000000000001 111.043 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 1.002 HG23 ' O ' ' A' ' 191' ' ' GLU . 21.3 t -80.94 3.26 2.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.547 1.154 . . . . 62.109999999999999 109.311 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . 0.431 ' O ' ' CD1' ' A' ' 211' ' ' PHE . . . -89.16 -3.01 76.56 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.467 1.105 . . . . 52.399999999999999 110.942 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.497 ' CD2' ' HG2' ' A' ' 208' ' ' PRO . 21.4 m-85 -136.69 14.59 3.15 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.474 0.749 . . . . 55.140000000000001 110.972 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.791 HG11 HG21 ' A' ' 207' ' ' VAL . 8.7 m -142.4 146.94 21.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.464 1.102 . . . . 72.129999999999995 109.324 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.898 ' HB2' HD21 ' A' ' 163' ' ' LEU . 26.0 t -129.33 160.76 32.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.551 1.157 . . . . 71.519999999999996 110.011 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.6 HG13 HG23 ' A' ' 227' ' ' VAL . 16.6 mm -102.65 145.75 11.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 75.219999999999999 109.306 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.53 ' O ' ' CE2' ' A' ' 159' ' ' TYR . 44.3 pt . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.571 1.17 . . . . 63.240000000000002 109.205 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 110.402 -0.222 . . . . 72.349999999999994 110.402 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 106.88 -0.58 36.0 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.51 1.132 . . . . 61.350000000000001 111.037 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.432 ' N ' HD22 ' A' ' 225' ' ' ASN . 1.7 m-80 -70.02 -175.92 1.03 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.528 0.781 . . . . 71.329999999999998 109.3 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -114.08 173.22 6.55 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.493 1.12 . . . . 64.420000000000002 109.352 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.854 HG13 HD12 ' A' ' 228' ' ' ILE . 2.8 p -84.16 -33.56 9.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.371 1.044 . . . . 64.109999999999999 109.329 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.854 HD12 HG13 ' A' ' 227' ' ' VAL . 1.8 mp -61.24 -50.87 78.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.498 1.123 . . . . 74.150000000000006 109.363 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -58.28 -31.42 67.45 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 61.439999999999998 110.351 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.449 ' HB3' HD11 ' A' ' 158' ' ' LEU . 1.0 OUTLIER -77.54 -35.74 52.96 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.497 1.123 . . . . 64.140000000000001 109.354 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.647 ' CD1' HG22 ' A' ' 227' ' ' VAL . 29.7 mt -68.34 -38.43 79.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.131 . . . . 73.540000000000006 109.29 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.29 -33.85 59.08 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.536 1.147 . . . . 74.540000000000006 109.336 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.7 m -58.79 -38.24 78.1 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.561 1.163 . . . . 73.409999999999997 109.989 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.0 p -112.6 6.93 8.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.494 1.121 . . . . 74.530000000000001 109.325 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 231' ' ' ILE . 9.2 p30 40.46 51.72 2.91 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.471 1.107 . . . . 74.299999999999997 109.269 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.534 HD23 ' HD2' ' A' ' 237' ' ' PRO . 1.1 tt -50.79 140.72 19.3 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.554 1.159 . . . . 71.230000000000004 109.369 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.534 ' HD2' HD23 ' A' ' 236' ' ' LEU . 18.1 Cg_endo -75.06 129.45 12.3 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.55 1.816 . . . . 64.109999999999999 111.002 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 3.0 p -67.17 152.39 45.84 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.479 1.112 . . . . 72.439999999999998 110.353 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.594 ' CG1' ' CD2' ' A' ' 188' ' ' HIS . 1.7 p -46.99 -25.58 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.544 1.153 . . . . 62.450000000000003 109.286 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -86.63 -50.43 6.81 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 71.299999999999997 110.337 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -57.1 -25.15 58.3 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.548 1.155 . . . . 74.540000000000006 110.249 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.602 ' CZ3' HG21 ' A' ' 194' ' ' ILE . 26.9 t90 -85.77 -61.85 1.66 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 74.439999999999998 108.022 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -50.88 -23.2 2.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.433 1.083 . . . . 70.010000000000005 109.284 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.9 t -86.85 -61.81 1.64 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.413 1.071 . . . . 75.209999999999994 110.007 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 C--N 1.324 -0.507 0 O-C-N 124.518 1.136 . . . . 73.409999999999997 109.289 179.946 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.723 ' HB2' HG11 ' A' ' 234' ' ' VAL . 61.4 tp . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.3 -0.63 . . . . 74.219999999999999 109.3 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.476 ' HB3' ' CE2' ' A' ' 183' ' ' PHE . 33.8 p90 -103.65 144.11 31.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.512 1.132 . . . . 75.219999999999999 110.998 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.458 ' CB ' HG12 ' A' ' 184' ' ' ILE . . . -140.83 141.83 34.67 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.557 1.161 . . . . 45.229999999999997 109.315 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.5 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -109.07 133.73 53.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 72.439999999999998 109.329 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.752 HG13 ' O ' ' A' ' 211' ' ' PHE . 3.4 t -86.05 125.1 40.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.452 1.095 . . . . 73.450000000000003 109.378 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.778 HD23 ' N ' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -112.88 12.88 19.53 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.538 1.149 . . . . 63.329999999999998 109.317 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.462 ' O ' HG12 ' A' ' 162' ' ' VAL . 97.4 m-85 -158.24 145.14 17.73 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.467 1.105 . . . . 73.140000000000001 111.02 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -79.92 103.01 9.52 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.406 1.066 . . . . 63.350000000000001 109.277 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.526 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 7.4 t80 -83.1 137.82 33.94 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 73.140000000000001 111.015 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.474 ' CE ' ' HA ' ' A' ' 167' ' ' LYS . 0.5 OUTLIER -105.47 123.54 48.06 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.532 1.145 . . . . 70.219999999999999 109.304 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.814 ' HB1' ' CG ' ' A' ' 173' ' ' GLU . . . -71.0 123.26 21.64 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.595 1.185 . . . . 75.140000000000001 109.313 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -126.78 -34.16 2.42 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.541 1.151 . . . . 72.409999999999997 110.309 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 0.4 OUTLIER -58.62 -164.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 O-C-N 124.435 1.084 . . . . 72.299999999999997 109.316 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.34 -51.22 5.67 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.487 1.117 . . . . 73.519999999999996 109.266 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.64 29.42 6.96 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.521 1.138 . . . . 72.150000000000006 109.287 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.814 ' CG ' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -58.95 -178.42 0.05 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.561 1.163 . . . . 75.25 110.251 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.834 HD23 ' HA3' ' A' ' 205' ' ' GLY . 0.0 OUTLIER -147.54 119.97 8.46 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.544 1.153 . . . . 71.319999999999993 109.277 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.53 130.41 35.95 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.555 1.159 . . . . 62.109999999999999 110.439 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.573 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.7 m -126.91 -176.08 3.6 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.593 1.183 . . . . 75.510000000000005 110.435 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.573 ' H ' HG22 ' A' ' 176' ' ' THR . 23.9 m-85 -136.09 143.35 44.56 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.558 1.161 . . . . 64.219999999999999 110.987 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.5 p -56.24 147.28 4.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.469 1.106 . . . . 64.510000000000005 109.291 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.81 58.07 13.85 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.495 1.122 . . . . 51.119999999999997 111.034 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.5 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 10.9 tp10 -121.83 166.16 14.8 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.547 0.792 . . . . 74.530000000000001 110.303 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.428 HD22 ' N ' ' A' ' 181' ' ' ASN . 2.3 m-80 -119.35 133.44 55.72 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.442 1.089 . . . . 71.310000000000002 109.292 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.666 ' C ' HD12 ' A' ' 182' ' ' LEU . 1.2 pp -166.93 -175.45 3.05 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.546 1.154 . . . . 71.209999999999994 109.309 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 159' ' ' TYR . 22.4 m-85 -134.07 139.91 46.29 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.474 1.109 . . . . 72.200000000000003 110.998 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.904 HD12 ' HB3' ' A' ' 193' ' ' PHE . 27.9 mm -77.7 138.08 21.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.487 1.117 . . . . 65.319999999999993 109.337 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.561 ' O ' HD11 ' A' ' 236' ' ' LEU . 0.6 OUTLIER -95.1 -28.13 15.24 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.102 . . . . 62.229999999999997 108.338 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.583 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -172.41 179.56 2.49 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.497 1.123 . . . . 70.230000000000004 109.325 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.814 ' CD2' HG21 ' A' ' 231' ' ' ILE . 8.5 p80 -136.56 154.32 50.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.486 1.116 . . . . 73.030000000000001 109.607 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.521 ' CD2' ' HB2' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -126.97 117.94 23.51 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.469 1.106 . . . . 64.25 109.511 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.568 ' CB ' ' HG2' ' A' ' 191' ' ' GLU . 2.2 m120 50.85 33.91 9.41 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.479 1.112 . . . . 73.0 109.292 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.465 ' HB3' ' CG1' ' A' ' 228' ' ' ILE . 99.2 m 43.77 38.16 1.93 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.473 1.108 . . . . 54.109999999999999 108.286 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.568 ' HG2' ' CB ' ' A' ' 189' ' ' ASN . 8.3 pt-20 -135.26 -40.51 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.562 1.164 . . . . 71.420000000000002 110.318 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.521 ' HB2' ' CD2' ' A' ' 188' ' ' HIS . 24.9 m95 -107.23 165.78 11.12 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.989 -1.115 . . . . 74.219999999999999 107.989 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.924 ' CE2' HG23 ' A' ' 209' ' ' VAL . 12.4 m-85 -137.79 159.03 43.11 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.499 1.124 . . . . 74.219999999999999 110.978 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.583 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 21.1 mm -100.37 114.43 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.504 1.127 . . . . 74.129999999999995 109.288 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.737 ' HB2' ' CG1' ' A' ' 207' ' ' VAL . . . -92.59 168.07 11.49 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.543 1.152 . . . . 75.230000000000004 109.273 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.496 ' CG ' ' O ' ' A' ' 196' ' ' LYS . 1.8 pttt . . . . . 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.128 . . . . 73.25 109.34 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.032 0 N-CA-C 111.014 -0.834 . . . . 62.240000000000002 111.014 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 18.3 Cg_endo -74.98 145.22 83.34 Favored 'Cis proline' 0 C--N 1.359 1.118 0 C-N-CA 121.048 -2.48 . . . . 73.120000000000005 111.017 0.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.834 ' HA3' HD23 ' A' ' 174' ' ' LEU . . . -119.09 -166.01 13.31 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.597 1.186 . . . . 65.510000000000005 111.006 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.486 HD23 HD13 ' A' ' 194' ' ' ILE . 3.1 mt -119.69 142.74 48.22 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.422 0.719 . . . . 43.219999999999999 109.302 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.737 ' CG1' ' HB2' ' A' ' 195' ' ' ALA . 1.6 m -143.9 155.06 59.32 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.487 1.117 . . . . 73.439999999999998 109.323 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.579 ' HG2' ' CD1' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.93 160.44 40.35 Favored 'Trans proline' 0 C--N 1.359 1.108 0 O-C-N 124.53 1.805 . . . . 74.319999999999993 111.055 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.924 HG23 ' CE2' ' A' ' 193' ' ' PHE . 10.1 p -84.97 -19.04 8.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 51.25 109.349 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -82.83 9.33 60.05 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.487 1.117 . . . . 70.120000000000005 110.994 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.752 ' O ' HG13 ' A' ' 162' ' ' VAL . 11.2 m-85 -128.46 18.67 6.35 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 0.768 . . . . 71.530000000000001 111.009 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.565 HG21 ' CD2' ' A' ' 193' ' ' PHE . 31.7 m -156.9 144.5 10.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.496 1.123 . . . . 65.0 109.333 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 22.3 t -134.73 140.19 45.76 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 72.540000000000006 110.03 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.868 HG21 ' CG ' ' A' ' 230' ' ' ASP . 11.0 mm -86.82 89.3 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.53 1.144 . . . . 73.010000000000005 109.339 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.426 ' CG2' ' C ' ' A' ' 214' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.501 1.125 . . . . 72.430000000000007 109.262 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 73.3 p . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 110.453 -0.203 . . . . 71.120000000000005 110.453 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 113.21 13.54 10.72 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.531 1.145 . . . . 70.549999999999997 111.008 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -88.49 -176.81 5.44 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.5 0.765 . . . . 63.140000000000001 109.331 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -130.1 171.28 13.0 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.526 1.141 . . . . 63.100000000000001 109.25 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.774 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 12.6 p -78.25 -40.88 25.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.478 1.111 . . . . 74.230000000000004 109.318 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.838 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.1 mp -50.7 -53.41 13.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.519 1.137 . . . . 72.430000000000007 109.386 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -61.82 -33.08 73.49 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.458 1.099 . . . . 74.200000000000003 110.286 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.868 ' CG ' HG21 ' A' ' 214' ' ' ILE . 1.1 m-20 -70.86 -30.5 66.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.492 1.12 . . . . 61.43 109.294 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 228' ' ' ILE . 19.2 mt -68.93 -36.25 73.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.529 1.143 . . . . 65.519999999999996 109.305 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -74.61 -20.53 59.88 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.53 1.144 . . . . 74.439999999999998 109.295 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 6.7 p -68.64 -34.66 76.11 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.44 1.087 . . . . 71.319999999999993 110.014 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.723 HG11 ' HB2' ' A' ' 158' ' ' LEU . 6.8 p -114.75 19.0 7.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.549 1.155 . . . . 72.129999999999995 109.267 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 43.06 28.17 0.13 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.567 1.167 . . . . 63.350000000000001 109.341 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.717 ' HB3' HG23 ' A' ' 231' ' ' ILE . 18.8 tp -51.55 109.95 1.61 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.48 1.112 . . . . 72.310000000000002 109.321 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.93 137.21 21.59 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.519 1.799 . . . . 75.25 110.966 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.617 HG22 ' CE1' ' A' ' 187' ' ' HIS . 10.2 p -57.04 157.97 5.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 71.420000000000002 110.37 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.473 ' CG1' ' HB2' ' A' ' 188' ' ' HIS . 1.5 p -54.04 -27.99 16.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.443 1.089 . . . . 72.340000000000003 109.261 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -80.03 -30.7 39.54 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.454 1.096 . . . . 63.530000000000001 110.327 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -81.78 -24.06 36.22 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.517 1.136 . . . . 71.5 110.282 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.443 ' O ' ' N ' ' A' ' 245' ' ' ASN . 9.5 t90 -83.3 -66.39 0.9 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.12 . . . . 73.040000000000006 108.046 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.5 -29.86 0.1 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.514 1.134 . . . . 74.420000000000002 109.282 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.433 ' N ' ' C ' ' A' ' 242' ' ' TRP . 47.4 t -64.16 -52.85 57.05 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.439 1.087 . . . . 64.439999999999998 110.004 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 242' ' ' TRP . 22.3 m-80 . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.479 1.112 . . . . 74.239999999999995 109.355 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.867 ' HG ' HG11 ' A' ' 234' ' ' VAL . 8.2 mt . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 109.262 -0.644 . . . . 73.049999999999997 109.262 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.584 ' CD1' ' C ' ' A' ' 158' ' ' LEU . 36.4 m-85 -157.56 115.06 3.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.493 1.121 . . . . 72.430000000000007 111.031 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.522 ' HB2' HD11 ' A' ' 214' ' ' ILE . . . -114.79 133.21 56.11 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.471 1.107 . . . . 74.430000000000007 109.292 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.565 HD12 ' O ' ' A' ' 180' ' ' GLU . 0.4 OUTLIER -100.62 130.78 49.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.449 1.093 . . . . 64.140000000000001 109.27 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.587 HG13 HG12 ' A' ' 212' ' ' VAL . 2.0 t -88.84 127.72 41.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.512 1.133 . . . . 72.430000000000007 109.365 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.728 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.1 OUTLIER -107.39 -5.97 17.41 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.477 1.111 . . . . 63.310000000000002 109.379 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.636 ' HE2' HD12 ' A' ' 163' ' ' LEU . 96.3 m-85 -147.05 147.34 30.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 73.219999999999999 111.059 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.676 ' N ' HG12 ' A' ' 178' ' ' VAL . 0.2 OUTLIER -79.4 111.71 15.92 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.47 1.106 . . . . 71.420000000000002 109.325 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.629 ' CG ' ' CD ' ' A' ' 208' ' ' PRO . 7.9 t80 -80.51 150.17 29.74 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.597 1.185 . . . . 75.109999999999999 111.002 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.545 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 0.1 OUTLIER -108.26 132.4 53.71 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.412 1.07 . . . . 73.230000000000004 109.272 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.822 ' HB1' ' OE2' ' A' ' 173' ' ' GLU . . . -78.47 127.51 32.28 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.598 1.186 . . . . 71.549999999999997 109.282 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.412 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 17.2 pt-20 -130.35 -33.18 1.71 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.498 1.124 . . . . 75.540000000000006 110.263 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -58.04 -166.15 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.567 1.167 . . . . 63.020000000000003 109.304 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.96 -45.35 9.26 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.497 1.123 . . . . 61.009999999999998 109.333 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -111.23 28.66 8.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 1.117 . . . . 74.200000000000003 109.326 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.822 ' OE2' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -63.44 -176.76 0.17 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.442 1.089 . . . . 74.340000000000003 110.298 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 174' ' ' LEU . 13.8 mt -157.25 133.15 9.43 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.509 1.131 . . . . 74.299999999999997 109.22 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.72 130.97 35.24 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.498 1.124 . . . . 61.520000000000003 110.387 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.6 m -111.11 -176.82 3.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.505 1.128 . . . . 75.049999999999997 110.373 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.543 ' H ' HG22 ' A' ' 176' ' ' THR . 15.5 m-85 -130.12 157.25 42.93 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.517 1.136 . . . . 73.430000000000007 110.944 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.676 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.0 OUTLIER -67.33 162.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.405 1.065 . . . . 60.350000000000001 109.252 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 37.28 61.34 1.01 Allowed Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.456 1.098 . . . . 64.319999999999993 110.997 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.565 ' O ' HD12 ' A' ' 161' ' ' ILE . 2.9 mm-40 -121.2 176.82 5.42 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 0.778 . . . . 64.140000000000001 110.298 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.464 ' C ' HD13 ' A' ' 182' ' ' LEU . 1.7 t-20 -146.71 134.48 21.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.458 1.099 . . . . 75.209999999999994 109.28 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.62 ' O ' HD22 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -166.48 160.32 15.31 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.494 1.121 . . . . 75.140000000000001 109.284 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.434 ' CE1' ' O ' ' A' ' 184' ' ' ILE . 5.5 t80 -92.07 137.21 32.55 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.593 1.183 . . . . 73.510000000000005 111.04 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.912 HD12 ' HB3' ' A' ' 193' ' ' PHE . 42.7 mm -77.54 124.78 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.496 1.122 . . . . 73.439999999999998 109.291 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.429 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 10.2 t -79.94 -26.24 40.15 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 50.149999999999999 108.274 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.571 ' HB3' HG13 ' A' ' 194' ' ' ILE . . . -176.84 166.95 2.56 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 43.409999999999997 109.312 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.6 ' CE1' HG22 ' A' ' 238' ' ' THR . 8.2 p80 -123.42 151.01 43.07 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.497 1.123 . . . . 71.010000000000005 109.545 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.619 ' HB2' HG11 ' A' ' 239' ' ' VAL . 3.8 t-160 -124.76 112.95 17.31 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.498 1.124 . . . . 75.519999999999996 109.556 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.401 ' C ' ' N ' ' A' ' 191' ' ' GLU . 8.4 t-20 57.26 23.45 8.78 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.547 1.154 . . . . 64.120000000000005 109.32 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.481 ' HG ' ' CE1' ' A' ' 187' ' ' HIS . 6.8 m 53.08 21.46 2.13 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.484 1.115 . . . . 51.539999999999999 108.235 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.484 ' O ' HG12 ' A' ' 209' ' ' VAL . 5.0 pt-20 -116.95 -31.95 5.24 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.465 1.103 . . . . 75.439999999999998 110.27 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.413 ' N ' ' HG2' ' A' ' 191' ' ' GLU . 4.3 m0 -118.92 166.45 12.83 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.923 -1.14 . . . . 74.120000000000005 107.923 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.912 ' HB3' HD12 ' A' ' 184' ' ' ILE . 36.3 m-85 -140.44 162.07 36.2 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.454 1.096 . . . . 73.140000000000001 111.021 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.571 HG13 ' HB3' ' A' ' 186' ' ' ALA . 34.6 mm -103.16 124.38 57.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.433 1.083 . . . . 63.219999999999999 109.343 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -112.56 174.9 5.67 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.493 1.12 . . . . 63.229999999999997 109.29 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.1 tptp . . . . . 0 C--N 1.324 -0.517 0 O-C-N 124.573 1.17 . . . . 73.209999999999994 109.326 179.96 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.075 0 N-CA-C 110.952 -0.859 . . . . 42.219999999999999 110.952 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.57 ' HG2' ' CH2' ' A' ' 242' ' ' TRP . 18.2 Cg_endo -75.1 165.92 84.6 Favored 'Cis proline' 0 C--N 1.36 1.174 0 C-N-CA 121.012 -2.495 . . . . 64.109999999999999 110.975 0.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.429 ' O ' HG23 ' A' ' 194' ' ' ILE . . . -122.46 179.72 16.11 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.545 1.153 . . . . 64.209999999999994 110.993 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.472 ' HG ' ' CD1' ' A' ' 194' ' ' ILE . 3.8 mp -117.59 168.49 10.37 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.439 0.729 . . . . 64.230000000000004 109.318 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.476 HG23 ' CD2' ' A' ' 166' ' ' PHE . 6.1 p -159.81 140.18 8.78 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.519 1.137 . . . . 64.310000000000002 109.223 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.629 ' CD ' ' CG ' ' A' ' 166' ' ' PHE . 18.1 Cg_endo -75.0 152.2 40.48 Favored 'Trans proline' 0 C--N 1.361 1.21 0 O-C-N 124.505 1.792 . . . . 64.310000000000002 110.997 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.729 ' HA ' HG22 ' A' ' 212' ' ' VAL . 11.6 p -78.83 -18.94 13.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.539 1.149 . . . . 65.219999999999999 109.26 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -73.83 -2.38 61.08 Favored Glycine 0 CA--C 1.531 1.091 0 O-C-N 124.539 1.149 . . . . 61.240000000000002 110.947 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.47 ' CD1' ' HG2' ' A' ' 208' ' ' PRO . 10.3 m-85 -126.52 -0.3 6.87 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.56 0.8 . . . . 73.209999999999994 110.976 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.729 HG22 ' HA ' ' A' ' 209' ' ' VAL . 11.8 m -133.5 153.01 36.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 71.310000000000002 109.326 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.728 ' HB2' HD21 ' A' ' 163' ' ' LEU . 1.7 t -143.2 155.91 44.64 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.5 1.125 . . . . 53.340000000000003 110.05 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.914 HG13 HG23 ' A' ' 227' ' ' VAL . 18.9 mm -111.41 154.26 13.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.507 1.129 . . . . 61.030000000000001 109.308 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.457 HD12 HG21 ' A' ' 161' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 O-C-N 124.513 1.133 . . . . 74.340000000000003 109.247 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 16.4 p . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 110.43 -0.211 . . . . 75.129999999999995 110.43 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 119.65 8.09 9.29 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.583 1.177 . . . . 45.130000000000003 110.982 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.717 ' N ' HD22 ' A' ' 225' ' ' ASN . 0.8 OUTLIER -85.44 -178.56 6.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.576 0.809 . . . . 74.420000000000002 109.289 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.2 172.58 10.45 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.5 1.125 . . . . 74.200000000000003 109.298 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.914 HG23 HG13 ' A' ' 214' ' ' ILE . 13.2 p -81.1 -37.76 16.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.548 1.155 . . . . 55.539999999999999 109.319 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.676 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.6 mp -54.69 -53.58 30.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.49 1.119 . . . . 75.430000000000007 109.268 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -55.44 -31.01 61.56 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.575 1.172 . . . . 70.540000000000006 110.306 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.761 ' CG ' HG21 ' A' ' 214' ' ' ILE . 0.5 OUTLIER -77.29 -34.9 55.47 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.509 1.131 . . . . 62.32 109.332 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' A' ' 228' ' ' ILE . 21.3 mt -67.6 -35.13 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.486 1.116 . . . . 73.200000000000003 109.3 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -82.39 -26.97 32.35 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.511 1.132 . . . . 74.010000000000005 109.245 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 46.8 p -60.06 -32.66 71.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.533 1.146 . . . . 74.310000000000002 109.991 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.867 HG11 ' HG ' ' A' ' 158' ' ' LEU . 2.6 p -118.06 10.65 7.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.135 . . . . 62.009999999999998 109.327 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 4.4 m120 40.51 35.79 0.32 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.505 1.128 . . . . 62.009999999999998 109.272 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.559 HD12 ' HD2' ' A' ' 237' ' ' PRO . 0.6 OUTLIER -50.49 144.04 12.84 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.472 1.107 . . . . 70.099999999999994 109.314 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.559 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.5 Cg_endo -74.97 151.45 39.66 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.474 1.776 . . . . 75.439999999999998 111.02 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.6 HG22 ' CE1' ' A' ' 187' ' ' HIS . 2.1 p -86.17 141.29 29.46 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.517 1.136 . . . . 74.329999999999998 110.386 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.619 HG11 ' HB2' ' A' ' 188' ' ' HIS . 4.4 p -42.76 -28.31 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.556 1.16 . . . . 63.200000000000003 109.323 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.474 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 14.7 mm-40 -78.78 -46.32 19.07 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.522 1.139 . . . . 50.210000000000001 110.249 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 238' ' ' THR . 17.3 mt-10 -66.3 -19.79 65.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.448 1.092 . . . . 72.310000000000002 110.273 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.57 ' CH2' ' HG2' ' A' ' 204' ' ' PRO . 2.0 t90 -81.37 -70.37 0.54 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 73.430000000000007 107.979 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -40.39 -29.93 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.398 1.061 . . . . 72.319999999999993 109.301 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.423 ' N ' ' C ' ' A' ' 242' ' ' TRP . 5.2 t -84.32 -59.24 2.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 60.210000000000001 110.044 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 . . . . . 0 C--N 1.326 -0.456 0 O-C-N 124.493 1.121 . . . . 71.319999999999993 109.254 179.97 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.437 HD11 ' HB3' ' A' ' 230' ' ' ASP . 11.4 tp . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 109.275 -0.639 . . . . 74.209999999999994 109.275 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -132.04 130.58 41.53 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.466 1.104 . . . . 75.200000000000003 110.97 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.491 ' O ' HD12 ' A' ' 182' ' ' LEU . . . -144.58 151.01 38.42 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.127 . . . . 55.210000000000001 109.259 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.541 HD12 ' ND2' ' A' ' 181' ' ' ASN . 0.1 OUTLIER -117.63 129.19 74.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.54 1.15 . . . . 71.540000000000006 109.322 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.959 ' CG2' HD21 ' A' ' 182' ' ' LEU . 1.9 t -76.96 132.64 32.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.557 1.161 . . . . 61.399999999999999 109.302 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.932 ' O ' HG23 ' A' ' 178' ' ' VAL . 0.2 OUTLIER -111.56 -7.38 14.31 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.572 1.17 . . . . 73.219999999999999 109.317 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.435 ' HB2' ' CD2' ' A' ' 211' ' ' PHE . 90.0 m-85 -142.23 143.56 32.95 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.548 1.155 . . . . 61.149999999999999 111.019 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.41 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 4.6 t0 -73.26 108.17 5.99 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.532 1.145 . . . . 75.019999999999996 109.326 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.684 ' CG ' HG13 ' A' ' 207' ' ' VAL . 3.8 t80 -80.41 147.31 31.05 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.533 1.146 . . . . 72.099999999999994 110.948 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.06 137.9 44.25 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.503 1.127 . . . . 71.219999999999999 109.29 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.828 ' HB1' ' OE1' ' A' ' 173' ' ' GLU . . . -89.45 122.74 32.93 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.547 1.154 . . . . 41.520000000000003 109.301 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.426 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 10.0 pt-20 -126.3 -29.42 2.99 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.484 1.115 . . . . 73.030000000000001 110.294 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 4.2 tttp -59.09 -173.34 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.463 1.102 . . . . 72.530000000000001 109.263 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.82 -29.49 17.54 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.394 1.059 . . . . 72.409999999999997 109.267 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.47 28.36 6.65 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.601 1.188 . . . . 74.109999999999999 109.323 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.828 ' OE1' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -68.49 -176.37 0.77 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.541 1.151 . . . . 74.150000000000006 110.319 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.433 ' HB2' ' CA ' ' A' ' 205' ' ' GLY . 0.1 OUTLIER -157.49 110.67 2.51 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.457 1.098 . . . . 72.329999999999998 109.329 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.1 t -68.29 136.2 53.1 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.465 1.103 . . . . 63.439999999999998 110.379 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.692 HG22 ' H ' ' A' ' 177' ' ' TYR . 3.2 m -120.38 -164.3 1.08 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.567 1.167 . . . . 64.340000000000003 110.437 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.692 ' H ' HG22 ' A' ' 176' ' ' THR . 31.3 m-85 -128.47 173.61 10.08 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.433 1.083 . . . . 63.409999999999997 111.008 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 163' ' ' LEU . 1.4 p -93.67 137.46 22.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.469 1.106 . . . . 63.240000000000002 109.349 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 67.16 52.58 31.12 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.451 1.094 . . . . 32.350000000000001 110.972 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.479 ' OE1' ' CB ' ' A' ' 177' ' ' TYR . 2.4 mp0 -121.9 165.67 15.58 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.542 0.789 . . . . 73.219999999999999 110.293 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.541 ' ND2' HD12 ' A' ' 161' ' ' ILE . 0.4 OUTLIER -115.85 126.82 54.46 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.501 1.126 . . . . 72.420000000000002 109.369 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.959 HD21 ' CG2' ' A' ' 162' ' ' VAL . 0.4 OUTLIER -148.97 177.79 9.26 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.473 1.108 . . . . 63.420000000000002 109.327 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -122.85 131.13 53.61 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.532 1.145 . . . . 75.329999999999998 111.044 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.907 HD12 ' HB3' ' A' ' 193' ' ' PHE . 38.3 mm -77.52 122.63 32.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.488 1.117 . . . . 73.400000000000006 109.344 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.556 ' C ' HD11 ' A' ' 236' ' ' LEU . 3.6 m -85.42 -28.97 24.75 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.122 . . . . 71.409999999999997 108.302 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -167.22 179.58 5.02 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.484 1.115 . . . . 71.319999999999993 109.252 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.468 ' NE2' HG21 ' A' ' 231' ' ' ILE . 7.5 p80 -136.26 154.65 50.84 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 75.340000000000003 109.605 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.471 ' CD2' ' HB2' ' A' ' 189' ' ' ASN . 0.2 OUTLIER -128.98 111.91 13.51 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.536 1.147 . . . . 71.109999999999999 109.596 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.471 ' HB2' ' CD2' ' A' ' 188' ' ' HIS . 0.5 OUTLIER 58.65 21.53 8.87 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.544 1.152 . . . . 61.109999999999999 109.36 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 69.9 m 56.33 19.2 3.82 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.495 1.122 . . . . 54.530000000000001 108.332 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.462 ' HG2' ' CB ' ' A' ' 189' ' ' ASN . 6.7 pt-20 -116.52 -31.74 5.45 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.566 1.166 . . . . 73.519999999999996 110.325 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.425 ' N ' ' HG3' ' A' ' 191' ' ' GLU . 16.7 m0 -115.33 165.12 13.31 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.613 1.196 . . . . 64.549999999999997 108.012 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.907 ' HB3' HD12 ' A' ' 184' ' ' ILE . 9.0 m-85 -143.87 159.16 43.03 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.518 1.136 . . . . 74.430000000000007 111.006 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.468 ' CG1' ' HB ' ' A' ' 239' ' ' VAL . 19.9 mm -100.9 121.91 52.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.525 1.141 . . . . 71.409999999999997 109.341 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -118.78 170.83 8.66 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.572 1.17 . . . . 64.430000000000007 109.336 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.498 1.123 . . . . 73.519999999999996 109.271 -179.999 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.971 0 N-CA-C 110.994 -0.842 . . . . 74.349999999999994 110.994 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 145.06 82.88 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 120.951 -2.52 . . . . 70.150000000000006 111.015 0.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 194' ' ' ILE . . . -90.61 156.73 24.97 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.531 1.145 . . . . 54.43 111.021 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.604 ' O ' ' CZ ' ' A' ' 166' ' ' PHE . 1.5 mt -119.94 135.74 54.79 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 0.763 . . . . 74.349999999999994 109.269 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.684 HG13 ' CG ' ' A' ' 166' ' ' PHE . 0.6 OUTLIER -148.17 139.37 13.64 Favored Pre-proline 0 C--N 1.323 -0.547 0 O-C-N 124.519 1.137 . . . . 71.019999999999996 109.34 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.573 ' HD2' HG12 ' A' ' 207' ' ' VAL . 18.3 Cg_endo -75.03 152.98 41.27 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.51 1.795 . . . . 74.310000000000002 110.979 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.615 ' HA ' HG22 ' A' ' 212' ' ' VAL . 3.9 p -67.57 -25.16 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.481 1.113 . . . . 71.049999999999997 109.314 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -67.51 -8.07 49.8 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.505 1.128 . . . . 43.210000000000001 111.016 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.609 ' O ' HG13 ' A' ' 162' ' ' VAL . 8.0 m-85 -120.08 15.57 12.4 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.5 0.765 . . . . 74.319999999999993 111.008 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.615 HG22 ' HA ' ' A' ' 209' ' ' VAL . 17.7 m -154.3 144.49 13.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.497 1.123 . . . . 43.009999999999998 109.291 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 42.0 t -128.27 147.91 50.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.495 1.122 . . . . 70.109999999999999 110.018 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 215' ' ' ILE . 23.0 mm -91.81 146.54 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.413 1.071 . . . . 62.119999999999997 109.258 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 214' ' ' ILE . 2.7 pp . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.464 1.102 . . . . 71.150000000000006 109.291 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.445 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 11.5 p . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 110.376 -0.231 . . . . 71.239999999999995 110.376 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 137.88 -11.8 3.65 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.5 1.125 . . . . 60.119999999999997 111.036 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.445 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 2.6 p30 -51.74 179.86 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.518 0.775 . . . . 74.430000000000007 109.353 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -118.74 172.48 7.48 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.484 1.115 . . . . 54.450000000000003 109.223 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.73 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 11.1 p -83.18 -40.49 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.459 1.099 . . . . 74.409999999999997 109.28 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.596 ' HA ' HD12 ' A' ' 231' ' ' ILE . 3.6 mp -55.14 -43.84 72.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.547 1.154 . . . . 64.439999999999998 109.28 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -66.04 -35.12 79.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.517 1.135 . . . . 52.140000000000001 110.311 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.437 ' HB3' HD11 ' A' ' 158' ' ' LEU . 1.1 m-20 -79.01 -21.43 46.97 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.515 1.135 . . . . 75.540000000000006 109.355 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 228' ' ' ILE . 21.6 mt -69.14 -36.74 74.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.485 1.116 . . . . 64.340000000000003 109.33 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -78.03 -28.67 49.08 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.553 1.158 . . . . 72.530000000000001 109.314 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.3 m -56.14 -40.14 73.35 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.459 1.1 . . . . 71.030000000000001 110.003 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.593 ' O ' HG22 ' A' ' 234' ' ' VAL . 7.2 p -111.65 21.29 5.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.521 1.138 . . . . 74.349999999999994 109.235 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 40.85 29.67 0.08 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.439 1.087 . . . . 73.030000000000001 109.251 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.581 ' HB2' HG13 ' A' ' 234' ' ' VAL . 38.7 tp -44.25 110.24 0.97 Allowed Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 73.219999999999999 109.3 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.07 140.88 25.79 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.589 1.836 . . . . 64.510000000000005 111.011 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 5.8 p -57.52 150.08 19.73 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.503 1.127 . . . . 72.349999999999994 110.367 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.468 ' HB ' ' CG1' ' A' ' 194' ' ' ILE . 0.9 OUTLIER -47.26 -25.6 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.474 1.109 . . . . 53.030000000000001 109.351 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -83.51 -49.63 9.06 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 72.340000000000003 110.319 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -56.94 -28.86 62.6 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.566 1.166 . . . . 73.109999999999999 110.361 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -78.13 -70.58 0.48 Allowed 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.478 1.111 . . . . 64.150000000000006 108.067 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.1 ptmm? -41.8 -33.75 0.55 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.435 1.084 . . . . 60.219999999999999 109.348 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 27.0 t -61.4 -59.0 5.93 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.476 1.11 . . . . 71.310000000000002 110.032 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.465 1.103 . . . . 70.230000000000004 109.325 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.784 HD22 HG21 ' A' ' 234' ' ' VAL . 33.9 tp . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.283 -0.636 . . . . 73.120000000000005 109.283 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.435 ' CD1' ' C ' ' A' ' 158' ' ' LEU . 3.0 m-85 -136.43 136.55 39.62 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.519 1.137 . . . . 74.209999999999994 111.004 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.469 ' HB2' ' CD1' ' A' ' 214' ' ' ILE . . . -125.92 136.76 53.4 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.419 1.074 . . . . 72.140000000000001 109.316 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.409 HD13 ' C ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -99.09 126.69 52.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.568 1.168 . . . . 72.310000000000002 109.303 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.74 HG13 ' O ' ' A' ' 211' ' ' PHE . 2.1 t -81.99 125.89 39.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.472 1.107 . . . . 71.310000000000002 109.292 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.491 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.5 OUTLIER -93.08 -28.04 16.59 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 65.340000000000003 109.316 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.66 ' O ' HG12 ' A' ' 162' ' ' VAL . 2.1 m-85 -128.07 -171.93 2.57 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.513 1.133 . . . . 74.409999999999997 110.973 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.524 ' N ' HG12 ' A' ' 178' ' ' VAL . 12.3 t0 -111.27 139.56 46.57 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.516 1.135 . . . . 74.239999999999995 109.363 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.58 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 4.8 t80 -113.11 132.31 55.48 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 73.099999999999994 111.024 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -99.97 101.59 12.73 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.517 1.136 . . . . 71.030000000000001 109.312 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.517 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -55.16 119.21 5.16 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.503 1.127 . . . . 73.540000000000006 109.232 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -115.63 -36.84 4.12 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.419 1.074 . . . . 65.200000000000003 110.341 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.429 ' CB ' ' HB2' ' A' ' 173' ' ' GLU . 5.1 tptt -74.82 152.81 38.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.453 1.096 . . . . 74.409999999999997 109.323 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.34 -28.78 67.15 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.523 1.139 . . . . 64.310000000000002 109.332 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -109.45 28.35 8.62 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.53 1.144 . . . . 72.109999999999999 109.361 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.473 ' HG3' ' CE2' ' A' ' 166' ' ' PHE . 5.6 tp10 -100.61 148.02 25.31 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.463 1.102 . . . . 73.420000000000002 110.247 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.619 HD11 ' HA3' ' A' ' 203' ' ' GLY . 7.7 mt -121.24 141.99 50.35 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 65.200000000000003 109.306 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 166' ' ' PHE . 3.3 m -84.86 155.01 21.92 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.534 1.146 . . . . 63.229999999999997 110.421 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.4 m -142.12 -175.04 4.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.474 1.109 . . . . 74.120000000000005 110.415 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.549 ' H ' HG22 ' A' ' 176' ' ' THR . 13.0 m-85 -139.87 158.33 44.25 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.534 1.146 . . . . 71.120000000000005 111.047 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.0 OUTLIER -67.72 153.64 8.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.49 1.119 . . . . 53.25 109.354 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 37.2 56.71 1.43 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.547 1.155 . . . . 73.140000000000001 110.983 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -120.71 172.33 7.95 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.523 0.778 . . . . 75.0 110.261 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -111.28 119.78 40.04 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.473 1.108 . . . . 74.530000000000001 109.319 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.7 tp -135.88 159.75 40.7 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.422 1.076 . . . . 73.209999999999994 109.283 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 0.4 OUTLIER -122.76 124.78 44.12 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.46 1.1 . . . . 75.349999999999994 110.957 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.773 HD12 ' HB3' ' A' ' 193' ' ' PHE . 23.1 mm -77.54 132.8 31.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.557 1.161 . . . . 75.329999999999998 109.275 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.492 ' C ' HD11 ' A' ' 236' ' ' LEU . 33.9 t -99.65 -27.91 13.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.443 1.089 . . . . 74.239999999999995 108.313 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.818 ' HB3' HG13 ' A' ' 194' ' ' ILE . . . -163.9 177.47 8.54 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.482 1.114 . . . . 41.329999999999998 109.268 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.442 ' NE2' HG21 ' A' ' 231' ' ' ILE . 10.3 p80 -143.54 156.76 44.7 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.431 1.082 . . . . 73.329999999999998 109.632 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.602 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 1.7 t-160 -131.92 116.4 17.11 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.567 1.167 . . . . 74.230000000000004 109.602 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 58.31 20.7 7.49 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.465 1.103 . . . . 64.409999999999997 109.327 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.442 ' HB3' ' CG1' ' A' ' 228' ' ' ILE . 42.5 m 55.79 19.87 3.73 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.438 1.086 . . . . 72.319999999999993 108.331 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 192' ' ' TRP . 4.4 pt-20 -117.02 -32.86 4.91 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.48 1.112 . . . . 73.400000000000006 110.29 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.619 ' HE3' HD22 ' A' ' 206' ' ' LEU . 7.7 m0 -112.4 160.26 17.91 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.542 1.151 . . . . 45.420000000000002 107.999 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.794 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 16.1 m-85 -132.78 161.45 34.05 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.121 . . . . 72.400000000000006 110.94 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.818 HG13 ' HB3' ' A' ' 186' ' ' ALA . 35.5 mm -109.46 120.32 60.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.56 1.162 . . . . 64.010000000000005 109.37 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -96.93 122.85 40.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.12 . . . . 70.5 109.332 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.513 0 O-C-N 124.536 1.148 . . . . 74.310000000000002 109.222 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.619 ' HA3' HD11 ' A' ' 174' ' ' LEU . . . . . . . . 0 CA--C 1.53 0.979 0 N-CA-C 110.995 -0.842 . . . . 41.450000000000003 110.995 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.9 151.97 97.61 Favored 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 120.947 -2.522 . . . . 53.32 111.033 -0.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.93 -164.5 11.08 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.454 1.096 . . . . 71.510000000000005 110.995 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.619 HD22 ' HE3' ' A' ' 192' ' ' TRP . 1.3 mt -109.19 164.6 12.31 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.508 0.769 . . . . 73.230000000000004 109.318 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.62 HG13 ' HB2' ' A' ' 193' ' ' PHE . 0.1 OUTLIER -155.24 137.46 9.95 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.428 1.08 . . . . 64.319999999999993 109.291 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.58 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.2 Cg_endo -75.03 144.32 30.0 Favored 'Trans proline' 0 C--N 1.362 1.243 0 O-C-N 124.44 1.758 . . . . 75.329999999999998 110.991 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.732 HG23 ' CE2' ' A' ' 193' ' ' PHE . 12.6 p -73.41 -16.91 17.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.505 1.128 . . . . 75.010000000000005 109.333 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -77.37 2.35 62.47 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.525 1.141 . . . . 53.020000000000003 110.994 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.74 ' O ' HG13 ' A' ' 162' ' ' VAL . 20.4 m-85 -133.46 23.85 4.06 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.435 0.726 . . . . 74.219999999999999 110.99 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.634 HG21 ' CD2' ' A' ' 193' ' ' PHE . 33.1 m -156.94 148.49 10.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.534 1.146 . . . . 63.210000000000001 109.251 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.491 ' HB2' HD11 ' A' ' 163' ' ' LEU . 3.1 t -133.65 159.29 40.95 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.488 1.117 . . . . 61.009999999999998 109.98 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.868 HG13 HG23 ' A' ' 227' ' ' VAL . 24.2 mm -110.83 102.42 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 72.200000000000003 109.276 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.763 ' C ' HD12 ' A' ' 215' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.324 -0.521 0 O-C-N 124.539 1.149 . . . . 72.549999999999997 109.321 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 77.8 p . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 110.435 -0.209 . . . . 72.310000000000002 110.435 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.53 6.06 17.97 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.534 1.146 . . . . 70.349999999999994 110.995 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -79.43 -179.2 6.67 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.583 0.814 . . . . 73.430000000000007 109.291 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.86 179.98 4.78 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.466 1.104 . . . . 71.120000000000005 109.292 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.868 HG23 HG13 ' A' ' 214' ' ' ILE . 5.6 p -82.1 -32.42 10.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 74.430000000000007 109.296 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.708 ' HA ' HD12 ' A' ' 231' ' ' ILE . 3.0 mp -62.02 -51.36 73.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.41 1.068 . . . . 54.409999999999997 109.323 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -62.1 -19.06 62.58 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.46 1.1 . . . . 64.510000000000005 110.392 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.653 ' O ' HG22 ' A' ' 234' ' ' VAL . 0.8 OUTLIER -88.89 -34.68 16.87 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.49 1.119 . . . . 63.439999999999998 109.263 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.708 HD12 ' HA ' ' A' ' 228' ' ' ILE . 19.5 mt -61.35 -26.39 39.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.534 1.146 . . . . 74.319999999999993 109.284 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -83.57 -11.49 57.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.448 1.092 . . . . 73.25 109.317 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.7 m -93.21 -5.49 49.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.517 1.136 . . . . 71.310000000000002 109.986 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.784 HG21 HD22 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -130.8 7.54 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.429 1.081 . . . . 50.240000000000002 109.317 -179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 4.1 m120 44.44 26.99 0.2 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.463 1.102 . . . . 64.349999999999994 109.288 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.666 HD11 ' HA ' ' A' ' 186' ' ' ALA . 3.5 tp -55.8 113.53 5.86 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.497 1.123 . . . . 71.239999999999995 109.317 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 145.08 31.1 Favored 'Trans proline' 0 C--N 1.361 1.231 0 O-C-N 124.505 1.792 . . . . 72.140000000000001 111.034 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 3.9 p -57.42 161.12 3.62 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.434 1.083 . . . . 73.299999999999997 110.367 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.602 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.8 p -61.32 -24.37 33.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.459 1.1 . . . . 64.200000000000003 109.317 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.513 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 4.4 mm100 -80.85 -36.64 31.19 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.119 . . . . 72.420000000000002 110.31 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -75.4 -25.77 57.88 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.498 1.124 . . . . 61.020000000000003 110.291 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -82.99 -63.61 1.33 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.003 -1.11 . . . . 71.140000000000001 108.003 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -44.04 -30.79 0.78 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.477 1.111 . . . . 61.299999999999997 109.315 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 22.7 t -72.99 -48.16 38.89 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.474 1.109 . . . . 62.32 110.01 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.324 -0.532 0 O-C-N 124.508 1.13 . . . . 60.549999999999997 109.26 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.711 ' CD2' HG11 ' A' ' 234' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 109.277 -0.638 . . . . 51.219999999999999 109.277 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -105.97 126.55 52.32 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.439 1.087 . . . . 75.420000000000002 111.06 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.499 ' HA ' HD13 ' A' ' 214' ' ' ILE . . . -105.66 162.74 13.25 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 51.520000000000003 109.273 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.433 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.0 OUTLIER -130.62 127.51 62.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.471 1.107 . . . . 72.239999999999995 109.26 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.705 ' CG2' HD23 ' A' ' 182' ' ' LEU . 4.9 t -86.14 122.55 38.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.488 1.118 . . . . 62.43 109.318 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.956 ' O ' HG23 ' A' ' 178' ' ' VAL . 0.3 OUTLIER -107.07 -9.42 16.19 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.13 . . . . 75.329999999999998 109.273 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.445 ' O ' HG12 ' A' ' 162' ' ' VAL . 66.7 m-85 -135.13 145.1 47.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.542 1.151 . . . . 75.329999999999998 110.992 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -82.58 104.59 12.96 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.56 1.162 . . . . 75.319999999999993 109.331 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 175' ' ' THR . 1.5 t80 -85.99 122.75 30.48 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.513 1.133 . . . . 62.25 111.007 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.78 99.94 11.3 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.454 1.096 . . . . 75.049999999999997 109.287 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.959 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -47.68 125.45 8.56 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.435 1.084 . . . . 74.120000000000005 109.324 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -120.38 -40.68 2.66 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.496 1.122 . . . . 64.209999999999994 110.289 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.88 170.57 10.88 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.523 1.139 . . . . 62.219999999999999 109.275 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.66 -38.09 62.56 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.497 1.123 . . . . 63.409999999999997 109.299 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -100.07 27.45 5.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.477 1.111 . . . . 63.450000000000003 109.353 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.593 ' OE2' ' CH2' ' A' ' 192' ' ' TRP . 3.5 mm-40 -108.57 153.17 23.76 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 74.409999999999997 110.317 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.959 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 17.3 mt -125.77 159.94 31.07 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.468 1.105 . . . . 63.140000000000001 109.313 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.522 ' N ' ' HB2' ' A' ' 168' ' ' ALA . 15.1 t -101.55 154.04 19.2 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.538 1.149 . . . . 62.310000000000002 110.439 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.3 m -138.25 -168.98 2.48 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.454 1.096 . . . . 74.019999999999996 110.366 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.613 ' H ' HG22 ' A' ' 176' ' ' THR . 54.5 m-85 -138.82 134.33 33.23 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.522 1.139 . . . . 74.430000000000007 111.014 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.956 HG23 ' O ' ' A' ' 163' ' ' LEU . 1.6 p -58.09 146.65 7.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.41 1.069 . . . . 64.129999999999995 109.28 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 58.74 47.17 91.72 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.457 1.098 . . . . 62.530000000000001 110.971 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -121.9 172.37 8.24 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.488 0.758 . . . . 63.109999999999999 110.306 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.414 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.4 OUTLIER -123.25 137.57 54.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.446 1.092 . . . . 64.510000000000005 109.374 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.705 HD23 ' CG2' ' A' ' 162' ' ' VAL . 3.1 pp -158.74 168.19 27.51 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 70.310000000000002 109.25 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.598 ' CE1' ' O ' ' A' ' 184' ' ' ILE . 4.2 t80 -112.13 148.24 34.4 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.487 1.117 . . . . 60.109999999999999 110.997 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.955 HD12 ' HB3' ' A' ' 193' ' ' PHE . 26.4 mm -90.51 134.12 30.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.394 1.059 . . . . 75.439999999999998 109.327 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.49 ' O ' HD11 ' A' ' 236' ' ' LEU . 16.5 t -101.59 -26.02 13.68 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.483 1.114 . . . . 51.310000000000002 108.325 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.707 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -164.27 179.38 6.87 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.135 . . . . 73.099999999999994 109.306 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.691 ' CD2' HG21 ' A' ' 231' ' ' ILE . 9.5 p80 -138.3 148.71 44.93 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 60.130000000000003 109.566 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.526 ' CG ' ' HB2' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -122.17 114.48 20.92 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.507 1.129 . . . . 54.310000000000002 109.555 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.438 ' C ' ' N ' ' A' ' 191' ' ' GLU . 2.4 m-20 55.8 27.42 10.83 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.541 1.151 . . . . 73.010000000000005 109.272 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 1.5 p 50.81 20.04 0.71 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.569 1.168 . . . . 72.329999999999998 108.303 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.445 ' O ' HG12 ' A' ' 209' ' ' VAL . 1.3 pt-20 -125.0 -10.45 7.14 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.497 1.123 . . . . 71.209999999999994 110.335 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.593 ' CH2' ' OE2' ' A' ' 173' ' ' GLU . 6.8 m95 -130.68 166.58 20.42 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.961 -1.126 . . . . 75.25 107.961 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.955 ' HB3' HD12 ' A' ' 184' ' ' ILE . 31.3 m-85 -139.59 163.31 32.89 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.427 1.079 . . . . 73.430000000000007 110.994 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.707 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 30.0 mm -109.35 117.67 55.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.506 1.129 . . . . 74.109999999999999 109.283 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.505 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -100.43 145.29 28.42 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 64.209999999999994 109.336 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.618 ' HD3' HG22 ' A' ' 194' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 O-C-N 124.534 1.146 . . . . 72.230000000000004 109.228 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.748 ' HA2' HD11 ' A' ' 174' ' ' LEU . . . . . . . . 0 CA--C 1.53 0.975 0 N-CA-C 111.04 -0.824 . . . . 65.25 111.04 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 170.47 71.76 Favored 'Cis proline' 0 C--N 1.359 1.101 0 C-N-CA 121.008 -2.497 . . . . 71.120000000000005 110.986 -0.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.473 ' HA3' HD12 ' A' ' 174' ' ' LEU . . . -134.9 167.06 24.17 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.502 1.126 . . . . 42.420000000000002 110.976 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.575 ' HB3' ' CE3' ' A' ' 192' ' ' TRP . 3.2 mt -108.68 155.32 20.85 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.483 0.755 . . . . 63.340000000000003 109.311 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.731 HG21 HG11 ' A' ' 212' ' ' VAL . 0.2 OUTLIER -156.42 118.28 2.21 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.57 1.169 . . . . 74.420000000000002 109.294 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.509 ' HD3' ' CZ3' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -75.04 137.94 22.28 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.544 1.813 . . . . 61.119999999999997 111.0 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.562 ' HB ' ' CE2' ' A' ' 193' ' ' PHE . 13.3 p -58.26 -17.32 9.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.516 1.135 . . . . 71.319999999999993 109.314 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -71.44 -3.87 55.13 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 124.453 1.096 . . . . 53.340000000000003 111.047 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -128.73 2.39 5.45 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.405 0.709 . . . . 71.439999999999998 111.063 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.731 HG11 HG21 ' A' ' 207' ' ' VAL . 14.8 m -143.34 163.88 16.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.439 1.087 . . . . 74.230000000000004 109.246 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.624 ' HB2' HD11 ' A' ' 163' ' ' LEU . 1.4 t -144.87 160.61 41.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.133 . . . . 71.319999999999993 109.981 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.696 HG13 HG23 ' A' ' 227' ' ' VAL . 28.1 mm -109.23 138.24 37.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.464 1.103 . . . . 62.539999999999999 109.349 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.514 1.134 . . . . 62.119999999999997 109.269 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 69.1 p . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 110.462 -0.199 . . . . 75.439999999999998 110.462 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 105.42 0.53 40.53 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.578 1.174 . . . . 51.43 111.014 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.549 ' N ' HD22 ' A' ' 225' ' ' ASN . 1.2 m-80 -74.97 -176.15 2.83 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.541 0.789 . . . . 75.299999999999997 109.345 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.22 158.57 38.67 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.493 1.121 . . . . 64.209999999999994 109.285 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.816 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 8.6 p -77.46 -34.86 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.504 1.127 . . . . 74.200000000000003 109.334 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.619 ' HA ' HD12 ' A' ' 231' ' ' ILE . 1.1 mp -52.1 -47.6 43.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 124.502 1.126 . . . . 72.140000000000001 109.227 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 233' ' ' SER . 7.0 mt-10 -66.75 -35.32 79.83 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.573 1.17 . . . . 62.0 110.268 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.24 -27.8 65.78 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.565 1.166 . . . . 70.239999999999995 109.309 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.691 HG21 ' CD2' ' A' ' 187' ' ' HIS . 26.8 mt -74.49 -40.96 49.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.387 1.054 . . . . 54.350000000000001 109.261 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 26.4 mmtt -83.77 -19.98 34.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.389 1.055 . . . . 71.140000000000001 109.296 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 229' ' ' GLU . 8.7 m -60.59 -23.35 64.61 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.489 1.118 . . . . 62.210000000000001 110.027 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.711 HG11 ' CD2' ' A' ' 158' ' ' LEU . 6.3 p -126.39 21.81 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.549 1.156 . . . . 60.25 109.29 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 53.0 t30 47.36 28.46 1.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.532 1.145 . . . . 73.109999999999999 109.301 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.629 HD23 HG23 ' A' ' 231' ' ' ILE . 10.4 tp -58.45 112.15 4.55 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.135 . . . . 60.119999999999997 109.307 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 149.34 36.66 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.493 1.786 . . . . 74.030000000000001 111.012 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.54 HG22 ' CE1' ' A' ' 187' ' ' HIS . 2.3 p -57.15 149.54 19.37 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.522 1.139 . . . . 75.439999999999998 110.342 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.495 HG11 ' HB2' ' A' ' 188' ' ' HIS . 0.4 OUTLIER -41.18 -31.02 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.109 . . . . 61.140000000000001 109.337 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.444 ' O ' ' CB ' ' A' ' 244' ' ' SER . 58.4 mm-40 -81.37 -49.34 10.79 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.455 1.097 . . . . 73.019999999999996 110.296 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -59.09 -21.84 59.84 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.449 1.093 . . . . 74.329999999999998 110.287 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.402 ' O ' ' N ' ' A' ' 245' ' ' ASN . 4.2 t90 -83.33 -71.17 0.51 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.507 1.129 . . . . 64.329999999999998 108.008 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.9 -24.51 1.5 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.455 1.097 . . . . 74.010000000000005 109.246 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 240' ' ' GLN . 43.9 t -77.4 -39.86 45.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.557 1.16 . . . . 70.239999999999995 110.004 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 242' ' ' TRP . 4.0 t-20 . . . . . 0 C--N 1.325 -0.485 0 O-C-N 124.46 1.1 . . . . 65.310000000000002 109.264 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 158' ' ' LEU . 9.0 mt . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 109.297 -0.631 . . . . 71.450000000000003 109.297 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -160.7 139.78 10.47 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.466 1.104 . . . . 73.510000000000005 111.039 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.411 ' HB2' HG12 ' A' ' 184' ' ' ILE . . . -132.85 162.28 31.96 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.467 1.105 . . . . 44.340000000000003 109.298 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.711 HG21 HD13 ' A' ' 215' ' ' ILE . 0.7 OUTLIER -127.95 121.16 55.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.478 1.111 . . . . 70.329999999999998 109.271 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.979 HG23 HD21 ' A' ' 182' ' ' LEU . 55.9 t -79.11 98.02 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 72.209999999999994 109.323 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.818 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.2 OUTLIER -92.05 35.08 0.99 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.576 1.172 . . . . 73.129999999999995 109.306 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.556 ' HB3' ' CD2' ' A' ' 211' ' ' PHE . 18.2 m-85 -170.98 133.4 0.9 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.469 1.106 . . . . 75.230000000000004 111.014 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.13 102.99 3.16 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.524 1.14 . . . . 62.219999999999999 109.3 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.6 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 7.3 t80 -80.35 153.04 28.61 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.488 1.118 . . . . 74.400000000000006 110.937 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.6 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 11.4 mmmm -112.04 135.21 52.97 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.55 1.156 . . . . 74.25 109.297 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.828 ' HB1' ' OE1' ' A' ' 173' ' ' GLU . . . -84.25 123.81 30.53 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.484 1.115 . . . . 52.049999999999997 109.278 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.439 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 6.5 pt-20 -126.4 -30.62 2.85 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.544 1.153 . . . . 75.319999999999993 110.328 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 3.7 tttt -59.03 -173.72 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.594 1.184 . . . . 70.349999999999994 109.293 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.5 -27.82 17.99 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.523 1.139 . . . . 72.129999999999995 109.319 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.54 28.75 6.49 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.517 1.135 . . . . 71.040000000000006 109.354 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.828 ' OE1' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -71.13 -176.4 1.42 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.448 1.092 . . . . 72.120000000000005 110.271 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.725 HD22 ' HA2' ' A' ' 203' ' ' GLY . 1.6 tp -157.62 113.94 2.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 62.140000000000001 109.285 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 2.0 t -68.95 145.29 53.75 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.562 1.164 . . . . 62.32 110.394 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.645 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.7 m -129.25 -169.5 2.11 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.103 . . . . 65.400000000000006 110.405 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.645 ' H ' HG22 ' A' ' 176' ' ' THR . 29.3 m-85 -138.4 133.73 33.23 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.438 1.087 . . . . 75.450000000000003 111.011 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' ' 177' ' ' TYR . 0.2 OUTLIER -39.41 156.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.515 1.134 . . . . 75.450000000000003 109.354 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 51.02 48.37 46.12 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.441 1.088 . . . . 53.229999999999997 110.991 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.452 ' HB3' ' CD1' ' A' ' 182' ' ' LEU . 7.6 mm-40 -107.36 151.49 25.43 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.53 0.782 . . . . 71.329999999999998 110.202 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.877 ' C ' HD13 ' A' ' 182' ' ' LEU . 0.3 OUTLIER -108.27 127.28 53.71 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.56 1.162 . . . . 53.420000000000002 109.282 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.979 HD21 HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -158.81 168.7 26.12 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.477 1.11 . . . . 64.209999999999994 109.311 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 184' ' ' ILE . 2.0 t80 -114.2 144.34 43.35 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.589 1.18 . . . . 73.409999999999997 111.002 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.501 HD12 ' HB3' ' A' ' 193' ' ' PHE . 9.3 mm -77.68 100.74 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.503 1.127 . . . . 62.25 109.308 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.425 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 1.3 t -73.6 -28.9 62.06 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.475 1.11 . . . . 70.329999999999998 108.246 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.412 ' HB1' ' N ' ' A' ' 239' ' ' VAL . . . -174.36 170.85 3.53 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.539 1.15 . . . . 65.340000000000003 109.352 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.49 ' NE2' HG21 ' A' ' 231' ' ' ILE . 6.4 p80 -129.16 149.51 50.94 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.559 1.162 . . . . 75.239999999999995 109.629 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.526 ' CE1' ' CD ' ' A' ' 240' ' ' GLN . 2.3 t-160 -124.54 114.94 20.08 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.441 1.088 . . . . 72.230000000000004 109.591 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.451 ' C ' ' N ' ' A' ' 191' ' ' GLU . 2.3 m120 53.85 32.8 15.75 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.491 1.12 . . . . 72.230000000000004 109.301 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 12.7 p 42.96 28.23 0.13 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 71.129999999999995 108.314 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.451 ' N ' ' C ' ' A' ' 189' ' ' ASN . 5.0 pt-20 -121.57 -34.79 3.36 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.465 1.103 . . . . 74.400000000000006 110.331 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.47 ' CE3' ' HB3' ' A' ' 206' ' ' LEU . 7.8 m0 -118.04 165.56 13.59 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.534 1.146 . . . . 75.349999999999994 107.945 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.749 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 20.3 m-85 -143.53 157.4 44.46 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 70.120000000000005 111.002 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.441 ' CG2' ' HB2' ' A' ' 204' ' ' PRO . 31.3 mm -95.62 101.93 12.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.497 1.123 . . . . 72.25 109.317 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.577 ' HB2' HG21 ' A' ' 207' ' ' VAL . . . -84.82 168.4 15.15 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.521 1.138 . . . . 54.32 109.245 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 63.119999999999997 109.262 -179.993 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.725 ' HA2' HD22 ' A' ' 174' ' ' LEU . . . . . . . . 0 CA--C 1.531 1.072 0 N-CA-C 110.958 -0.857 . . . . 74.349999999999994 110.958 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.441 ' HB2' ' CG2' ' A' ' 194' ' ' ILE . 18.4 Cg_endo -75.05 -178.72 24.31 Favored 'Cis proline' 0 C--N 1.36 1.153 0 C-N-CA 121.073 -2.47 . . . . 65.430000000000007 111.034 0.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 174' ' ' LEU . . . -133.8 172.38 21.67 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 124.475 1.11 . . . . 74.200000000000003 111.047 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.6 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 2.7 mt -106.41 129.6 54.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 0.754 . . . . 42.43 109.283 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.809 HG12 ' HD2' ' A' ' 208' ' ' PRO . 0.2 OUTLIER -135.88 145.82 54.36 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.471 1.107 . . . . 75.420000000000002 109.308 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.809 ' HD2' HG12 ' A' ' 207' ' ' VAL . 18.2 Cg_endo -75.03 157.68 42.49 Favored 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.515 1.797 . . . . 64.340000000000003 110.977 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.719 HG23 ' HE2' ' A' ' 193' ' ' PHE . 11.2 p -76.23 -20.27 15.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 124.416 1.072 . . . . 75.230000000000004 109.338 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -84.5 5.99 78.9 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.534 1.146 . . . . 32.420000000000002 110.977 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.572 ' CD1' ' HG2' ' A' ' 208' ' ' PRO . 11.5 m-85 -130.17 12.21 5.56 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.507 0.769 . . . . 72.510000000000005 111.023 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.696 HG12 HG22 ' A' ' 162' ' ' VAL . 2.4 m -149.4 148.04 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 62.109999999999999 109.309 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.818 ' HB2' HD21 ' A' ' 163' ' ' LEU . 10.6 t -126.87 147.43 50.06 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.514 1.134 . . . . 72.420000000000002 110.037 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.756 HG13 HG23 ' A' ' 227' ' ' VAL . 22.2 mm -94.12 133.66 34.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.557 1.161 . . . . 74.049999999999997 109.351 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.711 HD13 HG21 ' A' ' 161' ' ' ILE . 9.6 pt . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.442 1.089 . . . . 71.299999999999997 109.273 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.441 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 11.5 p . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 110.423 -0.214 . . . . 71.120000000000005 110.423 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 145.26 -18.47 1.9 Allowed Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.472 1.107 . . . . 20.129999999999999 111.021 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.441 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 2.3 p30 -47.8 172.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.449 0.735 . . . . 74.409999999999997 109.324 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.67 165.31 18.13 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.531 1.144 . . . . 72.540000000000006 109.269 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.756 HG23 HG13 ' A' ' 214' ' ' ILE . 12.3 p -75.55 -44.94 40.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.466 1.104 . . . . 74.409999999999997 109.267 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.779 ' HA ' HD12 ' A' ' 231' ' ' ILE . 1.7 mp -49.42 -54.47 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.42 1.075 . . . . 75.140000000000001 109.324 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.11 -28.67 69.26 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.554 1.159 . . . . 72.109999999999999 110.293 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.11 -14.96 58.09 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.475 1.109 . . . . 73.239999999999995 109.307 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.779 HD12 ' HA ' ' A' ' 228' ' ' ILE . 38.3 mt -83.87 -30.45 7.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.534 1.146 . . . . 72.129999999999995 109.267 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.52 ' CE ' HG22 ' A' ' 231' ' ' ILE . 7.5 mmpt? -82.97 -20.72 34.64 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.507 1.129 . . . . 74.340000000000003 109.332 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 36.8 m -66.41 -39.17 88.83 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.566 1.166 . . . . 72.120000000000005 110.004 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.634 ' O ' HG22 ' A' ' 234' ' ' VAL . 4.2 p -114.82 15.56 8.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.518 1.136 . . . . 42.420000000000002 109.326 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 41.41 29.4 0.1 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.496 1.123 . . . . 72.030000000000001 109.337 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.425 HD21 HG22 ' A' ' 184' ' ' ILE . 6.1 tp -41.37 121.01 2.04 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.524 1.14 . . . . 33.350000000000001 109.293 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 135.65 19.28 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.559 1.82 . . . . 62.009999999999998 111.002 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 2.3 p -57.97 152.36 16.48 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.508 1.13 . . . . 62.25 110.395 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.432 HG11 ' HB2' ' A' ' 188' ' ' HIS . 1.3 p -51.2 -22.9 2.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.544 1.153 . . . . 65.030000000000001 109.322 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.526 ' CD ' ' CE1' ' A' ' 188' ' ' HIS . 8.8 mm100 -86.63 -45.54 10.92 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.465 1.103 . . . . 74.450000000000003 110.366 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -63.86 -25.52 68.2 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.465 1.103 . . . . 72.510000000000005 110.29 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -77.43 -65.87 0.9 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.553 1.158 . . . . 74.5 107.968 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -52.08 -25.36 8.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 1.13 . . . . 70.109999999999999 109.26 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 43.9 t -76.89 -50.37 13.48 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.552 1.158 . . . . 70.510000000000005 110.009 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 . . . . . 0 C--N 1.325 -0.458 0 O-C-N 124.496 1.122 . . . . 73.25 109.331 179.961 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.741 ' CD2' HG11 ' A' ' 234' ' ' VAL . 1.6 mm? . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.274 -0.639 . . . . 72.040000000000006 109.274 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -138.52 122.71 18.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.485 1.116 . . . . 70.430000000000007 111.02 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.621 ' HB2' HG12 ' A' ' 184' ' ' ILE . . . -103.87 174.52 5.83 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.495 1.122 . . . . 74.439999999999998 109.299 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.522 HG21 ' CD1' ' A' ' 215' ' ' ILE . 0.0 OUTLIER -135.98 128.79 46.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.442 1.089 . . . . 72.209999999999994 109.251 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.897 HG21 ' CG2' ' A' ' 176' ' ' THR . 80.9 t -88.95 122.61 40.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.511 1.132 . . . . 74.109999999999999 109.252 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.2 OUTLIER -107.8 2.73 23.79 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.469 1.105 . . . . 73.049999999999997 109.278 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -153.96 131.59 11.44 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.446 1.091 . . . . 73.349999999999994 110.999 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -63.45 104.82 0.67 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.537 1.148 . . . . 74.340000000000003 109.261 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.578 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 7.3 t80 -80.42 139.46 36.48 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.556 1.16 . . . . 74.420000000000002 110.963 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.489 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 26.7 mmmt -98.31 141.92 30.6 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.128 . . . . 54.020000000000003 109.298 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.822 ' HB1' ' OE1' ' A' ' 173' ' ' GLU . . . -92.02 123.39 35.34 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.422 1.076 . . . . 62.32 109.313 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.448 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 5.9 pt-20 -125.61 -29.35 3.18 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.527 1.142 . . . . 72.239999999999995 110.297 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.45 ' HD3' HD13 ' A' ' 206' ' ' LEU . 3.9 tttp -59.15 -173.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.566 1.166 . . . . 74.030000000000001 109.332 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.19 -31.07 17.2 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.43 1.081 . . . . 63.420000000000002 109.332 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.91 27.93 7.04 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.51 1.131 . . . . 73.430000000000007 109.312 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.822 ' OE1' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -67.97 -176.24 0.66 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.478 1.111 . . . . 61.240000000000002 110.302 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.589 HD12 ' HA3' ' A' ' 205' ' ' GLY . 12.3 mt -151.85 132.36 13.86 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.467 1.104 . . . . 74.549999999999997 109.269 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 12.4 t -78.96 127.88 32.57 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.543 1.152 . . . . 74.019999999999996 110.426 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.897 ' CG2' HG21 ' A' ' 162' ' ' VAL . 2.5 m -106.47 -172.67 2.13 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.444 1.09 . . . . 61.229999999999997 110.374 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.603 ' H ' HG22 ' A' ' 176' ' ' THR . 52.0 m-85 -143.86 133.56 23.72 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.509 1.131 . . . . 74.349999999999994 110.972 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.435 ' CG2' ' N ' ' A' ' 179' ' ' GLY . 1.3 p -51.84 161.37 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.468 1.105 . . . . 75.010000000000005 109.249 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 37.56 51.47 1.86 Allowed Glycine 0 CA--C 1.531 1.057 0 O-C-N 124.533 1.146 . . . . 75.140000000000001 111.005 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.513 ' HG2' HD12 ' A' ' 182' ' ' LEU . 20.3 tt0 -121.85 167.59 12.84 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.555 0.797 . . . . 72.150000000000006 110.288 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.444 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.4 OUTLIER -119.58 120.99 38.32 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.508 1.13 . . . . 43.420000000000002 109.302 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.513 HD12 ' HG2' ' A' ' 180' ' ' GLU . 0.6 OUTLIER -138.02 156.9 47.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.417 1.073 . . . . 45.329999999999998 109.319 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -102.77 129.24 49.36 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.474 1.109 . . . . 71.540000000000006 111.035 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.686 HD12 ' HB3' ' A' ' 193' ' ' PHE . 25.1 mm -77.65 121.32 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 73.230000000000004 109.298 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.499 ' O ' HD11 ' A' ' 236' ' ' LEU . 0.9 OUTLIER -88.66 -26.77 21.68 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.557 1.161 . . . . 63.130000000000003 108.299 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -171.8 176.94 3.48 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.461 1.101 . . . . 74.450000000000003 109.272 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.598 ' CE1' HG21 ' A' ' 231' ' ' ILE . 8.3 p80 -137.27 151.89 49.19 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.495 1.122 . . . . 75.340000000000003 109.565 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.638 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.3 t-160 -124.61 114.72 19.74 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.129 . . . . 74.430000000000007 109.566 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.449 ' C ' ' N ' ' A' ' 191' ' ' GLU . 2.7 t30 54.18 33.21 17.51 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.484 1.115 . . . . 54.149999999999999 109.283 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 12.8 p 43.06 28.43 0.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.595 1.185 . . . . 75.540000000000006 108.237 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.8 ' O ' HG12 ' A' ' 209' ' ' VAL . 5.3 pt-20 -122.17 -34.88 3.24 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.539 1.149 . . . . 64.310000000000002 110.257 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.545 ' HE3' HD22 ' A' ' 206' ' ' LEU . 11.9 m0 -116.32 164.73 14.09 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.572 1.17 . . . . 74.340000000000003 108.005 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.736 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 16.6 m-85 -135.5 159.66 40.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.509 1.131 . . . . 72.400000000000006 111.002 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.469 ' CG1' ' HB ' ' A' ' 239' ' ' VAL . 20.2 mm -103.49 119.57 52.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.508 1.13 . . . . 73.109999999999999 109.303 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.77 175.98 5.45 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.489 1.118 . . . . 72.209999999999994 109.307 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.524 1.14 . . . . 70.209999999999994 109.305 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.948 0 N-CA-C 110.995 -0.842 . . . . 72.209999999999994 110.995 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.99 153.3 99.09 Favored 'Cis proline' 0 C--N 1.36 1.174 0 C-N-CA 121.033 -2.486 . . . . 62.119999999999997 110.97 0.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.589 ' HA3' HD12 ' A' ' 174' ' ' LEU . . . -117.25 178.33 17.03 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.503 1.127 . . . . 71.310000000000002 110.963 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.545 HD22 ' HE3' ' A' ' 192' ' ' TRP . 1.3 mt -118.88 165.19 14.36 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.437 0.728 . . . . 73.400000000000006 109.334 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.735 HG21 HG11 ' A' ' 212' ' ' VAL . 0.2 OUTLIER -162.66 129.96 2.6 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.443 1.089 . . . . 74.120000000000005 109.317 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.578 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.4 Cg_endo -74.9 137.58 22.14 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.488 1.783 . . . . 71.349999999999994 110.991 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.8 HG12 ' O ' ' A' ' 191' ' ' GLU . 7.3 p -67.14 -27.16 38.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.515 1.134 . . . . 71.299999999999997 109.251 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -68.81 -13.36 66.11 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.538 1.149 . . . . 34.240000000000002 111.017 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 7.8 m-30 -113.11 3.16 15.96 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.486 0.757 . . . . 71.310000000000002 111.007 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.842 HG12 HG22 ' A' ' 162' ' ' VAL . 15.0 m -140.08 173.78 9.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.541 1.15 . . . . 64.25 109.319 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.686 ' HB2' HD11 ' A' ' 163' ' ' LEU . 2.9 t -152.09 160.76 43.35 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.519 1.137 . . . . 34.009999999999998 109.995 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.682 HG13 HG23 ' A' ' 227' ' ' VAL . 19.1 mm -104.05 96.59 4.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.55 1.156 . . . . 62.219999999999999 109.314 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.522 ' CD1' HG21 ' A' ' 161' ' ' ILE . 1.2 pt . . . . . 0 C--N 1.324 -0.504 0 O-C-N 124.504 1.128 . . . . 74.340000000000003 109.353 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.425 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 12.6 p . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 110.424 -0.213 . . . . 51.520000000000003 110.424 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 139.65 -19.06 2.99 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.54 1.15 . . . . 54.329999999999998 111.052 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.425 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 2.2 p30 -50.08 176.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.465 0.744 . . . . 72.340000000000003 109.263 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -134.63 157.76 45.79 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.494 1.121 . . . . 65.5 109.312 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.737 HG13 HD12 ' A' ' 228' ' ' ILE . 2.5 p -77.67 -34.49 20.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.493 1.121 . . . . 73.25 109.298 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.737 HD12 HG13 ' A' ' 227' ' ' VAL . 1.9 mp -59.21 -44.87 92.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 124.531 1.145 . . . . 64.340000000000003 109.284 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.95 -45.81 90.69 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.551 1.157 . . . . 63.149999999999999 110.291 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -67.97 -26.0 65.72 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.396 1.06 . . . . 64.540000000000006 109.33 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.718 HD11 HG22 ' A' ' 227' ' ' VAL . 16.8 mt -67.69 -41.56 85.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.507 1.129 . . . . 72.329999999999998 109.332 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.426 ' HE3' HG22 ' A' ' 231' ' ' ILE . 3.4 mmtp -83.94 -20.16 33.43 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.558 1.161 . . . . 75.129999999999995 109.237 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 41.9 m -61.07 -25.73 67.15 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.49 1.119 . . . . 73.230000000000004 110.005 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.741 HG11 ' CD2' ' A' ' 158' ' ' LEU . 7.5 p -126.39 20.73 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.424 1.077 . . . . 72.310000000000002 109.351 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 40.55 30.12 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.504 1.128 . . . . 64.25 109.33 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.502 HD12 ' HD2' ' A' ' 237' ' ' PRO . 12.7 tp -46.88 120.31 6.25 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.426 1.079 . . . . 75.519999999999996 109.277 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.502 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -74.93 131.05 13.92 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.486 1.782 . . . . 72.120000000000005 110.99 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 2.7 p -57.04 157.07 6.18 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.107 . . . . 34.130000000000003 110.418 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.638 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.1 p -46.29 -27.11 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.477 1.111 . . . . 71.329999999999998 109.272 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.402 ' NE2' ' HD3' ' A' ' 243' ' ' LYS . 37.6 mm-40 -86.77 -47.02 9.45 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.514 1.134 . . . . 75.329999999999998 110.39 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -61.4 -20.47 63.09 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.409 1.068 . . . . 71.439999999999998 110.308 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.442 ' C ' ' N ' ' A' ' 244' ' ' SER . 13.9 t90 -88.12 -65.51 1.01 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.958 -1.127 . . . . 75.209999999999994 107.958 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.402 ' HD3' ' NE2' ' A' ' 240' ' ' GLN . 2.9 ptmm? -41.79 -28.87 0.17 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.514 1.134 . . . . 72.129999999999995 109.333 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.442 ' N ' ' C ' ' A' ' 242' ' ' TRP . 1.2 t -73.36 -65.83 0.76 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.453 1.096 . . . . 62.329999999999998 109.994 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.563 1.165 . . . . 54.329999999999998 109.346 179.997 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.584 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 109.236 -0.653 . . . . 71.25 109.236 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -120.01 141.87 49.32 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 74.0 110.993 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.454 ' CB ' HG12 ' A' ' 184' ' ' ILE . . . -140.14 143.21 36.06 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.419 1.075 . . . . 75.450000000000003 109.393 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.494 ' CG1' ' O ' ' A' ' 180' ' ' GLU . 0.8 OUTLIER -121.65 136.0 59.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.463 1.102 . . . . 75.519999999999996 109.313 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.955 HG21 HG21 ' A' ' 176' ' ' THR . 2.5 t -85.58 127.36 40.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.546 1.154 . . . . 45.020000000000003 109.313 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.484 ' O ' HG23 ' A' ' 178' ' ' VAL . 0.1 OUTLIER -96.8 -17.06 20.48 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.563 1.164 . . . . 72.349999999999994 109.338 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.654 ' O ' HG12 ' A' ' 162' ' ' VAL . 42.9 m-85 -137.94 148.46 45.28 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.502 1.127 . . . . 74.230000000000004 111.039 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.02 100.1 0.11 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.54 1.15 . . . . 63.149999999999999 109.299 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.559 ' CE2' ' O ' ' A' ' 174' ' ' LEU . 26.5 t80 -81.34 126.1 31.18 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.137 . . . . 65.140000000000001 111.009 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.39 129.63 55.53 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.539 1.149 . . . . 73.409999999999997 109.273 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.6 122.63 15.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.102 . . . . 64.430000000000007 109.332 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.447 ' CG ' ' N ' ' A' ' 170' ' ' LYS . 9.0 pt-20 -107.85 -43.73 4.39 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.543 1.152 . . . . 71.010000000000005 110.277 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.447 ' N ' ' CG ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -70.0 -176.07 1.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.137 . . . . 70.140000000000001 109.306 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.43 -19.01 30.26 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.515 1.135 . . . . 73.010000000000005 109.317 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -123.52 27.82 7.25 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.496 1.123 . . . . 45.219999999999999 109.327 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -91.88 155.88 17.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.453 1.096 . . . . 61.200000000000003 110.271 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.716 HD23 ' HA3' ' A' ' 205' ' ' GLY . 0.3 OUTLIER -112.45 159.97 18.23 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.484 1.115 . . . . 70.310000000000002 109.316 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 166' ' ' PHE . 13.1 t -118.58 122.8 43.49 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.495 1.122 . . . . 74.109999999999999 110.423 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.955 HG21 HG21 ' A' ' 162' ' ' VAL . 2.2 m -114.61 -168.82 1.43 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.521 1.138 . . . . 65.530000000000001 110.47 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.61 ' H ' HG22 ' A' ' 176' ' ' THR . 14.3 m-85 -134.44 143.6 47.65 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.404 1.065 . . . . 74.430000000000007 110.97 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 163' ' ' LEU . 0.3 OUTLIER -40.46 152.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.478 1.111 . . . . 70.299999999999997 109.321 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 36.93 64.87 0.61 Allowed Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.565 1.165 . . . . 52.520000000000003 110.999 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.494 ' O ' ' CG1' ' A' ' 161' ' ' ILE . 18.3 tt0 -121.72 148.58 44.43 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.48 0.753 . . . . 65.120000000000005 110.328 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.404 ' ND2' ' N ' ' A' ' 181' ' ' ASN . 0.2 OUTLIER -100.82 139.42 36.53 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.493 1.121 . . . . 71.319999999999993 109.301 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.471 HD21 ' CG2' ' A' ' 162' ' ' VAL . 4.5 pp -166.95 163.28 16.05 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.468 1.105 . . . . 65.340000000000003 109.272 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.584 ' CD2' ' O ' ' A' ' 158' ' ' LEU . 1.0 OUTLIER -115.29 134.13 55.4 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.479 1.112 . . . . 72.450000000000003 110.98 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.895 HD12 ' HB3' ' A' ' 193' ' ' PHE . 36.9 mm -78.21 134.0 29.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.506 1.128 . . . . 72.409999999999997 109.242 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.741 ' O ' HD11 ' A' ' 236' ' ' LEU . 3.3 m -96.09 -35.0 11.51 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.517 1.136 . . . . 71.409999999999997 108.297 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.602 ' HB1' ' N ' ' A' ' 239' ' ' VAL . . . -154.0 179.79 8.58 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.471 1.107 . . . . 73.120000000000005 109.28 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.621 ' CE1' HG21 ' A' ' 231' ' ' ILE . 12.7 p80 -147.38 138.53 23.73 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.464 1.102 . . . . 74.129999999999995 109.566 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.552 ' NE2' ' CG ' ' A' ' 240' ' ' GLN . 2.6 t-80 -114.21 116.42 29.02 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.485 1.116 . . . . 74.450000000000003 109.572 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.422 ' C ' ' N ' ' A' ' 191' ' ' GLU . 37.7 m-20 55.69 26.69 9.64 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.483 1.114 . . . . 62.119999999999997 109.276 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.436 ' HB3' ' CD1' ' A' ' 228' ' ' ILE . 3.6 m 49.83 22.8 0.9 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.51 1.131 . . . . 74.510000000000005 108.353 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.927 ' O ' HG23 ' A' ' 209' ' ' VAL . 5.1 pt-20 -116.81 -32.49 5.1 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.375 1.047 . . . . 63.130000000000003 110.335 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.508 ' CD1' ' HG3' ' A' ' 191' ' ' GLU . 19.2 m0 -117.08 159.34 22.71 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.468 1.105 . . . . 72.420000000000002 108.027 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 1.186 ' CE2' HG22 ' A' ' 209' ' ' VAL . 43.7 m-85 -138.4 156.77 47.28 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 52.030000000000001 111.004 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.944 HD11 HD23 ' A' ' 206' ' ' LEU . 0.5 OUTLIER -102.35 107.18 21.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.461 1.101 . . . . 60.240000000000002 109.247 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.676 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -97.85 151.61 20.04 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.476 1.11 . . . . 74.340000000000003 109.298 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.459 ' CG ' ' HA ' ' A' ' 204' ' ' PRO . 8.8 mtpp . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.525 1.14 . . . . 72.040000000000006 109.261 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.665 ' N ' HD11 ' A' ' 174' ' ' LEU . . . . . . . . 0 CA--C 1.531 1.059 0 N-CA-C 111.001 -0.84 . . . . 71.340000000000003 111.001 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.494 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.5 Cg_endo -74.99 134.74 37.3 Favored 'Cis proline' 0 C--N 1.359 1.113 0 C-N-CA 121.003 -2.499 . . . . 73.420000000000002 111.049 -0.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.716 ' HA3' HD23 ' A' ' 174' ' ' LEU . . . -126.86 158.22 20.78 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.431 1.082 . . . . 60.329999999999998 111.045 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.944 HD23 HD11 ' A' ' 194' ' ' ILE . 4.6 mt -81.07 147.55 30.07 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.546 0.792 . . . . 75.340000000000003 109.318 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.676 HG11 ' HB2' ' A' ' 195' ' ' ALA . 0.2 OUTLIER -146.36 125.39 6.53 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.531 1.144 . . . . 64.409999999999997 109.286 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.56 ' HG2' ' CD1' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.96 147.51 34.22 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.524 1.802 . . . . 74.049999999999997 110.997 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 1.186 HG22 ' CE2' ' A' ' 193' ' ' PHE . 3.5 t -63.83 -18.31 22.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.517 1.136 . . . . 73.319999999999993 109.265 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -74.07 -1.8 60.58 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.477 1.111 . . . . 70.420000000000002 111.08 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.829 ' O ' HG13 ' A' ' 162' ' ' VAL . 30.2 m-85 -128.66 2.37 5.5 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.562 0.801 . . . . 60.340000000000003 110.961 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.676 HG12 HG22 ' A' ' 162' ' ' VAL . 35.4 m -148.95 154.41 9.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.578 1.174 . . . . 74.420000000000002 109.251 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 42.3 t -139.63 160.27 40.25 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.491 1.12 . . . . 71.25 110.043 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.745 HG13 HG23 ' A' ' 227' ' ' VAL . 8.4 mm -109.14 164.8 5.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.495 1.122 . . . . 62.25 109.267 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.484 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.421 0 O-C-N 124.488 1.117 . . . . 72.329999999999998 109.264 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.441 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 11.0 p . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 120.559 0.219 . . . . 74.310000000000002 110.468 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 141.93 -17.44 2.57 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.5 1.125 . . . . 63.409999999999997 111.021 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.441 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 1.5 p30 -51.02 174.23 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 0.746 . . . . 71.109999999999999 109.341 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.77 172.96 7.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 54.329999999999998 109.296 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 1.02 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 12.3 p -78.94 -30.9 14.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.133 . . . . 63.210000000000001 109.291 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.77 HD12 HG13 ' A' ' 227' ' ' VAL . 1.4 mp -60.82 -46.49 96.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 63.119999999999997 109.339 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.73 -43.02 99.89 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.558 1.162 . . . . 75.109999999999999 110.304 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.98 -34.32 77.83 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.554 1.159 . . . . 64.430000000000007 109.282 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.621 HG21 ' CE1' ' A' ' 187' ' ' HIS . 38.8 mt -63.25 -46.22 96.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.141 . . . . 74.319999999999993 109.309 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -76.56 -15.73 59.78 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.499 1.125 . . . . 75.129999999999995 109.315 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.0 p -69.55 -40.03 77.06 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.429 1.081 . . . . 72.310000000000002 110.029 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.428 ' O ' HG22 ' A' ' 234' ' ' VAL . 11.3 p -109.4 14.03 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.511 1.132 . . . . 61.409999999999997 109.333 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 234' ' ' VAL . 7.5 t-20 40.35 43.1 1.39 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 71.420000000000002 109.287 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.973 HD12 ' HD2' ' A' ' 237' ' ' PRO . 3.3 tp -66.79 132.2 93.98 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.462 1.101 . . . . 71.010000000000005 109.284 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.973 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -75.03 156.43 42.85 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.478 1.778 . . . . 75.209999999999994 110.997 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 4.2 p -77.98 148.41 34.44 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.492 1.12 . . . . 75.420000000000002 110.336 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.602 ' N ' ' HB1' ' A' ' 186' ' ' ALA . 2.5 p -49.68 -23.57 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.45 1.093 . . . . 73.319999999999993 109.266 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.552 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 75.6 mm-40 -83.98 -41.71 17.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.476 1.11 . . . . 74.219999999999999 110.257 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -70.49 -23.16 62.63 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.432 1.082 . . . . 75.329999999999998 110.33 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -78.52 -59.99 2.56 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.501 1.125 . . . . 74.439999999999998 108.013 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.0 ptmm? -59.62 -17.44 33.48 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.116 . . . . 51.530000000000001 109.27 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.5 t -77.99 -26.51 48.69 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.59 1.181 . . . . 65.120000000000005 109.947 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.5 t30 . . . . . 0 C--N 1.325 -0.497 0 O-C-N 124.48 1.113 . . . . 73.310000000000002 109.25 -179.995 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.751 ' HG ' HG11 ' A' ' 234' ' ' VAL . 9.2 mt . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 109.317 -0.623 . . . . 75.219999999999999 109.317 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.401 ' CG ' ' O ' ' A' ' 158' ' ' LEU . 25.0 m-85 -163.7 118.4 1.58 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.48 1.113 . . . . 73.030000000000001 110.975 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.574 ' HB2' HG12 ' A' ' 184' ' ' ILE . . . -106.25 167.35 9.88 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.505 1.128 . . . . 60.200000000000003 109.361 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.597 HG21 HD11 ' A' ' 215' ' ' ILE . 0.1 OUTLIER -137.48 129.24 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.44 1.087 . . . . 73.109999999999999 109.317 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.803 ' CG2' HD21 ' A' ' 182' ' ' LEU . 2.7 t -81.72 117.73 28.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.538 1.149 . . . . 73.439999999999998 109.273 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.553 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -96.18 -3.86 43.61 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.545 1.153 . . . . 44.310000000000002 109.268 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.731 ' O ' HG12 ' A' ' 162' ' ' VAL . 53.4 m-85 -153.6 153.88 33.17 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.472 1.108 . . . . 71.430000000000007 110.968 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.424 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 11.0 t0 -83.47 103.58 12.94 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.433 1.083 . . . . 74.120000000000005 109.287 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.584 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 1.9 t80 -85.25 125.22 32.71 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.119 . . . . 73.109999999999999 111.0 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.87 115.79 29.64 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.455 1.097 . . . . 64.400000000000006 109.335 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.669 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -40.31 140.55 0.61 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.456 1.098 . . . . 24.449999999999999 109.342 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.467 ' CG ' ' N ' ' A' ' 170' ' ' LYS . 7.9 pt-20 -136.88 -45.28 0.58 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.427 1.079 . . . . 73.430000000000007 110.236 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.467 ' N ' ' CG ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -64.47 -170.7 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.506 1.129 . . . . 73.329999999999998 109.307 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.62 -33.25 20.21 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.432 1.083 . . . . 62.549999999999997 109.273 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.39 9.3 29.83 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.509 1.13 . . . . 73.5 109.254 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.402 ' HB2' ' N ' ' A' ' 170' ' ' LYS . 3.2 mm-40 -75.43 159.89 30.86 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.524 1.14 . . . . 75.340000000000003 110.249 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.669 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 2.8 tp -138.33 159.6 41.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.457 1.098 . . . . 72.120000000000005 109.299 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.2 t -91.64 153.46 19.68 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.496 1.123 . . . . 73.439999999999998 110.389 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 177' ' ' TYR . 3.3 m -139.19 -164.39 1.65 Allowed 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.514 1.134 . . . . 64.140000000000001 110.345 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.685 ' H ' HG22 ' A' ' 176' ' ' THR . 30.9 m-85 -136.8 138.04 40.42 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.546 1.154 . . . . 71.239999999999995 110.972 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.463 ' CG2' ' N ' ' A' ' 179' ' ' GLY . 1.4 p -56.57 163.41 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.452 1.095 . . . . 73.530000000000001 109.285 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.463 ' N ' ' CG2' ' A' ' 178' ' ' VAL . . . 37.59 59.47 1.3 Allowed Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.474 1.109 . . . . 64.109999999999999 110.961 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.491 ' O ' HD13 ' A' ' 161' ' ' ILE . 13.2 tp10 -121.4 166.9 13.43 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.557 0.798 . . . . 73.349999999999994 110.338 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -120.51 122.29 40.3 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.455 1.097 . . . . 62.119999999999997 109.352 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.803 HD21 ' CG2' ' A' ' 162' ' ' VAL . 0.6 OUTLIER -147.0 163.65 35.53 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.103 . . . . 74.540000000000006 109.362 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.591 ' CE1' ' O ' ' A' ' 184' ' ' ILE . 2.2 t80 -110.63 139.12 46.19 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.457 1.098 . . . . 62.039999999999999 111.023 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.591 ' O ' ' CE1' ' A' ' 183' ' ' PHE . 9.6 mm -77.7 120.92 29.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.471 1.107 . . . . 73.549999999999997 109.227 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 5.6 t -91.45 -24.42 19.7 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.432 1.082 . . . . 75.450000000000003 108.27 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.782 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -164.8 179.65 6.39 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.501 1.126 . . . . 75.019999999999996 109.253 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.526 ' CE1' ' HG ' ' A' ' 190' ' ' CYS . 9.3 p80 -149.38 129.86 13.91 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.466 1.104 . . . . 74.099999999999994 109.571 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.655 ' CG ' HG11 ' A' ' 239' ' ' VAL . 0.0 OUTLIER -111.0 119.03 37.69 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.536 1.148 . . . . 72.510000000000005 109.633 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.433 ' C ' ' N ' ' A' ' 191' ' ' GLU . 3.5 m120 54.0 32.82 16.21 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.48 1.112 . . . . 71.129999999999995 109.325 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.526 ' HG ' ' CE1' ' A' ' 187' ' ' HIS . 49.9 m 42.1 29.04 0.12 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 74.209999999999994 108.3 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.575 ' HG3' ' CD1' ' A' ' 192' ' ' TRP . 6.4 pt-20 -120.94 -38.04 2.89 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.509 1.131 . . . . 73.120000000000005 110.312 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.651 ' CB ' ' CD2' ' A' ' 188' ' ' HIS . 27.7 m0 -116.87 164.42 14.7 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.126 . . . . 74.25 107.987 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.724 ' HB2' HG13 ' A' ' 207' ' ' VAL . 39.5 m-85 -141.94 168.93 18.58 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.542 1.151 . . . . 75.400000000000006 110.995 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.782 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 47.0 mm -103.55 109.07 25.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.544 1.153 . . . . 53.439999999999998 109.324 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.748 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -116.57 163.78 15.58 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.488 1.117 . . . . 65.329999999999998 109.321 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 O-C-N 124.483 1.114 . . . . 75.430000000000007 109.267 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.012 0 N-CA-C 110.98 -0.848 . . . . 74.230000000000004 110.98 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.605 ' HB2' HG23 ' A' ' 194' ' ' ILE . 18.2 Cg_endo -74.95 179.42 30.67 Favored 'Cis proline' 0 C--N 1.36 1.181 0 C-N-CA 121.02 -2.492 . . . . 73.219999999999999 110.983 0.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -129.64 161.62 22.85 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.531 1.145 . . . . 52.43 110.967 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.566 ' CD2' ' CD1' ' A' ' 194' ' ' ILE . 9.3 mt -92.91 149.14 21.45 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.514 0.773 . . . . 64.219999999999999 109.272 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.91 HG21 HG11 ' A' ' 212' ' ' VAL . 0.6 OUTLIER -148.5 122.6 4.81 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.123 . . . . 73.430000000000007 109.32 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.584 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.6 Cg_endo -74.91 149.87 37.79 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.502 1.791 . . . . 62.439999999999998 111.026 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.417 ' HB ' ' CE2' ' A' ' 193' ' ' PHE . 5.0 p -63.71 -20.88 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 71.420000000000002 109.293 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -74.57 -0.91 60.01 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.446 1.091 . . . . 75.129999999999995 110.956 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.562 ' CD2' ' HB2' ' A' ' 166' ' ' PHE . 15.8 m-85 -129.8 3.32 4.93 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.491 0.759 . . . . 72.5 111.008 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.91 HG11 HG21 ' A' ' 207' ' ' VAL . 32.9 m -151.89 149.67 13.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 71.120000000000005 109.311 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.44 ' CB ' HD11 ' A' ' 163' ' ' LEU . 1.6 t -131.54 160.93 33.82 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.513 1.133 . . . . 75.519999999999996 109.966 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.827 HG13 HG23 ' A' ' 227' ' ' VAL . 32.1 mm -100.53 106.82 19.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.524 1.14 . . . . 75.349999999999994 109.295 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.597 HD11 HG21 ' A' ' 161' ' ' ILE . 11.0 pt . . . . . 0 C--N 1.324 -0.515 0 O-C-N 124.53 1.144 . . . . 75.140000000000001 109.275 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 69.2 p . . . . . 0 N--CA 1.453 -0.321 0 N-CA-C 110.402 -0.221 . . . . 71.140000000000001 110.402 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 123.86 -18.03 7.6 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.64 1.212 . . . . 43.549999999999997 110.956 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -75.71 177.08 7.12 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.527 0.781 . . . . 71.140000000000001 109.288 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.15 -178.65 3.72 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.524 1.14 . . . . 44.340000000000003 109.332 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.936 HG13 HD12 ' A' ' 228' ' ' ILE . 3.0 p -79.02 -34.25 16.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.531 1.145 . . . . 61.140000000000001 109.336 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.936 HD12 HG13 ' A' ' 227' ' ' VAL . 2.1 mp -65.44 -56.85 13.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.483 1.114 . . . . 52.32 109.334 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -58.29 -21.43 48.89 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.489 1.118 . . . . 71.329999999999998 110.283 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.663 ' O ' HG13 ' A' ' 234' ' ' VAL . 59.0 m-20 -86.8 -34.96 19.38 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.426 1.079 . . . . 72.340000000000003 109.29 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.778 HG23 ' HB3' ' A' ' 236' ' ' LEU . 18.8 mt -64.81 -27.42 42.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.576 1.172 . . . . 61.32 109.338 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.445 ' HE2' HG22 ' A' ' 231' ' ' ILE . 6.3 mmpt? -83.99 -11.59 56.58 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.46 1.1 . . . . 71.310000000000002 109.318 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 68.5 m -95.12 -8.9 35.14 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.464 1.103 . . . . 70.209999999999994 110.019 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.751 HG11 ' HG ' ' A' ' 158' ' ' LEU . 1.0 OUTLIER -127.13 5.98 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.465 1.103 . . . . 72.209999999999994 109.27 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.437 ' N ' ' OD1' ' A' ' 235' ' ' ASN . 0.6 OUTLIER 47.91 30.33 1.94 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.45 1.093 . . . . 72.140000000000001 109.275 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.778 ' HB3' HG23 ' A' ' 231' ' ' ILE . 0.7 OUTLIER -43.95 118.4 2.96 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.408 1.068 . . . . 71.430000000000007 109.261 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 135.57 19.16 Favored 'Trans proline' 0 C--N 1.361 1.211 0 O-C-N 124.453 1.765 . . . . 64.439999999999998 110.977 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 187' ' ' HIS . 2.0 p -69.51 144.07 53.27 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.521 1.138 . . . . 74.430000000000007 110.376 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.655 HG11 ' CG ' ' A' ' 188' ' ' HIS . 7.6 p -51.0 -31.23 10.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.556 1.16 . . . . 70.310000000000002 109.298 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -76.76 -32.07 57.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.127 . . . . 63.329999999999998 110.305 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.405 ' CG ' ' OG1' ' A' ' 238' ' ' THR . 69.0 mt-10 -76.71 -30.01 56.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.517 1.136 . . . . 75.219999999999999 110.274 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -72.88 -54.89 7.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.499 1.124 . . . . 70.340000000000003 108.046 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.88 -29.02 69.29 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.547 1.154 . . . . 64.030000000000001 109.302 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 18.3 t -77.26 -41.25 41.72 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.563 1.164 . . . . 74.439999999999998 110.057 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 . . . . . 0 C--N 1.324 -0.5 0 O-C-N 124.529 1.143 . . . . 74.230000000000004 109.323 179.932 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.665 ' HG ' HG11 ' A' ' 234' ' ' VAL . 13.2 mt . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 109.332 -0.618 . . . . 74.519999999999996 109.332 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.411 ' CD2' ' CE2' ' A' ' 183' ' ' PHE . 1.7 t80 -121.47 122.82 40.59 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.475 1.11 . . . . 72.349999999999994 111.021 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.655 ' HB2' HD13 ' A' ' 214' ' ' ILE . . . -117.82 170.84 8.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.564 1.165 . . . . 63.409999999999997 109.318 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.501 HG21 HD13 ' A' ' 215' ' ' ILE . 0.1 OUTLIER -142.29 126.69 16.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.479 1.112 . . . . 74.340000000000003 109.352 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.766 HG22 ' CZ ' ' A' ' 211' ' ' PHE . 18.1 t -72.04 133.99 30.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.546 1.154 . . . . 74.140000000000001 109.28 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.983 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.5 OUTLIER -113.9 0.33 14.39 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.441 1.088 . . . . 74.109999999999999 109.287 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.497 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 70.1 m-85 -144.66 147.02 32.57 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.581 1.175 . . . . 64.409999999999997 111.023 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -77.58 94.4 4.35 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.477 1.111 . . . . 71.209999999999994 109.298 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.502 ' CZ ' ' OE2' ' A' ' 173' ' ' GLU . 3.9 t80 -88.0 137.72 32.08 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.523 1.139 . . . . 71.120000000000005 110.97 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -119.85 103.38 9.3 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.469 1.106 . . . . 75.540000000000006 109.32 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.549 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -40.27 139.65 0.71 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.478 1.111 . . . . 51.420000000000002 109.278 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -123.73 -41.43 2.25 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.441 1.088 . . . . 63.340000000000003 110.236 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.32 -169.81 1.29 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.509 1.131 . . . . 74.329999999999998 109.304 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.29 -45.35 11.34 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.531 1.144 . . . . 54.509999999999998 109.279 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -94.43 26.59 3.33 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.455 1.097 . . . . 75.349999999999994 109.34 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.502 ' OE2' ' CZ ' ' A' ' 166' ' ' PHE . 2.9 mm-40 -96.82 140.88 30.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.473 1.108 . . . . 63.009999999999998 110.303 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.708 HD23 ' HA3' ' A' ' 205' ' ' GLY . 0.2 OUTLIER -102.53 160.07 14.88 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.545 1.153 . . . . 71.310000000000002 109.297 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.408 ' C ' ' OG1' ' A' ' 176' ' ' THR . 9.9 t -124.16 150.7 44.85 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.541 1.151 . . . . 61.43 110.426 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.684 HG22 ' H ' ' A' ' 177' ' ' TYR . 11.6 m -157.34 -177.11 6.36 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.516 1.135 . . . . 41.409999999999997 110.366 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.684 ' H ' HG22 ' A' ' 176' ' ' THR . 7.6 m-85 -121.03 156.7 31.62 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.46 1.1 . . . . 72.340000000000003 111.057 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 163' ' ' LEU . 1.8 p -59.83 131.25 24.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.559 1.162 . . . . 33.149999999999999 109.28 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 71.76 59.21 4.89 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.465 1.103 . . . . 51.539999999999999 111.032 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 162' ' ' VAL . 5.4 tp10 -122.16 165.76 15.64 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.563 0.802 . . . . 73.540000000000006 110.281 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.447 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.7 OUTLIER -115.63 119.53 36.43 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 51.310000000000002 109.273 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.551 HD13 ' O ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -152.35 158.63 42.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.533 1.146 . . . . 44.219999999999999 109.318 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.42 ' O ' HD22 ' A' ' 182' ' ' LEU . 4.6 m-85 -107.04 170.64 7.83 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 44.210000000000001 110.996 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.934 HD12 ' HB3' ' A' ' 193' ' ' PHE . 32.5 mm -107.9 147.31 12.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.534 1.146 . . . . 62.030000000000001 109.241 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 186' ' ' ALA . 0.1 OUTLIER -106.26 -19.46 13.69 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.535 1.147 . . . . 73.230000000000004 108.313 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.646 ' HA ' HD11 ' A' ' 236' ' ' LEU . . . 179.64 179.63 0.48 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.554 1.159 . . . . 52.329999999999998 109.309 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.687 ' CD2' HG21 ' A' ' 231' ' ' ILE . 6.2 p80 -137.39 152.98 50.23 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.549 1.156 . . . . 75.049999999999997 109.583 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.637 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 1.0 OUTLIER -129.45 112.8 14.15 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.463 1.102 . . . . 75.519999999999996 109.584 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 3.1 m120 57.97 21.24 7.52 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.436 1.085 . . . . 73.120000000000005 109.343 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.583 ' HG ' ' CE1' ' A' ' 187' ' ' HIS . 87.1 m 55.34 19.74 3.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 1.139 . . . . 62.520000000000003 108.336 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 192' ' ' TRP . 3.9 pt-20 -115.94 -30.94 5.91 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.548 1.155 . . . . 62.25 110.299 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.574 ' HE3' HD22 ' A' ' 206' ' ' LEU . 8.5 m0 -116.25 158.99 22.49 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.959 -1.126 . . . . 74.400000000000006 107.959 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.934 ' HB3' HD12 ' A' ' 184' ' ' ILE . 12.8 m-85 -133.92 161.33 35.08 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.534 1.146 . . . . 64.340000000000003 110.96 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.586 HG13 ' HB3' ' A' ' 186' ' ' ALA . 17.7 mm -105.56 85.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.486 1.116 . . . . 55.530000000000001 109.323 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.736 ' CB ' HG11 ' A' ' 207' ' ' VAL . . . -67.48 160.16 28.12 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.481 1.113 . . . . 43.140000000000001 109.345 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.407 ' HB2' ' NZ ' ' A' ' 196' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.465 0 O-C-N 124.558 1.161 . . . . 72.219999999999999 109.306 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.036 0 N-CA-C 111.019 -0.833 . . . . 74.430000000000007 111.019 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.474 ' HB2' ' CG2' ' A' ' 194' ' ' ILE . 18.4 Cg_endo -74.96 172.31 63.61 Favored 'Cis proline' 0 C--N 1.36 1.171 0 C-N-CA 120.95 -2.521 . . . . 32.329999999999998 111.011 -0.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.708 ' HA3' HD23 ' A' ' 174' ' ' LEU . . . -157.59 156.35 27.22 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.471 1.107 . . . . 73.340000000000003 110.947 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.574 HD22 ' HE3' ' A' ' 192' ' ' TRP . 3.1 mt -83.94 134.02 34.68 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.524 0.779 . . . . 73.430000000000007 109.262 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.736 HG11 ' CB ' ' A' ' 195' ' ' ALA . 2.0 m -143.34 151.92 56.04 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.544 1.153 . . . . 74.230000000000004 109.313 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.459 ' HG2' ' HB3' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -75.04 159.5 41.15 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.488 1.783 . . . . 53.030000000000001 111.003 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.69 HG23 ' HE2' ' A' ' 193' ' ' PHE . 3.0 p -84.85 -20.51 8.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.517 1.136 . . . . 65.400000000000006 109.22 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -82.47 11.84 49.22 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.5 1.125 . . . . 73.120000000000005 110.994 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.974 ' CD2' HG13 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -130.33 2.22 4.64 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.434 0.726 . . . . 73.019999999999996 110.943 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.974 HG13 ' CD2' ' A' ' 211' ' ' PHE . 14.3 m -137.8 145.8 28.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.456 1.098 . . . . 63.020000000000003 109.271 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.983 ' HB2' HD11 ' A' ' 163' ' ' LEU . 12.5 t -132.78 131.75 41.47 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 61.439999999999998 110.06 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.823 HG13 HG23 ' A' ' 227' ' ' VAL . 15.6 mm -83.77 149.73 4.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.113 . . . . 72.409999999999997 109.304 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 214' ' ' ILE . 18.9 pt . . . . . 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 73.109999999999999 109.302 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 17.6 p . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.549 0.214 . . . . 73.340000000000003 110.465 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 114.19 21.24 5.64 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.487 1.117 . . . . 63.210000000000001 110.957 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.487 ' ND2' ' N ' ' A' ' 225' ' ' ASN . 0.6 OUTLIER -84.16 171.95 12.36 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.488 0.758 . . . . 52.399999999999999 109.32 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.72 166.62 11.19 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.481 1.113 . . . . 72.439999999999998 109.335 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.823 HG23 HG13 ' A' ' 214' ' ' ILE . 11.2 p -78.92 -44.36 24.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.454 1.096 . . . . 73.219999999999999 109.278 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.637 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.3 mp -51.3 -53.25 16.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.607 1.192 . . . . 75.140000000000001 109.31 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -62.54 -32.76 73.76 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 64.439999999999998 110.275 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -73.91 -25.89 60.23 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.42 1.075 . . . . 71.010000000000005 109.255 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.687 HG21 ' CD2' ' A' ' 187' ' ' HIS . 42.0 mt -72.05 -34.79 51.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.519 1.137 . . . . 62.399999999999999 109.272 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.401 ' HE2' HG22 ' A' ' 231' ' ' ILE . 6.5 mmpt? -78.53 -29.84 46.69 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.466 1.104 . . . . 72.019999999999996 109.332 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.8 m -53.92 -40.78 67.0 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.472 1.108 . . . . 74.319999999999993 109.999 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.665 HG11 ' HG ' ' A' ' 158' ' ' LEU . 4.0 p -107.63 20.19 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.505 1.128 . . . . 74.430000000000007 109.287 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 41.94 28.86 0.1 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.532 1.145 . . . . 72.329999999999998 109.329 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.646 HD11 ' HA ' ' A' ' 186' ' ' ALA . 12.2 tp -47.16 115.53 3.56 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 75.430000000000007 109.281 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.01 147.15 33.51 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.551 1.816 . . . . 72.319999999999993 111.036 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 2.7 p -57.09 149.36 19.5 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.526 1.141 . . . . 71.109999999999999 110.411 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.637 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.4 p -48.78 -28.58 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.528 1.142 . . . . 70.150000000000006 109.291 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.412 ' HG2' ' NE2' ' A' ' 188' ' ' HIS . 76.6 mm-40 -80.17 -45.83 17.42 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.489 1.118 . . . . 71.540000000000006 110.311 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -58.46 -30.07 66.67 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.451 1.094 . . . . 60.329999999999998 110.285 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -76.91 -62.22 1.72 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.511 1.132 . . . . 71.150000000000006 108.003 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.38 -25.8 6.72 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 73.409999999999997 109.319 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 45.8 t -76.89 -36.47 56.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.444 1.09 . . . . 70.420000000000002 110.052 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.469 1.105 . . . . 60.109999999999999 109.302 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.987 0 N-CA-C 111.022 -0.831 . . . . 54.219999999999999 111.022 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.4 ' C ' HD23 ' A' ' 155' ' ' LEU . 18.4 Cg_endo -74.99 143.29 28.89 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.554 1.818 . . . . 60.130000000000003 111.018 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.755 HD23 ' N ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -126.92 -175.27 3.37 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.524 1.14 . . . . 71.519999999999996 109.279 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.43 -10.35 9.24 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.436 1.085 . . . . 62.130000000000003 111.018 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.7 p -150.65 114.52 5.01 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.5 0.765 . . . . 54.030000000000001 110.005 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.681 HD11 ' HB3' ' A' ' 230' ' ' ASP . 6.0 tp -110.96 153.48 25.46 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.445 1.091 . . . . 72.109999999999999 109.301 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.581 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 0.6 OUTLIER -147.8 160.57 42.6 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.521 1.138 . . . . 74.329999999999998 111.023 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.51 ' HB2' ' CD1' ' A' ' 214' ' ' ILE . . . -132.14 175.59 9.12 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 64.310000000000002 109.345 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.496 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -137.41 129.72 42.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.473 1.108 . . . . 60.539999999999999 109.334 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 164' ' ' TYR . 4.1 t -80.86 121.07 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.474 1.109 . . . . 63.32 109.329 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.466 HD11 ' CB ' ' A' ' 213' ' ' SER . 0.7 OUTLIER -100.33 -6.36 25.97 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.534 1.146 . . . . 70.219999999999999 109.28 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.64 ' O ' HG12 ' A' ' 162' ' ' VAL . 88.9 m-85 -148.58 151.65 35.42 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.115 . . . . 73.219999999999999 111.033 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -78.84 112.16 15.72 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.533 1.145 . . . . 52.299999999999997 109.328 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.557 ' CZ ' ' HD3' ' A' ' 208' ' ' PRO . 11.6 t80 -83.27 152.67 25.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.532 1.145 . . . . 72.450000000000003 111.032 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -125.75 116.35 21.48 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.483 1.114 . . . . 75.219999999999999 109.292 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.15 121.42 12.47 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.556 1.16 . . . . 64.200000000000003 109.256 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 170' ' ' LYS . 9.9 pt-20 -110.63 -46.15 3.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.509 1.131 . . . . 73.319999999999993 110.309 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -63.42 179.51 0.44 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.534 1.146 . . . . 74.430000000000007 109.31 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.11 -15.18 41.96 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.551 1.157 . . . . 75.239999999999995 109.317 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.82 10.19 10.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.471 1.107 . . . . 73.400000000000006 109.378 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -77.63 151.34 34.39 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.508 1.13 . . . . 44.409999999999997 110.348 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.642 HD11 ' HA2' ' A' ' 203' ' ' GLY . 14.4 mt -120.75 145.74 47.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.449 1.093 . . . . 65.209999999999994 109.247 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.2 m -88.03 154.33 20.57 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.47 1.107 . . . . 43.420000000000002 110.396 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.69 HG22 ' H ' ' A' ' 177' ' ' TYR . 5.8 m -135.92 -174.57 3.7 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.555 1.159 . . . . 73.109999999999999 110.372 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.69 ' H ' HG22 ' A' ' 176' ' ' THR . 24.5 m-85 -134.13 138.43 45.22 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.461 1.101 . . . . 75.209999999999994 111.01 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 163' ' ' LEU . 1.5 p -55.25 158.32 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.438 1.086 . . . . 55.530000000000001 109.228 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 38.94 57.63 1.99 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.508 1.13 . . . . 42.219999999999999 111.01 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 15.0 tp10 -121.83 166.34 14.52 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.423 0.719 . . . . 53.340000000000003 110.287 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.546 HD22 ' N ' ' A' ' 181' ' ' ASN . 1.5 m-80 -118.58 130.22 55.77 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.438 1.086 . . . . 61.350000000000001 109.268 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.62 HD21 ' CG2' ' A' ' 162' ' ' VAL . 1.8 pp -157.0 -179.73 8.49 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 75.239999999999995 109.297 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -131.45 142.28 49.97 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.428 1.08 . . . . 62.509999999999998 111.024 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.766 HD12 ' HB3' ' A' ' 193' ' ' PHE . 23.3 mm -78.53 141.44 15.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.452 1.095 . . . . 75.340000000000003 109.337 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 3.4 t -103.49 -24.71 13.42 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.504 1.128 . . . . 64.510000000000005 108.294 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.853 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -170.11 179.53 3.5 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.505 1.128 . . . . 72.319999999999993 109.33 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 238' ' ' THR . 7.7 p80 -145.53 142.24 29.01 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 74.420000000000002 109.581 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.637 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.6 t-160 -123.72 120.66 33.34 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.475 1.109 . . . . 63.310000000000002 109.599 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.453 ' C ' ' N ' ' A' ' 191' ' ' GLU . 14.8 m-20 54.14 30.1 11.55 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.119 . . . . 75.540000000000006 109.256 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 11.9 p 43.51 28.29 0.19 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.502 1.126 . . . . 55.25 108.29 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.453 ' N ' ' C ' ' A' ' 189' ' ' ASN . 8.7 pt-20 -123.88 -36.76 2.68 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.491 1.119 . . . . 62.43 110.28 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.53 ' HZ3' HD13 ' A' ' 206' ' ' LEU . 9.0 m0 -110.55 158.52 18.45 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.443 1.089 . . . . 74.420000000000002 108.1 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.766 ' HB3' HD12 ' A' ' 184' ' ' ILE . 8.5 m-85 -131.12 148.49 52.73 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.502 1.126 . . . . 50.229999999999997 110.983 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.864 ' CD1' HD23 ' A' ' 206' ' ' LEU . 12.7 mm -96.34 88.89 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.495 1.122 . . . . 73.109999999999999 109.291 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.469 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -71.04 164.1 26.23 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.506 1.129 . . . . 71.209999999999994 109.315 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -164.82 82.75 1.2 Allowed Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.586 1.179 . . . . 74.349999999999994 109.311 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 152.99 41.19 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.512 1.796 . . . . 73.420000000000002 111.016 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 14.8 pt -103.53 -21.98 5.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.57 1.169 . . . . 71.329999999999998 109.294 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -46.93 -29.4 4.44 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.503 1.127 . . . . 55.310000000000002 111.038 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -138.94 140.34 38.27 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.483 0.755 . . . . 74.239999999999995 110.241 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 49.0 tp -71.04 98.25 1.6 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.569 1.168 . . . . 63.450000000000003 109.311 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -172.04 -135.12 1.9 Allowed Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.475 1.11 . . . . 74.099999999999994 110.959 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.642 ' HA2' HD11 ' A' ' 174' ' ' LEU . . . 51.43 178.3 0.04 OUTLIER Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.949 -0.86 . . . . 61.399999999999999 110.949 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -178.65 24.09 Favored 'Cis proline' 0 C--N 1.361 1.201 0 C-N-CA 121.013 -2.495 . . . . 75.530000000000001 110.941 0.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 195' ' ' ALA . . . -149.13 166.13 29.42 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 124.499 1.124 . . . . 62.340000000000003 110.977 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.864 HD23 ' CD1' ' A' ' 194' ' ' ILE . 6.6 mt -93.51 134.34 35.89 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.61 0.829 . . . . 75.049999999999997 109.253 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.469 HG11 ' HB2' ' A' ' 195' ' ' ALA . 1.8 m -139.1 153.9 71.86 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.537 1.148 . . . . 70.150000000000006 109.284 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.568 ' HG2' ' CD2' ' A' ' 211' ' ' PHE . 18.2 Cg_endo -74.98 155.33 43.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.526 1.803 . . . . 72.099999999999994 110.974 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.678 HG23 ' HE2' ' A' ' 193' ' ' PHE . 3.6 p -81.39 -33.66 12.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.409 1.068 . . . . 64.310000000000002 109.263 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -64.77 -11.03 48.26 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.5 1.125 . . . . 40.43 110.949 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.568 ' CD2' ' HG2' ' A' ' 208' ' ' PRO . 8.2 m-30 -109.89 19.74 18.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.493 0.76 . . . . 74.019999999999996 110.974 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.595 HG21 ' CD2' ' A' ' 193' ' ' PHE . 26.9 m -156.16 141.95 10.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.442 1.089 . . . . 73.010000000000005 109.275 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.466 ' CB ' HD11 ' A' ' 163' ' ' LEU . 1.0 OUTLIER -131.06 148.86 52.79 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.475 1.109 . . . . 73.109999999999999 110.017 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.758 HG13 HG23 ' A' ' 227' ' ' VAL . 12.1 mm -103.95 128.25 57.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.527 1.142 . . . . 75.430000000000007 109.346 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.429 ' O ' ' CE2' ' A' ' 159' ' ' TYR . 0.2 OUTLIER -151.86 156.85 5.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.11 . . . . 54.509999999999998 109.277 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' A' ' 217' ' ' ILE . 12.6 t70 -86.35 167.56 14.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.532 1.145 . . . . 74.430000000000007 109.296 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.416 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 9.6 tt -53.11 113.85 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 71.219999999999999 109.303 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.504 ' HB1' ' CE2' ' A' ' 221' ' ' TYR . . . -172.87 -175.54 1.27 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.558 1.161 . . . . 52.539999999999999 109.296 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 5.1 t -54.61 -45.27 73.63 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.595 1.184 . . . . 73.120000000000005 110.428 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 133.99 79.28 0.13 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.442 1.089 . . . . 74.409999999999997 111.069 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.504 ' CE2' ' HB1' ' A' ' 218' ' ' ALA . 2.7 p90 -139.76 171.01 14.83 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.522 0.778 . . . . 63.329999999999998 110.983 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -107.89 114.18 27.93 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.471 1.107 . . . . 71.120000000000005 109.275 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 17.9 p -72.7 -26.25 61.53 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 61.340000000000003 110.382 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 116.23 4.93 17.69 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 124.481 1.113 . . . . 65.340000000000003 110.928 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.652 ' N ' HD22 ' A' ' 225' ' ' ASN . 0.9 OUTLIER -78.19 -176.32 4.56 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.432 0.724 . . . . 61.32 109.292 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.1 169.88 14.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.554 1.159 . . . . 73.109999999999999 109.273 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.758 HG23 HG13 ' A' ' 214' ' ' ILE . 12.1 p -80.77 -35.28 14.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.474 1.109 . . . . 61.350000000000001 109.254 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.572 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.4 mp -54.16 -50.37 55.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.517 1.136 . . . . 61.100000000000001 109.301 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -59.55 -35.61 74.55 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 74.219999999999999 110.295 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.681 ' HB3' HD11 ' A' ' 158' ' ' LEU . 5.0 m-20 -78.1 -22.93 48.21 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.468 1.105 . . . . 75.019999999999996 109.299 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.745 HG23 ' HB3' ' A' ' 236' ' ' LEU . 35.5 mt -70.61 -36.8 67.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.585 1.178 . . . . 62.210000000000001 109.266 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.625 ' HE2' HG22 ' A' ' 231' ' ' ILE . 6.1 mmpt? -80.72 -13.98 58.52 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.572 1.17 . . . . 73.400000000000006 109.309 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.562 ' O ' HD12 ' A' ' 155' ' ' LEU . 2.7 t -81.18 -44.39 17.91 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.526 1.141 . . . . 72.019999999999996 109.998 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.646 HG12 ' O ' ' A' ' 230' ' ' ASP . 7.7 p -99.17 24.25 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.494 1.121 . . . . 40.240000000000002 109.343 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 41.36 29.13 0.08 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.534 1.146 . . . . 73.310000000000002 109.338 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.745 ' HB3' HG23 ' A' ' 231' ' ' ILE . 1.1 tp -45.21 103.75 0.36 Allowed Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.106 . . . . 73.209999999999994 109.286 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 138.19 22.64 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.561 1.822 . . . . 62.25 111.049 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 7.4 p -57.01 148.88 20.27 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 72.409999999999997 110.411 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.637 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 3.5 p -53.99 -25.43 12.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.535 1.147 . . . . 63.219999999999999 109.323 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.547 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 3.8 mm100 -77.82 -34.36 51.99 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.407 1.067 . . . . 51.229999999999997 110.319 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -82.74 -20.87 35.11 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.553 1.158 . . . . 75.319999999999993 110.303 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.457 ' HE1' HD11 ' A' ' 246' ' ' ILE . 4.3 t90 -80.09 -53.25 6.88 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.516 1.135 . . . . 72.430000000000007 108.022 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -51.61 -28.17 13.42 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.527 1.142 . . . . 62.100000000000001 109.272 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.7 t -73.64 -35.2 65.26 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.451 1.094 . . . . 73.310000000000002 109.999 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -76.11 -24.06 54.95 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.497 1.123 . . . . 74.219999999999999 109.281 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.562 ' O ' ' HB3' ' A' ' 247' ' ' ALA . 8.3 mm -68.93 129.14 33.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.528 1.142 . . . . 64.200000000000003 109.261 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 246' ' ' ILE . . . 74.85 3.89 4.25 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.536 1.148 . . . . 74.219999999999999 109.362 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.04 -59.98 1.85 Allowed 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.499 1.124 . . . . 52.530000000000001 110.366 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -93.5 177.57 5.98 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.477 1.111 . . . . 73.200000000000003 110.955 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -130.87 152.19 50.46 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.445 1.091 . . . . 73.530000000000001 109.273 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -44.54 122.34 3.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.472 1.107 . . . . 51.439999999999998 109.325 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 87.0 p -139.65 179.32 6.64 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.518 1.136 . . . . 70.099999999999994 109.994 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.87 141.49 51.99 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.495 1.122 . . . . 74.140000000000001 109.336 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 19.5 tt -127.96 155.86 39.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.526 1.141 . . . . 64.109999999999999 109.264 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 13.6 t -57.96 144.19 40.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.544 1.152 . . . . 74.239999999999995 110.004 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 34.6 tp -137.58 142.62 41.31 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.513 1.133 . . . . 74.129999999999995 109.302 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -80.34 -161.76 25.18 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.537 1.148 . . . . 54.32 111.042 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.4 t -168.14 134.42 1.98 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.507 0.769 . . . . 74.140000000000001 109.979 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 259' ' ' VAL . 13.7 p -171.41 113.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.482 1.114 . . . . 73.329999999999998 109.283 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 C--N 1.324 -0.523 0 O-C-N 124.524 1.14 . . . . 75.540000000000006 110.258 -179.961 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.058 0 N-CA-C 110.96 -0.856 . . . . 70.030000000000001 110.96 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.95 149.48 36.98 Favored 'Trans proline' 0 C--N 1.359 1.113 0 O-C-N 124.489 1.784 . . . . 53.399999999999999 111.001 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.403 ' H ' HD12 ' A' ' 155' ' ' LEU . 2.4 mp -91.23 -176.4 4.57 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.528 1.143 . . . . 72.25 109.304 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 102.2 6.49 48.14 Favored Glycine 0 CA--C 1.531 1.057 0 O-C-N 124.544 1.153 . . . . 72.230000000000004 111.034 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.0 t -159.71 151.0 19.7 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.559 0.799 . . . . 73.239999999999995 109.973 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.812 ' HG ' HG11 ' A' ' 234' ' ' VAL . 6.5 mt -114.42 165.95 12.2 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.485 1.116 . . . . 64.329999999999998 109.301 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.43 ' CG ' ' C ' ' A' ' 158' ' ' LEU . 35.9 m-85 -154.65 116.73 4.22 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.466 1.104 . . . . 75.040000000000006 111.053 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.481 ' HB2' HD13 ' A' ' 214' ' ' ILE . . . -126.19 168.05 14.59 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.564 1.165 . . . . 51.149999999999999 109.382 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.543 HG21 HD11 ' A' ' 215' ' ' ILE . 0.1 OUTLIER -133.76 130.14 55.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.557 1.16 . . . . 74.010000000000005 109.385 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.843 HG23 HD11 ' A' ' 182' ' ' LEU . 39.7 t -89.66 111.22 22.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 53.200000000000003 109.304 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.64 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.2 OUTLIER -101.97 14.09 32.94 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.551 1.157 . . . . 52.030000000000001 109.287 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.57 ' HB3' ' CD2' ' A' ' 211' ' ' PHE . 63.5 m-85 -152.54 137.9 17.57 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.492 1.12 . . . . 73.049999999999997 111.031 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.417 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 25.8 t0 -80.16 107.96 13.37 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.482 1.114 . . . . 71.239999999999995 109.365 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.598 ' CE2' ' O ' ' A' ' 206' ' ' LEU . 17.1 t80 -80.33 136.58 36.43 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.517 1.136 . . . . 62.509999999999998 111.082 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.26 95.31 6.44 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.502 1.126 . . . . 62.439999999999998 109.316 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.777 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -57.86 133.4 55.4 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.563 1.164 . . . . 60.229999999999997 109.276 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -119.84 -38.63 2.94 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.523 1.139 . . . . 64.019999999999996 110.301 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.1 -177.96 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.517 1.135 . . . . 44.140000000000001 109.291 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.21 -29.95 22.78 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.459 1.099 . . . . 72.209999999999994 109.337 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.73 -11.62 28.76 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.423 1.077 . . . . 61.329999999999998 109.25 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.564 ' C ' ' HB1' ' A' ' 168' ' ' ALA . 8.6 mt-10 -74.74 134.4 41.88 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 75.329999999999998 110.263 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.777 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 5.4 mp -112.67 154.24 26.39 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.544 1.152 . . . . 72.409999999999997 109.329 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 175' ' ' THR . 14.9 t -91.65 115.82 28.37 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.503 1.127 . . . . 62.439999999999998 110.389 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.687 HG22 ' H ' ' A' ' 177' ' ' TYR . 6.0 m -94.0 -173.64 3.18 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.483 1.114 . . . . 71.209999999999994 110.384 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.687 ' H ' HG22 ' A' ' 176' ' ' THR . 37.3 m-85 -136.35 134.34 37.78 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.487 1.117 . . . . 72.430000000000007 110.996 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.625 HG23 ' C ' ' A' ' 163' ' ' LEU . 1.8 p -59.59 149.95 6.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.418 1.074 . . . . 74.340000000000003 109.286 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 68.22 36.77 85.71 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.505 1.128 . . . . 62.020000000000003 111.002 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.494 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 21.7 tp10 -113.42 165.02 12.86 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.527 0.781 . . . . 73.310000000000002 110.295 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.693 ' C ' HD13 ' A' ' 182' ' ' LEU . 2.7 m-80 -129.24 134.68 48.09 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.414 1.071 . . . . 73.549999999999997 109.332 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.843 HD11 HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -167.2 164.48 15.57 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.542 1.151 . . . . 74.109999999999999 109.363 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.566 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 0.6 OUTLIER -99.69 148.08 24.73 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.592 1.183 . . . . 70.25 110.958 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.625 HD12 ' HB3' ' A' ' 193' ' ' PHE . 24.2 mm -77.7 112.9 16.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.49 1.119 . . . . 53.240000000000002 109.296 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.459 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 0.5 OUTLIER -73.87 -27.56 61.13 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.476 1.11 . . . . 33.439999999999998 108.261 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.829 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -171.3 179.58 2.93 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.533 1.146 . . . . 73.150000000000006 109.289 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.522 ' NE2' HG21 ' A' ' 231' ' ' ILE . 9.2 p80 -143.28 143.58 31.77 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.545 1.153 . . . . 61.420000000000002 109.594 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.469 ' HB2' ' CG1' ' A' ' 239' ' ' VAL . 0.1 OUTLIER -124.01 121.58 35.64 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.483 1.115 . . . . 74.140000000000001 109.628 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.466 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 2.5 t-20 53.6 30.59 11.08 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.484 1.115 . . . . 74.409999999999997 109.309 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 13.1 p 42.68 29.0 0.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.125 . . . . 73.319999999999993 108.269 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.604 ' O ' HG12 ' A' ' 209' ' ' VAL . 13.3 pt-20 -123.38 -37.49 2.67 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 75.019999999999996 110.245 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.469 ' CD1' ' HG3' ' A' ' 191' ' ' GLU . 15.8 m0 -112.37 160.48 17.66 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.546 1.154 . . . . 73.439999999999998 107.989 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.859 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 21.0 m-85 -136.81 161.16 36.74 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.502 1.126 . . . . 74.219999999999999 111.016 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.829 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 9.5 mm -97.77 108.53 21.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.456 1.098 . . . . 73.010000000000005 109.317 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.681 ' CB ' HG21 ' A' ' 207' ' ' VAL . . . -99.42 167.98 10.28 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.525 1.14 . . . . 54.420000000000002 109.271 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -153.94 91.79 3.15 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.429 1.081 . . . . 73.549999999999997 109.287 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -162.47 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.198 0 O-C-N 124.518 1.799 . . . . 54.009999999999998 111.004 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.537 ' N ' HD13 ' A' ' 198' ' ' ILE . 0.1 OUTLIER -40.14 126.51 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 75.450000000000003 109.291 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -37.77 115.33 0.35 Allowed Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.546 1.154 . . . . 64.019999999999996 110.975 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 202' ' ' GLY . 44.5 ttt180 -151.23 115.99 5.19 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.451 0.736 . . . . 74.150000000000006 110.337 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 14.8 mt -49.21 94.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.501 1.126 . . . . 32.119999999999997 109.321 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 200' ' ' ARG . . . 165.84 -31.28 0.22 Allowed Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.468 1.105 . . . . 74.129999999999995 111.033 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -72.15 176.05 41.45 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.58 0.812 . . . . 70.120000000000005 111.091 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.472 ' CB ' ' O ' ' A' ' 195' ' ' ALA . 18.4 Cg_endo -75.03 -173.7 12.81 Favored 'Cis proline' 0 C--N 1.36 1.176 0 C-N-CA 121.0 -2.5 . . . . 72.420000000000002 111.027 -0.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.13 172.38 20.71 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.503 1.127 . . . . 73.530000000000001 110.988 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.598 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 6.5 mt -99.4 134.8 41.75 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.484 0.755 . . . . 74.109999999999999 109.316 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.78 HG12 ' HD2' ' A' ' 208' ' ' PRO . 0.7 OUTLIER -134.43 144.27 50.31 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.504 1.128 . . . . 71.099999999999994 109.309 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.78 ' HD2' HG12 ' A' ' 207' ' ' VAL . 18.2 Cg_endo -74.94 138.84 23.73 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.51 1.795 . . . . 62.219999999999999 111.005 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.721 ' HA ' HG22 ' A' ' 212' ' ' VAL . 7.5 p -61.13 -34.78 61.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.46 1.1 . . . . 63.32 109.301 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -61.27 -13.01 34.11 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.557 1.16 . . . . 52.039999999999999 111.031 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 164' ' ' TYR . 4.4 m-85 -113.51 18.41 17.67 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.546 0.792 . . . . 73.099999999999994 111.026 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.721 HG22 ' HA ' ' A' ' 209' ' ' VAL . 11.3 m -153.62 153.58 8.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.499 1.124 . . . . 75.25 109.336 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.64 ' HB2' HD21 ' A' ' 163' ' ' LEU . 1.7 t -139.27 141.55 37.79 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.458 1.098 . . . . 72.129999999999995 110.018 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.63 HG13 HG23 ' A' ' 227' ' ' VAL . 17.6 mm -82.34 91.71 2.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.535 1.147 . . . . 73.409999999999997 109.27 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.543 HD11 HG21 ' A' ' 161' ' ' ILE . 1.6 pt -148.6 131.86 7.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.125 . . . . 54.509999999999998 109.364 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -112.12 17.99 19.08 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.507 1.129 . . . . 71.450000000000003 109.318 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.56 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 61.1 mt -87.9 -35.13 7.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.511 1.132 . . . . 61.109999999999999 109.294 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 217' ' ' ILE . . . 74.51 49.21 0.11 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.499 1.124 . . . . 74.25 109.292 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.522 ' HB ' ' CE2' ' A' ' 221' ' ' TYR . 10.1 p -133.47 -49.48 0.84 Allowed 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.513 1.133 . . . . 70.109999999999999 110.411 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 129.19 -6.61 6.36 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.524 1.14 . . . . 50.109999999999999 110.973 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.522 ' CE2' ' HB ' ' A' ' 219' ' ' THR . 4.9 m-85 -85.8 -179.93 6.92 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.48 0.753 . . . . 54.119999999999997 111.009 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -139.71 155.73 47.2 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.472 1.108 . . . . 62.43 109.336 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 72.0 p -91.94 -17.85 24.57 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.517 1.135 . . . . 73.420000000000002 110.428 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.08 -1.22 22.7 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.467 1.104 . . . . 32.409999999999997 111.01 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -82.25 176.17 9.69 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.475 0.75 . . . . 63.210000000000001 109.261 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.44 171.73 9.72 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.458 1.099 . . . . 72.329999999999998 109.333 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.859 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 12.0 p -80.52 -40.27 19.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.47 1.106 . . . . 70.439999999999998 109.239 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.872 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.4 mp -51.04 -48.51 29.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.156 . . . . 73.340000000000003 109.301 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.03 -33.15 74.82 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.491 1.12 . . . . 55.520000000000003 110.25 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.626 ' O ' HD21 ' A' ' 158' ' ' LEU . 0.6 OUTLIER -76.89 -14.29 59.9 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.574 1.171 . . . . 71.099999999999994 109.292 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.872 HD12 ' HA ' ' A' ' 228' ' ' ILE . 34.6 mt -84.29 -32.4 8.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.483 1.114 . . . . 61.43 109.354 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -84.01 -18.73 36.12 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.421 1.076 . . . . 62.009999999999998 109.288 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 6.8 p -68.66 -29.01 67.39 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.527 1.142 . . . . 63.450000000000003 109.967 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.812 HG11 ' HG ' ' A' ' 158' ' ' LEU . 6.2 p -126.53 21.34 3.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.506 1.129 . . . . 72.299999999999997 109.318 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 40.68 29.74 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.559 1.162 . . . . 73.019999999999996 109.334 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.746 HD22 HD13 ' A' ' 158' ' ' LEU . 22.9 tp -42.11 113.34 1.2 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.521 1.138 . . . . 72.219999999999999 109.325 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 133.72 16.91 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.519 1.799 . . . . 71.239999999999995 110.956 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.522 HG22 ' CE1' ' A' ' 187' ' ' HIS . 9.4 p -57.12 151.56 15.1 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.513 1.133 . . . . 73.230000000000004 110.42 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.469 ' CG1' ' HB2' ' A' ' 188' ' ' HIS . 2.7 p -59.72 -24.89 30.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.549 1.156 . . . . 73.409999999999997 109.281 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -80.05 -28.59 39.22 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.455 1.097 . . . . 74.219999999999999 110.28 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -86.9 -25.06 24.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 74.099999999999994 110.233 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.687 ' CE2' HD11 ' A' ' 246' ' ' ILE . 4.0 t90 -76.75 -52.9 8.73 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.48 1.113 . . . . 63.399999999999999 108.001 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.707 ' HA ' HD12 ' A' ' 246' ' ' ILE . 32.5 pttt -48.1 -28.83 3.11 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.504 1.127 . . . . 65.310000000000002 109.35 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.6 t -81.32 -44.78 17.15 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.457 1.098 . . . . 32.229999999999997 109.98 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.433 ' N ' HD22 ' A' ' 245' ' ' ASN . 1.3 m-80 -63.07 -16.39 59.76 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.543 1.152 . . . . 70.450000000000003 109.26 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.707 HD12 ' HA ' ' A' ' 243' ' ' LYS . 55.5 mt -69.06 129.53 33.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 O-C-N 124.591 1.182 . . . . 64.310000000000002 109.299 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.03 153.71 40.77 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.486 1.116 . . . . 73.329999999999998 109.248 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -162.61 175.49 11.35 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.462 1.101 . . . . 74.219999999999999 110.304 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' ' 248' ' ' ARG . 25.1 t80 -35.07 112.57 0.16 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.128 . . . . 72.200000000000003 110.95 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -115.87 132.72 56.56 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.505 1.128 . . . . 75.140000000000001 109.3 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.99 176.77 7.6 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.477 1.111 . . . . 62.020000000000003 109.264 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 1.5 t -63.88 133.61 53.63 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.554 1.159 . . . . 73.230000000000004 110.07 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -152.82 -177.03 6.01 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.567 1.167 . . . . 74.129999999999995 109.28 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 255' ' ' SER . 19.6 mm -110.14 164.6 6.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.539 1.149 . . . . 74.010000000000005 109.363 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.466 ' N ' HG22 ' A' ' 254' ' ' ILE . 61.2 p -96.76 -175.88 3.42 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.548 1.155 . . . . 71.040000000000006 109.974 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.98 -66.7 0.98 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.528 1.142 . . . . 62.329999999999998 109.281 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 165.28 -170.79 40.38 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.573 1.17 . . . . 74.439999999999998 110.955 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.3 p -125.03 131.37 53.39 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.442 0.73 . . . . 70.019999999999996 109.978 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.8 m -54.55 177.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.547 1.154 . . . . 74.219999999999999 109.351 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 . . . . . 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 73.319999999999993 110.29 179.972 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.94 0 N-CA-C 111.07 -0.812 . . . . 63.009999999999998 111.07 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 107.97 2.61 Favored 'Trans proline' 0 C--N 1.361 1.205 0 O-C-N 124.466 1.772 . . . . 61.420000000000002 111.025 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 16.3 mt -87.51 -27.69 22.47 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.545 1.153 . . . . 75.219999999999999 109.271 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.442 ' H ' HG23 ' A' ' 234' ' ' VAL . . . 52.16 20.22 6.52 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.546 1.154 . . . . 60.32 110.99 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.2 p -166.32 153.49 9.62 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.474 0.75 . . . . 64.439999999999998 110.044 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 1.075 HD12 HD12 ' A' ' 236' ' ' LEU . 8.2 mt -146.64 -178.65 6.28 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.514 1.134 . . . . 62.509999999999998 109.3 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.54 ' CG ' ' O ' ' A' ' 158' ' ' LEU . 76.3 m-85 -164.69 141.62 6.2 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.588 1.18 . . . . 73.120000000000005 111.064 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.731 ' HB3' HD11 ' A' ' 184' ' ' ILE . . . -135.44 130.26 34.5 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.539 1.149 . . . . 35.420000000000002 109.297 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.463 ' CG1' ' O ' ' A' ' 180' ' ' GLU . 1.3 tt -100.83 138.85 23.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.519 1.137 . . . . 73.25 109.28 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 164' ' ' TYR . 2.9 t -90.88 114.21 27.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.456 1.097 . . . . 72.420000000000002 109.275 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.653 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.1 OUTLIER -94.32 12.99 25.02 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.481 1.113 . . . . 63.149999999999999 109.296 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.614 ' O ' HG12 ' A' ' 162' ' ' VAL . 35.3 m-85 -157.98 131.27 7.61 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.562 1.163 . . . . 62.210000000000001 110.969 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -54.06 108.67 0.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 72.040000000000006 109.236 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.586 ' CE2' ' O ' ' A' ' 174' ' ' LEU . 5.7 t80 -80.46 136.71 36.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.447 1.092 . . . . 73.219999999999999 110.992 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -113.68 111.75 22.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.458 1.099 . . . . 61.140000000000001 109.259 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.682 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -63.53 121.65 14.37 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.534 1.146 . . . . 53.439999999999998 109.301 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.452 ' CG ' ' N ' ' A' ' 170' ' ' LYS . 14.7 pt-20 -116.62 -44.41 2.85 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.543 1.152 . . . . 64.310000000000002 110.256 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.473 ' CB ' ' HB2' ' A' ' 173' ' ' GLU . 0.8 OUTLIER -59.78 161.71 6.06 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.537 1.148 . . . . 72.409999999999997 109.324 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.76 -19.61 64.33 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.441 1.088 . . . . 63.219999999999999 109.262 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -124.44 25.22 7.71 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.415 1.072 . . . . 62.039999999999999 109.393 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.473 ' HB2' ' CB ' ' A' ' 170' ' ' LYS . 6.3 tp10 -85.11 157.92 20.55 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 1.118 . . . . 73.519999999999996 110.33 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.682 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -115.86 149.83 38.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.153 . . . . 72.010000000000005 109.335 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 11.6 t -107.72 137.97 44.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.511 1.132 . . . . 74.530000000000001 110.402 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.622 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.5 m -136.54 -164.39 1.56 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.551 1.157 . . . . 65.299999999999997 110.463 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.622 ' H ' HG22 ' A' ' 176' ' ' THR . 76.3 m-85 -140.62 150.49 43.64 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.433 1.083 . . . . 71.319999999999993 111.039 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.428 ' H ' HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -45.81 156.47 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.436 1.085 . . . . 65.519999999999996 109.313 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 37.51 63.81 0.79 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.518 1.136 . . . . 71.150000000000006 111.025 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.463 ' O ' ' CG1' ' A' ' 161' ' ' ILE . 26.5 tp10 -121.85 155.93 34.34 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.541 0.789 . . . . 70.040000000000006 110.321 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.457 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.5 OUTLIER -101.5 126.99 48.37 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.534 1.146 . . . . 71.219999999999999 109.335 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.444 HD12 HG21 ' A' ' 176' ' ' THR . 11.1 mt -146.79 153.21 39.93 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.463 1.102 . . . . 72.230000000000004 109.3 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -111.56 131.73 55.04 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.546 1.154 . . . . 73.439999999999998 111.016 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.731 HD11 ' HB3' ' A' ' 160' ' ' ALA . 31.7 mm -77.71 129.59 37.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 71.040000000000006 109.238 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 1.3 t -103.78 -25.45 13.1 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.457 1.098 . . . . 64.340000000000003 108.288 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.769 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -164.49 171.95 13.94 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.484 1.115 . . . . 63.130000000000003 109.298 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.423 ' CE1' HG21 ' A' ' 231' ' ' ILE . 8.5 p80 -140.23 145.27 37.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.519 1.137 . . . . 72.5 109.616 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.649 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.6 t-160 -122.97 118.28 27.44 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.569 1.168 . . . . 73.430000000000007 109.593 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.45 ' C ' ' N ' ' A' ' 191' ' ' GLU . 57.1 m-80 53.82 31.51 13.22 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.549 1.155 . . . . 52.210000000000001 109.258 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 12.7 p 42.96 28.62 0.14 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 72.400000000000006 108.244 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.45 ' N ' ' C ' ' A' ' 189' ' ' ASN . 6.1 pt-20 -122.54 -36.05 2.99 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.457 1.098 . . . . 72.549999999999997 110.279 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.467 ' HE3' HD22 ' A' ' 206' ' ' LEU . 9.1 m0 -114.07 159.91 19.48 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.486 1.116 . . . . 73.230000000000004 108.01 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.952 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 28.4 m-85 -130.35 157.38 42.73 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.423 1.077 . . . . 74.140000000000001 111.02 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.769 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 22.8 mm -103.44 111.56 33.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.459 1.099 . . . . 60.030000000000001 109.228 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 204' ' ' PRO . . . -98.08 154.85 17.44 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.589 1.181 . . . . 71.439999999999998 109.34 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -142.9 154.64 62.37 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.467 1.104 . . . . 63.399999999999999 109.318 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 163.1 36.01 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.435 1.755 . . . . 75.140000000000001 111.034 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 18.2 tt -70.78 -21.21 22.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.481 1.113 . . . . 75.239999999999995 109.311 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 159.86 53.75 0.01 OUTLIER Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.462 1.101 . . . . 14.109999999999999 111.01 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 48.0 mmm-85 -150.01 -175.87 5.22 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.545 0.791 . . . . 73.420000000000002 110.279 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.25 123.47 30.17 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.503 1.127 . . . . 73.340000000000003 109.279 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 175.57 -96.21 0.1 Allowed Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.475 1.109 . . . . 63.149999999999999 111.005 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -50.14 -178.88 0.02 OUTLIER Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.022 -0.831 . . . . 53.420000000000002 111.022 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 18.2 Cg_endo -75.03 125.38 11.24 Favored 'Cis proline' 0 C--N 1.362 1.241 0 C-N-CA 120.987 -2.506 . . . . 64.310000000000002 110.972 0.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -105.25 172.28 19.47 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.532 1.145 . . . . 62.539999999999999 110.972 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.65 HD23 ' CD1' ' A' ' 194' ' ' ILE . 3.8 mt -106.07 137.23 44.35 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.507 0.769 . . . . 70.349999999999994 109.258 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.76 HG21 HG11 ' A' ' 212' ' ' VAL . 0.1 OUTLIER -132.56 138.59 32.42 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.535 1.147 . . . . 70.049999999999997 109.327 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.57 ' HD3' ' CZ ' ' A' ' 166' ' ' PHE . 18.2 Cg_endo -75.01 144.58 30.37 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.463 1.77 . . . . 71.010000000000005 111.012 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.624 HG23 ' CE2' ' A' ' 193' ' ' PHE . 12.0 p -75.19 -21.84 16.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.545 1.153 . . . . 74.349999999999994 109.316 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -75.68 -7.8 83.7 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.488 1.118 . . . . 73.120000000000005 111.037 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -113.67 -11.2 12.99 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.447 0.733 . . . . 73.230000000000004 111.11 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.76 HG11 HG21 ' A' ' 207' ' ' VAL . 15.4 m -128.48 161.55 36.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.527 1.142 . . . . 73.450000000000003 109.302 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.653 ' HB2' HD21 ' A' ' 163' ' ' LEU . 6.3 t -149.88 153.17 36.25 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.47 1.106 . . . . 73.340000000000003 110.027 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.756 HG13 HG23 ' A' ' 227' ' ' VAL . 12.3 mm -96.46 121.42 46.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 124.546 1.154 . . . . 71.319999999999993 109.295 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.894 HD12 ' HB3' ' A' ' 218' ' ' ALA . 7.6 pt -149.89 156.48 7.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.514 1.134 . . . . 73.409999999999997 109.335 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -85.94 -58.75 2.52 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.533 1.146 . . . . 62.299999999999997 109.311 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.6 mt -152.17 112.64 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.53 1.144 . . . . 73.540000000000006 109.295 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.894 ' HB3' HD12 ' A' ' 215' ' ' ILE . . . -174.33 132.62 0.39 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.43 1.081 . . . . 70.230000000000004 109.368 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 9.5 t -58.14 -30.84 66.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.577 1.173 . . . . 54.409999999999997 110.409 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 173.53 65.7 0.05 OUTLIER Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.524 1.14 . . . . 45.520000000000003 111.038 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.49 ' HB2' ' HB1' ' A' ' 218' ' ' ALA . 65.3 m-85 -137.11 -175.14 3.94 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 0.783 . . . . 75.310000000000002 111.069 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -155.64 109.62 2.83 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.483 1.115 . . . . 75.129999999999995 109.354 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.426 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 58.4 p -45.68 -48.33 15.0 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.485 1.115 . . . . 64.239999999999995 110.447 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 154.08 -22.8 0.68 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.473 1.108 . . . . 71.299999999999997 111.033 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.426 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 21.4 m-80 -62.88 -175.95 0.11 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.45 0.735 . . . . 61.020000000000003 109.318 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -135.04 176.98 8.17 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.47 1.106 . . . . 70.200000000000003 109.254 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.952 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 8.3 p -79.6 -32.95 14.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.524 1.14 . . . . 71.519999999999996 109.342 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.834 HD12 HG13 ' A' ' 227' ' ' VAL . 1.5 mp -57.75 -49.23 81.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.43 1.081 . . . . 72.129999999999995 109.258 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -59.92 -28.89 67.99 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.447 1.092 . . . . 74.140000000000001 110.298 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.44 ' O ' HD11 ' A' ' 158' ' ' LEU . 0.8 OUTLIER -80.75 -31.21 36.02 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.546 1.154 . . . . 42.219999999999999 109.277 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.572 HD11 HG22 ' A' ' 227' ' ' VAL . 24.3 mt -72.72 -39.03 59.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.459 1.099 . . . . 71.120000000000005 109.281 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -76.22 -32.7 59.08 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.536 1.147 . . . . 52.210000000000001 109.258 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.4 m -55.65 -39.86 71.45 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 74.129999999999995 110.04 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.62 HG11 ' HG ' ' A' ' 158' ' ' LEU . 11.8 p -118.58 13.54 7.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.501 1.126 . . . . 50.43 109.316 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 231' ' ' ILE . 8.5 m120 40.46 43.06 1.44 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.542 1.151 . . . . 73.200000000000003 109.321 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 1.075 HD12 HD12 ' A' ' 158' ' ' LEU . 2.1 tt -40.28 140.01 0.99 Allowed Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.525 1.14 . . . . 74.400000000000006 109.306 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.515 ' HD2' HD23 ' A' ' 236' ' ' LEU . 18.2 Cg_endo -75.01 139.23 24.02 Favored 'Trans proline' 0 C--N 1.361 1.207 0 O-C-N 124.566 1.824 . . . . 62.039999999999999 110.996 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.404 HG22 ' CE1' ' A' ' 187' ' ' HIS . 2.3 p -75.13 152.14 38.52 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.504 1.127 . . . . 64.230000000000004 110.41 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.649 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.7 p -53.32 -23.09 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.525 1.14 . . . . 63.149999999999999 109.33 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.498 ' O ' ' CB ' ' A' ' 244' ' ' SER . 99.3 mm-40 -86.06 -50.14 7.26 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.46 1.1 . . . . 63.240000000000002 110.254 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -59.01 -28.91 66.83 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.536 1.147 . . . . 63.350000000000001 110.327 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.645 ' HZ3' HG21 ' A' ' 194' ' ' ILE . 22.0 t90 -80.42 -68.0 0.72 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.98 -1.119 . . . . 75.25 107.98 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.8 pttp -50.41 -23.25 2.28 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.516 1.135 . . . . 72.219999999999999 109.254 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 240' ' ' GLN . 11.3 t -68.57 -59.67 2.97 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.64 1.213 . . . . 72.420000000000002 110.047 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -59.27 -24.33 63.14 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.542 1.151 . . . . 64.340000000000003 109.381 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 3.3 mm -78.47 155.06 5.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 63.329999999999998 109.216 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -43.75 155.91 0.07 Allowed 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.462 1.101 . . . . 65.219999999999999 109.32 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.431 ' C ' ' CD ' ' A' ' 248' ' ' ARG . 0.0 OUTLIER 175.06 -174.4 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.441 1.088 . . . . 75.109999999999999 110.322 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.413 ' N ' ' HD2' ' A' ' 248' ' ' ARG . 0.4 OUTLIER -125.89 172.26 10.04 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.456 1.097 . . . . 75.530000000000001 110.969 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -92.7 -40.66 10.59 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.558 1.161 . . . . 63.25 109.314 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -144.72 145.08 31.53 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.505 1.128 . . . . 52.119999999999997 109.35 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 55.0 m -116.7 163.13 16.59 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.477 1.111 . . . . 62.439999999999998 110.015 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -100.12 18.83 17.62 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.467 1.104 . . . . 74.019999999999996 109.246 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 3.8 pt -93.83 17.8 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.485 1.116 . . . . 73.530000000000001 109.288 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.7 t -97.43 138.32 35.06 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.484 1.115 . . . . 71.219999999999999 109.949 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 256' ' ' LEU . 13.8 mt -123.53 150.44 43.99 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.525 1.14 . . . . 45.32 109.318 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.94 71.79 2.35 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.503 1.127 . . . . 73.200000000000003 110.977 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.5 t -82.72 135.93 34.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.49 0.759 . . . . 54.020000000000003 109.997 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.65 130.25 16.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.433 1.083 . . . . 75.430000000000007 109.326 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.506 0 O-C-N 124.468 1.105 . . . . 72.310000000000002 110.277 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.047 0 N-CA-C 111.016 -0.834 . . . . 41.119999999999997 111.016 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 177.79 8.12 Favored 'Trans proline' 0 C--N 1.361 1.208 0 O-C-N 124.487 1.783 . . . . 73.329999999999998 110.984 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 233' ' ' SER . 7.0 mt -126.15 138.15 53.64 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.582 1.176 . . . . 72.400000000000006 109.368 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 169.03 58.21 0.03 OUTLIER Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.551 1.157 . . . . 54.109999999999999 111.009 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.8 m -166.13 121.36 1.22 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 0.769 . . . . 63.140000000000001 109.997 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.684 HD21 ' OD2' ' A' ' 230' ' ' ASP . 0.5 OUTLIER -164.32 122.68 1.81 Allowed 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.502 1.126 . . . . 53.520000000000003 109.33 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.541 ' CD2' ' HB3' ' A' ' 183' ' ' PHE . 6.0 m-85 -137.41 165.82 25.31 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.493 1.121 . . . . 72.310000000000002 110.985 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.422 ' HB1' ' HB ' ' A' ' 212' ' ' VAL . . . -125.66 150.7 47.38 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.51 1.131 . . . . 65.310000000000002 109.291 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.82 HD12 ' O ' ' A' ' 180' ' ' GLU . 1.0 OUTLIER -113.19 122.74 67.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.514 1.134 . . . . 63.520000000000003 109.287 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.761 HG21 ' CG2' ' A' ' 176' ' ' THR . 19.8 t -76.73 132.31 33.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 64.099999999999994 109.293 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 1.015 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.4 OUTLIER -110.25 -12.38 14.46 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 55.149999999999999 109.294 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.483 ' HB2' ' CD2' ' A' ' 211' ' ' PHE . 85.1 m-85 -143.06 151.57 40.93 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 72.120000000000005 110.939 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.642 ' N ' HG12 ' A' ' 178' ' ' VAL . 0.9 OUTLIER -78.96 104.67 9.75 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.468 1.105 . . . . 64.430000000000007 109.273 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.513 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 1.1 t80 -80.87 109.45 15.45 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 1.127 . . . . 72.219999999999999 110.992 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.485 ' CE ' ' OD2' ' A' ' 165' ' ' ASP . 13.8 mmtp -81.55 94.41 6.88 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.53 1.143 . . . . 65.310000000000002 109.276 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.662 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -43.96 124.4 3.79 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.406 1.066 . . . . 71.439999999999998 109.244 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -119.72 -38.66 2.95 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.493 1.12 . . . . 71.299999999999997 110.269 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.414 ' CB ' ' HB2' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -63.75 165.01 8.99 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.53 1.144 . . . . 74.25 109.29 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.85 -22.57 62.29 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.509 1.131 . . . . 72.409999999999997 109.334 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -117.9 25.25 10.5 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.514 1.134 . . . . 61.140000000000001 109.297 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.529 ' O ' HD22 ' A' ' 174' ' ' LEU . 5.1 tp10 -91.91 147.5 22.92 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.527 1.142 . . . . 74.519999999999996 110.373 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.868 HD12 ' CG ' ' A' ' 197' ' ' PRO . 0.4 OUTLIER -120.02 143.61 47.98 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.403 1.065 . . . . 65.219999999999999 109.287 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.6 t -81.59 143.72 31.77 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.502 1.126 . . . . 63.409999999999997 110.414 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.761 ' CG2' HG21 ' A' ' 162' ' ' VAL . 2.6 m -131.37 -176.75 4.13 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.469 1.105 . . . . 73.25 110.399 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.563 ' H ' HG22 ' A' ' 176' ' ' THR . 6.1 m-85 -130.46 155.48 46.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.468 1.105 . . . . 75.209999999999994 111.017 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.642 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.0 OUTLIER -68.09 156.02 7.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.545 1.153 . . . . 73.549999999999997 109.309 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.47 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 37.45 55.1 1.66 Allowed Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.524 1.14 . . . . 54.119999999999997 111.011 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.82 ' O ' HD12 ' A' ' 161' ' ' ILE . 14.9 tt0 -114.75 165.94 12.28 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.513 0.772 . . . . 63.340000000000003 110.307 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.477 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.0 OUTLIER -125.95 121.02 31.91 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.527 1.142 . . . . 72.319999999999993 109.269 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.423 ' C ' HD12 ' A' ' 182' ' ' LEU . 3.3 pp -140.63 168.27 20.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.462 1.101 . . . . 72.530000000000001 109.325 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.541 ' HB3' ' CD2' ' A' ' 159' ' ' TYR . 11.1 p90 -108.41 134.99 50.44 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.529 1.143 . . . . 63.450000000000003 110.965 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.708 HD12 ' HB3' ' A' ' 193' ' ' PHE . 22.9 mm -77.62 124.67 36.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.482 1.114 . . . . 75.450000000000003 109.304 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.464 ' HB2' HG22 ' A' ' 194' ' ' ILE . 39.7 m -88.59 -22.58 23.44 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.537 1.148 . . . . 71.430000000000007 108.316 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.774 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -172.6 179.19 2.5 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.522 1.139 . . . . 75.349999999999994 109.275 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.421 ' CE1' HG21 ' A' ' 231' ' ' ILE . 8.8 p80 -144.48 153.75 42.21 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.539 1.15 . . . . 73.319999999999993 109.616 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.463 ' HB2' ' CG1' ' A' ' 239' ' ' VAL . 0.2 OUTLIER -132.18 117.11 17.84 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 74.0 109.644 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.78 18.06 5.7 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.462 1.101 . . . . 71.430000000000007 109.319 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 4.0 m 57.92 18.62 5.16 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.452 1.095 . . . . 42.030000000000001 108.305 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.93 ' O ' HG23 ' A' ' 209' ' ' VAL . 11.6 pt-20 -115.97 -33.04 5.21 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.515 1.134 . . . . 71.140000000000001 110.284 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.472 ' HE3' HD22 ' A' ' 206' ' ' LEU . 12.9 m0 -112.58 158.47 19.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.568 1.167 . . . . 73.230000000000004 108.036 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 1.17 ' CE2' HG22 ' A' ' 209' ' ' VAL . 39.8 m-85 -134.44 163.55 29.43 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.466 1.104 . . . . 73.430000000000007 111.027 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.774 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 33.8 mm -105.97 120.67 57.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.596 1.185 . . . . 75.530000000000001 109.262 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.539 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -106.0 163.3 12.87 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.491 1.119 . . . . 74.540000000000006 109.353 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.418 ' HZ1' ' HD3' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -154.94 87.7 3.3 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 74.25 109.295 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.868 ' CG ' HD12 ' A' ' 174' ' ' LEU . 18.2 Cg_endo -75.06 95.03 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.488 1.783 . . . . 72.340000000000003 110.967 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 198' ' ' ILE . 7.8 tp -65.4 163.5 2.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.449 1.093 . . . . 60.240000000000002 109.317 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 113.11 -41.09 2.31 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.506 1.129 . . . . 74.430000000000007 111.015 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 60.3 mmt-85 -125.29 179.86 4.9 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.482 0.754 . . . . 72.310000000000002 110.32 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 11.7 mt -96.68 74.57 2.74 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.481 1.113 . . . . 72.239999999999995 109.32 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -156.01 113.8 0.58 Allowed Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.557 1.161 . . . . 43.229999999999997 110.995 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 133.67 177.4 14.91 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.977 -0.849 . . . . 75.540000000000006 110.977 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.418 ' HD3' ' HZ1' ' A' ' 196' ' ' LYS . 18.1 Cg_endo -75.06 160.11 96.98 Favored 'Cis proline' 0 C--N 1.36 1.147 0 C-N-CA 121.006 -2.497 . . . . 73.340000000000003 110.926 0.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.428 ' HA3' ' CG ' ' A' ' 174' ' ' LEU . . . -120.13 -172.11 14.76 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.5 1.125 . . . . 45.340000000000003 111.006 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.577 HD23 ' CD1' ' A' ' 194' ' ' ILE . 4.4 mt -108.52 154.98 21.16 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.469 0.746 . . . . 53.340000000000003 109.321 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.746 HG21 HG11 ' A' ' 212' ' ' VAL . 0.2 OUTLIER -153.74 119.04 2.78 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.531 1.144 . . . . 54.329999999999998 109.241 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.513 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.5 Cg_endo -74.93 156.68 43.3 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.56 1.821 . . . . 74.109999999999999 111.027 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 1.17 HG22 ' CE2' ' A' ' 193' ' ' PHE . 7.1 t -68.68 -15.33 19.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.473 1.108 . . . . 61.25 109.319 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -72.88 -2.5 57.59 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.471 1.107 . . . . 61.240000000000002 110.998 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.483 ' CD2' ' HB2' ' A' ' 164' ' ' TYR . 29.0 m-85 -134.07 11.24 3.91 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.518 0.775 . . . . 73.409999999999997 111.024 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.746 HG11 HG21 ' A' ' 207' ' ' VAL . 14.9 m -148.26 143.99 19.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.508 1.13 . . . . 75.209999999999994 109.307 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 1.015 ' HB2' HD11 ' A' ' 163' ' ' LEU . 9.7 t -128.52 154.61 45.96 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.461 1.101 . . . . 53.420000000000002 110.024 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.689 HG13 HG23 ' A' ' 227' ' ' VAL . 31.6 mm -107.15 141.73 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.47 1.106 . . . . 65.310000000000002 109.279 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.66 157.63 18.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.457 1.098 . . . . 45.009999999999998 109.299 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -136.23 127.47 28.18 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.481 1.113 . . . . 54.32 109.345 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 21.2 tt 42.15 44.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.477 1.111 . . . . 73.430000000000007 109.345 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -134.78 136.37 42.54 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.524 1.14 . . . . 44.130000000000003 109.282 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 219' ' ' THR . 8.8 t -89.09 76.13 7.81 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.486 1.116 . . . . 72.319999999999993 110.394 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.71 -28.51 8.38 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 124.511 1.132 . . . . 61.149999999999999 111.043 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -80.05 -176.41 5.51 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.505 0.768 . . . . 75.540000000000006 111.011 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -131.86 148.93 52.58 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.491 1.12 . . . . 75.109999999999999 109.289 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 55.1 p -92.11 -17.51 24.86 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.43 1.081 . . . . 75.25 110.427 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.87 -2.54 21.28 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.512 1.133 . . . . 74.099999999999994 111.06 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -69.47 171.93 8.01 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.535 0.785 . . . . 72.120000000000005 109.285 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.2 168.31 11.0 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.496 1.122 . . . . 71.409999999999997 109.281 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.883 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 10.4 p -78.47 -34.62 18.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.517 1.135 . . . . 63.43 109.293 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.748 HD12 HG13 ' A' ' 227' ' ' VAL . 1.3 mp -56.54 -50.94 71.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.585 1.178 . . . . 52.539999999999999 109.336 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -63.93 -31.95 73.31 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.541 1.151 . . . . 71.329999999999998 110.3 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.684 ' OD2' HD21 ' A' ' 158' ' ' LEU . 0.5 OUTLIER -70.33 -36.05 74.01 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.508 1.13 . . . . 72.120000000000005 109.307 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.421 HG21 ' CE1' ' A' ' 187' ' ' HIS . 23.0 mt -67.76 -43.03 86.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.496 1.123 . . . . 64.430000000000007 109.345 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 29.9 mmtt -74.36 -21.21 59.79 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.456 1.097 . . . . 64.530000000000001 109.251 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.448 ' O ' HD13 ' A' ' 155' ' ' LEU . 36.9 m -66.75 -37.44 84.62 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.494 1.121 . . . . 74.099999999999994 109.985 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.468 HG11 ' HB2' ' A' ' 158' ' ' LEU . 14.5 p -116.46 11.67 7.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.527 1.142 . . . . 62.149999999999999 109.275 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 57.7 t30 40.48 43.95 1.62 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.549 1.156 . . . . 71.140000000000001 109.282 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.541 HD12 ' HD2' ' A' ' 237' ' ' PRO . 1.6 tp -52.07 142.87 25.94 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.54 1.15 . . . . 65.209999999999994 109.282 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.541 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.3 Cg_endo -74.97 154.1 42.4 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.473 1.775 . . . . 62.219999999999999 110.988 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.411 ' C ' ' N ' ' A' ' 240' ' ' GLN . 3.1 p -94.11 142.06 27.83 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.552 1.158 . . . . 75.329999999999998 110.375 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.463 ' CG1' ' HB2' ' A' ' 188' ' ' HIS . 2.7 p -47.04 -25.5 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.445 1.091 . . . . 62.200000000000003 109.301 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.411 ' N ' ' C ' ' A' ' 238' ' ' THR . 37.3 mm-40 -80.97 -40.92 23.63 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.524 1.14 . . . . 73.519999999999996 110.255 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 238' ' ' THR . 74.9 mt-10 -72.15 -23.44 61.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.526 1.141 . . . . 74.409999999999997 110.323 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.434 ' O ' ' N ' ' A' ' 245' ' ' ASN . 3.5 t90 -77.59 -71.59 0.41 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.532 1.145 . . . . 63.539999999999999 107.979 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.412 ' HB2' ' NZ ' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -44.02 -27.76 0.4 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.561 1.163 . . . . 74.049999999999997 109.259 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.42 ' N ' ' C ' ' A' ' 242' ' ' TRP . 3.0 t -73.58 -46.92 44.35 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 63.200000000000003 110.025 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 242' ' ' TRP . 16.5 t-20 -56.25 -26.32 51.09 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.547 1.154 . . . . 72.140000000000001 109.254 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 16.4 mm -79.26 92.79 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.527 1.142 . . . . 52.439999999999998 109.269 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -174.48 116.06 0.19 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.529 1.143 . . . . 74.140000000000001 109.232 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 13.2 mmm-85 -84.5 174.41 10.06 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.52 1.138 . . . . 75.030000000000001 110.311 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 42.49 42.37 2.7 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.446 1.091 . . . . 73.319999999999993 110.975 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -112.75 -70.0 0.83 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.138 . . . . 74.010000000000005 109.252 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -158.6 145.46 17.45 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.496 1.122 . . . . 63.329999999999998 109.34 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 2.2 p -58.13 149.04 24.72 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.514 1.134 . . . . 71.019999999999996 110.007 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -134.5 109.39 8.68 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 72.120000000000005 109.251 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 29.6 mt -134.22 123.85 44.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.468 1.105 . . . . 71.230000000000004 109.278 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 5.4 t -55.16 159.19 2.63 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.465 1.103 . . . . 73.129999999999995 110.012 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 4.7 tp -127.58 94.7 4.03 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.548 1.155 . . . . 55.299999999999997 109.294 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -81.38 158.44 39.73 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.521 1.138 . . . . 70.420000000000002 110.998 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.2 m -116.03 -9.98 11.64 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.548 0.793 . . . . 62.549999999999997 110.017 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 259' ' ' VAL . 2.7 p -64.42 142.37 16.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.502 1.126 . . . . 70.450000000000003 109.325 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.125 . . . . 72.510000000000005 110.302 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.996 0 N-CA-C 110.994 -0.842 . . . . 75.510000000000005 110.994 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 148.32 35.32 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.498 1.788 . . . . 70.409999999999997 110.991 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.4 mt -110.99 162.96 14.32 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.523 1.14 . . . . 64.010000000000005 109.322 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.81 -16.74 6.89 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.519 1.137 . . . . 72.319999999999993 111.001 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.0 p -173.55 153.42 2.31 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.478 0.752 . . . . 72.219999999999999 110.02 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.779 HD11 HG11 ' A' ' 234' ' ' VAL . 0.0 OUTLIER -126.62 158.94 34.99 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.482 1.114 . . . . 75.030000000000001 109.357 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -114.13 135.42 54.05 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.478 1.111 . . . . 72.540000000000006 111.011 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -124.31 163.91 20.71 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 71.200000000000003 109.291 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.655 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -132.69 128.75 57.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.52 1.137 . . . . 73.430000000000007 109.359 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 164' ' ' TYR . 3.0 t -86.93 109.51 19.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.478 1.111 . . . . 71.239999999999995 109.32 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.655 HD23 ' O ' ' A' ' 161' ' ' ILE . 0.1 OUTLIER -97.64 17.34 18.06 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.546 1.154 . . . . 70.219999999999999 109.308 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.691 ' O ' HG12 ' A' ' 162' ' ' VAL . 53.3 m-85 -164.56 147.67 8.93 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.557 1.161 . . . . 64.420000000000002 110.984 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.727 ' H ' HG22 ' A' ' 178' ' ' VAL . 0.2 OUTLIER -73.3 158.6 34.81 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.479 1.112 . . . . 74.409999999999997 109.304 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.602 ' CD1' ' N ' ' A' ' 167' ' ' LYS . 1.9 t80 -135.55 157.85 45.86 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.575 1.172 . . . . 73.109999999999999 111.041 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.602 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 21.5 mmtp -124.76 134.51 52.77 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.483 1.114 . . . . 53.020000000000003 109.294 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.74 ' HB1' ' HB3' ' A' ' 173' ' ' GLU . . . -99.98 124.07 44.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.487 1.117 . . . . 72.010000000000005 109.338 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -117.18 -34.37 4.38 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.496 1.123 . . . . 45.100000000000001 110.304 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -68.82 -179.79 1.55 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.447 1.092 . . . . 72.129999999999995 109.329 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.51 -29.68 22.54 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.474 1.109 . . . . 72.109999999999999 109.294 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.25 21.68 16.13 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.564 1.165 . . . . 71.519999999999996 109.278 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.812 ' O ' HD22 ' A' ' 174' ' ' LEU . 3.9 tt0 -93.44 159.27 15.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.446 1.091 . . . . 72.019999999999996 110.295 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.812 HD22 ' O ' ' A' ' 173' ' ' GLU . 4.6 mm? -133.0 147.18 52.28 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 74.439999999999998 109.289 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 12.2 t -98.21 145.74 26.31 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.484 1.115 . . . . 71.430000000000007 110.355 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.7 m -146.52 -178.11 5.99 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.49 1.119 . . . . 73.140000000000001 110.44 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.542 ' H ' HG22 ' A' ' 176' ' ' THR . 26.7 m-85 -128.97 -179.79 5.31 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.559 1.162 . . . . 74.409999999999997 111.038 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.727 HG22 ' H ' ' A' ' 165' ' ' ASP . 28.8 t -74.26 165.01 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.475 1.109 . . . . 73.319999999999993 109.316 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.464 ' N ' HG12 ' A' ' 178' ' ' VAL . . . 37.57 71.74 0.2 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.507 1.129 . . . . 53.299999999999997 111.023 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -121.91 154.2 37.44 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.488 0.758 . . . . 74.010000000000005 110.208 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -112.75 119.74 39.09 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.561 1.163 . . . . 75.400000000000006 109.327 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.561 ' C ' HD12 ' A' ' 182' ' ' LEU . 0.2 OUTLIER -160.64 -175.42 4.97 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.466 1.104 . . . . 74.099999999999994 109.343 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -133.1 147.2 52.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.134 . . . . 74.439999999999998 111.004 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.768 HD12 ' HB3' ' A' ' 193' ' ' PHE . 30.6 mm -77.62 128.35 38.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.487 1.117 . . . . 74.349999999999994 109.305 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.625 ' HB2' HG22 ' A' ' 194' ' ' ILE . 38.6 m -86.9 -34.38 19.42 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.541 1.151 . . . . 54.530000000000001 108.313 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.554 ' HA ' HD11 ' A' ' 236' ' ' LEU . . . -164.57 179.13 6.85 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.486 1.116 . . . . 73.450000000000003 109.239 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.429 ' CE1' HG21 ' A' ' 231' ' ' ILE . 6.1 p80 -139.85 148.69 42.47 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 73.109999999999999 109.604 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.645 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.8 t-160 -125.18 115.62 20.72 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.453 1.096 . . . . 74.200000000000003 109.569 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.437 ' C ' ' N ' ' A' ' 191' ' ' GLU . 79.6 m-20 53.72 33.1 15.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.438 1.086 . . . . 72.510000000000005 109.268 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 12.6 p 42.95 28.28 0.13 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.55 1.156 . . . . 61.200000000000003 108.297 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.437 ' N ' ' C ' ' A' ' 189' ' ' ASN . 4.4 pt-20 -121.81 -35.43 3.2 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.494 1.121 . . . . 74.109999999999999 110.324 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.825 ' HE3' HD22 ' A' ' 206' ' ' LEU . 10.7 m0 -115.9 165.94 12.53 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.497 1.123 . . . . 73.239999999999995 108.029 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.768 ' HB3' HD12 ' A' ' 184' ' ' ILE . 9.9 m-85 -137.75 155.66 48.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.556 1.16 . . . . 63.310000000000002 111.003 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.625 HG22 ' HB2' ' A' ' 185' ' ' CYS . 20.7 mm -102.14 83.73 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.512 1.132 . . . . 71.040000000000006 109.336 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.645 ' HB3' HG11 ' A' ' 207' ' ' VAL . . . -104.43 179.22 4.33 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.537 1.148 . . . . 62.439999999999998 109.317 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.438 ' HB3' ' CA ' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -177.94 155.72 1.05 Allowed Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.505 1.128 . . . . 73.140000000000001 109.323 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 147.78 34.26 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.592 1.838 . . . . 71.319999999999993 110.996 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 8.7 pt -81.8 173.14 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.539 1.15 . . . . 75.510000000000005 109.326 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 104.41 -56.64 0.55 Allowed Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.476 1.11 . . . . 35.420000000000002 111.038 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 -147.0 145.56 29.77 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.569 0.805 . . . . 75.230000000000004 110.3 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.519 ' C ' HD23 ' A' ' 201' ' ' LEU . 7.9 tt -43.16 112.09 0.33 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.514 1.134 . . . . 52.340000000000003 109.332 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.494 ' O ' HD21 ' A' ' 174' ' ' LEU . . . -118.01 -44.48 0.53 Allowed Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.428 1.08 . . . . 63.229999999999997 110.965 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.438 ' CA ' ' HB3' ' A' ' 196' ' ' LYS . . . -56.51 -178.46 0.41 Allowed Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.995 -0.842 . . . . 71.109999999999999 110.995 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 121.02 7.05 Favored 'Cis proline' 0 C--N 1.36 1.184 0 C-N-CA 121.039 -2.484 . . . . 73.400000000000006 110.977 -0.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.468 ' CA ' ' O ' ' A' ' 195' ' ' ALA . . . -96.92 132.37 10.97 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.537 1.148 . . . . 34.350000000000001 111.055 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.825 HD22 ' HE3' ' A' ' 192' ' ' TRP . 17.9 mt -88.72 125.43 34.85 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.488 0.758 . . . . 74.129999999999995 109.275 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.645 HG11 ' HB3' ' A' ' 195' ' ' ALA . 1.2 m -141.18 149.44 55.3 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.494 1.121 . . . . 73.140000000000001 109.293 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.515 ' HG2' ' CG ' ' A' ' 211' ' ' PHE . 18.2 Cg_endo -74.9 160.28 40.63 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.486 1.782 . . . . 73.340000000000003 111.043 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.675 HG23 ' HE2' ' A' ' 193' ' ' PHE . 3.3 p -81.9 -25.07 9.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.416 1.072 . . . . 72.040000000000006 109.282 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -73.78 -12.04 80.84 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.526 1.141 . . . . 63.140000000000001 111.026 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.515 ' CG ' ' HG2' ' A' ' 208' ' ' PRO . 8.6 m-30 -109.46 24.96 12.36 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.426 0.721 . . . . 75.430000000000007 111.019 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.603 HG21 ' CD2' ' A' ' 193' ' ' PHE . 32.6 m -157.0 145.06 11.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.488 1.118 . . . . 51.030000000000001 109.315 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.49 ' HB2' HD21 ' A' ' 163' ' ' LEU . 21.6 t -134.19 144.59 48.56 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.548 1.155 . . . . 64.519999999999996 109.962 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.478 HG13 HG23 ' A' ' 227' ' ' VAL . 16.3 mm -96.73 96.88 5.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.538 1.149 . . . . 74.519999999999996 109.266 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 1.8 pt -141.16 150.39 20.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.511 1.132 . . . . 62.439999999999998 109.327 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -58.22 -178.73 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.496 1.122 . . . . 73.019999999999996 109.268 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.486 ' N ' HD13 ' A' ' 217' ' ' ILE . 0.0 OUTLIER -100.46 67.39 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.492 1.12 . . . . 73.400000000000006 109.268 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -120.0 -179.34 3.89 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.437 1.086 . . . . 43.439999999999998 109.339 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.405 HG22 ' CE2' ' A' ' 221' ' ' TYR . 6.2 t -42.37 -40.32 2.47 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.539 1.149 . . . . 51.009999999999998 110.381 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 152.07 87.64 0.06 OUTLIER Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.568 1.168 . . . . 61.229999999999997 110.997 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.405 ' CE2' HG22 ' A' ' 219' ' ' THR . 35.4 m-85 -131.65 178.71 6.54 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.463 0.743 . . . . 64.450000000000003 111.022 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -159.22 110.13 2.03 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.462 1.101 . . . . 74.230000000000004 109.3 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 61.1 p -52.04 -25.27 8.18 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.434 1.084 . . . . 72.120000000000005 110.395 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 105.32 -18.1 42.54 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.466 1.104 . . . . 72.239999999999995 111.003 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -58.15 -175.9 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.397 0.704 . . . . 71.340000000000003 109.312 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -123.74 172.68 8.66 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.492 1.12 . . . . 74.409999999999997 109.305 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.709 HG13 HD12 ' A' ' 228' ' ' ILE . 14.7 p -76.58 -38.61 31.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.468 1.105 . . . . 73.430000000000007 109.324 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.709 HD12 HG13 ' A' ' 227' ' ' VAL . 1.8 mp -53.59 -52.92 28.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 74.439999999999998 109.292 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -56.13 -34.93 66.55 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.476 1.11 . . . . 74.340000000000003 110.373 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.425 ' O ' HD21 ' A' ' 158' ' ' LEU . 0.6 OUTLIER -77.49 -26.96 51.75 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.431 1.082 . . . . 74.209999999999994 109.24 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.43 HD11 ' HE1' ' A' ' 193' ' ' PHE . 60.7 mt -71.5 -39.51 70.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.51 1.131 . . . . 60.109999999999999 109.326 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -29.56 60.21 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.477 1.111 . . . . 62.219999999999999 109.286 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 54.8 m -55.57 -44.87 77.28 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.491 1.119 . . . . 42.229999999999997 110.043 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.779 HG11 HD11 ' A' ' 158' ' ' LEU . 7.7 p -111.15 12.84 8.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.569 1.168 . . . . 71.239999999999995 109.309 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 13.7 m120 40.57 38.28 0.58 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.534 1.146 . . . . 70.239999999999995 109.313 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.933 HD12 ' HD2' ' A' ' 237' ' ' PRO . 3.9 tp -40.89 133.51 1.77 Allowed Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.405 1.066 . . . . 72.519999999999996 109.284 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.933 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.3 Cg_endo -75.06 131.89 14.74 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.479 1.779 . . . . 71.430000000000007 110.955 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.444 ' C ' ' N ' ' A' ' 240' ' ' GLN . 2.4 p -68.61 150.46 47.96 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.452 1.095 . . . . 71.109999999999999 110.348 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.645 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.1 p -40.41 -30.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.467 1.104 . . . . 62.450000000000003 109.281 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.444 ' N ' ' C ' ' A' ' 238' ' ' THR . 45.2 mm-40 -81.16 -56.12 4.29 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.474 1.109 . . . . 75.019999999999996 110.325 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -53.94 -22.03 9.32 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.531 1.145 . . . . 61.030000000000001 110.328 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.942 ' CE2' HD11 ' A' ' 246' ' ' ILE . 26.9 t90 -86.91 -60.46 1.98 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 64.140000000000001 108.046 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.722 ' HA ' HD12 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -50.81 -23.48 2.78 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.573 1.171 . . . . 71.299999999999997 109.346 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 32.2 t -81.07 -62.25 1.72 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.491 1.119 . . . . 73.230000000000004 109.963 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -46.15 -48.05 17.43 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.464 1.103 . . . . 63.530000000000001 109.315 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.942 HD11 ' CE2' ' A' ' 242' ' ' TRP . 62.4 mt -42.27 120.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.548 1.155 . . . . 75.25 109.348 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -86.3 -39.15 16.79 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.529 1.143 . . . . 55.350000000000001 109.269 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.408 ' O ' HG22 ' A' ' 246' ' ' ILE . 0.9 OUTLIER -68.93 159.83 31.92 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.487 1.117 . . . . 73.430000000000007 110.319 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 50.57 54.31 11.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 75.140000000000001 110.958 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -96.82 -32.31 12.17 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.458 1.099 . . . . 73.400000000000006 109.3 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -100.99 145.48 28.63 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.527 1.142 . . . . 75.400000000000006 109.242 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 48.5 t -97.86 57.25 1.3 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.525 1.141 . . . . 63.240000000000002 109.905 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -147.96 113.58 5.68 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.494 1.121 . . . . 61.210000000000001 109.262 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 14.6 tt -127.39 21.41 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.453 1.096 . . . . 73.430000000000007 109.237 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 47.8 t -171.51 128.19 0.66 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.462 1.101 . . . . 75.450000000000003 110.016 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 17.5 tp -98.33 -21.94 16.37 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.566 1.167 . . . . 72.129999999999995 109.294 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 126.48 -91.34 0.38 Allowed Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.487 1.117 . . . . 33.409999999999997 111.011 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 88.7 p 43.22 48.03 5.56 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.472 0.748 . . . . 61.539999999999999 109.998 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 49.4 t -92.83 140.97 15.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.462 1.101 . . . . 64.239999999999995 109.286 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 . . . . . 0 C--N 1.324 -0.526 0 O-C-N 124.494 1.122 . . . . 75.549999999999997 110.326 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.989 0 N-CA-C 111.073 -0.811 . . . . 64.420000000000002 111.073 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 119.21 5.56 Favored 'Trans proline' 0 C--N 1.359 1.095 0 O-C-N 124.491 1.785 . . . . 75.209999999999994 111.028 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.48 ' O ' HD12 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -42.82 134.82 3.17 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.454 1.096 . . . . 75.519999999999996 109.304 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.618 ' HA2' HG23 ' A' ' 234' ' ' VAL . . . -169.44 35.19 0.18 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.447 1.092 . . . . 75.319999999999993 110.947 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -177.94 149.7 0.59 Allowed 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.478 0.752 . . . . 75.519999999999996 109.966 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.729 HD11 HD13 ' A' ' 236' ' ' LEU . 0.4 OUTLIER -150.39 154.0 36.99 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.518 1.136 . . . . 73.519999999999996 109.339 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.524 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 1.3 p90 -136.41 155.14 50.44 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.499 1.124 . . . . 74.340000000000003 110.948 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.835 ' HB3' HD11 ' A' ' 184' ' ' ILE . . . -121.59 142.16 50.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.468 1.105 . . . . 74.140000000000001 109.263 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.515 ' O ' ' CD2' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -110.29 133.72 54.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.557 1.161 . . . . 74.310000000000002 109.302 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.957 HG21 HG21 ' A' ' 176' ' ' THR . 2.0 t -76.27 132.17 33.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.511 1.132 . . . . 75.150000000000006 109.31 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.757 ' O ' HG23 ' A' ' 178' ' ' VAL . 0.2 OUTLIER -95.54 -31.56 13.26 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.495 1.122 . . . . 72.400000000000006 109.287 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.592 ' O ' HG12 ' A' ' 162' ' ' VAL . 15.4 m-85 -130.19 159.34 37.14 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.54 1.15 . . . . 74.349999999999994 110.983 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.64 97.49 5.12 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.531 1.144 . . . . 53.109999999999999 109.335 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.564 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 1.7 t80 -82.67 123.91 29.71 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.476 1.11 . . . . 64.329999999999998 110.967 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 168' ' ' ALA . 11.4 mmmm -101.93 105.47 16.27 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.493 1.12 . . . . 71.010000000000005 109.261 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.589 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -40.54 123.8 1.89 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.474 1.109 . . . . 70.409999999999997 109.321 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -113.72 -28.94 7.27 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.514 1.134 . . . . 64.230000000000004 110.302 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.52 177.79 8.61 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.498 1.124 . . . . 74.209999999999994 109.308 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.62 -14.06 43.84 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.582 1.176 . . . . 52.229999999999997 109.302 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -124.53 23.43 8.14 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.54 1.15 . . . . 73.219999999999999 109.233 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.458 ' HB3' ' HB1' ' A' ' 168' ' ' ALA . 3.3 tp10 -96.39 163.21 13.16 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 72.140000000000001 110.305 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.589 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 19.5 mt -127.46 153.48 46.25 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.515 1.134 . . . . 75.120000000000005 109.27 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.4 t -103.37 147.9 26.54 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.572 1.17 . . . . 74.019999999999996 110.448 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.957 HG21 HG21 ' A' ' 162' ' ' VAL . 2.4 m -138.44 -165.86 1.89 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.502 1.126 . . . . 73.519999999999996 110.378 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.638 ' H ' HG22 ' A' ' 176' ' ' THR . 69.7 m-85 -134.44 134.0 41.11 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.523 1.139 . . . . 71.299999999999997 111.001 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 163' ' ' LEU . 0.5 OUTLIER -41.42 143.33 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.487 1.117 . . . . 45.310000000000002 109.294 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 52.03 63.64 4.63 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.583 1.177 . . . . 64.329999999999998 111.019 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.436 ' CG ' ' HB2' ' A' ' 177' ' ' TYR . 6.0 mm-40 -122.15 160.93 24.08 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.433 0.725 . . . . 74.209999999999994 110.264 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -113.21 119.66 38.52 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.454 1.096 . . . . 62.210000000000001 109.345 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.451 ' CD2' ' HB1' ' A' ' 195' ' ' ALA . 1.2 mp -136.99 159.88 40.56 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.456 1.098 . . . . 74.129999999999995 109.322 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -108.09 128.89 55.08 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.561 1.163 . . . . 63.539999999999999 111.01 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.835 HD11 ' HB3' ' A' ' 160' ' ' ALA . 30.2 mm -77.62 128.53 38.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.527 1.142 . . . . 74.040000000000006 109.293 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 49.7 t -100.55 -23.15 14.76 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.48 1.112 . . . . 52.240000000000002 108.261 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.71 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -166.62 179.62 5.35 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.494 1.121 . . . . 72.319999999999993 109.306 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.431 ' CE1' HG21 ' A' ' 231' ' ' ILE . 8.2 p80 -146.28 157.81 43.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.452 1.095 . . . . 75.010000000000005 109.663 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.464 ' HB2' ' CG1' ' A' ' 239' ' ' VAL . 0.6 OUTLIER -134.48 115.3 13.8 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.463 1.102 . . . . 63.340000000000003 109.596 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.466 ' CB ' ' HG2' ' A' ' 191' ' ' GLU . 2.2 m-20 58.74 19.89 7.32 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.59 1.181 . . . . 72.340000000000003 109.31 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 23.4 m 57.36 18.78 4.59 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.551 1.157 . . . . 71.239999999999995 108.273 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.466 ' HG2' ' CB ' ' A' ' 189' ' ' ASN . 10.1 pt-20 -116.28 -33.0 5.12 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.122 . . . . 73.340000000000003 110.277 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.659 ' HE3' HD22 ' A' ' 206' ' ' LEU . 9.6 m0 -110.21 155.4 22.04 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 124.5 1.125 . . . . 73.129999999999995 108.004 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.811 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 24.9 m-85 -133.04 152.22 51.98 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.488 1.117 . . . . 75.109999999999999 111.06 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.71 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 27.8 mm -99.09 94.28 3.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.533 1.145 . . . . 64.209999999999994 109.315 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.496 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -75.38 154.73 37.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.436 1.085 . . . . 75.030000000000001 109.31 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -148.54 78.89 9.03 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.406 1.066 . . . . 74.030000000000001 109.275 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 152.87 41.23 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.578 1.831 . . . . 74.129999999999995 110.972 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 198' ' ' ILE . 5.2 mp -112.8 143.31 22.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.385 1.053 . . . . 73.129999999999995 109.312 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 128.52 -26.52 4.6 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.49 1.119 . . . . 51.340000000000003 110.965 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -130.8 118.84 21.4 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.489 0.758 . . . . 74.209999999999994 110.295 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 8.8 mp -55.83 99.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.528 1.143 . . . . 71.409999999999997 109.279 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 172.49 -177.45 45.08 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.473 1.108 . . . . 75.129999999999995 111.015 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.432 ' HA2' HD11 ' A' ' 174' ' ' LEU . . . 92.46 -178.89 40.14 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.035 -0.826 . . . . 75.010000000000005 111.035 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.488 ' CB ' ' O ' ' A' ' 195' ' ' ALA . 18.3 Cg_endo -74.98 178.61 33.89 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 121.036 -2.485 . . . . 62.310000000000002 111.071 -0.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.56 ' N ' HD12 ' A' ' 174' ' ' LEU . . . -125.39 168.4 17.51 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.591 1.182 . . . . 71.219999999999999 111.016 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.659 HD22 ' HE3' ' A' ' 192' ' ' TRP . 2.5 mt -101.16 134.13 44.66 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.451 0.736 . . . . 44.439999999999998 109.223 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.798 HG21 HG11 ' A' ' 212' ' ' VAL . 0.1 OUTLIER -135.14 137.72 27.51 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.586 1.179 . . . . 61.119999999999997 109.299 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.568 ' HG2' ' CD1' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.92 148.85 36.24 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.542 1.811 . . . . 75.129999999999995 111.077 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.606 ' HA ' HG22 ' A' ' 212' ' ' VAL . 11.5 p -74.43 -14.06 15.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.504 1.128 . . . . 51.109999999999999 109.334 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . 0.52 ' C ' ' CD1' ' A' ' 211' ' ' PHE . . . -84.09 10.47 60.62 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.499 1.124 . . . . 45.43 111.053 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.568 ' CD1' ' HG2' ' A' ' 208' ' ' PRO . 17.3 m-85 -143.85 19.06 1.81 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.541 0.789 . . . . 70.310000000000002 111.001 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.798 HG11 HG21 ' A' ' 207' ' ' VAL . 30.8 m -145.68 147.94 17.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.524 1.14 . . . . 70.129999999999995 109.333 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 161' ' ' ILE . 46.5 t -130.74 152.44 50.09 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.594 1.184 . . . . 63.530000000000001 110.001 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.616 HG13 HG23 ' A' ' 227' ' ' VAL . 42.3 mm -106.26 161.07 5.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.527 1.142 . . . . 70.450000000000003 109.28 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.458 HG23 ' C ' ' A' ' 214' ' ' ILE . 0.2 OUTLIER -153.8 170.11 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.483 1.114 . . . . 74.209999999999994 109.235 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.742 ' C ' HD12 ' A' ' 217' ' ' ILE . 8.0 t0 -129.27 -59.3 1.1 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.419 1.075 . . . . 63.549999999999997 109.323 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.742 HD12 ' C ' ' A' ' 216' ' ' ASP . 2.8 mp -132.5 89.5 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.531 1.144 . . . . 73.319999999999993 109.334 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.671 ' HB1' ' HB2' ' A' ' 221' ' ' TYR . . . -172.45 155.47 3.45 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.425 1.078 . . . . 72.010000000000005 109.35 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 13.1 t -102.42 34.78 2.64 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.563 1.164 . . . . 74.129999999999995 110.417 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 139.0 -17.15 3.21 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.49 1.119 . . . . 71.200000000000003 111.04 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.671 ' HB2' ' HB1' ' A' ' 218' ' ' ALA . 61.9 m-85 -84.54 178.35 7.74 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.523 0.778 . . . . 70.140000000000001 110.982 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -129.37 131.4 46.85 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.487 1.117 . . . . 63.109999999999999 109.288 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.43 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 18.1 p -73.57 -25.26 60.29 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.494 1.121 . . . . 51.210000000000001 110.399 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.52 10.21 11.85 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.466 1.103 . . . . 74.420000000000002 111.008 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.439 ' N ' HD22 ' A' ' 225' ' ' ASN . 1.8 m-80 -74.62 -177.02 2.99 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 0.755 . . . . 64.140000000000001 109.312 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.41 159.05 35.67 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.592 1.182 . . . . 55.020000000000003 109.291 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.811 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 12.6 p -78.05 -40.57 26.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 124.45 1.093 . . . . 73.310000000000002 109.337 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.687 HD12 HG13 ' A' ' 227' ' ' VAL . 2.1 mp -61.46 -46.39 96.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.496 1.122 . . . . 64.340000000000003 109.391 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -64.99 -20.37 66.46 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.587 1.18 . . . . 74.150000000000006 110.314 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -89.73 -31.65 17.35 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.125 . . . . 73.239999999999995 109.313 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.683 HD12 ' HA ' ' A' ' 228' ' ' ILE . 15.1 mt -66.49 -39.02 82.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.439 1.087 . . . . 75.209999999999994 109.261 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.484 ' HE2' HG22 ' A' ' 231' ' ' ILE . 6.1 mmpt? -76.33 -31.86 58.37 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.513 1.133 . . . . 72.510000000000005 109.283 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 6.6 p -57.0 -44.94 83.25 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.455 1.097 . . . . 70.150000000000006 110.032 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.678 HG12 HD21 ' A' ' 158' ' ' LEU . 3.4 p -106.11 13.13 8.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 124.518 1.136 . . . . 75.420000000000002 109.26 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 40.52 32.46 0.14 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.555 1.16 . . . . 71.420000000000002 109.247 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.729 HD13 HD11 ' A' ' 158' ' ' LEU . 2.1 tp -40.49 142.65 0.74 Allowed Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.498 1.124 . . . . 63.240000000000002 109.229 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.1 Cg_endo -75.03 170.74 19.75 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.624 1.855 . . . . 63.549999999999997 110.936 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 241' ' ' GLU . 1.4 p -113.21 143.14 44.9 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.461 1.101 . . . . 75.109999999999999 110.4 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 188' ' ' HIS . 2.5 p -45.33 -26.36 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.489 1.118 . . . . 64.310000000000002 109.266 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.402 ' N ' ' C ' ' A' ' 238' ' ' THR . 86.6 mm-40 -76.23 -43.36 42.48 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.477 1.111 . . . . 62.039999999999999 110.26 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 238' ' ' THR . 5.2 mm-40 -74.41 -21.7 59.51 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.528 1.142 . . . . 71.200000000000003 110.253 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.444 ' O ' ' N ' ' A' ' 245' ' ' ASN . 9.4 t90 -75.26 -62.36 1.59 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.958 -1.127 . . . . 71.340000000000003 107.958 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.7 pttm -50.45 -24.32 3.03 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.465 1.103 . . . . 71.439999999999998 109.275 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 2.6 t -88.07 -29.21 20.82 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.494 1.121 . . . . 70.340000000000003 110.007 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 242' ' ' TRP . 1.9 t30 -72.08 -39.79 68.72 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.45 1.093 . . . . 75.540000000000006 109.246 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 5.6 mt -40.28 152.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.524 1.14 . . . . 65.349999999999994 109.321 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.585 ' O ' ' CE2' ' A' ' 249' ' ' TYR . . . -41.03 -78.69 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.52 1.137 . . . . 71.140000000000001 109.296 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.482 ' CB ' ' O ' ' A' ' 247' ' ' ALA . 1.8 tmm_? 83.79 22.01 0.15 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.464 1.103 . . . . 70.409999999999997 110.305 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.585 ' CE2' ' O ' ' A' ' 247' ' ' ALA . 5.2 p90 179.74 179.18 0.52 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.518 1.136 . . . . 70.040000000000006 110.996 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? 61.98 37.89 14.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.547 1.154 . . . . 71.109999999999999 109.253 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -119.99 170.13 9.55 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.492 1.12 . . . . 74.109999999999999 109.3 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 1.4 m -44.19 154.8 0.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.464 1.102 . . . . 74.420000000000002 110.007 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -75.63 96.71 3.62 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.41 1.069 . . . . 75.219999999999999 109.285 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.604 ' H ' HD13 ' A' ' 254' ' ' ILE . 0.2 OUTLIER -119.56 136.14 57.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.487 1.117 . . . . 74.319999999999993 109.295 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 36.2 t 45.43 40.27 5.38 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.441 1.088 . . . . 53.32 110.055 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.568 ' C ' HD13 ' A' ' 256' ' ' LEU . 2.5 tm? -46.85 -48.9 20.87 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.53 1.144 . . . . 73.230000000000004 109.329 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -52.16 98.67 0.03 OUTLIER Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.485 1.116 . . . . 53.32 111.02 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 10.4 m -161.67 165.62 27.93 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.547 0.792 . . . . 70.230000000000004 109.981 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 259' ' ' VAL . 28.9 m -133.98 57.96 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.471 1.107 . . . . 75.430000000000007 109.263 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 . . . . . 0 C--N 1.324 -0.521 0 O-C-N 124.591 1.182 . . . . 54.439999999999998 110.248 179.942 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.025 0 N-CA-C 110.953 -0.859 . . . . 63.039999999999999 110.953 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 129.69 12.52 Favored 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.43 1.752 . . . . 62.530000000000001 111.046 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.484 HD13 ' O ' ' A' ' 233' ' ' SER . 6.8 mt -78.45 158.36 28.69 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.522 1.139 . . . . 74.209999999999994 109.285 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 116.3 34.91 1.26 Allowed Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.469 1.106 . . . . 54.310000000000002 110.974 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 76.5 p -135.5 76.3 1.61 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.495 0.762 . . . . 74.329999999999998 109.976 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.475 ' HG ' HG11 ' A' ' 234' ' ' VAL . 0.5 OUTLIER -98.56 156.55 16.74 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.58 1.175 . . . . 73.519999999999996 109.295 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.459 ' CG ' ' O ' ' A' ' 158' ' ' LEU . 10.3 m-85 -168.31 107.98 0.52 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.385 1.053 . . . . 72.340000000000003 111.041 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.409 ' HB2' HG12 ' A' ' 184' ' ' ILE . . . -106.58 129.44 54.51 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.518 1.136 . . . . 71.409999999999997 109.248 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.554 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -99.2 127.38 51.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.121 . . . . 63.399999999999999 109.319 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.594 ' CG2' ' CD2' ' A' ' 182' ' ' LEU . 2.2 t -87.25 119.31 34.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.54 1.15 . . . . 75.140000000000001 109.328 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.704 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.1 OUTLIER -112.33 17.67 19.19 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.428 1.08 . . . . 71.430000000000007 109.203 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.656 ' CE2' HD12 ' A' ' 163' ' ' LEU . 95.6 m-85 -155.89 148.91 24.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.437 1.086 . . . . 75.329999999999998 111.041 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.429 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 0.6 OUTLIER -87.47 106.74 18.19 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.475 1.11 . . . . 72.409999999999997 109.322 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.66 ' CD2' HG13 ' A' ' 207' ' ' VAL . 3.7 t80 -80.41 153.04 28.52 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.578 1.174 . . . . 74.239999999999995 110.965 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.531 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.9 mptt -115.51 115.39 26.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 72.049999999999997 109.316 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.811 ' HB1' ' OE1' ' A' ' 173' ' ' GLU . . . -56.47 126.59 27.17 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 1.138 . . . . 71.129999999999995 109.335 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.4 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 7.5 pt-20 -130.36 -35.53 1.53 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.481 1.113 . . . . 75.430000000000007 110.307 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.879 ' HD3' HD13 ' A' ' 206' ' ' LEU . 10.9 tttt -58.37 -163.26 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.448 1.093 . . . . 73.099999999999994 109.265 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.78 -50.65 5.93 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.526 1.141 . . . . 64.510000000000005 109.345 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.09 28.99 7.12 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.528 1.142 . . . . 73.340000000000003 109.324 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.811 ' OE1' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -60.27 -176.9 0.05 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.491 1.119 . . . . 74.239999999999995 110.325 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 174' ' ' LEU . 13.1 mt -151.8 132.54 14.05 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 72.019999999999996 109.269 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 175' ' ' THR . 15.2 t -78.82 114.1 17.47 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.504 1.128 . . . . 73.129999999999995 110.394 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.717 HG22 ' H ' ' A' ' 177' ' ' TYR . 5.6 m -102.34 -172.14 2.08 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.505 1.128 . . . . 74.040000000000006 110.382 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.717 ' H ' HG22 ' A' ' 176' ' ' THR . 11.1 m-85 -133.3 175.54 9.31 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.429 1.081 . . . . 64.349999999999994 110.979 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 163' ' ' LEU . 1.3 p -97.47 110.65 25.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 124.474 1.109 . . . . 62.509999999999998 109.287 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.46 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 99.23 51.12 1.37 Allowed Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.495 1.122 . . . . 72.340000000000003 111.028 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.404 ' HA ' ' OE1' ' A' ' 180' ' ' GLU . 3.4 mm-40 -115.6 169.38 9.23 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.49 0.759 . . . . 72.319999999999993 110.313 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.94 128.1 43.06 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 60.439999999999998 109.358 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.655 ' CD1' ' HB1' ' A' ' 195' ' ' ALA . 0.6 OUTLIER -167.02 172.7 9.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.454 1.097 . . . . 73.310000000000002 109.267 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -112.41 151.15 30.18 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.52 1.138 . . . . 72.129999999999995 110.97 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.813 HD12 ' HB3' ' A' ' 193' ' ' PHE . 48.1 mm -79.7 136.79 22.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.468 1.105 . . . . 72.310000000000002 109.275 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 9.1 t -101.5 -22.86 14.41 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.499 1.125 . . . . 73.310000000000002 108.328 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.885 ' HB3' HG13 ' A' ' 194' ' ' ILE . . . -173.7 172.26 3.61 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.497 1.123 . . . . 75.120000000000005 109.309 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.718 ' CE1' HG22 ' A' ' 238' ' ' THR . 6.6 p80 -133.67 145.48 49.97 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.475 1.11 . . . . 73.450000000000003 109.588 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.643 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.1 t-160 -123.02 116.33 23.35 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.53 1.144 . . . . 73.439999999999998 109.629 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.45 ' C ' ' N ' ' A' ' 191' ' ' GLU . 71.3 m-20 53.79 32.22 14.49 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.465 1.103 . . . . 53.329999999999998 109.275 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 12.8 p 42.96 28.41 0.13 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.53 1.143 . . . . 74.219999999999999 108.339 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.716 ' O ' HG12 ' A' ' 209' ' ' VAL . 5.6 pt-20 -121.99 -35.3 3.19 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.482 1.113 . . . . 72.010000000000005 110.294 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.437 ' N ' ' HG2' ' A' ' 191' ' ' GLU . 7.2 m0 -118.1 167.29 11.61 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.922 -1.14 . . . . 71.140000000000001 107.922 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.927 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 23.7 m-85 -141.78 161.58 37.59 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.492 1.12 . . . . 73.530000000000001 111.031 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.885 HG13 ' HB3' ' A' ' 186' ' ' ALA . 20.8 mm -99.65 122.9 52.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.51 1.131 . . . . 61.219999999999999 109.258 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.655 ' HB1' ' CD1' ' A' ' 182' ' ' LEU . . . -106.24 153.09 22.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.548 1.155 . . . . 42.450000000000003 109.281 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.465 ' CG ' ' HD2' ' A' ' 197' ' ' PRO . 15.4 tttp -137.49 143.74 42.26 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 71.420000000000002 109.255 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.526 ' CB ' HD11 ' A' ' 201' ' ' LEU . 18.2 Cg_endo -74.98 -174.52 1.96 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 O-C-N 124.444 1.76 . . . . 70.239999999999995 111.024 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 10.6 mm -91.18 -69.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.136 . . . . 71.5 109.309 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -60.82 -120.24 0.01 OUTLIER Glycine 0 CA--C 1.529 0.947 0 O-C-N 124.476 1.11 . . . . 72.049999999999997 111.059 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -151.34 115.72 5.08 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.479 0.752 . . . . 73.340000000000003 110.318 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.892 ' O ' HD22 ' A' ' 201' ' ' LEU . 0.0 OUTLIER -170.8 111.46 0.37 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.456 1.098 . . . . 61.350000000000001 109.296 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 44.38 -127.87 6.85 Favored Glycine 0 CA--C 1.531 1.059 0 O-C-N 124.553 1.158 . . . . 4.4000000000000004 110.956 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 50.33 177.59 0.02 OUTLIER Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.028 -0.829 . . . . 64.439999999999998 111.028 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 174.41 52.88 Favored 'Cis proline' 0 C--N 1.36 1.134 0 C-N-CA 121.013 -2.495 . . . . 63.240000000000002 111.026 0.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 194' ' ' ILE . . . -123.13 -173.68 14.11 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.491 1.119 . . . . 61.119999999999997 110.985 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.879 HD13 ' HD3' ' A' ' 170' ' ' LYS . 3.3 mp -115.06 156.08 25.83 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.566 0.803 . . . . 53.340000000000003 109.29 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.875 HG12 ' HD2' ' A' ' 208' ' ' PRO . 0.2 OUTLIER -150.99 147.27 20.37 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.455 1.097 . . . . 71.239999999999995 109.297 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.875 ' HD2' HG12 ' A' ' 207' ' ' VAL . 18.3 Cg_endo -75.02 141.49 26.65 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.551 1.816 . . . . 73.450000000000003 110.968 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.755 HG23 ' HE2' ' A' ' 193' ' ' PHE . 7.2 p -64.48 -37.72 80.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.563 1.164 . . . . 73.129999999999995 109.322 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -60.06 -13.93 29.55 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.483 1.114 . . . . 45.219999999999999 111.004 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 164' ' ' TYR . 5.9 m-85 -112.19 18.53 18.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.519 0.776 . . . . 73.209999999999994 110.94 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.736 HG22 ' HA ' ' A' ' 209' ' ' VAL . 10.5 m -153.43 143.63 14.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.52 1.137 . . . . 41.109999999999999 109.292 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.704 ' HB2' HD21 ' A' ' 163' ' ' LEU . 3.5 t -129.5 148.08 51.37 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.476 1.11 . . . . 64.400000000000006 110.006 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.723 HG13 HG23 ' A' ' 227' ' ' VAL . 25.8 mm -98.87 119.1 46.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.577 1.173 . . . . 71.040000000000006 109.327 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 4.0 pt -145.89 116.96 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.507 1.129 . . . . 72.219999999999999 109.358 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.619 ' OD1' ' HB3' ' A' ' 218' ' ' ALA . 25.6 p-10 -57.89 142.22 46.79 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.516 1.135 . . . . 72.030000000000001 109.335 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 14.0 tt -60.19 -27.52 39.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.43 1.081 . . . . 45.439999999999998 109.29 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.619 ' HB3' ' OD1' ' A' ' 216' ' ' ASP . . . -49.88 -62.41 1.58 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 35.130000000000003 109.253 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.691 ' CG2' ' CE2' ' A' ' 221' ' ' TYR . 4.2 m -88.12 165.72 14.92 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 65.239999999999995 110.435 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -114.43 7.51 22.66 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.414 1.072 . . . . 70.329999999999998 110.948 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.691 ' CE2' ' CG2' ' A' ' 219' ' ' THR . 25.5 p90 -138.03 -177.26 4.75 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.569 0.805 . . . . 73.340000000000003 111.002 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -85.4 114.28 22.34 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.5 1.125 . . . . 70.400000000000006 109.336 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 60.9 p -81.48 -19.82 41.52 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.503 1.127 . . . . 74.329999999999998 110.467 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 111.53 18.03 8.29 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.479 1.112 . . . . 73.530000000000001 110.993 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.569 ' N ' HD22 ' A' ' 225' ' ' ASN . 1.0 OUTLIER -79.93 175.39 10.67 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 0.758 . . . . 54.149999999999999 109.322 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -131.1 162.42 29.89 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.408 1.068 . . . . 74.319999999999993 109.307 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.927 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 11.4 p -77.92 -45.01 28.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.56 1.162 . . . . 74.409999999999997 109.278 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.835 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.0 mp -54.09 -44.85 64.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.5 1.125 . . . . 60.530000000000001 109.345 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -63.76 -28.78 70.11 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.481 1.113 . . . . 64.400000000000006 110.237 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.41 -19.87 35.2 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 74.310000000000002 109.328 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.91 HG23 ' HB3' ' A' ' 236' ' ' LEU . 37.8 mt -76.76 -36.53 26.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.511 1.132 . . . . 53.509999999999998 109.279 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.583 ' HE2' HG22 ' A' ' 231' ' ' ILE . 6.0 mmpt? -83.97 -12.02 55.95 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.107 . . . . 73.409999999999997 109.282 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.484 ' O ' HD13 ' A' ' 155' ' ' LEU . 3.8 p -78.86 -41.67 29.35 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 71.25 109.961 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.475 HG11 ' HG ' ' A' ' 158' ' ' LEU . 7.7 p -108.72 26.28 2.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.527 1.142 . . . . 73.140000000000001 109.266 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 12.6 m120 45.6 26.21 0.31 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.518 1.136 . . . . 74.510000000000005 109.331 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.91 ' HB3' HG23 ' A' ' 231' ' ' ILE . 0.8 OUTLIER -43.91 103.8 0.34 Allowed Pre-proline 0 C--N 1.326 -0.433 0 O-C-N 124.484 1.115 . . . . 72.219999999999999 109.299 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 140.49 25.48 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.507 1.793 . . . . 64.319999999999993 111.0 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.718 HG22 ' CE1' ' A' ' 187' ' ' HIS . 15.7 p -57.66 155.69 9.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.551 1.157 . . . . 64.430000000000007 110.326 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.643 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 1.9 p -61.83 -21.04 24.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.458 1.099 . . . . 60.539999999999999 109.358 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.469 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 40.2 mm-40 -85.58 -26.23 26.25 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 75.549999999999997 110.286 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -84.3 -35.55 23.24 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.513 1.133 . . . . 73.219999999999999 110.291 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 245' ' ' ASN . 1.2 t90 -65.49 -52.07 55.42 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.001 -1.111 . . . . 72.439999999999998 108.001 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.484 ' HZ3' ' HB2' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -49.04 -33.32 11.13 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.435 1.084 . . . . 75.420000000000002 109.258 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.4 t -78.88 -30.23 44.88 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.441 1.088 . . . . 42.210000000000001 110.03 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 242' ' ' TRP . 5.4 t-20 -68.99 -36.7 78.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.46 1.1 . . . . 43.329999999999998 109.223 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.578 ' O ' ' HB3' ' A' ' 247' ' ' ALA . 96.6 mt -42.4 150.67 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.556 1.16 . . . . 71.120000000000005 109.278 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 246' ' ' ILE . . . 75.74 4.45 3.91 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.45 1.094 . . . . 73.299999999999997 109.321 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.537 ' CD ' ' CD2' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -46.55 141.18 3.86 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 74.340000000000003 110.376 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.537 ' CD2' ' CD ' ' A' ' 248' ' ' ARG . 8.6 m-85 44.77 46.01 8.51 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 72.439999999999998 110.935 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.91 151.54 50.08 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.532 1.145 . . . . 74.140000000000001 109.312 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -42.4 106.96 0.07 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.562 1.164 . . . . 74.239999999999995 109.331 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -175.32 157.28 2.16 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.526 1.141 . . . . 70.400000000000006 110.06 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -79.32 103.34 9.18 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.465 1.103 . . . . 75.030000000000001 109.29 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.89 HD12 ' N ' ' A' ' 255' ' ' SER . 1.0 OUTLIER -106.33 177.98 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.531 1.144 . . . . 70.540000000000006 109.244 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.89 ' N ' HD12 ' A' ' 254' ' ' ILE . 33.2 t -151.87 175.12 12.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.536 1.147 . . . . 34.140000000000001 110.033 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 3.5 tt -112.53 139.5 48.06 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.494 1.122 . . . . 73.5 109.312 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -73.81 -150.72 1.8 Allowed Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.472 1.108 . . . . 51.210000000000001 110.986 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 85.5 p -119.33 173.38 6.99 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.519 0.776 . . . . 54.109999999999999 109.958 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 13.6 m -123.86 -178.87 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.503 1.127 . . . . 65.409999999999997 109.316 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.472 1.108 . . . . 72.299999999999997 110.288 -179.99 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.963 0 N-CA-C 111.046 -0.822 . . . . 61.43 111.046 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 165.93 30.26 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.469 1.773 . . . . 73.109999999999999 110.965 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.1 mp -92.45 179.37 5.55 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.499 1.124 . . . . 74.420000000000002 109.336 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -119.49 0.91 14.12 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.523 1.14 . . . . 71.329999999999998 111.006 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.4 p -169.74 160.62 8.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.496 0.762 . . . . 72.430000000000007 110.003 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.718 ' HG ' HG11 ' A' ' 234' ' ' VAL . 0.2 OUTLIER -136.4 149.07 48.13 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.557 1.161 . . . . 70.430000000000007 109.266 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.988 ' OH ' HG23 ' A' ' 217' ' ' ILE . 1.1 p90 -129.95 116.43 18.6 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.507 1.13 . . . . 75.109999999999999 111.003 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.483 ' CB ' HD11 ' A' ' 184' ' ' ILE . . . -95.23 132.37 40.27 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.529 1.143 . . . . 65.019999999999996 109.297 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.59 HD12 ' ND2' ' A' ' 181' ' ' ASN . 0.1 OUTLIER -108.43 130.41 61.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.119 . . . . 54.439999999999998 109.322 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 211' ' ' PHE . 2.2 t -81.33 122.11 35.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.499 1.124 . . . . 74.150000000000006 109.265 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.697 ' O ' HG23 ' A' ' 178' ' ' VAL . 0.7 OUTLIER -90.44 -26.14 19.99 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.485 1.115 . . . . 73.450000000000003 109.295 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.648 ' O ' HG12 ' A' ' 162' ' ' VAL . 44.6 m-85 -130.67 147.83 52.39 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.517 1.136 . . . . 71.530000000000001 111.023 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -61.06 108.42 0.88 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 75.540000000000006 109.309 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.605 ' CE2' ' O ' ' A' ' 174' ' ' LEU . 1.7 t80 -80.95 132.31 35.39 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.434 1.084 . . . . 74.109999999999999 110.983 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.602 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 0.4 OUTLIER -103.66 140.96 36.87 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.433 1.083 . . . . 44.350000000000001 109.322 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.822 ' HB1' ' CG ' ' A' ' 173' ' ' GLU . . . -84.34 126.58 33.34 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.514 1.134 . . . . 42.32 109.322 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.411 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 6.9 pt-20 -127.67 -33.65 2.27 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.506 1.129 . . . . 74.319999999999993 110.299 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.471 ' HD2' ' CD1' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -58.09 -164.43 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.504 1.128 . . . . 61.329999999999998 109.283 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.16 -51.56 5.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.469 1.106 . . . . 71.120000000000005 109.323 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -107.57 28.64 7.95 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.427 1.08 . . . . 71.329999999999998 109.288 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.822 ' CG ' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -59.73 177.94 0.19 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.503 1.127 . . . . 74.400000000000006 110.313 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.769 HD11 ' HA2' ' A' ' 203' ' ' GLY . 12.4 mt -145.09 133.2 21.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 1.137 . . . . 71.049999999999997 109.277 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.8 t -81.47 154.92 26.08 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 71.049999999999997 110.44 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.751 HG21 HG21 ' A' ' 162' ' ' VAL . 2.6 m -142.46 -165.44 2.04 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.529 1.143 . . . . 74.129999999999995 110.393 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.64 ' H ' HG22 ' A' ' 176' ' ' THR . 20.7 m-85 -143.86 137.92 28.27 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.525 1.141 . . . . 73.439999999999998 111.011 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 163' ' ' LEU . 0.7 OUTLIER -44.53 146.52 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.46 1.1 . . . . 72.109999999999999 109.315 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.455 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 52.67 60.55 7.77 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.494 1.121 . . . . 73.239999999999995 111.04 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 161' ' ' ILE . 7.0 mm-40 -118.51 166.21 12.97 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.518 0.775 . . . . 72.099999999999994 110.322 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.59 ' ND2' HD12 ' A' ' 161' ' ' ILE . 0.5 OUTLIER -126.09 136.37 52.83 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.483 1.114 . . . . 71.010000000000005 109.257 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.547 ' CD1' ' HB1' ' A' ' 195' ' ' ALA . 0.5 OUTLIER -167.19 157.83 11.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.452 1.095 . . . . 64.439999999999998 109.329 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.459 ' CD1' ' C ' ' A' ' 183' ' ' PHE . 6.8 p90 -99.54 150.48 22.18 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.447 1.092 . . . . 60.030000000000001 111.059 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.914 HD12 ' HB3' ' A' ' 193' ' ' PHE . 19.6 mm -88.93 133.41 31.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 124.489 1.118 . . . . 73.340000000000003 109.334 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.463 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 3.6 t -97.56 -27.73 14.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.409 1.068 . . . . 73.099999999999994 108.249 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.891 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -160.62 179.44 8.57 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.568 1.168 . . . . 72.030000000000001 109.342 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.437 ' HB3' HD12 ' A' ' 236' ' ' LEU . 8.3 p80 -147.05 120.63 9.12 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.475 1.109 . . . . 74.239999999999995 109.58 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.414 ' CD2' ' CG1' ' A' ' 239' ' ' VAL . 0.9 OUTLIER -99.7 114.53 27.7 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.451 1.094 . . . . 64.549999999999997 109.619 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.428 ' C ' ' N ' ' A' ' 191' ' ' GLU . 9.6 t30 53.69 34.19 18.33 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.543 1.152 . . . . 75.109999999999999 109.356 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 13.4 p 42.53 28.47 0.12 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.482 1.114 . . . . 60.020000000000003 108.299 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.466 ' O ' HG12 ' A' ' 209' ' ' VAL . 3.8 pt-20 -121.64 -33.97 3.5 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.563 1.165 . . . . 54.210000000000001 110.297 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.473 ' HE3' HD22 ' A' ' 206' ' ' LEU . 8.2 m0 -117.22 157.48 25.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.518 1.136 . . . . 73.319999999999993 108.009 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 1.007 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 36.6 m-85 -130.66 159.14 38.11 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.478 1.111 . . . . 75.439999999999998 110.98 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.891 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 31.0 mm -102.7 96.0 4.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.456 1.098 . . . . 74.430000000000007 109.298 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.617 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -79.38 166.09 22.42 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.157 . . . . 45.530000000000001 109.233 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -166.36 90.48 0.82 Allowed Pre-proline 0 C--N 1.326 -0.434 0 O-C-N 124.514 1.134 . . . . 53.420000000000002 109.275 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.09 155.54 42.53 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.467 1.772 . . . . 62.210000000000001 110.968 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 27.1 mt -108.16 149.84 11.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.51 1.131 . . . . 74.140000000000001 109.321 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 125.23 -33.68 3.59 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.498 1.124 . . . . 62.420000000000002 111.034 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -151.22 117.82 5.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.52 0.776 . . . . 73.230000000000004 110.238 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 10.8 tp -54.18 101.06 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.541 1.151 . . . . 52.43 109.274 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -135.55 -52.25 0.07 OUTLIER Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.481 1.113 . . . . 64.150000000000006 110.991 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.769 ' HA2' HD11 ' A' ' 174' ' ' LEU . . . -49.17 179.55 0.01 OUTLIER Glycine 0 CA--C 1.531 1.053 0 N-CA-C 110.969 -0.852 . . . . 52.520000000000003 110.969 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 162.46 92.8 Favored 'Cis proline' 0 C--N 1.359 1.129 0 C-N-CA 120.973 -2.511 . . . . 73.209999999999994 110.935 0.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.416 ' HA3' ' CG ' ' A' ' 174' ' ' LEU . . . -133.64 160.28 23.97 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.545 1.153 . . . . 74.239999999999995 111.022 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.526 HD23 ' CD1' ' A' ' 194' ' ' ILE . 3.8 mt -99.61 137.27 38.32 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.531 0.783 . . . . 73.030000000000001 109.317 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.843 HG21 HG11 ' A' ' 212' ' ' VAL . 0.1 OUTLIER -133.94 136.78 27.02 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.583 1.177 . . . . 75.230000000000004 109.319 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.56 ' HD3' ' CE1' ' A' ' 166' ' ' PHE . 18.5 Cg_endo -74.93 138.12 22.79 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.491 1.785 . . . . 73.010000000000005 111.006 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.662 HG23 ' CE2' ' A' ' 193' ' ' PHE . 13.7 p -65.2 -15.66 18.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.525 1.14 . . . . 71.140000000000001 109.295 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -83.87 10.86 58.98 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.485 1.116 . . . . 73.129999999999995 111.052 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.805 ' O ' HG13 ' A' ' 162' ' ' VAL . 19.0 m-85 -140.7 15.53 2.33 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.501 0.765 . . . . 64.010000000000005 111.009 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.843 HG11 HG21 ' A' ' 207' ' ' VAL . 21.9 m -147.53 149.55 15.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.475 1.11 . . . . 74.319999999999993 109.283 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.456 ' HB3' HD11 ' A' ' 163' ' ' LEU . 0.3 OUTLIER -130.42 152.44 49.82 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.453 1.096 . . . . 71.319999999999993 109.952 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.692 HG13 HG23 ' A' ' 227' ' ' VAL . 31.0 mm -111.09 95.66 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 72.010000000000005 109.349 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 27.8 pt -99.81 171.33 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.455 1.097 . . . . 71.120000000000005 109.349 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -109.37 170.01 8.33 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.513 1.133 . . . . 72.219999999999999 109.285 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.988 HG23 ' OH ' ' A' ' 159' ' ' TYR . 2.0 pp -89.19 -44.72 15.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.555 1.159 . . . . 75.340000000000003 109.378 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.699 ' N ' HD12 ' A' ' 217' ' ' ILE . . . -41.08 -29.54 0.12 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.54 1.15 . . . . 64.310000000000002 109.28 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.644 ' CG2' ' CZ ' ' A' ' 221' ' ' TYR . 4.3 m -126.87 173.5 9.54 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.487 1.117 . . . . 74.25 110.369 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.423 ' H ' HG22 ' A' ' 219' ' ' THR . . . -112.32 3.62 26.66 Favored Glycine 0 CA--C 1.529 0.939 0 O-C-N 124.516 1.135 . . . . 65.319999999999993 111.032 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.644 ' CZ ' ' CG2' ' A' ' 219' ' ' THR . 3.0 p90 -140.73 -175.89 4.46 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.464 0.744 . . . . 73.129999999999995 111.053 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.25 117.03 6.6 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.478 1.111 . . . . 72.439999999999998 109.326 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 39.1 p -83.49 -24.04 31.9 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.449 1.093 . . . . 51.549999999999997 110.405 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 122.09 3.71 9.66 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.558 1.161 . . . . 52.409999999999997 111.017 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -83.1 -177.6 6.82 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.433 0.725 . . . . 74.310000000000002 109.306 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.23 178.61 6.84 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.564 1.165 . . . . 72.430000000000007 109.288 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 1.007 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 2.5 p -82.99 -34.37 11.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.522 1.139 . . . . 75.230000000000004 109.329 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.821 HD12 HG13 ' A' ' 227' ' ' VAL . 1.6 mp -59.87 -37.48 72.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.463 1.102 . . . . 62.140000000000001 109.241 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -67.15 -42.72 83.9 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.477 1.111 . . . . 74.140000000000001 110.266 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.408 ' CG ' HG21 ' A' ' 214' ' ' ILE . 0.6 OUTLIER -67.42 -32.99 74.24 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.496 1.123 . . . . 72.120000000000005 109.279 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.864 HG23 ' HB3' ' A' ' 236' ' ' LEU . 24.7 mt -63.61 -43.69 98.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.477 1.111 . . . . 60.310000000000002 109.311 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -78.46 -11.98 59.98 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 73.120000000000005 109.273 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.7 m -76.9 -44.89 30.05 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.526 1.141 . . . . 71.200000000000003 110.05 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.718 HG11 ' HG ' ' A' ' 158' ' ' LEU . 9.9 p -109.26 30.06 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.488 1.118 . . . . 73.109999999999999 109.31 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 42.41 28.46 0.11 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.516 1.135 . . . . 74.549999999999997 109.281 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.864 ' HB3' HG23 ' A' ' 231' ' ' ILE . 1.6 tm? -42.77 102.38 0.27 Allowed Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.587 1.179 . . . . 23.530000000000001 109.288 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.424 ' HD2' HD22 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -75.03 152.9 41.17 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.523 1.802 . . . . 72.519999999999996 111.02 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 8.8 p -67.17 151.41 47.6 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.549 1.155 . . . . 61.039999999999999 110.386 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.598 ' N ' ' HB1' ' A' ' 186' ' ' ALA . 1.3 p -50.79 -23.91 2.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.464 1.103 . . . . 71.439999999999998 109.318 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -83.82 -46.7 11.9 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.536 1.147 . . . . 71.140000000000001 110.342 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -63.25 -23.83 67.6 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.514 1.134 . . . . 74.049999999999997 110.343 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -80.14 -65.87 0.95 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.509 1.131 . . . . 75.349999999999994 107.98 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.39 -28.74 1.43 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.578 1.174 . . . . 75.140000000000001 109.28 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.4 t -71.49 -51.59 22.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.536 1.147 . . . . 72.439999999999998 109.973 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -61.95 -24.0 66.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.425 1.078 . . . . 61.219999999999999 109.346 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 3.4 mm -74.15 93.61 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.512 1.132 . . . . 73.319999999999993 109.349 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.529 ' HB3' ' CD ' ' A' ' 250' ' ' LYS . . . -154.64 163.82 39.66 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.549 1.155 . . . . 60.329999999999998 109.299 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -76.17 160.74 29.43 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.474 1.109 . . . . 61.039999999999999 110.252 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 52.45 42.8 31.35 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.552 1.157 . . . . 72.329999999999998 110.935 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.529 ' CD ' ' HB3' ' A' ' 247' ' ' ALA . 0.2 OUTLIER -102.52 104.1 14.49 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.485 1.116 . . . . 70.310000000000002 109.289 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -115.28 16.68 16.81 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.493 1.121 . . . . 65.519999999999996 109.257 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 2.1 p -60.2 106.29 0.5 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.436 1.085 . . . . 74.439999999999998 109.972 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.792 ' C ' HD13 ' A' ' 254' ' ' ILE . 14.9 t-20 -89.86 -21.86 22.34 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.474 1.109 . . . . 73.030000000000001 109.349 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.792 HD13 ' C ' ' A' ' 253' ' ' ASN . 0.2 OUTLIER 40.51 34.94 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 124.469 1.105 . . . . 73.439999999999998 109.374 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.5 p -51.48 104.21 0.08 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.465 1.103 . . . . 50.039999999999999 109.931 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 2.8 pp -147.87 137.11 22.26 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 74.420000000000002 109.282 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 164.26 148.25 5.37 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.505 1.128 . . . . 61.299999999999997 110.971 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 15.1 p -172.12 148.3 2.18 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.474 0.75 . . . . 71.439999999999998 110.082 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.483 HG22 ' N ' ' A' ' 260' ' ' GLU . 14.7 p -161.88 167.04 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.467 1.104 . . . . 71.239999999999995 109.305 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.483 ' N ' HG22 ' A' ' 259' ' ' VAL . 57.9 tt0 . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.441 1.088 . . . . 72.120000000000005 110.314 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.976 0 N-CA-C 110.981 -0.847 . . . . 63.0 110.981 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 136.74 20.73 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.455 1.766 . . . . 53.439999999999998 110.951 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.42 HD22 ' O ' ' A' ' 233' ' ' SER . 8.5 mt 40.15 47.17 2.01 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.529 1.143 . . . . 64.230000000000004 109.282 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -147.28 17.9 1.52 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.468 1.105 . . . . 72.540000000000006 110.999 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 68.2 p -135.42 115.08 12.78 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.536 0.786 . . . . 74.219999999999999 109.98 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.411 HD13 HG21 ' A' ' 234' ' ' VAL . 14.1 tp -132.31 160.34 36.53 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.445 1.091 . . . . 74.329999999999998 109.271 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -137.38 115.92 12.02 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.556 1.16 . . . . 74.349999999999994 111.012 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.438 ' HB2' ' CD1' ' A' ' 214' ' ' ILE . . . -115.51 152.18 33.46 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.521 1.138 . . . . 71.319999999999993 109.325 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.834 HD12 ' O ' ' A' ' 180' ' ' GLU . 1.4 tp -120.12 128.88 75.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.487 1.117 . . . . 65.239999999999995 109.264 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.779 HG23 HD11 ' A' ' 182' ' ' LEU . 18.2 t -92.83 112.17 25.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.529 1.143 . . . . 65.230000000000004 109.359 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.879 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.1 OUTLIER -101.03 28.95 4.91 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.496 1.123 . . . . 75.310000000000002 109.327 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.599 ' CD2' ' O ' ' A' ' 163' ' ' LEU . 78.9 m-85 -164.57 131.07 2.98 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.555 1.159 . . . . 73.299999999999997 110.958 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.547 ' H ' HG22 ' A' ' 178' ' ' VAL . 2.7 t0 -79.59 101.19 8.17 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 74.010000000000005 109.329 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.568 ' CD1' ' HD3' ' A' ' 208' ' ' PRO . 60.9 t80 -83.21 152.67 25.11 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 74.049999999999997 111.024 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.561 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 6.9 mmmm -110.69 154.82 23.31 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.514 1.134 . . . . 63.049999999999997 109.25 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.694 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -95.49 125.0 39.8 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.539 1.149 . . . . 63.439999999999998 109.287 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -121.68 -40.31 2.56 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.477 1.11 . . . . 73.030000000000001 110.365 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -174.56 0.23 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.573 1.171 . . . . 73.030000000000001 109.284 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.38 -34.05 20.32 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.546 1.154 . . . . 52.310000000000002 109.307 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.5 10.35 33.21 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.626 1.204 . . . . 73.400000000000006 109.264 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 173' ' ' GLU . 1.2 mm-40 -75.12 172.87 11.6 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.125 . . . . 70.219999999999999 110.296 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.694 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 1.3 tp -155.56 157.68 37.22 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.53 1.144 . . . . 74.219999999999999 109.265 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.0 t -102.89 137.08 41.57 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.496 1.122 . . . . 74.409999999999997 110.407 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.684 HG22 ' H ' ' A' ' 177' ' ' TYR . 3.4 m -113.71 -166.01 1.05 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.547 1.154 . . . . 60.219999999999999 110.366 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.684 ' H ' HG22 ' A' ' 176' ' ' THR . 54.4 m-85 -138.57 150.69 46.58 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.456 1.097 . . . . 74.400000000000006 110.965 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.547 HG22 ' H ' ' A' ' 165' ' ' ASP . 60.8 t -60.84 163.66 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.133 . . . . 72.439999999999998 109.301 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.461 ' N ' HG12 ' A' ' 178' ' ' VAL . . . 37.74 57.73 1.54 Allowed Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.45 1.094 . . . . 55.210000000000001 110.995 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.834 ' O ' HD12 ' A' ' 161' ' ' ILE . 12.7 mm-40 -114.19 155.89 25.26 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.485 0.756 . . . . 71.519999999999996 110.326 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.595 ' C ' HD13 ' A' ' 182' ' ' LEU . 2.3 m-80 -123.32 125.09 44.38 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.531 1.144 . . . . 53.43 109.349 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.779 HD11 HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -162.53 162.65 27.47 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.51 1.131 . . . . 74.420000000000002 109.308 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 184' ' ' ILE . 2.7 t80 -98.96 147.93 24.49 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.433 1.083 . . . . 73.140000000000001 111.007 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.527 HD12 ' HB3' ' A' ' 193' ' ' PHE . 8.9 mm -77.67 112.49 15.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.472 1.108 . . . . 71.420000000000002 109.325 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.522 ' HB3' HG22 ' A' ' 194' ' ' ILE . 10.9 t -78.71 -22.73 46.19 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.525 1.141 . . . . 62.350000000000001 108.285 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.8 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -171.9 179.65 2.67 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.58 1.175 . . . . 63.25 109.308 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.46 ' CE1' HG22 ' A' ' 238' ' ' THR . 8.0 p80 -148.05 151.25 35.37 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.526 1.141 . . . . 61.340000000000003 109.522 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.461 ' HB2' HG11 ' A' ' 239' ' ' VAL . 1.8 t-160 -132.48 122.45 24.92 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.493 1.12 . . . . 63.329999999999998 109.597 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.444 ' C ' ' N ' ' A' ' 191' ' ' GLU . 3.0 m-20 54.15 30.4 12.08 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.477 1.111 . . . . 74.209999999999994 109.281 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 12.7 p 42.95 28.95 0.15 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 72.430000000000007 108.299 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.444 ' N ' ' C ' ' A' ' 189' ' ' ASN . 9.8 pt-20 -124.5 -37.18 2.54 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.564 1.165 . . . . 73.25 110.257 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.693 ' HE3' HD22 ' A' ' 206' ' ' LEU . 11.2 m0 -109.71 158.2 18.34 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.492 1.12 . . . . 74.040000000000006 108.004 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.98 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 44.7 m-85 -137.56 157.16 47.12 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.532 1.145 . . . . 72.319999999999993 111.005 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.8 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 30.8 mm -96.83 98.85 8.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.543 1.152 . . . . 72.25 109.266 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.407 ' HB3' HG21 ' A' ' 207' ' ' VAL . . . -94.92 158.02 15.66 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.557 1.161 . . . . 72.530000000000001 109.267 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -152.42 157.61 33.66 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.527 1.142 . . . . 65.430000000000007 109.297 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.94 -167.33 0.41 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.564 1.823 . . . . 64.329999999999998 111.038 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 5.1 tp -85.6 -21.62 7.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.474 1.109 . . . . 72.209999999999994 109.368 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 166.03 85.28 0.06 OUTLIER Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.563 1.164 . . . . 33.530000000000001 110.967 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -150.94 131.47 13.85 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.492 0.76 . . . . 74.319999999999993 110.31 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.471 ' HA ' HD22 ' A' ' 201' ' ' LEU . 0.6 OUTLIER -68.87 72.72 0.25 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.477 1.11 . . . . 73.049999999999997 109.28 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -149.03 -59.19 0.01 OUTLIER Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.462 1.101 . . . . 74.349999999999994 110.92 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.675 ' HA2' HD22 ' A' ' 174' ' ' LEU . . . -55.67 -178.54 0.29 Allowed Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.027 -0.829 . . . . 64.109999999999999 111.027 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.528 ' HB2' HG23 ' A' ' 194' ' ' ILE . 18.2 Cg_endo -75.02 -170.45 8.28 Favored 'Cis proline' 0 C--N 1.359 1.124 0 C-N-CA 120.953 -2.52 . . . . 65.109999999999999 110.951 0.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -150.32 156.17 26.59 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.438 1.086 . . . . 74.409999999999997 110.983 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.693 HD22 ' HE3' ' A' ' 192' ' ' TRP . 1.7 mt -97.26 127.45 43.23 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.543 0.79 . . . . 73.219999999999999 109.343 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.812 HG12 ' HD2' ' A' ' 208' ' ' PRO . 0.3 OUTLIER -129.54 145.47 57.07 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.466 1.104 . . . . 72.230000000000004 109.35 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.812 ' HD2' HG12 ' A' ' 207' ' ' VAL . 18.6 Cg_endo -74.96 148.11 35.04 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.436 1.756 . . . . 74.230000000000004 110.994 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.709 ' HA ' HG22 ' A' ' 212' ' ' VAL . 8.0 p -66.79 -32.06 56.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.469 1.105 . . . . 64.230000000000004 109.297 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -66.01 -9.1 45.83 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.478 1.111 . . . . 74.439999999999998 111.046 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.575 ' HA ' ' CD2' ' A' ' 164' ' ' TYR . 4.6 m-85 -113.84 5.04 16.12 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.471 0.748 . . . . 71.019999999999996 110.928 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.709 HG22 ' HA ' ' A' ' 209' ' ' VAL . 18.4 m -140.47 162.14 24.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.49 1.119 . . . . 61.5 109.26 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.879 ' HB2' HD21 ' A' ' 163' ' ' LEU . 1.8 t -144.97 144.18 30.92 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.502 1.126 . . . . 72.030000000000001 110.008 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.761 HG13 HG23 ' A' ' 227' ' ' VAL . 36.0 mm -96.13 105.95 17.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.478 1.111 . . . . 62.450000000000003 109.303 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.409 HG23 ' C ' ' A' ' 214' ' ' ILE . 1.9 pt -151.5 177.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.497 1.123 . . . . 74.109999999999999 109.256 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.91 48.31 2.39 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.447 1.092 . . . . 72.109999999999999 109.293 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 2.8 pt -125.75 -46.23 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.522 1.139 . . . . 75.019999999999996 109.333 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -108.67 -45.34 3.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.527 1.142 . . . . 63.520000000000003 109.282 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.655 HG21 ' CZ ' ' A' ' 221' ' ' TYR . 3.3 m -128.56 177.66 6.86 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.514 1.134 . . . . 60.329999999999998 110.378 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.48 ' H ' HG22 ' A' ' 219' ' ' THR . . . -75.44 -5.98 79.25 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.509 1.131 . . . . 53.119999999999997 110.995 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.655 ' CZ ' HG21 ' A' ' 219' ' ' THR . 6.3 p90 -139.25 -176.97 4.71 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.502 0.766 . . . . 74.129999999999995 110.989 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -85.73 132.78 34.07 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.457 1.098 . . . . 73.129999999999995 109.339 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.446 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 11.0 p -92.17 -32.88 14.93 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.595 1.184 . . . . 74.400000000000006 110.411 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 138.99 -13.2 3.35 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.474 1.109 . . . . 32.229999999999997 110.979 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.446 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 2.6 p30 -54.4 168.51 0.25 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.505 0.768 . . . . 62.420000000000002 109.251 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -114.57 175.24 5.57 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.469 1.105 . . . . 73.319999999999993 109.311 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.98 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 11.0 p -80.77 -33.17 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.459 1.099 . . . . 72.400000000000006 109.316 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.711 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.6 mp -60.58 -51.49 72.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.477 1.111 . . . . 73.109999999999999 109.338 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -61.96 -22.66 65.83 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.49 1.118 . . . . 74.530000000000001 110.268 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.748 ' O ' HG22 ' A' ' 234' ' ' VAL . 2.9 m-20 -83.6 -35.91 24.31 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.454 1.096 . . . . 64.409999999999997 109.257 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.863 HG23 ' HB3' ' A' ' 236' ' ' LEU . 12.2 mt -59.87 -29.99 44.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 74.310000000000002 109.287 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -84.08 -11.52 56.55 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.445 1.09 . . . . 72.010000000000005 109.257 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.42 ' O ' HD22 ' A' ' 155' ' ' LEU . 0.8 OUTLIER -94.03 -11.85 29.87 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.478 1.111 . . . . 64.540000000000006 109.988 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.748 HG22 ' O ' ' A' ' 230' ' ' ASP . 0.0 OUTLIER -132.56 10.69 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.525 1.14 . . . . 53.32 109.295 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 236' ' ' LEU . 74.0 m-20 52.95 20.74 1.76 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 52.140000000000001 109.327 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.863 ' HB3' HG23 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -39.55 100.51 0.21 Allowed Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.476 1.11 . . . . 63.100000000000001 109.311 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.449 ' HD2' HD13 ' A' ' 236' ' ' LEU . 18.6 Cg_endo -74.89 142.94 28.83 Favored 'Trans proline' 0 C--N 1.359 1.099 0 O-C-N 124.445 1.76 . . . . 71.209999999999994 111.012 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.46 HG22 ' CE1' ' A' ' 187' ' ' HIS . 7.1 p -60.23 148.08 37.8 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.547 1.154 . . . . 73.530000000000001 110.434 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' A' ' 188' ' ' HIS . 1.4 p -52.82 -25.8 9.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.497 1.123 . . . . 73.409999999999997 109.281 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.453 HE21 ' CE1' ' A' ' 188' ' ' HIS . 98.3 mm-40 -75.5 -39.38 58.59 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.561 1.163 . . . . 74.150000000000006 110.37 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -76.99 -23.1 52.28 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.454 1.096 . . . . 74.120000000000005 110.326 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 1.069 ' CE2' HD11 ' A' ' 246' ' ' ILE . 4.7 t90 -79.93 -61.69 1.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.541 1.151 . . . . 74.219999999999999 107.978 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.407 ' HB2' ' NZ ' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -51.31 -25.03 5.21 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.49 1.119 . . . . 72.129999999999995 109.291 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 29.5 t -72.55 -35.7 68.07 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.128 . . . . 61.399999999999999 109.997 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -77.05 -38.09 53.37 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.542 1.151 . . . . 41.109999999999999 109.306 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 1.069 HD11 ' CE2' ' A' ' 242' ' ' TRP . 21.1 mt -42.13 -64.88 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.54 1.15 . . . . 64.430000000000007 109.283 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -146.62 120.52 9.33 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.522 1.139 . . . . 75.129999999999995 109.323 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -129.28 3.26 5.16 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.571 1.17 . . . . 73.409999999999997 110.318 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 248' ' ' ARG . 4.4 m-30 57.37 51.26 10.17 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.495 1.122 . . . . 73.019999999999996 111.031 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -157.66 162.84 38.67 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.522 1.139 . . . . 75.329999999999998 109.248 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -72.86 -75.16 0.15 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.544 1.153 . . . . 51.149999999999999 109.284 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 26.7 m 46.53 34.86 2.58 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.528 1.143 . . . . 74.230000000000004 109.985 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -60.42 104.37 0.32 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.541 1.15 . . . . 74.310000000000002 109.288 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 22.8 pt -134.31 143.69 37.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.54 1.15 . . . . 74.129999999999995 109.34 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 28.6 t -126.0 138.36 53.74 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.501 1.126 . . . . 54.210000000000001 109.983 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.623 ' H ' HD13 ' A' ' 256' ' ' LEU . 0.0 OUTLIER -98.23 178.95 4.91 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.505 1.128 . . . . 74.219999999999999 109.286 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -166.83 173.81 42.16 Favored Glycine 0 CA--C 1.531 1.057 0 O-C-N 124.578 1.174 . . . . 61.509999999999998 110.981 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 7.7 p -125.26 151.02 46.49 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.576 0.809 . . . . 71.340000000000003 109.998 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -110.8 153.74 12.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.513 1.133 . . . . 75.120000000000005 109.309 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 . . . . . 0 C--N 1.324 -0.507 0 O-C-N 124.527 1.142 . . . . 75.439999999999998 110.292 -179.99 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.984 0 N-CA-C 110.973 -0.851 . . . . 72.109999999999999 110.973 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 87.54 1.32 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.451 1.764 . . . . 55.549999999999997 111.003 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.424 ' C ' HG23 ' A' ' 234' ' ' VAL . 40.1 mt -97.67 77.79 2.58 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.598 1.186 . . . . 64.510000000000005 109.219 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.459 ' HA2' ' CG2' ' A' ' 234' ' ' VAL . . . -175.49 52.28 0.12 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.498 1.124 . . . . 70.239999999999995 111.043 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.4 m -174.33 122.2 0.28 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.503 0.767 . . . . 75.040000000000006 110.038 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 230' ' ' ASP . 2.7 tp -138.5 158.79 43.58 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.539 1.149 . . . . 73.450000000000003 109.348 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.53 ' CE2' ' O ' ' A' ' 215' ' ' ILE . 2.4 p90 -152.01 152.26 32.22 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.518 1.136 . . . . 73.340000000000003 110.974 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.771 ' HB3' HD11 ' A' ' 184' ' ' ILE . . . -122.39 141.27 51.76 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.513 1.133 . . . . 52.409999999999997 109.232 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.51 128.38 55.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.472 1.107 . . . . 73.430000000000007 109.255 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.809 HG21 HD12 ' A' ' 182' ' ' LEU . 43.4 t -84.56 92.54 3.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.547 1.155 . . . . 72.510000000000005 109.332 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.898 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.2 OUTLIER -92.51 25.09 3.16 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 52.450000000000003 109.321 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.832 ' CD2' HD13 ' A' ' 163' ' ' LEU . 37.3 m-85 -165.18 141.11 5.44 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.481 1.113 . . . . 71.439999999999998 111.014 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -67.22 98.66 0.62 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.493 1.121 . . . . 53.420000000000002 109.257 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.578 ' CE2' ' O ' ' A' ' 174' ' ' LEU . 0.6 OUTLIER -80.3 123.53 28.05 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.436 1.085 . . . . 75.030000000000001 111.017 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.515 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 7.8 mmmm -93.25 138.93 31.16 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.454 1.096 . . . . 73.200000000000003 109.341 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.816 ' HB1' ' OE1' ' A' ' 173' ' ' GLU . . . -82.0 122.1 27.37 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.415 1.072 . . . . 74.510000000000005 109.275 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -126.97 -34.93 2.31 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.562 1.164 . . . . 72.150000000000006 110.27 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.91 ' HD2' HD13 ' A' ' 206' ' ' LEU . 4.8 mttp -58.56 -164.09 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.423 1.077 . . . . 62.409999999999997 109.357 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.31 -51.28 5.65 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.578 1.174 . . . . 73.140000000000001 109.306 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -105.36 29.48 6.43 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.503 1.127 . . . . 74.109999999999999 109.262 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 1.005 ' O ' HD22 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -59.02 172.5 0.56 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.531 1.144 . . . . 70.430000000000007 110.325 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 1.005 HD22 ' O ' ' A' ' 173' ' ' GLU . 1.7 mm? -146.95 108.07 4.22 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.417 1.073 . . . . 75.340000000000003 109.278 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.09 143.28 54.24 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.461 1.1 . . . . 64.420000000000002 110.361 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.627 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.8 m -139.9 -169.01 2.63 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.525 1.14 . . . . 70.519999999999996 110.378 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.627 ' H ' HG22 ' A' ' 176' ' ' THR . 77.9 m-85 -130.94 147.43 52.58 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.448 1.092 . . . . 63.420000000000002 111.021 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.467 HG23 ' C ' ' A' ' 163' ' ' LEU . 1.9 p -59.15 155.55 2.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.576 1.172 . . . . 71.530000000000001 109.285 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 61.51 41.39 99.55 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.444 1.09 . . . . 43.140000000000001 110.972 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -121.84 171.33 8.98 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.428 0.723 . . . . 43.329999999999998 110.273 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -119.03 131.57 55.99 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.494 1.121 . . . . 75.239999999999995 109.318 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.809 HD12 HG21 ' A' ' 162' ' ' VAL . 18.2 mt -140.61 124.38 17.16 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.501 1.126 . . . . 70.349999999999994 109.332 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -79.25 128.32 33.16 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.471 1.107 . . . . 75.450000000000003 111.01 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.771 HD11 ' HB3' ' A' ' 160' ' ' ALA . 15.6 mm -77.68 121.29 30.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.453 1.096 . . . . 74.439999999999998 109.359 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.43 ' HB2' HG22 ' A' ' 194' ' ' ILE . 62.9 m -95.73 -31.37 13.25 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.494 1.121 . . . . 71.319999999999993 108.248 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.57 ' HB1' ' N ' ' A' ' 239' ' ' VAL . . . -164.03 161.66 22.73 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.498 1.124 . . . . 62.049999999999997 109.247 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.566 ' CE1' HG21 ' A' ' 231' ' ' ILE . 9.0 p80 -128.74 147.4 50.77 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.552 1.157 . . . . 74.040000000000006 109.577 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.594 ' CD2' ' CG1' ' A' ' 239' ' ' VAL . 1.0 OUTLIER -120.91 119.17 31.85 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.51 1.131 . . . . 70.400000000000006 109.542 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.554 ' CB ' ' HG2' ' A' ' 191' ' ' GLU . 5.5 m-80 48.62 37.92 10.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 73.049999999999997 109.302 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.5 p 38.72 38.77 0.29 Allowed 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.501 1.125 . . . . 63.329999999999998 108.251 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 1.002 ' O ' HG23 ' A' ' 209' ' ' VAL . 11.6 pt-20 -132.52 -37.52 1.06 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.509 1.131 . . . . 61.310000000000002 110.289 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.476 ' N ' ' HG3' ' A' ' 191' ' ' GLU . 20.8 m95 -113.51 163.1 15.35 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.482 1.114 . . . . 75.409999999999997 108.088 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.892 ' CE2' HG22 ' A' ' 209' ' ' VAL . 13.7 m-85 -133.59 161.72 33.87 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 74.109999999999999 111.002 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.602 HG21 ' CZ3' ' A' ' 242' ' ' TRP . 20.0 mm -111.92 95.38 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.145 . . . . 61.549999999999997 109.248 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.573 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -86.3 -175.18 5.39 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.532 1.145 . . . . 71.310000000000002 109.364 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.4 pttp -162.27 155.45 17.28 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 72.510000000000005 109.266 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 149.05 36.31 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.489 1.784 . . . . 63.140000000000001 110.987 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.9 pt -126.2 15.57 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 72.510000000000005 109.337 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -124.32 -47.16 0.24 Allowed Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.523 1.139 . . . . 52.420000000000002 111.01 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -130.01 178.03 6.85 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.468 0.746 . . . . 73.140000000000001 110.299 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.439 HD23 ' N ' ' A' ' 201' ' ' LEU . 5.4 mt -79.42 120.96 24.56 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.546 1.154 . . . . 64.530000000000001 109.319 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -168.43 -143.56 3.87 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.443 1.089 . . . . 45.200000000000003 110.964 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 51.1 176.74 0.02 OUTLIER Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.926 -0.87 . . . . 60.439999999999998 110.926 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.549 ' HB2' HG23 ' A' ' 194' ' ' ILE . 18.5 Cg_endo -74.89 144.95 82.57 Favored 'Cis proline' 0 C--N 1.361 1.2 0 C-N-CA 120.967 -2.514 . . . . 72.219999999999999 111.095 -0.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.993 ' CA ' HD23 ' A' ' 174' ' ' LEU . . . -106.99 160.06 14.38 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.509 1.13 . . . . 72.400000000000006 110.981 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.91 HD13 ' HD2' ' A' ' 170' ' ' LYS . 2.6 mt -103.55 139.63 38.61 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.465 0.744 . . . . 74.010000000000005 109.271 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.791 HG21 HG11 ' A' ' 212' ' ' VAL . 0.2 OUTLIER -143.89 127.52 9.03 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.49 1.119 . . . . 74.109999999999999 109.244 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.497 ' HG2' ' CD2' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.98 157.72 42.7 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.493 1.786 . . . . 75.530000000000001 111.043 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 1.002 HG23 ' O ' ' A' ' 191' ' ' GLU . 21.3 t -80.94 3.26 2.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.547 1.154 . . . . 62.109999999999999 109.311 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . 0.431 ' O ' ' CD1' ' A' ' 211' ' ' PHE . . . -89.16 -3.01 76.56 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.467 1.105 . . . . 52.399999999999999 110.942 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.497 ' CD2' ' HG2' ' A' ' 208' ' ' PRO . 21.4 m-85 -136.69 14.59 3.15 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.474 0.749 . . . . 55.140000000000001 110.972 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.791 HG11 HG21 ' A' ' 207' ' ' VAL . 8.7 m -142.4 146.94 21.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.464 1.102 . . . . 72.129999999999995 109.324 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.898 ' HB2' HD21 ' A' ' 163' ' ' LEU . 26.0 t -129.33 160.76 32.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.551 1.157 . . . . 71.519999999999996 110.011 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.6 HG13 HG23 ' A' ' 227' ' ' VAL . 16.6 mm -102.65 145.75 11.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 75.219999999999999 109.306 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.53 ' O ' ' CE2' ' A' ' 159' ' ' TYR . 44.3 pt -156.27 128.5 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.571 1.17 . . . . 63.240000000000002 109.205 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 218' ' ' ALA . 11.6 t0 -87.96 -177.71 5.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.568 1.168 . . . . 70.310000000000002 109.322 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 9.1 mm -41.6 99.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.424 1.078 . . . . 73.519999999999996 109.378 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -157.59 168.4 27.39 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.455 1.097 . . . . 44.119999999999997 109.292 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.418 HG22 ' HD2' ' A' ' 221' ' ' TYR . 12.7 t -93.23 28.88 2.05 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.148 . . . . 63.009999999999998 110.392 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 114.66 -1.85 23.28 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.536 1.147 . . . . 33.009999999999998 111.006 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.418 ' HD2' HG22 ' A' ' 219' ' ' THR . 33.4 m-85 -88.35 179.31 6.36 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.517 0.775 . . . . 74.0 111.038 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -134.29 153.52 51.83 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.518 1.137 . . . . 73.239999999999995 109.308 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 32.3 p -90.71 -24.0 20.55 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.565 1.165 . . . . 72.349999999999994 110.402 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 106.88 -0.58 36.0 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.51 1.132 . . . . 61.350000000000001 111.037 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.432 ' N ' HD22 ' A' ' 225' ' ' ASN . 1.7 m-80 -70.02 -175.92 1.03 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.528 0.781 . . . . 71.329999999999998 109.3 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -114.08 173.22 6.55 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.493 1.12 . . . . 64.420000000000002 109.352 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.854 HG13 HD12 ' A' ' 228' ' ' ILE . 2.8 p -84.16 -33.56 9.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.371 1.044 . . . . 64.109999999999999 109.329 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.854 HD12 HG13 ' A' ' 227' ' ' VAL . 1.8 mp -61.24 -50.87 78.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.498 1.123 . . . . 74.150000000000006 109.363 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -58.28 -31.42 67.45 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 61.439999999999998 110.351 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.449 ' HB3' HD11 ' A' ' 158' ' ' LEU . 1.0 OUTLIER -77.54 -35.74 52.96 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.497 1.123 . . . . 64.140000000000001 109.354 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.647 ' CD1' HG22 ' A' ' 227' ' ' VAL . 29.7 mt -68.34 -38.43 79.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.131 . . . . 73.540000000000006 109.29 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.29 -33.85 59.08 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.536 1.147 . . . . 74.540000000000006 109.336 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.7 m -58.79 -38.24 78.1 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.561 1.163 . . . . 73.409999999999997 109.989 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.459 ' CG2' ' HA2' ' A' ' 156' ' ' GLY . 2.0 p -112.6 6.93 8.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.494 1.121 . . . . 74.530000000000001 109.325 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 231' ' ' ILE . 9.2 p30 40.46 51.72 2.91 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.471 1.107 . . . . 74.299999999999997 109.269 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.534 HD23 ' HD2' ' A' ' 237' ' ' PRO . 1.1 tt -50.79 140.72 19.3 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.554 1.159 . . . . 71.230000000000004 109.369 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.534 ' HD2' HD23 ' A' ' 236' ' ' LEU . 18.1 Cg_endo -75.06 129.45 12.3 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.55 1.816 . . . . 64.109999999999999 111.002 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 3.0 p -67.17 152.39 45.84 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.479 1.112 . . . . 72.439999999999998 110.353 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.594 ' CG1' ' CD2' ' A' ' 188' ' ' HIS . 1.7 p -46.99 -25.58 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.544 1.153 . . . . 62.450000000000003 109.286 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -86.63 -50.43 6.81 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 71.299999999999997 110.337 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -57.1 -25.15 58.3 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.548 1.155 . . . . 74.540000000000006 110.249 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.801 ' NE1' HD11 ' A' ' 246' ' ' ILE . 26.9 t90 -85.77 -61.85 1.66 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 74.439999999999998 108.022 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -50.88 -23.2 2.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.433 1.083 . . . . 70.010000000000005 109.284 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.9 t -86.85 -61.81 1.64 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.413 1.071 . . . . 75.209999999999994 110.007 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -41.62 -54.8 3.13 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.518 1.136 . . . . 73.409999999999997 109.289 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.801 HD11 ' NE1' ' A' ' 242' ' ' TRP . 63.6 mt -42.62 106.91 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.524 1.14 . . . . 61.450000000000003 109.26 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.686 ' HB3' ' HB2' ' A' ' 250' ' ' LYS . . . -137.79 173.64 11.42 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.485 1.116 . . . . 71.310000000000002 109.271 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -84.98 112.26 20.44 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.425 1.078 . . . . 74.519999999999996 110.31 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 249' ' ' TYR . 1.0 OUTLIER 50.64 38.92 20.29 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.495 1.122 . . . . 73.530000000000001 110.971 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.686 ' HB2' ' HB3' ' A' ' 247' ' ' ALA . 48.8 tttm -44.77 132.62 6.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.483 1.114 . . . . 74.129999999999995 109.246 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -82.17 159.04 23.38 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.528 1.142 . . . . 52.109999999999999 109.287 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 4.2 p -126.21 162.63 24.98 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.481 1.113 . . . . 61.43 109.99 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -133.49 84.75 2.15 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.505 1.128 . . . . 65.430000000000007 109.36 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 2.7 mm -53.93 106.63 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.499 1.125 . . . . 73.409999999999997 109.265 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.4 t -57.84 99.1 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 74.439999999999998 109.992 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 11.5 tp -60.53 103.51 0.25 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.468 1.105 . . . . 74.420000000000002 109.344 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -164.24 72.09 0.19 Allowed Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.529 1.143 . . . . 75.329999999999998 110.98 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 24.5 m -113.63 22.92 13.62 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.392 0.701 . . . . 75.040000000000006 109.971 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 35.3 t -81.37 94.47 2.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.501 1.126 . . . . 60.409999999999997 109.305 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.324 -0.503 0 O-C-N 124.465 1.103 . . . . 73.450000000000003 110.253 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.03 0 N-CA-C 110.972 -0.851 . . . . 33.200000000000003 110.972 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 118.53 5.31 Favored 'Trans proline' 0 C--N 1.361 1.209 0 O-C-N 124.449 1.762 . . . . 71.129999999999995 110.982 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 14.4 mt -108.87 134.28 51.76 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.526 1.141 . . . . 74.400000000000006 109.318 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -160.05 27.05 0.33 Allowed Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.551 1.157 . . . . 62.039999999999999 111.025 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.9 m -160.14 107.4 1.62 Allowed 'General case' 0 C--N 1.326 -0.423 0 O-C-N 124.498 0.764 . . . . 73.209999999999994 110.014 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.723 ' HB2' HG11 ' A' ' 234' ' ' VAL . 61.4 tp -98.08 124.7 42.72 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 74.219999999999999 109.3 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.476 ' HB3' ' CE2' ' A' ' 183' ' ' PHE . 33.8 p90 -103.65 144.11 31.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.512 1.132 . . . . 75.219999999999999 110.998 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.458 ' CB ' HG12 ' A' ' 184' ' ' ILE . . . -140.83 141.83 34.67 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.557 1.161 . . . . 45.229999999999997 109.315 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.5 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -109.07 133.73 53.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 72.439999999999998 109.329 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.752 HG13 ' O ' ' A' ' 211' ' ' PHE . 3.4 t -86.05 125.1 40.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.452 1.095 . . . . 73.450000000000003 109.378 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.778 HD23 ' N ' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -112.88 12.88 19.53 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.538 1.149 . . . . 63.329999999999998 109.317 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.462 ' O ' HG12 ' A' ' 162' ' ' VAL . 97.4 m-85 -158.24 145.14 17.73 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.467 1.105 . . . . 73.140000000000001 111.02 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -79.92 103.01 9.52 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.406 1.066 . . . . 63.350000000000001 109.277 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.526 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 7.4 t80 -83.1 137.82 33.94 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 73.140000000000001 111.015 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.474 ' CE ' ' HA ' ' A' ' 167' ' ' LYS . 0.5 OUTLIER -105.47 123.54 48.06 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.532 1.145 . . . . 70.219999999999999 109.304 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.814 ' HB1' ' CG ' ' A' ' 173' ' ' GLU . . . -71.0 123.26 21.64 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.595 1.185 . . . . 75.140000000000001 109.313 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -126.78 -34.16 2.42 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.541 1.151 . . . . 72.409999999999997 110.309 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 0.4 OUTLIER -58.62 -164.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 O-C-N 124.435 1.084 . . . . 72.299999999999997 109.316 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.34 -51.22 5.67 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.487 1.117 . . . . 73.519999999999996 109.266 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.64 29.42 6.96 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.521 1.138 . . . . 72.150000000000006 109.287 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.814 ' CG ' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -58.95 -178.42 0.05 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.561 1.163 . . . . 75.25 110.251 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.834 HD23 ' HA3' ' A' ' 205' ' ' GLY . 0.0 OUTLIER -147.54 119.97 8.46 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.544 1.153 . . . . 71.319999999999993 109.277 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.53 130.41 35.95 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.555 1.159 . . . . 62.109999999999999 110.439 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.573 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.7 m -126.91 -176.08 3.6 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.593 1.183 . . . . 75.510000000000005 110.435 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.573 ' H ' HG22 ' A' ' 176' ' ' THR . 23.9 m-85 -136.09 143.35 44.56 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.558 1.161 . . . . 64.219999999999999 110.987 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.5 p -56.24 147.28 4.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.469 1.106 . . . . 64.510000000000005 109.291 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.81 58.07 13.85 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.495 1.122 . . . . 51.119999999999997 111.034 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.5 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 10.9 tp10 -121.83 166.16 14.8 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.547 0.792 . . . . 74.530000000000001 110.303 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.428 HD22 ' N ' ' A' ' 181' ' ' ASN . 2.3 m-80 -119.35 133.44 55.72 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.442 1.089 . . . . 71.310000000000002 109.292 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.666 ' C ' HD12 ' A' ' 182' ' ' LEU . 1.2 pp -166.93 -175.45 3.05 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.546 1.154 . . . . 71.209999999999994 109.309 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 159' ' ' TYR . 22.4 m-85 -134.07 139.91 46.29 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.474 1.109 . . . . 72.200000000000003 110.998 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.904 HD12 ' HB3' ' A' ' 193' ' ' PHE . 27.9 mm -77.7 138.08 21.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.487 1.117 . . . . 65.319999999999993 109.337 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.561 ' O ' HD11 ' A' ' 236' ' ' LEU . 0.6 OUTLIER -95.1 -28.13 15.24 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.102 . . . . 62.229999999999997 108.338 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.583 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -172.41 179.56 2.49 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.497 1.123 . . . . 70.230000000000004 109.325 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.814 ' CD2' HG21 ' A' ' 231' ' ' ILE . 8.5 p80 -136.56 154.32 50.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.486 1.116 . . . . 73.030000000000001 109.607 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.521 ' CD2' ' HB2' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -126.97 117.94 23.51 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.469 1.106 . . . . 64.25 109.511 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.568 ' CB ' ' HG2' ' A' ' 191' ' ' GLU . 2.2 m120 50.85 33.91 9.41 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.479 1.112 . . . . 73.0 109.292 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.465 ' HB3' ' CG1' ' A' ' 228' ' ' ILE . 99.2 m 43.77 38.16 1.93 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.473 1.108 . . . . 54.109999999999999 108.286 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.568 ' HG2' ' CB ' ' A' ' 189' ' ' ASN . 8.3 pt-20 -135.26 -40.51 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.562 1.164 . . . . 71.420000000000002 110.318 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.521 ' HB2' ' CD2' ' A' ' 188' ' ' HIS . 24.9 m95 -107.23 165.78 11.12 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.989 -1.115 . . . . 74.219999999999999 107.989 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.924 ' CE2' HG23 ' A' ' 209' ' ' VAL . 12.4 m-85 -137.79 159.03 43.11 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.499 1.124 . . . . 74.219999999999999 110.978 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.583 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 21.1 mm -100.37 114.43 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.504 1.127 . . . . 74.129999999999995 109.288 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.737 ' HB2' ' CG1' ' A' ' 207' ' ' VAL . . . -92.59 168.07 11.49 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.543 1.152 . . . . 75.230000000000004 109.273 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.496 ' CG ' ' O ' ' A' ' 196' ' ' LYS . 1.8 pttt -174.91 91.09 0.3 Allowed Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.128 . . . . 73.25 109.34 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.777 ' HG3' HD11 ' A' ' 174' ' ' LEU . 18.4 Cg_endo -74.96 94.59 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.528 1.804 . . . . 62.219999999999999 111.039 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 5.2 tt -59.31 153.84 3.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 72.140000000000001 109.301 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 89.63 -34.43 4.04 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.486 1.116 . . . . 73.319999999999993 111.028 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -124.24 120.17 31.45 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.494 0.761 . . . . 71.430000000000007 110.274 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.592 ' H ' HD12 ' A' ' 201' ' ' LEU . 5.7 mp -57.1 153.91 10.81 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.464 1.102 . . . . 71.019999999999996 109.305 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 148.37 -52.1 0.55 Allowed Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.553 1.158 . . . . 15.23 111.07 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -78.52 -178.48 50.0 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.014 -0.834 . . . . 62.240000000000002 111.014 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 18.3 Cg_endo -74.98 145.22 83.34 Favored 'Cis proline' 0 C--N 1.359 1.118 0 C-N-CA 121.048 -2.48 . . . . 73.120000000000005 111.017 0.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.834 ' HA3' HD23 ' A' ' 174' ' ' LEU . . . -119.09 -166.01 13.31 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.597 1.186 . . . . 65.510000000000005 111.006 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.486 HD23 HD13 ' A' ' 194' ' ' ILE . 3.1 mt -119.69 142.74 48.22 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.422 0.719 . . . . 43.219999999999999 109.302 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.737 ' CG1' ' HB2' ' A' ' 195' ' ' ALA . 1.6 m -143.9 155.06 59.32 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.487 1.117 . . . . 73.439999999999998 109.323 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.579 ' HG2' ' CD1' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.93 160.44 40.35 Favored 'Trans proline' 0 C--N 1.359 1.108 0 O-C-N 124.53 1.805 . . . . 74.319999999999993 111.055 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.924 HG23 ' CE2' ' A' ' 193' ' ' PHE . 10.1 p -84.97 -19.04 8.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 51.25 109.349 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -82.83 9.33 60.05 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.487 1.117 . . . . 70.120000000000005 110.994 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.752 ' O ' HG13 ' A' ' 162' ' ' VAL . 11.2 m-85 -128.46 18.67 6.35 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 0.768 . . . . 71.530000000000001 111.009 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.565 HG21 ' CD2' ' A' ' 193' ' ' PHE . 31.7 m -156.9 144.5 10.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.496 1.123 . . . . 65.0 109.333 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 22.3 t -134.73 140.19 45.76 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 72.540000000000006 110.03 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.868 HG21 ' CG ' ' A' ' 230' ' ' ASP . 11.0 mm -86.82 89.3 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.53 1.144 . . . . 73.010000000000005 109.339 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.426 ' CG2' ' C ' ' A' ' 214' ' ' ILE . 0.3 OUTLIER -149.87 165.93 3.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.501 1.125 . . . . 72.430000000000007 109.262 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.56 138.37 43.9 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.499 1.124 . . . . 71.140000000000001 109.227 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 218' ' ' ALA . 35.7 pt -54.88 -42.35 62.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.453 1.096 . . . . 63.240000000000002 109.309 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 220' ' ' GLY . . . -46.53 165.64 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.524 1.14 . . . . 72.319999999999993 109.298 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 218' ' ' ALA . 52.0 m -38.85 -30.08 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.483 1.114 . . . . 71.120000000000005 110.329 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 218' ' ' ALA . . . -62.81 89.32 0.06 OUTLIER Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.537 1.148 . . . . 34.0 110.975 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -97.38 -171.76 2.27 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.537 0.786 . . . . 72.349999999999994 111.068 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -42.29 109.32 0.12 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.512 1.132 . . . . 42.420000000000002 109.361 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 73.3 p -88.08 -16.38 33.7 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.441 1.088 . . . . 71.120000000000005 110.453 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 113.21 13.54 10.72 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.531 1.145 . . . . 70.549999999999997 111.008 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -88.49 -176.81 5.44 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.5 0.765 . . . . 63.140000000000001 109.331 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -130.1 171.28 13.0 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.526 1.141 . . . . 63.100000000000001 109.25 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.774 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 12.6 p -78.25 -40.88 25.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.478 1.111 . . . . 74.230000000000004 109.318 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.838 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.1 mp -50.7 -53.41 13.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.519 1.137 . . . . 72.430000000000007 109.386 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -61.82 -33.08 73.49 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.458 1.099 . . . . 74.200000000000003 110.286 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.868 ' CG ' HG21 ' A' ' 214' ' ' ILE . 1.1 m-20 -70.86 -30.5 66.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.492 1.12 . . . . 61.43 109.294 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 228' ' ' ILE . 19.2 mt -68.93 -36.25 73.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.529 1.143 . . . . 65.519999999999996 109.305 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -74.61 -20.53 59.88 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.53 1.144 . . . . 74.439999999999998 109.295 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 6.7 p -68.64 -34.66 76.11 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.44 1.087 . . . . 71.319999999999993 110.014 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.723 HG11 ' HB2' ' A' ' 158' ' ' LEU . 6.8 p -114.75 19.0 7.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.549 1.155 . . . . 72.129999999999995 109.267 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 43.06 28.17 0.13 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.567 1.167 . . . . 63.350000000000001 109.341 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.717 ' HB3' HG23 ' A' ' 231' ' ' ILE . 18.8 tp -51.55 109.95 1.61 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.48 1.112 . . . . 72.310000000000002 109.321 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.93 137.21 21.59 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.519 1.799 . . . . 75.25 110.966 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.617 HG22 ' CE1' ' A' ' 187' ' ' HIS . 10.2 p -57.04 157.97 5.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 71.420000000000002 110.37 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.473 ' CG1' ' HB2' ' A' ' 188' ' ' HIS . 1.5 p -54.04 -27.99 16.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.443 1.089 . . . . 72.340000000000003 109.261 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -80.03 -30.7 39.54 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.454 1.096 . . . . 63.530000000000001 110.327 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -81.78 -24.06 36.22 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.517 1.136 . . . . 71.5 110.282 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.591 ' CE2' HD11 ' A' ' 246' ' ' ILE . 9.5 t90 -83.3 -66.39 0.9 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.12 . . . . 73.040000000000006 108.046 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.5 -29.86 0.1 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.514 1.134 . . . . 74.420000000000002 109.282 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.433 ' N ' ' C ' ' A' ' 242' ' ' TRP . 47.4 t -64.16 -52.85 57.05 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.439 1.087 . . . . 64.439999999999998 110.004 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 242' ' ' TRP . 22.3 m-80 -54.65 -45.19 73.77 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.479 1.112 . . . . 74.239999999999995 109.355 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.591 HD11 ' CE2' ' A' ' 242' ' ' TRP . 7.8 mt -47.75 110.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.418 1.074 . . . . 61.439999999999998 109.292 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -102.85 132.36 49.1 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.484 1.115 . . . . 62.039999999999999 109.301 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -113.37 -54.33 2.62 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.482 1.114 . . . . 74.340000000000003 110.26 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -113.12 172.54 6.88 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.538 1.149 . . . . 74.239999999999995 110.93 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.96 106.84 5.84 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.538 1.149 . . . . 74.340000000000003 109.264 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -56.05 127.81 32.29 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.567 1.167 . . . . 65.329999999999998 109.257 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 15.3 m -64.59 178.74 0.71 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.509 1.131 . . . . 64.310000000000002 110.006 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -124.56 142.54 51.28 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.483 1.114 . . . . 65.439999999999998 109.283 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.468 ' N ' HD13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -119.59 145.12 26.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.429 1.08 . . . . 74.230000000000004 109.332 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.2 m -41.41 145.84 0.24 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.475 1.109 . . . . 70.510000000000005 109.951 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 8.5 tt -43.71 134.74 4.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 63.409999999999997 109.258 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -89.17 137.25 14.06 Favored Glycine 0 CA--C 1.531 1.057 0 O-C-N 124.563 1.164 . . . . 63.039999999999999 110.992 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 53.9 p -86.56 156.13 20.19 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.49 0.759 . . . . 33.350000000000001 109.967 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -80.94 -16.57 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.533 1.146 . . . . 73.030000000000001 109.294 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 . . . . . 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 72.510000000000005 110.289 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.006 0 N-CA-C 110.926 -0.87 . . . . 53.109999999999999 110.926 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -74.98 109.57 2.95 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.497 1.788 . . . . 71.219999999999999 110.972 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.941 HD13 ' O ' ' A' ' 233' ' ' SER . 10.4 mt -127.69 102.99 7.06 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.449 1.093 . . . . 64.010000000000005 109.335 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -153.38 36.39 0.75 Allowed Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.47 1.106 . . . . 64.439999999999998 111.067 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 39.7 t -158.36 150.1 21.37 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.484 0.755 . . . . 50.409999999999997 110.024 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.867 ' HG ' HG11 ' A' ' 234' ' ' VAL . 8.2 mt -144.42 172.52 12.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 73.049999999999997 109.262 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.584 ' CD1' ' C ' ' A' ' 158' ' ' LEU . 36.4 m-85 -157.56 115.06 3.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.493 1.121 . . . . 72.430000000000007 111.031 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.522 ' HB2' HD11 ' A' ' 214' ' ' ILE . . . -114.79 133.21 56.11 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.471 1.107 . . . . 74.430000000000007 109.292 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.565 HD12 ' O ' ' A' ' 180' ' ' GLU . 0.4 OUTLIER -100.62 130.78 49.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.449 1.093 . . . . 64.140000000000001 109.27 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.587 HG13 HG12 ' A' ' 212' ' ' VAL . 2.0 t -88.84 127.72 41.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.512 1.133 . . . . 72.430000000000007 109.365 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.728 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.1 OUTLIER -107.39 -5.97 17.41 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.477 1.111 . . . . 63.310000000000002 109.379 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.636 ' HE2' HD12 ' A' ' 163' ' ' LEU . 96.3 m-85 -147.05 147.34 30.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 73.219999999999999 111.059 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.676 ' N ' HG12 ' A' ' 178' ' ' VAL . 0.2 OUTLIER -79.4 111.71 15.92 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.47 1.106 . . . . 71.420000000000002 109.325 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.629 ' CG ' ' CD ' ' A' ' 208' ' ' PRO . 7.9 t80 -80.51 150.17 29.74 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.597 1.185 . . . . 75.109999999999999 111.002 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.545 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 0.1 OUTLIER -108.26 132.4 53.71 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.412 1.07 . . . . 73.230000000000004 109.272 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.822 ' HB1' ' OE2' ' A' ' 173' ' ' GLU . . . -78.47 127.51 32.28 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.598 1.186 . . . . 71.549999999999997 109.282 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.412 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 17.2 pt-20 -130.35 -33.18 1.71 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.498 1.124 . . . . 75.540000000000006 110.263 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -58.04 -166.15 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.567 1.167 . . . . 63.020000000000003 109.304 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.96 -45.35 9.26 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.497 1.123 . . . . 61.009999999999998 109.333 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -111.23 28.66 8.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 1.117 . . . . 74.200000000000003 109.326 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.822 ' OE2' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -63.44 -176.76 0.17 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.442 1.089 . . . . 74.340000000000003 110.298 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.677 HD13 ' HD2' ' A' ' 197' ' ' PRO . 13.8 mt -157.25 133.15 9.43 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.509 1.131 . . . . 74.299999999999997 109.22 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.72 130.97 35.24 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.498 1.124 . . . . 61.520000000000003 110.387 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.6 m -111.11 -176.82 3.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.505 1.128 . . . . 75.049999999999997 110.373 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.543 ' H ' HG22 ' A' ' 176' ' ' THR . 15.5 m-85 -130.12 157.25 42.93 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.517 1.136 . . . . 73.430000000000007 110.944 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.676 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.0 OUTLIER -67.33 162.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.405 1.065 . . . . 60.350000000000001 109.252 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 37.28 61.34 1.01 Allowed Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.456 1.098 . . . . 64.319999999999993 110.997 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.565 ' O ' HD12 ' A' ' 161' ' ' ILE . 2.9 mm-40 -121.2 176.82 5.42 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 0.778 . . . . 64.140000000000001 110.298 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.464 ' C ' HD13 ' A' ' 182' ' ' LEU . 1.7 t-20 -146.71 134.48 21.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.458 1.099 . . . . 75.209999999999994 109.28 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.62 ' O ' HD22 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -166.48 160.32 15.31 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.494 1.121 . . . . 75.140000000000001 109.284 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.434 ' CE1' ' O ' ' A' ' 184' ' ' ILE . 5.5 t80 -92.07 137.21 32.55 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.593 1.183 . . . . 73.510000000000005 111.04 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.912 HD12 ' HB3' ' A' ' 193' ' ' PHE . 42.7 mm -77.54 124.78 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.496 1.122 . . . . 73.439999999999998 109.291 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.429 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 10.2 t -79.94 -26.24 40.15 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 50.149999999999999 108.274 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.571 ' HB3' HG13 ' A' ' 194' ' ' ILE . . . -176.84 166.95 2.56 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 43.409999999999997 109.312 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.6 ' CE1' HG22 ' A' ' 238' ' ' THR . 8.2 p80 -123.42 151.01 43.07 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.497 1.123 . . . . 71.010000000000005 109.545 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.619 ' HB2' HG11 ' A' ' 239' ' ' VAL . 3.8 t-160 -124.76 112.95 17.31 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.498 1.124 . . . . 75.519999999999996 109.556 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.401 ' C ' ' N ' ' A' ' 191' ' ' GLU . 8.4 t-20 57.26 23.45 8.78 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.547 1.154 . . . . 64.120000000000005 109.32 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.481 ' HG ' ' CE1' ' A' ' 187' ' ' HIS . 6.8 m 53.08 21.46 2.13 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.484 1.115 . . . . 51.539999999999999 108.235 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.484 ' O ' HG12 ' A' ' 209' ' ' VAL . 5.0 pt-20 -116.95 -31.95 5.24 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.465 1.103 . . . . 75.439999999999998 110.27 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.413 ' N ' ' HG2' ' A' ' 191' ' ' GLU . 4.3 m0 -118.92 166.45 12.83 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.923 -1.14 . . . . 74.120000000000005 107.923 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.912 ' HB3' HD12 ' A' ' 184' ' ' ILE . 36.3 m-85 -140.44 162.07 36.2 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.454 1.096 . . . . 73.140000000000001 111.021 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.571 HG13 ' HB3' ' A' ' 186' ' ' ALA . 34.6 mm -103.16 124.38 57.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.433 1.083 . . . . 63.219999999999999 109.343 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -112.56 174.9 5.67 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.493 1.12 . . . . 63.229999999999997 109.29 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.411 ' N ' ' HD3' ' A' ' 197' ' ' PRO . 19.1 tptp -166.46 64.44 0.84 Allowed Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.573 1.17 . . . . 73.209999999999994 109.326 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.677 ' HD2' HD13 ' A' ' 174' ' ' LEU . 18.3 Cg_endo -75.05 167.51 26.85 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.552 1.817 . . . . 44.229999999999997 110.989 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.518 ' H ' HD13 ' A' ' 198' ' ' ILE . 2.5 mm 40.47 69.26 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.478 1.112 . . . . 54.329999999999998 109.317 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -46.61 94.02 0.01 OUTLIER Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.495 1.122 . . . . 64.230000000000004 111.019 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.428 ' HE ' HG22 ' A' ' 198' ' ' ILE . 12.5 ptp180 -147.46 -170.6 3.6 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.571 0.806 . . . . 52.340000000000003 110.262 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.26 89.54 0.13 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 75.25 109.267 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 172.51 -155.66 23.69 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.463 1.102 . . . . 71.310000000000002 110.93 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 48.84 -178.72 0.01 OUTLIER Glycine 0 CA--C 1.531 1.075 0 N-CA-C 110.952 -0.859 . . . . 42.219999999999999 110.952 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.57 ' HG2' ' CH2' ' A' ' 242' ' ' TRP . 18.2 Cg_endo -75.1 165.92 84.6 Favored 'Cis proline' 0 C--N 1.36 1.174 0 C-N-CA 121.012 -2.495 . . . . 64.109999999999999 110.975 0.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.429 ' O ' HG23 ' A' ' 194' ' ' ILE . . . -122.46 179.72 16.11 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.545 1.153 . . . . 64.209999999999994 110.993 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.472 ' HG ' ' CD1' ' A' ' 194' ' ' ILE . 3.8 mp -117.59 168.49 10.37 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.439 0.729 . . . . 64.230000000000004 109.318 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.476 HG23 ' CD2' ' A' ' 166' ' ' PHE . 6.1 p -159.81 140.18 8.78 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.519 1.137 . . . . 64.310000000000002 109.223 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.629 ' CD ' ' CG ' ' A' ' 166' ' ' PHE . 18.1 Cg_endo -75.0 152.2 40.48 Favored 'Trans proline' 0 C--N 1.361 1.21 0 O-C-N 124.505 1.792 . . . . 64.310000000000002 110.997 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.729 ' HA ' HG22 ' A' ' 212' ' ' VAL . 11.6 p -78.83 -18.94 13.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.539 1.149 . . . . 65.219999999999999 109.26 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -73.83 -2.38 61.08 Favored Glycine 0 CA--C 1.531 1.091 0 O-C-N 124.539 1.149 . . . . 61.240000000000002 110.947 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.47 ' CD1' ' HG2' ' A' ' 208' ' ' PRO . 10.3 m-85 -126.52 -0.3 6.87 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.56 0.8 . . . . 73.209999999999994 110.976 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.729 HG22 ' HA ' ' A' ' 209' ' ' VAL . 11.8 m -133.5 153.01 36.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 71.310000000000002 109.326 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.728 ' HB2' HD21 ' A' ' 163' ' ' LEU . 1.7 t -143.2 155.91 44.64 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.5 1.125 . . . . 53.340000000000003 110.05 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.914 HG13 HG23 ' A' ' 227' ' ' VAL . 18.9 mm -111.41 154.26 13.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.507 1.129 . . . . 61.030000000000001 109.308 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.457 HD12 HG21 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -152.86 146.36 14.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.513 1.133 . . . . 74.340000000000003 109.247 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.678 ' CG ' HG21 ' A' ' 223' ' ' THR . 2.2 p30 -88.37 157.36 18.73 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.134 . . . . 64.129999999999995 109.304 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 217' ' ' ILE . 22.8 mm 50.41 28.32 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.529 1.143 . . . . 74.129999999999995 109.31 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 40.7 40.63 0.98 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.486 1.116 . . . . 73.140000000000001 109.272 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.699 HG22 ' H ' ' A' ' 221' ' ' TYR . 54.3 m -59.78 150.87 26.85 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.54 1.15 . . . . 70.319999999999993 110.401 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -74.18 -2.9 63.64 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.567 1.167 . . . . 43.310000000000002 110.995 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.699 ' H ' HG22 ' A' ' 219' ' ' THR . 1.5 p90 -140.37 -174.86 4.07 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.519 0.776 . . . . 71.310000000000002 111.01 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -90.88 134.83 34.15 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.125 . . . . 60.030000000000001 109.362 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.678 HG21 ' CG ' ' A' ' 216' ' ' ASP . 16.4 p -91.97 -25.53 18.82 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.521 1.138 . . . . 75.129999999999995 110.43 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 119.65 8.09 9.29 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.583 1.177 . . . . 45.130000000000003 110.982 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.717 ' N ' HD22 ' A' ' 225' ' ' ASN . 0.8 OUTLIER -85.44 -178.56 6.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.576 0.809 . . . . 74.420000000000002 109.289 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.2 172.58 10.45 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.5 1.125 . . . . 74.200000000000003 109.298 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.914 HG23 HG13 ' A' ' 214' ' ' ILE . 13.2 p -81.1 -37.76 16.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.548 1.155 . . . . 55.539999999999999 109.319 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.676 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.6 mp -54.69 -53.58 30.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.49 1.119 . . . . 75.430000000000007 109.268 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -55.44 -31.01 61.56 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.575 1.172 . . . . 70.540000000000006 110.306 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.761 ' CG ' HG21 ' A' ' 214' ' ' ILE . 0.5 OUTLIER -77.29 -34.9 55.47 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.509 1.131 . . . . 62.32 109.332 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' A' ' 228' ' ' ILE . 21.3 mt -67.6 -35.13 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.486 1.116 . . . . 73.200000000000003 109.3 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -82.39 -26.97 32.35 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.511 1.132 . . . . 74.010000000000005 109.245 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.941 ' O ' HD13 ' A' ' 155' ' ' LEU . 46.8 p -60.06 -32.66 71.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.533 1.146 . . . . 74.310000000000002 109.991 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.867 HG11 ' HG ' ' A' ' 158' ' ' LEU . 2.6 p -118.06 10.65 7.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.135 . . . . 62.009999999999998 109.327 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 4.4 m120 40.51 35.79 0.32 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.505 1.128 . . . . 62.009999999999998 109.272 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.559 HD12 ' HD2' ' A' ' 237' ' ' PRO . 0.6 OUTLIER -50.49 144.04 12.84 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.472 1.107 . . . . 70.099999999999994 109.314 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.559 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.5 Cg_endo -74.97 151.45 39.66 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.474 1.776 . . . . 75.439999999999998 111.02 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.6 HG22 ' CE1' ' A' ' 187' ' ' HIS . 2.1 p -86.17 141.29 29.46 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.517 1.136 . . . . 74.329999999999998 110.386 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.619 HG11 ' HB2' ' A' ' 188' ' ' HIS . 4.4 p -42.76 -28.31 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.556 1.16 . . . . 63.200000000000003 109.323 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.474 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 14.7 mm-40 -78.78 -46.32 19.07 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.522 1.139 . . . . 50.210000000000001 110.249 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 238' ' ' THR . 17.3 mt-10 -66.3 -19.79 65.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.448 1.092 . . . . 72.310000000000002 110.273 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.57 ' CH2' ' HG2' ' A' ' 204' ' ' PRO . 2.0 t90 -81.37 -70.37 0.54 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 73.430000000000007 107.979 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -40.39 -29.93 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.398 1.061 . . . . 72.319999999999993 109.301 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.423 ' N ' ' C ' ' A' ' 242' ' ' TRP . 5.2 t -84.32 -59.24 2.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 60.210000000000001 110.044 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 246' ' ' ILE . 10.0 t-20 -40.37 -40.35 1.16 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.493 1.121 . . . . 71.319999999999993 109.254 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 245' ' ' ASN . 15.9 mm -40.51 132.1 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.488 1.117 . . . . 50.25 109.32 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -40.61 124.98 2.14 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.542 1.152 . . . . 73.140000000000001 109.233 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -118.02 -62.39 1.55 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.468 1.105 . . . . 75.319999999999993 110.322 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -120.97 154.49 35.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.463 1.102 . . . . 65.340000000000003 111.029 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -99.51 103.75 15.52 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.491 1.119 . . . . 72.0 109.306 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -164.9 142.62 6.27 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.543 1.152 . . . . 75.040000000000006 109.332 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 21.1 p -45.58 98.21 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 73.150000000000006 110.035 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -41.24 -76.23 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 65.230000000000004 109.309 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.485 ' C ' HD12 ' A' ' 254' ' ' ILE . 2.8 pp -126.65 16.67 3.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.483 1.114 . . . . 42.210000000000001 109.298 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.9 m -96.27 47.67 1.09 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.532 1.145 . . . . 61.310000000000002 109.966 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.765 ' C ' HD22 ' A' ' 256' ' ' LEU . 0.0 OUTLIER -86.81 -16.37 36.42 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.555 1.159 . . . . 54.140000000000001 109.305 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 118.34 170.52 14.93 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.499 1.124 . . . . 72.150000000000006 110.992 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 3.8 t -101.32 178.43 4.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.516 0.774 . . . . 72.519999999999996 110.04 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.77 113.28 38.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.127 . . . . 74.319999999999993 109.302 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.521 0 O-C-N 124.533 1.146 . . . . 54.539999999999999 110.302 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.02 0 N-CA-C 110.981 -0.847 . . . . 74.140000000000001 110.981 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.86 -162.83 0.16 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.504 1.792 . . . . 72.340000000000003 111.048 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.715 ' HB2' HG23 ' A' ' 234' ' ' VAL . 0.5 OUTLIER -84.91 163.56 18.91 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.496 1.122 . . . . 64.109999999999999 109.325 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -170.51 49.51 0.2 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.586 1.179 . . . . 73.510000000000005 110.992 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.518 ' H ' HG21 ' A' ' 234' ' ' VAL . 1.9 t -175.46 110.37 0.11 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.486 0.757 . . . . 71.329999999999998 110.037 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.437 HD11 ' HB3' ' A' ' 230' ' ' ASP . 11.4 tp -97.63 165.62 11.89 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.546 1.154 . . . . 74.209999999999994 109.275 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -132.04 130.58 41.53 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.466 1.104 . . . . 75.200000000000003 110.97 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.491 ' O ' HD12 ' A' ' 182' ' ' LEU . . . -144.58 151.01 38.42 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.127 . . . . 55.210000000000001 109.259 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.541 HD12 ' ND2' ' A' ' 181' ' ' ASN . 0.1 OUTLIER -117.63 129.19 74.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.54 1.15 . . . . 71.540000000000006 109.322 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.959 ' CG2' HD21 ' A' ' 182' ' ' LEU . 1.9 t -76.96 132.64 32.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.557 1.161 . . . . 61.399999999999999 109.302 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.932 ' O ' HG23 ' A' ' 178' ' ' VAL . 0.2 OUTLIER -111.56 -7.38 14.31 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.572 1.17 . . . . 73.219999999999999 109.317 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.435 ' HB2' ' CD2' ' A' ' 211' ' ' PHE . 90.0 m-85 -142.23 143.56 32.95 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.548 1.155 . . . . 61.149999999999999 111.019 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.41 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 4.6 t0 -73.26 108.17 5.99 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.532 1.145 . . . . 75.019999999999996 109.326 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.684 ' CG ' HG13 ' A' ' 207' ' ' VAL . 3.8 t80 -80.41 147.31 31.05 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.533 1.146 . . . . 72.099999999999994 110.948 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.06 137.9 44.25 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.503 1.127 . . . . 71.219999999999999 109.29 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.828 ' HB1' ' OE1' ' A' ' 173' ' ' GLU . . . -89.45 122.74 32.93 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.547 1.154 . . . . 41.520000000000003 109.301 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.426 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 10.0 pt-20 -126.3 -29.42 2.99 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.484 1.115 . . . . 73.030000000000001 110.294 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 4.2 tttp -59.09 -173.34 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.463 1.102 . . . . 72.530000000000001 109.263 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.82 -29.49 17.54 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.394 1.059 . . . . 72.409999999999997 109.267 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.47 28.36 6.65 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.601 1.188 . . . . 74.109999999999999 109.323 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.828 ' OE1' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -68.49 -176.37 0.77 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.541 1.151 . . . . 74.150000000000006 110.319 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.433 ' HB2' ' CA ' ' A' ' 205' ' ' GLY . 0.1 OUTLIER -157.49 110.67 2.51 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.457 1.098 . . . . 72.329999999999998 109.329 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.1 t -68.29 136.2 53.1 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.465 1.103 . . . . 63.439999999999998 110.379 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.692 HG22 ' H ' ' A' ' 177' ' ' TYR . 3.2 m -120.38 -164.3 1.08 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.567 1.167 . . . . 64.340000000000003 110.437 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.692 ' H ' HG22 ' A' ' 176' ' ' THR . 31.3 m-85 -128.47 173.61 10.08 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.433 1.083 . . . . 63.409999999999997 111.008 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 163' ' ' LEU . 1.4 p -93.67 137.46 22.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.469 1.106 . . . . 63.240000000000002 109.349 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 67.16 52.58 31.12 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.451 1.094 . . . . 32.350000000000001 110.972 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.479 ' OE1' ' CB ' ' A' ' 177' ' ' TYR . 2.4 mp0 -121.9 165.67 15.58 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.542 0.789 . . . . 73.219999999999999 110.293 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.541 ' ND2' HD12 ' A' ' 161' ' ' ILE . 0.4 OUTLIER -115.85 126.82 54.46 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.501 1.126 . . . . 72.420000000000002 109.369 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.959 HD21 ' CG2' ' A' ' 162' ' ' VAL . 0.4 OUTLIER -148.97 177.79 9.26 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.473 1.108 . . . . 63.420000000000002 109.327 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -122.85 131.13 53.61 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.532 1.145 . . . . 75.329999999999998 111.044 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.907 HD12 ' HB3' ' A' ' 193' ' ' PHE . 38.3 mm -77.52 122.63 32.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.488 1.117 . . . . 73.400000000000006 109.344 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.556 ' C ' HD11 ' A' ' 236' ' ' LEU . 3.6 m -85.42 -28.97 24.75 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.122 . . . . 71.409999999999997 108.302 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -167.22 179.58 5.02 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.484 1.115 . . . . 71.319999999999993 109.252 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.468 ' NE2' HG21 ' A' ' 231' ' ' ILE . 7.5 p80 -136.26 154.65 50.84 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 75.340000000000003 109.605 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.471 ' CD2' ' HB2' ' A' ' 189' ' ' ASN . 0.2 OUTLIER -128.98 111.91 13.51 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.536 1.147 . . . . 71.109999999999999 109.596 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.471 ' HB2' ' CD2' ' A' ' 188' ' ' HIS . 0.5 OUTLIER 58.65 21.53 8.87 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.544 1.152 . . . . 61.109999999999999 109.36 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 69.9 m 56.33 19.2 3.82 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.495 1.122 . . . . 54.530000000000001 108.332 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.462 ' HG2' ' CB ' ' A' ' 189' ' ' ASN . 6.7 pt-20 -116.52 -31.74 5.45 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.566 1.166 . . . . 73.519999999999996 110.325 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.425 ' N ' ' HG3' ' A' ' 191' ' ' GLU . 16.7 m0 -115.33 165.12 13.31 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.613 1.196 . . . . 64.549999999999997 108.012 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.907 ' HB3' HD12 ' A' ' 184' ' ' ILE . 9.0 m-85 -143.87 159.16 43.03 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.518 1.136 . . . . 74.430000000000007 111.006 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.468 ' CG1' ' HB ' ' A' ' 239' ' ' VAL . 19.9 mm -100.9 121.91 52.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.525 1.141 . . . . 71.409999999999997 109.341 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -118.78 170.83 8.66 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.572 1.17 . . . . 64.430000000000007 109.336 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.457 ' CG ' ' HD2' ' A' ' 197' ' ' PRO . 1.5 ttpm? -169.03 144.79 2.75 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.498 1.123 . . . . 73.519999999999996 109.271 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.698 ' CG ' HD13 ' A' ' 201' ' ' LEU . 18.0 Cg_endo -75.07 140.63 25.48 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.483 1.78 . . . . 71.299999999999997 110.958 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.512 HG23 ' N ' ' A' ' 199' ' ' GLY . 0.0 OUTLIER -41.54 -54.19 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.522 1.139 . . . . 73.420000000000002 109.223 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.512 ' N ' HG23 ' A' ' 198' ' ' ILE . . . -70.31 -130.15 0.07 OUTLIER Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.519 1.137 . . . . 52.32 111.049 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 35.4 mmm-85 -142.64 117.01 9.61 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.515 0.773 . . . . 74.409999999999997 110.32 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.698 HD13 ' CG ' ' A' ' 197' ' ' PRO . 5.0 mp -122.45 -43.63 2.28 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.455 1.097 . . . . 75.420000000000002 109.339 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 171.49 -76.09 0.1 OUTLIER Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.442 1.089 . . . . 74.409999999999997 111.045 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 53.25 177.19 0.07 OUTLIER Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.994 -0.842 . . . . 74.349999999999994 110.994 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 145.06 82.88 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 120.951 -2.52 . . . . 70.150000000000006 111.015 0.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 194' ' ' ILE . . . -90.61 156.73 24.97 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.531 1.145 . . . . 54.43 111.021 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.604 ' O ' ' CZ ' ' A' ' 166' ' ' PHE . 1.5 mt -119.94 135.74 54.79 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 0.763 . . . . 74.349999999999994 109.269 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.684 HG13 ' CG ' ' A' ' 166' ' ' PHE . 0.6 OUTLIER -148.17 139.37 13.64 Favored Pre-proline 0 C--N 1.323 -0.547 0 O-C-N 124.519 1.137 . . . . 71.019999999999996 109.34 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.573 ' HD2' HG12 ' A' ' 207' ' ' VAL . 18.3 Cg_endo -75.03 152.98 41.27 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.51 1.795 . . . . 74.310000000000002 110.979 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.615 ' HA ' HG22 ' A' ' 212' ' ' VAL . 3.9 p -67.57 -25.16 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.481 1.113 . . . . 71.049999999999997 109.314 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -67.51 -8.07 49.8 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.505 1.128 . . . . 43.210000000000001 111.016 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.609 ' O ' HG13 ' A' ' 162' ' ' VAL . 8.0 m-85 -120.08 15.57 12.4 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.5 0.765 . . . . 74.319999999999993 111.008 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.615 HG22 ' HA ' ' A' ' 209' ' ' VAL . 17.7 m -154.3 144.49 13.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.497 1.123 . . . . 43.009999999999998 109.291 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 42.0 t -128.27 147.91 50.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.495 1.122 . . . . 70.109999999999999 110.018 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 215' ' ' ILE . 23.0 mm -91.81 146.54 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.413 1.071 . . . . 62.119999999999997 109.258 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 1.033 HG22 ' HB2' ' A' ' 222' ' ' ALA . 2.7 pp -157.8 141.92 7.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.464 1.102 . . . . 71.150000000000006 109.291 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.497 ' O ' HD12 ' A' ' 215' ' ' ILE . 19.4 m-20 -55.75 -174.3 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.135 . . . . 74.209999999999994 109.325 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 10.3 pt -90.86 15.94 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.498 1.124 . . . . 64.010000000000005 109.335 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -64.28 -175.68 0.18 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.488 1.117 . . . . 72.340000000000003 109.272 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.613 ' CG2' ' CE2' ' A' ' 221' ' ' TYR . 2.9 t -49.43 -23.45 1.53 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.139 . . . . 65.540000000000006 110.4 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 135.39 59.92 0.06 OUTLIER Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.516 1.135 . . . . 71.140000000000001 110.967 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.613 ' CE2' ' CG2' ' A' ' 219' ' ' THR . 21.5 m-85 -139.75 170.51 15.75 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.538 0.787 . . . . 74.299999999999997 111.006 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 1.033 ' HB2' HG22 ' A' ' 215' ' ' ILE . . . -124.69 148.96 47.7 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.451 1.094 . . . . 73.129999999999995 109.306 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.445 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 11.5 p -92.14 -36.05 13.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.476 1.11 . . . . 71.239999999999995 110.376 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 137.88 -11.8 3.65 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.5 1.125 . . . . 60.119999999999997 111.036 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.445 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 2.6 p30 -51.74 179.86 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.518 0.775 . . . . 74.430000000000007 109.353 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -118.74 172.48 7.48 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.484 1.115 . . . . 54.450000000000003 109.223 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.73 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 11.1 p -83.18 -40.49 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.459 1.099 . . . . 74.409999999999997 109.28 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.596 ' HA ' HD12 ' A' ' 231' ' ' ILE . 3.6 mp -55.14 -43.84 72.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.547 1.154 . . . . 64.439999999999998 109.28 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -66.04 -35.12 79.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.517 1.135 . . . . 52.140000000000001 110.311 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.437 ' HB3' HD11 ' A' ' 158' ' ' LEU . 1.1 m-20 -79.01 -21.43 46.97 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.515 1.135 . . . . 75.540000000000006 109.355 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 228' ' ' ILE . 21.6 mt -69.14 -36.74 74.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.485 1.116 . . . . 64.340000000000003 109.33 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -78.03 -28.67 49.08 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.553 1.158 . . . . 72.530000000000001 109.314 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.481 ' O ' HD13 ' A' ' 155' ' ' LEU . 50.3 m -56.14 -40.14 73.35 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.459 1.1 . . . . 71.030000000000001 110.003 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.715 HG23 ' HB2' ' A' ' 155' ' ' LEU . 7.2 p -111.65 21.29 5.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.521 1.138 . . . . 74.349999999999994 109.235 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 40.85 29.67 0.08 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.439 1.087 . . . . 73.030000000000001 109.251 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.581 ' HB2' HG13 ' A' ' 234' ' ' VAL . 38.7 tp -44.25 110.24 0.97 Allowed Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 73.219999999999999 109.3 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.07 140.88 25.79 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.589 1.836 . . . . 64.510000000000005 111.011 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 5.8 p -57.52 150.08 19.73 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.503 1.127 . . . . 72.349999999999994 110.367 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.468 ' HB ' ' CG1' ' A' ' 194' ' ' ILE . 0.9 OUTLIER -47.26 -25.6 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.474 1.109 . . . . 53.030000000000001 109.351 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -83.51 -49.63 9.06 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 72.340000000000003 110.319 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -56.94 -28.86 62.6 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.566 1.166 . . . . 73.109999999999999 110.361 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -78.13 -70.58 0.48 Allowed 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.478 1.111 . . . . 64.150000000000006 108.067 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.1 ptmm? -41.8 -33.75 0.55 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.435 1.084 . . . . 60.219999999999999 109.348 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 27.0 t -61.4 -59.0 5.93 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.476 1.11 . . . . 71.310000000000002 110.032 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -50.37 -38.31 41.8 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.465 1.103 . . . . 70.230000000000004 109.325 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 7.1 mm -57.43 119.12 2.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.521 1.138 . . . . 71.420000000000002 109.27 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -154.1 179.04 9.31 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.502 1.126 . . . . 70.329999999999998 109.29 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.41 ' NE ' ' O ' ' A' ' 248' ' ' ARG . 0.0 OUTLIER -52.69 -49.59 65.0 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.52 1.138 . . . . 70.430000000000007 110.292 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -84.8 104.84 15.12 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.522 1.139 . . . . 75.140000000000001 111.011 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 17.3 mtmm -115.58 163.91 15.1 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.432 1.083 . . . . 54.020000000000003 109.273 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -154.29 140.37 18.4 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.506 1.129 . . . . 64.329999999999998 109.351 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 48.3 t -161.04 161.27 31.33 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.448 1.093 . . . . 65.140000000000001 109.983 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -169.47 126.79 0.92 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.474 1.109 . . . . 73.109999999999999 109.301 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 2.5 tp -127.64 126.52 67.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.493 1.12 . . . . 51.009999999999998 109.288 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 45.7 p -106.54 147.89 28.88 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.521 1.138 . . . . 72.109999999999999 109.941 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 8.0 tp -155.71 125.86 6.64 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.489 1.118 . . . . 75.129999999999995 109.265 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -115.07 150.29 18.74 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.469 1.106 . . . . 74.540000000000006 110.974 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 51.4 p -144.77 148.32 33.95 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.492 0.76 . . . . 73.219999999999999 109.933 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 59.3 t -102.56 123.7 56.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.459 1.099 . . . . 72.230000000000004 109.311 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.553 1.158 . . . . 74.319999999999993 110.329 -179.993 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.939 0 N-CA-C 111.073 -0.811 . . . . 74.150000000000006 111.073 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 170.36 20.59 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.498 1.788 . . . . 65.409999999999997 111.021 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.8 HD13 ' O ' ' A' ' 233' ' ' SER . 4.3 mp -83.31 -85.61 0.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.499 1.124 . . . . 71.239999999999995 109.254 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.29 -7.0 82.87 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.531 1.145 . . . . 70.109999999999999 110.977 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.4 m -139.24 127.64 22.87 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.528 0.781 . . . . 72.140000000000001 109.98 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.784 HD22 HG21 ' A' ' 234' ' ' VAL . 33.9 tp -117.0 161.67 19.01 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.556 1.16 . . . . 73.120000000000005 109.283 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.435 ' CD1' ' C ' ' A' ' 158' ' ' LEU . 3.0 m-85 -136.43 136.55 39.62 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.519 1.137 . . . . 74.209999999999994 111.004 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.469 ' HB2' ' CD1' ' A' ' 214' ' ' ILE . . . -125.92 136.76 53.4 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.419 1.074 . . . . 72.140000000000001 109.316 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.409 HD13 ' C ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -99.09 126.69 52.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.568 1.168 . . . . 72.310000000000002 109.303 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.74 HG13 ' O ' ' A' ' 211' ' ' PHE . 2.1 t -81.99 125.89 39.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.472 1.107 . . . . 71.310000000000002 109.292 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.491 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.5 OUTLIER -93.08 -28.04 16.59 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 65.340000000000003 109.316 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.66 ' O ' HG12 ' A' ' 162' ' ' VAL . 2.1 m-85 -128.07 -171.93 2.57 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.513 1.133 . . . . 74.409999999999997 110.973 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.524 ' N ' HG12 ' A' ' 178' ' ' VAL . 12.3 t0 -111.27 139.56 46.57 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.516 1.135 . . . . 74.239999999999995 109.363 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.58 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 4.8 t80 -113.11 132.31 55.48 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 73.099999999999994 111.024 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -99.97 101.59 12.73 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.517 1.136 . . . . 71.030000000000001 109.312 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.517 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -55.16 119.21 5.16 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.503 1.127 . . . . 73.540000000000006 109.232 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -115.63 -36.84 4.12 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.419 1.074 . . . . 65.200000000000003 110.341 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.429 ' CB ' ' HB2' ' A' ' 173' ' ' GLU . 5.1 tptt -74.82 152.81 38.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.453 1.096 . . . . 74.409999999999997 109.323 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.34 -28.78 67.15 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.523 1.139 . . . . 64.310000000000002 109.332 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -109.45 28.35 8.62 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.53 1.144 . . . . 72.109999999999999 109.361 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.473 ' HG3' ' CE2' ' A' ' 166' ' ' PHE . 5.6 tp10 -100.61 148.02 25.31 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.463 1.102 . . . . 73.420000000000002 110.247 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.715 HD13 ' HB ' ' A' ' 198' ' ' ILE . 7.7 mt -121.24 141.99 50.35 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 65.200000000000003 109.306 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 166' ' ' PHE . 3.3 m -84.86 155.01 21.92 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.534 1.146 . . . . 63.229999999999997 110.421 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.4 m -142.12 -175.04 4.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.474 1.109 . . . . 74.120000000000005 110.415 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.549 ' H ' HG22 ' A' ' 176' ' ' THR . 13.0 m-85 -139.87 158.33 44.25 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.534 1.146 . . . . 71.120000000000005 111.047 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.0 OUTLIER -67.72 153.64 8.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.49 1.119 . . . . 53.25 109.354 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 37.2 56.71 1.43 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.547 1.155 . . . . 73.140000000000001 110.983 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -120.71 172.33 7.95 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.523 0.778 . . . . 75.0 110.261 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -111.28 119.78 40.04 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.473 1.108 . . . . 74.530000000000001 109.319 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.7 tp -135.88 159.75 40.7 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.422 1.076 . . . . 73.209999999999994 109.283 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 0.4 OUTLIER -122.76 124.78 44.12 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.46 1.1 . . . . 75.349999999999994 110.957 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.773 HD12 ' HB3' ' A' ' 193' ' ' PHE . 23.1 mm -77.54 132.8 31.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.557 1.161 . . . . 75.329999999999998 109.275 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.492 ' C ' HD11 ' A' ' 236' ' ' LEU . 33.9 t -99.65 -27.91 13.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.443 1.089 . . . . 74.239999999999995 108.313 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.818 ' HB3' HG13 ' A' ' 194' ' ' ILE . . . -163.9 177.47 8.54 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.482 1.114 . . . . 41.329999999999998 109.268 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.442 ' NE2' HG21 ' A' ' 231' ' ' ILE . 10.3 p80 -143.54 156.76 44.7 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.431 1.082 . . . . 73.329999999999998 109.632 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.602 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 1.7 t-160 -131.92 116.4 17.11 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.567 1.167 . . . . 74.230000000000004 109.602 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 58.31 20.7 7.49 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.465 1.103 . . . . 64.409999999999997 109.327 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.442 ' HB3' ' CG1' ' A' ' 228' ' ' ILE . 42.5 m 55.79 19.87 3.73 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.438 1.086 . . . . 72.319999999999993 108.331 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 192' ' ' TRP . 4.4 pt-20 -117.02 -32.86 4.91 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.48 1.112 . . . . 73.400000000000006 110.29 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.619 ' HE3' HD22 ' A' ' 206' ' ' LEU . 7.7 m0 -112.4 160.26 17.91 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.542 1.151 . . . . 45.420000000000002 107.999 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.794 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 16.1 m-85 -132.78 161.45 34.05 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.121 . . . . 72.400000000000006 110.94 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.818 HG13 ' HB3' ' A' ' 186' ' ' ALA . 35.5 mm -109.46 120.32 60.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.56 1.162 . . . . 64.010000000000005 109.37 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -96.93 122.85 40.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.12 . . . . 70.5 109.332 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.522 ' CB ' ' HD3' ' A' ' 197' ' ' PRO . 0.0 OUTLIER -87.59 -60.33 0.25 Allowed Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.536 1.148 . . . . 74.310000000000002 109.222 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.522 ' HD3' ' CB ' ' A' ' 196' ' ' LYS . 18.2 Cg_endo -75.03 173.36 14.65 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.516 1.798 . . . . 72.349999999999994 111.022 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.715 ' HB ' HD13 ' A' ' 174' ' ' LEU . 9.9 tp -175.18 160.5 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.537 1.148 . . . . 74.219999999999999 109.239 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.423 ' N ' HG13 ' A' ' 198' ' ' ILE . . . -82.09 8.64 59.97 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.467 1.104 . . . . 35.32 111.071 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.578 ' O ' HG23 ' A' ' 198' ' ' ILE . 12.0 tpt180 -151.47 126.69 9.9 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 0.764 . . . . 72.200000000000003 110.341 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 15.4 mt -40.27 98.22 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.455 1.097 . . . . 75.450000000000003 109.314 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 200' ' ' ARG . . . -165.95 -140.47 2.89 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.61 1.194 . . . . 74.340000000000003 110.982 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.619 ' HA3' HD11 ' A' ' 174' ' ' LEU . . . 54.43 175.47 0.1 OUTLIER Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.995 -0.842 . . . . 41.450000000000003 110.995 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.9 151.97 97.61 Favored 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 120.947 -2.522 . . . . 53.32 111.033 -0.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.93 -164.5 11.08 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.454 1.096 . . . . 71.510000000000005 110.995 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.619 HD22 ' HE3' ' A' ' 192' ' ' TRP . 1.3 mt -109.19 164.6 12.31 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.508 0.769 . . . . 73.230000000000004 109.318 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.62 HG13 ' HB2' ' A' ' 193' ' ' PHE . 0.1 OUTLIER -155.24 137.46 9.95 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.428 1.08 . . . . 64.319999999999993 109.291 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.58 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.2 Cg_endo -75.03 144.32 30.0 Favored 'Trans proline' 0 C--N 1.362 1.243 0 O-C-N 124.44 1.758 . . . . 75.329999999999998 110.991 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.732 HG23 ' CE2' ' A' ' 193' ' ' PHE . 12.6 p -73.41 -16.91 17.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.505 1.128 . . . . 75.010000000000005 109.333 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -77.37 2.35 62.47 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.525 1.141 . . . . 53.020000000000003 110.994 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.74 ' O ' HG13 ' A' ' 162' ' ' VAL . 20.4 m-85 -133.46 23.85 4.06 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.435 0.726 . . . . 74.219999999999999 110.99 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.634 HG21 ' CD2' ' A' ' 193' ' ' PHE . 33.1 m -156.94 148.49 10.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.534 1.146 . . . . 63.210000000000001 109.251 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.491 ' HB2' HD11 ' A' ' 163' ' ' LEU . 3.1 t -133.65 159.29 40.95 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.488 1.117 . . . . 61.009999999999998 109.98 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.868 HG13 HG23 ' A' ' 227' ' ' VAL . 24.2 mm -110.83 102.42 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 72.200000000000003 109.276 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.763 ' C ' HD12 ' A' ' 215' ' ' ILE . 0.8 OUTLIER -142.77 151.45 17.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.539 1.149 . . . . 72.549999999999997 109.321 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.431 ' N ' HD12 ' A' ' 215' ' ' ILE . 9.8 t0 -79.85 111.57 16.29 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.531 1.144 . . . . 74.340000000000003 109.327 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 217' ' ' ILE . 9.5 mm -51.78 -24.26 4.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 124.466 1.104 . . . . 74.530000000000001 109.257 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.26 99.14 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.433 1.083 . . . . 72.439999999999998 109.373 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 13.7 m -83.68 -71.99 0.48 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.513 1.133 . . . . 71.450000000000003 110.388 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 109.35 13.42 17.28 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.504 1.127 . . . . 73.439999999999998 111.043 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -139.58 -175.6 4.25 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 0.769 . . . . 72.5 111.0 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -118.17 137.8 52.73 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.532 1.145 . . . . 55.100000000000001 109.208 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 77.8 p -91.45 -16.2 27.68 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.518 1.136 . . . . 72.310000000000002 110.435 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.53 6.06 17.97 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.534 1.146 . . . . 70.349999999999994 110.995 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -79.43 -179.2 6.67 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.583 0.814 . . . . 73.430000000000007 109.291 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.86 179.98 4.78 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.466 1.104 . . . . 71.120000000000005 109.292 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.868 HG23 HG13 ' A' ' 214' ' ' ILE . 5.6 p -82.1 -32.42 10.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 74.430000000000007 109.296 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.708 ' HA ' HD12 ' A' ' 231' ' ' ILE . 3.0 mp -62.02 -51.36 73.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.41 1.068 . . . . 54.409999999999997 109.323 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -62.1 -19.06 62.58 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.46 1.1 . . . . 64.510000000000005 110.392 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.653 ' O ' HG22 ' A' ' 234' ' ' VAL . 0.8 OUTLIER -88.89 -34.68 16.87 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.49 1.119 . . . . 63.439999999999998 109.263 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.708 HD12 ' HA ' ' A' ' 228' ' ' ILE . 19.5 mt -61.35 -26.39 39.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.534 1.146 . . . . 74.319999999999993 109.284 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -83.57 -11.49 57.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.448 1.092 . . . . 73.25 109.317 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.8 ' O ' HD13 ' A' ' 155' ' ' LEU . 3.7 m -93.21 -5.49 49.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.517 1.136 . . . . 71.310000000000002 109.986 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.784 HG21 HD22 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -130.8 7.54 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.429 1.081 . . . . 50.240000000000002 109.317 -179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 4.1 m120 44.44 26.99 0.2 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.463 1.102 . . . . 64.349999999999994 109.288 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.666 HD11 ' HA ' ' A' ' 186' ' ' ALA . 3.5 tp -55.8 113.53 5.86 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.497 1.123 . . . . 71.239999999999995 109.317 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 145.08 31.1 Favored 'Trans proline' 0 C--N 1.361 1.231 0 O-C-N 124.505 1.792 . . . . 72.140000000000001 111.034 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 3.9 p -57.42 161.12 3.62 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.434 1.083 . . . . 73.299999999999997 110.367 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.602 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.8 p -61.32 -24.37 33.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.459 1.1 . . . . 64.200000000000003 109.317 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.513 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 4.4 mm100 -80.85 -36.64 31.19 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.119 . . . . 72.420000000000002 110.31 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -75.4 -25.77 57.88 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.498 1.124 . . . . 61.020000000000003 110.291 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 1.002 ' CE2' HD11 ' A' ' 246' ' ' ILE . 8.1 t90 -82.99 -63.61 1.33 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.003 -1.11 . . . . 71.140000000000001 108.003 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.658 ' HA ' HD12 ' A' ' 246' ' ' ILE . 8.6 ptmt -44.04 -30.79 0.78 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.477 1.111 . . . . 61.299999999999997 109.315 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 22.7 t -72.99 -48.16 38.89 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.474 1.109 . . . . 62.32 110.01 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.58 -37.38 65.43 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.508 1.13 . . . . 60.549999999999997 109.26 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 1.002 HD11 ' CE2' ' A' ' 242' ' ' TRP . 50.6 mt -62.77 118.35 4.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.485 1.116 . . . . 73.430000000000007 109.267 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -137.27 164.66 28.02 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.474 1.109 . . . . 54.25 109.31 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.43 ' CD ' ' O ' ' A' ' 248' ' ' ARG . 0.0 OUTLIER -61.33 -34.11 74.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.505 1.128 . . . . 75.329999999999998 110.276 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.475 ' C ' ' CD1' ' A' ' 249' ' ' TYR . 6.7 p90 -174.78 159.17 2.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.478 1.111 . . . . 74.239999999999995 111.0 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -140.17 174.53 10.42 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 64.219999999999999 109.35 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.23 -68.01 0.6 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.526 1.141 . . . . 52.409999999999997 109.308 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 69.2 m -117.22 154.86 30.43 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.534 1.146 . . . . 62.32 110.032 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -174.63 -176.99 1.11 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.543 1.152 . . . . 65.120000000000005 109.282 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.679 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.7 pp -130.11 176.34 8.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 72.439999999999998 109.276 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 47.5 t -163.85 132.82 3.83 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.501 1.126 . . . . 75.450000000000003 110.01 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 90.5 mt -104.47 87.29 2.68 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.446 1.091 . . . . 75.540000000000006 109.359 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -95.14 121.47 6.84 Favored Glycine 0 CA--C 1.531 1.073 0 O-C-N 124.544 1.152 . . . . 64.420000000000002 110.97 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.86 148.58 21.9 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 124.546 0.792 . . . . 65.439999999999998 110.031 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 54.8 t -102.44 134.6 42.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.546 1.153 . . . . 72.439999999999998 109.304 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.324 -0.504 0 O-C-N 124.45 1.094 . . . . 51.509999999999998 110.299 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.937 0 N-CA-C 111.021 -0.832 . . . . 61.450000000000003 111.021 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 145.92 32.25 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.5 1.789 . . . . 71.549999999999997 111.047 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.566 ' C ' HD12 ' A' ' 155' ' ' LEU . 3.0 pp -113.48 163.38 14.98 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.478 1.111 . . . . 62.539999999999999 109.234 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 113.04 -21.01 18.84 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.523 1.139 . . . . 65.109999999999999 110.991 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.58 109.12 0.51 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.477 0.751 . . . . 73.519999999999996 110.039 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.711 ' CD2' HG11 ' A' ' 234' ' ' VAL . 0.2 OUTLIER -97.54 135.22 39.69 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.489 1.118 . . . . 51.219999999999999 109.277 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -105.97 126.55 52.32 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.439 1.087 . . . . 75.420000000000002 111.06 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.499 ' HA ' HD13 ' A' ' 214' ' ' ILE . . . -105.66 162.74 13.25 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 51.520000000000003 109.273 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.433 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.0 OUTLIER -130.62 127.51 62.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.471 1.107 . . . . 72.239999999999995 109.26 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.705 ' CG2' HD23 ' A' ' 182' ' ' LEU . 4.9 t -86.14 122.55 38.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.488 1.118 . . . . 62.43 109.318 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.956 ' O ' HG23 ' A' ' 178' ' ' VAL . 0.3 OUTLIER -107.07 -9.42 16.19 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.13 . . . . 75.329999999999998 109.273 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.445 ' O ' HG12 ' A' ' 162' ' ' VAL . 66.7 m-85 -135.13 145.1 47.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.542 1.151 . . . . 75.329999999999998 110.992 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -82.58 104.59 12.96 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.56 1.162 . . . . 75.319999999999993 109.331 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 175' ' ' THR . 1.5 t80 -85.99 122.75 30.48 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.513 1.133 . . . . 62.25 111.007 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.78 99.94 11.3 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.454 1.096 . . . . 75.049999999999997 109.287 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.959 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -47.68 125.45 8.56 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.435 1.084 . . . . 74.120000000000005 109.324 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -120.38 -40.68 2.66 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.496 1.122 . . . . 64.209999999999994 110.289 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.88 170.57 10.88 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.523 1.139 . . . . 62.219999999999999 109.275 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.66 -38.09 62.56 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.497 1.123 . . . . 63.409999999999997 109.299 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -100.07 27.45 5.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.477 1.111 . . . . 63.450000000000003 109.353 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.593 ' OE2' ' CH2' ' A' ' 192' ' ' TRP . 3.5 mm-40 -108.57 153.17 23.76 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 74.409999999999997 110.317 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.959 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 17.3 mt -125.77 159.94 31.07 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.468 1.105 . . . . 63.140000000000001 109.313 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.522 ' N ' ' HB2' ' A' ' 168' ' ' ALA . 15.1 t -101.55 154.04 19.2 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.538 1.149 . . . . 62.310000000000002 110.439 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.3 m -138.25 -168.98 2.48 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.454 1.096 . . . . 74.019999999999996 110.366 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.613 ' H ' HG22 ' A' ' 176' ' ' THR . 54.5 m-85 -138.82 134.33 33.23 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.522 1.139 . . . . 74.430000000000007 111.014 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.956 HG23 ' O ' ' A' ' 163' ' ' LEU . 1.6 p -58.09 146.65 7.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.41 1.069 . . . . 64.129999999999995 109.28 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 58.74 47.17 91.72 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.457 1.098 . . . . 62.530000000000001 110.971 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -121.9 172.37 8.24 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.488 0.758 . . . . 63.109999999999999 110.306 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.414 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.4 OUTLIER -123.25 137.57 54.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.446 1.092 . . . . 64.510000000000005 109.374 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.705 HD23 ' CG2' ' A' ' 162' ' ' VAL . 3.1 pp -158.74 168.19 27.51 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 70.310000000000002 109.25 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.598 ' CE1' ' O ' ' A' ' 184' ' ' ILE . 4.2 t80 -112.13 148.24 34.4 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.487 1.117 . . . . 60.109999999999999 110.997 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.955 HD12 ' HB3' ' A' ' 193' ' ' PHE . 26.4 mm -90.51 134.12 30.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.394 1.059 . . . . 75.439999999999998 109.327 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.49 ' O ' HD11 ' A' ' 236' ' ' LEU . 16.5 t -101.59 -26.02 13.68 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.483 1.114 . . . . 51.310000000000002 108.325 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.707 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -164.27 179.38 6.87 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.135 . . . . 73.099999999999994 109.306 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.691 ' CD2' HG21 ' A' ' 231' ' ' ILE . 9.5 p80 -138.3 148.71 44.93 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 60.130000000000003 109.566 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.526 ' CG ' ' HB2' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -122.17 114.48 20.92 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.507 1.129 . . . . 54.310000000000002 109.555 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.438 ' C ' ' N ' ' A' ' 191' ' ' GLU . 2.4 m-20 55.8 27.42 10.83 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.541 1.151 . . . . 73.010000000000005 109.272 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 1.5 p 50.81 20.04 0.71 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.569 1.168 . . . . 72.329999999999998 108.303 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.445 ' O ' HG12 ' A' ' 209' ' ' VAL . 1.3 pt-20 -125.0 -10.45 7.14 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.497 1.123 . . . . 71.209999999999994 110.335 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.593 ' CH2' ' OE2' ' A' ' 173' ' ' GLU . 6.8 m95 -130.68 166.58 20.42 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.961 -1.126 . . . . 75.25 107.961 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.955 ' HB3' HD12 ' A' ' 184' ' ' ILE . 31.3 m-85 -139.59 163.31 32.89 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.427 1.079 . . . . 73.430000000000007 110.994 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.707 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 30.0 mm -109.35 117.67 55.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.506 1.129 . . . . 74.109999999999999 109.283 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.505 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -100.43 145.29 28.42 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 64.209999999999994 109.336 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.618 ' HD3' HG22 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -121.22 162.66 34.51 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.534 1.146 . . . . 72.230000000000004 109.228 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 108.82 2.81 Favored 'Trans proline' 0 C--N 1.361 1.222 0 O-C-N 124.442 1.759 . . . . 65.219999999999999 111.03 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 7.6 tt -114.98 27.62 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.475 1.109 . . . . 70.019999999999996 109.287 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -165.11 -43.23 0.02 OUTLIER Glycine 0 CA--C 1.531 1.074 0 O-C-N 124.527 1.142 . . . . 73.540000000000006 110.985 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -137.63 127.26 25.2 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.571 0.807 . . . . 65.329999999999998 110.263 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.527 ' C ' HD23 ' A' ' 201' ' ' LEU . 7.7 tt -40.61 138.0 1.04 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.521 1.138 . . . . 71.129999999999995 109.27 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.469 ' N ' HD23 ' A' ' 201' ' ' LEU . . . 145.55 109.6 0.63 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.543 1.152 . . . . 70.450000000000003 110.957 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.748 ' HA2' HD11 ' A' ' 174' ' ' LEU . . . 166.93 175.77 37.34 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.04 -0.824 . . . . 65.25 111.04 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 170.47 71.76 Favored 'Cis proline' 0 C--N 1.359 1.101 0 C-N-CA 121.008 -2.497 . . . . 71.120000000000005 110.986 -0.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.473 ' HA3' HD12 ' A' ' 174' ' ' LEU . . . -134.9 167.06 24.17 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.502 1.126 . . . . 42.420000000000002 110.976 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.575 ' HB3' ' CE3' ' A' ' 192' ' ' TRP . 3.2 mt -108.68 155.32 20.85 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.483 0.755 . . . . 63.340000000000003 109.311 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.731 HG21 HG11 ' A' ' 212' ' ' VAL . 0.2 OUTLIER -156.42 118.28 2.21 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.57 1.169 . . . . 74.420000000000002 109.294 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.509 ' HD3' ' CZ3' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -75.04 137.94 22.28 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.544 1.813 . . . . 61.119999999999997 111.0 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.562 ' HB ' ' CE2' ' A' ' 193' ' ' PHE . 13.3 p -58.26 -17.32 9.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.516 1.135 . . . . 71.319999999999993 109.314 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -71.44 -3.87 55.13 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 124.453 1.096 . . . . 53.340000000000003 111.047 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -128.73 2.39 5.45 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.405 0.709 . . . . 71.439999999999998 111.063 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.731 HG11 HG21 ' A' ' 207' ' ' VAL . 14.8 m -143.34 163.88 16.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.439 1.087 . . . . 74.230000000000004 109.246 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.624 ' HB2' HD11 ' A' ' 163' ' ' LEU . 1.4 t -144.87 160.61 41.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.133 . . . . 71.319999999999993 109.981 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.696 HG13 HG23 ' A' ' 227' ' ' VAL . 28.1 mm -109.23 138.24 37.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.464 1.103 . . . . 62.539999999999999 109.349 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.73 167.26 3.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.514 1.134 . . . . 62.119999999999997 109.269 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.558 ' HB2' HG21 ' A' ' 223' ' ' THR . 11.2 t70 -87.71 -57.82 2.8 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.571 1.169 . . . . 72.319999999999993 109.285 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.401 HG22 HG23 ' A' ' 219' ' ' THR . 22.9 mm -87.72 153.27 3.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.479 1.112 . . . . 74.239999999999995 109.292 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -79.94 55.48 2.12 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.493 1.121 . . . . 73.299999999999997 109.293 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.401 HG23 HG22 ' A' ' 217' ' ' ILE . 2.5 p -126.9 -177.11 3.91 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.51 1.131 . . . . 72.450000000000003 110.388 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -91.13 20.62 38.99 Favored Glycine 0 CA--C 1.529 0.925 0 O-C-N 124.487 1.117 . . . . 73.340000000000003 111.024 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -106.17 -179.66 4.0 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.409 0.711 . . . . 73.140000000000001 110.978 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -141.42 149.79 41.49 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.443 1.09 . . . . 61.039999999999999 109.332 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.558 HG21 ' HB2' ' A' ' 216' ' ' ASP . 69.1 p -91.65 -21.38 20.82 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.546 1.154 . . . . 75.439999999999998 110.462 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 105.42 0.53 40.53 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.578 1.174 . . . . 51.43 111.014 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.549 ' N ' HD22 ' A' ' 225' ' ' ASN . 1.2 m-80 -74.97 -176.15 2.83 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.541 0.789 . . . . 75.299999999999997 109.345 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.22 158.57 38.67 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.493 1.121 . . . . 64.209999999999994 109.285 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.816 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 8.6 p -77.46 -34.86 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.504 1.127 . . . . 74.200000000000003 109.334 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.619 ' HA ' HD12 ' A' ' 231' ' ' ILE . 1.1 mp -52.1 -47.6 43.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 124.502 1.126 . . . . 72.140000000000001 109.227 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 233' ' ' SER . 7.0 mt-10 -66.75 -35.32 79.83 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.573 1.17 . . . . 62.0 110.268 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.24 -27.8 65.78 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.565 1.166 . . . . 70.239999999999995 109.309 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.691 HG21 ' CD2' ' A' ' 187' ' ' HIS . 26.8 mt -74.49 -40.96 49.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.387 1.054 . . . . 54.350000000000001 109.261 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 26.4 mmtt -83.77 -19.98 34.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.389 1.055 . . . . 71.140000000000001 109.296 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 229' ' ' GLU . 8.7 m -60.59 -23.35 64.61 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.489 1.118 . . . . 62.210000000000001 110.027 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.711 HG11 ' CD2' ' A' ' 158' ' ' LEU . 6.3 p -126.39 21.81 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.549 1.156 . . . . 60.25 109.29 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 53.0 t30 47.36 28.46 1.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.532 1.145 . . . . 73.109999999999999 109.301 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.629 HD23 HG23 ' A' ' 231' ' ' ILE . 10.4 tp -58.45 112.15 4.55 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.135 . . . . 60.119999999999997 109.307 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 149.34 36.66 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.493 1.786 . . . . 74.030000000000001 111.012 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.54 HG22 ' CE1' ' A' ' 187' ' ' HIS . 2.3 p -57.15 149.54 19.37 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.522 1.139 . . . . 75.439999999999998 110.342 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.495 HG11 ' HB2' ' A' ' 188' ' ' HIS . 0.4 OUTLIER -41.18 -31.02 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.109 . . . . 61.140000000000001 109.337 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.444 ' O ' ' CB ' ' A' ' 244' ' ' SER . 58.4 mm-40 -81.37 -49.34 10.79 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.455 1.097 . . . . 73.019999999999996 110.296 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -59.09 -21.84 59.84 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.449 1.093 . . . . 74.329999999999998 110.287 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.422 ' O ' ' N ' ' A' ' 246' ' ' ILE . 4.2 t90 -83.33 -71.17 0.51 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.507 1.129 . . . . 64.329999999999998 108.008 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.9 -24.51 1.5 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.455 1.097 . . . . 74.010000000000005 109.246 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 240' ' ' GLN . 43.9 t -77.4 -39.86 45.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.557 1.16 . . . . 70.239999999999995 110.004 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 242' ' ' TRP . 4.0 t-20 -92.18 -71.19 0.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.46 1.1 . . . . 65.310000000000002 109.264 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.422 ' N ' ' O ' ' A' ' 242' ' ' TRP . 14.1 mt 64.47 97.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.591 1.182 . . . . 72.200000000000003 109.269 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -122.92 5.13 9.36 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.566 1.166 . . . . 71.430000000000007 109.332 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -40.26 -45.42 2.08 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.474 1.109 . . . . 72.209999999999994 110.282 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -132.79 145.88 51.37 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.541 1.15 . . . . 63.409999999999997 110.981 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 252' ' ' SER . 0.0 OUTLIER -73.41 -64.24 1.03 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.39 1.056 . . . . 72.430000000000007 109.316 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' A' ' 255' ' ' SER . . . -66.95 76.48 0.12 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.466 1.103 . . . . 74.319999999999993 109.332 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 250' ' ' LYS . 45.8 m -108.72 -72.74 0.71 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.52 1.137 . . . . 72.230000000000004 110.007 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -49.98 -26.76 4.56 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.567 1.167 . . . . 51.329999999999998 109.329 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.548 ' O ' HD12 ' A' ' 254' ' ' ILE . 1.7 pp -127.5 165.22 26.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.492 1.12 . . . . 62.43 109.259 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.51 ' HB2' ' HB1' ' A' ' 251' ' ' ALA . 5.6 m 52.84 34.65 16.97 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 74.430000000000007 109.981 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -44.35 155.6 0.09 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.493 1.121 . . . . 75.430000000000007 109.257 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -66.12 -103.11 0.02 OUTLIER Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.522 1.139 . . . . 73.549999999999997 110.984 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 54.2 m -69.42 158.0 35.99 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.487 0.757 . . . . 73.519999999999996 110.037 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.5 134.54 54.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.476 1.11 . . . . 63.219999999999999 109.312 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 . . . . . 0 C--N 1.325 -0.495 0 O-C-N 124.468 1.105 . . . . 75.209999999999994 110.239 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.031 0 N-CA-C 110.977 -0.849 . . . . 70.019999999999996 110.977 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.03 164.64 32.91 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.586 1.834 . . . . 64.230000000000004 110.966 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.467 HD22 ' O ' ' A' ' 233' ' ' SER . 1.1 mp -100.61 169.74 8.84 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.477 1.111 . . . . 61.340000000000003 109.294 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.499 ' HA2' HG23 ' A' ' 234' ' ' VAL . . . 150.78 -23.67 1.03 Allowed Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.41 1.069 . . . . 43.43 111.021 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.1 p -122.65 163.74 19.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.52 0.776 . . . . 62.140000000000001 110.022 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 158' ' ' LEU . 9.0 mt -154.16 -175.75 5.54 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.119 . . . . 71.450000000000003 109.297 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -160.7 139.78 10.47 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.466 1.104 . . . . 73.510000000000005 111.039 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.411 ' HB2' HG12 ' A' ' 184' ' ' ILE . . . -132.85 162.28 31.96 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.467 1.105 . . . . 44.340000000000003 109.298 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.711 HG21 HD13 ' A' ' 215' ' ' ILE . 0.7 OUTLIER -127.95 121.16 55.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.478 1.111 . . . . 70.329999999999998 109.271 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.979 HG23 HD21 ' A' ' 182' ' ' LEU . 55.9 t -79.11 98.02 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 72.209999999999994 109.323 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.818 HD21 ' HB2' ' A' ' 213' ' ' SER . 0.2 OUTLIER -92.05 35.08 0.99 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.576 1.172 . . . . 73.129999999999995 109.306 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.556 ' HB3' ' CD2' ' A' ' 211' ' ' PHE . 18.2 m-85 -170.98 133.4 0.9 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.469 1.106 . . . . 75.230000000000004 111.014 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.13 102.99 3.16 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.524 1.14 . . . . 62.219999999999999 109.3 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.6 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 7.3 t80 -80.35 153.04 28.61 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.488 1.118 . . . . 74.400000000000006 110.937 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.6 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 11.4 mmmm -112.04 135.21 52.97 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.55 1.156 . . . . 74.25 109.297 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.828 ' HB1' ' OE1' ' A' ' 173' ' ' GLU . . . -84.25 123.81 30.53 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.484 1.115 . . . . 52.049999999999997 109.278 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.439 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 6.5 pt-20 -126.4 -30.62 2.85 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.544 1.153 . . . . 75.319999999999993 110.328 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 173' ' ' GLU . 3.7 tttt -59.03 -173.72 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.594 1.184 . . . . 70.349999999999994 109.293 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.5 -27.82 17.99 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.523 1.139 . . . . 72.129999999999995 109.319 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.54 28.75 6.49 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.517 1.135 . . . . 71.040000000000006 109.354 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.828 ' OE1' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -71.13 -176.4 1.42 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.448 1.092 . . . . 72.120000000000005 110.271 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.725 HD22 ' HA2' ' A' ' 203' ' ' GLY . 1.6 tp -157.62 113.94 2.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 62.140000000000001 109.285 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 2.0 t -68.95 145.29 53.75 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.562 1.164 . . . . 62.32 110.394 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.645 HG22 ' H ' ' A' ' 177' ' ' TYR . 2.7 m -129.25 -169.5 2.11 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.103 . . . . 65.400000000000006 110.405 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.645 ' H ' HG22 ' A' ' 176' ' ' THR . 29.3 m-85 -138.4 133.73 33.23 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.438 1.087 . . . . 75.450000000000003 111.011 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' ' 177' ' ' TYR . 0.2 OUTLIER -39.41 156.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.515 1.134 . . . . 75.450000000000003 109.354 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 51.02 48.37 46.12 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.441 1.088 . . . . 53.229999999999997 110.991 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.452 ' HB3' ' CD1' ' A' ' 182' ' ' LEU . 7.6 mm-40 -107.36 151.49 25.43 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.53 0.782 . . . . 71.329999999999998 110.202 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.877 ' C ' HD13 ' A' ' 182' ' ' LEU . 0.3 OUTLIER -108.27 127.28 53.71 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.56 1.162 . . . . 53.420000000000002 109.282 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.979 HD21 HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -158.81 168.7 26.12 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.477 1.11 . . . . 64.209999999999994 109.311 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 184' ' ' ILE . 2.0 t80 -114.2 144.34 43.35 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.589 1.18 . . . . 73.409999999999997 111.002 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.501 HD12 ' HB3' ' A' ' 193' ' ' PHE . 9.3 mm -77.68 100.74 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.503 1.127 . . . . 62.25 109.308 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.425 ' HB3' ' CG2' ' A' ' 194' ' ' ILE . 1.3 t -73.6 -28.9 62.06 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.475 1.11 . . . . 70.329999999999998 108.246 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.412 ' HB1' ' N ' ' A' ' 239' ' ' VAL . . . -174.36 170.85 3.53 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.539 1.15 . . . . 65.340000000000003 109.352 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.49 ' NE2' HG21 ' A' ' 231' ' ' ILE . 6.4 p80 -129.16 149.51 50.94 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.559 1.162 . . . . 75.239999999999995 109.629 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.526 ' CE1' ' CD ' ' A' ' 240' ' ' GLN . 2.3 t-160 -124.54 114.94 20.08 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.441 1.088 . . . . 72.230000000000004 109.591 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.451 ' C ' ' N ' ' A' ' 191' ' ' GLU . 2.3 m120 53.85 32.8 15.75 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.491 1.12 . . . . 72.230000000000004 109.301 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 12.7 p 42.96 28.23 0.13 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 71.129999999999995 108.314 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.451 ' N ' ' C ' ' A' ' 189' ' ' ASN . 5.0 pt-20 -121.57 -34.79 3.36 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.465 1.103 . . . . 74.400000000000006 110.331 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.47 ' CE3' ' HB3' ' A' ' 206' ' ' LEU . 7.8 m0 -118.04 165.56 13.59 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.534 1.146 . . . . 75.349999999999994 107.945 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.749 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 20.3 m-85 -143.53 157.4 44.46 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 70.120000000000005 111.002 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.441 ' CG2' ' HB2' ' A' ' 204' ' ' PRO . 31.3 mm -95.62 101.93 12.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.497 1.123 . . . . 72.25 109.317 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.577 ' HB2' HG21 ' A' ' 207' ' ' VAL . . . -84.82 168.4 15.15 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.521 1.138 . . . . 54.32 109.245 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -140.54 162.11 51.05 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 63.119999999999997 109.262 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 176.24 10.16 Favored 'Trans proline' 0 C--N 1.361 1.203 0 O-C-N 124.473 1.775 . . . . 75.140000000000001 110.934 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 9.4 tt -91.97 -48.11 13.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.577 1.173 . . . . 75.409999999999997 109.24 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -169.19 46.99 0.22 Allowed Glycine 0 CA--C 1.529 0.934 0 O-C-N 124.474 1.108 . . . . 43.219999999999999 111.003 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -138.53 129.38 26.64 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.419 0.717 . . . . 75.409999999999997 110.271 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.4 tt -48.91 112.14 0.57 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.397 1.061 . . . . 71.010000000000005 109.306 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 160.89 -171.63 37.02 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.481 1.113 . . . . 43.439999999999998 111.035 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.725 ' HA2' HD22 ' A' ' 174' ' ' LEU . . . 67.01 -179.57 13.45 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 110.958 -0.857 . . . . 74.349999999999994 110.958 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.441 ' HB2' ' CG2' ' A' ' 194' ' ' ILE . 18.4 Cg_endo -75.05 -178.72 24.31 Favored 'Cis proline' 0 C--N 1.36 1.153 0 C-N-CA 121.073 -2.47 . . . . 65.430000000000007 111.034 0.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 174' ' ' LEU . . . -133.8 172.38 21.67 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 124.475 1.11 . . . . 74.200000000000003 111.047 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.6 ' O ' ' CE2' ' A' ' 166' ' ' PHE . 2.7 mt -106.41 129.6 54.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 0.754 . . . . 42.43 109.283 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.809 HG12 ' HD2' ' A' ' 208' ' ' PRO . 0.2 OUTLIER -135.88 145.82 54.36 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.471 1.107 . . . . 75.420000000000002 109.308 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.809 ' HD2' HG12 ' A' ' 207' ' ' VAL . 18.2 Cg_endo -75.03 157.68 42.49 Favored 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.515 1.797 . . . . 64.340000000000003 110.977 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.719 HG23 ' HE2' ' A' ' 193' ' ' PHE . 11.2 p -76.23 -20.27 15.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 124.416 1.072 . . . . 75.230000000000004 109.338 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -84.5 5.99 78.9 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.534 1.146 . . . . 32.420000000000002 110.977 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.572 ' CD1' ' HG2' ' A' ' 208' ' ' PRO . 11.5 m-85 -130.17 12.21 5.56 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.507 0.769 . . . . 72.510000000000005 111.023 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.696 HG12 HG22 ' A' ' 162' ' ' VAL . 2.4 m -149.4 148.04 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 62.109999999999999 109.309 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.818 ' HB2' HD21 ' A' ' 163' ' ' LEU . 10.6 t -126.87 147.43 50.06 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.514 1.134 . . . . 72.420000000000002 110.037 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.756 HG13 HG23 ' A' ' 227' ' ' VAL . 22.2 mm -94.12 133.66 34.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.557 1.161 . . . . 74.049999999999997 109.351 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.711 HD13 HG21 ' A' ' 161' ' ' ILE . 9.6 pt -155.02 115.56 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.442 1.089 . . . . 71.299999999999997 109.273 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.03 38.12 4.15 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.494 1.121 . . . . 70.209999999999994 109.255 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.468 HD11 ' O ' ' A' ' 221' ' ' TYR . 2.2 pt -107.8 21.52 4.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 124.438 1.086 . . . . 64.540000000000006 109.245 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 49.89 44.29 25.21 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 71.150000000000006 109.358 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.1 t -161.35 179.7 8.09 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.592 1.182 . . . . 71.519999999999996 110.405 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -103.9 47.26 1.11 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.514 1.134 . . . . 52.109999999999999 110.994 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.468 ' O ' HD11 ' A' ' 217' ' ' ILE . 23.0 m-85 -139.08 177.18 8.08 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.501 0.765 . . . . 63.509999999999998 111.031 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -135.5 141.77 45.36 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.531 1.144 . . . . 73.349999999999994 109.236 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.441 ' OG1' ' ND2' ' A' ' 225' ' ' ASN . 11.5 p -88.97 -37.63 15.08 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.537 1.148 . . . . 71.120000000000005 110.423 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 145.26 -18.47 1.9 Allowed Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.472 1.107 . . . . 20.129999999999999 111.021 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.441 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 2.3 p30 -47.8 172.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.449 0.735 . . . . 74.409999999999997 109.324 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.67 165.31 18.13 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.531 1.144 . . . . 72.540000000000006 109.269 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.756 HG23 HG13 ' A' ' 214' ' ' ILE . 12.3 p -75.55 -44.94 40.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.466 1.104 . . . . 74.409999999999997 109.267 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.779 ' HA ' HD12 ' A' ' 231' ' ' ILE . 1.7 mp -49.42 -54.47 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.42 1.075 . . . . 75.140000000000001 109.324 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.11 -28.67 69.26 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.554 1.159 . . . . 72.109999999999999 110.293 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.11 -14.96 58.09 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.475 1.109 . . . . 73.239999999999995 109.307 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.779 HD12 ' HA ' ' A' ' 228' ' ' ILE . 38.3 mt -83.87 -30.45 7.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.534 1.146 . . . . 72.129999999999995 109.267 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.52 ' CE ' HG22 ' A' ' 231' ' ' ILE . 7.5 mmpt? -82.97 -20.72 34.64 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.507 1.129 . . . . 74.340000000000003 109.332 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.467 ' O ' HD22 ' A' ' 155' ' ' LEU . 36.8 m -66.41 -39.17 88.83 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.566 1.166 . . . . 72.120000000000005 110.004 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.634 ' O ' HG22 ' A' ' 234' ' ' VAL . 4.2 p -114.82 15.56 8.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.518 1.136 . . . . 42.420000000000002 109.326 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 41.41 29.4 0.1 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.496 1.123 . . . . 72.030000000000001 109.337 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.425 HD21 HG22 ' A' ' 184' ' ' ILE . 6.1 tp -41.37 121.01 2.04 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.524 1.14 . . . . 33.350000000000001 109.293 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 135.65 19.28 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.559 1.82 . . . . 62.009999999999998 111.002 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 2.3 p -57.97 152.36 16.48 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.508 1.13 . . . . 62.25 110.395 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.432 HG11 ' HB2' ' A' ' 188' ' ' HIS . 1.3 p -51.2 -22.9 2.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.544 1.153 . . . . 65.030000000000001 109.322 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.526 ' CD ' ' CE1' ' A' ' 188' ' ' HIS . 8.8 mm100 -86.63 -45.54 10.92 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.465 1.103 . . . . 74.450000000000003 110.366 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -63.86 -25.52 68.2 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.465 1.103 . . . . 72.510000000000005 110.29 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.957 ' NE1' HD11 ' A' ' 246' ' ' ILE . 11.2 t90 -77.43 -65.87 0.9 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.553 1.158 . . . . 74.5 107.968 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -52.08 -25.36 8.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 1.13 . . . . 70.109999999999999 109.26 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 43.9 t -76.89 -50.37 13.48 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.552 1.158 . . . . 70.510000000000005 110.009 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -51.97 -39.33 59.15 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.496 1.122 . . . . 73.25 109.331 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.957 HD11 ' NE1' ' A' ' 242' ' ' TRP . 13.2 mt -72.22 158.12 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.477 1.111 . . . . 64.420000000000002 109.279 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 246' ' ' ILE . . . 78.3 8.96 2.2 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.466 1.104 . . . . 74.5 109.282 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -125.63 -176.62 3.65 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.429 1.08 . . . . 74.230000000000004 110.264 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.425 ' O ' ' C ' ' A' ' 250' ' ' LYS . 4.3 t80 -36.57 -63.37 0.41 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 75.409999999999997 111.014 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 249' ' ' TYR . 7.3 ttpp -38.77 -66.81 0.25 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.534 1.146 . . . . 60.450000000000003 109.294 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.625 ' HB2' ' HA ' ' A' ' 246' ' ' ILE . . . -47.12 171.35 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.484 1.115 . . . . 63.350000000000001 109.331 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 3.9 m -39.96 132.43 1.8 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.484 1.115 . . . . 71.120000000000005 110.022 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -57.03 109.22 0.61 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.475 1.109 . . . . 74.450000000000003 109.323 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 34.2 mt -117.67 149.79 19.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.484 1.115 . . . . 74.030000000000001 109.329 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.9 p -44.22 133.01 5.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.474 1.109 . . . . 74.430000000000007 110.024 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.67 162.92 26.73 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.522 1.139 . . . . 73.340000000000003 109.266 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -164.67 146.06 10.94 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.474 1.109 . . . . 34.140000000000001 111.024 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 9.0 t -88.11 128.25 35.42 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.533 0.784 . . . . 65.450000000000003 110.01 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.9 t -136.94 141.97 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.461 1.101 . . . . 73.230000000000004 109.306 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 . . . . . 0 C--N 1.324 -0.519 0 O-C-N 124.481 1.113 . . . . 61.350000000000001 110.314 -179.991 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.989 0 N-CA-C 111.002 -0.839 . . . . 64.230000000000004 111.002 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 155.72 42.79 Favored 'Trans proline' 0 C--N 1.361 1.204 0 O-C-N 124.528 1.804 . . . . 70.209999999999994 110.964 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 12.5 mt -64.82 148.02 52.1 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 71.439999999999998 109.293 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 163.51 48.62 0.02 OUTLIER Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.484 1.115 . . . . 64.150000000000006 111.02 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.2 m -166.29 105.58 0.65 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.46 0.741 . . . . 63.100000000000001 110.013 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.741 ' CD2' HG11 ' A' ' 234' ' ' VAL . 1.6 mm? -110.25 129.55 55.71 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.518 1.136 . . . . 72.040000000000006 109.274 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -138.52 122.71 18.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.485 1.116 . . . . 70.430000000000007 111.02 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.621 ' HB2' HG12 ' A' ' 184' ' ' ILE . . . -103.87 174.52 5.83 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.495 1.122 . . . . 74.439999999999998 109.299 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.522 HG21 ' CD1' ' A' ' 215' ' ' ILE . 0.0 OUTLIER -135.98 128.79 46.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.442 1.089 . . . . 72.209999999999994 109.251 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.897 HG21 ' CG2' ' A' ' 176' ' ' THR . 80.9 t -88.95 122.61 40.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.511 1.132 . . . . 74.109999999999999 109.252 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.2 OUTLIER -107.8 2.73 23.79 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.469 1.105 . . . . 73.049999999999997 109.278 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -153.96 131.59 11.44 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.446 1.091 . . . . 73.349999999999994 110.999 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -63.45 104.82 0.67 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.537 1.148 . . . . 74.340000000000003 109.261 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.578 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 7.3 t80 -80.42 139.46 36.48 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.556 1.16 . . . . 74.420000000000002 110.963 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.489 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 26.7 mmmt -98.31 141.92 30.6 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.128 . . . . 54.020000000000003 109.298 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.822 ' HB1' ' OE1' ' A' ' 173' ' ' GLU . . . -92.02 123.39 35.34 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.422 1.076 . . . . 62.32 109.313 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.448 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 5.9 pt-20 -125.61 -29.35 3.18 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.527 1.142 . . . . 72.239999999999995 110.297 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.45 ' HD3' HD13 ' A' ' 206' ' ' LEU . 3.9 tttp -59.15 -173.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.566 1.166 . . . . 74.030000000000001 109.332 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.19 -31.07 17.2 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.43 1.081 . . . . 63.420000000000002 109.332 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.91 27.93 7.04 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.51 1.131 . . . . 73.430000000000007 109.312 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.822 ' OE1' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -67.97 -176.24 0.66 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.478 1.111 . . . . 61.240000000000002 110.302 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.589 HD12 ' HA3' ' A' ' 205' ' ' GLY . 12.3 mt -151.85 132.36 13.86 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.467 1.104 . . . . 74.549999999999997 109.269 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 12.4 t -78.96 127.88 32.57 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.543 1.152 . . . . 74.019999999999996 110.426 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.897 ' CG2' HG21 ' A' ' 162' ' ' VAL . 2.5 m -106.47 -172.67 2.13 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.444 1.09 . . . . 61.229999999999997 110.374 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.603 ' H ' HG22 ' A' ' 176' ' ' THR . 52.0 m-85 -143.86 133.56 23.72 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.509 1.131 . . . . 74.349999999999994 110.972 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.435 ' CG2' ' N ' ' A' ' 179' ' ' GLY . 1.3 p -51.84 161.37 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.468 1.105 . . . . 75.010000000000005 109.249 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 37.56 51.47 1.86 Allowed Glycine 0 CA--C 1.531 1.057 0 O-C-N 124.533 1.146 . . . . 75.140000000000001 111.005 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.513 ' HG2' HD12 ' A' ' 182' ' ' LEU . 20.3 tt0 -121.85 167.59 12.84 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.555 0.797 . . . . 72.150000000000006 110.288 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.444 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.4 OUTLIER -119.58 120.99 38.32 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.508 1.13 . . . . 43.420000000000002 109.302 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.513 HD12 ' HG2' ' A' ' 180' ' ' GLU . 0.6 OUTLIER -138.02 156.9 47.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.417 1.073 . . . . 45.329999999999998 109.319 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -102.77 129.24 49.36 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.474 1.109 . . . . 71.540000000000006 111.035 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.686 HD12 ' HB3' ' A' ' 193' ' ' PHE . 25.1 mm -77.65 121.32 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 73.230000000000004 109.298 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.499 ' O ' HD11 ' A' ' 236' ' ' LEU . 0.9 OUTLIER -88.66 -26.77 21.68 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.557 1.161 . . . . 63.130000000000003 108.299 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -171.8 176.94 3.48 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.461 1.101 . . . . 74.450000000000003 109.272 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.598 ' CE1' HG21 ' A' ' 231' ' ' ILE . 8.3 p80 -137.27 151.89 49.19 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.495 1.122 . . . . 75.340000000000003 109.565 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.638 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 2.3 t-160 -124.61 114.72 19.74 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.129 . . . . 74.430000000000007 109.566 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.449 ' C ' ' N ' ' A' ' 191' ' ' GLU . 2.7 t30 54.18 33.21 17.51 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.484 1.115 . . . . 54.149999999999999 109.283 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 12.8 p 43.06 28.43 0.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.595 1.185 . . . . 75.540000000000006 108.237 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.8 ' O ' HG12 ' A' ' 209' ' ' VAL . 5.3 pt-20 -122.17 -34.88 3.24 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.539 1.149 . . . . 64.310000000000002 110.257 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.545 ' HE3' HD22 ' A' ' 206' ' ' LEU . 11.9 m0 -116.32 164.73 14.09 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.572 1.17 . . . . 74.340000000000003 108.005 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.736 ' CZ ' HG21 ' A' ' 227' ' ' VAL . 16.6 m-85 -135.5 159.66 40.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.509 1.131 . . . . 72.400000000000006 111.002 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.469 ' CG1' ' HB ' ' A' ' 239' ' ' VAL . 20.2 mm -103.49 119.57 52.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.508 1.13 . . . . 73.109999999999999 109.303 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.77 175.98 5.45 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.489 1.118 . . . . 72.209999999999994 109.307 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -151.07 156.05 35.17 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.524 1.14 . . . . 70.209999999999994 109.305 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.401 ' HG3' ' CA ' ' A' ' 202' ' ' GLY . 18.2 Cg_endo -74.94 161.29 39.16 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.536 1.808 . . . . 74.019999999999996 111.048 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.8 tp -136.25 114.21 14.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 124.505 1.128 . . . . 74.310000000000002 109.287 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 95.13 -17.38 59.43 Favored Glycine 0 CA--C 1.529 0.943 0 O-C-N 124.461 1.101 . . . . 74.129999999999995 111.006 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.609 ' NH2' ' H ' ' A' ' 201' ' ' LEU . 0.0 OUTLIER -133.25 154.86 50.3 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.467 0.745 . . . . 74.430000000000007 110.289 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.609 ' H ' ' NH2' ' A' ' 200' ' ' ARG . 0.6 OUTLIER -85.02 128.19 34.53 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 74.439999999999998 109.3 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.401 ' CA ' ' HG3' ' A' ' 197' ' ' PRO . . . -175.23 -140.74 3.45 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.55 1.156 . . . . 73.239999999999995 111.02 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 52.6 -178.13 0.1 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.995 -0.842 . . . . 72.209999999999994 110.995 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.99 153.3 99.09 Favored 'Cis proline' 0 C--N 1.36 1.174 0 C-N-CA 121.033 -2.486 . . . . 62.119999999999997 110.97 0.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.589 ' HA3' HD12 ' A' ' 174' ' ' LEU . . . -117.25 178.33 17.03 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.503 1.127 . . . . 71.310000000000002 110.963 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.545 HD22 ' HE3' ' A' ' 192' ' ' TRP . 1.3 mt -118.88 165.19 14.36 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.437 0.728 . . . . 73.400000000000006 109.334 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.735 HG21 HG11 ' A' ' 212' ' ' VAL . 0.2 OUTLIER -162.66 129.96 2.6 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.443 1.089 . . . . 74.120000000000005 109.317 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.578 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.4 Cg_endo -74.9 137.58 22.14 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.488 1.783 . . . . 71.349999999999994 110.991 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.8 HG12 ' O ' ' A' ' 191' ' ' GLU . 7.3 p -67.14 -27.16 38.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.515 1.134 . . . . 71.299999999999997 109.251 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -68.81 -13.36 66.11 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.538 1.149 . . . . 34.240000000000002 111.017 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 7.8 m-30 -113.11 3.16 15.96 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.486 0.757 . . . . 71.310000000000002 111.007 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.842 HG12 HG22 ' A' ' 162' ' ' VAL . 15.0 m -140.08 173.78 9.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.541 1.15 . . . . 64.25 109.319 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.686 ' HB2' HD11 ' A' ' 163' ' ' LEU . 2.9 t -152.09 160.76 43.35 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.519 1.137 . . . . 34.009999999999998 109.995 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.682 HG13 HG23 ' A' ' 227' ' ' VAL . 19.1 mm -104.05 96.59 4.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.55 1.156 . . . . 62.219999999999999 109.314 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.522 ' CD1' HG21 ' A' ' 161' ' ' ILE . 1.2 pt -137.29 -174.2 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.504 1.128 . . . . 74.340000000000003 109.353 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -123.45 153.46 40.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.527 1.142 . . . . 70.030000000000001 109.332 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 5.4 mm -67.8 -23.65 29.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.51 1.131 . . . . 73.129999999999995 109.299 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -70.62 -56.02 7.44 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.49 1.119 . . . . 72.0 109.254 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.543 HG21 ' CG2' ' A' ' 223' ' ' THR . 3.5 m -62.63 -70.41 0.2 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.545 1.153 . . . . 71.340000000000003 110.452 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.52 -17.54 53.06 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.435 1.084 . . . . 71.510000000000005 111.04 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.498 ' CE1' HG22 ' A' ' 219' ' ' THR . 24.1 p90 -132.88 -176.51 4.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.489 0.758 . . . . 71.25 111.004 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -94.58 119.86 33.91 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.508 1.13 . . . . 60.109999999999999 109.3 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.543 ' CG2' HG21 ' A' ' 219' ' ' THR . 12.6 p -82.95 -27.19 30.7 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.517 1.136 . . . . 51.520000000000003 110.424 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 139.65 -19.06 2.99 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.54 1.15 . . . . 54.329999999999998 111.052 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.425 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 2.2 p30 -50.08 176.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.465 0.744 . . . . 72.340000000000003 109.263 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -134.63 157.76 45.79 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.494 1.121 . . . . 65.5 109.312 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.737 HG13 HD12 ' A' ' 228' ' ' ILE . 2.5 p -77.67 -34.49 20.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.493 1.121 . . . . 73.25 109.298 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.737 HD12 HG13 ' A' ' 227' ' ' VAL . 1.9 mp -59.21 -44.87 92.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 124.531 1.145 . . . . 64.340000000000003 109.284 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.95 -45.81 90.69 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.551 1.157 . . . . 63.149999999999999 110.291 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -67.97 -26.0 65.72 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.396 1.06 . . . . 64.540000000000006 109.33 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.718 HD11 HG22 ' A' ' 227' ' ' VAL . 16.8 mt -67.69 -41.56 85.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.507 1.129 . . . . 72.329999999999998 109.332 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.426 ' HE3' HG22 ' A' ' 231' ' ' ILE . 3.4 mmtp -83.94 -20.16 33.43 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.558 1.161 . . . . 75.129999999999995 109.237 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 41.9 m -61.07 -25.73 67.15 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.49 1.119 . . . . 73.230000000000004 110.005 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.741 HG11 ' CD2' ' A' ' 158' ' ' LEU . 7.5 p -126.39 20.73 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.424 1.077 . . . . 72.310000000000002 109.351 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 40.55 30.12 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.504 1.128 . . . . 64.25 109.33 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.502 HD12 ' HD2' ' A' ' 237' ' ' PRO . 12.7 tp -46.88 120.31 6.25 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.426 1.079 . . . . 75.519999999999996 109.277 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.502 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -74.93 131.05 13.92 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.486 1.782 . . . . 72.120000000000005 110.99 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 2.7 p -57.04 157.07 6.18 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.107 . . . . 34.130000000000003 110.418 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.638 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.1 p -46.29 -27.11 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.477 1.111 . . . . 71.329999999999998 109.272 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.402 ' NE2' ' HD3' ' A' ' 243' ' ' LYS . 37.6 mm-40 -86.77 -47.02 9.45 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.514 1.134 . . . . 75.329999999999998 110.39 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -61.4 -20.47 63.09 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.409 1.068 . . . . 71.439999999999998 110.308 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.442 ' C ' ' N ' ' A' ' 244' ' ' SER . 13.9 t90 -88.12 -65.51 1.01 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.958 -1.127 . . . . 75.209999999999994 107.958 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.739 ' HA ' HD12 ' A' ' 246' ' ' ILE . 2.9 ptmm? -41.79 -28.87 0.17 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.514 1.134 . . . . 72.129999999999995 109.333 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.442 ' N ' ' C ' ' A' ' 242' ' ' TRP . 1.2 t -73.36 -65.83 0.76 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.453 1.096 . . . . 62.329999999999998 109.994 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 246' ' ' ILE . 4.7 t-20 -45.04 -38.92 5.26 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.563 1.165 . . . . 54.329999999999998 109.346 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.739 HD12 ' HA ' ' A' ' 243' ' ' LYS . 31.3 mt -40.03 -60.18 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.533 1.146 . . . . 51.32 109.332 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 248' ' ' ARG . . . -153.49 -56.77 0.12 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.561 1.163 . . . . 61.43 109.272 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 247' ' ' ALA . 4.2 mmm180 -39.01 155.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 74.230000000000004 110.276 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 54.22 56.97 6.32 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.521 1.138 . . . . 72.209999999999994 110.982 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.84 116.93 2.59 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.532 1.145 . . . . 74.25 109.313 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.11 144.43 52.08 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.526 1.141 . . . . 74.209999999999994 109.293 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 90.6 p -71.36 175.67 5.24 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.558 1.161 . . . . 54.509999999999998 110.007 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -99.49 -174.42 2.72 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.564 1.165 . . . . 55.240000000000002 109.315 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 2.7 tp 43.16 38.26 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.459 1.099 . . . . 72.409999999999997 109.265 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 63.4 p -106.75 177.19 4.93 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.527 1.142 . . . . 72.400000000000006 110.061 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 57.1 tp -48.36 121.09 4.09 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.459 1.099 . . . . 70.109999999999999 109.308 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 131.19 86.85 0.39 Allowed Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.52 1.137 . . . . 64.540000000000006 111.065 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.7 m -57.1 -61.33 2.54 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.463 0.743 . . . . 71.239999999999995 110.02 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 24.3 t -54.2 111.0 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.493 1.121 . . . . 74.310000000000002 109.324 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 . . . . . 0 C--N 1.325 -0.476 0 O-C-N 124.433 1.083 . . . . 63.109999999999999 110.198 -179.925 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.046 0 N-CA-C 111.04 -0.824 . . . . 73.209999999999994 111.04 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 84.76 1.61 Allowed 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.548 1.814 . . . . 75.319999999999993 111.034 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 233' ' ' SER . 2.6 pp -54.6 158.75 2.4 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.499 1.125 . . . . 71.230000000000004 109.281 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 138.65 -14.63 3.39 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.556 1.16 . . . . 72.230000000000004 110.964 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 32.4 t -154.95 138.08 15.62 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.551 0.794 . . . . 70.540000000000006 110.027 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.584 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -97.9 120.2 37.88 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.488 1.117 . . . . 71.25 109.236 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -120.01 141.87 49.32 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 74.0 110.993 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.454 ' CB ' HG12 ' A' ' 184' ' ' ILE . . . -140.14 143.21 36.06 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.419 1.075 . . . . 75.450000000000003 109.393 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.494 ' CG1' ' O ' ' A' ' 180' ' ' GLU . 0.8 OUTLIER -121.65 136.0 59.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.463 1.102 . . . . 75.519999999999996 109.313 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.955 HG21 HG21 ' A' ' 176' ' ' THR . 2.5 t -85.58 127.36 40.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.546 1.154 . . . . 45.020000000000003 109.313 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.484 ' O ' HG23 ' A' ' 178' ' ' VAL . 0.1 OUTLIER -96.8 -17.06 20.48 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.563 1.164 . . . . 72.349999999999994 109.338 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.654 ' O ' HG12 ' A' ' 162' ' ' VAL . 42.9 m-85 -137.94 148.46 45.28 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.502 1.127 . . . . 74.230000000000004 111.039 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.02 100.1 0.11 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.54 1.15 . . . . 63.149999999999999 109.299 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.559 ' CE2' ' O ' ' A' ' 174' ' ' LEU . 26.5 t80 -81.34 126.1 31.18 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.137 . . . . 65.140000000000001 111.009 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.39 129.63 55.53 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.539 1.149 . . . . 73.409999999999997 109.273 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.6 122.63 15.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.102 . . . . 64.430000000000007 109.332 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.447 ' CG ' ' N ' ' A' ' 170' ' ' LYS . 9.0 pt-20 -107.85 -43.73 4.39 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.543 1.152 . . . . 71.010000000000005 110.277 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.447 ' N ' ' CG ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -70.0 -176.07 1.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.137 . . . . 70.140000000000001 109.306 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.43 -19.01 30.26 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.515 1.135 . . . . 73.010000000000005 109.317 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -123.52 27.82 7.25 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.496 1.123 . . . . 45.219999999999999 109.327 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -91.88 155.88 17.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.453 1.096 . . . . 61.200000000000003 110.271 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.904 HD21 ' C ' ' A' ' 202' ' ' GLY . 0.3 OUTLIER -112.45 159.97 18.23 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.484 1.115 . . . . 70.310000000000002 109.316 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 166' ' ' PHE . 13.1 t -118.58 122.8 43.49 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.495 1.122 . . . . 74.109999999999999 110.423 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.955 HG21 HG21 ' A' ' 162' ' ' VAL . 2.2 m -114.61 -168.82 1.43 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.521 1.138 . . . . 65.530000000000001 110.47 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.61 ' H ' HG22 ' A' ' 176' ' ' THR . 14.3 m-85 -134.44 143.6 47.65 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.404 1.065 . . . . 74.430000000000007 110.97 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 163' ' ' LEU . 0.3 OUTLIER -40.46 152.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.478 1.111 . . . . 70.299999999999997 109.321 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 162' ' ' VAL . . . 36.93 64.87 0.61 Allowed Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.565 1.165 . . . . 52.520000000000003 110.999 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.494 ' O ' ' CG1' ' A' ' 161' ' ' ILE . 18.3 tt0 -121.72 148.58 44.43 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.48 0.753 . . . . 65.120000000000005 110.328 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.404 ' ND2' ' N ' ' A' ' 181' ' ' ASN . 0.2 OUTLIER -100.82 139.42 36.53 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.493 1.121 . . . . 71.319999999999993 109.301 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.471 HD21 ' CG2' ' A' ' 162' ' ' VAL . 4.5 pp -166.95 163.28 16.05 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.468 1.105 . . . . 65.340000000000003 109.272 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.584 ' CD2' ' O ' ' A' ' 158' ' ' LEU . 1.0 OUTLIER -115.29 134.13 55.4 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.479 1.112 . . . . 72.450000000000003 110.98 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.895 HD12 ' HB3' ' A' ' 193' ' ' PHE . 36.9 mm -78.21 134.0 29.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.506 1.128 . . . . 72.409999999999997 109.242 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.741 ' O ' HD11 ' A' ' 236' ' ' LEU . 3.3 m -96.09 -35.0 11.51 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.517 1.136 . . . . 71.409999999999997 108.297 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.602 ' HB1' ' N ' ' A' ' 239' ' ' VAL . . . -154.0 179.79 8.58 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.471 1.107 . . . . 73.120000000000005 109.28 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.621 ' CE1' HG21 ' A' ' 231' ' ' ILE . 12.7 p80 -147.38 138.53 23.73 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.464 1.102 . . . . 74.129999999999995 109.566 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.552 ' NE2' ' CG ' ' A' ' 240' ' ' GLN . 2.6 t-80 -114.21 116.42 29.02 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.485 1.116 . . . . 74.450000000000003 109.572 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.422 ' C ' ' N ' ' A' ' 191' ' ' GLU . 37.7 m-20 55.69 26.69 9.64 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.483 1.114 . . . . 62.119999999999997 109.276 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.436 ' HB3' ' CD1' ' A' ' 228' ' ' ILE . 3.6 m 49.83 22.8 0.9 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.51 1.131 . . . . 74.510000000000005 108.353 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.927 ' O ' HG23 ' A' ' 209' ' ' VAL . 5.1 pt-20 -116.81 -32.49 5.1 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.375 1.047 . . . . 63.130000000000003 110.335 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.508 ' CD1' ' HG3' ' A' ' 191' ' ' GLU . 19.2 m0 -117.08 159.34 22.71 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.468 1.105 . . . . 72.420000000000002 108.027 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 1.186 ' CE2' HG22 ' A' ' 209' ' ' VAL . 43.7 m-85 -138.4 156.77 47.28 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 52.030000000000001 111.004 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.944 HD11 HD23 ' A' ' 206' ' ' LEU . 0.5 OUTLIER -102.35 107.18 21.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.461 1.101 . . . . 60.240000000000002 109.247 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.676 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -97.85 151.61 20.04 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.476 1.11 . . . . 74.340000000000003 109.298 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.459 ' CG ' ' HA ' ' A' ' 204' ' ' PRO . 8.8 mtpp -145.32 103.94 4.35 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.525 1.14 . . . . 72.040000000000006 109.261 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.451 ' CG ' HD11 ' A' ' 201' ' ' LEU . 18.3 Cg_endo -75.0 166.48 29.12 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.454 1.765 . . . . 73.5 110.934 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 197' ' ' PRO . 44.7 pt -40.05 154.29 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.521 1.138 . . . . 64.140000000000001 109.294 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 40.16 -121.1 1.61 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.495 1.122 . . . . 62.219999999999999 110.993 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -148.92 115.62 5.95 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.53 0.782 . . . . 74.150000000000006 110.286 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.451 HD11 ' CG ' ' A' ' 197' ' ' PRO . 4.0 pp -141.7 16.07 2.15 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.522 1.139 . . . . 61.100000000000001 109.252 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.904 ' C ' HD21 ' A' ' 174' ' ' LEU . . . 155.05 -52.83 0.44 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.51 1.131 . . . . 74.109999999999999 110.978 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.684 ' H ' HD11 ' A' ' 174' ' ' LEU . . . -48.28 156.76 1.07 Allowed Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.001 -0.84 . . . . 71.340000000000003 111.001 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.494 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.5 Cg_endo -74.99 134.74 37.3 Favored 'Cis proline' 0 C--N 1.359 1.113 0 C-N-CA 121.003 -2.499 . . . . 73.420000000000002 111.049 -0.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.716 ' HA3' HD23 ' A' ' 174' ' ' LEU . . . -126.86 158.22 20.78 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.431 1.082 . . . . 60.329999999999998 111.045 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.944 HD23 HD11 ' A' ' 194' ' ' ILE . 4.6 mt -81.07 147.55 30.07 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.546 0.792 . . . . 75.340000000000003 109.318 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.676 HG11 ' HB2' ' A' ' 195' ' ' ALA . 0.2 OUTLIER -146.36 125.39 6.53 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.531 1.144 . . . . 64.409999999999997 109.286 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.56 ' HG2' ' CD1' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.96 147.51 34.22 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.524 1.802 . . . . 74.049999999999997 110.997 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 1.186 HG22 ' CE2' ' A' ' 193' ' ' PHE . 3.5 t -63.83 -18.31 22.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.517 1.136 . . . . 73.319999999999993 109.265 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -74.07 -1.8 60.58 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.477 1.111 . . . . 70.420000000000002 111.08 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.829 ' O ' HG13 ' A' ' 162' ' ' VAL . 30.2 m-85 -128.66 2.37 5.5 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.562 0.801 . . . . 60.340000000000003 110.961 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.676 HG12 HG22 ' A' ' 162' ' ' VAL . 35.4 m -148.95 154.41 9.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.578 1.174 . . . . 74.420000000000002 109.251 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 42.3 t -139.63 160.27 40.25 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.491 1.12 . . . . 71.25 110.043 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.745 HG13 HG23 ' A' ' 227' ' ' VAL . 8.4 mm -109.14 164.8 5.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.495 1.122 . . . . 62.25 109.267 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.484 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 0.2 OUTLIER -155.82 145.02 12.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.488 1.117 . . . . 72.329999999999998 109.264 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.603 ' OD2' HG21 ' A' ' 223' ' ' THR . 47.4 p-10 -75.87 70.45 2.62 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.462 1.101 . . . . 53.329999999999998 109.295 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 7.7 tt 41.54 44.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.492 1.12 . . . . 73.219999999999999 109.33 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -80.09 -175.86 5.23 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.457 1.098 . . . . 65.329999999999998 109.289 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.511 ' O ' HG22 ' A' ' 219' ' ' THR . 1.1 m -83.67 8.33 14.76 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.499 1.124 . . . . 70.409999999999997 110.367 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 129.61 -3.61 6.15 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 124.551 1.157 . . . . 71.099999999999994 111.008 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -106.7 176.32 5.21 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.44 0.729 . . . . 73.040000000000006 111.02 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -119.64 146.98 45.07 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.549 1.156 . . . . 52.32 109.3 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.603 HG21 ' OD2' ' A' ' 216' ' ' ASP . 11.0 p -91.61 -29.86 16.68 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.49 1.118 . . . . 74.310000000000002 110.468 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 141.93 -17.44 2.57 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.5 1.125 . . . . 63.409999999999997 111.021 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.441 ' ND2' ' OG1' ' A' ' 223' ' ' THR . 1.5 p30 -51.02 174.23 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 0.746 . . . . 71.109999999999999 109.341 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.77 172.96 7.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 54.329999999999998 109.296 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 1.02 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 12.3 p -78.94 -30.9 14.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.133 . . . . 63.210000000000001 109.291 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.77 HD12 HG13 ' A' ' 227' ' ' VAL . 1.4 mp -60.82 -46.49 96.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 63.119999999999997 109.339 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.73 -43.02 99.89 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.558 1.162 . . . . 75.109999999999999 110.304 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.98 -34.32 77.83 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.554 1.159 . . . . 64.430000000000007 109.282 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.621 HG21 ' CE1' ' A' ' 187' ' ' HIS . 38.8 mt -63.25 -46.22 96.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.141 . . . . 74.319999999999993 109.309 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -76.56 -15.73 59.78 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.499 1.125 . . . . 75.129999999999995 109.315 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.492 ' O ' HD22 ' A' ' 155' ' ' LEU . 5.0 p -69.55 -40.03 77.06 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.429 1.081 . . . . 72.310000000000002 110.029 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.428 ' O ' HG22 ' A' ' 234' ' ' VAL . 11.3 p -109.4 14.03 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.511 1.132 . . . . 61.409999999999997 109.333 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 234' ' ' VAL . 7.5 t-20 40.35 43.1 1.39 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 71.420000000000002 109.287 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.973 HD12 ' HD2' ' A' ' 237' ' ' PRO . 3.3 tp -66.79 132.2 93.98 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.462 1.101 . . . . 71.010000000000005 109.284 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.973 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -75.03 156.43 42.85 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.478 1.778 . . . . 75.209999999999994 110.997 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 4.2 p -77.98 148.41 34.44 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.492 1.12 . . . . 75.420000000000002 110.336 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.602 ' N ' ' HB1' ' A' ' 186' ' ' ALA . 2.5 p -49.68 -23.57 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.45 1.093 . . . . 73.319999999999993 109.266 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.552 ' CG ' ' NE2' ' A' ' 188' ' ' HIS . 75.6 mm-40 -83.98 -41.71 17.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.476 1.11 . . . . 74.219999999999999 110.257 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -70.49 -23.16 62.63 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.432 1.082 . . . . 75.329999999999998 110.33 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.669 ' HE1' HD11 ' A' ' 246' ' ' ILE . 2.6 t90 -78.52 -59.99 2.56 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.501 1.125 . . . . 74.439999999999998 108.013 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.427 ' HA ' ' CG1' ' A' ' 246' ' ' ILE . 7.0 ptmm? -59.62 -17.44 33.48 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.116 . . . . 51.530000000000001 109.27 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.5 t -77.99 -26.51 48.69 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.59 1.181 . . . . 65.120000000000005 109.947 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -94.67 -26.06 16.48 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.48 1.113 . . . . 73.310000000000002 109.25 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.669 HD11 ' HE1' ' A' ' 242' ' ' TRP . 14.2 mm -40.68 -82.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.51 1.131 . . . . 73.409999999999997 109.351 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.545 ' N ' HG22 ' A' ' 246' ' ' ILE . . . -130.67 7.23 4.8 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.539 1.149 . . . . 71.109999999999999 109.336 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 250' ' ' LYS . 0.2 OUTLIER -101.6 -153.6 0.46 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.439 1.087 . . . . 74.239999999999995 110.29 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -47.14 94.85 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.481 1.113 . . . . 60.509999999999998 111.022 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 248' ' ' ARG . 0.0 OUTLIER -76.56 104.3 6.99 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.542 1.151 . . . . 75.140000000000001 109.268 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.22 124.7 20.32 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.492 1.12 . . . . 35.32 109.353 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 3.6 t -57.54 113.45 1.8 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.502 1.126 . . . . 75.319999999999993 109.956 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -171.15 170.14 6.21 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.47 1.106 . . . . 52.219999999999999 109.276 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 254' ' ' ILE . 6.5 tt -60.22 94.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.492 1.12 . . . . 71.439999999999998 109.25 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.72 135.81 35.13 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.562 1.164 . . . . 73.129999999999995 109.99 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 12.2 tp -95.03 -27.49 15.59 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.474 1.109 . . . . 54.229999999999997 109.327 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 106.17 -145.89 16.0 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.48 1.113 . . . . 72.140000000000001 110.972 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 7.6 t -163.25 134.83 4.95 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.547 0.793 . . . . 52.229999999999997 110.012 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.703 HG22 ' H ' ' A' ' 260' ' ' GLU . 2.4 p -93.12 -176.3 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.439 1.087 . . . . 74.310000000000002 109.282 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.703 ' H ' HG22 ' A' ' 259' ' ' VAL . 3.7 tm-20 . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.451 1.094 . . . . 74.409999999999997 110.256 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 N-CA-C 111.023 -0.831 . . . . 73.209999999999994 111.023 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 112.91 3.67 Favored 'Trans proline' 0 C--N 1.361 1.203 0 O-C-N 124.528 1.804 . . . . 71.430000000000007 111.017 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 7.0 mt -48.15 121.75 4.59 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.536 1.147 . . . . 65.349999999999994 109.411 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -160.02 49.72 0.38 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.539 1.15 . . . . 62.299999999999997 111.026 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.2 p -174.22 161.69 3.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.511 0.771 . . . . 65.329999999999998 110.076 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.751 ' HG ' HG11 ' A' ' 234' ' ' VAL . 9.2 mt -148.46 -171.08 3.76 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.549 1.155 . . . . 75.219999999999999 109.317 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.401 ' CG ' ' O ' ' A' ' 158' ' ' LEU . 25.0 m-85 -163.7 118.4 1.58 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.48 1.113 . . . . 73.030000000000001 110.975 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.574 ' HB2' HG12 ' A' ' 184' ' ' ILE . . . -106.25 167.35 9.88 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.505 1.128 . . . . 60.200000000000003 109.361 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.597 HG21 HD11 ' A' ' 215' ' ' ILE . 0.1 OUTLIER -137.48 129.24 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.44 1.087 . . . . 73.109999999999999 109.317 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.803 ' CG2' HD21 ' A' ' 182' ' ' LEU . 2.7 t -81.72 117.73 28.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.538 1.149 . . . . 73.439999999999998 109.273 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.553 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -96.18 -3.86 43.61 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.545 1.153 . . . . 44.310000000000002 109.268 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.731 ' O ' HG12 ' A' ' 162' ' ' VAL . 53.4 m-85 -153.6 153.88 33.17 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.472 1.108 . . . . 71.430000000000007 110.968 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.424 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 11.0 t0 -83.47 103.58 12.94 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.433 1.083 . . . . 74.120000000000005 109.287 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.584 ' CE2' ' HD3' ' A' ' 208' ' ' PRO . 1.9 t80 -85.25 125.22 32.71 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.119 . . . . 73.109999999999999 111.0 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.87 115.79 29.64 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.455 1.097 . . . . 64.400000000000006 109.335 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.669 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -40.31 140.55 0.61 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.456 1.098 . . . . 24.449999999999999 109.342 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.467 ' CG ' ' N ' ' A' ' 170' ' ' LYS . 7.9 pt-20 -136.88 -45.28 0.58 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.427 1.079 . . . . 73.430000000000007 110.236 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.467 ' N ' ' CG ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -64.47 -170.7 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.506 1.129 . . . . 73.329999999999998 109.307 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.62 -33.25 20.21 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.432 1.083 . . . . 62.549999999999997 109.273 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.39 9.3 29.83 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.509 1.13 . . . . 73.5 109.254 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.402 ' HB2' ' N ' ' A' ' 170' ' ' LYS . 3.2 mm-40 -75.43 159.89 30.86 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.524 1.14 . . . . 75.340000000000003 110.249 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.669 ' C ' ' HB2' ' A' ' 168' ' ' ALA . 2.8 tp -138.33 159.6 41.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.457 1.098 . . . . 72.120000000000005 109.299 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.2 t -91.64 153.46 19.68 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.496 1.123 . . . . 73.439999999999998 110.389 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 177' ' ' TYR . 3.3 m -139.19 -164.39 1.65 Allowed 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.514 1.134 . . . . 64.140000000000001 110.345 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.685 ' H ' HG22 ' A' ' 176' ' ' THR . 30.9 m-85 -136.8 138.04 40.42 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.546 1.154 . . . . 71.239999999999995 110.972 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.463 ' CG2' ' N ' ' A' ' 179' ' ' GLY . 1.4 p -56.57 163.41 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.452 1.095 . . . . 73.530000000000001 109.285 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.463 ' N ' ' CG2' ' A' ' 178' ' ' VAL . . . 37.59 59.47 1.3 Allowed Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.474 1.109 . . . . 64.109999999999999 110.961 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.491 ' O ' HD13 ' A' ' 161' ' ' ILE . 13.2 tp10 -121.4 166.9 13.43 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.557 0.798 . . . . 73.349999999999994 110.338 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -120.51 122.29 40.3 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.455 1.097 . . . . 62.119999999999997 109.352 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.803 HD21 ' CG2' ' A' ' 162' ' ' VAL . 0.6 OUTLIER -147.0 163.65 35.53 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.103 . . . . 74.540000000000006 109.362 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.591 ' CE1' ' O ' ' A' ' 184' ' ' ILE . 2.2 t80 -110.63 139.12 46.19 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.457 1.098 . . . . 62.039999999999999 111.023 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.591 ' O ' ' CE1' ' A' ' 183' ' ' PHE . 9.6 mm -77.7 120.92 29.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.471 1.107 . . . . 73.549999999999997 109.227 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 5.6 t -91.45 -24.42 19.7 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.432 1.082 . . . . 75.450000000000003 108.27 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.782 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -164.8 179.65 6.39 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.501 1.126 . . . . 75.019999999999996 109.253 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.526 ' CE1' ' HG ' ' A' ' 190' ' ' CYS . 9.3 p80 -149.38 129.86 13.91 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.466 1.104 . . . . 74.099999999999994 109.571 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.655 ' CG ' HG11 ' A' ' 239' ' ' VAL . 0.0 OUTLIER -111.0 119.03 37.69 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.536 1.148 . . . . 72.510000000000005 109.633 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.433 ' C ' ' N ' ' A' ' 191' ' ' GLU . 3.5 m120 54.0 32.82 16.21 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.48 1.112 . . . . 71.129999999999995 109.325 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.526 ' HG ' ' CE1' ' A' ' 187' ' ' HIS . 49.9 m 42.1 29.04 0.12 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 74.209999999999994 108.3 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.575 ' HG3' ' CD1' ' A' ' 192' ' ' TRP . 6.4 pt-20 -120.94 -38.04 2.89 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.509 1.131 . . . . 73.120000000000005 110.312 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.651 ' CB ' ' CD2' ' A' ' 188' ' ' HIS . 27.7 m0 -116.87 164.42 14.7 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.126 . . . . 74.25 107.987 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.724 ' HB2' HG13 ' A' ' 207' ' ' VAL . 39.5 m-85 -141.94 168.93 18.58 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.542 1.151 . . . . 75.400000000000006 110.995 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.782 ' CG1' ' HB3' ' A' ' 186' ' ' ALA . 47.0 mm -103.55 109.07 25.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.544 1.153 . . . . 53.439999999999998 109.324 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.748 ' HB2' HG11 ' A' ' 207' ' ' VAL . . . -116.57 163.78 15.58 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.488 1.117 . . . . 65.329999999999998 109.321 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.76 78.71 0.24 Allowed Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.483 1.114 . . . . 75.430000000000007 109.267 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 -165.67 0.3 Allowed 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.499 1.789 . . . . 52.329999999999998 110.987 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 96.7 mt -90.1 89.82 3.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.47 1.106 . . . . 72.150000000000006 109.363 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -140.26 -62.82 0.04 OUTLIER Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.571 1.17 . . . . 73.25 111.036 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 9.5 ttt85 -126.28 172.4 10.13 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.536 0.786 . . . . 72.129999999999995 110.278 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.554 ' O ' HD13 ' A' ' 201' ' ' LEU . 0.8 OUTLIER -84.85 -19.2 32.76 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.482 1.114 . . . . 53.030000000000001 109.231 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -60.56 -152.48 0.02 OUTLIER Glycine 0 CA--C 1.529 0.935 0 O-C-N 124.537 1.148 . . . . 71.040000000000006 111.03 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 94.68 175.61 38.43 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.98 -0.848 . . . . 74.230000000000004 110.98 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.605 ' HB2' HG23 ' A' ' 194' ' ' ILE . 18.2 Cg_endo -74.95 179.42 30.67 Favored 'Cis proline' 0 C--N 1.36 1.181 0 C-N-CA 121.02 -2.492 . . . . 73.219999999999999 110.983 0.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -129.64 161.62 22.85 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.531 1.145 . . . . 52.43 110.967 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.566 ' CD2' ' CD1' ' A' ' 194' ' ' ILE . 9.3 mt -92.91 149.14 21.45 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.514 0.773 . . . . 64.219999999999999 109.272 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.91 HG21 HG11 ' A' ' 212' ' ' VAL . 0.6 OUTLIER -148.5 122.6 4.81 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.123 . . . . 73.430000000000007 109.32 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.584 ' HD3' ' CE2' ' A' ' 166' ' ' PHE . 18.6 Cg_endo -74.91 149.87 37.79 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.502 1.791 . . . . 62.439999999999998 111.026 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.417 ' HB ' ' CE2' ' A' ' 193' ' ' PHE . 5.0 p -63.71 -20.88 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 71.420000000000002 109.293 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -74.57 -0.91 60.01 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.446 1.091 . . . . 75.129999999999995 110.956 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.562 ' CD2' ' HB2' ' A' ' 166' ' ' PHE . 15.8 m-85 -129.8 3.32 4.93 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.491 0.759 . . . . 72.5 111.008 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.91 HG11 HG21 ' A' ' 207' ' ' VAL . 32.9 m -151.89 149.67 13.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 71.120000000000005 109.311 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.44 ' CB ' HD11 ' A' ' 163' ' ' LEU . 1.6 t -131.54 160.93 33.82 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.513 1.133 . . . . 75.519999999999996 109.966 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.827 HG13 HG23 ' A' ' 227' ' ' VAL . 32.1 mm -100.53 106.82 19.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.524 1.14 . . . . 75.349999999999994 109.295 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.597 HD11 HG21 ' A' ' 161' ' ' ILE . 11.0 pt -153.18 147.06 14.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.53 1.144 . . . . 75.140000000000001 109.275 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -61.32 -173.58 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.121 . . . . 60.020000000000003 109.235 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 41.2 mt -102.18 -39.96 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.563 1.164 . . . . 61.539999999999999 109.348 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -73.18 -173.82 1.41 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.464 1.102 . . . . 62.329999999999998 109.306 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 221' ' ' TYR . 25.8 m -47.91 -23.89 0.89 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.558 1.161 . . . . 75.409999999999997 110.432 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -53.17 88.75 0.01 OUTLIER Glycine 0 CA--C 1.531 1.075 0 O-C-N 124.446 1.091 . . . . 61.32 110.965 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.449 ' N ' ' O ' ' A' ' 219' ' ' THR . 2.8 m-85 -95.0 -171.17 2.36 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 124.604 0.826 . . . . 72.439999999999998 111.033 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 221' ' ' TYR . . . -40.41 111.45 0.2 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.45 1.093 . . . . 73.230000000000004 109.318 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 69.2 p -85.1 -16.99 38.71 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.458 1.099 . . . . 71.140000000000001 110.402 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 123.86 -18.03 7.6 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.64 1.212 . . . . 43.549999999999997 110.956 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -75.71 177.08 7.12 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.527 0.781 . . . . 71.140000000000001 109.288 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.15 -178.65 3.72 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.524 1.14 . . . . 44.340000000000003 109.332 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.936 HG13 HD12 ' A' ' 228' ' ' ILE . 3.0 p -79.02 -34.25 16.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.531 1.145 . . . . 61.140000000000001 109.336 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.936 HD12 HG13 ' A' ' 227' ' ' VAL . 2.1 mp -65.44 -56.85 13.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.483 1.114 . . . . 52.32 109.334 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -58.29 -21.43 48.89 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.489 1.118 . . . . 71.329999999999998 110.283 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.663 ' O ' HG13 ' A' ' 234' ' ' VAL . 59.0 m-20 -86.8 -34.96 19.38 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.426 1.079 . . . . 72.340000000000003 109.29 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.778 HG23 ' HB3' ' A' ' 236' ' ' LEU . 18.8 mt -64.81 -27.42 42.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.576 1.172 . . . . 61.32 109.338 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.445 ' HE2' HG22 ' A' ' 231' ' ' ILE . 6.3 mmpt? -83.99 -11.59 56.58 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.46 1.1 . . . . 71.310000000000002 109.318 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 68.5 m -95.12 -8.9 35.14 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.464 1.103 . . . . 70.209999999999994 110.019 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.751 HG11 ' HG ' ' A' ' 158' ' ' LEU . 1.0 OUTLIER -127.13 5.98 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.465 1.103 . . . . 72.209999999999994 109.27 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.437 ' N ' ' OD1' ' A' ' 235' ' ' ASN . 0.6 OUTLIER 47.91 30.33 1.94 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.45 1.093 . . . . 72.140000000000001 109.275 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.778 ' HB3' HG23 ' A' ' 231' ' ' ILE . 0.7 OUTLIER -43.95 118.4 2.96 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.408 1.068 . . . . 71.430000000000007 109.261 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 135.57 19.16 Favored 'Trans proline' 0 C--N 1.361 1.211 0 O-C-N 124.453 1.765 . . . . 64.439999999999998 110.977 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 187' ' ' HIS . 2.0 p -69.51 144.07 53.27 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.521 1.138 . . . . 74.430000000000007 110.376 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.655 HG11 ' CG ' ' A' ' 188' ' ' HIS . 7.6 p -51.0 -31.23 10.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.556 1.16 . . . . 70.310000000000002 109.298 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -76.76 -32.07 57.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.127 . . . . 63.329999999999998 110.305 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.405 ' CG ' ' OG1' ' A' ' 238' ' ' THR . 69.0 mt-10 -76.71 -30.01 56.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.517 1.136 . . . . 75.219999999999999 110.274 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.979 ' NE1' HD11 ' A' ' 246' ' ' ILE . 9.9 t90 -72.88 -54.89 7.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.499 1.124 . . . . 70.340000000000003 108.046 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.88 -29.02 69.29 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.547 1.154 . . . . 64.030000000000001 109.302 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 18.3 t -77.26 -41.25 41.72 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.563 1.164 . . . . 74.439999999999998 110.057 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -64.29 -31.86 73.23 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.529 1.143 . . . . 74.230000000000004 109.323 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.979 HD11 ' NE1' ' A' ' 242' ' ' TRP . 80.2 mt -71.45 -72.93 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.536 1.147 . . . . 74.420000000000002 109.264 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.454 ' O ' ' CB ' ' A' ' 248' ' ' ARG . . . -169.98 130.84 1.0 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.533 1.146 . . . . 65.010000000000005 109.258 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.454 ' CB ' ' O ' ' A' ' 247' ' ' ALA . 0.8 OUTLIER 161.99 -167.74 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.45 1.094 . . . . 54.219999999999999 110.238 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 250' ' ' LYS . 0.3 OUTLIER -102.75 175.84 5.36 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.498 1.124 . . . . 71.420000000000002 111.054 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.576 ' N ' ' CD1' ' A' ' 249' ' ' TYR . 12.7 tttp -151.55 161.61 42.39 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.488 1.117 . . . . 53.140000000000001 109.267 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.451 ' N ' ' CG ' ' A' ' 250' ' ' LYS . . . -161.77 140.33 9.41 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.422 1.076 . . . . 51.530000000000001 109.279 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 1.4 t -81.84 157.78 24.28 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 61.409999999999997 110.049 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -169.36 143.25 2.83 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.454 1.096 . . . . 71.010000000000005 109.317 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.537 HG23 ' O ' ' A' ' 254' ' ' ILE . 3.1 tp -113.54 104.85 17.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.496 1.122 . . . . 74.030000000000001 109.255 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.7 t -124.93 48.35 2.01 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.485 1.116 . . . . 74.219999999999999 109.972 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.549 HD23 ' C ' ' A' ' 256' ' ' LEU . 7.1 tt -147.65 118.68 7.69 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.441 1.088 . . . . 72.239999999999995 109.31 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -128.03 -164.0 11.49 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.581 1.176 . . . . 64.329999999999998 110.99 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.5 t -65.13 114.79 4.89 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.452 0.736 . . . . 71.409999999999997 110.059 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.7 p -109.84 75.74 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.487 1.117 . . . . 71.340000000000003 109.264 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 . . . . . 0 C--N 1.326 -0.444 0 O-C-N 124.535 1.147 . . . . 61.409999999999997 110.362 179.908 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.995 0 N-CA-C 111.017 -0.833 . . . . 63.409999999999997 111.017 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.572 ' HB2' HD12 ' A' ' 155' ' ' LEU . 18.5 Cg_endo -75.01 -91.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.499 1.789 . . . . 62.310000000000002 110.991 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.572 HD12 ' HB2' ' A' ' 154' ' ' PRO . 0.0 OUTLIER -117.76 -174.01 2.55 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.443 1.089 . . . . 75.219999999999999 109.308 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.515 ' HA2' HG23 ' A' ' 234' ' ' VAL . . . 126.71 -8.18 7.32 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.498 1.124 . . . . 71.409999999999997 110.995 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 36.6 t -131.66 161.53 32.53 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.514 0.773 . . . . 63.549999999999997 109.955 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.665 ' HG ' HG11 ' A' ' 234' ' ' VAL . 13.2 mt -138.56 131.35 29.4 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.449 1.093 . . . . 74.519999999999996 109.332 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.411 ' CD2' ' CE2' ' A' ' 183' ' ' PHE . 1.7 t80 -121.47 122.82 40.59 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.475 1.11 . . . . 72.349999999999994 111.021 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.655 ' HB2' HD13 ' A' ' 214' ' ' ILE . . . -117.82 170.84 8.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.564 1.165 . . . . 63.409999999999997 109.318 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.501 HG21 HD13 ' A' ' 215' ' ' ILE . 0.1 OUTLIER -142.29 126.69 16.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.479 1.112 . . . . 74.340000000000003 109.352 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.766 HG22 ' CZ ' ' A' ' 211' ' ' PHE . 18.1 t -72.04 133.99 30.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.546 1.154 . . . . 74.140000000000001 109.28 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.983 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.5 OUTLIER -113.9 0.33 14.39 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.441 1.088 . . . . 74.109999999999999 109.287 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.497 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 70.1 m-85 -144.66 147.02 32.57 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.581 1.175 . . . . 64.409999999999997 111.023 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -77.58 94.4 4.35 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.477 1.111 . . . . 71.209999999999994 109.298 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.502 ' CZ ' ' OE2' ' A' ' 173' ' ' GLU . 3.9 t80 -88.0 137.72 32.08 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.523 1.139 . . . . 71.120000000000005 110.97 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -119.85 103.38 9.3 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.469 1.106 . . . . 75.540000000000006 109.32 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.549 ' HB2' ' C ' ' A' ' 174' ' ' LEU . . . -40.27 139.65 0.71 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.478 1.111 . . . . 51.420000000000002 109.278 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -123.73 -41.43 2.25 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.441 1.088 . . . . 63.340000000000003 110.236 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.32 -169.81 1.29 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.509 1.131 . . . . 74.329999999999998 109.304 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.29 -45.35 11.34 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.531 1.144 . . . . 54.509999999999998 109.279 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -94.43 26.59 3.33 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.455 1.097 . . . . 75.349999999999994 109.34 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.502 ' OE2' ' CZ ' ' A' ' 166' ' ' PHE . 2.9 mm-40 -96.82 140.88 30.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.473 1.108 . . . . 63.009999999999998 110.303 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.708 HD23 ' HA3' ' A' ' 205' ' ' GLY . 0.2 OUTLIER -102.53 160.07 14.88 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.545 1.153 . . . . 71.310000000000002 109.297 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.408 ' C ' ' OG1' ' A' ' 176' ' ' THR . 9.9 t -124.16 150.7 44.85 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.541 1.151 . . . . 61.43 110.426 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.684 HG22 ' H ' ' A' ' 177' ' ' TYR . 11.6 m -157.34 -177.11 6.36 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.516 1.135 . . . . 41.409999999999997 110.366 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.684 ' H ' HG22 ' A' ' 176' ' ' THR . 7.6 m-85 -121.03 156.7 31.62 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.46 1.1 . . . . 72.340000000000003 111.057 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 163' ' ' LEU . 1.8 p -59.83 131.25 24.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.559 1.162 . . . . 33.149999999999999 109.28 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 71.76 59.21 4.89 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.465 1.103 . . . . 51.539999999999999 111.032 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 162' ' ' VAL . 5.4 tp10 -122.16 165.76 15.64 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.563 0.802 . . . . 73.540000000000006 110.281 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.447 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.7 OUTLIER -115.63 119.53 36.43 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 51.310000000000002 109.273 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.551 HD13 ' O ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -152.35 158.63 42.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.533 1.146 . . . . 44.219999999999999 109.318 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.42 ' O ' HD22 ' A' ' 182' ' ' LEU . 4.6 m-85 -107.04 170.64 7.83 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 44.210000000000001 110.996 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.934 HD12 ' HB3' ' A' ' 193' ' ' PHE . 32.5 mm -107.9 147.31 12.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.534 1.146 . . . . 62.030000000000001 109.241 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 186' ' ' ALA . 0.1 OUTLIER -106.26 -19.46 13.69 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.535 1.147 . . . . 73.230000000000004 108.313 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.646 ' HA ' HD11 ' A' ' 236' ' ' LEU . . . 179.64 179.63 0.48 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.554 1.159 . . . . 52.329999999999998 109.309 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.687 ' CD2' HG21 ' A' ' 231' ' ' ILE . 6.2 p80 -137.39 152.98 50.23 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.549 1.156 . . . . 75.049999999999997 109.583 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.637 ' CG ' ' CG1' ' A' ' 239' ' ' VAL . 1.0 OUTLIER -129.45 112.8 14.15 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.463 1.102 . . . . 75.519999999999996 109.584 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 3.1 m120 57.97 21.24 7.52 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.436 1.085 . . . . 73.120000000000005 109.343 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.583 ' HG ' ' CE1' ' A' ' 187' ' ' HIS . 87.1 m 55.34 19.74 3.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 1.139 . . . . 62.520000000000003 108.336 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 192' ' ' TRP . 3.9 pt-20 -115.94 -30.94 5.91 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.548 1.155 . . . . 62.25 110.299 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.574 ' HE3' HD22 ' A' ' 206' ' ' LEU . 8.5 m0 -116.25 158.99 22.49 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.959 -1.126 . . . . 74.400000000000006 107.959 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.934 ' HB3' HD12 ' A' ' 184' ' ' ILE . 12.8 m-85 -133.92 161.33 35.08 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.534 1.146 . . . . 64.340000000000003 110.96 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.586 HG13 ' HB3' ' A' ' 186' ' ' ALA . 17.7 mm -105.56 85.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.486 1.116 . . . . 55.530000000000001 109.323 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.736 ' CB ' HG11 ' A' ' 207' ' ' VAL . . . -67.48 160.16 28.12 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.481 1.113 . . . . 43.140000000000001 109.345 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.407 ' HB2' ' NZ ' ' A' ' 196' ' ' LYS . 0.0 OUTLIER -171.38 152.54 3.33 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.558 1.161 . . . . 72.219999999999999 109.306 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -164.33 0.23 Allowed 'Trans proline' 0 C--N 1.359 1.103 0 O-C-N 124.479 1.779 . . . . 52.329999999999998 110.994 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.9 tp -110.39 -20.71 6.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.496 1.123 . . . . 63.310000000000002 109.275 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -167.54 47.76 0.24 Allowed Glycine 0 CA--C 1.529 0.931 0 O-C-N 124.455 1.097 . . . . 61.130000000000003 111.027 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.7 tpp85 -138.14 159.36 42.23 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.403 0.708 . . . . 63.520000000000003 110.295 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.58 HD13 ' H ' ' A' ' 201' ' ' LEU . 0.0 OUTLIER -91.57 17.44 8.73 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.525 1.14 . . . . 45.439999999999998 109.241 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.406 ' O ' HD21 ' A' ' 174' ' ' LEU . . . -69.88 -51.16 25.63 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 124.531 1.145 . . . . 74.230000000000004 111.078 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -88.8 -179.54 46.04 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 111.019 -0.833 . . . . 74.430000000000007 111.019 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.474 ' HB2' ' CG2' ' A' ' 194' ' ' ILE . 18.4 Cg_endo -74.96 172.31 63.61 Favored 'Cis proline' 0 C--N 1.36 1.171 0 C-N-CA 120.95 -2.521 . . . . 32.329999999999998 111.011 -0.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.708 ' HA3' HD23 ' A' ' 174' ' ' LEU . . . -157.59 156.35 27.22 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.471 1.107 . . . . 73.340000000000003 110.947 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.574 HD22 ' HE3' ' A' ' 192' ' ' TRP . 3.1 mt -83.94 134.02 34.68 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.524 0.779 . . . . 73.430000000000007 109.262 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.736 HG11 ' CB ' ' A' ' 195' ' ' ALA . 2.0 m -143.34 151.92 56.04 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.544 1.153 . . . . 74.230000000000004 109.313 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.459 ' HG2' ' HB3' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -75.04 159.5 41.15 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.488 1.783 . . . . 53.030000000000001 111.003 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.69 HG23 ' HE2' ' A' ' 193' ' ' PHE . 3.0 p -84.85 -20.51 8.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.517 1.136 . . . . 65.400000000000006 109.22 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -82.47 11.84 49.22 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.5 1.125 . . . . 73.120000000000005 110.994 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.974 ' CD2' HG13 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -130.33 2.22 4.64 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.434 0.726 . . . . 73.019999999999996 110.943 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.974 HG13 ' CD2' ' A' ' 211' ' ' PHE . 14.3 m -137.8 145.8 28.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.456 1.098 . . . . 63.020000000000003 109.271 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.983 ' HB2' HD11 ' A' ' 163' ' ' LEU . 12.5 t -132.78 131.75 41.47 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 61.439999999999998 110.06 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.823 HG13 HG23 ' A' ' 227' ' ' VAL . 15.6 mm -83.77 149.73 4.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.113 . . . . 72.409999999999997 109.304 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 214' ' ' ILE . 18.9 pt -154.2 116.69 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 73.109999999999999 109.302 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -48.17 172.9 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.493 1.121 . . . . 51.219999999999999 109.261 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 217' ' ' ILE . 8.8 tp -71.24 109.4 3.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.512 1.132 . . . . 74.209999999999994 109.347 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -161.1 170.53 20.25 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.522 1.138 . . . . 74.329999999999998 109.343 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.427 ' CG2' ' CE2' ' A' ' 221' ' ' TYR . 1.7 t -55.16 -27.01 42.51 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 50.219999999999999 110.389 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 142.88 61.56 0.02 OUTLIER Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.531 1.144 . . . . 71.540000000000006 110.993 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.427 ' CE2' ' CG2' ' A' ' 219' ' ' THR . 17.3 m-85 -132.5 169.91 15.9 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 0.765 . . . . 74.540000000000006 110.992 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -117.15 129.4 55.93 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.51 1.131 . . . . 61.340000000000003 109.332 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 17.6 p -88.58 -34.3 17.38 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.454 1.096 . . . . 73.340000000000003 110.465 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 114.19 21.24 5.64 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.487 1.117 . . . . 63.210000000000001 110.957 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.487 ' ND2' ' N ' ' A' ' 225' ' ' ASN . 0.6 OUTLIER -84.16 171.95 12.36 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.488 0.758 . . . . 52.399999999999999 109.32 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.72 166.62 11.19 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.481 1.113 . . . . 72.439999999999998 109.335 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.823 HG23 HG13 ' A' ' 214' ' ' ILE . 11.2 p -78.92 -44.36 24.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.454 1.096 . . . . 73.219999999999999 109.278 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.637 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.3 mp -51.3 -53.25 16.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.607 1.192 . . . . 75.140000000000001 109.31 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -62.54 -32.76 73.76 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 64.439999999999998 110.275 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -73.91 -25.89 60.23 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.42 1.075 . . . . 71.010000000000005 109.255 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.687 HG21 ' CD2' ' A' ' 187' ' ' HIS . 42.0 mt -72.05 -34.79 51.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.519 1.137 . . . . 62.399999999999999 109.272 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.401 ' HE2' HG22 ' A' ' 231' ' ' ILE . 6.5 mmpt? -78.53 -29.84 46.69 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.466 1.104 . . . . 72.019999999999996 109.332 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.8 m -53.92 -40.78 67.0 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.472 1.108 . . . . 74.319999999999993 109.999 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.665 HG11 ' HG ' ' A' ' 158' ' ' LEU . 4.0 p -107.63 20.19 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.505 1.128 . . . . 74.430000000000007 109.287 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 41.94 28.86 0.1 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.532 1.145 . . . . 72.329999999999998 109.329 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.646 HD11 ' HA ' ' A' ' 186' ' ' ALA . 12.2 tp -47.16 115.53 3.56 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 75.430000000000007 109.281 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.01 147.15 33.51 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.551 1.816 . . . . 72.319999999999993 111.036 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 187' ' ' HIS . 2.7 p -57.09 149.36 19.5 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.526 1.141 . . . . 71.109999999999999 110.411 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.637 ' CG1' ' CG ' ' A' ' 188' ' ' HIS . 2.4 p -48.78 -28.58 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.528 1.142 . . . . 70.150000000000006 109.291 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.412 ' HG2' ' NE2' ' A' ' 188' ' ' HIS . 76.6 mm-40 -80.17 -45.83 17.42 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.489 1.118 . . . . 71.540000000000006 110.311 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -58.46 -30.07 66.67 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.451 1.094 . . . . 60.329999999999998 110.285 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -76.91 -62.22 1.72 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.511 1.132 . . . . 71.150000000000006 108.003 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.536 ' HA ' HD12 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -51.38 -25.8 6.72 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 73.409999999999997 109.319 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 45.8 t -76.89 -36.47 56.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.444 1.09 . . . . 70.420000000000002 110.052 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -75.08 -31.92 61.35 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.469 1.105 . . . . 60.109999999999999 109.302 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 243' ' ' LYS . 42.5 mt -45.16 110.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.431 1.082 . . . . 75.219999999999999 109.31 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -150.17 -177.02 5.69 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.463 1.102 . . . . 60.130000000000003 109.318 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.507 ' O ' ' C ' ' A' ' 249' ' ' TYR . 1.4 tpt85 -160.78 166.07 29.26 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 62.140000000000001 110.292 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.507 ' C ' ' O ' ' A' ' 248' ' ' ARG . 5.9 m-85 -29.1 96.31 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.418 1.074 . . . . 64.230000000000004 111.008 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 248' ' ' ARG . 16.8 mtpp -134.41 115.35 13.9 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.463 1.102 . . . . 73.439999999999998 109.279 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.07 112.35 0.66 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.536 1.147 . . . . 52.240000000000002 109.311 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 88.4 p -153.68 162.87 40.86 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 74.409999999999997 110.029 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -130.39 112.01 12.86 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.488 1.118 . . . . 74.540000000000006 109.304 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.466 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.8 OUTLIER -95.1 -35.95 6.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.409 1.068 . . . . 63.340000000000003 109.3 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 87.7 p -97.51 97.16 8.84 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.438 1.086 . . . . 45.530000000000001 109.998 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.523 HD13 ' N ' ' A' ' 257' ' ' GLY . 0.2 OUTLIER -108.88 122.73 47.81 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.541 1.151 . . . . 72.230000000000004 109.274 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.523 ' N ' HD13 ' A' ' 256' ' ' LEU . . . 62.04 143.36 0.01 OUTLIER Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.451 1.095 . . . . 65.040000000000006 110.966 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 3.1 m -149.26 125.59 10.85 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.511 0.771 . . . . 35.340000000000003 109.945 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -174.74 167.33 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.452 1.095 . . . . 64.310000000000002 109.355 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 . . . . . 0 C--N 1.325 -0.488 0 O-C-N 124.469 1.106 . . . . 64.109999999999999 110.271 -179.984 . . . . . . . . 0 0 . 1 stop_ save_